<SEC-DOCUMENT>0000010795-23-000039.txt : 20230504
<SEC-HEADER>0000010795-23-000039.hdr.sgml : 20230504
<ACCEPTANCE-DATETIME>20230504163524
ACCESSION NUMBER:		0000010795-23-000039
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		68
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230504
DATE AS OF CHANGE:		20230504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BECTON DICKINSON & CO
		CENTRAL INDEX KEY:			0000010795
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				220760120
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04802
		FILM NUMBER:		23889427

	BUSINESS ADDRESS:	
		STREET 1:		ONE BECTON DR
		CITY:			FRANKLIN LAKES
		STATE:			NJ
		ZIP:			07417-1880
		BUSINESS PHONE:		2018476800

	MAIL ADDRESS:	
		STREET 1:		ONE BECTON DR
		CITY:			FRANKLIN LAKE
		STATE:			NJ
		ZIP:			07417
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bdx-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:c18e2de7-cbd8-4499-b946-e1533dbcca3e,g:06687f9f-d051-4540-9898-7752ada2060d,d:c901e28da78f443cab3564a79902c5bb--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:bdx="http://www.bd.com/20230331" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bdx-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80L2ZyYWc6NDJmMDc3N2RkYjBiNDg1MmJjMWIyZDBhNWViN2IwMTgvdGFibGU6NDE2OTc2ODMzZTFkNDllMzhmMGVkNjU1NDljMjI5ZmEvdGFibGVyYW5nZTo0MTY5NzY4MzNlMWQ0OWUzOGYwZWQ2NTU0OWMyMjlmYV8yLTEtMS0xLTE0OTExNw_8b8bbd11-b37b-4edc-97cc-a2e861d5076d">0000010795</ix:nonNumeric><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80L2ZyYWc6NDJmMDc3N2RkYjBiNDg1MmJjMWIyZDBhNWViN2IwMTgvdGFibGU6NDE2OTc2ODMzZTFkNDllMzhmMGVkNjU1NDljMjI5ZmEvdGFibGVyYW5nZTo0MTY5NzY4MzNlMWQ0OWUzOGYwZWQ2NTU0OWMyMjlmYV8zLTEtMS0xLTE0OTExNw_1cfed2a4-62c7-407a-af1a-79c4b4398e86">9/30</ix:nonNumeric><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80L2ZyYWc6NDJmMDc3N2RkYjBiNDg1MmJjMWIyZDBhNWViN2IwMTgvdGFibGU6NDE2OTc2ODMzZTFkNDllMzhmMGVkNjU1NDljMjI5ZmEvdGFibGVyYW5nZTo0MTY5NzY4MzNlMWQ0OWUzOGYwZWQ2NTU0OWMyMjlmYV80LTEtMS0xLTE0OTExNw_19cb0dfb-a9a5-46e2-9737-613fdb9c91ba">2023</ix:nonNumeric><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80L2ZyYWc6NDJmMDc3N2RkYjBiNDg1MmJjMWIyZDBhNWViN2IwMTgvdGFibGU6NDE2OTc2ODMzZTFkNDllMzhmMGVkNjU1NDljMjI5ZmEvdGFibGVyYW5nZTo0MTY5NzY4MzNlMWQ0OWUzOGYwZWQ2NTU0OWMyMjlmYV81LTEtMS0xLTE0OTExNw_613d3e71-c50c-4af2-a8c2-e0e8a553fbec">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80L2ZyYWc6NDJmMDc3N2RkYjBiNDg1MmJjMWIyZDBhNWViN2IwMTgvdGFibGU6NDE2OTc2ODMzZTFkNDllMzhmMGVkNjU1NDljMjI5ZmEvdGFibGVyYW5nZTo0MTY5NzY4MzNlMWQ0OWUzOGYwZWQ2NTU0OWMyMjlmYV82LTEtMS0xLTE0OTExNw_0e6e04bf-050c-411e-b580-fbd824aeec14">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bdx-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbd00d98847d4346bbbb95d667436629_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ac9970494e4587812cec9482d864f2_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8689c0dffdb740849c7558594b18d09e_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d6885122ce848019de4e5ba402acae7_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i172bee2a01394be3b975442f6778fdf5_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.020dueMay242025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i251c5edff8504792bf4d77355a515f20_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea9376c80dbf43e1a4985f4578efd18d_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad1f5fe5077d4b74b42910c15b30993a_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1213NotesDueFebruary122036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9fc4c1858fb4a4296c2836d425fc4e3_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e4270210b441d8a749af6681865102_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i798de8f735874f948c11fa53069df187_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88f747ff4b7f43869b7fa5bb86a41c80_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c3c3fab267a46a88f3f39dfcc2cf90a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2574ec0c91f14c3f937606f7e1fa9cff_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85998d24a6604a978712c8df1da2a7c9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8832464205e4aec9d9dc8cdc63dcb72_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id83705567a26476994261cc7b5a25d33_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f12e83843f74a02ae51ea3d6b8a6a20_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i671cc096e3784769a513d12258a4a23c_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c23e44aea374d2fb54a3b6aedeadc11_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia116d571cab942aeb5f677df8f19d44c_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15828c3d0e91477790a5db6c52c366cc_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1646e6cae76e477ea277db5cfc3e2db2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8944e67417c44f49a70a8c33ea2603c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a00598163e14d4ba75663154d5576e6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i093e1c6251c446969afe57366b0f9d4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i868aa31ce93e406aaad8f6e77dc6b180_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfd5089106d54575b654a9e7e308e583_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf7721ab8534ff39ac5f79dc98c0378_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53fc9c3af28f47f7ab9ed1893b981c2a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04e93ba713f84c2293fdbd3f08dd5eb9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9161e65f73442d4a2e22bfce36dc56d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79acf93fa3e9494198d48e60df910f20_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8ca5cb05c6f4abaaba6eeeeea095bd8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i382cb5c56e50416a96a86b779a0dd809_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6921b343dee4c03b1537facc8f6e180_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i547348e51c474a16aabca1490b09fed7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d5b4db143146d3bb147d94438ec1fd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9075e2707bb44b9ebba0bff02efce052_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20cfc39ccaee446ba852752323e51724_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3dddbf166b34f98ab399f4fcb3f2ebe_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i336f8c4b2c4b4be4a1d5e5e1c5497d18_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e15f85977ce439d9169b789f07b511d_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04e794f49df74ce1bbe110052dc73130_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9feb4047fcf64ef0af2f6485859117a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f99435036b34bd2a24d925a56120f91_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d976db8005448e0afc273870324e7ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d02aecab48442e86778fa7099b3161_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a0740ea75854a55b2cdec3baa4f058f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb38e09788ba4aecab8c912c9af71397_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i706eb0202c0e496fb7a2947d80c016d2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddbd8602678b425dbb7e0ea97f55fb4b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38c11f85d6c5428f8a5759883d9c4623_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5930df7450554cf3a1702154aa7730a1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59879870004c4696b50bacebdf8bcae1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee4905aacc8d41638bc2468d4a3aa787_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if965b175d9504baba439a1be95582e62_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1850d5cec6e84eb88c655caaf1c6c1c2_I20130924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa9e6f344374994b897a26cc64ef107_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22e38a99ac5c405ebd50cfe207177871_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4628e244401242e9bab162e1505a9dfc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7858fb0adb264894a55e4fd4a4920f2d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460c979af9204674924048511da49f37_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6d62e03f8b42f0baf0cd748c67b33e_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee28abe315584e678b6d0f8d1b55cc26_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6484295e8f144d2ca1b524717f92829c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b3958263aac436d944c047db32c756d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ffdd529f695442cbae3dcc9fb039743_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19815e83945a4850ad5382563a523f5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0351329551fe4153b41300f0e72fb456_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife590ddfab834d788b4a069ff3e68d73_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81ebc98ee32546b19b83fb3e2840c977_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddd2e59573d94341b0593806ecbb2b66_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7572947a7339481dbfa89e6c783ec342_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ae99b2183b243ea802f1c0ed0b8683a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34563c7f6e514f3db19ecc98619eddd9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9e294f037204c3cbf4ef8d9020868bb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f33c5109e8848e994e743835c4960c0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i393529c2cae1491ebcb200f597fe10b6_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0ff75f2224d450085c05c8c295a92e6_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2eccb757d0246f0b29f6b496ee41a6f_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57ce0d1979c14028a69248c8a1c3d791_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie11149ff1cbe4132939e7ba61c7ab73b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id309abc3d0f943158c9c635b60c3eb5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i262febcea4f54f9dbc968f38708aba55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac52748f1bd40758c972a0bcd5b63b8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id944a60370e646709b33b07adb648682_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f262081f40a4906ba90bc6c1a7ee290_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83f3c899736b48bdb1be13f9cb594bc1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87f59be873544367bac32f07887de058_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a175b22e49a4de78fd2e4b373cdb8d7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01fbd913bf3a47cba0482d35f46f5378_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibad42ccfdde04dfeab3962ec66d145cd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23e198e459c54dbea71d1e6b83cfd466_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5186e284952c4354937b2883eb1ed3c9_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if312210c4d564f8ca13516875c02a909_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81e88067fa28438ba8960a6e5bc92844_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20be471d9fcf485d8a8e25204e5c84de_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ce1dc78d6a642b08e49f83600f8f112_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i185f69d2666a40e4a30b82e27d557e28_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">bdx:HerniaProductClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>bdx:claim</xbrli:measure></xbrli:unit><xbrli:context id="i17ab8a33ac194031acaea6ce23adb206_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85d6531a6a844787a70ff90d4a02d6d2_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75b32e3d8e8340148d564fd167111da6_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:GwinnettCountyGeorgiaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7b1e10a6ef444648b8782378dd142ad_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>bdx:lawsuit</xbrli:measure></xbrli:unit><xbrli:unit id="plaintiff"><xbrli:measure>bdx:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="i742947532c9941f6849b56745999efdf_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:GwinnettCountyGeorgiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieadfd52ff47344dfb0623e297b9b64ac_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ProductsandorServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idedcceb572a947ea828bc036cbc9e150_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68fed519b8cd4c66b77d2a0a682a2b45_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>bdx:segment</xbrli:measure></xbrli:unit><xbrli:context id="i4e6cfe7b18de4673af52bf049d65ba26_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i841c8c1c798a45e383da584c83869082_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95a4dcf151164a38b3e08ed29a9e68b0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i480503378bf24ffb84276d4a75ebeccf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i850e88e8269243c1868bfdf976704aa5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if70224594e54407c8dd9540e8e74477c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b2a45e650ea481fb6ca48710434086b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f4a58a812d48d593df5bcd251c3825_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dc5cef384ba465f8ab03695864d424b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if90dbbe1b6674b059da0798a1fc9ea36_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91cc5d94e87144d2a0196c9c9a1bc9c8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81baf0b1c1814041b160e3e27a6f6d6d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb10a2eb439f431591e11fb203a7fb1b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecb2838196d148ddb37b681f30800842_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6fee6e221a248209720d8a0e606b821_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12c9c9d66d504014a5a55dde651ad588_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6779e1ee9eb34798ba7826f0deb428d2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5042268ba57746368d9792ad3b7053f5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie714b836ac7743ceb2e70b68ac3982e7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1642dd23d79c4ea2a197172a38abeb19_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a102dfb15ad4d198bd87f3bc598fc50_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb0c35da7f9f433891a2e11f5d381e5c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f33f7206b1249e7a4ffc0c52c4ea01b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id16e4ff23fc7479ebc10e4339a6b8316_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib10678e67d194aea9b79aeba4ae564b7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8f00ef36a864b3999035cdb8ca1ee40_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4bf63d0944d4969b56d747a6c4aeb85_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4d29cbf115b4cd089b94dca6058cf55_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffd3f6c968b14773be92bfcc86c33822_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a2ad16216754861899cd606d682d1d2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac9e2fef4302405ab4e45ed6c9f072a2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00d4dd1d35ad4ec39bf242fec7861a8d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb6fc50a3487452ea53c1aee2fe9c14d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4639b945d6594926868a1a5ff039304c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i974dfe38797443ae9e91fe0d747005d8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a9c34ff96cf4cc6847d29c3560db0d2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e867a4015f4a468735111b4fe9d81b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99bc7afb1cf047caaff82d8a6516065c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i830727d2878946c7a8c7364a0ae99248_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa75e3193e3740ee93a99cb81d32c403_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfbdecd6ec9547c59053303e9f460db8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if875d3bce9114d8a858c7e589c047056_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49e6649d813d4bd4bb104a487c73ea90_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d0af07733084d968cb84d8736f680e1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib97632afcf314eb4af27293756ab1c1e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0e000d0a8774353b9d53bade6b21fd0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1354f7e1cf648458386b045b469c10b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i833303fa6d4c4eaf8bffbb0864a695e5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06722ea31e2b4061818de6fa498196a9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie60c2aa29c68466aac9d1af165f3af43_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88e20f23d8d1419989d15f68c97503c9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9732021b95147b48552d9d3400e0eb5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id76c90ada79245109d735834db48fef0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5693529ca4bf4fd99017046f306ad832_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibff7917a45934be1ba662f42794d4841_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04846b7cd7654f27ada57fc63f9519fb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i812ecaa6f69a4d0bb57f4bc354aae8be_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8117301a37b74e709259d5375dc30d4e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d0e86f8e82342be9d1959871d421a6e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaa76677d46442d6a7e1c895ce1f71f6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfbbee50f40c4484ae7bfad73328da8b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4353504b6abc40a8a4e50df3b63865ff_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i781b5ad29da34317ae891593af457aaf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06e1a559e5074fabab4366e975d71095_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac6febd1d5d74cf894e20097ea0c3390_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c82c8da537457ba89775a6dd6f0b63_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36d58f5ff4a94d7c856a21852d1578b7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53fe0413309b43b185ddaeb63704cdb0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74cf5d046cdc48458773f0a0e6bf124f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1c7400b54fe4071a338cdd26f00e096_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b866a81d48541e088ce519c699ba906_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i841975175f6d48f9998a0e2f82f4053f_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6f0652aab2a42f7b530f8be482e3007_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf48c33124124a6384e276cfa077767c_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb44f9df8a8441409d61f508251b69aa_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ec08bb3ff4a4875acf201b377a5a9b0_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39d0373baf3640f7b41985d5833685d7_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0f23cf9a7224b2c96d80a76679ed1c7_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia89519a3b58a4032909e18f5a356e5a1_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ffb55ab8ff54c96b1bce767d9e6a6f7_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d6c43b47e544ef87eb3da99d03b1f8_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87cda00c76043079c6b7f0a255628d4_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9624f4572d0a44edaf5bf06b2c5e83da_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5db5726397684d848e7e71ffe39a0df9_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5e183c9ad474d139768c9162aa1e53f_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38080f49c0974324a50d6dc48d77476b_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa34ed7252744dce9d3eba22fbc460f8_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77fe6f0478484e77ad34a61a2fd7bd78_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f4358855e40480593e5e0d8f0a7e32b_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36bf788445f641f087a217afce45d835_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f2c8adfb65e496fb380376104a49088_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id377017a26ec446cad1d57bd60564384_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4ff1d287bc641a68106273fcd8ed5ef_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie90ad306379a4c1599fe2b2e0c34c487_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbfde066976740859db427662a57e26b_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11d3d3ae80f74f4dbf461c7291881e0e_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6739aa1eaa040ea8aaddd516c1851c7_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5db012c6f554b589b2cd464565b693a_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia046d9031e8949509f12a761a4224417_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a3976b2f0f14c4e810f7005d15f1f87_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibca9b2a4d3aa462596e3df837b933591_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e4cad3300d84f2689a1f443e74e0314_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0edb37cc9b764458800e90102f48a86e_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6fe277067c2414fbf929d3d6a219636_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31eb79bf50ec41998fb767b6987ce2c4_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2438e94418c407792bbee2d9179b645_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32ae32f54613472793706f04236ad157_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fdb48a107794c3980fba70b8372a30d_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0960222376b41418e431c7c966fc960_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i251719fc5666450f8e498d90117d7c34_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb8cdd96ead14cd69f012accd6f4cb9d_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a0b9a3d052c46ca890a9c69797e68df_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78cb2306c82a4761a95fcb3e304bdb8c_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5894b055a36a458e8e85e4215a55ce54_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i062534c0a42743d2ad7922a783a173e7_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd38fe9a5f124e0e8b44cb18e864a957_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee1acdcb66d4d898504b646745a30bd_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d0fc699d0c846a289328d4a13ae3b9f_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67d3a9dbf7fa414fb11aa805abb03094_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86ee63bfe8004d68970b72dd4b8b7d1a_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28e6ab6ff6df496ca592e90b3d330de5_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f24e1d9f83e4d8eb797dd90c4d7bedf_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c7297cc444f4d0b8d08c060e92ae0c2_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8831acd8644cdeb56db066b2fd08a3_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09b09ea684154e4ebccff4d00f43571e_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i340d4b0fbfa344bfabdd8b6f46ab528f_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i844e28d1b31e43c882cf05e613660ac9_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i937287b0005849adba3700159c44bb1c_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i703a5ae640f84088b9eb12321f883fcf_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if00d7790a83c4d398536842126ba0870_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0498cba50954a96b0f4785b9369da89_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0f0d62528e643e486e8b63e17adcab2_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icda13f7ccb434390a542b94eedf89184_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8accfab0194747e99802361c4bcba9f8_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea5cc875dbfa4dd69f9ffea1d08fc7bd_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i068965d16303486fb4323bb08ee4bc27_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd93e9175cc64c60bbc8a3d92a9e7649_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39cfb89f6f8b448f9b5f3bfcc58dc9dc_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f1ebdedf0894f6f9d6eb7853eecb428_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib85825c4d3c641cc99a05dc9d8c18d83_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb7bc81847b84350b2fab646e9bcd447_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i255166fe111d4bd2b7b0f9c57d1e3013_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0fc6cb6378a44c4a1cd9a34c079468c_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieab59e058d394ac989a56f0af7be79db_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62acc25f7e924071a6f2be9aaaf46d77_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf252968a2584238b4d790d9ccf2097d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if641350edac64e2986b37525b239f9b8_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i022895c1add14102909469676a06a30a_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8bcf14bc4de46d4ab342052f56f0f63_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50d91ec151c8409cb91d3361be377daf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7af6142a51f740c396515df1281ab028_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if415726d4f1042da942db59fd9b75797_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d85cf2e75c44573a9069a35792fbae2_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59035e46fc504f16bd9ced72ced1a8c3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80186f01cae8428cb7bbf64cc561eb04_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a8a4974f9e942689ee74356ba8c98ba_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43c15c774be8471399b53c4f55f32175_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e6ce19cb68c42798ae7f6c22f37cc17_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide33f573b2814d269fa446f57a3a0186_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aa9ecd5e70e410190486fa72a3b558e_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iced9cd9c70654eb388559493c61723b9_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58665f2a2c8643dcb3ad595e2d019b33_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bdx:OtherInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52290dbfca2d4f50a401175ba723901f_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bdx:OtherInitiativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f40fa9998b54795b2c752de8c531048_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bdx:OtherInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0dbe3ded00545ab83fb4e0b4a84ec32_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia23a5e3848cd4f44a166523143770660_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5df4422b58204b28a8c87b3ec9a100d4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0ee2f4c36e04145806001b090363988_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cf4edbbb2c84bebb017b70ec26907d9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9763e9cfce3546598374a98e82482d84_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5909630c3dc3461db24bb07bbef1d70f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4bcaff2cdea468f9adea6ca88bfd572_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55f7422c872948b7aa942c44ddec9006_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i244628a30e084b02a041278475ead62a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i369713e8a2814ee3b1545e6f40f52598_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09ed9f30fe6f49b080fbe7dafbf98b8e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3102b14dbddd4ffc86e7d5d2db6bce27_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1a34123952a4177976f05690781d3d7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4127c3a1dc864463babc0aa7d4467455_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9a28f207cd5467ba5f864965c31b4d2_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c0d32994d5d4acb92ad95e9804d5595_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f5415d8bbac4b359e15026a6417f893_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6c6efdde649461c9e16742dfa4f98cb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73beddac0b344212a9ac5a9c6b13e93c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65aae17d8b844902ba366c6f8483abbe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12b6aa99d5be460d83d9bca02ddddd61_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aeb4d2755fe46f299e5a6c74bc5a32b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3304ad8423a4080868ba0df9040363c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f298aa8db0e4d16915009c38a45b4fd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a7b5571b4914526a7939314fe5ac29b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc31e4316a5f42a9af36adc57ea908b0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82512cdc5bbe47b99fd3ea95885689f8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bdfaba42a0147ab9cf6e5fe931bcb98_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39c3539460274df6ac6d2c96ecc34090_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67552823db3d48dba3a132df51727d27_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13543c57601d49cdad0d49ed6c6a810e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0266480813824139b60fa979b8c5a110_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3c212ff13284f898a191374e5b1fb18_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a554cbf33a4c3cbe41709cb273beba_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26ec7721173741bfa63336e0a220a540_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:TerminatedCurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac6d0546403e4cb8bee77368cc2a109d_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:TerminatedCurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21832cc6769747ce9b9665d67123f229_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52fcd6bc58b842908f344893c07f0e4a_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6efa31d0f394c2fa26a85b8356810a7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f198f784a2e4fbebfc73c9adccb8ca7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28e41cac0d444490be6885ce232f8d86_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cf2158a605543ce9c94011e2077fc47_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i028e3d9d8c454377856d5376339cff80_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i404c88c20ea54232a7e62321ba370898_D20221001-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5012eda058545d5b7ac41306aa4ba16_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0781942758c64dd5afd26d84a4911721_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4693DueFebruary132028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2642155c253549deb25e07021badb5aa_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3553DueSeptember132029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i37b7d299193b4c9989d811dd4b4236cf_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3553DueSeptember132029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i031378f9d14d45c988ebf0bc09980e9d_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3553DueSeptember132029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic901e28da78f443cab3564a79902c5bb_1"></div><div style="min-height:40.5pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQ3_9d66de0a-2afd-4177-9f80-210339b7ad57">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:0.1%"></td><td style="width:2.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6MDgzNjAzZTI3MTIyNGM5YmI1NzM1ZjJjNDRiN2E4MDMvdGFibGVyYW5nZTowODM2MDNlMjcxMjI0YzliYjU3MzVmMmM0NGI3YTgwM18wLTAtMS0xLTE0OTExNw_b979e29c-56a3-4222-bca3-446f23ac5616">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xMzI_45029796-04d8-4544-b17e-bc3567a71c71">March 31, 2023</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NGQ0NDYyYmU4MWRiNGQwZGJkMTg3Zjk2MjI5MjdjMTMvdGFibGVyYW5nZTo0ZDQ0NjJiZTgxZGI0ZDBkYmQxODdmOTYyMjkyN2MxM18wLTAtMS0xLTE0OTExNw_f67833f0-3310-416d-86f1-3abdeebd8d9a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQy_c3c8f276-4012-4102-9df9-1e7971fd3b6a">001-4802</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQz_5f681ada-ff72-48f9-9c58-33be2c1ff986">Becton, Dickinson and Company</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.545%"><tr><td style="width:1.0%"></td><td style="width:13.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.877%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.153%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8wLTAtMS0xLTE0OTExNw_f1a81998-017c-4973-aef4-83e607383387">New Jersey</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8wLTUtMS0xLTE0OTExNw_29f96356-df79-4020-97ed-e62087e5cd5f">22-0760120</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTAtMS0xLTE0OTExNw_4a4b7c0c-d51f-40c6-b23f-45d8f42e27be">1 Becton Drive,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTEtMS0xLTE0OTExNw_e75ef6dd-9833-40cc-8081-b3256beca0c0">Franklin Lakes,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTItMS0xLTE0OTExNw_177ff6c2-a4c8-44ff-9eac-5ec8c80586f9">New Jersey</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTMtMS0xLTE0OTExNw_7ae5f182-2dfe-4a74-983f-0b5471389c43">07417-1880</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTUtMS0xLTE0OTExNw_f8bc0138-0e3a-40cd-90cb-e7ae2b48dffb">(201)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTYtMS0xLTE0OTExNw_d0039a23-8f5d-4089-acd1-181ca809153b">847-6800</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices) (Zip Code)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code) </span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:41.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Each Exchange on Which Registered </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idbd00d98847d4346bbbb95d667436629_D20221001-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xLTAtMS0xLTE0OTExNw_7c4c5c93-fd97-4432-8cb3-738d8583a5f3">Common stock, par value $1.00</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idbd00d98847d4346bbbb95d667436629_D20221001-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xLTItMS0xLTE0OTExNw_19ea8e96-38d5-43ed-b546-62e716fc91a9">BDX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idbd00d98847d4346bbbb95d667436629_D20221001-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xLTQtMS0xLTE0OTExNw_493260b8-b487-460c-aa51-d839b67f9fa1">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i72ac9970494e4587812cec9482d864f2_D20221001-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8yLTAtMS0xLTE0OTExNw_cd4737b3-303c-41ae-86a8-270d8a5ad7eb">Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i72ac9970494e4587812cec9482d864f2_D20221001-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8yLTItMS0xLTE0OTExNw_2d65265c-731d-4697-a08f-2e820a561a2d">BDXB</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i72ac9970494e4587812cec9482d864f2_D20221001-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8yLTQtMS0xLTE0OTExNw_6791f81b-dfdf-425a-a22a-5e923117d06a">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8689c0dffdb740849c7558594b18d09e_D20221001-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8zLTAtMS0xLTE0OTExNw_5615f150-971a-4f61-ab84-a12255b68cd1">1.900% Notes due December 15, 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8689c0dffdb740849c7558594b18d09e_D20221001-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8zLTItMS0xLTE0OTExNw_053facae-04e1-4ca6-9c44-716e17e9dc7d">BDX26</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8689c0dffdb740849c7558594b18d09e_D20221001-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8zLTQtMS0xLTE0OTExNw_1b28c3d9-7b18-4488-a8e7-a0de871e35f5">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d6885122ce848019de4e5ba402acae7_D20221001-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl80LTAtMS0xLTE0OTExNw_ffabfc52-9eb8-465e-9d1c-87ad34aa8ad5">1.401% Notes due May 24, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d6885122ce848019de4e5ba402acae7_D20221001-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl80LTItMS0xLTE0OTExNw_334e83e1-cc1c-4ded-8dde-65386492d09c">BDX23A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d6885122ce848019de4e5ba402acae7_D20221001-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl80LTQtMS0xLTE0OTExNw_cddedbec-40d1-43d8-be19-a9d20395ba97">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i172bee2a01394be3b975442f6778fdf5_D20221001-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl81LTAtMS0xLTE0OTExNw_b2e4f815-a040-4caa-8efa-191c3dba13f0">3.020% Notes due May 24, 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i172bee2a01394be3b975442f6778fdf5_D20221001-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl81LTItMS0xLTE0OTExNw_a9181b40-bad4-47b5-84c9-512b0bbc83ab">BDX25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i172bee2a01394be3b975442f6778fdf5_D20221001-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl81LTQtMS0xLTE0OTExNw_bafa1ca6-af98-41e3-bc2e-32a876bfa048">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i251c5edff8504792bf4d77355a515f20_D20221001-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl82LTAtMS0xLTE0OTExNw_5b4f8d5e-42ef-4b9b-a117-fc210bc99162">0.632% Notes due June 4, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i251c5edff8504792bf4d77355a515f20_D20221001-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl82LTItMS0xLTE0OTExNw_a8454913-9c0c-4b69-8771-afd23e3db11f">BDX/23A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i251c5edff8504792bf4d77355a515f20_D20221001-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl82LTQtMS0xLTE0OTExNw_d207db66-aeff-4f88-b295-5d16f097b1da">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iea9376c80dbf43e1a4985f4578efd18d_D20221001-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl83LTAtMS0xLTE0OTExNw_0395e236-bdd3-4281-8c58-c713d2bac3f8">1.208% Notes due June 4, 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iea9376c80dbf43e1a4985f4578efd18d_D20221001-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl83LTItMS0xLTE0OTExNw_4deb1225-bb15-4c82-a35e-bef216f42ac5">BDX/26A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iea9376c80dbf43e1a4985f4578efd18d_D20221001-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl83LTQtMS0xLTE0OTExNw_61cf60b2-e445-420f-a17d-91a7dcb1cde5">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iad1f5fe5077d4b74b42910c15b30993a_D20221001-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl84LTAtMS0xLTE0OTExNw_4a24d97e-355d-4951-92ea-a76b5f54c757">1.213% Notes due February 12, 2036</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iad1f5fe5077d4b74b42910c15b30993a_D20221001-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl84LTItMS0xLTE0OTExNw_31c5f11e-20bd-417d-a896-e9aa1baf5a17">BDX/36</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iad1f5fe5077d4b74b42910c15b30993a_D20221001-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl84LTQtMS0xLTE0OTExNw_1536bfc1-48cb-4b9d-bdca-c4dffac5717d">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib9fc4c1858fb4a4296c2836d425fc4e3_D20221001-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl85LTAtMS0xLTE0OTExNw_e7231451-d5a7-470f-ac50-cc903cc8715a">0.000% Notes due August 13, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib9fc4c1858fb4a4296c2836d425fc4e3_D20221001-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl85LTItMS0xLTE0OTExNw_4a84ae68-a2d7-4ca5-abe9-17d284e10c84">BDX23B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib9fc4c1858fb4a4296c2836d425fc4e3_D20221001-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl85LTQtMS0xLTE0OTExNw_85367e5f-8166-43a2-ada6-e7d7caee14d9">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i50e4270210b441d8a749af6681865102_D20221001-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xMC0wLTEtMS0xNDkxMTc_68770428-3d66-4bf5-bb56-f41dbf4044c1">0.034% Notes due August 13, 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i50e4270210b441d8a749af6681865102_D20221001-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xMC0yLTEtMS0xNDkxMTc_615b1075-d627-4a3b-ad87-8ba31b28d4cd">BDX25A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i50e4270210b441d8a749af6681865102_D20221001-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xMC00LTEtMS0xNDkxMTc_962bb023-829d-47ac-8c1b-0d9571346800">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQ0_237a87c5-ad06-4d7c-a7d9-dde0a30c4d54">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQ1_39d5de6e-27a4-4b63-971c-05c36e28e09e">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160; &#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.695%"><tr><td style="width:1.0%"></td><td style="width:32.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OGUxMzBlMTYwNzA5NGUyODk0OGYxY2UzZTMwNTdhNWYvdGFibGVyYW5nZTo4ZTEzMGUxNjA3MDk0ZTI4OTQ4ZjFjZTNlMzA1N2E1Zl8wLTAtMS0xLTE0OTExNw_112f6c0c-3e7c-4ffd-82a7-b7fd7f3fa121">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OGUxMzBlMTYwNzA5NGUyODk0OGYxY2UzZTMwNTdhNWYvdGFibGVyYW5nZTo4ZTEzMGUxNjA3MDk0ZTI4OTQ4ZjFjZTNlMzA1N2E1Zl8xLTYtMS0xLTE0OTExNw_53f6f12c-4f78-44b4-bfa6-520f3895a286">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OGUxMzBlMTYwNzA5NGUyODk0OGYxY2UzZTMwNTdhNWYvdGFibGVyYW5nZTo4ZTEzMGUxNjA3MDk0ZTI4OTQ4ZjFjZTNlMzA1N2E1Zl8yLTItMS0xLTE0OTExNw_3a961993-585f-4dec-a3b2-775bb012c004">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQ2_0f0219a7-9185-4c2c-a152-825aa58f19e4">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNTgx_0766854e-a321-4562-a572-ad084054f012">284,014,905</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Common Stock, $1.00 par value, outstanding at March&#160;31, 2023.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended March&#160;31, 2023</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Number</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Part I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_13">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_16">Condensed Consolidated Statements of Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_19">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_22">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_25">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_28">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_70">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_70">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_73">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_73">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_76">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_76">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Part II.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_79">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_82">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_82">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_85">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_85">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_88">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_88">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_91">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_91">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_94">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_94">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_97">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_97">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_100">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_100">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic901e28da78f443cab3564a79902c5bb_103">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic901e28da78f443cab3564a79902c5bb_103">42</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ITEM&#160;1. FINANCIAL STATEMENTS</span></div><div id="ic901e28da78f443cab3564a79902c5bb_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars, except per share data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.219%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMi0xLTEtMS0xNDkxMTc_96a52fc7-c56a-40dc-81f4-80ec2ede8719">4,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMi0zLTEtMS0xNDkxMTc_347ce05c-fefc-4b85-b394-f187a2fa880c">4,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMi01LTEtMS0xNDkxMTc_3ae3870d-7805-417a-a92d-0630768a58e1">9,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMi03LTEtMS0xNDkxMTc_9ef3b662-b961-4803-937e-e8377608e817">9,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMy0xLTEtMS0xNDkxMTc_a2ddbc62-8c1c-4584-8c98-0bcfd839db6a">2,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMy0zLTEtMS0xNDkxMTc_b4d03f8d-110a-4a2f-b05b-bc69a6c0c104">2,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMy01LTEtMS0xNDkxMTc_cc45aaaf-0f01-41c4-9e17-a5c6c88a121b">5,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMy03LTEtMS0xNDkxMTc_b3bce7f1-95f2-4ac5-8b0b-5c515d8ebc0e">5,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNC0xLTEtMS0xNDkxMTc_1dcec54f-79a4-4408-b06e-f1a7245cfed6">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNC0zLTEtMS0xNDkxMTc_f0fe4b29-e19e-4cbb-8bf2-e11970ad5761">1,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNC01LTEtMS0xNDkxMTc_9e038bc7-4512-4a51-87be-bed90282851e">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNC03LTEtMS0xNDkxMTc_b252a794-cd06-4230-8839-0d8bade3defb">2,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNS0xLTEtMS0xNDkxMTc_2bdc6847-5590-4040-b3aa-40339bdd71cb">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNS0zLTEtMS0xNDkxMTc_c0395348-dbf4-41e5-b45b-5a7bb53ee3ce">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNS01LTEtMS0xNDkxMTc_5e71f705-06cf-47db-bdbc-c17d61d82e52">651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNS03LTEtMS0xNDkxMTc_1c62ca18-7562-4ac5-9edb-04df72f260f6">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNi0xLTEtMS0xNDkxMTc_d9e87879-c179-4d2a-bcc9-e5a3ec0adcf3">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNi0zLTEtMS0xNDkxMTc_88ec2d80-e5a2-4d94-b806-107bb6c9fdd4">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNi01LTEtMS0xNDkxMTc_2a4b4b50-1eab-4753-a2b4-9f339e0f0f8b">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNi03LTEtMS0xNDkxMTc_ea2f4d79-8a2e-458e-b648-10567a2afa78">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNy0xLTEtMS0xNDkxMTc_619e6608-1bbe-42fa-9800-cfde10b8a87f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNy0zLTEtMS0xNDkxMTc_17b3e4f7-4d59-410f-a191-943325630fea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNy01LTEtMS0xNDkxMTc_378f7a01-7f8e-45b3-a10b-3ec9ebe2a744">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNy03LTEtMS0xNDkxMTc_ab7283df-276e-42bd-a37f-8f2adb0e3ded">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOC0xLTEtMS0xNDkxMTc_61dd8db1-8f4f-4786-91c6-594d9f4b1fd9">4,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOC0zLTEtMS0xNDkxMTc_c7309ef8-6d61-4333-88c3-43a4d1ab4997">4,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOC01LTEtMS0xNDkxMTc_cd1e75a6-9b02-4723-b37d-c6d43e34f56a">8,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOC03LTEtMS0xNDkxMTc_de480c18-fd17-4c7f-8970-33217c704f3a">8,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOS0xLTEtMS0xNDkxMTc_8ec8b47f-49bc-4bd3-8a22-248b7817441f">628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOS0zLTEtMS0xNDkxMTc_e7691b3a-2f0c-4b25-a6c4-fc5d8705456b">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOS01LTEtMS0xNDkxMTc_3cc15252-9b48-4bc8-8845-fe6cc3c1944b">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOS03LTEtMS0xNDkxMTc_46c04840-3e90-4285-bef4-731138c44415">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTAtMS0xLTEtMTQ5MTE3_b07a4f31-9e25-487e-837c-2f5885d06c6b">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTAtMy0xLTEtMTQ5MTE3_b7420bd9-8491-46ac-9b45-84e64841d66f">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTAtNS0xLTEtMTQ5MTE3_23723d0a-a04f-46be-807b-6da50bcb8095">220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTAtNy0xLTEtMTQ5MTE3_4013d0b9-5d94-4ea6-8a0f-4ddf0d7f6c7d">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTEtMS0xLTEtMTQ5MTE3_c8be47f5-836d-454b-abcb-d49037c92c3c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTEtMy0xLTEtMTQ5MTE3_4f16f618-91e4-47e5-af42-0204150ed7dd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTEtNS0xLTEtMTQ5MTE3_051a5084-69b8-4077-ab19-d187e41424cf">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTEtNy0xLTEtMTQ5MTE3_82cbb1bc-3abb-4ea6-a114-f19de7f1f96a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTItMS0xLTEtMTQ5MTE3_66e53d96-1ce8-48fd-8fae-cd46f836b562">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTItMy0xLTEtMTQ5MTE3_2cd3416c-7032-462d-9a10-3c48d28a0957">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTItNS0xLTEtMTQ5MTE3_62ae7e8b-d3e4-4ad4-8c27-4627f2ee4036">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTItNy0xLTEtMTQ5MTE3_43cd22ba-f7d6-41a8-a3b2-2381c173aa81">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations Before Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTMtMS0xLTEtMTQ5MTE3_57742137-c217-4524-9438-6cdb05cf539d">529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTMtMy0xLTEtMTQ5MTE3_01062956-bbcd-4006-a332-7a6a75f04baa">442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTMtNS0xLTEtMTQ5MTE3_037bd451-2d40-47f3-8b71-7b2d9cf0ac1d">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTMtNy0xLTEtMTQ5MTE3_1c64b442-b330-4e7d-82a9-1985ba3fc9e7">1,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTQtMS0xLTEtMTQ5MTE3_8060a42d-e3c6-4a3b-941f-08c7577e6ed3">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTQtMy0xLTEtMTQ5MTE3_0a85795a-67e5-4550-a63b-4cbf7869bb96">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTQtNS0xLTEtMTQ5MTE3_4662ca78-1eb6-41e9-85f2-552c81b72f89">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTQtNy0xLTEtMTQ5MTE3_64fbd5de-0277-4b74-9845-c936fadfe674">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income from Continuing Operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTUtMS0xLTEtMTQ5MTE3_41d3ab6c-c627-4bee-8153-be4912acbc1a">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTUtMy0xLTEtMTQ5MTE3_3b21d80f-d7ee-4b77-b851-cbaebc913a02">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTUtNS0xLTEtMTQ5MTE3_dedcb556-24c4-4af0-b7e6-b0eaee95f547">969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTUtNy0xLTEtMTQ5MTE3_899e1c31-712c-4b71-8dd2-6d2dc99d48e3">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations, Net of Tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTYtMS0xLTEtMTQ5MTE3_752b7718-22aa-4364-b7ca-1fbe69e7dd91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTYtMy0xLTEtMTQ5MTE3_3f5f31d8-ac64-41fb-8ee0-ce63b981b3f0">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTYtNS0xLTEtMTQ5MTE3_e152fc48-35e7-44e5-b8bd-318b90519fc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTYtNy0xLTEtMTQ5MTE3_597e067c-e049-450b-82fe-20903731abfc">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTctMS0xLTEtMTQ5MTE3_7a7dd197-ea6e-496d-9947-c1575f79b7b6">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTctMy0xLTEtMTQ5MTE3_ef55d009-a3b5-4b7e-81be-f5deb57db10f">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTctNS0xLTEtMTQ5MTE3_2f7aabfb-e4e6-4947-9459-ef0d59f60c9d">969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTctNy0xLTEtMTQ5MTE3_6aaa18d6-4c7b-4ac7-aabd-a95c9ef2288c">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTgtMS0xLTEtMTQ5MTE3_dd4ba358-765e-4ddd-9fc2-2f8d9f6bcd07">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTgtMy0xLTEtMTQ5MTE3_4bd4065e-51c9-40f0-874d-0778c2240414">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTgtNS0xLTEtMTQ5MTE3_f749df6c-5f99-4eab-82cf-0b251848108f">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTgtNy0xLTEtMTQ5MTE3_08f9f29e-eb82-4b5e-a9da-825a59d326db">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income applicable to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTktMS0xLTEtMTQ5MTE3_ca3b8644-b3c8-4da7-a835-c0f6041fa29d">438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTktMy0xLTEtMTQ5MTE3_114bd32b-ce51-4ab2-8bb5-1c9d80d4b165">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTktNS0xLTEtMTQ5MTE3_9d50b97f-8fac-4c16-bdfa-3caeadbcf8c6">924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTktNy0xLTEtMTQ5MTE3_8de02365-9045-4377-8909-e79ff27d0fb1">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings per Share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjItMS0xLTEtMTQ5MTE3_2c54ff0b-54e4-4730-b40c-0264a18f2cbf">1.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjItMy0xLTEtMTQ5MTE3_8fcfca6c-197f-444e-8ced-dc4ef3ad8dfd">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjItNS0xLTEtMTQ5MTE3_3abcb279-6362-4a73-b76e-f6398fbaf475">3.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjItNy0xLTEtMTQ5MTE3_491912e7-2896-4d71-b344-b1d1c97d05ca">3.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjMtMS0xLTEtMTQ5MTE3_4a0e6b14-c713-4b58-989b-27f7ba51692a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjMtMy0xLTEtMTQ5MTE3_f8836939-91a6-4c69-8770-86ac78965228">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjMtNS0xLTEtMTQ5MTE3_4ace10bf-ff68-4e12-bdbc-fa1655bdb8c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjMtNy0xLTEtMTQ5MTE3_362a4fba-17f4-49d0-996e-5addc9f7f096">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings per Share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjQtMS0xLTEtMTQ5MTE3_bc709717-4c81-4631-b233-66cf4a8b0460">1.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjQtMy0xLTEtMTQ5MTE3_49b1d022-d219-447c-b417-b26f179390de">1.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjQtNS0xLTEtMTQ5MTE3_009b02da-4161-4dac-be12-716e43b069e7">3.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjQtNy0xLTEtMTQ5MTE3_e4d1e6e3-62be-4519-a235-28818022f6fa">3.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjctMS0xLTEtMTQ5MTE3_97b1b8f1-79b3-46c1-b7e8-d02af13fae70">1.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjctMy0xLTEtMTQ5MTE3_eefd0218-27ae-4124-b899-505522d8de87">1.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjctNS0xLTEtMTQ5MTE3_04711d06-f026-4cd7-a55c-2a8004eb06bd">3.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjctNy0xLTEtMTQ5MTE3_122c7523-db33-493c-85ca-5c47959cb85e">3.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjgtMS0xLTEtMTQ5MTE3_18c8a283-3a41-4573-b98b-0e688aa6efa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjgtMy0xLTEtMTQ5MTE3_44421f8b-15e7-461b-99bd-a1e204afa433">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjgtNS0xLTEtMTQ5MTE3_3297bf50-3d57-4688-98ca-c20791f62a77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjgtNy0xLTEtMTQ5MTE3_f3008e14-9c78-44a0-8e5e-c864c67947ac">0.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjktMS0xLTEtMTQ5MTE3_8ada95db-4696-4b66-8904-3b158b52b5e9">1.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjktMy0xLTEtMTQ5MTE3_d1d47001-34af-413f-8bd2-129e761804b4">1.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjktNS0xLTEtMTQ5MTE3_66b30e64-01dd-4016-b303-950daf0e4df5">3.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjktNy0xLTEtMTQ5MTE3_fd251a3f-19fc-4133-b012-3e55f463e43a">3.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends per Common Share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMzEtMS0xLTEtMTQ5MTE3_723bcf96-1132-4ee7-ac07-2a047698b1cc">0.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMzEtMy0xLTEtMTQ5MTE3_cb86fed7-3eb6-4c39-bb4c-da748faef1ab">0.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMzEtNS0xLTEtMTQ5MTE3_d4ae086c-b4d5-4774-8447-88071729dda9">1.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMzEtNy0xLTEtMTQ5MTE3_c98a7756-c08f-486c-ba68-ca0a7867f4d1">1.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfMi0xLTEtMS0xNDkxMTc_7a7dd197-ea6e-496d-9947-c1575f79b7b6">460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfMi0zLTEtMS0xNDkxMTc_ef55d009-a3b5-4b7e-81be-f5deb57db10f">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfMi01LTEtMS0xNDkxMTc_2f7aabfb-e4e6-4947-9459-ef0d59f60c9d">969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfMi03LTEtMS0xNDkxMTc_6aaa18d6-4c7b-4ac7-aabd-a95c9ef2288c">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive (Loss) Income, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNC0xLTEtMS0xNDkxMTc_9089620c-0234-43f0-a697-da8b81324b7a">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNC0zLTEtMS0xNDkxMTc_fd6ec6cc-8378-4980-81b3-2858cc42ea5a">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNC01LTEtMS0xNDkxMTc_ab28c56e-88e7-4140-a0d6-c3682178dab5">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNC03LTEtMS0xNDkxMTc_b0965b71-6d4b-4b3a-8a86-cd9416788c4b">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and postretirement plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNS0xLTEtMS0xNDkxMTc_b03b0e9e-03f3-47cf-ab21-5b703301f341">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNS0zLTEtMS0xNDkxMTc_7e852491-ac70-4153-a3b7-060f1476b7f8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNS01LTEtMS0xNDkxMTc_e82e0962-a079-45cc-9788-568848013d94">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNS03LTEtMS0xNDkxMTc_db20ac6a-592c-4643-ac0b-942c87245b57">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNi0xLTEtMS0xNDkxMTc_da1408e6-1203-4e87-8222-c9b61ea18afa">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNi0zLTEtMS0xNDkxMTc_aeb555fb-1502-4bad-a214-703cc667f008">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNi01LTEtMS0xNDkxMTc_04e8d9d1-ed3a-4fe8-bc91-a756133ea06d">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNi03LTEtMS0xNDkxMTc_8fb01ac1-d77d-4893-aa3e-b67bd6db59ad">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive (Loss) Income, Net of Tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNy0xLTEtMS0xNDkxMTc_bd227e31-f2eb-4e8b-a8f7-a1a086846d43">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNy0zLTEtMS0xNDkxMTc_02569dd4-a86e-4a80-b5d7-1591596b701b">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNy01LTEtMS0xNDkxMTc_53c7b0eb-018a-40bc-9b8c-a9ac7a197ef0">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNy03LTEtMS0xNDkxMTc_a81e72be-9a96-4595-8abe-7bff5c3dd55a">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfOC0xLTEtMS0xNDkxMTc_65528c4f-e6fd-4d66-ba77-021e6b8e3506">445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfOC0zLTEtMS0xNDkxMTc_13015da0-db80-4b5d-b69d-de66732b5a60">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfOC01LTEtMS0xNDkxMTc_f8850fa6-0c0a-4e07-ba23-7162e0ecaea4">882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfOC03LTEtMS0xNDkxMTc_c376ad11-b003-4a24-8c0a-8ed734918f4c">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars, except per share amounts and numbers of shares</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMy0xLTEtMS0xNDkxMTc_4719c5d1-02bf-4315-9131-e6560480e924">1,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMy0zLTEtMS0xNDkxMTc_3a85763c-b28a-4a10-9923-dae6ad639e26">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNC0xLTEtMS0xNDkxMTc_12b7d64f-4b21-4099-bf71-0f447ee32c8f">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNC0zLTEtMS0xNDkxMTc_83582b45-704c-4fb0-b17a-77002bd54427">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNS0xLTEtMS0xNDkxMTc_4fe12d78-b368-44d1-8c7c-17572ab785eb">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNS0zLTEtMS0xNDkxMTc_671d1181-5966-4701-8041-343a8e5bbda5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNi0xLTEtMS0xNDkxMTc_40af5d22-70ab-40e2-9463-7d4f464c11b2">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNi0zLTEtMS0xNDkxMTc_a7cd2854-6938-4999-b695-e2f19d22d1da">2,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfOC0xLTEtMS0xNDkxMTc_cca60849-0af1-4e19-89b1-e5f2a71279de">788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfOC0zLTEtMS0xNDkxMTc_ad7e35ee-f7a9-48e0-be79-389aac9d0e23">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfOS0xLTEtMS0xNDkxMTc_4fe0195b-0adf-4767-b72a-edd19a8aea42">428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfOS0zLTEtMS0xNDkxMTc_40ea40c2-9190-4c69-aa89-7247f678e941">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTAtMS0xLTEtMTQ5MTE3_4e8ccef3-718b-4e35-b580-8cb2ebf69142">2,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTAtMy0xLTEtMTQ5MTE3_c0a8b6cd-6b8a-42ac-86ba-6f847efdc557">2,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTEtMS0xLTEtMTQ5MTE3_13691a55-80bb-4dbe-98a0-402793843f65">3,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTEtMy0xLTEtMTQ5MTE3_12664e87-8aa3-4d8d-9e89-b0822a6c06a0">3,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTMtMS0xLTEtMTQ5MTE3_7370afd9-dbaf-4b3c-a7ec-1c96f7ef41ce">1,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTMtMy0xLTEtMTQ5MTE3_e601f792-87f6-4590-8d77-1e24c949e543">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTUtMS0xLTEtMTQ5MTE3_b7f0bbe6-7f73-4175-9891-d833da5558e7">9,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTUtMy0xLTEtMTQ5MTE3_5ab30852-3ebc-433a-b3af-56c18c7580cc">8,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTYtMS0xLTEtMTQ5MTE3_b25a4aee-c053-4553-b511-efbb47bae534">13,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTYtMy0xLTEtMTQ5MTE3_f359dd63-bd44-495a-9de6-5354308961bb">12,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowances for depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTctMS0xLTEtMTQ5MTE3_3fe93b4e-b5ff-4305-a609-290c7f5dd68d">6,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTctMy0xLTEtMTQ5MTE3_8e8867a5-d0ab-4d11-8739-ff9cc29acff1">6,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment, Net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTgtMS0xLTEtMTQ5MTE3_cae71b3f-c6f4-490e-9c19-08396fc272b1">6,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTgtMy0xLTEtMTQ5MTE3_467457f9-d4a1-4937-9e84-fb3394cfb9fd">6,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTktMS0xLTEtMTQ5MTE3_a3017483-2378-4b3b-aa07-c60014aa1942">24,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTktMy0xLTEtMTQ5MTE3_6fa79489-7cb3-4ff8-9ff0-aac12252b81d">24,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology, Net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="bdx:CoreAndDevelopedTechnologyNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjAtMS0xLTEtMTQ5MTE3_9e86cefb-e372-45ec-a3cc-4bf771f98f2c">8,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="bdx:CoreAndDevelopedTechnologyNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjAtMy0xLTEtMTQ5MTE3_27c86afe-dd9c-4a45-a1f5-b0a9932cfc70">9,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Relationships, Net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="bdx:FiniteLivedCustomerRelationshipsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjEtMS0xLTEtMTQ5MTE3_9f05476a-2c71-4b6a-8ba8-9ff8a5414c81">2,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="bdx:FiniteLivedCustomerRelationshipsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjEtMy0xLTEtMTQ5MTE3_85b750f4-6888-440d-b560-e97e7ba05340">2,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Intangibles, Net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjItMS0xLTEtMTQ5MTE3_18c7559a-7195-4a87-a30b-3937ab1f4e8d">555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjItMy0xLTEtMTQ5MTE3_fbbf6c87-824b-4005-a138-3cbac1c5904f">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjQtMS0xLTEtMTQ5MTE3_5a7dcefe-663e-4c0c-b804-548b4af1e789">1,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjQtMy0xLTEtMTQ5MTE3_f5fe15ce-ca8d-4212-9491-4d889fa37054">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjYtMS0xLTEtMTQ5MTE3_f3963ee6-3219-4d38-a717-c81204bd5bc3">54,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjYtMy0xLTEtMTQ5MTE3_6717a753-3c1a-46e2-ab63-e3371be0f910">52,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjktMS0xLTEtMTQ5MTE3_447d14b1-f5f7-42f2-9bcc-d089ce514ec4">2,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjktMy0xLTEtMTQ5MTE3_a5fb1fd4-872e-4305-b195-e081a1df1345">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payables, accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzAtMS0xLTEtMTQ5MTE3_a39197b3-063b-4658-9bce-9eeddedba489">5,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzAtMy0xLTEtMTQ5MTE3_8629e0eb-ba0f-427f-80e5-644b59ca5ff3">5,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzMtMS0xLTEtMTQ5MTE3_0b7dddf3-7bbc-4207-9f75-ba53e3e92177">7,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzMtMy0xLTEtMTQ5MTE3_99d02a97-518d-4106-845a-c2e9e3c4aacb">7,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzQtMS0xLTEtMTQ5MTE3_1dfe8713-42bd-46fb-b195-b8f6cbcda299">16,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzQtMy0xLTEtMTQ5MTE3_ef8f8921-6dac-4aed-9d25-d017104ced6c">13,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Employee Benefit Obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzUtMS0xLTEtMTQ5MTE3_c55bb87d-b7e4-44d8-b416-8b5fd0c92b68">920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzUtMy0xLTEtMTQ5MTE3_8591c175-5ea8-4a7f-873f-55117149e3ae">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Income Taxes and Other Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzYtMS0xLTEtMTQ5MTE3_84fc7e31-89ba-43e6-80ac-dd5b6760e1a3">4,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzYtMy0xLTEtMTQ5MTE3_59fcbd2e-825a-4fe4-a3fd-8c58453ed1d9">5,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and Contingencies (See Note 5)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzgtMS0xLTEtMTQ5MTE3_80a6cc06-33ce-4f22-96d9-d061d5ea20d6"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzgtMy0xLTEtMTQ5MTE3_9c038dc1-458e-4d17-998a-e7417a37f31a"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDAtMS0xLTEtMTQ5MTE3_27a92972-9086-4ef8-8b3d-17bc0b69d767">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDAtMy0xLTEtMTQ5MTE3_6266256b-4e6c-461c-84ac-1aa23b34c887">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock &#8212; $<ix:nonFraction unitRef="usdPerShare" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMTY0OTI2NzQ0MTgyNA_4b51e3e9-d031-4c9a-80de-b0b03d931139"><ix:nonFraction unitRef="usdPerShare" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMTY0OTI2NzQ0MTgyNA_b70c915c-4ef2-44b4-8d80-21844fbece7b">1</ix:nonFraction></ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">par value; authorized &#8212; <ix:nonFraction unitRef="shares" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMTY0OTI2NzQ0MTgyNw_26d837c5-9539-4c9b-bae6-766d58997244"><ix:nonFraction unitRef="shares" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMTY0OTI2NzQ0MTgyNw_9049aba7-8c61-487c-bda6-7d53141219e1">640,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">; issued &#8212; <ix:nonFraction unitRef="shares" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMjE5OTAyMzI1NTcxOA_026388fe-6dd2-4239-bd4f-008119ffb66c"><ix:nonFraction unitRef="shares" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMjE5OTAyMzI1NTcxOA_23340a34-4c15-44e8-a444-29afe88d2b9b">364,639,901</ix:nonFraction></ix:nonFraction> shares in March&#160;31, 2023 and September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMS0xLTEtMTQ5MTE3_ed22dde8-a043-44a0-8241-cc2ec58825bf">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMy0xLTEtMTQ5MTE3_7f778c4e-02a4-45d2-a1bf-14716f7751e0">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDItMS0xLTEtMTQ5MTE3_8cc3ec89-7430-4392-9c74-c1a1f22e6118">19,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDItMy0xLTEtMTQ5MTE3_195afbfe-64be-43d5-9263-8daade370fe8">19,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDMtMS0xLTEtMTQ5MTE3_afc3a1c5-b68b-454f-b6ac-6613fbe06739">15,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDMtMy0xLTEtMTQ5MTE3_d3248ad2-c901-4c94-9c16-3616785130d7">15,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="bdx:CommonStockSharesHeldInEmployeeTrust1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDQtMS0xLTEtMTQ5MTE3_e4c6faee-4617-4ad0-a0f3-97135d14ae04">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="bdx:CommonStockSharesHeldInEmployeeTrust1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDQtMy0xLTEtMTQ5MTE3_e83a1448-d306-48ab-8015-5920b1493ded">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDUtMS0xLTEtMTQ5MTE3_7840cff1-765f-4246-89de-040f6959774c">8,327</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDUtMy0xLTEtMTQ5MTE3_728a272c-2df8-48b6-9a62-edc441db29c4">8,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDYtMS0xLTEtMTQ5MTE3_b3db876d-85c3-4216-b869-f5b28beb3acd">1,575</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDYtMy0xLTEtMTQ5MTE3_3f8009c8-5399-44ee-931b-1dadfb29ec63">1,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Shareholders&#8217; Equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDctMS0xLTEtMTQ5MTE3_f7b4e8df-c3a3-41b9-b251-494e30cca2cf">25,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDctMy0xLTEtMTQ5MTE3_a547caff-299e-4f72-b264-51c0dba7cdf5">25,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Shareholders&#8217; Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDgtMS0xLTEtMTQ5MTE3_7a3275d0-b204-450d-96ee-24085168adcf">54,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDgtMy0xLTEtMTQ5MTE3_e6f3a1a4-14b4-4265-963f-4f639a5649f2">52,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMy0xLTEtMS0xNDkxMTc_2f7aabfb-e4e6-4947-9459-ef0d59f60c9d">969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMy0zLTEtMS0xNDkxMTc_6aaa18d6-4c7b-4ac7-aabd-a95c9ef2288c">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Income from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNC0xLTEtMS0xNDkxMTc_e152fc48-35e7-44e5-b8bd-318b90519fc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNC0zLTEtMS0xNDkxMTc_597e067c-e049-450b-82fe-20903731abfc">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNS0xLTEtMS0xNDkxMTc_dedcb556-24c4-4af0-b7e6-b0eaee95f547">969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNS0zLTEtMS0xNDkxMTc_899e1c31-712c-4b71-8dd2-6d2dc99d48e3">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to net income from continuing operations to derive net cash provided by continuing operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNy0xLTEtMS0xNDkxMTc_984c463b-8ad3-48a8-a868-58f6163f199e">1,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNy0zLTEtMS0xNDkxMTc_89109b41-74a9-4961-a56b-045bafd485b5">1,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfOC0xLTEtMS0xNDkxMTc_26bfca9b-8db5-4adc-888a-a25b68ee51ad">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfOC0zLTEtMS0xNDkxMTc_cfb1cbd5-16ba-457f-8696-37d3ea32b574">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfOS0xLTEtMS0xNDkxMTc_a19a87fb-3c8f-4234-bb1c-54910aacd9bd">325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfOS0zLTEtMS0xNDkxMTc_f43e4ee3-11e7-4f3a-8105-e75506dcb611">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInOperatingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTAtMS0xLTEtMTQ5MTE3_eeb74707-70e7-4704-85cd-52897a11310d">1,274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOperatingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTAtMy0xLTEtMTQ5MTE3_cb4f8b29-fcb1-47ca-95f5-b8790cdfe5c9">1,076</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="bdx:IncreaseDecreaseinPensionBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTEtMS0xLTEtMTQ5MTE3_d600ffdf-8b86-42c0-a9f3-45d68cef6725">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" sign="-" name="bdx:IncreaseDecreaseinPensionBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTEtMy0xLTEtMTQ5MTE3_1b7c16f3-c957-4304-bd8c-f80a40436af5">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTUtMS0xLTEtMTQ5MTE3_9d31b706-7a43-4ee9-ab61-39ff0b54d8dc">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTUtMy0xLTEtMTQ5MTE3_b2366867-3e5d-4f0f-9822-339e7572c9da">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by Continuing Operating Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTYtMS0xLTEtMTQ5MTE3_425dd271-9af4-40bf-b32b-33abee18098e">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTYtMy0xLTEtMTQ5MTE3_ac1856b0-ad9a-480e-8abb-fb08d4d15b6c">820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTgtMS0xLTEtMTQ5MTE3_b678d00d-29cb-44ff-99bf-aad9a47bfc5f">389</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTgtMy0xLTEtMTQ5MTE3_fb62afa6-4e5a-40d0-9419-8970ea3606f6">405</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjEtMS0xLTEtMTQ5MTE3_53f6507a-79c8-45e0-b428-c56e654c1b5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjEtMy0xLTEtMTQ5MTE3_9f416010-9ab3-4daa-975e-4ec3b0d16809">450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjMtMS0xLTEtMTQ5MTE3_32d994e3-6bae-486e-a223-a26c5166a127">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjMtMy0xLTEtMTQ5MTE3_9a8b44bb-0169-4aed-ae9b-3bcaea0c520c">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Used for Continuing Investing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjQtMS0xLTEtMTQ5MTE3_13f4ac7e-8832-4b4a-9244-350db7ce1839">524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjQtMy0xLTEtMTQ5MTE3_a5dc4442-351e-42ff-98b2-085426912fbb">979</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financing Activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in short-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjYtMS0xLTEtMTQ5MTE3_8218b90b-b4b9-42b3-a600-c1a4265a35f9">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjYtMy0xLTEtMTQ5MTE3_13c44798-9827-45e5-abf0-b4f303559884">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjctMS0xLTEtMTQ5MTE3_5dd9cf29-f2a4-4c5a-9bb8-3fee1434d336">1,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjctMy0xLTEtMTQ5MTE3_337dce12-2cf3-4984-b84e-021303e6c9b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution from Embecta Corp. (see Note 2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="bdx:ProceedsFromSpinoffTransaction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjgtMS0xLTEtMTQ5MTE3_8135f745-a7c5-4a40-879d-a41ed8e7174c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="bdx:ProceedsFromSpinoffTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjgtMy0xLTEtMTQ5MTE3_20bfd7c6-d688-401c-b70e-1577a6d1be03">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzEtMS0xLTEtMTQ5MTE3_a925e6bb-4fc8-488f-88a7-cbe66ec481fc">529</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzEtMy0xLTEtMTQ5MTE3_29805b22-6ed5-4b9b-a471-9ab42ced4965">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzQtMS0xLTEtMTQ5MTE3_e6d719f4-0344-4f71-a466-c9cf11479c0c">563</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzQtMy0xLTEtMTQ5MTE3_bbc838e0-9efc-42df-a69a-d11b854ba09d">541</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzUtMS0xLTEtMTQ5MTE3_53f1defb-809f-43bf-aec2-181299aa0484">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzUtMy0xLTEtMTQ5MTE3_506e53c8-3307-4d55-b530-0114efbdc07a">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by Continuing Financing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzYtMS0xLTEtMTQ5MTE3_48e0bd9b-2534-4352-8ac9-02d74b938ca4">835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzYtMy0xLTEtMTQ5MTE3_66d3bdac-59cd-4a93-a030-b097e021edb6">659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Discontinued Operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzgtMS0xLTEtMTQ5MTE3_d77c74b8-ef86-4fa0-a2da-941aa89dde71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzgtMy0xLTEtMTQ5MTE3_6de9edac-9ecf-4908-be42-93e0dc0d1a30">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzktMS0xLTEtMTQ5MTE3_548220da-3372-45d2-bbd9-29fa38ef21cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzktMy0xLTEtMTQ5MTE3_486d4011-24a5-4574-86cf-2bc11f5eda6e">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDAtMS0xLTEtMTQ5MTE3_f5671190-ba04-4767-9eeb-71406db27a8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDAtMy0xLTEtMTQ5MTE3_dc00a919-3087-485a-87f7-2420691c23a3">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by Discontinued Operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDEtMS0xLTEtMTQ5MTE3_31993be6-bedf-43a2-8cc5-978e52de1ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDEtMy0xLTEtMTQ5MTE3_afc9f1e9-6735-4cbd-9b14-6b34e5a707c1">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDItMS0xLTEtMTQ5MTE3_dc522829-e486-4a5a-8f12-491a9bd73875">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDItMy0xLTEtMTQ5MTE3_2b32be12-e30b-4fe9-817b-0fc6cb343919">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDMtMS0xLTEtMTQ5MTE3_c3498db5-f310-44ed-bc3e-9741efa78d07">909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDMtMy0xLTEtMTQ5MTE3_37199dce-4020-4f6e-9022-b287a476c239">928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening Cash and Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDQtMS0xLTEtMTQ5MTE3_ca46ae5a-0fb0-40fd-90e7-213f30ea1150">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i798de8f735874f948c11fa53069df187_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDQtMy0xLTEtMTQ5MTE3_a59a2aa0-06d1-483d-8ca9-4328c702be03">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing Cash and Equivalents and Restricted Cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDUtMS0xLTEtMTQ5MTE3_13f338db-6b26-4ac9-9cbb-58295de49854">2,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88f747ff4b7f43869b7fa5bb86a41c80_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDUtMy0xLTEtMTQ5MTE3_15e6f277-790b-4aa7-ab9f-ac19404b0ccc">3,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023</span></div><div id="ic901e28da78f443cab3564a79902c5bb_31"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zMS9mcmFnOmU2NWExZDExMGVkYzQ5ZTBhYzgzNzQ5OTU4OTY2NzQzL3RleHRyZWdpb246ZTY1YTFkMTEwZWRjNDllMGFjODM3NDk5NTg5NjY3NDNfMTg3Mw_9c6aaf41-6e1f-45bd-a7c2-cfcf03e629cb" continuedAt="id7d40e393622431a9989ee676244d94e" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="id7d40e393622431a9989ee676244d94e"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, in the opinion of the management of Becton, Dickinson and Company (the "Company" or "BD"), include all adjustments which are of a normal recurring nature, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented. However, the financial statements do not include all information and accompanying notes required for a presentation in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#8217;s 2022 Annual Report on Form 10-K.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company. The historical results of the Diabetes Care business (previously included in BD&#8217;s Medical segment) that was contributed to Embecta Corp (&#8220;Embecta&#8221;) in the spin-off, as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in the Company&#8217;s condensed consolidated financial statements for the three and six months ended March 31, 2022. Additional disclosures regarding the spin-off are provided in Note 2.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div></ix:continuation><div id="ic901e28da78f443cab3564a79902c5bb_34"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RleHRyZWdpb246YThhMzVmMWEyYmJiNDY3MjhkZTAzZmI4NTEwOTFjOWVfMjcxNA_91969039-c6f0-4a71-938e-2a3260c6a6eb" continuedAt="i84b56a6775bd43d599ec7be35941a833" escape="true">Spin-Off of Embecta Corp.</ix:nonNumeric></span></div><ix:continuation id="i84b56a6775bd43d599ec7be35941a833" continuedAt="i7be337cd38f94ad58ee63a5c344c4b03"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta through a distribution of Embecta&#8217;s publicly traded common stock (listed on NASDAQ under the ticker symbol &#8220;EMBC&#8221;) to BD&#8217;s shareholders of record as of the close of business on March 22, 2022 (the &#8220;record date&#8221;). The Company distributed one share of Embecta common stock for every five common shares of BD outstanding as of the record date and shareholders received cash in lieu of fractional shares of Embecta common stock. BD retained no ownership interest in Embecta subsequent to the spin-off. The distribution is expected to qualify and has been treated as tax-free to the Company and its shareholders for U.S. federal income tax purposes.  On March 31, 2022, Embecta used a portion of the proceeds from its financing transactions to make a cash distribution of approximately $<ix:nonFraction unitRef="usd" contextRef="i9c3c3fab267a46a88f3f39dfcc2cf90a_I20220331" decimals="-6" name="bdx:DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RleHRyZWdpb246YThhMzVmMWEyYmJiNDY3MjhkZTAzZmI4NTEwOTFjOWVfMTY0OTI2NzQ0NTEzMg_ac62a791-7176-4098-8e4d-0424c827117d">1.266</ix:nonFraction>&#160;billion to the Company.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off. Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and supply agreements, a lease agreement, a distribution agreement to support commercial operations, a logistics services agreement and other agreements including an employee matters agreement and a tax matters agreement. Under these agreements, the Company will continue to provide certain products and services to Embecta following the spin-off. The agreements do not provide the Company with the ability to influence the operating or financial policies of Embecta subsequent to the spin-off date. Amounts included in the Company&#8217;s condensed consolidated statements of income during the three and six months ended March&#160;31, 2023 as a result of these agreements were</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> immaterial.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7be337cd38f94ad58ee63a5c344c4b03" continuedAt="i864c02d5d8b64c42b3904e8bcf7bd5d9"><div style="margin-top:9pt"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RleHRyZWdpb246YThhMzVmMWEyYmJiNDY3MjhkZTAzZmI4NTEwOTFjOWVfMjcxNQ_8044e44c-f311-47fc-9e6c-efe14339565b" continuedAt="ibf2a7619a7874b0db09823bdd9fa895c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are as follows:</span></ix:nonNumeric></div><div style="margin-top:6pt;text-align:center"><ix:continuation id="ibf2a7619a7874b0db09823bdd9fa895c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.309%"><tr><td style="width:1.0%"></td><td style="width:67.283%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.820%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.821%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMi0zLTEtMS0xNDkxMTc_af31ed31-8521-4bbb-bb7d-c8a09c383c69">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMi01LTEtMS0xNDkxMTc_76e3646c-806e-4f1a-8bf5-9c9b386432c2">538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMy0zLTEtMS0xNDkxMTc_aed91252-b15d-458c-9ffc-004b4ac0ffed">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMy01LTEtMS0xNDkxMTc_4cb8cc38-9fbe-4f87-81c7-09239c8fad2b">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNC0zLTEtMS0xNDkxMTc_a1f9e388-852b-4600-b53e-9a061572b8cc">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNC01LTEtMS0xNDkxMTc_c3c96660-dcd1-4f28-a486-b26c99777292">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNS0zLTEtMS0xNDkxMTc_9129996e-209f-48d8-a473-ad07bf3e2a43">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNS01LTEtMS0xNDkxMTc_504a0f8c-926d-4468-9ee6-119300767ec5">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" sign="-" name="bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNy0zLTEtMS0xNDkxMTc_143f91e7-3a79-4b3e-ba3d-85bf43444055">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" sign="-" name="bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNy01LTEtMS0xNDkxMTc_80322b03-fdfd-4e1a-9cc7-b10db78f07b5">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfOC0zLTEtMS0xNDkxMTc_5b38756a-8d6a-4755-91c2-4c43fafd72fe">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfOC01LTEtMS0xNDkxMTc_71e8b26c-529d-4ea8-9fbe-341f40c9ea3c">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfOS0zLTEtMS0xNDkxMTc_ef2a9f2b-17e9-40e4-bab2-4e7a8a506f3e">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfOS01LTEtMS0xNDkxMTc_abbd2838-5813-40f2-bcd6-ff1e76be06db">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTAtMy0xLTEtMTQ5MTE3_999eaa2c-a6a6-4eb3-9277-81dfa5450a12">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTAtNS0xLTEtMTQ5MTE3_e3e04480-d7b3-4d18-90dd-b5ef1bb2a985">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations Before Income Taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTMtMy0xLTEtMTQ5MTE3_94d119cf-745b-47be-bcd9-e26d9146853c">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTMtNS0xLTEtMTQ5MTE3_b1bc8b46-4847-4ee1-adf5-01777570a95f">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTQtMy0xLTEtMTQ5MTE3_89237e4e-db4e-4d49-bdd1-9d4596b0d7b5">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTQtNS0xLTEtMTQ5MTE3_c05c1419-f198-452e-967e-e84ee0f382fa">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations, Net of Tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTUtMy0xLTEtMTQ5MTE3_a453af54-c4bc-4cdf-9b94-584b32f0d9f2">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTUtNS0xLTEtMTQ5MTE3_6ed322e5-4330-4d9a-92b0-0a1c9600b81f">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="margin-top:9pt"><ix:continuation id="i864c02d5d8b64c42b3904e8bcf7bd5d9" continuedAt="ie4d7be354ea54831a47a01a693dcb146"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended March&#160;31, 2022, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RleHRyZWdpb246YThhMzVmMWEyYmJiNDY3MjhkZTAzZmI4NTEwOTFjOWVfMjE5OTAyMzI1ODMzNg_83885d53-8466-4575-b146-f1c12ca85477">53</ix:nonFraction>&#160;million and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RleHRyZWdpb246YThhMzVmMWEyYmJiNDY3MjhkZTAzZmI4NTEwOTFjOWVfMjA0Nw_d2cfe6fd-f2af-428b-ac86-9816b693c3df">78</ix:nonFraction>&#160;million, respectively,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of separation costs, including those for consulting, legal, tax and other advisory services associated with the spin-off, which were previously recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense (income), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These amounts were recast as components of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income from Discontinued Operations, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as detailed above</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The amounts of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie4d7be354ea54831a47a01a693dcb146"> from discontinued operations detailed above include previously eliminated intercompany transactions that occurred between BD and Embecta, which resulted in a third-party sale in the same period.</ix:continuation>     </span></div><div id="ic901e28da78f443cab3564a79902c5bb_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RleHRyZWdpb246Mjc4OTAxMmQxYTU1NDg3YWFiNDkxYzU2ZjE1MDg0NTRfMTc0Nw_18397658-b000-462b-bcf2-a4e836bd2db2" continuedAt="iaa6729c600694763bf851e8df51fa17e" escape="true">Shareholders' Equity</ix:nonNumeric></span></div><ix:continuation id="iaa6729c600694763bf851e8df51fa17e" continuedAt="i8dbaf0510ec64d6d937df0e07d1b3e8e"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RleHRyZWdpb246Mjc4OTAxMmQxYTU1NDg3YWFiNDkxYzU2ZjE1MDg0NTRfMTc0OA_cee6e82a-153c-48ce-811e-91d7204d18d5" continuedAt="i18fe6b253ffc4256acaacc150181f99f" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:35.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.027%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2574ec0c91f14c3f937606f7e1fa9cff_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi0xLTEtMS0xNDkxMTc_e4c19846-d296-46e7-a039-68644ad1304f">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85998d24a6604a978712c8df1da2a7c9_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi0zLTEtMS0xNDkxMTc_04d29ac7-b0b9-47d6-9185-dd0ec69fd291">19,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8832464205e4aec9d9dc8cdc63dcb72_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi01LTEtMS0xNDkxMTc_51b5bfeb-f823-4b8d-aa5f-c74c354d0986">15,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id83705567a26476994261cc7b5a25d33_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi03LTEtMS0xNDkxMTc_0bbba762-3033-40f9-ab58-349a70cddf0e">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2f12e83843f74a02ae51ea3d6b8a6a20_I20220930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi05LTEtMS0xNDkxMTc_d354a63d-5186-42c6-8a1a-20423d609b9c">81,283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f12e83843f74a02ae51ea3d6b8a6a20_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi0xMS0xLTEtMTQ5MTE3_c9238249-b782-44be-952b-5ffae3b70e31">8,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671cc096e3784769a513d12258a4a23c_D20221001-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMy01LTEtMS0xNDkxMTc_81373c45-a2b8-42ee-b589-d454a6c92133">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="i7c23e44aea374d2fb54a3b6aedeadc11_D20221001-20221231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNC0wLTEtMS0xNDkxMTcvdGV4dHJlZ2lvbjo4N2Q2YTNjZDIxNjM0YzNiYjdhNDY2MzQzYzE0OTczNF8yMg_f3ec6c39-93aa-4b11-a072-52a27e6ccaa5">0.91</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671cc096e3784769a513d12258a4a23c_D20221001-20221231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNC01LTEtMS0xNDkxMTc_351d5853-dc31-4ea0-a770-303e3afa9e22">259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671cc096e3784769a513d12258a4a23c_D20221001-20221231" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNS01LTEtMS0xNDkxMTc_455a6848-f9bf-4afa-865b-c3311f9966e2">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia116d571cab942aeb5f677df8f19d44c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNi0zLTEtMS0xNDkxMTc_adc1b275-77b4-4e0e-8e59-a7c6745d7ff6">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15828c3d0e91477790a5db6c52c366cc_D20221001-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNi05LTEtMS0xNDkxMTc_bc041931-7754-4756-87f9-dcc375898148">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15828c3d0e91477790a5db6c52c366cc_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNi0xMS0xLTEtMTQ5MTE3_3dc8b425-04b8-4efb-a602-de140e4823cc">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia116d571cab942aeb5f677df8f19d44c_D20221001-20221231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNy0zLTEtMS0xNDkxMTc_14db326f-e7ef-4687-ad65-c249562366a8">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i15828c3d0e91477790a5db6c52c366cc_D20221001-20221231" decimals="-3" sign="-" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfOC05LTEtMS0xNDkxMTc_40bdfa8a-2aad-4c87-a270-c40745b568c9">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1646e6cae76e477ea277db5cfc3e2db2_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtMS0xLTEtMTQ5MTE3_a8183193-59e4-43cf-a704-a71523e946fb">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8944e67417c44f49a70a8c33ea2603c_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtMy0xLTEtMTQ5MTE3_9b4a5bbb-1f6d-4da4-bbaf-bbb483a3ec3d">19,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a00598163e14d4ba75663154d5576e6_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtNS0xLTEtMTQ5MTE3_173cf6c4-ab76-4899-9975-a60ddd312a6a">15,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093e1c6251c446969afe57366b0f9d4f_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtNy0xLTEtMTQ5MTE3_a341d946-b1f3-4b79-b57f-9e91118187a7">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i868aa31ce93e406aaad8f6e77dc6b180_I20221231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtOS0xLTEtMTQ5MTE3_cab50311-a2dc-4711-83c7-a09451f47bb3">80,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i868aa31ce93e406aaad8f6e77dc6b180_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtMTEtMS0xLTE0OTExNw_c7e6eba8-868f-4ed2-a969-68e00314edf8">8,333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfd5089106d54575b654a9e7e308e583_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTItNS0xLTEtMTQ5MTE3_e9e11959-3ca7-418c-9b52-8e2def9c7bbf">460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTMtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246YzI5NzY4MzZjYTU4NGVhMGE5YWZiMjBiNDIzNzE2YmVfMjI_6bcb6eed-a60e-4cbb-9bcd-ff963c1fbe1b">0.91</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfd5089106d54575b654a9e7e308e583_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTMtNS0xLTEtMTQ5MTE3_9424e555-4ab4-40df-8115-602af4b6284c">259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfd5089106d54575b654a9e7e308e583_D20230101-20230331" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTQtNS0xLTEtMTQ5MTE3_0734aa4b-6a38-48e2-a490-425775c1f934">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cf7721ab8534ff39ac5f79dc98c0378_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTUtMy0xLTEtMTQ5MTE3_ed0bb620-5d2e-4946-a5e3-18d13eb8dbfb">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53fc9c3af28f47f7ab9ed1893b981c2a_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTUtOS0xLTEtMTQ5MTE3_617c54f2-eeb7-4f71-8ef8-4d576f50a6f6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fc9c3af28f47f7ab9ed1893b981c2a_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTUtMTEtMS0xLTE0OTExNw_de381790-a57a-4e01-9149-9f8c522b3e83">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf7721ab8534ff39ac5f79dc98c0378_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTYtMy0xLTEtMTQ5MTE3_84664160-542b-4bb5-ba36-39bbf5d6ab91">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53fc9c3af28f47f7ab9ed1893b981c2a_D20230101-20230331" decimals="-3" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTctOS0xLTEtMTQ5MTE3_606d4935-8068-4c80-a9f5-ed3319a4a240">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e93ba713f84c2293fdbd3f08dd5eb9_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtMS0xLTEtMTQ5MTE3_2f897f06-642e-4597-a949-5d1d12e2278d">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9161e65f73442d4a2e22bfce36dc56d_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtMy0xLTEtMTQ5MTE3_b0b12b77-7f5b-4389-9298-ba645c080108">19,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79acf93fa3e9494198d48e60df910f20_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtNS0xLTEtMTQ5MTE3_6c6af018-16b3-48fe-9415-09c3f673e2cf">15,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ca5cb05c6f4abaaba6eeeeea095bd8_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtNy0xLTEtMTQ5MTE3_1be25388-c79f-4f8e-a7c9-18d62c5b0335">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i382cb5c56e50416a96a86b779a0dd809_I20230331" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtOS0xLTEtMTQ5MTE3_669b49d1-1987-4a44-ae6d-68dedd9aaec6">80,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i382cb5c56e50416a96a86b779a0dd809_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtMTEtMS0xLTE0OTExNw_6ab65834-b537-4ca4-9a24-8fa95b147b3f">8,327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8dbaf0510ec64d6d937df0e07d1b3e8e" continuedAt="i1b0ee08f4edc4aae9345ac6133f62acc"><ix:continuation id="i18fe6b253ffc4256acaacc150181f99f"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:35.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.027%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6921b343dee4c03b1537facc8f6e180_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi0xLTEtMS0xNDkxMTc_5ff34fd8-a8b5-4245-881e-1318a9419954">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547348e51c474a16aabca1490b09fed7_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi0zLTEtMS0xNDkxMTc_c2563488-3fb9-4871-b0cc-f0a73d03434a">19,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d5b4db143146d3bb147d94438ec1fd_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi01LTEtMS0xNDkxMTc_58aa9af9-3562-4627-955d-8fb4fd8aaccb">13,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9075e2707bb44b9ebba0bff02efce052_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi03LTEtMS0xNDkxMTc_ca49c010-81dc-47b9-98b8-fdebd399f5c1">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i20cfc39ccaee446ba852752323e51724_I20210930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi05LTEtMS0xNDkxMTc_3a700d89-403e-468f-9f55-dcffab0b47a6">80,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20cfc39ccaee446ba852752323e51724_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi0xMS0xLTEtMTQ5MTE3_5f100c68-245b-49b5-ae0e-8d2f21054098">7,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3dddbf166b34f98ab399f4fcb3f2ebe_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMy01LTEtMS0xNDkxMTc_a32ede28-384d-432f-996d-e0996a276bc3">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="i336f8c4b2c4b4be4a1d5e5e1c5497d18_D20211001-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNC0wLTEtMS0xNDkxMTcvdGV4dHJlZ2lvbjoyZDUyNjA4Y2MwMjM0ZjBiOWU4YmUyYzMwM2UxNjNlN18yMg_cc7c4448-75db-4c7a-a44d-140e20f95265">0.87</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3dddbf166b34f98ab399f4fcb3f2ebe_D20211001-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNC01LTEtMS0xNDkxMTc_0d5d7081-0174-4fd8-aa6b-159acc81a752">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3dddbf166b34f98ab399f4fcb3f2ebe_D20211001-20211231" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNS01LTEtMS0xNDkxMTc_cbfcc9ff-bd56-4121-a1db-584af44bfa62">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e15f85977ce439d9169b789f07b511d_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNi0zLTEtMS0xNDkxMTc_e533df7d-1664-4d9e-ab5d-c80d83e509bb">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNi05LTEtMS0xNDkxMTc_7f943475-2005-4936-9222-a765ebc79954">762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNi0xMS0xLTEtMTQ5MTE3_9e370c7e-88fc-4be0-bac7-375ee9d31acc">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e15f85977ce439d9169b789f07b511d_D20211001-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNy0zLTEtMS0xNDkxMTc_1b7fc83c-7b66-4626-b197-14badfde0da0">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231" decimals="-3" sign="-" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfOC05LTEtMS0xNDkxMTc_3052c9e3-14dd-4d2d-b989-bbb301b246e6">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e15f85977ce439d9169b789f07b511d_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTAtMy0xLTEtMTQ5MTE3_5fe44c83-d88b-4b68-a488-89dcc34dfcc5">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTAtOS0xLTEtMTQ5MTE3_e96fa935-2118-479e-9c00-3615fc0a9d49">462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTAtMTEtMS0xLTE0OTExNw_5d1562ba-2664-49a1-bbb4-aeba9cfe3b06">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e794f49df74ce1bbe110052dc73130_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtMS0xLTEtMTQ5MTE3_fddfb3ce-220a-483c-9213-7f2f467c4756">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9feb4047fcf64ef0af2f6485859117a9_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtMy0xLTEtMTQ5MTE3_86d36064-9aa1-4d43-b18c-1d8984fc231f">19,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f99435036b34bd2a24d925a56120f91_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtNS0xLTEtMTQ5MTE3_2fec68d2-9b2e-4dd0-b78b-2569b84b4097">14,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d976db8005448e0afc273870324e7ad_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtNy0xLTEtMTQ5MTE3_2d6237df-9a32-43fd-b657-35ddb82e0544">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i76d02aecab48442e86778fa7099b3161_I20211231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtOS0xLTEtMTQ5MTE3_6a80f935-7b67-4609-907f-471b2be94c28">79,869</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76d02aecab48442e86778fa7099b3161_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtMTEtMS0xLTE0OTExNw_3449bec7-6fec-4ae6-8b46-39401eb90e36">7,855</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a0740ea75854a55b2cdec3baa4f058f_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTItNS0xLTEtMTQ5MTE3_ad74e57d-cb0c-4917-bcc6-fa9663937e55">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTMtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MWY0ZTQwM2E0NDgyNDJmOTlmZGJlY2Y5ZmY4OTY1MmRfMjI_455e84c5-a36d-451a-9a41-c334d2ade703">0.87</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a0740ea75854a55b2cdec3baa4f058f_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTMtNS0xLTEtMTQ5MTE3_594a7974-6835-44b6-822a-cd090aaa62b4">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a0740ea75854a55b2cdec3baa4f058f_D20220101-20220331" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTQtNS0xLTEtMTQ5MTE3_72eb1326-e370-4c29-af5b-3daa5a4533cf">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb38e09788ba4aecab8c912c9af71397_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTUtMy0xLTEtMTQ5MTE3_c2b1de3a-d1bc-4daf-ba56-131d8a157d4c">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i706eb0202c0e496fb7a2947d80c016d2_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTUtNy0xLTEtMTQ5MTE3_5ae2006c-6c53-4474-89a7-1a485d4a87b9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iddbd8602678b425dbb7e0ea97f55fb4b_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTUtOS0xLTEtMTQ5MTE3_43254f42-faca-4846-827d-ef4f74abbd68">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddbd8602678b425dbb7e0ea97f55fb4b_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTUtMTEtMS0xLTE0OTExNw_b9666298-d91c-4609-a887-b1ef5e4ef385">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb38e09788ba4aecab8c912c9af71397_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTYtMy0xLTEtMTQ5MTE3_4b5ec39a-06ad-4856-ad3f-65ede182b755">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb38e09788ba4aecab8c912c9af71397_D20220101-20220331" decimals="-6" name="bdx:CommonStockHeldInTrustsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTctMy0xLTEtMTQ5MTE3_9f6c6a08-8173-4411-8bcd-f1570a630c5e">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iddbd8602678b425dbb7e0ea97f55fb4b_D20220101-20220331" decimals="-3" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTctOS0xLTEtMTQ5MTE3_a97d4516-ba86-4314-8dee-434679384911">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddbd8602678b425dbb7e0ea97f55fb4b_D20220101-20220331" decimals="-6" sign="-" name="bdx:CommonStockHeldInTrustsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTctMTEtMS0xLTE0OTExNw_f4381af5-42c9-45ae-900b-1c781a49167d">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38c11f85d6c5428f8a5759883d9c4623_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktMS0xLTEtMTQ5MTE3_daee2532-bb0c-4305-b7cd-1ef47f3db9f8">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5930df7450554cf3a1702154aa7730a1_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktMy0xLTEtMTQ5MTE3_801cc7b6-59ff-4519-a99d-a98c13aca698">19,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59879870004c4696b50bacebdf8bcae1_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktNS0xLTEtMTQ5MTE3_bfda0159-18de-4959-b2a7-00f6a0a3d84d">14,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4905aacc8d41638bc2468d4a3aa787_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktNy0xLTEtMTQ5MTE3_d864355b-6996-4d9f-8134-cdecc74aeec0">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if965b175d9504baba439a1be95582e62_I20220331" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktOS0xLTEtMTQ5MTE3_2a7fa864-b54e-41ed-ba14-156430926a4d">79,575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if965b175d9504baba439a1be95582e62_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktMTEtMS0xLTE0OTExNw_676cbb6a-5e93-4e26-8a89-dd467269b109">7,866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Common stock held in trusts consists of the Company&#8217;s shares held in rabbi trusts in connection with deferred compensation under the Company&#8217;s employee salary and bonus deferral plan and directors&#8217; deferral plan. During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company&#8217;s Series C preferred shares to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business was completed on April 1, 2022.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for <ix:nonFraction unitRef="shares" contextRef="i1850d5cec6e84eb88c655caaf1c6c1c2_I20130924" decimals="-6" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RleHRyZWdpb246Mjc4OTAxMmQxYTU1NDg3YWFiNDkxYzU2ZjE1MDg0NTRfNjk4_5b6aa7f2-a7bd-43f0-ab87-a0cde741907b">10</ix:nonFraction>&#160;million shares, which has been fully utilized. In November 2021, the Board of Directors authorized the Company to repurchase up to an additional <ix:nonFraction unitRef="shares" contextRef="iafa9e6f344374994b897a26cc64ef107_I20211130" decimals="-6" name="bdx:StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RleHRyZWdpb246Mjc4OTAxMmQxYTU1NDg3YWFiNDkxYzU2ZjE1MDg0NTRfODQ2_6e927e76-2081-408d-b883-76ddaba65708">10</ix:nonFraction>&#160;million shares of BD common stock, for which there is also no expiration date.</span></div></ix:continuation></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1b0ee08f4edc4aae9345ac6133f62acc"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RleHRyZWdpb246Mjc4OTAxMmQxYTU1NDg3YWFiNDkxYzU2ZjE1MDg0NTRfMTc1MA_fe9bfc37-d3e2-48c5-801e-1258901bda48" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components and changes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the first two quarters of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"></td><td style="width:47.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMS0xLTEtMS0xNDkxMTc_3f8009c8-5399-44ee-931b-1dadfb29ec63">1,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22e38a99ac5c405ebd50cfe207177871_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMS0zLTEtMS0xNDkxMTc_89cae44f-a2a6-4173-90ee-050ee6374bd3">987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4628e244401242e9bab162e1505a9dfc_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMS01LTEtMS0xNDkxMTc_65e191aa-fbb6-4d91-b36c-122c0a05bac1">574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7858fb0adb264894a55e4fd4a4920f2d_I20220930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMS03LTEtMS0xNDkxMTc_a8adefac-566b-4b4d-8283-0a3910425c82">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c23e44aea374d2fb54a3b6aedeadc11_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMi0xLTEtMS0xNDkxMTc_bcfdf5e0-0faa-40a3-a44d-5efa2d70164a">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i460c979af9204674924048511da49f37_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMi0zLTEtMS0xNDkxMTc_6cabf589-0541-479e-b0a7-37456379da3b">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6d62e03f8b42f0baf0cd748c67b33e_D20221001-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMi01LTEtMS0xNDkxMTc_1278fa8f-ac95-4223-afaa-2e8189743a08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee28abe315584e678b6d0f8d1b55cc26_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMi03LTEtMS0xNDkxMTc_57993455-6994-42f7-8775-6acc769bac34">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c23e44aea374d2fb54a3b6aedeadc11_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMy0xLTEtMS0xNDkxMTc_e6081b4c-49bd-420d-9c84-f4183993ec58">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460c979af9204674924048511da49f37_D20221001-20221231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMy0zLTEtMS0xNDkxMTc_fefdc846-2e6b-4243-9115-df5d049623be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6d62e03f8b42f0baf0cd748c67b33e_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMy01LTEtMS0xNDkxMTc_22321ecd-e04e-44cc-bef2-915ae0ab9958">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee28abe315584e678b6d0f8d1b55cc26_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMy03LTEtMS0xNDkxMTc_cd5f85f0-2c0f-4055-94ca-7f783ccdd6a8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6484295e8f144d2ca1b524717f92829c_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNC0xLTEtMS0xNDkxMTc_c5626ba6-748a-485d-ba3e-7a9f7d2dbb5a">1,559</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3958263aac436d944c047db32c756d_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNC0zLTEtMS0xNDkxMTc_1a86af5a-ffb8-4a01-b19c-fe1907154e17">1,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ffdd529f695442cbae3dcc9fb039743_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNC01LTEtMS0xNDkxMTc_b5372c5c-8fbc-4c7f-8dfd-ac3d1b41b8cd">563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19815e83945a4850ad5382563a523f5b_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNC03LTEtMS0xNDkxMTc_a4fc9323-c92c-4b74-b84f-0ca4286eeb55">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNS0xLTEtMS0xNDkxMTc_7a964a50-571a-4109-98a3-5d7dd420be64">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0351329551fe4153b41300f0e72fb456_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNS0zLTEtMS0xNDkxMTc_b95821e0-2765-468e-8f1b-e08d0e5ce939">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife590ddfab834d788b4a069ff3e68d73_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNS01LTEtMS0xNDkxMTc_4f359fb7-b14b-4bfe-bcc6-03a42c07d999">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81ebc98ee32546b19b83fb3e2840c977_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNS03LTEtMS0xNDkxMTc_cf3bd5f8-5d27-486d-9367-12e014d59129">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNi0xLTEtMS0xNDkxMTc_abacc837-7e8d-47a1-93e3-f7922cea112c">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0351329551fe4153b41300f0e72fb456_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNi0zLTEtMS0xNDkxMTc_364581f1-7d97-40ab-843a-ba2258383f38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife590ddfab834d788b4a069ff3e68d73_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNi01LTEtMS0xNDkxMTc_4ecc0be7-fb13-4f19-bde8-35c3fa0b94aa">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ebc98ee32546b19b83fb3e2840c977_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNi03LTEtMS0xNDkxMTc_9ef5c3ac-5907-4242-a224-ac4885b9785e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNy0xLTEtMS0xNDkxMTc_f6412d20-9f47-442d-a833-1731c560e8eb">1,575</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddd2e59573d94341b0593806ecbb2b66_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNy0zLTEtMS0xNDkxMTc_6be7b92e-e71d-4567-9e5f-3a0409bd7666">1,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7572947a7339481dbfa89e6c783ec342_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNy01LTEtMS0xNDkxMTc_e17cd644-6680-4cd8-8076-f45935afb770">552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae99b2183b243ea802f1c0ed0b8683a_I20230331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNy03LTEtMS0xNDkxMTc_5ac7823f-ddd4-45ab-9147-b902f92d14a9">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"><tr><td style="width:1.0%"></td><td style="width:47.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i798de8f735874f948c11fa53069df187_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMS0xLTEtMS0xNDkxMTc_ea1aa7de-acd3-4bbd-b897-5027e80700bc">2,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34563c7f6e514f3db19ecc98619eddd9_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMS0zLTEtMS0xNDkxMTc_2037dd24-d3cf-4b46-9bd8-8b6aafd70c98">1,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9e294f037204c3cbf4ef8d9020868bb_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMS01LTEtMS0xNDkxMTc_f4724d96-1a04-4aca-b8a1-3586fc12717d">784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f33c5109e8848e994e743835c4960c0_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMS03LTEtMS0xNDkxMTc_50660e21-3309-4539-8385-1e791638293e">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336f8c4b2c4b4be4a1d5e5e1c5497d18_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMi0xLTEtMS0xNDkxMTc_21994857-0484-4e51-a213-e4c1ab2a6354">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i393529c2cae1491ebcb200f597fe10b6_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMi0zLTEtMS0xNDkxMTc_ee3fdd99-acca-455e-b808-250e38b3be9c">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ff75f2224d450085c05c8c295a92e6_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMi01LTEtMS0xNDkxMTc_7ec18b1b-b860-4f11-8e46-e8d4a51a5c3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2eccb757d0246f0b29f6b496ee41a6f_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMi03LTEtMS0xNDkxMTc_0f23fe09-8b9f-41c3-8515-041a8e988540">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336f8c4b2c4b4be4a1d5e5e1c5497d18_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMy0xLTEtMS0xNDkxMTc_bb9d0480-dbbf-4899-b26f-77f31eb3a11f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i393529c2cae1491ebcb200f597fe10b6_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMy0zLTEtMS0xNDkxMTc_e8b470bc-d736-42e1-b89f-d323c95b522a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ff75f2224d450085c05c8c295a92e6_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMy01LTEtMS0xNDkxMTc_7a40d330-80b7-4db2-830f-89b6b9b953c1">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2eccb757d0246f0b29f6b496ee41a6f_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMy03LTEtMS0xNDkxMTc_820a3616-e3d6-47c0-b8b9-5b634df51641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57ce0d1979c14028a69248c8a1c3d791_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNC0xLTEtMS0xNDkxMTc_9325703a-eadf-437c-8310-c17b2fa26174">2,043</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie11149ff1cbe4132939e7ba61c7ab73b_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNC0zLTEtMS0xNDkxMTc_a1f8b58a-c81b-4bb0-8554-eb724268bbb3">1,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id309abc3d0f943158c9c635b60c3eb5f_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNC01LTEtMS0xNDkxMTc_060e2bf7-7919-4bd8-976b-cb022e33290a">774</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i262febcea4f54f9dbc968f38708aba55_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNC03LTEtMS0xNDkxMTc_84cd9828-2bc5-41f0-b09a-657d773499e2">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNS0xLTEtMS0xNDkxMTc_bda00eae-2ece-4ed0-959a-fdf987144ace">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac52748f1bd40758c972a0bcd5b63b8_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNS0zLTEtMS0xNDkxMTc_25d41c3e-3322-44df-9fd6-6f40dd31f240">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id944a60370e646709b33b07adb648682_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNS01LTEtMS0xNDkxMTc_72bda1c1-6a94-4900-a2cd-1caa761ecad6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f262081f40a4906ba90bc6c1a7ee290_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNS03LTEtMS0xNDkxMTc_de8cd2e9-ee2e-43ba-91fd-8399521f6e47">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNi0xLTEtMS0xNDkxMTc_4299b8a3-46e2-4094-8d81-0b0e84c9c19f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac52748f1bd40758c972a0bcd5b63b8_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNi0zLTEtMS0xNDkxMTc_4564f5fb-4ff2-42c2-bb9d-d84b17c1bde1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id944a60370e646709b33b07adb648682_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNi01LTEtMS0xNDkxMTc_b40d8487-769a-4aff-b8bc-9d3d3732fc62">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f262081f40a4906ba90bc6c1a7ee290_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNi03LTEtMS0xNDkxMTc_2cb4d47d-66ef-4fda-9a9c-32740ea15b14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88f747ff4b7f43869b7fa5bb86a41c80_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNy0xLTEtMS0xNDkxMTc_19f17c3c-5e32-43e0-83d5-54f7fa991d8d">1,910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83f3c899736b48bdb1be13f9cb594bc1_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNy0zLTEtMS0xNDkxMTc_5749a7af-51da-4d74-8ff0-02d7060a3894">1,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87f59be873544367bac32f07887de058_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNy01LTEtMS0xNDkxMTc_4caa9d8d-ee68-4392-970e-914a19fc9e9b">763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a175b22e49a4de78fd2e4b373cdb8d7_I20220331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNy03LTEtMS0xNDkxMTc_4080ce1b-9ea4-4ed9-85e4-17f929a7a85c">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of foreign currency translation recognized in other comprehensive income during the three and six months ended March&#160;31, 2023 and 2022 included net (losses) gains relating to net investment hedges. The amounts recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022 are primarily related to forward starting interest rate swaps. Additional disclosures regarding amounts the Company recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022 are provided in Note 11.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impacts for amounts recognized in other comprehensive income (loss) before reclassifications and for reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to benefit plans and cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results.</span></div></ix:continuation><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"><tr><td style="width:1.0%"></td><td style="width:48.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.826%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RleHRyZWdpb246NDQyMDlkYzgxNTRmNDEyNGJhZTdlZjY5YjIzN2MwYTJfNDU0_dd5a5c21-0aad-463c-8ee8-0510e4cbff5d" continuedAt="i5446472430424e4285b5b5042b37be94" escape="true">Earnings per Share</ix:nonNumeric></span></div><ix:continuation id="i5446472430424e4285b5b5042b37be94"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RleHRyZWdpb246NDQyMDlkYzgxNTRmNDEyNGJhZTdlZjY5YjIzN2MwYTJfNDU2_9e1754d5-c6e5-406b-bbb9-cbdbbaae5d14" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:49.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.512%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMi0xLTEtMS0xNDkxMTc_41bf5ef0-7a6b-40b1-99af-268fae7fae31">284,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMi0zLTEtMS0xNDkxMTc_83629d01-a630-4df2-b7f1-acb0c9d1e11a">285,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMi01LTEtMS0xNDkxMTc_cb99f2a2-3e00-4891-a33d-87dfd75ba047">284,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMi03LTEtMS0xNDkxMTc_715a9e89-86cc-4b7c-bc2a-28f0ec1c7ab6">284,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from share-based plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMy0xLTEtMS0xNDkxMTc_27151d00-d40f-4428-bd43-8274426f055a">1,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMy0zLTEtMS0xNDkxMTc_6285226a-f2da-4fed-be66-8b1f216fb9ae">2,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMy01LTEtMS0xNDkxMTc_19d4377f-345b-4ce0-83e4-8449f561c012">1,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMy03LTEtMS0xNDkxMTc_a802d434-c78d-4d89-a1b5-0d363fc4d886">2,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from Series C preferred shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNC0xLTEtMS0xNDkxMTc_4faa33dd-88c8-444d-b879-4afcdd99e1c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNC0zLTEtMS0xNDkxMTc_1df34ab3-924c-442f-8f92-36042f6525ee">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNC01LTEtMS0xNDkxMTc_f272e895-9cbe-44b7-8277-819b0d8366ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNC03LTEtMS0xNDkxMTc_e8487a2c-5fe4-4fc6-b62f-4f14a084fb0e">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common and common equivalent shares outstanding &#8211; assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNS0xLTEtMS0xNDkxMTc_0e9d5440-567a-4eb9-a61a-4b99aaf53c21">285,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNS0zLTEtMS0xNDkxMTc_ffbd2691-b517-472e-adcc-133740418cac">287,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNS01LTEtMS0xNDkxMTc_57fd3315-06c7-4cd1-acad-3302862d9f36">285,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNS03LTEtMS0xNDkxMTc_69e24c8c-238b-4511-b437-ccd4a7e4e90c">287,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share equivalents excluded from the diluted shares outstanding calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mandatory convertible preferred stock (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01fbd913bf3a47cba0482d35f46f5378_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOC0xLTEtMS0xNDkxMTc_3a60eca9-6d3d-41b6-b555-a96d2c21c523">6,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibad42ccfdde04dfeab3962ec66d145cd_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOC0zLTEtMS0xNDkxMTc_23d8a539-ab32-4557-9dd6-0da77c369b77">5,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23e198e459c54dbea71d1e6b83cfd466_D20221001-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOC01LTEtMS0xNDkxMTc_c3392451-84e1-4f98-adbd-42ee94420665">6,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5186e284952c4354937b2883eb1ed3c9_D20211001-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOC03LTEtMS0xNDkxMTc_1589bc80-2cbd-42ce-9748-f4e0d2ca3082">5,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based plans (c)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if312210c4d564f8ca13516875c02a909_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOS0xLTEtMS0xNDkxMTc_275653a5-21e9-41db-b65e-811813f3c16e">617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81e88067fa28438ba8960a6e5bc92844_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOS0zLTEtMS0xNDkxMTc_17b2725f-8014-407e-8bfe-14f61c7b25d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i20be471d9fcf485d8a8e25204e5c84de_D20221001-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOS01LTEtMS0xNDkxMTc_6d4d5177-735c-4b24-8b19-6b5450ee6c15">617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ce1dc78d6a642b08e49f83600f8f112_D20211001-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOS03LTEtMS0xNDkxMTc_fdbf3854-8a07-40d1-acf6-b552600df461">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business on April 1, 2022 was completed.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#8217;s common shares.</span></div></ix:nonNumeric></ix:continuation><div id="ic901e28da78f443cab3564a79902c5bb_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTQyMDU_631c28fe-f51b-4284-aa8e-3ea764622b67" continuedAt="i4e584290b805491fb349edadbff72dea" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="i4e584290b805491fb349edadbff72dea" continuedAt="i47677ec8ef7544cfbeacc3aae71715b6"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTQyMTA_0f2e8fce-e0ed-47de-bf01-d2994e2f5393" continuedAt="ieda170ea949a42e7a0c19bd4b0f4d58a" escape="true">The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations. Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries). With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#8220;CIDs&#8221;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company is defending approximately <ix:nonFraction unitRef="claim" contextRef="i185f69d2666a40e4a30b82e27d557e28_I20230331" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTc1NA_59ce5350-e51d-4067-9dca-9985662ad618">33,285</ix:nonFraction> product liability claims involving the Company&#8217;s line of hernia repair devices (collectively, the &#8220;Hernia Product Claims&#8221;). The majority of those claims are currently pending in a coordinated proceeding in Rhode Island State Court (&#8220;RI&#8221;) and in a federal multi-district litigation (&#8220;MDL&#8221;) established in the Southern District of Ohio, but claims are also pending in other state and/or federal court jurisdictions. In addition, those claims include multiple putative class actions in Canada. Generally, the Hernia Product Claims seek damages for personal injury allegedly resulting from use of the products. From time to time, the Company engages in resolution discussions with plaintiffs&#8217; law firms regarding certain of the Hernia Product Claims, but the Company also intends to vigorously defend Hernia Product Claims that do not settle, including through litigation. The outcome in any one trial is not representative of potential outcomes of all cases or claims related to the Company&#8217;s product liability matters.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The first bellwether trial in the hernia MDL resulted in a complete defense verdict in favor of the Company in September 2021.  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The second hernia MDL bellwether resulted in a $<ix:nonFraction unitRef="usd" contextRef="i17ab8a33ac194031acaea6ce23adb206_D20220401-20220430" decimals="-3" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMjgwNQ_7966f73f-b082-4649-8a5f-a8298e13f15f">255</ix:nonFraction>&#160;thousand verdict in April 2022. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The first bellwether trial in RI resulted in a $<ix:nonFraction unitRef="usd" contextRef="i85d6531a6a844787a70ff90d4a02d6d2_D20220801-20220831" decimals="-5" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMjg3OQ_ddf9a605-2390-49c5-9335-05d04a45a43d">4.8</ix:nonFraction>&#160;million verdict in August 2022, which the Company plans to appeal.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trials are currently scheduled in state and/or federal courts, including additional bellwether trials in the MDL in October 2023 </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i47677ec8ef7544cfbeacc3aae71715b6" continuedAt="i3dc333fe7c6b440ea07e3a1a60d1d62f"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and January 2024. The Company also expects additional trials of Hernia Product Claims to take place over the next 12 months in RI, including trials in September 2023 and October 2023.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also continues to be a defendant in certain other mass tort litigation. As of March&#160;31, 2023, the Company is defending product liability claims involving the Company&#8217;s line of pelvic mesh products, the majority of which are pending in various federal court jurisdictions and in a coordinated proceeding in New Jersey Superior Court. Also, as of March&#160;31, 2023, the Company is defending product liability claims involving the Company&#8217;s line of inferior vena cava (&#8220;IVC&#8221;) filter products. The majority of those claims are pending in various federal court jurisdictions after having been remanded from the MDL in the United States District Court for the District of Arizona.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In most product liability litigations like those described above, plaintiffs allege a wide variety of claims, ranging from allegations of serious injury caused by the products to efforts to obtain compensation notwithstanding the absence of any injury. In many of these cases, the Company has not yet received and reviewed complete information regarding the plaintiffs and their medical conditions and, consequently, is unable to fully evaluate the claims. The Company expects that it will receive and review additional information regarding any remaining unsettled product liability matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, a putative class action captioned Kabak v. Becton, Dickinson and Company, et al., Civ. No. 2:20-cv-02155 (SRC) (CLW), now captioned Industriens Pensionsforsikring v. Becton, Dickinson and Company, et al., was filed in the U.S. District Court for the District of New Jersey against the Company and certain of its officers. The complaint, which purports to be brought on behalf of all persons (other than defendants) who purchased or otherwise acquired the Company's common stock from November 5, 2019 through February 5, 2020, asserts claims for purported violations of Sections 10 and 20 of the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;) and Securities and Exchange Commission (&#8220;SEC&#8221;) Rule 10b-5 promulgated thereunder, and seeks, among other things, damages and costs. The complaint alleges that defendants concealed certain material information regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, allegedly rendering certain public statements about the Company&#8217;s business, operations and prospects false or misleading, thereby allegedly causing investors to purchase stock at an inflated price. After an initial without prejudice dismissal, the plaintiff filed amended pleadings, which the Company in turn moved to dismiss. Ultimately, the court permitted certain aspects of the case to proceed. An answer with affirmative defenses was thereafter filed on October 3, 2022. Discovery has commenced and plaintiff&#8217;s motion for class certification was filed on January 17, 2023. The Company believes that it has strong defenses to the allegations that were not dismissed and it intends to defend itself vigorously.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 2, 2020, a putative shareholder derivative action captioned Jankowski v. Forlenza, et al., Civ. No. 2:20-cv-15474, was filed in the U.S. District Court for the District of New Jersey by a shareholder, derivatively on behalf of the Company, against certain of the Company&#8217;s directors and officers. The complaint asserts claims for breach of fiduciary duty, violations of sections 10(b), 14(a) and 21D of the Exchange Act, and insider trading. The complaint principally alleges that the Company made misleading statements regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> infusion pumps in a proxy statement and other SEC filings. A second derivative action was filed on January 24, 2021, and the two actions were consolidated. In March 2021, the Company received letters from two additional shareholders which, in general, mirrored the allegations in the derivative actions, and demanded, among other things, that the Board of Directors pursue claims against members of management for claimed breaches of fiduciary duties. Consistent with New Jersey law, the Board appointed a special committee to review the allegations and demands in the derivative actions and demand letters. Following an investigation, the special committee determined that no action was warranted, and rejected the shareholders&#8217; demands, communicating its determination to counsel for the shareholders. On January 10, 2023, one of the two shareholders referenced above filed a separate derivative action that: (i) is generally consistent with the shareholder letter and the two prior actions; and (ii) purports to challenge the reasonableness of the special committee&#8217;s process and determination. The Company believes that is has strong defenses to these claims and intends to defend itself vigorously.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company was sued by a competitor in the Northern District of New York, alleging antitrust violations related to certain aspects of the Company&#8217;s medical delivery solutions business in a case captioned AngioDynamics, Inc. v. C. R. Bard, Inc. et al., Civ. No. 1:17-CV-0598. Trial began on September 19, 2022, resulting in a complete defense verdict for the Company on October 6, 2022, from which AngioDynamics filed a notice of appeal. AngioDynamics withdrew its appeal and on February 17, 2023, the Second Circuit Court of Appeals entered an order dismissing the appeal, which preserved the trial victory and closed the case.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company received a subpoena from the Enforcement Division of the SEC requesting information from the Company relating to, among other things, Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps. The Company is cooperating with the SEC and responding to these requests. The Company cannot anticipate the timing, scope, outcome or possible impact of the investigation, financial or otherwise. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3dc333fe7c6b440ea07e3a1a60d1d62f" continuedAt="i61331ece1b6e4447bc1ac53de2cd4b44"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Department of Justice served the Company and CareFusion with CIDs seeking information regarding certain of CareFusion&#8217;s contracts with the Department of Veteran&#8217;s Affairs for certain products, including Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Pyxis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, in connection with a civil investigation of possible violations of the False Claims Act, and the government recently expanded the investigation to include several additional contracts. The government has made several requests for documents and interviews or depositions of Company personnel. The Company is cooperating with the government and responding to these requests. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company received a CID related to an inquiry initiated by the Northern District of Georgia in 2018.  The requests concern sales and marketing practices with respect to certain aspects of the Company&#8217;s urology business. The government has made requests for documents and has interviewed employees. The inquiry is ongoing and the Company is cooperating with the government and responding to its requests.  The Company and the government have agreed to mediation in an effort to resolve this dispute. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023, the Department of Justice served the Company with a CID seeking information regarding the Company&#8217;s Genesis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> container products in connection with an investigation of possible violations of the False Claims Act. The government has made requests for documents and the Company is cooperating with the government and responding to its requests.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company was served with a complaint from the New Mexico Attorney General, alleging violations of the state&#8217;s consumer protection laws in connection with the sales and marketing of its IVC filters. The Company&#8217;s motion to dismiss certain of the claims was granted on May 10, 2022 and discovery is proceeding as to the remaining claims. The Company intends to vigorously defend itself in the litigation. As the case is in its early stages, the Company cannot anticipate the timing, scope, outcome or possible impact at present.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company was sued in state and federal courts in Georgia by plaintiffs who work or reside near Company facilities in Covington, GA, where ethylene oxide (&#8220;EtO&#8221;) sterilization activities take place. The federal cases have been dismissed and refiled in state court. The plaintiffs in the cases seek compensatory and punitive damages. Pursuant to Georgia statute, punitive damages in these cases are generally capped at $<ix:nonFraction unitRef="usd" contextRef="i75b32e3d8e8340148d564fd167111da6_D20221001-20230331" decimals="-3" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTA2ODg_2e766885-a8e9-4876-8ae5-c706d35cb2c8">250,000</ix:nonFraction> per claimant. The cases allege a variety of injuries, including but not limited to multiple types of cancer, allegedly attributable to exposure to EtO. The Company does not believe these cases are appropriate for class action treatment and they have not been filed as such. The Company currently has approximately <ix:nonFraction unitRef="lawsuit" contextRef="ic7b1e10a6ef444648b8782378dd142ad_D20221001-20230331" decimals="0" name="bdx:NumberOfEtOSterilizationLawsuitsFiled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTEwMDU_6d942a65-dbb3-44d8-ae2f-e4b5b59f8627">220</ix:nonFraction> of such suits involving approximately <ix:nonFraction unitRef="plaintiff" contextRef="ic7b1e10a6ef444648b8782378dd142ad_D20221001-20230331" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTEwNDY_9905c6e8-739a-475f-9421-8d160baa54a4">320</ix:nonFraction> plaintiffs; approximately <ix:nonFraction unitRef="lawsuit" contextRef="i742947532c9941f6849b56745999efdf_D20221001-20230331" decimals="0" name="bdx:NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTEwNzU_1f637520-8469-4c33-b012-0e02f6866156">45</ix:nonFraction> of the cases also allege injury caused by exposure to a chemical of another defendant entirely unrelated to the Company. Three trial dates have been set in 2024. The Company has meritorious defenses and intends to defend itself vigorously and believes that future claims would generally face statute of limitations hurdles.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business. The Company believes that it has meritorious defenses to these suits pending against the Company and is engaged in a vigorous defense of each of these matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict the outcome of these other legal matters discussed above, nor can it predict whether any outcome will have a material adverse effect on the Company&#8217;s consolidated results of operations and/or consolidated cash flows. Accordingly, the Company has made no provisions for these other legal matters in its consolidated results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a potentially responsible party to a number of federal administrative proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#8220;Superfund,&#8221; and similar state laws. The Company also is subject to administrative proceedings under environmental laws in jurisdictions outside the U.S. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are underway or commencing. For several sites, there are other potentially responsible parties that may be jointly or severally liable to pay all or part of cleanup costs. While it is not feasible to predict the outcome of these proceedings, based upon the Company&#8217;s experience, current information and applicable law, the Company does not expect these proceedings to have a material adverse effect on its consolidated results of operations and/or consolidated cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Accruals</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly monitors and evaluates the status of product liability and other legal matters, and may, from time-to-time, engage in settlement and mediation discussions taking into consideration developments in the matters and the risks and uncertainties surrounding litigation. These discussions could result in settlements of one or more of these claims at any time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the following information when estimating its product liability accruals, including, but not limited to: the nature, quantity, and quality of unfiled and filed claims; the continued rate of claims being filed in certain product liability matters; the status of certain settlement discussions with plaintiffs&#8217; counsel; the allegations and documentation supporting or refuting such allegations; publicly available information regarding similar medical device mass tort settlements; historical </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i61331ece1b6e4447bc1ac53de2cd4b44"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information regarding other product liability settlements involving the Company; and the stage of litigation. Because the information that is currently available regarding product liability matters is often limited, there is inherent uncertainty and volatility relating to the Company&#8217;s estimate of product liability. As additional information becomes available, the Company records adjustments to its product liability accruals as required.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for the Company's product liability claims which are discussed above, as well as the related legal defense costs, amounted to approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTM1NzM_2195d2a4-55a9-48c7-85f1-a2556994a363">1.9</ix:nonFraction>&#160;billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTM1ODA_d5089eac-d373-48e3-8562-d246babb0b3e">2.1</ix:nonFraction> billion on March&#160;31, 2023 and September&#160;30, 2022, respectively. These accruals, which are generally long-term in nature, are largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the Company's condensed consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieda170ea949a42e7a0c19bd4b0f4d58a">In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition, and/or consolidated cash flows.</ix:continuation></span></div></ix:continuation><div id="ic901e28da78f443cab3564a79902c5bb_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMzk0OA_b6fa7402-847f-4662-ab1e-b764f32c949a" continuedAt="i9377dd640da74d46ba76fa1da932705b" escape="true">Revenues</ix:nonNumeric></span></div><ix:continuation id="i9377dd640da74d46ba76fa1da932705b" continuedAt="i185fdeeff3724b2fbce4fc3dfab50175"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policies for recognizing sales have not changed from those described in the Company&#8217;s 2022 Annual Report on Form 10-K. The Company sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products which are distributed through independent distribution channels and directly by BD through sales representatives. End-users of the Company's products include healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.</span></div><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMzk1Mw_709afed8-638a-4435-a3a5-a1dd9a167844" continuedAt="i5656c3b0f23a4aa9b1722e26001f84d8" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5656c3b0f23a4aa9b1722e26001f84d8">The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns.</ix:continuation> The Company&#8217;s rebate liability at March&#160;31, 2023 and September&#160;30, 2022 was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="bdx:ContractWithCustomerRebateLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMTQwNg_3ec9ae92-3e24-4269-a5d1-8a40ecc2fe3c">541</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="bdx:ContractWithCustomerRebateLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMTQxMw_4f253278-a97d-4b46-a004-c4ff9a671a4f">525</ix:nonFraction>&#160;million, respectively. The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Revenue Arrangements on Consolidated Balance Sheets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized contract costs associated with the costs to fulfill contracts for certain products in the Medication Management Solutions organizational unit are immaterial to the Company's condensed consolidated balance sheets. Commissions relating to revenues recognized over a period longer than one year are recorded as assets which are amortized over the period over which the revenues underlying the commissions are recognized. Capitalized contract costs related to such commissions are immaterial to the Company's condensed consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities for unearned revenue that is allocable to performance obligations, such as extended warranty and software maintenance contracts, which are performed over time are immaterial to the Company's consolidated financial results. The Company's liability for product warranties provided under its agreements with customers is not material to its condensed consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligations relative to service contracts and pending installations of equipment, primarily in the Company's Medication Management Solutions unit, represent unsatisfied performance obligations of the Company. The revenues under existing contracts with original expected durations of more than one year, which are attributable to products and/or services that have not yet been installed or provided are estimated to be approximately $<ix:nonFraction unitRef="usd" contextRef="ieadfd52ff47344dfb0623e297b9b64ac_I20230331" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMzA3MQ_620d06e8-863b-42ff-ab75-1cabb020c125">2.5</ix:nonFraction> billion at March&#160;31, 2023. The Company expects to recognize the majority of this revenue over the next <ix:nonNumeric contextRef="idedcceb572a947ea828bc036cbc9e150_I20230331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMzE1Nw_c5649e49-ef2f-43f9-b5e4-a9282e6254ff">three years</ix:nonNumeric>.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Company's Medication Management Solutions, Medication Delivery Solutions, Integrated Diagnostic Solutions, and Biosciences units, some contracts also contain minimum purchase commitments of reagents or other consumables, and the future sales of these consumables represent additional unsatisfied performance obligations of the Company. The revenue attributable to the unsatisfied minimum purchase commitment-related performance obligations, for contracts with original </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i185fdeeff3724b2fbce4fc3dfab50175"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expected durations of more than one year, is estimated to be approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i68fed519b8cd4c66b77d2a0a682a2b45_I20230331" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMzcxOA_234c7d2d-6577-47bc-9e3d-1f038ab8a35c">2.2</ix:nonFraction> billion&#160;at&#160;March&#160;31, 2023.&#160;This revenue will be recognized over the customer relationship periods.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A disaggregation of the Company's revenues by segment, organizational unit and geographic region is provided in Note 7.</span></div></ix:continuation><div id="ic901e28da78f443cab3564a79902c5bb_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMTY1Mg_ddcb17e9-9624-4a77-9c3e-57ddc7656117" continuedAt="ide73a5195c6a476f8d2df106f96b01c9" escape="true">Segment Data</ix:nonNumeric></span></div><ix:continuation id="ide73a5195c6a476f8d2df106f96b01c9" continuedAt="i29a7f9358c6d4d0f913b579c241a1667"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's organizational structure is based upon <ix:nonFraction unitRef="segment" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfODA_2502689d-625c-4549-a3e6-e36a3700b515">three</ix:nonFraction> worldwide business segments: BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional (&#8220;Interventional&#8221;). The Company's segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services. Segment disclosures are on a performance basis consistent with internal management reporting. The Company evaluates performance of its business segments and allocates resources to them primarily based upon segment operating income, which represents revenues reduced by product costs and operating expenses. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to its spin-off on April 1, 2022, the Company reported the Diabetes Care business as an organizational unit within the Medical segment. As such, historical financial information of the Medical segment has been recast in the tables below to reflect the total segment revenues and revenues from continuing operations. Revenues and operating income from the Diabetes Care business prior to its spin-off are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 2 for further information.</span></div><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMTYzOA_acbbcf5a-0711-43da-a71f-a3ef69485a62" continuedAt="i8371f690c8f641b797209b1a8659dda4" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by segment, organizational unit and geographical areas for the three and six-month periods are detailed below. The Company has no material intersegment revenues. </span></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6cfe7b18de4673af52bf049d65ba26_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC0xLTEtMS0xNDkxMTc_ca805d41-61b6-417e-834f-656851cd30d6">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c8c1c798a45e383da584c83869082_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC0zLTEtMS0xNDkxMTc_a5139dc2-3380-4d4c-af2e-00c6c0cacca5">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a4dcf151164a38b3e08ed29a9e68b0_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC01LTEtMS0xNDkxMTc_b60ab2e0-3662-4690-b014-23f72f4997f2">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i480503378bf24ffb84276d4a75ebeccf_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC03LTEtMS0xNDkxMTc_f924e8ed-6e7b-41bb-a722-fad649ec7f8f">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850e88e8269243c1868bfdf976704aa5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC05LTEtMS0xNDkxMTc_8b0ff1b7-ce39-4c98-83a5-a8c2d080b4ec">460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70224594e54407c8dd9540e8e74477c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC0xMS0xLTEtMTQ5MTE3_20e113a3-2ba5-4026-afaf-e00fa135deb0">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2a45e650ea481fb6ca48710434086b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS0xLTEtMS0xNDkxMTc_1d8db30b-e8ee-4ddd-97ae-1905980aff29">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f4a58a812d48d593df5bcd251c3825_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS0zLTEtMS0xNDkxMTc_3153bf2f-8482-4157-adfe-4186d3a1a85d">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc5cef384ba465f8ab03695864d424b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS01LTEtMS0xNDkxMTc_1456e591-fe66-469e-9284-3dccbc963af4">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90dbbe1b6674b059da0798a1fc9ea36_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS03LTEtMS0xNDkxMTc_3fd5fb78-9e5d-4eb7-ab14-fa4169dca473">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91cc5d94e87144d2a0196c9c9a1bc9c8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS05LTEtMS0xNDkxMTc_abbfb1d7-9926-46b7-84dc-8123e8c76edc">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81baf0b1c1814041b160e3e27a6f6d6d_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS0xMS0xLTEtMTQ5MTE3_ba09ded9-fa59-4772-b3e8-64e379c7494a">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb10a2eb439f431591e11fb203a7fb1b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi0xLTEtMS0xNDkxMTc_88b85663-1ea0-490c-84c5-1ff5b1781370">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb2838196d148ddb37b681f30800842_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi0zLTEtMS0xNDkxMTc_032b9866-151e-40a5-b9a5-7d7581cfde9b">394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6fee6e221a248209720d8a0e606b821_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi01LTEtMS0xNDkxMTc_409bcadc-e35f-47e9-b20a-0c46d1dc2d52">567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12c9c9d66d504014a5a55dde651ad588_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi03LTEtMS0xNDkxMTc_b4c40b5b-6f8d-4a8b-925b-af9abb50c49c">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6779e1ee9eb34798ba7826f0deb428d2_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi05LTEtMS0xNDkxMTc_043efd29-0e9c-4f1a-bd64-b43c8fc7195d">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5042268ba57746368d9792ad3b7053f5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi0xMS0xLTEtMTQ5MTE3_39c1165b-4a73-4bf5-a395-051a866f53a3">501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie714b836ac7743ceb2e70b68ac3982e7_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy0xLTEtMS0xNDkxMTc_b0a901a7-4a41-4ad9-b07d-d764a9d78ff7">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1642dd23d79c4ea2a197172a38abeb19_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy0zLTEtMS0xNDkxMTc_0acaa3dd-36cf-4154-a046-b4afb86bf818">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a102dfb15ad4d198bd87f3bc598fc50_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy01LTEtMS0xNDkxMTc_2ec31718-e9b3-4022-9a0c-a9a76a708970">2,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0c35da7f9f433891a2e11f5d381e5c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy03LTEtMS0xNDkxMTc_a64ce22c-a422-4904-b553-81e66f2c1487">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f33f7206b1249e7a4ffc0c52c4ea01b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy05LTEtMS0xNDkxMTc_ff14d52e-bbd8-46cf-bf9a-3c49d6827ff5">978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id16e4ff23fc7479ebc10e4339a6b8316_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy0xMS0xLTEtMTQ5MTE3_0734829c-a10b-4712-8129-671db85e7f76">2,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib10678e67d194aea9b79aeba4ae564b7_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtMS0xLTEtMTQ5MTE3_212435c3-5902-466c-b5ca-864b56a5aa03">422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f00ef36a864b3999035cdb8ca1ee40_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtMy0xLTEtMTQ5MTE3_1f1dc3dd-8764-4eff-b974-6fc7f26a14ae">466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4bf63d0944d4969b56d747a6c4aeb85_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtNS0xLTEtMTQ5MTE3_6563ccb1-7d64-42e9-9b50-9437ed9aaed8">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d29cbf115b4cd089b94dca6058cf55_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtNy0xLTEtMTQ5MTE3_53913aa1-31b9-43c0-a7a3-95455959f2de">618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffd3f6c968b14773be92bfcc86c33822_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtOS0xLTEtMTQ5MTE3_bc2edaeb-c0c0-4e21-9a4a-a7767208af3d">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a2ad16216754861899cd606d682d1d2_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtMTEtMS0xLTE0OTExNw_820f864d-2b73-46e2-9ce0-aad2012d189d">1,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac9e2fef4302405ab4e45ed6c9f072a2_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtMS0xLTEtMTQ5MTE3_147f8ccb-4d4e-438b-922e-dc86ce91af04">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d4dd1d35ad4ec39bf242fec7861a8d_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtMy0xLTEtMTQ5MTE3_2f86ff57-8834-4e83-a5be-3046c90e5888">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6fc50a3487452ea53c1aee2fe9c14d_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtNS0xLTEtMTQ5MTE3_5134b1e3-9543-4ca0-bc84-376d16b6a01a">386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4639b945d6594926868a1a5ff039304c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtNy0xLTEtMTQ5MTE3_9c5b7c04-7701-457a-9197-3b487b829450">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i974dfe38797443ae9e91fe0d747005d8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtOS0xLTEtMTQ5MTE3_933da8f0-6a1a-4f78-8d72-35c7677f786e">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9c34ff96cf4cc6847d29c3560db0d2_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtMTEtMS0xLTE0OTExNw_f1fed8fe-f876-4149-8b25-4df5022b10e9">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e867a4015f4a468735111b4fe9d81b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItMS0xLTEtMTQ5MTE3_3efe0217-a239-4aa4-bd5c-5db3d7ca7bd6">581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99bc7afb1cf047caaff82d8a6516065c_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItMy0xLTEtMTQ5MTE3_4faa880b-41bf-4ed5-8336-9995c152d0b0">694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830727d2878946c7a8c7364a0ae99248_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItNS0xLTEtMTQ5MTE3_4d5a5f97-d945-4e33-a00f-5188fd620e63">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa75e3193e3740ee93a99cb81d32c403_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItNy0xLTEtMTQ5MTE3_da8572df-4aa0-45fc-90b2-dfeeb0bf0c2c">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbdecd6ec9547c59053303e9f460db8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItOS0xLTEtMTQ5MTE3_385b4d61-6278-4740-b5cb-cb0f475341e5">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if875d3bce9114d8a858c7e589c047056_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItMTEtMS0xLTE0OTExNw_4b650030-ee65-49f2-ae67-c82ad6f314ca">1,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49e6649d813d4bd4bb104a487c73ea90_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtMS0xLTEtMTQ5MTE3_08fd1def-1f23-4cfd-8f27-f6f075dd6ef1">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0af07733084d968cb84d8736f680e1_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtMy0xLTEtMTQ5MTE3_3d9df253-92f4-4948-918e-dd1f9c36e9de">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib97632afcf314eb4af27293756ab1c1e_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtNS0xLTEtMTQ5MTE3_575f305f-96c0-46b0-821a-76d7750e65d8">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e000d0a8774353b9d53bade6b21fd0_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtNy0xLTEtMTQ5MTE3_afc4e756-8b9c-4ee0-a962-33f8af1606dd">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1354f7e1cf648458386b045b469c10b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtOS0xLTEtMTQ5MTE3_4c058005-5071-429a-a94f-049454772405">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i833303fa6d4c4eaf8bffbb0864a695e5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtMTEtMS0xLTE0OTExNw_8aa86511-ecf3-42a9-b0ce-03eda2183b82">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06722ea31e2b4061818de6fa498196a9_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtMS0xLTEtMTQ5MTE3_ebfed4cd-d02b-4cf5-b109-0908c0bb462e">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60c2aa29c68466aac9d1af165f3af43_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtMy0xLTEtMTQ5MTE3_4ffe90ea-308e-47a0-bd77-9a953ada9067">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88e20f23d8d1419989d15f68c97503c9_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtNS0xLTEtMTQ5MTE3_bfc537f0-d289-4401-925d-4b3a55edc953">468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9732021b95147b48552d9d3400e0eb5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtNy0xLTEtMTQ5MTE3_dc85554c-6725-43de-ad97-deab53d52b27">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id76c90ada79245109d735834db48fef0_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtOS0xLTEtMTQ5MTE3_4cf459aa-4f6e-4e0c-90c3-bee259eab862">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5693529ca4bf4fd99017046f306ad832_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtMTEtMS0xLTE0OTExNw_6d281a89-5163-4a60-a644-8c036980cde5">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibff7917a45934be1ba662f42794d4841_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctMS0xLTEtMTQ5MTE3_c014ba7e-d502-4dd7-a6ac-d79864bec70b">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04846b7cd7654f27ada57fc63f9519fb_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctMy0xLTEtMTQ5MTE3_20f74378-50d2-4a5c-8089-a1c1fe063a7a">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i812ecaa6f69a4d0bb57f4bc354aae8be_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctNS0xLTEtMTQ5MTE3_7e01ee7f-b896-406d-8ac9-5cfed8ea7e4d">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8117301a37b74e709259d5375dc30d4e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctNy0xLTEtMTQ5MTE3_4427091f-8622-48c3-880d-7b4720ae082e">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d0e86f8e82342be9d1959871d421a6e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctOS0xLTEtMTQ5MTE3_e7610d63-4c64-4e85-934d-980a2488d4dc">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaa76677d46442d6a7e1c895ce1f71f6_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctMTEtMS0xLTE0OTExNw_03bcc567-f6ed-4a32-929c-e3c69fd2eb0f">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbbee50f40c4484ae7bfad73328da8b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtMS0xLTEtMTQ5MTE3_d09973b9-7dca-4baa-8e1a-a5ea9644abf7">813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4353504b6abc40a8a4e50df3b63865ff_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtMy0xLTEtMTQ5MTE3_33dc121c-2f51-4f10-9c86-5640244487b8">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781b5ad29da34317ae891593af457aaf_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtNS0xLTEtMTQ5MTE3_b682605a-50dc-451f-bb76-afd535e516e6">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06e1a559e5074fabab4366e975d71095_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtNy0xLTEtMTQ5MTE3_3d3bf558-2fe9-4197-b4ba-c0b495fe313a">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac6febd1d5d74cf894e20097ea0c3390_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtOS0xLTEtMTQ5MTE3_871a562b-389e-4a60-884e-d36f9c366623">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c82c8da537457ba89775a6dd6f0b63_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtMTEtMS0xLTE0OTExNw_138ecf90-d504-459b-a659-9255e3222491">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from continuing operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d58f5ff4a94d7c856a21852d1578b7_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtMS0xLTEtMTQ5MTE3_f17dea4d-c26f-4c7d-ac3e-a13eee076538">2,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fe0413309b43b185ddaeb63704cdb0_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtMy0xLTEtMTQ5MTE3_446afdb0-1d46-46fa-95ac-5a2fb936ca76">2,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtNS0xLTEtMTQ5MTE3_96a52fc7-c56a-40dc-81f4-80ec2ede8719">4,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74cf5d046cdc48458773f0a0e6bf124f_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtNy0xLTEtMTQ5MTE3_5f2f412b-ecd9-47f5-955f-0e0e17e4c125">2,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c7400b54fe4071a338cdd26f00e096_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtOS0xLTEtMTQ5MTE3_1fa9be59-455f-4a9a-9f48-e2dd7528cd9d">2,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtMTEtMS0xLTE0OTExNw_347ce05c-fefc-4b85-b394-f187a2fa880c">4,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i29a7f9358c6d4d0f913b579c241a1667" continuedAt="ia09fa6afc83b4bf6b111f7645919aac3"><ix:continuation id="i8371f690c8f641b797209b1a8659dda4"><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.624%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b866a81d48541e088ce519c699ba906_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS0xLTEtMS0xNDkxMTc_fa89f386-1b27-475d-9b50-a2edb2973a93">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841975175f6d48f9998a0e2f82f4053f_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS0zLTEtMS0xNDkxMTc_1056f8a0-53f7-4e7e-ab98-313057e892b3">873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f0652aab2a42f7b530f8be482e3007_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS01LTEtMS0xNDkxMTc_beb7c7e3-66ea-4426-92a0-edc8ef3787f8">2,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf48c33124124a6384e276cfa077767c_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS03LTEtMS0xNDkxMTc_06e3c67f-a1a7-4295-a36b-86b04a8d0579">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb44f9df8a8441409d61f508251b69aa_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS05LTEtMS0xNDkxMTc_7c9c6a64-d61f-4b52-94cd-71a079f87814">936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec08bb3ff4a4875acf201b377a5a9b0_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS0xMS0xLTEtMTQ5MTE3_b98205d1-9305-4aa0-a3c0-9ddb194460e9">2,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d0373baf3640f7b41985d5833685d7_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi0xLTEtMS0xNDkxMTc_08ea338a-b5ca-4dc2-b57a-491780375520">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f23cf9a7224b2c96d80a76679ed1c7_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi0zLTEtMS0xNDkxMTc_934d55d4-e902-4b17-865d-57e2a893c8b0">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89519a3b58a4032909e18f5a356e5a1_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi01LTEtMS0xNDkxMTc_cd70a79e-ad9f-4522-8cb9-18596715a2b4">1,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ffb55ab8ff54c96b1bce767d9e6a6f7_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi03LTEtMS0xNDkxMTc_a55f4fb0-4a23-4a28-8374-9ead22c80c28">945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d6c43b47e544ef87eb3da99d03b1f8_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi05LTEtMS0xNDkxMTc_327f2ac8-e359-4227-b9ea-e8b1c4d27b89">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87cda00c76043079c6b7f0a255628d4_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi0xMS0xLTEtMTQ5MTE3_311b1d79-afd6-407a-9952-31b97bab3b2c">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9624f4572d0a44edaf5bf06b2c5e83da_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy0xLTEtMS0xNDkxMTc_4e0b9ce5-4643-40a4-b867-3b4581cc4c43">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db5726397684d848e7e71ffe39a0df9_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy0zLTEtMS0xNDkxMTc_9732d4f7-d20d-43c8-a175-078d2e176281">684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e183c9ad474d139768c9162aa1e53f_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy01LTEtMS0xNDkxMTc_4efe3b53-0e88-469b-8fc9-3d19ec466119">976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38080f49c0974324a50d6dc48d77476b_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy03LTEtMS0xNDkxMTc_16ec090a-eedb-4526-8504-7c747e26936f">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa34ed7252744dce9d3eba22fbc460f8_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy05LTEtMS0xNDkxMTc_a2ffe1e5-ad93-45d7-8d33-c9fd8884ca5a">669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77fe6f0478484e77ad34a61a2fd7bd78_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy0xMS0xLTEtMTQ5MTE3_3afab318-f959-471b-b7a6-a5e7a741730e">897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4358855e40480593e5e0d8f0a7e32b_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC0xLTEtMS0xNDkxMTc_ee6bc8fd-fa88-439b-9bf7-24ef56382e07">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36bf788445f641f087a217afce45d835_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC0zLTEtMS0xNDkxMTc_42526b1f-6b6c-45db-a4e4-17ac2146a125">1,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f2c8adfb65e496fb380376104a49088_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC01LTEtMS0xNDkxMTc_b76ac210-e8ea-4f83-a121-c85603750e3b">4,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id377017a26ec446cad1d57bd60564384_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC03LTEtMS0xNDkxMTc_ba2bb96c-c036-4a60-96ce-f31b7f62660f">2,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ff1d287bc641a68106273fcd8ed5ef_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC05LTEtMS0xNDkxMTc_b90b7a33-6aab-4610-8a0e-010ac4c668a6">1,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90ad306379a4c1599fe2b2e0c34c487_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC0xMS0xLTEtMTQ5MTE3_4f3e6fc7-4df5-4d60-a6d3-8d1b71724877">4,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbfde066976740859db427662a57e26b_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtMS0xLTEtMTQ5MTE3_f889735e-bd4e-4484-b51d-e32aa6e08d8b">930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d3d3ae80f74f4dbf461c7291881e0e_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtMy0xLTEtMTQ5MTE3_bc204bfd-5a7f-44b0-9ed5-877049f19067">911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6739aa1eaa040ea8aaddd516c1851c7_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtNS0xLTEtMTQ5MTE3_5cd736d0-81a2-4c5d-bb5b-a32b463573ed">1,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5db012c6f554b589b2cd464565b693a_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtNy0xLTEtMTQ5MTE3_6ac03dfa-53bd-4ca5-986c-2eca59cc2a43">1,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia046d9031e8949509f12a761a4224417_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtOS0xLTEtMTQ5MTE3_83155267-8daa-4237-97a7-138b96f3f1fd">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3976b2f0f14c4e810f7005d15f1f87_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtMTEtMS0xLTE0OTExNw_639848f5-816f-4cfd-9e97-6174346de924">2,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibca9b2a4d3aa462596e3df837b933591_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItMS0xLTEtMTQ5MTE3_4c24b0d8-32f1-4c9a-bda3-0d389649b20f">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e4cad3300d84f2689a1f443e74e0314_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItMy0xLTEtMTQ5MTE3_030974a8-fa09-460e-b7f6-438d73ad9840">440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0edb37cc9b764458800e90102f48a86e_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItNS0xLTEtMTQ5MTE3_0f57a35f-d65f-40f1-9420-784fb250d11b">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fe277067c2414fbf929d3d6a219636_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItNy0xLTEtMTQ5MTE3_1cebcdc6-86cc-4b0e-94ea-d47afc10ed54">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31eb79bf50ec41998fb767b6987ce2c4_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItOS0xLTEtMTQ5MTE3_f5eeac08-dbd4-4660-8e9c-ce584905e265">416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2438e94418c407792bbee2d9179b645_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItMTEtMS0xLTE0OTExNw_f84634e7-cdab-4820-b0d8-49b786c1528d">674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32ae32f54613472793706f04236ad157_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtMS0xLTEtMTQ5MTE3_e20aadfe-0387-4752-b6c6-273d181dc5a2">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdb48a107794c3980fba70b8372a30d_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtMy0xLTEtMTQ5MTE3_513e1aff-829e-4902-a38e-da0b07c29336">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0960222376b41418e431c7c966fc960_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtNS0xLTEtMTQ5MTE3_a92ef40d-1016-4505-b593-b7e3ae3e7da6">2,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i251719fc5666450f8e498d90117d7c34_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtNy0xLTEtMTQ5MTE3_6987e422-0d42-4745-b74f-3e4014893a2b">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8cdd96ead14cd69f012accd6f4cb9d_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtOS0xLTEtMTQ5MTE3_70f67556-c729-411d-b8ad-97045e10a0b9">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a0b9a3d052c46ca890a9c69797e68df_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtMTEtMS0xLTE0OTExNw_d2b2de67-8a2c-40e1-87b4-5f25947150cc">2,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78cb2306c82a4761a95fcb3e304bdb8c_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtMS0xLTEtMTQ5MTE3_8ff9cb56-c14a-444f-a004-afe9d7d8e653">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5894b055a36a458e8e85e4215a55ce54_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtMy0xLTEtMTQ5MTE3_8b740b94-ec6a-432d-b235-23e630146ab3">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i062534c0a42743d2ad7922a783a173e7_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtNS0xLTEtMTQ5MTE3_ea9f8ff1-8840-4def-a789-d00aaf954131">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd38fe9a5f124e0e8b44cb18e864a957_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtNy0xLTEtMTQ5MTE3_dafe96ec-5a2a-4888-946b-0c31b1556b66">549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee1acdcb66d4d898504b646745a30bd_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtOS0xLTEtMTQ5MTE3_8ad02ea3-060c-4a3e-acef-d5b06d0f60f1">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d0fc699d0c846a289328d4a13ae3b9f_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtMTEtMS0xLTE0OTExNw_7254dae8-9954-4e7f-bb86-292feaa6c467">701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67d3a9dbf7fa414fb11aa805abb03094_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctMS0xLTEtMTQ5MTE3_037b0726-2031-4188-9657-488f820f2ee7">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86ee63bfe8004d68970b72dd4b8b7d1a_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctMy0xLTEtMTQ5MTE3_f4dc7e96-4c24-4579-91de-d16276971682">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e6ab6ff6df496ca592e90b3d330de5_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctNS0xLTEtMTQ5MTE3_c7a74ff8-242d-4081-bbad-3d45357f6932">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f24e1d9f83e4d8eb797dd90c4d7bedf_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctNy0xLTEtMTQ5MTE3_da35df87-736a-441c-93cf-f13a0158019c">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7297cc444f4d0b8d08c060e92ae0c2_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctOS0xLTEtMTQ5MTE3_b736595b-27d1-416a-b0f3-b06e0c3e0abc">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8831acd8644cdeb56db066b2fd08a3_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctMTEtMS0xLTE0OTExNw_5d740ce2-2f95-4aad-9a87-ecdd5d07e9b3">863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09b09ea684154e4ebccff4d00f43571e_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtMS0xLTEtMTQ5MTE3_63dc309b-5578-40cb-b14d-7ad40c7551a9">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340d4b0fbfa344bfabdd8b6f46ab528f_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtMy0xLTEtMTQ5MTE3_1824c7ec-ddd6-4a09-acf4-509c936beacd">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i844e28d1b31e43c882cf05e613660ac9_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtNS0xLTEtMTQ5MTE3_b2898e30-500d-41fe-86de-52b38d1526ec">670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i937287b0005849adba3700159c44bb1c_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtNy0xLTEtMTQ5MTE3_a8b2bdf9-4245-4859-86b5-79c14a152830">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i703a5ae640f84088b9eb12321f883fcf_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtOS0xLTEtMTQ5MTE3_cc8e0aa8-a973-480c-a52c-8d34366ed787">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if00d7790a83c4d398536842126ba0870_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtMTEtMS0xLTE0OTExNw_14fa3a86-211a-41ca-9798-730c0cc2e954">661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0498cba50954a96b0f4785b9369da89_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktMS0xLTEtMTQ5MTE3_00fc0427-34d8-46ef-bd61-5147c67d6d2f">1,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f0d62528e643e486e8b63e17adcab2_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktMy0xLTEtMTQ5MTE3_099ab3d5-33f5-4707-8ddd-76753f0bac27">720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icda13f7ccb434390a542b94eedf89184_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktNS0xLTEtMTQ5MTE3_da7bf537-8d4c-46ce-95d1-29ac5fab5431">2,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8accfab0194747e99802361c4bcba9f8_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktNy0xLTEtMTQ5MTE3_3b83b0c0-2905-42fd-8394-0a86105dba09">1,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea5cc875dbfa4dd69f9ffea1d08fc7bd_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktOS0xLTEtMTQ5MTE3_f8d7f6ac-4dbb-4bc6-979c-b815af16414c">727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i068965d16303486fb4323bb08ee4bc27_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktMTEtMS0xLTE0OTExNw_d01b4878-4863-456f-aef0-99075deed1e8">2,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Company revenues from continuing operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd93e9175cc64c60bbc8a3d92a9e7649_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtMS0xLTEtMTQ5MTE3_1d094329-cf57-4eb8-854e-8f4f756012e7">5,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39cfb89f6f8b448f9b5f3bfcc58dc9dc_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtMy0xLTEtMTQ5MTE3_fcef99fa-e160-4e28-aa73-bf1605bcef66">3,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtNS0xLTEtMTQ5MTE3_3ae3870d-7805-417a-a92d-0630768a58e1">9,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1ebdedf0894f6f9d6eb7853eecb428_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtNy0xLTEtMTQ5MTE3_8657c4b7-0baa-43fc-8227-1fb613534aa1">5,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib85825c4d3c641cc99a05dc9d8c18d83_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtOS0xLTEtMTQ5MTE3_b81c1a70-5ed4-4712-84d9-10f48f96758b">4,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtMTEtMS0xLTE0OTExNw_9ef3b662-b961-4803-937e-e8377608e817">9,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div></ix:continuation><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMTY0NQ_0c10f7b1-2103-43b4-a2c1-92a3f7a5a2d3" continuedAt="i780d49762b7a4a7282c41b4cd8107e64" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment income for the three and six-month periods was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Income from Continuing Operations Before Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a102dfb15ad4d198bd87f3bc598fc50_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMy0xLTEtMS0xNDkxMTc_24b7736b-6934-4e90-95ed-3160fa3b2180">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id16e4ff23fc7479ebc10e4339a6b8316_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMy0zLTEtMS0xNDkxMTc_fcc202b2-65e6-4bf9-9cbf-9a89325a9ea6">476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f2c8adfb65e496fb380376104a49088_D20221001-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMy01LTEtMS0xNDkxMTc_febd6515-baa2-4482-9b86-ad4619675b8a">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90ad306379a4c1599fe2b2e0c34c487_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMy03LTEtMS0xNDkxMTc_b43f42a7-ba99-4484-813e-c66240838e5c">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830727d2878946c7a8c7364a0ae99248_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNC0xLTEtMS0xNDkxMTc_2fccc533-6f90-4a02-a514-614ab14b1d8c">394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if875d3bce9114d8a858c7e589c047056_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNC0zLTEtMS0xNDkxMTc_ea7aece5-e6c2-46a9-a1be-f6c85774776b">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0960222376b41418e431c7c966fc960_D20221001-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNC01LTEtMS0xNDkxMTc_ab4b34c5-58be-4449-970d-6b46dd5b05a6">827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a0b9a3d052c46ca890a9c69797e68df_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNC03LTEtMS0xNDkxMTc_1dba1b02-5bbb-45bd-8fd9-211fe581495e">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781b5ad29da34317ae891593af457aaf_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNS0xLTEtMS0xNDkxMTc_3618edbc-3da7-47c5-bd7b-adc8728b2a94">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c82c8da537457ba89775a6dd6f0b63_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNS0zLTEtMS0xNDkxMTc_19f6f79c-4318-468f-be98-265f5157b3e8">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icda13f7ccb434390a542b94eedf89184_D20221001-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNS01LTEtMS0xNDkxMTc_510d1a66-91f8-401d-b54c-bcf65116c01e">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i068965d16303486fb4323bb08ee4bc27_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNS03LTEtMS0xNDkxMTc_6815ca5c-d82a-437e-8d6a-42ae5535e13c">544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Segment Operating Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb7bc81847b84350b2fab646e9bcd447_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNi0xLTEtMS0xNDkxMTc_da741d46-7854-4cf7-ae8b-dd1c2cff6aba">1,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i255166fe111d4bd2b7b0f9c57d1e3013_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNi0zLTEtMS0xNDkxMTc_48087077-e18f-4039-adf1-c81397057e7d">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0fc6cb6378a44c4a1cd9a34c079468c_D20221001-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNi01LTEtMS0xNDkxMTc_f192bf6f-9cc8-4b7d-b6bd-3ca1c9a182ef">2,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieab59e058d394ac989a56f0af7be79db_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNi03LTEtMS0xNDkxMTc_6525a433-27af-4c22-9003-1cdbac32ffc9">2,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62acc25f7e924071a6f2be9aaaf46d77_D20230101-20230331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNy0xLTEtMS0xNDkxMTc_223fe803-6b0d-4584-88c3-328e7579677f">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf252968a2584238b4d790d9ccf2097d_D20220101-20220331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNy0zLTEtMS0xNDkxMTc_69192512-a2bb-4a0a-9db2-b4077fd6b458">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if641350edac64e2986b37525b239f9b8_D20221001-20230331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNy01LTEtMS0xNDkxMTc_a29f60bf-d930-4f7f-b50d-60056b2a7783">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i022895c1add14102909469676a06a30a_D20211001-20220331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNy03LTEtMS0xNDkxMTc_f6ef5802-6609-4472-8ca1-20f5a3dbf173">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62acc25f7e924071a6f2be9aaaf46d77_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOC0xLTEtMS0xNDkxMTc_8f59155c-ff4a-45d7-b503-d592d6240acb">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf252968a2584238b4d790d9ccf2097d_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOC0zLTEtMS0xNDkxMTc_e0e57df3-56b8-45d2-a285-ad43ebbec39e">95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if641350edac64e2986b37525b239f9b8_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOC01LTEtMS0xNDkxMTc_6ab7646c-384a-445e-aece-d2e8cabc21b8">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i022895c1add14102909469676a06a30a_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOC03LTEtMS0xNDkxMTc_647251af-0c95-4a20-8219-ca8f89c53e77">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other unallocated items (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8bcf14bc4de46d4ab342052f56f0f63_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOS0xLTEtMS0xNDkxMTc_8b63908d-ae9a-45e0-8b2e-5553587b41bd">635</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50d91ec151c8409cb91d3361be377daf_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOS0zLTEtMS0xNDkxMTc_1d95f5c1-bfc4-4d82-ac44-7d15bd639428">665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7af6142a51f740c396515df1281ab028_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOS01LTEtMS0xNDkxMTc_e3cfd5cc-8587-4f3d-83e5-bab61d452af1">1,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if415726d4f1042da942db59fd9b75797_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOS03LTEtMS0xNDkxMTc_75b7b591-16bf-4d57-b781-2ff1f4680803">1,307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income from Continuing Operations Before Income Taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMTAtMS0xLTEtMTQ5MTE3_57742137-c217-4524-9438-6cdb05cf539d">529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMTAtMy0xLTEtMTQ5MTE3_01062956-bbcd-4006-a332-7a6a75f04baa">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMTAtNS0xLTEtMTQ5MTE3_037bd451-2d40-47f3-8b71-7b2d9cf0ac1d">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMTAtNy0xLTEtMTQ5MTE3_1c64b442-b330-4e7d-82a9-1985ba3fc9e7">1,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The amounts for the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended March 31, 2022 include a charge of $<ix:nonFraction unitRef="usd" contextRef="i5d85cf2e75c44573a9069a35792fbae2_D20211001-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMjE5OTAyMzI1NzQwOA_4e1894a8-b2f5-4bfb-999f-aef5edbd41aa"><ix:nonFraction unitRef="usd" contextRef="i59035e46fc504f16bd9ced72ced1a8c3_D20220101-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMjE5OTAyMzI1NzQwOA_ee9bf3fa-04e4-492d-b38e-8e1ece5f46fd">54</ix:nonFraction></ix:nonFraction>&#160;million recorded to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to write down the carrying value of certain fixed assets in the Pharmaceutical Systems unit, as well as a charge of $<ix:nonFraction unitRef="usd" contextRef="i80186f01cae8428cb7bbf64cc561eb04_D20211001-20220331" decimals="-6" name="us-gaap:InventoryRecallExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMTY0OTI2NzQ0NDE5NA_3c9f97d5-0962-4ce6-9ad9-edd08b5eb0ac"><ix:nonFraction unitRef="usd" contextRef="i0a8a4974f9e942689ee74356ba8c98ba_D20220101-20220331" decimals="-6" name="us-gaap:InventoryRecallExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMTY0OTI2NzQ0NDE5NA_f298b512-7fee-46e7-bc2a-14ad36a32e07">35</ix:nonFraction></ix:nonFraction>&#160;million to adjust estimated future product remediation costs.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia09fa6afc83b4bf6b111f7645919aac3" continuedAt="ia2152371da484723ac7691d5b0d3618e"><ix:continuation id="i780d49762b7a4a7282c41b4cd8107e64" continuedAt="idd4b71970d71465383c828f00ddfc4bb">(b)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"><ix:continuation id="ia2152371da484723ac7691d5b0d3618e"><ix:continuation id="idd4b71970d71465383c828f00ddfc4bb">Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.</ix:continuation></ix:continuation> </span></div><div id="ic901e28da78f443cab3564a79902c5bb_52"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RleHRyZWdpb246OGMxYzA0MzE4YTM4NGIwMzk1NWNkNzIzY2FkMmQzZWFfNzcx_56a0a085-18c8-48f8-9e2c-c9c0c63f98f6" continuedAt="ib4f8555ac7aa42d4852c54b2532108e8" escape="true">Benefit Plans</ix:nonNumeric></span></div><ix:continuation id="ib4f8555ac7aa42d4852c54b2532108e8" continuedAt="icc8122cf10ed40078b4bf1a4edf8094a"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has defined benefit pension plans covering certain employees in the United States and certain international locations. The measurement date used for these plans is September&#160;30.</span></div><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RleHRyZWdpb246OGMxYzA0MzE4YTM4NGIwMzk1NWNkNzIzY2FkMmQzZWFfNzcz_d7d1bc79-343e-4c34-ba68-0050d11e96ad" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension cost included the following components for the three and six-month periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:45.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMi0xLTEtMS0xNDkxMTc_cc2d9bec-3bb5-44b3-9857-564d6740fbd2">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMi0zLTEtMS0xNDkxMTc_ab77d2f7-13df-47dc-b31a-bed4e710de02">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMi01LTEtMS0xNDkxMTc_9bcec139-fe99-4f04-a033-f1fa2c29fabf">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMi03LTEtMS0xNDkxMTc_15c7e549-b766-45da-ac39-54589a4acc86">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMy0xLTEtMS0xNDkxMTc_db4cc149-466f-4226-a142-89da3ed71086">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMy0zLTEtMS0xNDkxMTc_c78f82eb-9d2e-43fb-86f1-faac77afe813">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMy01LTEtMS0xNDkxMTc_562c49a1-2546-4154-965a-653cde1035f1">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMy03LTEtMS0xNDkxMTc_17cbe58c-8527-4e3f-963b-74693db0be72">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNC0xLTEtMS0xNDkxMTc_ba92e248-5c92-49b1-b9e2-72d875e83658">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNC0zLTEtMS0xNDkxMTc_f9cdd3d2-5925-420a-94b1-88654c018c2a">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNC01LTEtMS0xNDkxMTc_314ad441-455b-4568-936c-fa2e95004421">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNC03LTEtMS0xNDkxMTc_e0f9e573-8ebd-458a-86c9-73ffc2cfe438">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNS0xLTEtMS0xNDkxMTc_fa8c0e48-03be-426b-bc52-0905404eb4ae">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNS0zLTEtMS0xNDkxMTc_99242894-5f03-4581-bc4a-86eb87869729">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNS01LTEtMS0xNDkxMTc_ed04676d-f21a-4783-8d81-e267c0b3dffb">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNS03LTEtMS0xNDkxMTc_2c28c2e9-8f9c-4b6c-bbe3-906fa86896e9">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNi0xLTEtMS0xNDkxMTc_1116e9c7-2fb5-43a0-9e78-2f05682d2bb6">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNi0zLTEtMS0xNDkxMTc_2b26c60b-35dc-494e-8ba3-b477700616b2">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNi01LTEtMS0xNDkxMTc_94e67184-1b2c-463d-8a0e-e02a2bfc1f70">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNi03LTEtMS0xNDkxMTc_527ed179-7355-46b7-8b43-c0e8818e3af2">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNy0xLTEtMS0xNDkxMTc_9ca48b83-f314-4b7e-9517-ec0cbf8e514d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNy0zLTEtMS0xNDkxMTc_080e0534-5a0a-49d4-bbf3-3fb29523744e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNy01LTEtMS0xNDkxMTc_c0b40c7a-5c36-4dcb-a14f-51627e997037">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNy03LTEtMS0xNDkxMTc_cfc8cc0e-1890-4b4c-a4ca-8d060d43024e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfOC0xLTEtMS0xNDkxMTc_40d3497a-b4f6-45f8-a79a-7c1ce41c5328">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfOC0zLTEtMS0xNDkxMTc_7b04dc1b-3878-4708-be8f-a13edc412cc6">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfOC01LTEtMS0xNDkxMTc_b615ce99-ba1f-4a93-90ec-df325584a5b0">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfOC03LTEtMS0xNDkxMTc_efd461b5-edb3-4ea7-a4d8-ca003fc919bd">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt"><ix:continuation id="icc8122cf10ed40078b4bf1a4edf8094a" continuedAt="if4628216c0cd482da31e4ea8536e84da"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in prior periods. All components of the Company&#8217;s net periodic pension and postretirement benefit costs, aside from service cost, are recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense), net</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if4628216c0cd482da31e4ea8536e84da"> on its condensed consolidated statements of income.</ix:continuation> </span></div><div id="ic901e28da78f443cab3564a79902c5bb_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RleHRyZWdpb246Y2JjYTAyMzBiZjMxNGU5ZDg5ZGQ1NmEwMjkzN2E3ODJfNjAy_0e8a36bf-fac9-4218-bf23-38761c348c3c" continuedAt="i0d4572b643d74d9888e220015522ecee" escape="true">Business Restructuring Charges</ix:nonNumeric></span></div><ix:continuation id="i0d4572b643d74d9888e220015522ecee" continuedAt="ia913ff3294874919bb1627be5cee3de5"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred restructuring costs during the six months ended March&#160;31, 2023, primarily in connection with the Company's simplification and other cost saving initiatives, which were recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These simplification and other costs saving initiatives are focused on reducing complexity, enhancing product quality, refining customer experience, and improving cost efficiency across all of the Company&#8217;s segments. </span></div><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RleHRyZWdpb246Y2JjYTAyMzBiZjMxNGU5ZDg5ZGQ1NmEwMjkzN2E3ODJfNTk5_ada5dfd4-cd21-4a27-9dc2-36f7e4df1cc2" continuedAt="icdbb8bbb26cf404c9cb958cff7441a67" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring liability activity for the six months ended March&#160;31, 2023 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"><tr><td style="width:1.0%"></td><td style="width:36.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.041%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee<br/>Termination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6ce19cb68c42798ae7f6c22f37cc17_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMS0xLTEtMS0xNDkxMTc_73cc2082-d85b-4898-880e-eaea9e03e764">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide33f573b2814d269fa446f57a3a0186_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMS0zLTEtMS0xNDkxMTc_99289e7a-64d3-49f8-8cd9-57e51024a77a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMS01LTEtMS0xNDkxMTc_96e46b5c-00e2-4b43-963f-ca3997e9e35a">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa9ecd5e70e410190486fa72a3b558e_D20221001-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMy0xLTEtMS0xNDkxMTc_b2423018-f6de-42c6-8a34-ee6dec00acf9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced9cd9c70654eb388559493c61723b9_D20221001-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMy0zLTEtMS0xNDkxMTc_4fd64d5f-0b85-4aeb-8e45-88fc07723576">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMy01LTEtMS0xNDkxMTc_368b8256-13fd-467c-b325-2223802c7192">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4aa9ecd5e70e410190486fa72a3b558e_D20221001-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNC0xLTEtMS0xNDkxMTc_9422cb4e-3717-4aeb-bb60-45f99edb0750">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iced9cd9c70654eb388559493c61723b9_D20221001-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNC0zLTEtMS0xNDkxMTc_0a1ebbcb-f554-4dab-9958-2a195919f495">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNC01LTEtMS0xNDkxMTc_df117282-72d7-4def-9784-b65ca775a299">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58665f2a2c8643dcb3ad595e2d019b33_D20221001-20230331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNS0xLTEtMS0xNDkxMTc_ec2c9a11-ed45-46a0-be6e-adf159760ba3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52290dbfca2d4f50a401175ba723901f_D20221001-20230331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNS0zLTEtMS0xNDkxMTc_8ed099b5-cb8e-4635-911c-961715634637">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f40fa9998b54795b2c752de8c531048_D20221001-20230331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNS01LTEtMS0xNDkxMTc_f1a48b2d-61b8-4eca-8f3a-2e6a3ddd5f01">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0dbe3ded00545ab83fb4e0b4a84ec32_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNy0xLTEtMS0xNDkxMTc_3108c2e8-f3ea-481a-b356-e56a6d5219d3">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23a5e3848cd4f44a166523143770660_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNy0zLTEtMS0xNDkxMTc_07b84236-7530-4dfd-944c-0eb520cde23f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNy01LTEtMS0xNDkxMTc_610a46b6-2fb6-4840-8d97-5bb122b6f759">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia913ff3294874919bb1627be5cee3de5"><ix:continuation id="icdbb8bbb26cf404c9cb958cff7441a67">(a)&#160;&#160;&#160;&#160;Expense primarily relates to other costs associated with the execution of the Company&#8217;s cost efficiency and restructuring programs, such as incremental project management costs and asset write-offs.</ix:continuation></ix:continuation> </span></div><div style="margin-top:3pt;text-indent:-18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_58"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMjQ1_9372d94a-1d31-4a18-abc7-a07ca6614479" continuedAt="if380eabf1d0641fb93c5a54a3d483c9e" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="if380eabf1d0641fb93c5a54a3d483c9e"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMjQw_ed45fcbe-440d-4a09-a187-9e03dc24e6b8" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df4422b58204b28a8c87b3ec9a100d4_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy0xLTEtMS0xNDkxMTc_6b958b64-8724-46ec-8550-129ec5ec6770">15,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5df4422b58204b28a8c87b3ec9a100d4_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy0zLTEtMS0xNDkxMTc_8d1b4409-4bb7-42c2-8f81-f54018fc8b84">6,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df4422b58204b28a8c87b3ec9a100d4_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy01LTEtMS0xNDkxMTc_58ebce00-9b3e-4f1d-8a02-7777170870c7">8,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ee2f4c36e04145806001b090363988_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy03LTEtMS0xNDkxMTc_e157d2f1-6a34-440d-8ebc-c843f6e975a5">15,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ee2f4c36e04145806001b090363988_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy05LTEtMS0xNDkxMTc_8c4f84cb-9481-4c45-af9c-bc6bdd08195d">5,979</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ee2f4c36e04145806001b090363988_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy0xMS0xLTEtMTQ5MTE3_6b0f37b9-db5a-4e54-b0d8-21fe4699e8e7">9,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf4edbbb2c84bebb017b70ec26907d9_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC0xLTEtMS0xNDkxMTc_c0c5d9d5-ce81-4cf6-bfe0-58e6fe650f30">4,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cf4edbbb2c84bebb017b70ec26907d9_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC0zLTEtMS0xNDkxMTc_70413714-12b6-4b02-8203-5db98901e593">2,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf4edbbb2c84bebb017b70ec26907d9_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC01LTEtMS0xNDkxMTc_5de61cee-29b6-4751-b487-963dda482eb6">2,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9763e9cfce3546598374a98e82482d84_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC03LTEtMS0xNDkxMTc_f485aaaf-6c28-44ff-a736-783295c6234d">4,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9763e9cfce3546598374a98e82482d84_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC05LTEtMS0xNDkxMTc_c95dfd6f-07b0-4909-ad39-af0e8ac906ad">2,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9763e9cfce3546598374a98e82482d84_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC0xMS0xLTEtMTQ5MTE3_5cfe90ea-192b-4449-9e2d-362195e6b25a">2,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, trademarks and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5909630c3dc3461db24bb07bbef1d70f_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy0xLTEtMS0xNDkxMTc_d346a904-64f0-4dee-878c-cea0849bb6af">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5909630c3dc3461db24bb07bbef1d70f_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy0zLTEtMS0xNDkxMTc_94c9c173-e67f-40f2-bbb5-30502aa4340a">604</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5909630c3dc3461db24bb07bbef1d70f_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy01LTEtMS0xNDkxMTc_ccb3d513-13c5-43a9-8bc3-976e227b4f47">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4bcaff2cdea468f9adea6ca88bfd572_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy03LTEtMS0xNDkxMTc_0ca478d4-fbb5-47d2-8101-3bc66b71625e">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4bcaff2cdea468f9adea6ca88bfd572_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy05LTEtMS0xNDkxMTc_3acfc73e-fdf9-4199-8632-097777edce7a">574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4bcaff2cdea468f9adea6ca88bfd572_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy0xMS0xLTEtMTQ5MTE3_5ee11b62-bc37-4e1d-9cb9-a3d534b3f986">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC0xLTEtMS0xNDkxMTc_0a89aa68-6bc4-469e-8a00-5aff85a63ef6">21,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC0zLTEtMS0xNDkxMTc_a93118a2-82da-4062-952f-d8f091b3cfbc">9,481</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC01LTEtMS0xNDkxMTc_709dba96-e006-4182-bd30-6b17978f71a9">11,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC03LTEtMS0xNDkxMTc_1d83e297-6f61-41a9-b291-aa9f59a00311">20,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC05LTEtMS0xNDkxMTc_9f60e648-aacd-4453-a754-f88bd82e1e8a">8,723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC0xMS0xLTEtMTQ5MTE3_61fc56b8-0b53-4c9c-b8ac-240bc8fc976a">12,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f7422c872948b7aa942c44ddec9006_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTAtMS0xLTEtMTQ5MTE3_0e9b62b7-5949-4143-83c4-5c51c213e4f8">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244628a30e084b02a041278475ead62a_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTAtNy0xLTEtMTQ5MTE3_8fee57ab-c56e-4280-8499-8bbfa4b9c35a">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369713e8a2814ee3b1545e6f40f52598_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTEtMS0xLTEtMTQ5MTE3_a6c0264f-f5de-4d11-9f74-014e79fbf48f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09ed9f30fe6f49b080fbe7dafbf98b8e_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTEtNy0xLTEtMTQ5MTE3_985cbaf3-b4dc-4705-9a28-6e892869b0b3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTItMS0xLTEtMTQ5MTE3_6b4097f6-3579-4cad-814a-e2e300f0ca3e">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTItNy0xLTEtMTQ5MTE3_8219c65d-ccfa-4aea-bb10-ebe23cb78122">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible amortization expense for the three months ended&#160;March&#160;31, 2023 and 2022&#160;was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMTQw_57f0a5e0-89bf-4cde-b483-345cabcc93f4">366</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and $<ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMTQ3_40471a3e-0045-48f7-97d2-e90e2d4489d1">352</ix:nonFraction> million, respectively.  Intangible amortization expense for the six months ended&#160;March&#160;31, 2023 and 2022&#160;was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMjE5OTAyMzI1NTk3Mg_e5e7f6cd-2b93-40db-859e-546688347e34">731</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMjE5OTAyMzI1NTk3Ng_945f279a-1603-4c04-bad3-095468a7eca6">707</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMjQz_4376a9ba-04a5-4b9e-aa35-2d1718192a11" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"></td><td style="width:38.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life&#160;Sciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interventional</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3102b14dbddd4ffc86e7d5d2db6bce27_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfMS0xLTEtMS0xNDkxMTc_fc6bc246-3e42-4971-b880-b3f3ba203731">10,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1a34123952a4177976f05690781d3d7_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfMS0zLTEtMS0xNDkxMTc_c38eed6d-f611-4c1f-819f-0723b21b7ed8">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4127c3a1dc864463babc0aa7d4467455_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfMS01LTEtMS0xNDkxMTc_db6712e4-2191-435b-9156-a58e313477d5">12,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfMS03LTEtMS0xNDkxMTc_9325682b-ce2b-475e-ae30-bf01160dd2bf">24,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a28f207cd5467ba5f864965c31b4d2_D20221001-20230331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNC0xLTEtMS0xNDkxMTc_0dd91eab-cf10-4a8d-a144-48048c2f28af">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0d32994d5d4acb92ad95e9804d5595_D20221001-20230331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNC0zLTEtMS0xNDkxMTc_8ea6d9b7-e72b-47b9-b6fd-8e5fd63fa7cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5415d8bbac4b359e15026a6417f893_D20221001-20230331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNC01LTEtMS0xNDkxMTc_b830c0b9-f0e9-41ac-87a6-1145234d3e2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNC03LTEtMS0xNDkxMTc_c8b932cd-b8d2-4608-b261-9d450269a2b9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a28f207cd5467ba5f864965c31b4d2_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNS0xLTEtMS0xNDkxMTc_c1addbfd-84e4-4bcb-9014-ca4972bd4b22">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0d32994d5d4acb92ad95e9804d5595_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNS0zLTEtMS0xNDkxMTc_ac867880-8bab-4d42-99b0-95910beaacb0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5415d8bbac4b359e15026a6417f893_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNS01LTEtMS0xNDkxMTc_63094a90-940d-403d-b5df-56843c0a3ef2">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNS03LTEtMS0xNDkxMTc_5a50d770-4cd8-4ba0-969f-039dd9842fc1">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c6efdde649461c9e16742dfa4f98cb_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNi0xLTEtMS0xNDkxMTc_cbecf115-da3f-40e0-9421-6ab5515f8211">10,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73beddac0b344212a9ac5a9c6b13e93c_I20230331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNi0zLTEtMS0xNDkxMTc_43446f51-45ae-4057-bbf5-10996e9b3155">899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65aae17d8b844902ba366c6f8483abbe_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNi01LTEtMS0xNDkxMTc_92ab9c47-1e6d-4bb2-bfee-e400c0307f91">12,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNi03LTEtMS0xNDkxMTc_a3017483-2378-4b3b-aa07-c60014aa1942">24,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt"><span><br/></span></div><div id="ic901e28da78f443cab3564a79902c5bb_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfNTkyNg_8b755c49-78b0-4d6b-961d-2af7890335bf" continuedAt="iaedd54d8d1bf4ec895ed50fe492ac0e5" escape="true">Derivative Instruments and Hedging Activities</ix:nonNumeric></span></div><ix:continuation id="iaedd54d8d1bf4ec895ed50fe492ac0e5" continuedAt="i3b74ef7dc3a64787b300401134dbbb1e"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfNTkyMw_8fca047c-5b7b-49a4-8b22-5143dc1b936f" continuedAt="id87b95200f58492cabbced190f5c7a3e" escape="true">The Company uses derivative instruments to mitigate certain exposures. The Company does not enter into derivative financial instruments for trading or speculative purposes.</ix:nonNumeric> The effects these derivative instruments and hedged items had on the Company&#8217;s balance sheets and the fair values of the derivatives outstanding at March&#160;31, 2023 and September&#160;30, 2022 were not material. The effects on the Company&#8217;s financial performance and cash flows are provided below.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risks and Related Strategies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts. In order to mitigate foreign currency exposure relating to its investments in certain foreign subsidiaries, the Company has hedged the currency risk associated with those investments with certain instruments, such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3b74ef7dc3a64787b300401134dbbb1e" continuedAt="i4579e2c421af420d9d319068db3c3206"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfNTkxMA_ea03b312-9f40-473d-a8ef-f9e5376a7b8b" continuedAt="icfb1a467afbe4dd78886a7620ea098a4" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments as of March&#160;31, 2023 and September&#160;30, 2022 were as follows:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"></td><td style="width:36.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b6aa99d5be460d83d9bca02ddddd61_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMS0zLTEtMS0xNDkxMTc_44340347-0633-4b26-af28-9894cf8fb650">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aeb4d2755fe46f299e5a6c74bc5a32b_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMS01LTEtMS0xNDkxMTc_380a8588-5fdc-45fc-8353-e151cc45ff8c">2,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3304ad8423a4080868ba0df9040363c_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMi0zLTEtMS0xNDkxMTc_fba448b9-ee0b-4fde-9f7d-a16d79758c0d">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f298aa8db0e4d16915009c38a45b4fd_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMi01LTEtMS0xNDkxMTc_96f6344d-4a17-4fce-b388-f479c497dbe3">2,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7b5571b4914526a7939314fe5ac29b_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMy0zLTEtMS0xNDkxMTc_de317776-1d55-4030-ab7f-7a2ae81a6fa0">2,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc31e4316a5f42a9af36adc57ea908b0_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMy01LTEtMS0xNDkxMTc_542f3160-1894-4431-ac2b-a0229d3edd0e">910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains or losses relating to the net investment hedges, which are attributable to changes in the foreign currencies to U.S. dollar spot exchange rates, are recorded as accumulated foreign currency translation in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the termination of a net investment hedge, any net gain or loss included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relative to the investment hedge remains until the foreign subsidiary investment is disposed of or is substantially liquidated.  </span></div><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfNTkyOQ_f4bf2c52-5a7b-4781-8856-664bd1047dd5" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (losses) gains recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the Company's net investment hedges for the three and six-month periods were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:45.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82512cdc5bbe47b99fd3ea95885689f8_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMi0xLTEtMS0xNDkxMTc_16d9dd2d-a561-4e73-a1a0-f7e8ddea1fc8">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bdfaba42a0147ab9cf6e5fe931bcb98_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMi0zLTEtMS0xNDkxMTc_6356e893-839e-449b-abb0-d6313f63b000">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39c3539460274df6ac6d2c96ecc34090_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMi01LTEtMS0xNDkxMTc_d7255812-b3ee-4d52-a519-3c08b39b874a">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67552823db3d48dba3a132df51727d27_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMi03LTEtMS0xNDkxMTc_05a0fac7-0758-4473-a65a-87359b6a67c2">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13543c57601d49cdad0d49ed6c6a810e_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMy0xLTEtMS0xNDkxMTc_0d31b42e-2fcc-4688-981c-144082276466">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0266480813824139b60fa979b8c5a110_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMy0zLTEtMS0xNDkxMTc_52bf7d64-a60d-4246-a800-a99a6ed2d1b3">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3c212ff13284f898a191374e5b1fb18_D20221001-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMy01LTEtMS0xNDkxMTc_04c9e267-b62e-45db-9feb-6c8ebf06814e">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a554cbf33a4c3cbe41709cb273beba_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMy03LTEtMS0xNDkxMTc_1ab088ff-0b14-4bbc-9303-d885eae036f0">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The amounts for the three and six months ended March&#160;31, 2023 include a gain, net of tax, of $<ix:nonFraction unitRef="usd" contextRef="i26ec7721173741bfa63336e0a220a540_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfMTY0OTI2NzQ0OTA2Ng_95dd1d32-eb72-459e-96e6-4b5ad512c417"><ix:nonFraction unitRef="usd" contextRef="iac6d0546403e4cb8bee77368cc2a109d_D20221001-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfMTY0OTI2NzQ0OTA2Ng_a0e39a93-2a03-40e8-b024-51eb89f6581c">13</ix:nonFraction></ix:nonFraction>&#160;million recognized on terminated cross-currency swaps.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risks and Related Strategies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id87b95200f58492cabbced190f5c7a3e" continuedAt="i536ed35a6fe848f4a81db46f647fbb48">The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.</ix:continuation></span></div><div style="margin-top:9pt"><ix:continuation id="i536ed35a6fe848f4a81db46f647fbb48" continuedAt="i78b84370ca214842b3abf05c6aac4da1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If interest rate derivatives designated as cash flow hedges are terminated, the balance in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attributable to those derivatives is reclassified into earnings, within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense,</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i78b84370ca214842b3abf05c6aac4da1" continuedAt="id9fc2ec182f54798920eee1208d18b42"> over the remaining life of the hedged debt.</ix:continuation> The amounts reclassified from accumulated other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022, as well as the amounts expected to be reclassified within the next 12 months, are not material to the Company's consolidated financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net after-tax gains (losses) recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to interest rate cash flow hedges during the three and six months ended March&#160;31, 2023 were immaterial to the Company&#8217;s consolidated financial results and were $<ix:nonFraction unitRef="usd" contextRef="i21832cc6769747ce9b9665d67123f229_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfMjE5OTAyMzI2MjIwNg_9a8ae716-51bc-423b-816c-835681be5832">43</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i52fcd6bc58b842908f344893c07f0e4a_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfMjE5OTAyMzI2MjIxOQ_138d9944-6c52-40f6-b06e-3c42b3bbfe63">39</ix:nonFraction>&#160;million during the three and six months ended March&#160;31, 2022, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id9fc2ec182f54798920eee1208d18b42">For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.</ix:continuation> Amounts recorded during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4579e2c421af420d9d319068db3c3206" continuedAt="idcfb664809cc44a789d38e9b22fc7d18"><ix:continuation id="icfb1a467afbe4dd78886a7620ea098a4" continuedAt="ica8a7beec0dd48e9b25a0ad697857eb4"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s interest rate-related derivative instruments as of March&#160;31, 2023 and September&#160;30, 2022 were as follows: </span></div><div style="margin-top:3pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"></td><td style="width:39.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6efa31d0f394c2fa26a85b8356810a7_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmVkY2E5ZmMzODk1YzQ1YzhiOTY4NDYwNzc0Y2ZjMGJlL3RhYmxlcmFuZ2U6ZWRjYTlmYzM4OTVjNDVjOGI5Njg0NjA3NzRjZmMwYmVfMS0zLTEtMS0xNDkxMTc_96724509-6d6e-4343-afd0-3518e3124cfd">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f198f784a2e4fbebfc73c9adccb8ca7_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmVkY2E5ZmMzODk1YzQ1YzhiOTY4NDYwNzc0Y2ZjMGJlL3RhYmxlcmFuZ2U6ZWRjYTlmYzM4OTVjNDVjOGI5Njg0NjA3NzRjZmMwYmVfMS01LTEtMS0xNDkxMTc_cf592aa9-dc37-4c2a-ad02-100bcfb65cc9">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e41cac0d444490be6885ce232f8d86_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmVkY2E5ZmMzODk1YzQ1YzhiOTY4NDYwNzc0Y2ZjMGJlL3RhYmxlcmFuZ2U6ZWRjYTlmYzM4OTVjNDVjOGI5Njg0NjA3NzRjZmMwYmVfMi0zLTEtMS0xNDkxMTc_1602f6b2-906c-40e4-85c7-369157a55c35">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf2158a605543ce9c94011e2077fc47_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmVkY2E5ZmMzODk1YzQ1YzhiOTY4NDYwNzc0Y2ZjMGJlL3RhYmxlcmFuZ2U6ZWRjYTlmYzM4OTVjNDVjOGI5Njg0NjA3NzRjZmMwYmVfMi01LTEtMS0xNDkxMTc_3c867986-b119-4683-982b-7b016704b96e">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  </span></div></ix:continuation><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ica8a7beec0dd48e9b25a0ad697857eb4" continuedAt="i3127c76b56234b2ba6632bef45cdaf43">(b)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i3127c76b56234b2ba6632bef45cdaf43">Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.</ix:continuation>   </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Risk Exposures</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idcfb664809cc44a789d38e9b22fc7d18">The Company purchases resins, which are oil-based components used in the manufacture of certain products. Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results. From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts. The Company's commodity derivative forward contracts at March&#160;31, 2023 and September&#160;30, 2022 were immaterial to the Company's consolidated financial results.</ix:continuation> </span></div><div><span><br/></span></div><div id="ic901e28da78f443cab3564a79902c5bb_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjI0Mw_a169da8f-29cd-431d-b854-700d7a86be8b" continuedAt="ib868c74a093243d6844dcca6ba503096" escape="true">Financial Instruments and Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="ib868c74a093243d6844dcca6ba503096" continuedAt="ice2edec6bc224455b08fdf8f250d2559"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjI2MA_a3ddc64a-eab9-4883-805b-3587028356e6" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciles cash and equivalents and restricted cash reported within the Company's condensed consolidated balance sheets at March&#160;31, 2023 and September&#160;30, 2022 to the total of these amounts shown on the Company's condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"><tr><td style="width:1.0pt"></td><td style="width:166.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMS0xLTEtMS0xNDkxMTc_4719c5d1-02bf-4315-9131-e6560480e924">1,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMS0zLTEtMS0xNDkxMTc_3a85763c-b28a-4a10-9923-dae6ad639e26">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMi0xLTEtMS0xNDkxMTc_12b7d64f-4b21-4099-bf71-0f447ee32c8f">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMi0zLTEtMS0xNDkxMTc_83582b45-704c-4fb0-b17a-77002bd54427">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMy0xLTEtMS0xNDkxMTc_13f338db-6b26-4ac9-9cbb-58295de49854">2,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMy0zLTEtMS0xNDkxMTc_ca46ae5a-0fb0-40fd-90e7-213f30ea1150">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjI1Nw_70c3e506-43ff-4069-ab67-8d3b84567842" escape="true">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.</ix:nonNumeric> <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjIzOA_c24c057e-0780-45a9-b68b-4da2a99e2966" escape="true">Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjIzOQ_3d044a59-3ba9-44d6-ac62-09d8926ef92d" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s financial instruments are as follows:</span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"></td><td style="width:40.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional money market accounts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMS0zLTEtMS0xNDkxMTc_d5563dfd-e255-429f-9864-c9525ee5cb0e">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMS01LTEtMS0xNDkxMTc_454b7943-6950-452e-afb9-b77ccf26dae7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMi0zLTEtMS0xNDkxMTc_cc221de1-d6e7-4222-8586-eee279a74758">1,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMi01LTEtMS0xNDkxMTc_75a98c31-2eb4-4c60-a6ed-80e34bc2b09e">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMy0zLTEtMS0xNDkxMTc_2c2ec983-8153-4fe7-ae6c-21142c4ee5ae">14,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMy01LTEtMS0xNDkxMTc_28a4f71a-8895-4a4e-adc4-8cc94fc7ae24">12,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">These financial instruments are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the condensed consolidated balance sheets. The institutional money market accounts permit daily redemption. <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjI1OA_6882c660-3dff-4d03-8f26-517ec072d47e" continuedAt="i5749db986e6e4fa89d4f9ac347817389" escape="true">The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions.</ix:nonNumeric> </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i5749db986e6e4fa89d4f9ac347817389" continuedAt="i4b5aae77db2048d78f9e62b23e306838">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.</ix:continuation></span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4b5aae77db2048d78f9e62b23e306838">Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The short-term investments consist of instruments with maturities greater than <ix:nonNumeric contextRef="i028e3d9d8c454377856d5376339cff80_D20221001-20230331" name="bdx:MaturityPeriodOfShortTermInvestment" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMTI3OA_5ef97a76-e04a-497d-88d9-3a3cbddcb7bd">three months</ix:nonNumeric> and less than <ix:nonNumeric contextRef="i404c88c20ea54232a7e62321ba370898_D20221001-20230331" name="bdx:MaturityPeriodOfShortTermInvestment" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMTI5NQ_05ee9eb9-082c-450e-b5c6-0f1a283452ce">one year</ix:nonNumeric>.</ix:continuation> All other instruments measured by the Company at fair value, including derivatives and contingent consideration liabilities, are immaterial to the Company's condensed consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonrecurring Fair Value Measurements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of fiscal year 2022, the Company recorded a noncash asset impairment charge of $<ix:nonFraction unitRef="usd" contextRef="if5012eda058545d5b7ac41306aa4ba16_D20220101-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjE5OTAyMzI1OTAxOQ_b1db8a6e-a18b-4608-9ccc-7df1a77a613a">54</ix:nonFraction>&#160;million to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Medical segment. The amount recognized was recorded to adjust the carrying amount of assets to the assets' fair values, which was estimated, based upon a market participant's perspective, using Level 3 inputs, including values estimated using the income approach.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ice2edec6bc224455b08fdf8f250d2559" continuedAt="i21d10cb92731488f9d5c24aacc8e2aec"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transfers of trade receivables</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the normal course of its business activities, the Company transfers certain trade receivable assets to third parties under factoring agreements. Per the terms of these agreements, the Company surrenders control over its trade receivables upon transfer.&#160;Accordingly, the Company accounts for the transfers as sales of trade receivables by recognizing an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade receivables, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when proceeds from the transactions are received.&#160;The costs incurred by the Company in connection with factoring activities were not material to its consolidated financial results. <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjI1MA_9f11f826-0d40-4042-951a-0f2cec783915" continuedAt="i3c8cafcc0d1c42449cb3887ec998e011" escape="true">The amounts transferred and yet to be remitted under factoring arrangements are provided below.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><ix:continuation id="i3c8cafcc0d1c42449cb3887ec998e011" continuedAt="i18f9e09f96a345248f43e87594c366de"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables transferred to third parties under factoring arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmFlOGU2OGY0NTZkZDRjYTE5NmIyN2JjNDlmMDBlNjNmL3RhYmxlcmFuZ2U6YWU4ZTY4ZjQ1NmRkNGNhMTk2YjI3YmM0OWYwMGU2M2ZfMi0xLTEtMS0xNDkxMTc_5062c237-853d-4335-b561-663bb1a5f2ea">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmFlOGU2OGY0NTZkZDRjYTE5NmIyN2JjNDlmMDBlNjNmL3RhYmxlcmFuZ2U6YWU4ZTY4ZjQ1NmRkNGNhMTk2YjI3YmM0OWYwMGU2M2ZfMi0zLTEtMS0xNDkxMTc_4d8a41ee-b8bf-485a-bf42-5b0f05ecdea7">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmFlOGU2OGY0NTZkZDRjYTE5NmIyN2JjNDlmMDBlNjNmL3RhYmxlcmFuZ2U6YWU4ZTY4ZjQ1NmRkNGNhMTk2YjI3YmM0OWYwMGU2M2ZfMi01LTEtMS0xNDkxMTc_3df3f3ab-aa96-4805-9e0a-432668d17e11">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmFlOGU2OGY0NTZkZDRjYTE5NmIyN2JjNDlmMDBlNjNmL3RhYmxlcmFuZ2U6YWU4ZTY4ZjQ1NmRkNGNhMTk2YjI3YmM0OWYwMGU2M2ZfMi03LTEtMS0xNDkxMTc_0d429775-5821-4f0b-9031-d2e0d75b4d38">434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><ix:continuation id="i21d10cb92731488f9d5c24aacc8e2aec"><ix:continuation id="i18f9e09f96a345248f43e87594c366de"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:56.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.810%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts yet to be collected and remitted to the third parties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmEzNWVlMjk5NWEyMTRkNGM4NjVjNDM0YjM0ZTIxZDc4L3RhYmxlcmFuZ2U6YTM1ZWUyOTk1YTIxNGQ0Yzg2NWM0MzRiMzRlMjFkNzhfMS0xLTEtMS0xNDkxMTc_a726d4d2-327b-4257-9053-f2337b3d7699">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmEzNWVlMjk5NWEyMTRkNGM4NjVjNDM0YjM0ZTIxZDc4L3RhYmxlcmFuZ2U6YTM1ZWUyOTk1YTIxNGQ0Yzg2NWM0MzRiMzRlMjFkNzhfMS0zLTEtMS0xNDkxMTc_67bc8d3b-1755-4c8e-9a7c-c4e4c9774f3d">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ic901e28da78f443cab3564a79902c5bb_846"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13 &#8211; <ix:nonNumeric contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzE2NDkyNjc0NTAzMTE_441d47a4-e7cc-47e5-b256-1ae1f07a87f5" continuedAt="i9aa3edb18dc3439fafda0dceddc7a64a" escape="true">Debt</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9aa3edb18dc3439fafda0dceddc7a64a">In February 2023, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i0781942758c64dd5afd26d84a4911721_I20230228" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzIxOTkwMjMyNjEzNTg_1d8fbc91-d457-4cdd-b42f-4efe919e8ad2">800</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i0781942758c64dd5afd26d84a4911721_I20230228" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzIxOTkwMjMyNjEzNzI_bba14ec8-f333-4db5-a9f0-a0731123286c">4.693</ix:nonFraction>% notes due February 13, 2028. Also in February 2023, Becton Dickinson Euro Finance S.&#224; r.l., a private limited liability company (soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e), which is an indirect, wholly-owned finance subsidiary of the Company, issued &#8364;<ix:nonFraction unitRef="eur" contextRef="i2642155c253549deb25e07021badb5aa_I20230228" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzIxOTkwMjMyNjEzODA_472593f5-0ff9-4bf0-88b4-c20cdc0bc389">800</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i37b7d299193b4c9989d811dd4b4236cf_I20230228" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzIxOTkwMjMyNjEzOTM_9d98cedf-edd3-4500-b3ac-d7014a841f05">868</ix:nonFraction>&#160;million) of <ix:nonFraction unitRef="number" contextRef="i031378f9d14d45c988ebf0bc09980e9d_I20230228" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzIxOTkwMjMyNjE0MDU_2d81eb1f-300f-4ce3-a750-d77bddb72e8d">3.553</ix:nonFraction>% Euro-denominated notes due September 13, 2029 (the &#8220;BD Finance Notes&#8221;). The BD Finance Notes are fully and unconditionally guaranteed on a senior unsecured basis by the Company. No other of the Company's subsidiaries provide any guarantees with respect to the BD Finance Notes. The indenture covenants included a limitation on liens and a restriction on sale and leasebacks, change of control and consolidation, merger and sale of assets covenants. These covenants are subject to a number of exceptions, limitations and qualifications. The indenture does not restrict the Company, Becton Dickinson Euro Finance S.&#224; r.l., or any other of the Company's subsidiaries from incurring additional debt or other liabilities, including additional senior debt. Additionally, the indenture does not restrict Becton Dickinson Euro Finance S.&#224; r.l. and the Company from granting security interests over its assets.</ix:continuation> </span><span style="background-color:#dbdbdb;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following commentary should be read in conjunction with the condensed consolidated financial statements and accompanying notes presented in this report.  Within the tables presented throughout this discussion, certain columns may not add due to the use of rounded numbers for disclosure purposes.  Percentages and earnings per share amounts presented are calculated from the underlying amounts.  References to years throughout this discussion relate to our fiscal years, which end on September 30.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Becton, Dickinson and Company (&#8220;BD&#8221;) is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's organizational structure is based upon three principal business segments, BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional (&#8220;Interventional&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s products are manufactured and sold worldwide. Our products are marketed in the United States and internationally through independent distribution channels and directly to end-users by BD and independent sales representatives. We organize our operations outside the United States as follows: EMEA (which includes Europe, the Middle East and Africa); Greater Asia (which includes countries in Greater China, Japan, South Asia, Southeast Asia, Korea, Australia and New Zealand); Latin America (which includes Mexico, Central America, the Caribbean and South America); and Canada. We continue to pursue growth opportunities in emerging markets, which include the following geographic regions: Eastern Europe, the Middle East, Africa, Latin America and certain countries within Greater Asia. We are primarily focused on certain countries whose healthcare systems are expanding. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BD&#8217;s Spin-Off of Diabetes Care</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, BD completed the separation and distribution of Embecta Corp. (&#8220;Embecta&#8221;), formerly BD's Diabetes Care business, into a separate, publicly-traded company.  The historical results of the Diabetes Care business (previously included in BD&#8217;s Medical segment), as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in our condensed consolidated financial statements for the three and six months ended March 31, 2022.  Additional disclosures regarding our spin-off of the Diabetes Care business are provided in Note 2 in the Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Trends Affecting Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our BD 2025 strategy for growth is anchored in three pillars: grow, simplify and empower. As we execute this strategy, we continue to invest in research and development, strategic tuck-in acquisitions, geographic expansion, and new product programs to drive further revenue and profit growth. Our ability to sustain our long-term growth will depend on a number of factors, including our ability to expand our core business (including geographical expansion), develop innovative new products, as well as continue to improve operating efficiency and organizational effectiveness, despite continued challenges posed by the global macroeconomic environment.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations, supply chain and suppliers are exposed to various global macroeconomic factors. The factors which were most impactful to our results in the second quarter of fiscal year 2023 included the following: </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inflation, which has continued to drive higher costs of raw materials, electronic components, labor, energy, and logistical services. We expect inflation to persist throughout our fiscal year 2023.  However, we are experiencing improvements for certain raw material and logistics costs.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The availability of energy sources in certain markets, as well as the availability of certain raw materials and electronic components on a global basis. There is also a limited supply of skilled labor in certain markets which continues to drive higher overall labor costs, as noted above.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Logistics capacity constraints continue to ease compared to our fiscal year 2022; however, lead times remain elevated globally. Also, more frequent extreme weather events continue to impact global supply chain conditions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain COVID-19 pandemic-related impacts were experienced by our businesses in the prior-year period, as discussed in greater detail below. The pandemic has changed the ways healthcare services are delivered due to budget constraints and staffing shortages, particularly shortages of nursing staff. Current healthcare delivery has transitioned more care from acute to non-acute settings and has increased focus on chronic disease management; this transition may place additional financial pressure on hospitals and the broader healthcare system. Healthcare institutions may take actions to mitigate any persistent pressures on their budgets and such actions could impact the future demand for our products and services. Additionally, a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">worsening of staffing shortages within healthcare systems may affect the prioritization of healthcare services, which could also impact the demand for certain of our products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain geopolitical conditions, including the conflict between Russia and Ukraine, have contributed to the macroeconomic conditions discussed above. This conflict has not materially impacted our results of operations to date; however, the continuation of the Russia-Ukraine military conflict and/or an escalation of the conflict beyond its current scope may further weaken the global economy and could result in additional inflationary pressures and supply chain constraints, including the unavailability and cost of energy. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been mitigating the impacts of the macroeconomic factors discussed above through various strategies which leverage our procurement, logistics and manufacturing capabilities.  However, there can be no assurance that we will be able to effectively mitigate these pressures in future periods and an inability to offset these pressures through our strategies, at least in part, could adversely impact our results of operations.  Due to the significant uncertainty that exists relative to the duration and overall impact of the macroeconomic factors discussed above, our future operating performance, particularly in the short-term, may be subject to volatility. The impacts of macroeconomic conditions on our business, results of operations, financial condition and cash flows are dependent on certain factors, including those discussed in Part I, Item&#160;1A. Risk Factors of our 2022 Annual Report on Form 10-K (the &#8220;2022 Annual Report&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Financial Results and Financial Condition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, worldwide revenues of $4.821 billion increased 1.5% from the prior-year period. This increase reflected the following impacts:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:71.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.758%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease) in current-period revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume/other</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period-over-period decline in revenues related to COVID-19-only testing </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pricing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in revenues from the prior-year period</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">See the &#8220;Results of Continuing Operations&#8221; section below for further discussion of our segments&#8217; second quarter fiscal year 2023 results. Our second quarter fiscal year 2023 revenues reflected sales related to COVID-19-only diagnostic testing on the BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Plus and BD Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Systems of $16 million, compared with revenues from such testing products in the prior-year period of $214 million.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from continuing operating activities were&#160;$584 million&#160;in the first six months of fiscal year 2023.  At March&#160;31, 2023, we had $2.074 billion in cash and equivalents and short-term investments, including restricted cash.  We continued to return value to our shareholders in the form of dividends.  During the first six months of fiscal year 2023, we paid cash dividends of $563 million, including $517 million paid to common shareholders and $45 million paid to preferred shareholders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each reporting period, we face currency exposure that arises from translating the results of our worldwide operations to the U.S. dollar at exchange rates that fluctuate from the beginning of such period.  A stronger U.S. dollar, compared to the prior-year period, resulted in an unfavorable foreign currency translation impact to our revenues and earnings during the second quarter of fiscal year 2023.  We evaluate our results of operations on both a reported and a foreign currency-neutral basis, which excludes the impact of fluctuations in foreign currency exchange rates. As exchange rates are an important factor in understanding period-to-period comparisons, we believe the presentation of results on a foreign currency-neutral basis in addition to reported results helps improve investors&#8217; ability to understand our operating results and evaluate our performance in comparison to prior periods. Foreign currency-neutral ("FXN") information compares results between periods as if exchange rates had remained constant period-over-period. We use results on a foreign currency-neutral basis as one measure to evaluate our performance. We calculate foreign currency-neutral percentages by converting our current-period local currency financial results using the prior-period foreign currency exchange rates and comparing these adjusted amounts to our current-period results. These results should be considered in addition to, not as a substitute for, results reported in accordance with U.S. generally accepted accounting principles ("GAAP"). Results on a foreign currency-neutral basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not measures of performance presented in accordance with U.S. GAAP.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Continuing Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes second quarter Medical revenues by organizational unit:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:36.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.481%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medical Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Medical segment&#8217;s revenue growth in the second quarter of 2023 primarily reflected the following:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strong global sales of catheters and vascular care products in the Medication Delivery Solutions unit, partially offset by strategically planned product discontinuations and an unfavorable comparison to the prior-year period, which benefited from stronger demand for syringes used in COVID-19 vaccination efforts.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strong performance of the Medication Management Solutions unit&#8217;s pharmacy automation portfolio, including Parata Systems, which we acquired in fiscal year 2022, and our BD Rowa&#8482; technologies, as well as double-digit growth in sales of dispensing systems.  Revenue growth attributable to the unit&#8217;s recent acquisitions was approximately 12.6% in the second quarter of 2023.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Continued strong demand for the Pharmaceutical Systems unit&#8217;s prefillable solutions in high-growth markets such as biologic drugs and vaccine categories.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:34.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medical Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical segment income for the three and six-month periods is provided below. </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:45.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.139%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment income as % of Medical revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical segment's higher income as a percentage of revenues in the second quarter of 2023 compared with the second quarter of 2022 reflected the following:   </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Higher gross profit margin in the second quarter of 2023 compared with the second quarter of 2022, which primarily reflected:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">A favorable comparison to the prior-year period, which included a noncash asset impairment charge of $54 million and a charge of $35 million to adjust estimated future product remediation costs.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Favorable impacts due to lower manufacturing costs resulting from continuous improvement projects, which enhanced the efficiency of our operations, and pricing.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Unfavorable impacts of higher raw material, labor and freight costs, as well as unfavorable foreign currency translation and product mix.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lower selling and administrative expense as a percentage of revenues in the second quarter of 2023 compared with the second quarter of 2022 primarily reflected lower shipping and selling costs.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lower research and development expense as a percentage of revenues in the second quarter of 2023 compared with the second quarter of 2022 due to the timing of project spending.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Life Sciences Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes second quarter Life Sciences revenues by organizational unit:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:39.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.671%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Life Sciences Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously discussed above, the Integrated Diagnostic Solutions unit&#8217;s revenues related to COVID-19-only diagnostic testing on the BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plus and BD Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Systems in the second quarter of 2023 were $16 million compared with revenues of $214 million in the prior-year period. The Life Sciences segment&#8217;s revenues in the second quarter of 2023 also reflected the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">An unfavorable comparison in the Integrated Diagnostic Solutions unit to the prior-year period which benefited from a stronger respiratory illness season, partially offset by growth driven by the unit&#8217;s installations of BD Kiestra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> lab automation systems, strong demand for our specimen management products, and continued leverage of the unit&#8217;s larger installed base of BD MAX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> instruments.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Strong demand for the Biosciences unit&#8217;s research reagents and the unit&#8217;s flow cytometry instruments, including the unit&#8217;s recently launched BD FACSymphony</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> cell analyzers.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:43.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.425%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Life Sciences Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Life Sciences segment income for the three and six-month periods is provided below.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:47.212%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment income as % of Life Sciences revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Life Sciences segment's lower income as a percentage of revenues in the second quarter of 2023 compared with the second quarter of 2022 primarily reflected the following: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross profit margin in the second quarter of 2023 was flat compared with the second quarter of 2022, which primarily reflected favorable impacts from price and continuous improvement projects, offset by the current-period decline in revenues attributable to higher-margin testing solutions, as further discussed above, as well as higher raw material, labor and freight costs.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Lower selling and administrative expense as a percentage of revenues in the second quarter of 2023 compared with the second quarter of 2022 primarily reflected lower administrative costs.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Higher research and development expense, as percentages of revenues in the second quarter of 2023 compared with the second quarter of 2022, which primarily reflected the current-period decline in revenues attributable to testing solutions and the timing of project spending.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes second quarter Interventional revenues by organizational unit:</span></div><div style="margin-bottom:6pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:36.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.481%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interventional Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Interventional segment&#8217;s revenue growth in the second quarter of 2023 primarily reflected the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Double-digit growth in sales of the Surgery unit&#8217;s advanced repair and reconstruction platforms and biosurgery products, as well as a favorable comparison to the prior-year period, which was unfavorably impacted by pandemic-related deferrals of elective medical procedures.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The relaunch of the Peripheral Intervention unit&#8217;s Venovo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> system, global market penetration of the Rotarex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> system, and strong growth in Oncology within the United States and Greater Asia that was aided by a favorable comparison to the prior-year period, which was unfavorably impacted by supplier-driven backlogs.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Continued strong demand for the Urology and Critical Care unit&#8217;s PureWick</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">offerings in the acute and alternative care settings, aided by the recent launch of PureWick&#8482; Male, as well as strong growth in sales of endourology products, which reflected improvement in supplier-driven backlogs compared with the prior-year period.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:34.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interventional Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interventional segment income for the three and six-month periods is provided below.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:47.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment income as % of Interventional revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interventional segment's income as a percentage of revenues in the second quarter of 2023 was relatively flat compared with the second quarter of 2022, which reflected the following:  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lower gross profit margin in the second quarter of 2023 compared with the second quarter of 2022, which primarily reflected:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Unfavorable foreign currency translation, as well as higher raw material, labor and freight costs.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">Favorable impacts from price, continuous improvement projects, and a comparison to the prior-year period, which was unfavorably impacted by certain purchase accounting adjustments.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Lower selling and administrative expense, as well as research and development expense, as percentages of revenues in the second quarter of 2023 compared with the second quarter of 2022, which primarily reflected revenue growth that outpaced spending.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s worldwide second quarter revenues by geography were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:24.054%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,733&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. revenue growth in the second quarter of 2023 was particularly driven by strong sales in the Medical segment&#8217;s Medication Management Solutions and Pharmaceutical Systems units, as well as by strong sales in the Life Sciences segment&#8217;s Biosciences unit and the Interventional segment&#8217;s Surgery unit.  Second quarter U.S. revenues were unfavorably impacted by a decline in COVID-19-only diagnostic testing sales compared with the prior-year period, as discussed further above.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenue growth in the second quarter of 2023 was particularly driven by strong sales in all three of the Medical segment&#8217;s units, as well as by strong sales in the Life Sciences segment&#8217;s Biosciences unit.  Second quarter International revenues were unfavorably impacted by a decline in COVID-19-only diagnostic testing sales compared with the prior-year period, as discussed further above.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging market revenues were as follows and primarily reflected growth in China and the Middle East and Africa:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:34.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Specified Items</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reflected in the financial results for the three and six-month periods of fiscal years 2023 and 2022 were the following specified items:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.789%"><tr><td style="width:1.0%"></td><td style="width:46.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.333%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.333%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.333%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.335%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration costs (a)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation-related items (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European regulatory initiative-related costs (d)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product, litigation, and other items (e)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total specified items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: tax impact of specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax impact of specified items</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Represents amounts associated with integration and restructuring activities which are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are further discussed below.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents costs recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense (income), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and incurred in connection with the separation of BD's former Diabetes Care business.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Includes amortization and other adjustments related to the purchase accounting for acquisitions.  BD&#8217;s amortization expense is recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents costs incurred to develop processes and systems to establish initial compliance with the European Union Medical Device Regulation and the European Union In Vitro Diagnostic Medical Device Regulation, which represent a significant, unusual change to the existing regulatory framework. We consider these costs to be duplicative of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">previously incurred costs and/or one-off costs, which are limited to a specific period of time. These expenses, which are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, include the cost of labor, other services and consulting (in particular, research and development and clinical trials) and supplies, travel and other miscellaneous costs.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Includes certain (income) expense items which are not part of ordinary operations and affect the comparability of the periods presented. Such items may include certain product remediation costs, certain product liability and legal defense costs, certain investment gains and losses, and certain asset impairment charges. The amounts in 2022 largely represented a noncash asset impairment charge of $54 million and a charge of $35 million to adjust estimated future product remediation costs, which were both recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit Margin</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit margin for the three and six-month periods of fiscal year 2023 compared with the prior-year periods in fiscal year 2022 reflected the following impacts:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"></td><td style="width:60.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.621%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three-month period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six-month period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022 gross profit margin % </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of purchase accounting adjustments and other specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating performance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023 gross profit margin %</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impacts of other specified items on gross profit margin in the three and six-month periods of 2023 reflected a favorable comparison to the prior-year periods, which were impacted by a noncash asset impairment charge of $54 million and a charge of $35 million to adjust estimated future product remediation costs. These charges were recorded in the Medical segment. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating performance in the three-month period of 2023 primarily reflected favorable impacts of lower manufacturing costs resulting from our ongoing continuous improvement projects and pricing, partially offset by higher raw material, labor and freight costs. Operating performance in the six-month period of 2023 reflected higher raw material, labor and freight costs, partially offset by favorable impacts of lower manufacturing costs resulting from our ongoing continuous improvement projects and pricing. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of operating expenses for the three and six-month periods of fiscal years 2023 and 2022 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.531%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease) in basis points</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease) in basis points</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Selling and administrative expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lower selling and administrative expense as a percentage of revenues in the three-month period of 2023 compared with the prior-year period primarily reflected higher revenues in the current period and favorable foreign currency translation, partially offset by higher selling costs and an increase in our deferred compensation plan liability due to market performance. Higher selling and administrative expense as a percentage of revenues in the six-month period of 2023 compared with the prior-year </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period primarily reflected higher selling and shipping costs in the current-year period, as well as an increase in our deferred compensation plan liability due to market performance, partially offset by favorable foreign currency translation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Research and development expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense as a percentage of revenues in the three and six-month periods of 2023 was relatively flat compared with the prior-year period, which primarily reflected the timing of project spending. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisition-related integration and restructuring expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense in the three and six-month periods of 2023 and 2022 included restructuring costs related to simplification and other cost saving initiatives, as well as system integration costs. For further disclosures regarding restructuring costs, refer to Note 9 in the Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonoperating Income</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Net interest expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components for the three and six-month periods of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.087%"><tr><td style="width:1.0%"></td><td style="width:40.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Higher interest expense for the three and six-month periods of fiscal year 2023 compared with the prior-year periods was largely attributable to the level of commercial paper borrowings outstanding in the current-year periods and to higher overall interest rates on debt outstanding.  Additional disclosures regarding debt issuances in the current-year period are provided in Note 13 in the Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax rates for continuing operations for the three and six-month periods of fiscal years 2023 and 2022 are provided below.  </span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"></td><td style="width:45.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.820%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.820%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.820%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate for continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impact, in basis points, from specified items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective income tax rate for the three-month period of fiscal year 2023 primarily reflected a tax impact from specified items that was less favorable compared with the benefit associated with specified items recognized in the prior-year period. The effective income tax rate for the six-month period of fiscal year 2023 compared with the prior-year period primarily reflected the impact of a remeasurement of deferred tax assets and liabilities upon the approval of a tax incentive, as well as a tax impact from specified items that was more favorable compared with the benefit associated with specified items recognized in the prior-year period.   </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income and Diluted Earnings per Share from Continuing Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income and diluted earnings per share from continuing operations for the three and six-month periods of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"></td><td style="width:58.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.077%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.212%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income from Continuing Operations (Millions of dollars)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share from Continuing Operations</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.24&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.18&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfavorable impact-specified items</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfavorable impact-foreign currency translation</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.26)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our condensed consolidated statements of cash flows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:70.255%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.459%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used for) continuing operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(979)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Continuing Operating Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from continuing operating activities in the first six months of fiscal year 2023 reflected net income, adjusted by a change in operating assets and liabilities that was a net use of cash.  This net use of cash primarily reflected lower levels of accounts payable and accrued expenses, as well as higher levels of inventory and trade receivables.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from continuing operating activities in the first six months of fiscal year 2022 reflected net income, adjusted by a change in operating assets and liabilities that was a net use of cash. This net use of cash primarily reflected lower levels of accounts payable and accrued expenses and higher levels of inventory and prepaid expenses, partially offset by lower levels of trade receivables.  Cash flows from continuing operating activities in 2022 additionally reflected a discretionary cash contribution of $134 million to fund our pension obligation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Continuing Investing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in capital expenditures are focused on projects that enhance our cost structure and manufacturing capabilities, as well as support our BD 2025 strategy for growth and simplification.&#160;Net outflows from continuing investing activities in the first six months of fiscal year 2023 included capital expenditure-related outflows of $389 million, compared with $405 million in the prior-year period. Net outflows from investing activities in the first six months of fiscal year 2022 also included cash payments of $450 million relating to various strategic acquisitions we executed as part of our growth strategy.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Continuing Financing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash from continuing financing activities in the first six months of fiscal years 2023 and 2022 included the following significant cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"><tr><td style="width:1.0%"></td><td style="width:62.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.981%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash inflow (outflow)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in short-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution from Embecta</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(541)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional disclosures regarding debt issuances are provided in Note 13 in the Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain measures relating to our total debt were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"></td><td style="width:63.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average cost of total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt as a percentage of total capital*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Represents shareholders&#8217; equity, net non-current deferred income tax liabilities, and debt.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Short-Term Investments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, total worldwide cash and equivalents and short-term investments, including restricted cash, were approximately $2.074 billion. These assets were largely held in Europe and the United States. We regularly review the amount of cash and short-term investments held outside of the United States and our historical foreign earnings are used to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs. To fund cash needs in the United States, we rely on ongoing cash flow from U.S. operations, access to capital markets and remittances from foreign subsidiaries of earnings that are not considered to be permanently reinvested. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a five-year senior unsecured revolving credit facility in place which will expire in September 2026.  The credit facility, which was amended and restated in January 2023, provides borrowings of up to $2.750 billion, with separate sub-limits of $100 million and $194 million for letters of credit and swingline loans, respectively.  The expiration date of the credit facility may be extended for up to two additional one year periods, subject to certain restrictions (including the consent of the lenders). The credit facility provides that we may, subject to additional commitments by lenders, request an additional $500 million of financing, for a maximum aggregate commitment under the credit facility of up to $3.250 billion. Proceeds from this facility may be used for general corporate purposes and Becton Dickinson Euro Finance S.&#224; r.l., an indirect, wholly-owned finance subsidiary of the Company, is authorized as an additional borrower under the credit facility. There were no borrowings outstanding under the revolving credit facility at March&#160;31, 2023.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement for our revolving credit facility contains the following financial covenants.  We were in compliance with these covenants, as applicable, as of March&#160;31, 2023.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are required to have a leverage coverage ratio of no more than:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">4.25-to-1 as of the last day of each fiscal quarter following the closing of the credit facility; or</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">4.75-to-1 for the four full fiscal quarters following the consummation of a material acquisition. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may access commercial paper programs over the normal course of our business activities. In March 2023, we amended the agreement for our U.S. commercial paper program. The amendment provided, among other things, an increase of the maximum amount of unsecured borrowings available under the program to $2.750 billion. Also in March 2023, we entered into an agreement to establish a multicurrency euro commercial paper program.  This multicurrency program allows for a maximum amount of unsecured borrowings that, when aggregated with the amount outstanding under the U.S. commercial paper program, will not exceed $2.750 billion at any time. Proceeds from these programs may be used for working capital purposes and general </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">corporate purposes, which may include acquisitions, share repurchases and repayments of debt. We had $595 million of commercial paper borrowings outstanding as of March&#160;31, 2023. We have additional informal lines of credit outside the United States. Also, over the normal course of our business activities, we transfer certain trade receivable assets to third parties under factoring agreements.  Additional disclosures regarding sales of trade receivable assets are provided in Note 12 in the Notes to Condensed Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Access to Capital and Credit Ratings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate credit ratings with Standard &amp; Poor's Ratings Services (&#8220;S&amp;P&#8221;), Moody&#8217;s Investors Service (&#8220;Moody&#8217;s) and Fitch Ratings (&#8220;Fitch&#8221;) at March&#160;31, 2023 were unchanged compared with our ratings at September&#160;30, 2022. S&amp;P, Moody&#8217;s and Fitch assigned ratings of A-2, P-2 and F2, respectively, to the multicurrency euro commercial paper program we entered into in March 2023.  These ratings were consistent with the ratings already assigned to our U.S. commercial paper program.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lower corporate debt ratings and downgrades of our corporate credit ratings or other credit ratings may increase our cost of borrowing.  We believe that given our debt ratings, our financial management policies, our ability to generate cash flow and the non-cyclical, geographically diversified nature of our businesses, we would have access to additional short-term and long-term capital should the need arise.  A rating reflects only the view of a rating agency and is not a recommendation to buy, sell or hold securities.  Ratings can be revised upward or downward at any time by a rating agency if such rating agency decides that circumstances warrant such a change.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continually evaluate our accounts receivables for potential credit losses, particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries, as payment may be dependent upon the financial stability and creditworthiness of those countries&#8217; national economies. In addition to continually evaluating all governmental receivables for potential credit losses based upon historical loss experiences, we also evaluate such receivables based upon the availability of government funding and reimbursement practices. We believe the current reserves related to all governmental receivables are adequate and that these receivables will not have a material adverse impact on our financial position or liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not experienced a significant increased risk of credit losses in general as a result of current macroeconomic conditions.  No assurances can be given that the risk of credit losses will not increase in the future given the uncertainty around the duration of the current macroeconomic challenges and pressures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to our critical accounting policies from those disclosed in our 2022 Annual Report.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">FDA Warning Letter</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2018, BD received a Warning Letter from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) with respect to our former BD Preanalytical Systems ("PAS") unit, citing certain alleged violations of quality system regulations and of law. The Warning Letter states that, until BD resolves the outstanding issues covered by the Warning Letter, the FDA will not approve any premarket submissions for Class III devices to which the non-conformances are reasonably related or grant requests for certificates to foreign governments. BD has worked closely with the FDA and implemented corrective actions to address the quality management system concerns identified in the Warning Letter.  In March 2020, the FDA conducted a subsequent inspection of PAS, which it classified as Voluntary Action Indicated, which means the FDA will not take or recommend any administrative or regulatory action as a result of the unit&#8217;s response to the observations associated with the quality management concerns in the inspection. BD continues to work with the FDA to generate additional clinical evidence and file 510(k)s as remaining commitments associated with the Warning Letter. In January 2022, BD received FDA clearance for its BD Vacutainer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ACD Blood Collection Tubes used in immunohematology. The FDA review of these remaining commitments is ongoing, and no assurances can be given regarding further action by the FDA as a result of these commitments, including but not limited to action pursuant to the Warning Letter.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ethylene Oxide/Consent Order &#8212; Covington, Georgia, USA</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2019, BD entered into a consent order with the Environmental Protection Division of the Georgia Department of Natural Resources (the &#8220;EPD&#8221;), following the filing of a complaint and motion for temporary restraining order by the EPD seeking to enjoin BD from continuing sterilization operations at its Covington, Georgia facility.  Under the terms of the consent order,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which has been amended two times upon mutual agreement of BD and EPD, BD voluntarily agreed to a nu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mber of operational changes at its Covington and Madison, Georgia facilities, as well as at its distribution center in Covington, designed </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to further reduce ethylene oxide emissions, including but not limited to operating at a reduced capacity until successful implementation of fugitive emission control technology, ongoing ambient air monitoring and operational controls at such facilities. Following submission of data relating to the implementation of these operational changes, BD was permitted to return to normal operations in December 2021 at its facilities in Georgia in accordance with the operating conditions set forth in its permit applications, including a condition to continue ambient air monitoring. However, BD&#8217;s sterilization operations in Georgia remain subject to the EPD&#8217;s final approval of BD&#8217;s air permit applications and could be subject to additional restrictions.  On February 22, 2023, EPD published draft air permits for the Covington and Madison facilities. The public comment period for these draft air permits closed on April 3, 2023. There is no regulatory or statutory time requirement for EPD to issue the final air permits. BD has business continuity plans in place to mitigate the impact of any additional restrictions on our operations at these facilities, although it is possible that these plans will not be able to fully offset such impact, especially considering the reduced capacity of third-party sterilization service providers and the regulatory timelines associated with transferring sterilization operations for regulated products.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At a broader level, there is increased focus on the use and emission of ethylene oxide by the U.S. Environmental Protection Agency and state environmental regulatory agencies. Additional regulatory requirements associated with the use and emission of ethylene oxide may be imposed in the future, either domestically or outside the U.S. Ethylene oxide is the most frequently used sterilant for medical devices and healthcare products in the U.S., and in certain cases is the only option to sterilize critical medical device products for the safe administration to patients. This increased regulation could require BD or sterilization service providers, including providers used by BD, to temporarily suspend operations to install additional fugitive emissions control technology, limit the use of ethylene oxide or take other actions, which would impact BD&#8217;s operations and further reduce the available capacity to sterilize medical devices and healthcare products, and could also result in additional costs. To this end, BD has been proactively installing fugitive emissions controls at our facilities in East Columbus, NE and Sandy, UT, though such controls are not currently required by law. A few states have filed lawsuits to require additional air quality controls and expand limitations on the use of ethylene oxide at sterilization facilities. For example, in December 2020, the State of New Mexico filed a lawsuit seeking a temporary restraining order and a preliminary and permanent injunction against a major medical device sterilizer, which sterilizes certain of our surgery products, to reduce ethylene oxide emissions associated with their sterilization process.  On April 13, 2023, the U.S. Environmental Protection Agency (&#8220;EPA&#8221;) published a proposed revision of the National Emission Standards for Hazardous Air Pollutants: Ethylene Oxide Emissions Standards for Sterilization Facilities and a Pesticide Registration Review; Proposed Interim Decision and Draft Risk Assessment Addendum for Ethylene Oxide. The public comment period for these two proposed regulations will close on June 12, 2023, unless the public comment period is extended. We cannot predict what any final regulations adopted by the EPA may require and therefore we are not able to assess the impact they may have on our sterilization facilities, on the third-party sterilization facilities that BD utilizes and our operations more generally. It is possible that there may also be increased regulation outside the U.S.  If any existing regulatory requirements or any such proceedings or rulemaking result in the suspension or interruption of sterilization operations at BD or at medical device sterilizers used by BD, or otherwise limit the availability of third-party sterilization capacity, this could interrupt or otherwise adversely impact production of certain of our products or lead to civil litigation or other claims against BD. BD has business continuity plans in place to mitigate the impact of any such disruptions, although these plans may not be able to fully offset such impact, for the reasons noted above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consent Decree with FDA</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, our BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pump organizational unit is operating under an amended consent decree entered into by CareFusion (the &#8220;Consent Decree&#8221;) that includes all infusion pumps manufactured by or for CareFusion 303, Inc., the organizational unit that manufactures and sells Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps in the United States.&#160; </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following an inspection that began in March 2020 of our Medication Management Systems facility (CareFusion 303, Inc.) in San Diego, California, the FDA issued to BD a Form 483 Notice (the &#8220;Form 483 Notice&#8221;) that contains a number of observations of non-conformance with the FDA&#8217;s quality system regulations. In December 2021, the FDA issued to CareFusion 303, Inc. a letter of non-compliance with respect to the Consent Decree (the &#8220;Non-Compliance Letter&#8221;) stating that, among other things, it had determined that certain of BD&#8217;s corrective actions with respect to the Form 483 Notice appeared to be adequate, some were still in progress such that adequacy could not be determined yet, and certain others were not adequate (e.g., complaint handling and corrective and preventive actions (&#8220;CAPA&#8221;), design verification and medical device reporting). Per the terms of the Non-Compliance Letter, CareFusion 303, Inc. provided the FDA with a proposed comprehensive corrective action plan and has retained an independent expert to conduct periodic audits of the CareFusion 303, Inc. infusion pump facilities over the next four years. CareFusion 303, Inc. will update its corrective action plan to address any observations that may arise during the course of these audits. The FDA&#8217;s review of the items raised in the Form 483 Notice and Non-Compliance Letter remains ongoing, and no assurances can be given regarding further action by the FDA as a result of the observations, including but not limited to action pursuant to the Consent Decree, or that corrective actions proposed by CareFusion 303, Inc. will be adequate to address these observations. Additionally, we cannot currently predict the amount of additional monetary investment that will be incurred to resolve this matter or the matter&#8217;s ultimate impact on our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consent Decree authorizes the FDA, in the event of any violations in the future, to order us to cease manufacturing and distributing infusion pumps, recall products and take other actions. We may be required to pay damages of $15,000 per day per violation if we fail to comply with any provision of the Consent Decree, up to $15 million per year. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be obligated to pay more costs in the future because, among other things, the FDA may determine that we are not fully compliant with the Consent Decree and Non-Compliance Letter and therefore impose penalties under the Consent Decree, and/or we may also be subject to future proceedings and litigation relating to the matters addressed in the Consent Decree, including, but not limited to, additional fines, penalties, other monetary remedies, and expansion of the terms of the Consent Decree.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are undertaking certain remediation of our BD Alaris&#8482; System, and are currently shipping the product in the United States only in cases of medical necessity and to remediate recalled software versions.  As previously disclosed, we submitted our 510(k) premarket notification to the FDA for the BD Alaris&#8482; System in April 2021. The 510(k) submission is intended to bring the regulatory clearance for the BD Alaris&#8482; System up-to-date, address open recall issues, and provide other updates and features, including a new version of BD Alaris&#8482; System software that will provide clinical, operational and cybersecurity updates. We will not be able to fully resume commercial operations for the BD Alaris&#8482; System in the United States until BD&#8217;s 510(k) submission relating to the product has been cleared by the FDA. No assurances can be given as to when or if clearance will be obtained from the FDA.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of risks relating to the regulations to which we are subject, see Part I, Item 1A, of our 2022 Annual Report.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report includes forward-looking statements within the meaning of the federal securities laws.  BD and its representatives may also, from time to time, make certain forward-looking statements in publicly released materials, both written and oral, including statements contained in filings with the SEC, press releases, and our reports to shareholders. Forward-looking statements may be identified by the use of words such as &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;estimate&#8221; and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.  All statements that address our future operating performance or events or developments that we expect or anticipate will occur in the future are forward-looking statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are, and will be, based on management&#8217;s then-current views and assumptions regarding future events, developments and operating performance, and speak only as of their dates.  Investors should realize that if underlying assumptions prove inaccurate, or risks or uncertainties materialize, actual results could vary materially from our expectations and projections.  Investors are therefore cautioned not to place undue reliance on any forward-looking statements.  Furthermore, we undertake no obligation to update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events and developments or otherwise, except as required by applicable law or regulations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements.  For further discussion of certain of these factors, see Item&#160;1A. Risk Factors in our 2022 Annual Report.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of inflation and disruptions in our global supply chain on BD and our suppliers (particularly sole-source suppliers and providers of sterilization services), including fluctuations in the cost and availability of oil-based resins and other raw materials, as well as certain components, used in the production or sterilization of our products, transportation constraints and delays, product shortages, energy shortages or increased energy costs, labor shortages in the United States and elsewhere, and increased operating and labor costs.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:line-through">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General global, regional or national economic downturns and macroeconomic trends, including heightened inflation, capital market volatility, interest rate and currency rate fluctuations, and economic slowdown or recession, that may result in unfavorable conditions that could negatively affect demand for our products and services, impact the prices we can charge for our products and services, or impair our ability to produce our products.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competitive factors that could adversely affect our operations, including new product introductions and technologies (for example, new forms of drug delivery) by our current or future competitors, consolidation or strategic alliances among healthcare companies, distributors and/or payers of healthcare to improve their competitive position or develop new models for the delivery of healthcare, increased pricing pressure due to the impact of low-cost manufacturers, patents attained by competitors (particularly as patents on our products expire), new entrants into our markets and changes in the practice of medicine.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the way healthcare services are delivered, including transition of more care from acute to non-acute settings and increased focus on chronic disease management, which may affect the demand for our products and services. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, budget constraints and staffing shortages, particularly shortages of nursing staff, may affect the prioritization of healthcare services, which could also impact the demand for certain of our products and services.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks relating to our overall level of indebtedness, including our ability to service our debt and refinance our indebtedness, which is dependent upon the capital markets and the overall macroeconomic environment and our financial condition at such time.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The adverse financial impact resulting from unfavorable changes in foreign currency exchange rates.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conditions in international markets, including social and political conditions, geopolitical developments such as the ongoing Russia and Ukraine conflict and the evolving conditions in Asia, civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across borders, sanctions, tariffs and other protectionist measures, difficulties in protecting and enforcing our intellectual property rights and governmental expropriation of assets. Our international operations also increase our compliance risks, including risks under the Foreign Corrupt Practices Act and other anti-corruption laws, as well as regulatory and privacy laws. </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to achieve our projected level or mix of product sales, as our earnings forecasts are based on projected sales volumes and pricing of many product types, some of which are more profitable than others.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in reimbursement practices of governments or third-party payers, or adverse decisions relating to our products by such payers, which could reduce demand for our products or the price we can charge for such products.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost-containment efforts in the U.S. or in other countries in which we do business, such as alternative payment reform and increased use of competitive bidding and tenders, including, without limitation, any expansion of the volume-based procurement process in China or implementation of similar cost-containment efforts.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the domestic and foreign healthcare industry or in medical practices that result in a reduction in procedures using our products or increased pricing pressures, including cost-reduction measures instituted by and the continued consolidation among healthcare providers.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changing customer preferences and requirements, such as increased demand for products with lower environmental footprints, and for companies to produce and demonstrate progress against greenhouse gas reduction plans and targets.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any impact of COVID-19, including resurgences in COVID-19 infections or new strains of the virus or additional or extended lockdowns or other restrictions imposed by government entities, may have on our business, the global economy and the global healthcare system. This may include decreases in the demand for our products, disruptions to our operations or the operations of our suppliers and customers or disruptions to our supply chain.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Factors such as the rate of vaccination, the effectiveness of vaccines against different strains, the rate of infections, and competitive factors that could impact the demand and pricing for our COVID-19 diagnostics testing.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in U.S. federal or foreign laws and policies that could affect fiscal and tax policies, taxation (including tax reforms, such as the implementation of a global minimum tax, that could adversely impact multinational corporations), and international trade, including import and export regulation and international trade agreements. In particular, tariffs or other trade barriers imposed by the U.S. or other countries could adversely impact our supply chain costs or otherwise adversely impact our results of operations.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The risks associated with the spin-off of our former Diabetes Care business, including factors that could adversely affect our ability to realize the expected benefits of the spin-off, or the qualification of the spin-off as a tax-free transaction for U.S. federal income tax purposes.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Security breaches of our information systems or our products, which could impair our ability to conduct business, result in the loss of BD trade secrets or otherwise compromise sensitive information of BD or its customers, suppliers and other business partners, or of patients, including sensitive personal data, or result in product efficacy or safety concerns for certain of our products, and result in actions by regulatory bodies or civil litigation.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Difficulties inherent in product development, including the potential inability to successfully continue technological innovation, successfully complete clinical trials, obtain and maintain regulatory approvals and registrations in the United States and abroad, obtain intellectual property protection for our products, obtain coverage and adequate reimbursement for new products, or gain and maintain market approval of products, as well as the possibility of infringement claims by competitors with respect to patents or other intellectual property rights, all of which could preclude or delay commercialization of a product. Delays in obtaining necessary approvals or clearances from the FDA or other regulatory agencies or changes in the regulatory process may also delay product launches and increase development costs.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of business combinations or divestitures, including any volatility in earnings relating to acquisition-related costs, and our ability to successfully integrate any business we may acquire.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to penetrate or expand our operations in emerging markets, which depends on local economic and political conditions, and how well we are able to make necessary infrastructure enhancements to production facilities and distribution networks.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deficit reduction efforts or other actions that reduce the availability of government funding for healthcare and research, which could weaken demand for our products and result in additional pricing pressures, as well as create potential collection risks associated with such sales.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fluctuations in university or U.S. and international governmental funding and policies for life sciences research.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to recruit and retain key employees and the impact of labor conditions which could increase employee turnover or increase our labor and operating costs and negatively affect our ability to efficiently operate our business.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fluctuations in the demand for products we sell to pharmaceutical companies that are used to manufacture, or are sold with, the products of such companies, as a result of funding constraints, consolidation or otherwise.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effects of regulatory or other events that adversely impact our supply chain, including our ability to manufacture (including sterilize) our products (particularly where production of a product line or sterilization operations are concentrated in one or more plants), source materials or components or services from suppliers (including sole-source suppliers) that are needed for such manufacturing (including sterilization), or provide products to our customers, including events that impact key distributors. </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Natural disasters, including the impacts of climate change, hurricanes, tornadoes, windstorms, fires, earthquakes and floods and other extreme weather events, global health pandemics, war, terrorism, labor disruptions and international conflicts that could cause significant economic disruption and political and social instability, resulting in decreased demand for our products, adversely affect our manufacturing and distribution capabilities or cause interruptions in our supply chain.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pending and potential future litigation or other proceedings asserting, and/or investigations concerning and/or subpoenas and requests seeking information with respect to, alleged violations of law (including in connection with federal and/or state healthcare programs (such as Medicare or Medicaid) and/or sales and marketing practices (such as investigative subpoenas and the civil investigative demands received by BD)), potential anti-corruption and related internal control violations under the Foreign Corrupt Practices Act, antitrust claims, securities law claims, product liability (which may involve lawsuits seeking class action status or seeking to establish multi-district litigation proceedings, including pending claims relating to our hernia repair implant products, surgical continence products for women and vena cava filter products), claims with respect to environmental matters, data privacy breaches and patent infringement, and the availability or collectability of insurance relating to any such claims.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">New or changing laws and regulations affecting our domestic and foreign operations, or changes in enforcement practices, including, without limitation, laws relating to sales practices, environmental protection, price controls, privacy, cybersecurity, and licensing and regulatory requirements for new products and products in the post-marketing phase. In particular, the U.S. and other countries may impose new requirements regarding registration, labeling or prohibited materials that may require us to re-register products already on the market or otherwise impact our ability to market our products. Environmental laws, particularly with respect to the emission of greenhouse gases, are also becoming more stringent throughout the world, which may increase our costs of operations or necessitate changes in our manufacturing plants or processes or those of our suppliers, or result in liability to BD.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product efficacy or safety concerns regarding our products resulting in product holds or recalls, regulatory action on the part of the FDA or foreign counterparts (including restrictions on future product clearances and civil penalties), declining sales and product liability claims, and damage to our reputation. As a result of the CareFusion acquisition, our U.S. infusion pump business is operating under a Consent Decree with the FDA. The Consent Decree authorizes the FDA, in the event of any violations in the future, to order our U.S. infusion pump business to cease manufacturing and distributing products, recall products or take other actions, and order the payment of significant monetary damages if the business subject to the decree fails to comply with any provision of the Consent Decree. We are undertaking certain remediation of our BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System, and are currently shipping the product in the U.S., only in cases of medical necessity and to remediate recalled software versions. We will not be able to fully resume commercial operations for the BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System in the U.S. until BD&#8217;s 510(k) submission relating to the product has been cleared by the FDA. No assurances can be given as to when or if clearance will be obtained from the FDA.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of adverse media exposure or other publicity regarding BD&#8217;s business or operations, including the effect on BD&#8217;s reputation or demand for its products.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of market fluctuations on the value of assets in BD&#8217;s pension plans and on actuarial interest rate and asset return assumptions, which could require BD to make additional contributions to the plans or increase our pension plan expense.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to obtain the anticipated benefits of restructuring programs, if any, that we may undertake.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Issuance of new or revised accounting standards by the FASB or the SEC.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing list sets forth many, but not all, of the factors that could impact our ability to achieve results described in any forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider this list to be a complete statement of all potential risks and uncertainties.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in information reported since the end of the fiscal year ended September&#160;30, 2022.</span></div><div id="ic901e28da78f443cab3564a79902c5bb_76"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controls and Procedures</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was carried out by BD&#8217;s management, with the participation of BD&#8217;s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of BD&#8217;s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) as of March&#160;31, 2023.  Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were, as of the end of the period covered by this report, effective and designed to ensure that material information relating to BD and its consolidated subsidiaries would be made known to them by others within these entities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the fiscal quarter ended March&#160;31, 2023 identified in connection with the above-referenced evaluation that have materially affected, or are reasonably likely to materially affect, BD&#8217;s internal control over financial reporting.</span></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="ic901e28da78f443cab3564a79902c5bb_82"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Proceedings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved, both as a plaintiff and a defendant, in various legal proceedings, including product liability and environmental matters as set forth in our 2022 Annual Report, and in Note 5 of the Notes to Condensed Consolidated Financial Statements in this report, which is incorporated herein by reference.  </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors previously disclosed in Part I, Item&#160;1A, of our 2022 Annual Report.</span></div><div id="ic901e28da78f443cab3564a79902c5bb_88"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth certain information regarding our purchases of common stock of BD during the quarter ended March&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Issuer Purchases of Equity Securities</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.733%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the three months ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average&#160;Price<br/>Paid per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>as Part of<br/>Publicly<br/>Announced&#160;Plans<br/>or Programs </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maximum&#160;Number<br/>of&#160;Shares&#160;that&#160;May<br/>Yet Be Purchased<br/>Under&#160;the&#160;Plans&#160;or<br/>Programs (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 - 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 &#8211; 28, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 &#8211; 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.85&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,998&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Includes 1,125 shares purchased during the quarter in open market transactions by the trust relating to BD&#8217;s Deferred Compensation and Retirement Benefit Restoration Plan and 1996 Directors&#8217; Deferral Plan.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents shares available under a repurchase program authorized by the Board of Directors on November 3, 2021 for 10 million shares, for which there is no expiration date.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ic901e28da78f443cab3564a79902c5bb_94"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ic901e28da78f443cab3564a79902c5bb_97"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Information</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ic901e28da78f443cab3564a79902c5bb_100"></div><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibits</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:6.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.741%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036123006356/ny20007273x8_ex4-1.htm">4.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Fourth Supplemental Indenture, dated as of February 13, 2023, among Becton Dickinson Euro Finance S.&#224; r.l., as issuer, Becton, Dickinson and Company, as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the registrant&#8217;s Current Report on Form 8-K filed on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036123006356/ny20007273x8_ex4-2.htm">4.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Form of 3.553% Notes due September 13, 2029 of Becton Dickinson Euro Finance S.&#224; r.l. (incorporated by reference to Exhibit 4.2 to the registrant&#8217;s Current Report on Form 8-K filed on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036123006356/ny20007273x8_ex4-3.htm">4.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Form of 4.693% Notes due February 13, 2028 of Becton, Dickinson and Company (incorporated by reference to Exhibit 4.3 to the registrant&#8217;s Current Report on Form 8-K filed on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000001079523000015/a2004employeeanddirectoreq.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2004 Employee and Director Equity-Based Compensation Plan, as amended and restated as of January 24, 2023 (incorporated by reference to Exhibit 10.1 to the registrant&#8217;s Current Report on Form 8-K filed on January 30, 2023).*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036123002734/brhc10046929_ex10-1.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Second Amended and Restated Credit Agreement, dated as of January 25, 2023, by and among Becton, Dickinson and Company, the other entities party thereto and Citibank, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 to the registrant&#8217;s Current Report on Form 8-K filed on January 25, 2023). </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036123010990/brhc10049567_ex10-1.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Omnibus Amendment, dated as of March 9, 2023, among Becton, Dickinson and Company and each of the financial institutions party thereto as dealer (incorporated by reference to Exhibit 10.1 to the registrant&#8217;s Current Report on Form 8-K filed on March 10, 2023).**</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036123010990/brhc10049567_ex10-2.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dealer Agreement, dated March 9, 2023, among Becton, Dickinson and Company and each of the financial institutions party thereto as dealer (incorporated by reference to Exhibit 10.2 to the registrant&#8217;s Current Report on Form 8-K filed on March 10, 2023).**</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex2203312023.htm">22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Subsidiary Issuer of Guaranteed Securities.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex3103312023.htm">31</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to SEC Rule 13a - 14(a).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex3203312023.htm">32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to Rule 13a - 14(b) and Section 1350 of Chapter 63 of Title 18 of the U.S. Code.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from this report, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*    Denotes a management contract or compensatory plan or arrangement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**  Portions omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ic901e28da78f443cab3564a79902c5bb_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Becton,&#160;Dickinson&#160;and&#160;Company</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: May&#160;4, 2023 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christopher J. DelOrefice</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. DelOrefice</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas J. Spoerel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas J. Spoerel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Controller and Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>2
<FILENAME>ex2203312023.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0311939e814248b88124add19f303307_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 22</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Subsidiary Issuers of Guaranteed Securities</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">As of March&#160;31, 2023, Becton, Dickinson and Company (&#8220;BD&#8221;) is the guarantor of the senior unsecured registered notes listed below issued by Becton Dickinson Euro Finance S.&#224; r.l. (&#8220;BD Finance&#8221;). BD owns, directly or indirectly, 100% of BD Finance.</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Becton Dickinson Euro Finance S.&#224; r.l. </font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">0.632% Notes due June 4, 2023</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">1.208% Notes due June 4, 2026</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">0.334% Notes due August 13, 2028</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">3.553% Notes due September 13, 2029</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">1.213% Notes due February 12, 2036</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">1.336% Notes due August 13, 2041</font></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>3
<FILENAME>ex3103312023.htm
<DESCRIPTION>EX-31
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if11c77caedf543cfb40c3af0689175fb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-bottom:10pt;margin-top:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas E. Polen, certify that&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Becton, Dickinson and Company&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;4, 2023 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.689%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas E. Polen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas E. Polen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and President</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:12pt;text-align:center;text-indent:18pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:12pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-bottom:10pt;margin-top:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christopher J. DelOrefice, certify that&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Becton, Dickinson and Company&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;4, 2023 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.689%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer </font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>ex3203312023.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iccffa7a1eff3404b9e942c984e189637_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="margin-top:12pt;text-align:center;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report on Form 10-Q of Becton, Dickinson and Company for the quarter ended March&#160;31, 2023 (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a &#8211; 14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section&#160;1350 of Chapter 63 of Title 18 of the United States Code.</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas E. Polen, the Chief Executive Officer of Becton, Dickinson and Company, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">such Report fully complies with the requirements of Section&#160;13(a) of the Exchange Act&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Becton, Dickinson and Company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;4, 2023 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.689%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas E. Polen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Thomas E. Polen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-indent:27pt"><font><br></font></div><div style="text-align:center;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-indent:27pt"><font><br></font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report on Form 10-Q of Becton, Dickinson and Company for the quarter ended March&#160;31, 2023 (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a &#8211; 14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section&#160;1350 of Chapter 63 of Title 18 of the United States Code.</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christopher J. DelOrefice, the Chief Financial Officer of Becton, Dickinson and Company, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">such Report fully complies with the requirements of Section&#160;13(a) of the Exchange Act&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Becton, Dickinson and Company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;4, 2023 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.689%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>bdx-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c18e2de7-cbd8-4499-b946-e1533dbcca3e,g:06687f9f-d051-4540-9898-7752ada2060d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bdx="http://www.bd.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bd.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.bd.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncome" roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome">
        <link:definition>0000002 - Statement - Condensed Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.bd.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000004 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.bd.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.bd.com/role/BasisofPresentation">
        <link:definition>0000007 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinOffofEmbectaCorp" roleURI="http://www.bd.com/role/SpinOffofEmbectaCorp">
        <link:definition>0000008 - Disclosure - Spin-Off of Embecta Corp.</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.bd.com/role/ShareholdersEquity">
        <link:definition>0000009 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.bd.com/role/EarningsPerShare">
        <link:definition>0000010 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.bd.com/role/Contingencies">
        <link:definition>0000011 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenues" roleURI="http://www.bd.com/role/Revenues">
        <link:definition>0000012 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentData" roleURI="http://www.bd.com/role/SegmentData">
        <link:definition>0000013 - Disclosure - Segment Data</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.bd.com/role/BenefitPlans">
        <link:definition>0000014 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessRestructuringCharges" roleURI="http://www.bd.com/role/BusinessRestructuringCharges">
        <link:definition>0000015 - Disclosure - Business Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.bd.com/role/IntangibleAssets">
        <link:definition>0000016 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivities" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities">
        <link:definition>0000017 - Disclosure - Derivative Instruments and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurements" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements">
        <link:definition>0000018 - Disclosure - Financial Instruments and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.bd.com/role/Debt">
        <link:definition>0000019 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://www.bd.com/role/BasisofPresentationPolicies">
        <link:definition>0000020 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinOffofEmbectaCorpTables" roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpTables">
        <link:definition>0000021 - Disclosure - Spin-Off of Embecta Corp. (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.bd.com/role/ShareholdersEquityTables">
        <link:definition>0000022 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.bd.com/role/EarningsPerShareTables">
        <link:definition>0000023 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataTables" roleURI="http://www.bd.com/role/SegmentDataTables">
        <link:definition>0000024 - Disclosure - Segment Data (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTables" roleURI="http://www.bd.com/role/BenefitPlansTables">
        <link:definition>0000025 - Disclosure - Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessRestructuringChargesTables" roleURI="http://www.bd.com/role/BusinessRestructuringChargesTables">
        <link:definition>0000026 - Disclosure - Business Restructuring Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.bd.com/role/IntangibleAssetsTables">
        <link:definition>0000027 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesTables" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables">
        <link:definition>0000028 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsTables" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables">
        <link:definition>0000029 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinOffofEmbectaCorpAdditionalInformationDetails" roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails">
        <link:definition>0000030 - Disclosure - Spin-Off of Embecta Corp. - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails" roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails">
        <link:definition>0000031 - Disclosure - Spin-Off of Embecta Corp. - Income from Discontinued Operations, Net of Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails">
        <link:definition>0000032 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" roleURI="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail">
        <link:definition>0000033 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" roleURI="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail">
        <link:definition>0000034 - Disclosure - Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesDetail" roleURI="http://www.bd.com/role/ContingenciesDetail">
        <link:definition>0000035 - Disclosure - Contingencies (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDetails" roleURI="http://www.bd.com/role/RevenuesDetails">
        <link:definition>0000036 - Disclosure - Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDetails_1" roleURI="http://www.bd.com/role/RevenuesDetails_1">
        <link:definition>0000036 - Disclosure - Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataAdditionalInformationDetail" roleURI="http://www.bd.com/role/SegmentDataAdditionalInformationDetail">
        <link:definition>0000037 - Disclosure - Segment Data - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataRevenuesbyGeographicAreasDetail" roleURI="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail">
        <link:definition>0000038 - Disclosure - Segment Data - Revenues by Geographic Areas (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataFinancialInformationforCompanysSegmentsDetail" roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail">
        <link:definition>0000039 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansDetail" roleURI="http://www.bd.com/role/BenefitPlansDetail">
        <link:definition>0000040 - Disclosure - Benefit Plans (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessRestructuringChargesDetail" roleURI="http://www.bd.com/role/BusinessRestructuringChargesDetail">
        <link:definition>0000041 - Disclosure - Business Restructuring Charges (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsComponentsofIntangibleAssetsDetail" roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail">
        <link:definition>0000042 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAdditionalInformationDetail" roleURI="http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail">
        <link:definition>0000043 - Disclosure - Intangible Assets - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" roleURI="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail">
        <link:definition>0000044 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail">
        <link:definition>0000045 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails">
        <link:definition>0000046 - Disclosure - Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail">
        <link:definition>0000047 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails">
        <link:definition>0000048 - Disclosure - Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>0000049 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail">
        <link:definition>0000050 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails">
        <link:definition>0000051 - Disclosure - Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetail" roleURI="http://www.bd.com/role/DebtDetail">
        <link:definition>0000052 - Disclosure - Debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_CommonStockHeldInTrustsAcquired" abstract="false" name="CommonStockHeldInTrustsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_MedicationManagementSolutionsMember" abstract="true" name="MedicationManagementSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_BiosciencesMember" abstract="true" name="BiosciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_InterventionalMember" abstract="true" name="InterventionalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_GwinnettCountyGeorgiaMember" abstract="true" name="GwinnettCountyGeorgiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_CoreAndDevelopedTechnologyNet" abstract="false" name="CoreAndDevelopedTechnologyNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes3.020dueMay242025Member" abstract="true" name="Notes3.020dueMay242025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ContractWithCustomerRebateLiability" abstract="false" name="ContractWithCustomerRebateLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_MaturityPeriodOfShortTermInvestment" abstract="false" name="MaturityPeriodOfShortTermInvestment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" abstract="false" name="StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_ForeignCurrencyDenominatedDebtMember" abstract="true" name="ForeignCurrencyDenominatedDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_SurgeryMember" abstract="true" name="SurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_TransfersOfFinancialAssetsDuringThePeriod" abstract="false" name="TransfersOfFinancialAssetsDuringThePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes1.401dueMay242023Member" abstract="true" name="Notes1.401dueMay242023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" abstract="false" name="FairValueOfDebtClassifiedFromLongTermToShortTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" abstract="false" name="DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_OrganizationalUnitAxis" abstract="true" name="OrganizationalUnitAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bdx_UrologyandCriticalCareMember" abstract="true" name="UrologyandCriticalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes0000DueAugust132023Member" abstract="true" name="Notes0000DueAugust132023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_OtherInitiativesMember" abstract="true" name="OtherInitiativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_CommonStockSharesHeldInEmployeeTrust1" abstract="false" name="CommonStockSharesHeldInEmployeeTrust1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_LifeSciencesMember" abstract="true" name="LifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_PeripheralInterventionMember" abstract="true" name="PeripheralInterventionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_MedicationDeliverySolutionsMember" abstract="true" name="MedicationDeliverySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" abstract="false" name="NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bdx_IntegratedDiagnosticSolutionsMember" abstract="true" name="IntegratedDiagnosticSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bdx_Notes1.900dueDecember152026Member" abstract="true" name="Notes1.900dueDecember152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationMember" abstract="true" name="ShareBasedCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes1.208dueJune42026Member" abstract="true" name="Notes1.208dueJune42026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_AcquisitionRelatedCostsAndRestructuringCharges" abstract="false" name="AcquisitionRelatedCostsAndRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bdx_Notes3553DueSeptember132029Member" abstract="true" name="Notes3553DueSeptember132029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes0034DueAugust132025Member" abstract="true" name="Notes0034DueAugust132025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_PharmaceuticalSystemsMember" abstract="true" name="PharmaceuticalSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes0.632dueJune42023Member" abstract="true" name="Notes0.632dueJune42023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" abstract="false" name="ProceedsfromIssuanceofLongTermDebtandTermLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_FixedToFloatingMember" abstract="true" name="FixedToFloatingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_HerniaProductClaimsMember" abstract="true" name="HerniaProductClaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_TerminatedCurrencySwapMember" abstract="true" name="TerminatedCurrencySwapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_CommonStockHeldInTrustsNetShares" abstract="false" name="CommonStockHeldInTrustsNetShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_Notes1213NotesDueFebruary122036Member" abstract="true" name="Notes1213NotesDueFebruary122036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_FiniteLivedCustomerRelationshipsNet" abstract="false" name="FiniteLivedCustomerRelationshipsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_MedicalMember" abstract="true" name="MedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes4693DueFebruary132028Member" abstract="true" name="Notes4693DueFebruary132028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_NumberOfEtOSterilizationLawsuitsFiled" abstract="false" name="NumberOfEtOSterilizationLawsuitsFiled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bdx_ProductsandorServicesMember" abstract="true" name="ProductsandorServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ProceedsFromSpinoffTransaction" abstract="false" name="ProceedsFromSpinoffTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_OrganizationalUnitDomain" abstract="true" name="OrganizationalUnitDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_IncreaseDecreaseinPensionBenefitObligation" abstract="false" name="IncreaseDecreaseinPensionBenefitObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>bdx-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c18e2de7-cbd8-4499-b946-e1533dbcca3e,g:06687f9f-d051-4540-9898-7752ada2060d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="bdx-20230331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d8360fd8-1f75-4356-bfc9-936a851100cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_5e9fc030-a7a7-4b9f-84d9-df8a66c5c33a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d8360fd8-1f75-4356-bfc9-936a851100cb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_5e9fc030-a7a7-4b9f-84d9-df8a66c5c33a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a240afb8-70b7-4dbf-b90f-37b57c99cd50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d8360fd8-1f75-4356-bfc9-936a851100cb" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a240afb8-70b7-4dbf-b90f-37b57c99cd50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_52859055-c69c-4412-921a-8eab4b5898e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_ca10df95-9ad3-473d-8b36-dd751bcabd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_52859055-c69c-4412-921a-8eab4b5898e9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_ca10df95-9ad3-473d-8b36-dd751bcabd5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_6e092b60-7a14-46c0-bab1-abc2191f64bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_52859055-c69c-4412-921a-8eab4b5898e9" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_6e092b60-7a14-46c0-bab1-abc2191f64bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_eede9cc8-6bed-437b-9a1d-f8f62cbeac29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ddc46173-62ea-4d2c-bf8f-faec88952eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_eede9cc8-6bed-437b-9a1d-f8f62cbeac29" xlink:to="loc_us-gaap_NetIncomeLoss_ddc46173-62ea-4d2c-bf8f-faec88952eed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_5d8ea069-cfa6-48a2-a331-8b9182513b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_eede9cc8-6bed-437b-9a1d-f8f62cbeac29" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_5d8ea069-cfa6-48a2-a331-8b9182513b56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_42bd24f8-b39d-4ffb-bc95-eca498526e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_6a3ff2b9-e9fb-4a84-8c33-11d4149b178d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_42bd24f8-b39d-4ffb-bc95-eca498526e46" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_6a3ff2b9-e9fb-4a84-8c33-11d4149b178d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_136b5d23-20f3-40e6-b45b-33ce0d3d645a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_42bd24f8-b39d-4ffb-bc95-eca498526e46" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_136b5d23-20f3-40e6-b45b-33ce0d3d645a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_46171eae-7ee1-41cb-b099-425bf5433c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_0b962f3d-5955-4c60-80e1-cd6b9e60c2dd" xlink:href="bdx-20230331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_46171eae-7ee1-41cb-b099-425bf5433c57" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_0b962f3d-5955-4c60-80e1-cd6b9e60c2dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_652017f0-0fe3-4ab5-97dc-27517663971e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_46171eae-7ee1-41cb-b099-425bf5433c57" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_652017f0-0fe3-4ab5-97dc-27517663971e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_efd13916-508f-4a19-a82f-926dc5727a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_46171eae-7ee1-41cb-b099-425bf5433c57" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_efd13916-508f-4a19-a82f-926dc5727a9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_61730dad-a1b7-4418-ba2c-137390919e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_46171eae-7ee1-41cb-b099-425bf5433c57" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_61730dad-a1b7-4418-ba2c-137390919e75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_98a78a99-d102-4646-8749-713409cbd113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_46171eae-7ee1-41cb-b099-425bf5433c57" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_98a78a99-d102-4646-8749-713409cbd113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_a78253e6-5b4c-4f5c-9062-e2c7fb34cda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0df97856-ea31-4065-8bc2-9d9b27b380c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_a78253e6-5b4c-4f5c-9062-e2c7fb34cda9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0df97856-ea31-4065-8bc2-9d9b27b380c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3792d60a-1be6-4861-a6c5-1b9c3c2bfed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_a78253e6-5b4c-4f5c-9062-e2c7fb34cda9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3792d60a-1be6-4861-a6c5-1b9c3c2bfed3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bcae1d07-1a9a-4e82-8235-1628c179dc33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_851b2ea3-4ede-4e33-82f9-47804a436198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bcae1d07-1a9a-4e82-8235-1628c179dc33" xlink:to="loc_us-gaap_Revenues_851b2ea3-4ede-4e33-82f9-47804a436198" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_409f0a3e-24c6-481c-a842-04aa678cefa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bcae1d07-1a9a-4e82-8235-1628c179dc33" xlink:to="loc_us-gaap_CostsAndExpenses_409f0a3e-24c6-481c-a842-04aa678cefa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9492a7f3-d1c5-4201-82ce-51950988383a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_29d2730f-06b8-474e-afa2-3ae9cbe26705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9492a7f3-d1c5-4201-82ce-51950988383a" xlink:to="loc_us-gaap_OperatingIncomeLoss_29d2730f-06b8-474e-afa2-3ae9cbe26705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3efdcfa6-8206-4843-9c0f-357201ec141d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9492a7f3-d1c5-4201-82ce-51950988383a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3efdcfa6-8206-4843-9c0f-357201ec141d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_d304119c-32ed-432c-8034-20399dbe8967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9492a7f3-d1c5-4201-82ce-51950988383a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_d304119c-32ed-432c-8034-20399dbe8967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e041e2d3-9f1a-4149-ada5-c62053134750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9492a7f3-d1c5-4201-82ce-51950988383a" xlink:to="loc_us-gaap_InterestExpense_e041e2d3-9f1a-4149-ada5-c62053134750" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="bdx-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_724a301c-76c5-41b0-96bc-f7541c599d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c4ddb2b1-cec2-4a01-890b-26267678b68b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_724a301c-76c5-41b0-96bc-f7541c599d10" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c4ddb2b1-cec2-4a01-890b-26267678b68b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1dbe97b0-f0df-4d4d-b926-fec32d7aa092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_724a301c-76c5-41b0-96bc-f7541c599d10" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1dbe97b0-f0df-4d4d-b926-fec32d7aa092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_6dbaddeb-551c-42c9-89b2-6f7540144c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_724a301c-76c5-41b0-96bc-f7541c599d10" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_6dbaddeb-551c-42c9-89b2-6f7540144c51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0f93453c-fbcb-47dc-a218-aa0180a3f844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9e27947a-524b-47fd-8f40-f7b1507beca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0f93453c-fbcb-47dc-a218-aa0180a3f844" xlink:to="loc_us-gaap_NetIncomeLoss_9e27947a-524b-47fd-8f40-f7b1507beca5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8cad9d98-ff94-46ee-8877-735ca228f379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0f93453c-fbcb-47dc-a218-aa0180a3f844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8cad9d98-ff94-46ee-8877-735ca228f379" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bdx-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_065b633a-d9cd-4564-96f2-7a2efbf4eb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ba1e32ed-60c3-4d08-a239-04299ba13f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_065b633a-d9cd-4564-96f2-7a2efbf4eb4b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ba1e32ed-60c3-4d08-a239-04299ba13f3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3fc6e8d0-2bd9-4e73-8f7f-5009c229178e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_065b633a-d9cd-4564-96f2-7a2efbf4eb4b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3fc6e8d0-2bd9-4e73-8f7f-5009c229178e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4718e311-e936-4e1c-beb1-c2a5f15617d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_762bb4b2-0b0f-4795-9f18-6ed96b91651f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4718e311-e936-4e1c-beb1-c2a5f15617d0" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_762bb4b2-0b0f-4795-9f18-6ed96b91651f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ee1173c8-e9ee-4d58-a7ed-963744f35625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4718e311-e936-4e1c-beb1-c2a5f15617d0" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ee1173c8-e9ee-4d58-a7ed-963744f35625" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6112f884-d089-41ed-960b-6bd0b55d6144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4718e311-e936-4e1c-beb1-c2a5f15617d0" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6112f884-d089-41ed-960b-6bd0b55d6144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c8e8259-bc90-49ef-8c40-d41905573358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_5fc291d5-a88c-4e0f-b8e1-eedeef813020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c8e8259-bc90-49ef-8c40-d41905573358" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_5fc291d5-a88c-4e0f-b8e1-eedeef813020" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3c7639d8-3aef-408f-bd32-c669caaf96c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c8e8259-bc90-49ef-8c40-d41905573358" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3c7639d8-3aef-408f-bd32-c669caaf96c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_778d89a5-ad54-435b-bb6d-5cd9c5435ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c8e8259-bc90-49ef-8c40-d41905573358" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_778d89a5-ad54-435b-bb6d-5cd9c5435ea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_26f6d3a4-8ee6-4b4d-a95c-a6ac6397836a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c8e8259-bc90-49ef-8c40-d41905573358" xlink:to="loc_us-gaap_LiabilitiesCurrent_26f6d3a4-8ee6-4b4d-a95c-a6ac6397836a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_422b161c-9656-4286-bf8d-2b5cc2e5e8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c8e8259-bc90-49ef-8c40-d41905573358" xlink:to="loc_us-gaap_CommitmentsAndContingencies_422b161c-9656-4286-bf8d-2b5cc2e5e8b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_60bf8bc1-118a-437a-bd49-00e94c1d66b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c8e8259-bc90-49ef-8c40-d41905573358" xlink:to="loc_us-gaap_StockholdersEquity_60bf8bc1-118a-437a-bd49-00e94c1d66b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_01270cdb-ddf9-4a11-8dfc-755a7194df53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_81b6af5b-fe88-492f-a5d4-0ce447ff88a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01270cdb-ddf9-4a11-8dfc-755a7194df53" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_81b6af5b-fe88-492f-a5d4-0ce447ff88a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments_66220bf1-9a01-4502-afdf-6a120ae12ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01270cdb-ddf9-4a11-8dfc-755a7194df53" xlink:to="loc_us-gaap_OtherShortTermInvestments_66220bf1-9a01-4502-afdf-6a120ae12ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_44f4d35c-453e-4603-8792-3a94669a596e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01270cdb-ddf9-4a11-8dfc-755a7194df53" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_44f4d35c-453e-4603-8792-3a94669a596e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_39de4861-786f-4d97-b3a2-1a8eee564566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01270cdb-ddf9-4a11-8dfc-755a7194df53" xlink:to="loc_us-gaap_OtherAssetsCurrent_39de4861-786f-4d97-b3a2-1a8eee564566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bdfe569e-fa75-442e-8c83-880257d7afa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01270cdb-ddf9-4a11-8dfc-755a7194df53" xlink:to="loc_us-gaap_InventoryNet_bdfe569e-fa75-442e-8c83-880257d7afa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_74ab1b8e-0c92-4f0d-9c13-b2d2f319691d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01270cdb-ddf9-4a11-8dfc-755a7194df53" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_74ab1b8e-0c92-4f0d-9c13-b2d2f319691d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_636121df-c2fe-45da-aeeb-7959e084ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreAndDevelopedTechnologyNet_deaab564-86da-4d02-b727-258045ae0204" xlink:href="bdx-20230331.xsd#bdx_CoreAndDevelopedTechnologyNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_636121df-c2fe-45da-aeeb-7959e084ad8e" xlink:to="loc_bdx_CoreAndDevelopedTechnologyNet_deaab564-86da-4d02-b727-258045ae0204" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5541ef93-96aa-4f34-bdea-5e78ec69d6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_636121df-c2fe-45da-aeeb-7959e084ad8e" xlink:to="loc_us-gaap_AssetsCurrent_5541ef93-96aa-4f34-bdea-5e78ec69d6b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteLivedCustomerRelationshipsNet_4d736a27-66ce-485f-bd16-93f1c66faf03" xlink:href="bdx-20230331.xsd#bdx_FiniteLivedCustomerRelationshipsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_636121df-c2fe-45da-aeeb-7959e084ad8e" xlink:to="loc_bdx_FiniteLivedCustomerRelationshipsNet_4d736a27-66ce-485f-bd16-93f1c66faf03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_fdb7864e-51a9-4bab-b78a-dcf667c2b1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_636121df-c2fe-45da-aeeb-7959e084ad8e" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_fdb7864e-51a9-4bab-b78a-dcf667c2b1b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d3588b6f-3597-42a0-92fd-991b0d7886ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_636121df-c2fe-45da-aeeb-7959e084ad8e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d3588b6f-3597-42a0-92fd-991b0d7886ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e9bc41ff-1b49-430b-ba61-bee5fd274c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_636121df-c2fe-45da-aeeb-7959e084ad8e" xlink:to="loc_us-gaap_Goodwill_e9bc41ff-1b49-430b-ba61-bee5fd274c57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c554e6f9-5f04-4b32-8d21-0e8b222fc032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_636121df-c2fe-45da-aeeb-7959e084ad8e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c554e6f9-5f04-4b32-8d21-0e8b222fc032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4d56147f-4022-47ab-8f57-f97f160a2f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_1ea02241-e39b-4123-93fa-b7713c2cd75f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4d56147f-4022-47ab-8f57-f97f160a2f15" xlink:to="loc_us-gaap_DebtCurrent_1ea02241-e39b-4123-93fa-b7713c2cd75f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6423113f-be40-4cc1-941e-ba8bf2af0ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4d56147f-4022-47ab-8f57-f97f160a2f15" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6423113f-be40-4cc1-941e-ba8bf2af0ba7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_58907224-d2c1-4ff2-a9d3-2a89370a3417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_78f5a7fb-dcc4-429b-b266-19e43fc70459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_58907224-d2c1-4ff2-a9d3-2a89370a3417" xlink:to="loc_us-gaap_PreferredStockValue_78f5a7fb-dcc4-429b-b266-19e43fc70459" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_e792bda6-1e64-4cb6-8bca-5b876df231b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_58907224-d2c1-4ff2-a9d3-2a89370a3417" xlink:to="loc_us-gaap_CommonStockValue_e792bda6-1e64-4cb6-8bca-5b876df231b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_71cc9ffb-d292-4751-91ef-bb4a6c1d55bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_58907224-d2c1-4ff2-a9d3-2a89370a3417" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_71cc9ffb-d292-4751-91ef-bb4a6c1d55bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_be5681b6-bff6-47ff-9118-200dcc2acf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_58907224-d2c1-4ff2-a9d3-2a89370a3417" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_be5681b6-bff6-47ff-9118-200dcc2acf0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_22c7638d-23b5-4939-99c5-586ace0fbc8f" xlink:href="bdx-20230331.xsd#bdx_CommonStockSharesHeldInEmployeeTrust1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_58907224-d2c1-4ff2-a9d3-2a89370a3417" xlink:to="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_22c7638d-23b5-4939-99c5-586ace0fbc8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_159d7169-3426-458a-943e-37064dfecce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_58907224-d2c1-4ff2-a9d3-2a89370a3417" xlink:to="loc_us-gaap_TreasuryStockValue_159d7169-3426-458a-943e-37064dfecce0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d9db328f-d972-4d71-aefa-32c6727df4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_58907224-d2c1-4ff2-a9d3-2a89370a3417" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d9db328f-d972-4d71-aefa-32c6727df4c5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bdx-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a2cd7d9-11ca-4948-9475-09f7b4a17400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_c3acf0ce-3a43-40a0-966b-7438fa88bf49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a2cd7d9-11ca-4948-9475-09f7b4a17400" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_c3acf0ce-3a43-40a0-966b-7438fa88bf49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_acee1ac7-fab1-44a0-815d-ba7518b34aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a2cd7d9-11ca-4948-9475-09f7b4a17400" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_acee1ac7-fab1-44a0-815d-ba7518b34aca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1a31e33b-7b99-4dfc-a674-a6ecd636ec76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a2cd7d9-11ca-4948-9475-09f7b4a17400" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1a31e33b-7b99-4dfc-a674-a6ecd636ec76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b12e9da-478f-4549-8ecf-416da531cd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a2cd7d9-11ca-4948-9475-09f7b4a17400" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b12e9da-478f-4549-8ecf-416da531cd0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_68526401-c0af-4012-aaa9-a94d2dce159b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a2cd7d9-11ca-4948-9475-09f7b4a17400" xlink:to="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_68526401-c0af-4012-aaa9-a94d2dce159b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_85f3e5ef-89da-4fce-b09d-9cb3b565aef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_28c3d03f-31dd-4437-82ea-8d5bf4d27517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_85f3e5ef-89da-4fce-b09d-9cb3b565aef6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_28c3d03f-31dd-4437-82ea-8d5bf4d27517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6607e5e1-92d0-4597-9650-e7984ec5bf18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_85f3e5ef-89da-4fce-b09d-9cb3b565aef6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6607e5e1-92d0-4597-9650-e7984ec5bf18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_bf0b6265-f995-46ad-9676-eaeb60a05dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_85f3e5ef-89da-4fce-b09d-9cb3b565aef6" xlink:to="loc_us-gaap_ShareBasedCompensation_bf0b6265-f995-46ad-9676-eaeb60a05dfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_5e79ec24-65f7-43c1-b3d1-da42761e9f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_85f3e5ef-89da-4fce-b09d-9cb3b565aef6" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_5e79ec24-65f7-43c1-b3d1-da42761e9f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_7436d7c5-5f35-4673-a2ce-e11db311e61d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_85f3e5ef-89da-4fce-b09d-9cb3b565aef6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_7436d7c5-5f35-4673-a2ce-e11db311e61d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_190fe6ba-e67f-4b9e-80f9-f5992b91d739" xlink:href="bdx-20230331.xsd#bdx_IncreaseDecreaseinPensionBenefitObligation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_85f3e5ef-89da-4fce-b09d-9cb3b565aef6" xlink:to="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_190fe6ba-e67f-4b9e-80f9-f5992b91d739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_5b66ffd7-cd79-4af6-9052-12dab92e627a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_85f3e5ef-89da-4fce-b09d-9cb3b565aef6" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_5b66ffd7-cd79-4af6-9052-12dab92e627a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_b63f8b55-aa75-46ee-9a0d-df004a952a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f132b3e0-b723-4b2f-bf74-0dc49db61639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_b63f8b55-aa75-46ee-9a0d-df004a952a62" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f132b3e0-b723-4b2f-bf74-0dc49db61639" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e79402a2-940f-4c87-8d76-b3664cfc9cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_b63f8b55-aa75-46ee-9a0d-df004a952a62" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e79402a2-940f-4c87-8d76-b3664cfc9cd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_7f721f46-a6c9-4274-8639-a1fe54879ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_b63f8b55-aa75-46ee-9a0d-df004a952a62" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_7f721f46-a6c9-4274-8639-a1fe54879ae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_45209f66-a65a-4152-9dec-a5d5307cf14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_407e8ef1-e298-4a7e-bea4-2ea4d7a0e987" xlink:href="bdx-20230331.xsd#bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_45209f66-a65a-4152-9dec-a5d5307cf14f" xlink:to="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_407e8ef1-e298-4a7e-bea4-2ea4d7a0e987" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f026bfa1-0fc3-40c9-b90c-faaf92baf729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_45209f66-a65a-4152-9dec-a5d5307cf14f" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f026bfa1-0fc3-40c9-b90c-faaf92baf729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_d9255645-6929-4165-af1f-1edaedf400d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_45209f66-a65a-4152-9dec-a5d5307cf14f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_d9255645-6929-4165-af1f-1edaedf400d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsFromSpinoffTransaction_09e65d1e-b9ed-451e-8e94-909b967bfc5c" xlink:href="bdx-20230331.xsd#bdx_ProceedsFromSpinoffTransaction"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_45209f66-a65a-4152-9dec-a5d5307cf14f" xlink:to="loc_bdx_ProceedsFromSpinoffTransaction_09e65d1e-b9ed-451e-8e94-909b967bfc5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_fd63446c-7fc2-4811-b967-0978f2ffbf84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_45209f66-a65a-4152-9dec-a5d5307cf14f" xlink:to="loc_us-gaap_PaymentsOfDividends_fd63446c-7fc2-4811-b967-0978f2ffbf84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_905f340b-424f-43bc-a7e2-7a971f3fd504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_45209f66-a65a-4152-9dec-a5d5307cf14f" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_905f340b-424f-43bc-a7e2-7a971f3fd504" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_2bcbd82c-1c60-4ab8-9567-3732333ff72c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_02331ced-b23a-4657-a759-870cf82dd26e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_2bcbd82c-1c60-4ab8-9567-3732333ff72c" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_02331ced-b23a-4657-a759-870cf82dd26e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_9e8841ff-65d0-4519-a02f-1c9156158a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_2bcbd82c-1c60-4ab8-9567-3732333ff72c" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_9e8841ff-65d0-4519-a02f-1c9156158a39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_c1343a5d-6024-4e5d-a5e9-f6934772b1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_2bcbd82c-1c60-4ab8-9567-3732333ff72c" xlink:to="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_c1343a5d-6024-4e5d-a5e9-f6934772b1ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_fa21dc38-9371-4bcb-bf37-63db3d8f6713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_df44d4f7-43c9-4528-bc1d-533ec58d12ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_fa21dc38-9371-4bcb-bf37-63db3d8f6713" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_df44d4f7-43c9-4528-bc1d-533ec58d12ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_f201df3d-a37e-428f-afd3-80fd211ec575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_fa21dc38-9371-4bcb-bf37-63db3d8f6713" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_f201df3d-a37e-428f-afd3-80fd211ec575" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_a2f0f8e9-c550-4b7c-86f8-aacf2493b8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_62dd0ef6-5043-403f-ab2d-fe8950197201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_a2f0f8e9-c550-4b7c-86f8-aacf2493b8a1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_62dd0ef6-5043-403f-ab2d-fe8950197201" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_7df24446-6337-4cca-b7d0-990471587b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_a2f0f8e9-c550-4b7c-86f8-aacf2493b8a1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_7df24446-6337-4cca-b7d0-990471587b48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_c4e3520f-3ac9-45e4-a629-28f41d00dc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_5f73f63e-7b69-49da-9d4b-0673fba5574b" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_c4e3520f-3ac9-45e4-a629-28f41d00dc0b" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_5f73f63e-7b69-49da-9d4b-0673fba5574b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_72de9495-dfa0-464b-bd92-181ad30bc346" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_c4e3520f-3ac9-45e4-a629-28f41d00dc0b" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_72de9495-dfa0-464b-bd92-181ad30bc346" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_767f70e5-2c7f-4523-aec8-a76d416dcbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_c4e3520f-3ac9-45e4-a629-28f41d00dc0b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_767f70e5-2c7f-4523-aec8-a76d416dcbe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_516b8e6c-6490-40df-80a9-958b3f13b2d9" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_c4e3520f-3ac9-45e4-a629-28f41d00dc0b" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_516b8e6c-6490-40df-80a9-958b3f13b2d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ecdaa57a-9187-4439-abe9-58e40043fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_d25ab815-0cb5-4462-9806-5969b3c53ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ecdaa57a-9187-4439-abe9-58e40043fa39" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_d25ab815-0cb5-4462-9806-5969b3c53ab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_db82db77-b8a7-4555-a77d-388c44927f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ecdaa57a-9187-4439-abe9-58e40043fa39" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_db82db77-b8a7-4555-a77d-388c44927f2e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bfe7f939-db59-4f16-b024-ce01da3ec95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca017c89-656f-4fee-876e-0a4b8f8e5764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bfe7f939-db59-4f16-b024-ce01da3ec95b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca017c89-656f-4fee-876e-0a4b8f8e5764" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_94826ebc-269b-4a35-a353-af3bfa1a3713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bfe7f939-db59-4f16-b024-ce01da3ec95b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_94826ebc-269b-4a35-a353-af3bfa1a3713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_62491d3c-7f18-42d3-8e64-25117411825e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bfe7f939-db59-4f16-b024-ce01da3ec95b" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_62491d3c-7f18-42d3-8e64-25117411825e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#BenefitPlansDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/BenefitPlansDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6f38d546-26a2-4983-83bf-a7d104d7c144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_5211048a-e407-4cb2-951a-41c54b994fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6f38d546-26a2-4983-83bf-a7d104d7c144" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_5211048a-e407-4cb2-951a-41c54b994fb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_06daa948-c7b8-474f-a922-1eeec793fa96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6f38d546-26a2-4983-83bf-a7d104d7c144" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_06daa948-c7b8-474f-a922-1eeec793fa96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_2dc375f3-a9fc-4100-a062-9c483ea95db8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6f38d546-26a2-4983-83bf-a7d104d7c144" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_2dc375f3-a9fc-4100-a062-9c483ea95db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8ded082f-3452-4bac-ba0a-9e0e76d1d11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6f38d546-26a2-4983-83bf-a7d104d7c144" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8ded082f-3452-4bac-ba0a-9e0e76d1d11b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_0193ad53-085b-4e4f-93f1-719ca5bc8ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6f38d546-26a2-4983-83bf-a7d104d7c144" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_0193ad53-085b-4e4f-93f1-719ca5bc8ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_894b53bb-0ce4-4020-b1d5-9933a58def46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6f38d546-26a2-4983-83bf-a7d104d7c144" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_894b53bb-0ce4-4020-b1d5-9933a58def46" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#IntangibleAssetsComponentsofIntangibleAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ebf4af49-6446-4b88-a55f-dca8cc36484e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_98dde260-01c5-49c8-9e19-566e141343ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ebf4af49-6446-4b88-a55f-dca8cc36484e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_98dde260-01c5-49c8-9e19-566e141343ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3d757aa6-b977-4da6-8af2-a1b78e2fc1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ebf4af49-6446-4b88-a55f-dca8cc36484e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3d757aa6-b977-4da6-8af2-a1b78e2fc1fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_799f49a0-82b2-4cec-bdea-fe698e2b2675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3d8392f3-e75c-4cc5-9cac-0bdb0ab56359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_799f49a0-82b2-4cec-bdea-fe698e2b2675" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3d8392f3-e75c-4cc5-9cac-0bdb0ab56359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_58207cb6-cda9-4aec-bb02-ee06d91cde31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_799f49a0-82b2-4cec-bdea-fe698e2b2675" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_58207cb6-cda9-4aec-bb02-ee06d91cde31" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>bdx-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c18e2de7-cbd8-4499-b946-e1533dbcca3e,g:06687f9f-d051-4540-9898-7752ada2060d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bd.com/role/CoverPage" xlink:type="simple" xlink:href="bdx-20230331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/CoverPage" xlink:type="extended" id="i43908a67dc064d2885464e79d800dde8_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_0cbbdfd1-d37c-419b-86b6-3e75ab33daa7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentType_0cbbdfd1-d37c-419b-86b6-3e75ab33daa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_c18057f5-e54d-4e83-9589-432c14d7feba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentQuarterlyReport_c18057f5-e54d-4e83-9589-432c14d7feba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f861cf68-d3b3-4505-b749-9d98f12c99a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentPeriodEndDate_f861cf68-d3b3-4505-b749-9d98f12c99a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_54e2c0f4-ba16-4025-be41-e63c49209260" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentTransitionReport_54e2c0f4-ba16-4025-be41-e63c49209260" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d8b50061-0acb-41e1-a2f8-f69d09c08fbf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityFileNumber_d8b50061-0acb-41e1-a2f8-f69d09c08fbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_54d46bad-0e24-49e3-a072-c280da164b38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityRegistrantName_54d46bad-0e24-49e3-a072-c280da164b38" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_45318d18-ed8e-4e25-9c42-629f3a2c6731" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityIncorporationStateCountryCode_45318d18-ed8e-4e25-9c42-629f3a2c6731" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9818ad56-0e78-496a-8679-d04c11685515" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityTaxIdentificationNumber_9818ad56-0e78-496a-8679-d04c11685515" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7fda6ce7-1ff8-439b-bf1c-07b7e9996e61" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityAddressAddressLine1_7fda6ce7-1ff8-439b-bf1c-07b7e9996e61" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c4c02d88-8c9e-4507-8236-f1335341df0e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityAddressCityOrTown_c4c02d88-8c9e-4507-8236-f1335341df0e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f2e4a42a-c45d-4614-84b5-3df9e1011081" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityAddressStateOrProvince_f2e4a42a-c45d-4614-84b5-3df9e1011081" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_0abadfb0-789a-499c-91a8-b1fee48c056a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityAddressPostalZipCode_0abadfb0-789a-499c-91a8-b1fee48c056a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ee66d712-e855-435e-8632-ec4bc9080b15" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_CityAreaCode_ee66d712-e855-435e-8632-ec4bc9080b15" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_405d9d1b-c898-4aae-8396-abbee40adad0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_LocalPhoneNumber_405d9d1b-c898-4aae-8396-abbee40adad0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_08926cdd-0bbe-4f58-8f47-1543290e2f7e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_Security12bTitle_08926cdd-0bbe-4f58-8f47-1543290e2f7e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_73412947-1009-4dbc-b567-5a4b265072c9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_TradingSymbol_73412947-1009-4dbc-b567-5a4b265072c9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fff33a09-176b-4224-b201-69ee6532a5ee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_SecurityExchangeName_fff33a09-176b-4224-b201-69ee6532a5ee" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_077dc0b0-d186-4e7e-9391-263310e0ddc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityCurrentReportingStatus_077dc0b0-d186-4e7e-9391-263310e0ddc5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9c0ff051-e760-4def-8625-41530b9c6e76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityInteractiveDataCurrent_9c0ff051-e760-4def-8625-41530b9c6e76" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_72152015-d080-40d0-ad18-8bb66d4090b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityFilerCategory_72152015-d080-40d0-ad18-8bb66d4090b4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f1be3f4b-be5e-471c-bcee-482bf49f732d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntitySmallBusiness_f1be3f4b-be5e-471c-bcee-482bf49f732d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ba9e8bd0-df93-4418-abf9-d907c2c105da" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityEmergingGrowthCompany_ba9e8bd0-df93-4418-abf9-d907c2c105da" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9d6048c3-9ec0-4426-b49b-1d8fff70027c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityShellCompany_9d6048c3-9ec0-4426-b49b-1d8fff70027c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_21d25d76-03c7-4a9e-9b09-279cc2b7acae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_21d25d76-03c7-4a9e-9b09-279cc2b7acae" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7370a4c4-6b71-4e03-8198-55c17ceabc17" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityCentralIndexKey_7370a4c4-6b71-4e03-8198-55c17ceabc17" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_613c27cb-2f75-4503-a579-24538d799289" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_CurrentFiscalYearEndDate_613c27cb-2f75-4503-a579-24538d799289" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e9cb2719-858d-4e9e-8b02-ad4671d1e9d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentFiscalYearFocus_e9cb2719-858d-4e9e-8b02-ad4671d1e9d3" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_5f0f28b6-9dd8-4b31-b95c-8a9d19d309fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentFiscalPeriodFocus_5f0f28b6-9dd8-4b31-b95c-8a9d19d309fb" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_377a8d17-98cb-4049-b345-6ce44bdb3e0e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_AmendmentFlag_377a8d17-98cb-4049-b345-6ce44bdb3e0e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_3aa2b0d3-facf-4485-8e16-bd43670fd637" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntitiesTable_3aa2b0d3-facf-4485-8e16-bd43670fd637" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b901a231-78d3-4579-8a83-f55305969c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_3aa2b0d3-facf-4485-8e16-bd43670fd637" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b901a231-78d3-4579-8a83-f55305969c8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b901a231-78d3-4579-8a83-f55305969c8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b901a231-78d3-4579-8a83-f55305969c8a" xlink:to="loc_us-gaap_ClassOfStockDomain_b901a231-78d3-4579-8a83-f55305969c8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b901a231-78d3-4579-8a83-f55305969c8a" xlink:to="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9c6fa71a-ae96-4c2b-8252-4660e5835822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_us-gaap_CommonStockMember_9c6fa71a-ae96-4c2b-8252-4660e5835822" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_988f9290-f8e8-4ab4-b1b7-b03cd72e0878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_988f9290-f8e8-4ab4-b1b7-b03cd72e0878" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member_a165ee50-ce40-4486-9e2f-481f4f722a35" xlink:href="bdx-20230331.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes1.900dueDecember152026Member_a165ee50-ce40-4486-9e2f-481f4f722a35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member_67672bb9-02f9-4fab-bd82-a452311caaf5" xlink:href="bdx-20230331.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes1.401dueMay242023Member_67672bb9-02f9-4fab-bd82-a452311caaf5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member_cd652c19-0910-489e-a759-0b56dd10eb4e" xlink:href="bdx-20230331.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes3.020dueMay242025Member_cd652c19-0910-489e-a759-0b56dd10eb4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member_b7578ca4-1d9b-4f9d-82bd-344111649970" xlink:href="bdx-20230331.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes0.632dueJune42023Member_b7578ca4-1d9b-4f9d-82bd-344111649970" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member_b02b34a4-22a3-4a25-a4e7-997d7580b7d5" xlink:href="bdx-20230331.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes1.208dueJune42026Member_b02b34a4-22a3-4a25-a4e7-997d7580b7d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213NotesDueFebruary122036Member_93d237de-68ec-4086-bef4-23f6e01d6e77" xlink:href="bdx-20230331.xsd#bdx_Notes1213NotesDueFebruary122036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes1213NotesDueFebruary122036Member_93d237de-68ec-4086-bef4-23f6e01d6e77" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_d06e4d64-bdc1-49be-b24d-918999774d45" xlink:href="bdx-20230331.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes0000DueAugust132023Member_d06e4d64-bdc1-49be-b24d-918999774d45" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_9cd45965-2ff3-4f3e-9f32-0b07379e7fbc" xlink:href="bdx-20230331.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes0034DueAugust132025Member_9cd45965-2ff3-4f3e-9f32-0b07379e7fbc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_f7b1d203-51bc-4531-b830-48640ba0d0b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_3aa2b0d3-facf-4485-8e16-bd43670fd637" xlink:to="loc_dei_EntityListingsExchangeAxis_f7b1d203-51bc-4531-b830-48640ba0d0b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_f7b1d203-51bc-4531-b830-48640ba0d0b1_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_f7b1d203-51bc-4531-b830-48640ba0d0b1" xlink:to="loc_dei_ExchangeDomain_f7b1d203-51bc-4531-b830-48640ba0d0b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_0086e526-88bb-4206-8fb7-3dd471b8ab6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_f7b1d203-51bc-4531-b830-48640ba0d0b1" xlink:to="loc_dei_ExchangeDomain_0086e526-88bb-4206-8fb7-3dd471b8ab6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_ac060622-4b42-415d-8df1-4fbec05b5114" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_0086e526-88bb-4206-8fb7-3dd471b8ab6f" xlink:to="loc_exch_XNYS_ac060622-4b42-415d-8df1-4fbec05b5114" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#SpinOffofEmbectaCorpAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails" xlink:type="extended" id="idf731aed996a4ff48b749ca565d060ba_SpinOffofEmbectaCorpAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2d3106f3-e6fa-4078-a7cc-e8a509842dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_158c7563-fa48-41fb-af82-0691b6cef05c" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2d3106f3-e6fa-4078-a7cc-e8a509842dc1" xlink:to="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_158c7563-fa48-41fb-af82-0691b6cef05c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_c35a34c1-3440-4ef6-b101-e300afe13d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2d3106f3-e6fa-4078-a7cc-e8a509842dc1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_c35a34c1-3440-4ef6-b101-e300afe13d54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1c147155-023a-4cdc-b5d8-9f1b0862ec74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2d3106f3-e6fa-4078-a7cc-e8a509842dc1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1c147155-023a-4cdc-b5d8-9f1b0862ec74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_90aa442f-a5a1-445d-8289-762ac07c5ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1c147155-023a-4cdc-b5d8-9f1b0862ec74" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_90aa442f-a5a1-445d-8289-762ac07c5ce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_90aa442f-a5a1-445d-8289-762ac07c5ce3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_90aa442f-a5a1-445d-8289-762ac07c5ce3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_90aa442f-a5a1-445d-8289-762ac07c5ce3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d9f8ab1a-dbbc-43dd-8d22-354de373c3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_90aa442f-a5a1-445d-8289-762ac07c5ce3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d9f8ab1a-dbbc-43dd-8d22-354de373c3e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_ba1c1a4c-a0a5-4c2f-adbd-ad34fd70d153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d9f8ab1a-dbbc-43dd-8d22-354de373c3e8" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_ba1c1a4c-a0a5-4c2f-adbd-ad34fd70d153" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails" xlink:type="extended" id="i2c0508620887410bbb4d972553d6b869_SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_50bd9e8c-b31f-4e34-914b-e13baa56b9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_50bd9e8c-b31f-4e34-914b-e13baa56b9e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_f4ddfb40-c2bf-41d1-9735-c913f0c9b20d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_f4ddfb40-c2bf-41d1-9735-c913f0c9b20d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_c798d9be-0891-4d19-8458-04cbce074d99" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_c798d9be-0891-4d19-8458-04cbce074d99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_bed8e4c9-c407-4c14-8c6b-b9c596ccc00d" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_bed8e4c9-c407-4c14-8c6b-b9c596ccc00d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_9e8af93e-9064-4e64-a522-354aa52d6f89" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_9e8af93e-9064-4e64-a522-354aa52d6f89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_82593d47-fad5-4226-a33b-76fe4551804c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_82593d47-fad5-4226-a33b-76fe4551804c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_53ea9401-f503-44e0-b969-d2d75ff46f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_53ea9401-f503-44e0-b969-d2d75ff46f4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_b6b7be64-99b1-4d7a-818b-cdb4ccdc1eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_b6b7be64-99b1-4d7a-818b-cdb4ccdc1eea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_e761f037-2257-4e53-bb24-2c13191f29aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_e761f037-2257-4e53-bb24-2c13191f29aa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_832a5041-8a16-4cf4-b1a8-c731a9fb4bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_832a5041-8a16-4cf4-b1a8-c731a9fb4bc6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_7a7c2176-f17a-42b5-9892-2e2300dc873c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_7a7c2176-f17a-42b5-9892-2e2300dc873c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_429f966e-97f3-433d-9a57-77d5eb978f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_429f966e-97f3-433d-9a57-77d5eb978f33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4bc82ef4-35e0-42cf-9d54-ef7b2ccf99ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_429f966e-97f3-433d-9a57-77d5eb978f33" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4bc82ef4-35e0-42cf-9d54-ef7b2ccf99ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4bc82ef4-35e0-42cf-9d54-ef7b2ccf99ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4bc82ef4-35e0-42cf-9d54-ef7b2ccf99ae" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4bc82ef4-35e0-42cf-9d54-ef7b2ccf99ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_71b3a87b-26d6-413e-86cd-d44c8a9ec6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4bc82ef4-35e0-42cf-9d54-ef7b2ccf99ae" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_71b3a87b-26d6-413e-86cd-d44c8a9ec6c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_3e95528c-facf-4220-befa-580012d8d9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_71b3a87b-26d6-413e-86cd-d44c8a9ec6c7" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_3e95528c-facf-4220-befa-580012d8d9eb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" xlink:type="extended" id="i3159230429514ae7a2cf26f18517f9ed_ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0c956519-7cbc-4d47-b15c-8de17fdd2899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_StockholdersEquity_0c956519-7cbc-4d47-b15c-8de17fdd2899" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_cfc35d68-5a56-4436-b58b-1aaccf8dba96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_TreasuryStockShares_cfc35d68-5a56-4436-b58b-1aaccf8dba96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_18ef8b4d-893f-44c5-a73c-435f28710413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_NetIncomeLoss_18ef8b4d-893f-44c5-a73c-435f28710413" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_03b033c8-5f3e-4232-98f2-8840e36c9faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_DividendsCommonStockCash_03b033c8-5f3e-4232-98f2-8840e36c9faf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock_4f726833-f234-43cd-b5d5-9fd05ec83c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_DividendsPreferredStock_4f726833-f234-43cd-b5d5-9fd05ec83c9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_04dc8298-6fa2-4162-8808-d7b6f03869f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_04dc8298-6fa2-4162-8808-d7b6f03869f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5777dc25-1437-495a-9e1f-223a4d8ec12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5777dc25-1437-495a-9e1f-223a4d8ec12b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f9bcbfc0-317c-4019-8485-0580cf1e0913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f9bcbfc0-317c-4019-8485-0580cf1e0913" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsAcquired_7333efef-2c5e-4fc0-920b-c9d68948d03d" xlink:href="bdx-20230331.xsd#bdx_CommonStockHeldInTrustsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_bdx_CommonStockHeldInTrustsAcquired_7333efef-2c5e-4fc0-920b-c9d68948d03d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsNetShares_251c7f6b-036f-4202-a930-17fe584a2c36" xlink:href="bdx-20230331.xsd#bdx_CommonStockHeldInTrustsNetShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_bdx_CommonStockHeldInTrustsNetShares_251c7f6b-036f-4202-a930-17fe584a2c36" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_8c0dcbeb-e524-4686-b936-31bd76f4599b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_8c0dcbeb-e524-4686-b936-31bd76f4599b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_fe0098f5-3159-44ef-a55c-d04ec4baf6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_fe0098f5-3159-44ef-a55c-d04ec4baf6b4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5532d90f-6a46-44a9-b5ea-fceabf8d766a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_edf52d13-e0ba-41fd-8aac-49be4b8fc110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_319e1bea-4577-4372-8d93-60d905d5bf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_319e1bea-4577-4372-8d93-60d905d5bf1a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_76cde591-fdf7-470f-8939-ea3ed31a4e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_76cde591-fdf7-470f-8939-ea3ed31a4e35" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_14f45dca-77fa-4f8e-a00b-8977a006476b" xlink:href="bdx-20230331.xsd#bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_14f45dca-77fa-4f8e-a00b-8977a006476b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b6555dc2-629c-464d-9cf7-5672027e0cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_StatementTable_b6555dc2-629c-464d-9cf7-5672027e0cfa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e4979aa3-2404-4a92-9ad3-0df4a4816954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b6555dc2-629c-464d-9cf7-5672027e0cfa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e4979aa3-2404-4a92-9ad3-0df4a4816954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e4979aa3-2404-4a92-9ad3-0df4a4816954_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4979aa3-2404-4a92-9ad3-0df4a4816954" xlink:to="loc_us-gaap_EquityComponentDomain_e4979aa3-2404-4a92-9ad3-0df4a4816954_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4979aa3-2404-4a92-9ad3-0df4a4816954" xlink:to="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a9408ac1-09f1-45ad-9a18-1030e1fd162f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:to="loc_us-gaap_CommonStockMember_a9408ac1-09f1-45ad-9a18-1030e1fd162f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_01c5e164-8a82-40f5-838d-e8c2b615852e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_01c5e164-8a82-40f5-838d-e8c2b615852e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6b7910e2-a7ae-49c5-8c85-f617e1496c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:to="loc_us-gaap_RetainedEarningsMember_6b7910e2-a7ae-49c5-8c85-f617e1496c35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_28dff813-de6e-412b-aa6f-d15cc15d3824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_28dff813-de6e-412b-aa6f-d15cc15d3824" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_966afd98-245a-4416-8631-31c5de934777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:to="loc_us-gaap_TreasuryStockMember_966afd98-245a-4416-8631-31c5de934777" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="extended" id="ifb86ef8f6a02401b9053331bfd622e43_ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_cab4f2c3-4582-49c0-ba5b-04a0016f3e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_cab4f2c3-4582-49c0-ba5b-04a0016f3e83" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_237abcc5-2766-4cb9-9c91-1bffb39956e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_237abcc5-2766-4cb9-9c91-1bffb39956e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_51ca9776-f60b-4b79-9f8d-9e23a2e3d6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_51ca9776-f60b-4b79-9f8d-9e23a2e3d6d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_75af89b9-4091-472c-8513-df9365874d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_75af89b9-4091-472c-8513-df9365874d73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3bdf85e2-79f0-48e4-8eec-4a1bc43860f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_caeda11a-5a33-4b1c-8ef5-8427f1ca7b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_cab4f2c3-4582-49c0-ba5b-04a0016f3e83" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_caeda11a-5a33-4b1c-8ef5-8427f1ca7b41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_03c57d06-599f-4d00-89fc-230c27ef3fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_caeda11a-5a33-4b1c-8ef5-8427f1ca7b41" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_03c57d06-599f-4d00-89fc-230c27ef3fc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_03c57d06-599f-4d00-89fc-230c27ef3fc1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_03c57d06-599f-4d00-89fc-230c27ef3fc1" xlink:to="loc_us-gaap_EquityComponentDomain_03c57d06-599f-4d00-89fc-230c27ef3fc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e8818ac6-c022-4d88-adf8-97ec8d8f485e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_03c57d06-599f-4d00-89fc-230c27ef3fc1" xlink:to="loc_us-gaap_EquityComponentDomain_e8818ac6-c022-4d88-adf8-97ec8d8f485e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_247231c6-1f43-4561-8ce5-87eda1f68200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e8818ac6-c022-4d88-adf8-97ec8d8f485e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_247231c6-1f43-4561-8ce5-87eda1f68200" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_fa5827b5-d17b-474a-ad87-97e5bbe8d15f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e8818ac6-c022-4d88-adf8-97ec8d8f485e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_fa5827b5-d17b-474a-ad87-97e5bbe8d15f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0e59506f-b99f-44ff-a7e9-6e8ab29e85b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e8818ac6-c022-4d88-adf8-97ec8d8f485e" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0e59506f-b99f-44ff-a7e9-6e8ab29e85b3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="extended" id="i5ce430f1e82a4a76b0e2dfdf8b700251_EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_236f7478-201a-46bf-82f0-65b9d377061d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2ecc42cd-2207-4210-8fa9-8f7ce3f4765c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_236f7478-201a-46bf-82f0-65b9d377061d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2ecc42cd-2207-4210-8fa9-8f7ce3f4765c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9b97217b-3d2c-4252-83b6-0134778a28d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_236f7478-201a-46bf-82f0-65b9d377061d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9b97217b-3d2c-4252-83b6-0134778a28d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53019abe-b141-49e0-bd61-38a9aac97ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9b97217b-3d2c-4252-83b6-0134778a28d0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53019abe-b141-49e0-bd61-38a9aac97ec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_53019abe-b141-49e0-bd61-38a9aac97ec3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53019abe-b141-49e0-bd61-38a9aac97ec3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_53019abe-b141-49e0-bd61-38a9aac97ec3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e389e668-27e1-4ff4-9b7d-7e5ee6c49309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53019abe-b141-49e0-bd61-38a9aac97ec3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e389e668-27e1-4ff4-9b7d-7e5ee6c49309" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_7b27d86f-0b22-4faa-9b58-7cf57b72a704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e389e668-27e1-4ff4-9b7d-7e5ee6c49309" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_7b27d86f-0b22-4faa-9b58-7cf57b72a704" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationMember_6d901147-e4a3-48fb-a26d-e8cfcbf3b0ba" xlink:href="bdx-20230331.xsd#bdx_ShareBasedCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e389e668-27e1-4ff4-9b7d-7e5ee6c49309" xlink:to="loc_bdx_ShareBasedCompensationMember_6d901147-e4a3-48fb-a26d-e8cfcbf3b0ba" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ContingenciesDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#ContingenciesDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ContingenciesDetail" xlink:type="extended" id="i839484ac17b546c7ae2be3e9e4044a75_ContingenciesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_553fcbe4-f1b2-4917-9133-59d0832e5c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_553fcbe4-f1b2-4917-9133-59d0832e5c9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_ef325ffc-116b-4b0b-8774-6d08150a0f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_ef325ffc-116b-4b0b-8774-6d08150a0f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_85249563-0f4a-4d45-8d80-a1138e547d84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_85249563-0f4a-4d45-8d80-a1138e547d84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled_f2a29010-026e-45dd-83ac-84575ae661da" xlink:href="bdx-20230331.xsd#bdx_NumberOfEtOSterilizationLawsuitsFiled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled_f2a29010-026e-45dd-83ac-84575ae661da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_04cb75cd-2faa-434a-a7b9-108f0125f509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_04cb75cd-2faa-434a-a7b9-108f0125f509" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_1bee89a7-4482-4be6-81a3-953c4dc3b18e" xlink:href="bdx-20230331.xsd#bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_1bee89a7-4482-4be6-81a3-953c4dc3b18e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_07bccd76-9c8b-4a75-a6cf-188f9369e4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_07bccd76-9c8b-4a75-a6cf-188f9369e4c5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ee021d0b-a453-4b34-8ffa-c3d2489c2a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ee021d0b-a453-4b34-8ffa-c3d2489c2a75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ee021d0b-a453-4b34-8ffa-c3d2489c2a75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ee021d0b-a453-4b34-8ffa-c3d2489c2a75" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ee021d0b-a453-4b34-8ffa-c3d2489c2a75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_6a55aa6b-3686-409f-a997-519f3e557a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ee021d0b-a453-4b34-8ffa-c3d2489c2a75" xlink:to="loc_us-gaap_LossContingencyNatureDomain_6a55aa6b-3686-409f-a997-519f3e557a11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_HerniaProductClaimsMember_ca9c676e-48b6-462e-975d-b961efe1f53b" xlink:href="bdx-20230331.xsd#bdx_HerniaProductClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_6a55aa6b-3686-409f-a997-519f3e557a11" xlink:to="loc_bdx_HerniaProductClaimsMember_ca9c676e-48b6-462e-975d-b961efe1f53b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5885f1be-bb68-4139-82bf-8ec794544861" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:to="loc_srt_StatementGeographicalAxis_5885f1be-bb68-4139-82bf-8ec794544861" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5885f1be-bb68-4139-82bf-8ec794544861_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5885f1be-bb68-4139-82bf-8ec794544861" xlink:to="loc_srt_SegmentGeographicalDomain_5885f1be-bb68-4139-82bf-8ec794544861_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c79a51ff-676b-41ae-b2f7-986e0fd18c4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5885f1be-bb68-4139-82bf-8ec794544861" xlink:to="loc_srt_SegmentGeographicalDomain_c79a51ff-676b-41ae-b2f7-986e0fd18c4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GwinnettCountyGeorgiaMember_de12e9bb-8872-453e-85a4-f3c8870b98c4" xlink:href="bdx-20230331.xsd#bdx_GwinnettCountyGeorgiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c79a51ff-676b-41ae-b2f7-986e0fd18c4c" xlink:to="loc_bdx_GwinnettCountyGeorgiaMember_de12e9bb-8872-453e-85a4-f3c8870b98c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA_81a9478d-aa91-42ab-825b-a39ca577bb3e" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_GA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c79a51ff-676b-41ae-b2f7-986e0fd18c4c" xlink:to="loc_stpr_GA_81a9478d-aa91-42ab-825b-a39ca577bb3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4cff7803-6f54-4ecc-86ff-94629d5f7f0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:to="loc_srt_RangeAxis_4cff7803-6f54-4ecc-86ff-94629d5f7f0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4cff7803-6f54-4ecc-86ff-94629d5f7f0d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4cff7803-6f54-4ecc-86ff-94629d5f7f0d" xlink:to="loc_srt_RangeMember_4cff7803-6f54-4ecc-86ff-94629d5f7f0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a6d31fb7-239d-425a-b778-1a71ff240d3a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4cff7803-6f54-4ecc-86ff-94629d5f7f0d" xlink:to="loc_srt_RangeMember_a6d31fb7-239d-425a-b778-1a71ff240d3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7cd7950f-c7e5-49b6-94fc-5d2e540baef7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a6d31fb7-239d-425a-b778-1a71ff240d3a" xlink:to="loc_srt_MaximumMember_7cd7950f-c7e5-49b6-94fc-5d2e540baef7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#RevenuesDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/RevenuesDetails" xlink:type="extended" id="i258f5674b58d4680b7cc50f40504f143_RevenuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability_12f26963-4725-4dee-9dee-b899e5a9b665" xlink:href="bdx-20230331.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_bdx_ContractWithCustomerRebateLiability_12f26963-4725-4dee-9dee-b899e5a9b665" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_3eab0d47-76d5-4a24-b7eb-a48b89075b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_3eab0d47-76d5-4a24-b7eb-a48b89075b2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_580eec8a-7d72-4821-be75-faa4f215d9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_580eec8a-7d72-4821-be75-faa4f215d9ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_93aee6a9-fe61-4854-9108-6e05a3b73eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_93aee6a9-fe61-4854-9108-6e05a3b73eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:to="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5769e288-b858-409c-abd0-e57944fc9992_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:to="loc_srt_ProductsAndServicesDomain_5769e288-b858-409c-abd0-e57944fc9992_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:to="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember_7903477c-373c-43f7-9bf9-17020947f9c2" xlink:href="bdx-20230331.xsd#bdx_ProductsandorServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:to="loc_bdx_ProductsandorServicesMember_7903477c-373c-43f7-9bf9-17020947f9c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember_5664daa5-9c42-4108-ac18-b5b492900d12" xlink:href="bdx-20230331.xsd#bdx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:to="loc_bdx_ConsumablesMember_5664daa5-9c42-4108-ac18-b5b492900d12" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails_1" xlink:type="simple" xlink:href="bdx-20230331.xsd#RevenuesDetails_1"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/RevenuesDetails_1" xlink:type="extended" id="i793fc8ac3d2b412d97b9426749040bde_RevenuesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability_12f26963-4725-4dee-9dee-b899e5a9b665" xlink:href="bdx-20230331.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_bdx_ContractWithCustomerRebateLiability_12f26963-4725-4dee-9dee-b899e5a9b665" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_3eab0d47-76d5-4a24-b7eb-a48b89075b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_3eab0d47-76d5-4a24-b7eb-a48b89075b2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_580eec8a-7d72-4821-be75-faa4f215d9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_580eec8a-7d72-4821-be75-faa4f215d9ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:to="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5769e288-b858-409c-abd0-e57944fc9992_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:to="loc_srt_ProductsAndServicesDomain_5769e288-b858-409c-abd0-e57944fc9992_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:to="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember_7903477c-373c-43f7-9bf9-17020947f9c2" xlink:href="bdx-20230331.xsd#bdx_ProductsandorServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:to="loc_bdx_ProductsandorServicesMember_7903477c-373c-43f7-9bf9-17020947f9c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember_5664daa5-9c42-4108-ac18-b5b492900d12" xlink:href="bdx-20230331.xsd#bdx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:to="loc_bdx_ConsumablesMember_5664daa5-9c42-4108-ac18-b5b492900d12" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#SegmentDataRevenuesbyGeographicAreasDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail" xlink:type="extended" id="if59400494dbb4468bc4e5b9d6281cd8e_SegmentDataRevenuesbyGeographicAreasDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cfa074c7-8b55-4b1d-a4a7-ce9bfe0899d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3574c023-27d6-402e-ab79-adeb3479f680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cfa074c7-8b55-4b1d-a4a7-ce9bfe0899d0" xlink:to="loc_us-gaap_Revenues_3574c023-27d6-402e-ab79-adeb3479f680" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cfa074c7-8b55-4b1d-a4a7-ce9bfe0899d0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitAxis_9b6fcc0e-ad5e-4e13-a90f-2ae6bf1a2994" xlink:href="bdx-20230331.xsd#bdx_OrganizationalUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:to="loc_bdx_OrganizationalUnitAxis_9b6fcc0e-ad5e-4e13-a90f-2ae6bf1a2994" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain_9b6fcc0e-ad5e-4e13-a90f-2ae6bf1a2994_default" xlink:href="bdx-20230331.xsd#bdx_OrganizationalUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bdx_OrganizationalUnitAxis_9b6fcc0e-ad5e-4e13-a90f-2ae6bf1a2994" xlink:to="loc_bdx_OrganizationalUnitDomain_9b6fcc0e-ad5e-4e13-a90f-2ae6bf1a2994_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:href="bdx-20230331.xsd#bdx_OrganizationalUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bdx_OrganizationalUnitAxis_9b6fcc0e-ad5e-4e13-a90f-2ae6bf1a2994" xlink:to="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationDeliverySolutionsMember_e699baab-55e3-4d79-a86e-6384f0315512" xlink:href="bdx-20230331.xsd#bdx_MedicationDeliverySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_MedicationDeliverySolutionsMember_e699baab-55e3-4d79-a86e-6384f0315512" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationManagementSolutionsMember_554ad1e8-6c00-4ad7-a838-6e62f272c7d0" xlink:href="bdx-20230331.xsd#bdx_MedicationManagementSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_MedicationManagementSolutionsMember_554ad1e8-6c00-4ad7-a838-6e62f272c7d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PharmaceuticalSystemsMember_60980341-b5fb-4e62-abc0-7eb3cf92bc91" xlink:href="bdx-20230331.xsd#bdx_PharmaceuticalSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_PharmaceuticalSystemsMember_60980341-b5fb-4e62-abc0-7eb3cf92bc91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IntegratedDiagnosticSolutionsMember_79830f20-1268-49eb-a280-a5c1147bcd8f" xlink:href="bdx-20230331.xsd#bdx_IntegratedDiagnosticSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_IntegratedDiagnosticSolutionsMember_79830f20-1268-49eb-a280-a5c1147bcd8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BiosciencesMember_1eb5bdee-ff6d-4e53-90d4-c0e14cc89259" xlink:href="bdx-20230331.xsd#bdx_BiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_BiosciencesMember_1eb5bdee-ff6d-4e53-90d4-c0e14cc89259" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SurgeryMember_dc01933d-6e98-4a68-be2e-6cf843e5600b" xlink:href="bdx-20230331.xsd#bdx_SurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_SurgeryMember_dc01933d-6e98-4a68-be2e-6cf843e5600b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PeripheralInterventionMember_92dd5595-9764-4b23-a56b-d85d5fc852a2" xlink:href="bdx-20230331.xsd#bdx_PeripheralInterventionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_PeripheralInterventionMember_92dd5595-9764-4b23-a56b-d85d5fc852a2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UrologyandCriticalCareMember_50cf7280-93a2-4308-bc4d-4f72d0143942" xlink:href="bdx-20230331.xsd#bdx_UrologyandCriticalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_UrologyandCriticalCareMember_50cf7280-93a2-4308-bc4d-4f72d0143942" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_14ba7102-5724-466d-9b02-837b333daeec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:to="loc_srt_StatementGeographicalAxis_14ba7102-5724-466d-9b02-837b333daeec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_14ba7102-5724-466d-9b02-837b333daeec_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_14ba7102-5724-466d-9b02-837b333daeec" xlink:to="loc_srt_SegmentGeographicalDomain_14ba7102-5724-466d-9b02-837b333daeec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_979964bb-339a-42d4-a705-9bca2edef950" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_14ba7102-5724-466d-9b02-837b333daeec" xlink:to="loc_srt_SegmentGeographicalDomain_979964bb-339a-42d4-a705-9bca2edef950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_40cc1509-53bc-40fc-b011-f224462416f4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_979964bb-339a-42d4-a705-9bca2edef950" xlink:to="loc_country_US_40cc1509-53bc-40fc-b011-f224462416f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_cba02767-8b5b-443c-bff9-fea3b8794eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_979964bb-339a-42d4-a705-9bca2edef950" xlink:to="loc_us-gaap_NonUsMember_cba02767-8b5b-443c-bff9-fea3b8794eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8a4b06d3-1e48-458a-b599-d41b10e4ccd9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:to="loc_srt_ConsolidationItemsAxis_8a4b06d3-1e48-458a-b599-d41b10e4ccd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8a4b06d3-1e48-458a-b599-d41b10e4ccd9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_8a4b06d3-1e48-458a-b599-d41b10e4ccd9" xlink:to="loc_srt_ConsolidationItemsDomain_8a4b06d3-1e48-458a-b599-d41b10e4ccd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_32a5a7ef-3694-45df-9454-e70a754b347e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_8a4b06d3-1e48-458a-b599-d41b10e4ccd9" xlink:to="loc_srt_ConsolidationItemsDomain_32a5a7ef-3694-45df-9454-e70a754b347e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6e5b74fe-4fe5-4bd4-a737-d8aaceabb132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_32a5a7ef-3694-45df-9454-e70a754b347e" xlink:to="loc_us-gaap_OperatingSegmentsMember_6e5b74fe-4fe5-4bd4-a737-d8aaceabb132" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_44b8a51f-fc8e-44ef-990b-fefbd79691e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_44b8a51f-fc8e-44ef-990b-fefbd79691e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_44b8a51f-fc8e-44ef-990b-fefbd79691e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_44b8a51f-fc8e-44ef-990b-fefbd79691e7" xlink:to="loc_us-gaap_SegmentDomain_44b8a51f-fc8e-44ef-990b-fefbd79691e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6212b34f-d5d1-4dd1-a8bd-521302689fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_44b8a51f-fc8e-44ef-990b-fefbd79691e7" xlink:to="loc_us-gaap_SegmentDomain_6212b34f-d5d1-4dd1-a8bd-521302689fe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_943ebe92-d9a9-4ab1-aec9-76ce699d12fb" xlink:href="bdx-20230331.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6212b34f-d5d1-4dd1-a8bd-521302689fe2" xlink:to="loc_bdx_MedicalMember_943ebe92-d9a9-4ab1-aec9-76ce699d12fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_4befe374-6d20-4af8-8633-12af01a8a616" xlink:href="bdx-20230331.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6212b34f-d5d1-4dd1-a8bd-521302689fe2" xlink:to="loc_bdx_LifeSciencesMember_4befe374-6d20-4af8-8633-12af01a8a616" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_0d4bce51-1793-4c0e-8180-ad0682f022c2" xlink:href="bdx-20230331.xsd#bdx_InterventionalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6212b34f-d5d1-4dd1-a8bd-521302689fe2" xlink:to="loc_bdx_InterventionalMember_0d4bce51-1793-4c0e-8180-ad0682f022c2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#SegmentDataFinancialInformationforCompanysSegmentsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="extended" id="i0c8d13aa021049a99c2dd9672db12988_SegmentDataFinancialInformationforCompanysSegmentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_75942f63-8c3a-464e-a346-71c88597245a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_75942f63-8c3a-464e-a346-71c88597245a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_c3fa3eda-3334-4c7f-a91c-25c1855e5c26" xlink:href="bdx-20230331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_c3fa3eda-3334-4c7f-a91c-25c1855e5c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_4abcf1d6-c8d4-45f5-8782-ac1e3b4e5c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_4abcf1d6-c8d4-45f5-8782-ac1e3b4e5c15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4844fc4f-b610-42af-b663-554958267c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4844fc4f-b610-42af-b663-554958267c2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b280e104-7328-4475-aa4c-d59b3aae58ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_AssetImpairmentCharges_b280e104-7328-4475-aa4c-d59b3aae58ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_f6f617a5-f2e6-4547-9015-0bc9db67f5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_InventoryRecallExpense_f6f617a5-f2e6-4547-9015-0bc9db67f5ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_01cc4a52-40c0-45fe-a828-2d48e5b2c6ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:to="loc_srt_ConsolidationItemsAxis_01cc4a52-40c0-45fe-a828-2d48e5b2c6ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_01cc4a52-40c0-45fe-a828-2d48e5b2c6ec_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_01cc4a52-40c0-45fe-a828-2d48e5b2c6ec" xlink:to="loc_srt_ConsolidationItemsDomain_01cc4a52-40c0-45fe-a828-2d48e5b2c6ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_336f5045-f49b-4176-9269-a3c80ab73d86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_01cc4a52-40c0-45fe-a828-2d48e5b2c6ec" xlink:to="loc_srt_ConsolidationItemsDomain_336f5045-f49b-4176-9269-a3c80ab73d86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_93699b92-43e4-45db-82de-409a210234b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_336f5045-f49b-4176-9269-a3c80ab73d86" xlink:to="loc_us-gaap_OperatingSegmentsMember_93699b92-43e4-45db-82de-409a210234b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_3895f11b-3a3b-4124-b42a-659011ef9e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_336f5045-f49b-4176-9269-a3c80ab73d86" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_3895f11b-3a3b-4124-b42a-659011ef9e69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_ee95af0c-e12b-4444-ac6d-16418f051aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_336f5045-f49b-4176-9269-a3c80ab73d86" xlink:to="loc_us-gaap_CorporateNonSegmentMember_ee95af0c-e12b-4444-ac6d-16418f051aec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_911b23b5-65c9-4645-8f34-4d2c09bd67e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_911b23b5-65c9-4645-8f34-4d2c09bd67e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_911b23b5-65c9-4645-8f34-4d2c09bd67e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_911b23b5-65c9-4645-8f34-4d2c09bd67e6" xlink:to="loc_us-gaap_SegmentDomain_911b23b5-65c9-4645-8f34-4d2c09bd67e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_58942fee-bf70-467c-a9c4-0262773b494d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_911b23b5-65c9-4645-8f34-4d2c09bd67e6" xlink:to="loc_us-gaap_SegmentDomain_58942fee-bf70-467c-a9c4-0262773b494d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_7d33d1c2-2fb7-4310-9f45-4c0cced002c7" xlink:href="bdx-20230331.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_58942fee-bf70-467c-a9c4-0262773b494d" xlink:to="loc_bdx_MedicalMember_7d33d1c2-2fb7-4310-9f45-4c0cced002c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_d6de455b-126b-439d-839a-3eb16fbb3b48" xlink:href="bdx-20230331.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_58942fee-bf70-467c-a9c4-0262773b494d" xlink:to="loc_bdx_LifeSciencesMember_d6de455b-126b-439d-839a-3eb16fbb3b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_71c42c2b-50cc-493a-be4d-7fdc83c65c85" xlink:href="bdx-20230331.xsd#bdx_InterventionalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_58942fee-bf70-467c-a9c4-0262773b494d" xlink:to="loc_bdx_InterventionalMember_71c42c2b-50cc-493a-be4d-7fdc83c65c85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_845fd5a7-c793-4f8b-b38c-819d95c8ba99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_845fd5a7-c793-4f8b-b38c-819d95c8ba99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_845fd5a7-c793-4f8b-b38c-819d95c8ba99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_845fd5a7-c793-4f8b-b38c-819d95c8ba99" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_845fd5a7-c793-4f8b-b38c-819d95c8ba99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_349c6cdc-ea14-4ecf-9ce7-eaad1ae67004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_845fd5a7-c793-4f8b-b38c-819d95c8ba99" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_349c6cdc-ea14-4ecf-9ce7-eaad1ae67004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d045a686-e734-4533-bcf0-bba5b6a0ba32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_349c6cdc-ea14-4ecf-9ce7-eaad1ae67004" xlink:to="loc_us-gaap_CostOfSalesMember_d045a686-e734-4533-bcf0-bba5b6a0ba32" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#BenefitPlansDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BenefitPlansDetail" xlink:type="extended" id="i78265f96742d4a5ca89dac51e870a90f_BenefitPlansDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_f7cac3f6-19e2-4f61-86fb-75f1fb9b4a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_f7cac3f6-19e2-4f61-86fb-75f1fb9b4a06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_7e187e85-8e0e-4bd1-99e0-dda7b89d9c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_7e187e85-8e0e-4bd1-99e0-dda7b89d9c05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_228ce03b-e2c5-4f1a-9f85-28f36d04d451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_228ce03b-e2c5-4f1a-9f85-28f36d04d451" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_46d503da-88f3-463c-a64d-f250f94b89d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_46d503da-88f3-463c-a64d-f250f94b89d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3bede745-0ea2-4bd3-81bb-f2c09ce3c1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3bede745-0ea2-4bd3-81bb-f2c09ce3c1b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_fd5c3262-cc99-4c15-b80b-52cbda02a8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_fd5c3262-cc99-4c15-b80b-52cbda02a8ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e6d9642b-31bb-41a3-898e-47d13ac4155c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e6d9642b-31bb-41a3-898e-47d13ac4155c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_947e4436-8865-4317-87c6-c3653c54b7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_947e4436-8865-4317-87c6-c3653c54b7e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_18791002-eb40-4419-b4c4-c0f5158e68ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_947e4436-8865-4317-87c6-c3653c54b7e8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_18791002-eb40-4419-b4c4-c0f5158e68ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_18791002-eb40-4419-b4c4-c0f5158e68ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_18791002-eb40-4419-b4c4-c0f5158e68ab" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_18791002-eb40-4419-b4c4-c0f5158e68ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_57f7c818-5191-48c2-935a-0ff6d8da81ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_18791002-eb40-4419-b4c4-c0f5158e68ab" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_57f7c818-5191-48c2-935a-0ff6d8da81ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a4a3218f-5ba9-4f37-9686-7dddde8093b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_57f7c818-5191-48c2-935a-0ff6d8da81ef" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a4a3218f-5ba9-4f37-9686-7dddde8093b1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringChargesDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#BusinessRestructuringChargesDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BusinessRestructuringChargesDetail" xlink:type="extended" id="i9ed219954eee43d0937774ef27207897_BusinessRestructuringChargesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_3d54b63e-2328-4ef1-affb-ffb08ccaee41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3d54b63e-2328-4ef1-affb-ffb08ccaee41" xlink:to="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_424db4ae-cf61-43d0-bff5-685c43d2efda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:to="loc_us-gaap_RestructuringReserve_424db4ae-cf61-43d0-bff5-685c43d2efda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c75256ec-2197-474a-a76d-c8516354afc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:to="loc_us-gaap_RestructuringCharges_c75256ec-2197-474a-a76d-c8516354afc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f2dc5c84-26f5-4a3b-8614-3f3a5c2f302b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:to="loc_us-gaap_PaymentsForRestructuring_f2dc5c84-26f5-4a3b-8614-3f3a5c2f302b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_7f74bb21-a6b3-4168-9234-b43662c9e367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_7f74bb21-a6b3-4168-9234-b43662c9e367" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_47ebc257-06ef-4d90-adaf-1e94a77c4082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c6605927-6394-4088-aae9-9ef0e91a0a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3d54b63e-2328-4ef1-affb-ffb08ccaee41" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c6605927-6394-4088-aae9-9ef0e91a0a65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_ac24eda1-4702-4e19-a021-1106c29576e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c6605927-6394-4088-aae9-9ef0e91a0a65" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_ac24eda1-4702-4e19-a021-1106c29576e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_ac24eda1-4702-4e19-a021-1106c29576e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_ac24eda1-4702-4e19-a021-1106c29576e4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_ac24eda1-4702-4e19-a021-1106c29576e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_570f8ca5-038b-4b7c-85c6-89d6fdb6e570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_ac24eda1-4702-4e19-a021-1106c29576e4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_570f8ca5-038b-4b7c-85c6-89d6fdb6e570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_95a66673-916d-4baf-9056-c30156efb1be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_570f8ca5-038b-4b7c-85c6-89d6fdb6e570" xlink:to="loc_us-gaap_EmployeeSeveranceMember_95a66673-916d-4baf-9056-c30156efb1be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_7b23492e-3d8d-4e31-ad58-47b7b7919e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_570f8ca5-038b-4b7c-85c6-89d6fdb6e570" xlink:to="loc_us-gaap_OtherRestructuringMember_7b23492e-3d8d-4e31-ad58-47b7b7919e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_fac87a82-ede9-4542-9dbe-a199957de889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c6605927-6394-4088-aae9-9ef0e91a0a65" xlink:to="loc_us-gaap_RestructuringPlanAxis_fac87a82-ede9-4542-9dbe-a199957de889" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_fac87a82-ede9-4542-9dbe-a199957de889_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_fac87a82-ede9-4542-9dbe-a199957de889" xlink:to="loc_us-gaap_RestructuringPlanDomain_fac87a82-ede9-4542-9dbe-a199957de889_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9f28b531-455d-4aa6-b8cf-a4e77e210069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_fac87a82-ede9-4542-9dbe-a199957de889" xlink:to="loc_us-gaap_RestructuringPlanDomain_9f28b531-455d-4aa6-b8cf-a4e77e210069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherInitiativesMember_11465aac-7557-4768-8a4f-02e412902031" xlink:href="bdx-20230331.xsd#bdx_OtherInitiativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_9f28b531-455d-4aa6-b8cf-a4e77e210069" xlink:to="loc_bdx_OtherInitiativesMember_11465aac-7557-4768-8a4f-02e412902031" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#IntangibleAssetsComponentsofIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="extended" id="i69ec8b84c589477399eb2e28285a42a8_IntangibleAssetsComponentsofIntangibleAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:href="bdx-20230331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f320f0bd-f44d-4384-9b8e-010bc17b9639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f320f0bd-f44d-4384-9b8e-010bc17b9639" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5ca70602-92a6-4b09-ab3a-de5ef134b77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5ca70602-92a6-4b09-ab3a-de5ef134b77c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_40136ff5-89b8-4682-a0e5-165e45d9b034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_40136ff5-89b8-4682-a0e5-165e45d9b034" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_566fe542-db91-4b8a-9bca-e6af58ac7791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_566fe542-db91-4b8a-9bca-e6af58ac7791" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_0e3712c2-f4ab-4d4b-b3fe-b9b582b4b335" xlink:href="bdx-20230331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:to="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_0e3712c2-f4ab-4d4b-b3fe-b9b582b4b335" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_309b9f0a-6401-4bb9-bc7f-3d4ebf09e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_0e3712c2-f4ab-4d4b-b3fe-b9b582b4b335" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_309b9f0a-6401-4bb9-bc7f-3d4ebf09e84f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_309b9f0a-6401-4bb9-bc7f-3d4ebf09e84f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_309b9f0a-6401-4bb9-bc7f-3d4ebf09e84f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_309b9f0a-6401-4bb9-bc7f-3d4ebf09e84f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a64333f7-659c-40ba-87be-4ec5c2013bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_309b9f0a-6401-4bb9-bc7f-3d4ebf09e84f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a64333f7-659c-40ba-87be-4ec5c2013bcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_5e6633a7-332c-4e83-a99f-dbe378119750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a64333f7-659c-40ba-87be-4ec5c2013bcc" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_5e6633a7-332c-4e83-a99f-dbe378119750" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4ab64d75-d696-40ce-abc9-f654bb65f2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a64333f7-659c-40ba-87be-4ec5c2013bcc" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4ab64d75-d696-40ce-abc9-f654bb65f2bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_dfe2c1d0-856c-4918-9b5a-777451d4fb07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a64333f7-659c-40ba-87be-4ec5c2013bcc" xlink:to="loc_us-gaap_IntellectualPropertyMember_dfe2c1d0-856c-4918-9b5a-777451d4fb07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cc35e967-1b0e-4fef-8d4b-8f6674e10090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_0e3712c2-f4ab-4d4b-b3fe-b9b582b4b335" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cc35e967-1b0e-4fef-8d4b-8f6674e10090" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cc35e967-1b0e-4fef-8d4b-8f6674e10090_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cc35e967-1b0e-4fef-8d4b-8f6674e10090" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cc35e967-1b0e-4fef-8d4b-8f6674e10090_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b586e160-b7a6-44f5-99de-0586f37a4683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cc35e967-1b0e-4fef-8d4b-8f6674e10090" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b586e160-b7a6-44f5-99de-0586f37a4683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_ed4752f1-dcf6-47e5-839c-9b911bf5d02f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b586e160-b7a6-44f5-99de-0586f37a4683" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_ed4752f1-dcf6-47e5-839c-9b911bf5d02f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_545b6d8c-fca0-4e67-85d6-02ff1822ad0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b586e160-b7a6-44f5-99de-0586f37a4683" xlink:to="loc_us-gaap_TrademarksMember_545b6d8c-fca0-4e67-85d6-02ff1822ad0c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="extended" id="i98712ae1f6ee4659ae5b7af857ab0bcd_IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_141181a0-d0a1-413b-9e2f-fc2a5eb6514b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_141181a0-d0a1-413b-9e2f-fc2a5eb6514b" xlink:to="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_62edcb0d-a876-4bb9-b7b7-d6ec5ceb8349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:to="loc_us-gaap_Goodwill_62edcb0d-a876-4bb9-b7b7-d6ec5ceb8349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_95a2369d-ac49-4832-8ecc-9f913557e7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_95a2369d-ac49-4832-8ecc-9f913557e7a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_25853c46-ffaa-401c-897b-7e8b85f34362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_25853c46-ffaa-401c-897b-7e8b85f34362" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3ce0bb01-edae-4235-9d87-73fb23fed5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_dbe217b8-1f31-4568-8706-732a8da136b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_141181a0-d0a1-413b-9e2f-fc2a5eb6514b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_dbe217b8-1f31-4568-8706-732a8da136b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_88997e2c-2d17-412a-b784-c719e17548a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_dbe217b8-1f31-4568-8706-732a8da136b3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_88997e2c-2d17-412a-b784-c719e17548a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_88997e2c-2d17-412a-b784-c719e17548a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_88997e2c-2d17-412a-b784-c719e17548a0" xlink:to="loc_us-gaap_SegmentDomain_88997e2c-2d17-412a-b784-c719e17548a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a13e213b-72c4-4796-81f1-10c994e55245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_88997e2c-2d17-412a-b784-c719e17548a0" xlink:to="loc_us-gaap_SegmentDomain_a13e213b-72c4-4796-81f1-10c994e55245" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_6b2aa087-dcf4-4db0-a053-6e5df3d00b33" xlink:href="bdx-20230331.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a13e213b-72c4-4796-81f1-10c994e55245" xlink:to="loc_bdx_MedicalMember_6b2aa087-dcf4-4db0-a053-6e5df3d00b33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_4f6aba36-20ec-48fc-b3d6-5fe81ee668dd" xlink:href="bdx-20230331.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a13e213b-72c4-4796-81f1-10c994e55245" xlink:to="loc_bdx_LifeSciencesMember_4f6aba36-20ec-48fc-b3d6-5fe81ee668dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_4d1ea7e8-8789-4259-a97a-39f5f0ddc2fc" xlink:href="bdx-20230331.xsd#bdx_InterventionalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a13e213b-72c4-4796-81f1-10c994e55245" xlink:to="loc_bdx_InterventionalMember_4d1ea7e8-8789-4259-a97a-39f5f0ddc2fc" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="extended" id="iee11d771cbdf4c9a8104fbabfe2da578_DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f2546f03-ef73-4825-8359-7e9a05913b70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e62d2cf8-0ae0-4e12-9f60-2806ae6fcaad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f2546f03-ef73-4825-8359-7e9a05913b70" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e62d2cf8-0ae0-4e12-9f60-2806ae6fcaad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f2546f03-ef73-4825-8359-7e9a05913b70" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_04607df6-6b71-4903-b271-5af2dccccacb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:to="loc_us-gaap_DebtInstrumentAxis_04607df6-6b71-4903-b271-5af2dccccacb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_04607df6-6b71-4903-b271-5af2dccccacb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_04607df6-6b71-4903-b271-5af2dccccacb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_04607df6-6b71-4903-b271-5af2dccccacb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35ddfb73-997c-4158-9313-06603b520588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_04607df6-6b71-4903-b271-5af2dccccacb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35ddfb73-997c-4158-9313-06603b520588" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember_f0c4e88f-feb9-4b08-8260-c854753f4182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35ddfb73-997c-4158-9313-06603b520588" xlink:to="loc_us-gaap_DebtMember_f0c4e88f-feb9-4b08-8260-c854753f4182" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0cdebd0a-fcb9-442b-a68d-b079dc012041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0cdebd0a-fcb9-442b-a68d-b079dc012041" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0cdebd0a-fcb9-442b-a68d-b079dc012041_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0cdebd0a-fcb9-442b-a68d-b079dc012041" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0cdebd0a-fcb9-442b-a68d-b079dc012041_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0cdebd0a-fcb9-442b-a68d-b079dc012041" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_12febc82-6918-4bec-8546-21adae2bed77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:to="loc_us-gaap_ForeignExchangeContractMember_12febc82-6918-4bec-8546-21adae2bed77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_9e900714-30b4-4c8a-9ca7-1ba568e7194f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:to="loc_us-gaap_CurrencySwapMember_9e900714-30b4-4c8a-9ca7-1ba568e7194f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FixedToFloatingMember_9a843f92-5666-4dcb-a9b4-c8eeb1a99a35" xlink:href="bdx-20230331.xsd#bdx_FixedToFloatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:to="loc_bdx_FixedToFloatingMember_9a843f92-5666-4dcb-a9b4-c8eeb1a99a35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_96c10ed5-84be-484a-b8a8-c6302c180087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:to="loc_us-gaap_InterestRateSwapMember_96c10ed5-84be-484a-b8a8-c6302c180087" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_493494c9-9656-46dd-8236-e17aaa58b90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_493494c9-9656-46dd-8236-e17aaa58b90e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_493494c9-9656-46dd-8236-e17aaa58b90e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_493494c9-9656-46dd-8236-e17aaa58b90e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_493494c9-9656-46dd-8236-e17aaa58b90e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c2297438-0de5-4101-9370-b8d66b2cc740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_493494c9-9656-46dd-8236-e17aaa58b90e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c2297438-0de5-4101-9370-b8d66b2cc740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6eb7c83d-020a-4177-b225-c7c48ffa695a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c2297438-0de5-4101-9370-b8d66b2cc740" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6eb7c83d-020a-4177-b225-c7c48ffa695a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_64b0c87c-c9c1-4941-a3d6-5dc45b8f6b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c2297438-0de5-4101-9370-b8d66b2cc740" xlink:to="loc_us-gaap_FairValueHedgingMember_64b0c87c-c9c1-4941-a3d6-5dc45b8f6b8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_f7dd6011-0fb9-4d5a-8c07-5319e8c983dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c2297438-0de5-4101-9370-b8d66b2cc740" xlink:to="loc_us-gaap_CashFlowHedgingMember_f7dd6011-0fb9-4d5a-8c07-5319e8c983dd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="extended" id="ia6cdfc3c49164312820744f037ca52f2_DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cd2625d2-7b8b-4285-8f5f-a07f5e8a3c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e90c64d0-cabd-4117-95df-203919d5640f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cd2625d2-7b8b-4285-8f5f-a07f5e8a3c14" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e90c64d0-cabd-4117-95df-203919d5640f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d89670d-85e0-4b55-877a-3341b105313a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cd2625d2-7b8b-4285-8f5f-a07f5e8a3c14" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d89670d-85e0-4b55-877a-3341b105313a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_40d7814d-784a-4ef8-b67b-eb29e858f560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d89670d-85e0-4b55-877a-3341b105313a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_40d7814d-784a-4ef8-b67b-eb29e858f560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_40d7814d-784a-4ef8-b67b-eb29e858f560_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40d7814d-784a-4ef8-b67b-eb29e858f560" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_40d7814d-784a-4ef8-b67b-eb29e858f560_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_304b5672-3b2a-43cb-8782-d85eb014bf16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40d7814d-784a-4ef8-b67b-eb29e858f560" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_304b5672-3b2a-43cb-8782-d85eb014bf16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ForeignCurrencyDenominatedDebtMember_56619512-a0df-47a3-a0ed-7e89499c912f" xlink:href="bdx-20230331.xsd#bdx_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_304b5672-3b2a-43cb-8782-d85eb014bf16" xlink:to="loc_bdx_ForeignCurrencyDenominatedDebtMember_56619512-a0df-47a3-a0ed-7e89499c912f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_8153504f-5301-4f0c-8d46-79df8bac3641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_304b5672-3b2a-43cb-8782-d85eb014bf16" xlink:to="loc_us-gaap_CurrencySwapMember_8153504f-5301-4f0c-8d46-79df8bac3641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TerminatedCurrencySwapMember_cb4c7b60-725c-4865-a93e-654d06334887" xlink:href="bdx-20230331.xsd#bdx_TerminatedCurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_304b5672-3b2a-43cb-8782-d85eb014bf16" xlink:to="loc_bdx_TerminatedCurrencySwapMember_cb4c7b60-725c-4865-a93e-654d06334887" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="extended" id="ic2a7bfdbce8843d9bdeacc2a9be66380_DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_3e9892b3-1da0-4c5f-ae0f-087032a18e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_4298b0b6-4b8c-404d-a82f-b187310e7b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_3e9892b3-1da0-4c5f-ae0f-087032a18e3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_4298b0b6-4b8c-404d-a82f-b187310e7b83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a252bd2b-073e-4641-b373-05751a97ef20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_3e9892b3-1da0-4c5f-ae0f-087032a18e3a" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a252bd2b-073e-4641-b373-05751a97ef20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_04059ef1-fb02-4db9-965b-dfcfbe141f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a252bd2b-073e-4641-b373-05751a97ef20" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_04059ef1-fb02-4db9-965b-dfcfbe141f1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_04059ef1-fb02-4db9-965b-dfcfbe141f1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_04059ef1-fb02-4db9-965b-dfcfbe141f1a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_04059ef1-fb02-4db9-965b-dfcfbe141f1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3e8ef257-09b6-4bd5-993b-dae3e48848a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_04059ef1-fb02-4db9-965b-dfcfbe141f1a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3e8ef257-09b6-4bd5-993b-dae3e48848a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_bc9e2cbc-9b7d-4a96-8e35-5bb9865e24a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e8ef257-09b6-4bd5-993b-dae3e48848a2" xlink:to="loc_us-gaap_InterestRateSwapMember_bc9e2cbc-9b7d-4a96-8e35-5bb9865e24a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d6716f96-3b3d-4fcd-b0fd-5104410a099c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a252bd2b-073e-4641-b373-05751a97ef20" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d6716f96-3b3d-4fcd-b0fd-5104410a099c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d6716f96-3b3d-4fcd-b0fd-5104410a099c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d6716f96-3b3d-4fcd-b0fd-5104410a099c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d6716f96-3b3d-4fcd-b0fd-5104410a099c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_da98fc07-837e-4e0d-a364-9546632170fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d6716f96-3b3d-4fcd-b0fd-5104410a099c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_da98fc07-837e-4e0d-a364-9546632170fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_211e1ff6-b21c-44c4-b28e-e3966e8e2e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_da98fc07-837e-4e0d-a364-9546632170fb" xlink:to="loc_us-gaap_CashFlowHedgingMember_211e1ff6-b21c-44c4-b28e-e3966e8e2e02" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" id="i6f40181886cd4e4fa14ed462c749efd1_FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c8b5199-0f1c-4354-a363-c7706f0680e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MaturityPeriodOfShortTermInvestment_9587b89d-b21b-4900-965e-617a48fe2a90" xlink:href="bdx-20230331.xsd#bdx_MaturityPeriodOfShortTermInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c8b5199-0f1c-4354-a363-c7706f0680e2" xlink:to="loc_bdx_MaturityPeriodOfShortTermInvestment_9587b89d-b21b-4900-965e-617a48fe2a90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_7484eba3-52b6-416b-aaa0-a04026c7b45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c8b5199-0f1c-4354-a363-c7706f0680e2" xlink:to="loc_us-gaap_AssetImpairmentCharges_7484eba3-52b6-416b-aaa0-a04026c7b45e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2673961f-ddbc-4716-bbc9-00bba67b7f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c8b5199-0f1c-4354-a363-c7706f0680e2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2673961f-ddbc-4716-bbc9-00bba67b7f95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c2953d64-7007-4145-8fde-4575bb48856c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2673961f-ddbc-4716-bbc9-00bba67b7f95" xlink:to="loc_srt_RangeAxis_c2953d64-7007-4145-8fde-4575bb48856c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c2953d64-7007-4145-8fde-4575bb48856c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c2953d64-7007-4145-8fde-4575bb48856c" xlink:to="loc_srt_RangeMember_c2953d64-7007-4145-8fde-4575bb48856c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd7810d8-1a5a-4096-a8c3-0bf685c043e8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c2953d64-7007-4145-8fde-4575bb48856c" xlink:to="loc_srt_RangeMember_fd7810d8-1a5a-4096-a8c3-0bf685c043e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_82f4a446-fd9e-4ae6-b4ce-ef58fbaf42e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fd7810d8-1a5a-4096-a8c3-0bf685c043e8" xlink:to="loc_srt_MinimumMember_82f4a446-fd9e-4ae6-b4ce-ef58fbaf42e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8425d79a-49d8-4886-bbe9-b68fb932e0ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fd7810d8-1a5a-4096-a8c3-0bf685c043e8" xlink:to="loc_srt_MaximumMember_8425d79a-49d8-4886-bbe9-b68fb932e0ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_110fee6d-09cf-4c1a-8d00-d3a5fa4b7036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2673961f-ddbc-4716-bbc9-00bba67b7f95" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_110fee6d-09cf-4c1a-8d00-d3a5fa4b7036" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_110fee6d-09cf-4c1a-8d00-d3a5fa4b7036_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_110fee6d-09cf-4c1a-8d00-d3a5fa4b7036" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_110fee6d-09cf-4c1a-8d00-d3a5fa4b7036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_299c31c4-448e-49cf-a04e-7d7fe7094c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_110fee6d-09cf-4c1a-8d00-d3a5fa4b7036" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_299c31c4-448e-49cf-a04e-7d7fe7094c1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_55c65cb2-20f5-4084-9d69-5cbefa2efb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_299c31c4-448e-49cf-a04e-7d7fe7094c1f" xlink:to="loc_us-gaap_CostOfSalesMember_55c65cb2-20f5-4084-9d69-5cbefa2efb64" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#DebtDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DebtDetail" xlink:type="extended" id="i95d3516a32624d3186da348c2350b502_DebtDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_275f54c6-195d-4d77-a789-94e0bc30f176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_66cc72c8-56d6-47bf-ba71-a5bc3720a8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_275f54c6-195d-4d77-a789-94e0bc30f176" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_66cc72c8-56d6-47bf-ba71-a5bc3720a8ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_37951be1-d937-4ed2-adff-f39dc349d7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_275f54c6-195d-4d77-a789-94e0bc30f176" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_37951be1-d937-4ed2-adff-f39dc349d7a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_265bc6ff-e070-4d9d-9cff-0539241c5ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_275f54c6-195d-4d77-a789-94e0bc30f176" xlink:to="loc_us-gaap_DebtInstrumentTable_265bc6ff-e070-4d9d-9cff-0539241c5ce8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_da15e184-aa19-470f-923a-394769bde136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_265bc6ff-e070-4d9d-9cff-0539241c5ce8" xlink:to="loc_us-gaap_DebtInstrumentAxis_da15e184-aa19-470f-923a-394769bde136" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_da15e184-aa19-470f-923a-394769bde136_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_da15e184-aa19-470f-923a-394769bde136" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_da15e184-aa19-470f-923a-394769bde136_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_74ea4cd7-aafb-404a-ae22-7a3f9cea4389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_da15e184-aa19-470f-923a-394769bde136" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_74ea4cd7-aafb-404a-ae22-7a3f9cea4389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4693DueFebruary132028Member_d05601cb-73b8-4fa1-a38d-180b1fe92412" xlink:href="bdx-20230331.xsd#bdx_Notes4693DueFebruary132028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_74ea4cd7-aafb-404a-ae22-7a3f9cea4389" xlink:to="loc_bdx_Notes4693DueFebruary132028Member_d05601cb-73b8-4fa1-a38d-180b1fe92412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3553DueSeptember132029Member_04bdc2a9-2f0f-49db-b37c-5872548ba49d" xlink:href="bdx-20230331.xsd#bdx_Notes3553DueSeptember132029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_74ea4cd7-aafb-404a-ae22-7a3f9cea4389" xlink:to="loc_bdx_Notes3553DueSeptember132029Member_04bdc2a9-2f0f-49db-b37c-5872548ba49d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_f35e904f-0d56-44d2-b885-5fc3a9a736f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_265bc6ff-e070-4d9d-9cff-0539241c5ce8" xlink:to="loc_srt_CurrencyAxis_f35e904f-0d56-44d2-b885-5fc3a9a736f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_f35e904f-0d56-44d2-b885-5fc3a9a736f7_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_f35e904f-0d56-44d2-b885-5fc3a9a736f7" xlink:to="loc_currency_AllCurrenciesDomain_f35e904f-0d56-44d2-b885-5fc3a9a736f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_9c1e8f31-1c98-47f5-abc2-09550f55b628" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_f35e904f-0d56-44d2-b885-5fc3a9a736f7" xlink:to="loc_currency_AllCurrenciesDomain_9c1e8f31-1c98-47f5-abc2-09550f55b628" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_e9755db2-5043-45a7-981f-0dac4e25558b" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_9c1e8f31-1c98-47f5-abc2-09550f55b628" xlink:to="loc_currency_EUR_e9755db2-5043-45a7-981f-0dac4e25558b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_5b26717d-2f1d-4aac-98d1-ab1c4e5363df" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_9c1e8f31-1c98-47f5-abc2-09550f55b628" xlink:to="loc_currency_USD_5b26717d-2f1d-4aac-98d1-ab1c4e5363df" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>bdx-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c18e2de7-cbd8-4499-b946-e1533dbcca3e,g:06687f9f-d051-4540-9898-7752ada2060d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_13694ee6-2b9f-4b78-b61a-61e27c5d0e2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified into income, net of taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_6098eb55-40fb-45d6-9ebc-c64108316acd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_e4e9a420-760c-4ddb-8058-61cc107c85dc_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PharmaceuticalSystemsMember_58ad0cb8-8602-4ff5-a471-43faf41093e6_terseLabel_en-US" xlink:label="lab_bdx_PharmaceuticalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Systems</link:label>
    <link:label id="lab_bdx_PharmaceuticalSystemsMember_label_en-US" xlink:label="lab_bdx_PharmaceuticalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Systems [Member]</link:label>
    <link:label id="lab_bdx_PharmaceuticalSystemsMember_documentation_en-US" xlink:label="lab_bdx_PharmaceuticalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PharmaceuticalSystemsMember" xlink:href="bdx-20230331.xsd#bdx_PharmaceuticalSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PharmaceuticalSystemsMember" xlink:to="lab_bdx_PharmaceuticalSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_fa5939dc-5279-413b-87b3-f197252d26d4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_95d4ee2a-9911-4403-ae48-1f3ca00bbc2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shareholders Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_45d827e8-dc86-4aae-9f5e-5a6b854a136d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_a4d57815-b147-41c6-b8c6-534571899a68_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_2c794b95-be4f-4940-a4aa-7f916d57c4d0_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_694e0dc9-99cd-44d3-854f-442d42f5f14f_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_fb398160-0a1c-4487-a673-f0b5a133fa62_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_4a724c5d-b64c-42a0-bdee-d54fd4eab42b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_62dd3cd7-36af-45d4-bea2-3d27ce28ae2b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_ef5f3e32-ad70-4c69-ba68-47638163146d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_69a6f7fc-f27c-4f8e-ac04-c18c8c2df5ee_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_a4d170e4-93d8-4377-90dd-947edccdc886_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_d36887e9-34ad-4176-9119-9d56876d5e27_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6f8397dc-b08b-470b-9c9e-983fdc221e5b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c1be3d29-0eb8-4cbd-9ef3-55d7c83c3006_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7035b51d-e2e3-4c29-b239-b161eabc9fad_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_f1f0de29-0dab-4c6c-9711-55192649e4bb_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Means Other than Sale, Spinoff</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Means Other than Sale, Spinoff [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_f4857fcf-dbca-4607-afdf-f5922ea183f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_9b8d9639-977a-4aff-ab75-4cb7f781923d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_3d855a80-6ce4-4852-9390-cbb2bebeb3f2_terseLabel_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.900% due December 15, 2026</link:label>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_label_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.900% due December 15, 2026 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_documentation_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.900% due December 15, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member" xlink:href="bdx-20230331.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.900dueDecember152026Member" xlink:to="lab_bdx_Notes1.900dueDecember152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bc534c67-58e6-46e8-93e5-9fc583749442_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net pension cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStock_c6e96e96-b241-41c3-87ec-b8a4dcc07e18_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStock" xlink:to="lab_us-gaap_DividendsPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_402ef807-c9b0-4c22-b1dd-ebd1fe433542_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_bc1a66d4-ace7-4553-ae85-1f8a50cd802e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_1930cb8a-1afa-4914-9bcf-83bf5fb46442_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0c85e6ec-1b7a-485c-9e74-e4f7c587f63c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b6b6d256-d7e2-406f-a991-e5fed8d1e76d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share equivalents excluded from the diluted shares outstanding calculation (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_fbaba160-9888-4401-baf9-46f9ed098614_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ConsumablesMember_779c658f-fb1d-4e69-b11e-43794d05e1f8_terseLabel_en-US" xlink:label="lab_bdx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_bdx_ConsumablesMember_label_en-US" xlink:label="lab_bdx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_bdx_ConsumablesMember_documentation_en-US" xlink:label="lab_bdx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember" xlink:href="bdx-20230331.xsd#bdx_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ConsumablesMember" xlink:to="lab_bdx_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_SurgeryMember_72f1050f-f22b-4c34-8713-7c17fd5e0814_terseLabel_en-US" xlink:label="lab_bdx_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery</link:label>
    <link:label id="lab_bdx_SurgeryMember_label_en-US" xlink:label="lab_bdx_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery [Member]</link:label>
    <link:label id="lab_bdx_SurgeryMember_documentation_en-US" xlink:label="lab_bdx_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SurgeryMember" xlink:href="bdx-20230331.xsd#bdx_SurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_SurgeryMember" xlink:to="lab_bdx_SurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_0cdcd5d9-eef3-4de2-b40d-4a505fc8a254_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_7b711e0f-9c02-40be-9d11-d56f5fd21c3d_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_4f48221f-41c6-4fbd-9b9c-66b3daaa142d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ContractWithCustomerRebateLiability_7373b452-e0e3-48e5-8b0c-8343ad7e83de_terseLabel_en-US" xlink:label="lab_bdx_ContractWithCustomerRebateLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate liability</link:label>
    <link:label id="lab_bdx_ContractWithCustomerRebateLiability_label_en-US" xlink:label="lab_bdx_ContractWithCustomerRebateLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Rebate Liability</link:label>
    <link:label id="lab_bdx_ContractWithCustomerRebateLiability_documentation_en-US" xlink:label="lab_bdx_ContractWithCustomerRebateLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Rebate Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability" xlink:href="bdx-20230331.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ContractWithCustomerRebateLiability" xlink:to="lab_bdx_ContractWithCustomerRebateLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MedicationDeliverySolutionsMember_169cfd7c-bfd0-4d5e-8549-f2842490b223_terseLabel_en-US" xlink:label="lab_bdx_MedicationDeliverySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery Solutions</link:label>
    <link:label id="lab_bdx_MedicationDeliverySolutionsMember_label_en-US" xlink:label="lab_bdx_MedicationDeliverySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery Solutions [Member]</link:label>
    <link:label id="lab_bdx_MedicationDeliverySolutionsMember_documentation_en-US" xlink:label="lab_bdx_MedicationDeliverySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationDeliverySolutionsMember" xlink:href="bdx-20230331.xsd#bdx_MedicationDeliverySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MedicationDeliverySolutionsMember" xlink:to="lab_bdx_MedicationDeliverySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_e14d39e3-3fdb-4f04-b0a6-f62abfe9c3f1_terseLabel_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="bdx-20230331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationMember_218af823-b319-4e3d-9e1d-f64c588881a1_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationMember_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation [Member]</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationMember_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationMember" xlink:href="bdx-20230331.xsd#bdx_ShareBasedCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationMember" xlink:to="lab_bdx_ShareBasedCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4ffa3e70-7565-4640-964a-b3c18df583e6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Continuing Operations, Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_afba4fa3-e262-4d3a-8656-5fa1dab8c688_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_f000d63b-f20d-4f32-98cc-9a5dcebe1fe7_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of principal business segments (segment)</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ForeignCurrencyDenominatedDebtMember_5bd2814c-67df-423d-b6c7-fb95cd32253b_terseLabel_en-US" xlink:label="lab_bdx_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency-Denominated Debt</link:label>
    <link:label id="lab_bdx_ForeignCurrencyDenominatedDebtMember_label_en-US" xlink:label="lab_bdx_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency-Denominated Debt [Member]</link:label>
    <link:label id="lab_bdx_ForeignCurrencyDenominatedDebtMember_documentation_en-US" xlink:label="lab_bdx_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign-Currency Denominated Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ForeignCurrencyDenominatedDebtMember" xlink:href="bdx-20230331.xsd#bdx_ForeignCurrencyDenominatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ForeignCurrencyDenominatedDebtMember" xlink:to="lab_bdx_ForeignCurrencyDenominatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_dbec4312-6384-4c07-8e08-4ccb0a00f4be_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_b6894143-4a96-4a3c-b335-0750f4386a44_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_55129871-cf4a-42e7-ad58-93825103db8f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_8d456e73-34f3-44c4-91a1-69ca03fdcb24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_a2f5a670-951d-41c0-bbbf-b678c51533d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CommonStockSharesHeldInEmployeeTrust1_e5193f5d-16e4-4cca-86b3-680ca88a8623_terseLabel_en-US" xlink:label="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_bdx_CommonStockSharesHeldInEmployeeTrust1_label_en-US" xlink:label="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Held in Employee Trust1</link:label>
    <link:label id="lab_bdx_CommonStockSharesHeldInEmployeeTrust1_documentation_en-US" xlink:label="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of common stock issued to a trust (for example, but not limited to, rabbi trust) set up specifically to accumulate stock for the sole purpose of distribution to participating employees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:href="bdx-20230331.xsd#bdx_CommonStockSharesHeldInEmployeeTrust1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:to="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_029987b6-8d2f-486e-9bde-1ec8549f16e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss) Income, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0.632dueJune42023Member_dfd60ea0-9392-4efd-ae47-42f23f3b8b92_terseLabel_en-US" xlink:label="lab_bdx_Notes0.632dueJune42023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.632% due June 4, 2023</link:label>
    <link:label id="lab_bdx_Notes0.632dueJune42023Member_label_en-US" xlink:label="lab_bdx_Notes0.632dueJune42023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.632% due June 4, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes0.632dueJune42023Member_documentation_en-US" xlink:label="lab_bdx_Notes0.632dueJune42023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.632% due June 4, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member" xlink:href="bdx-20230331.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0.632dueJune42023Member" xlink:to="lab_bdx_Notes0.632dueJune42023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_6fb3c69c-e775-4bdb-a770-918acb633108_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b893b8ae-f60a-4b07-b02f-250c6721288a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermInvestments_7a25ca0d-c0bd-42cc-af71-501099dad4d4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_OtherShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermInvestments" xlink:to="lab_us-gaap_OtherShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_9c69916e-38bf-49a3-aec7-bb99f57f1beb_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_7b09d351-7735-4372-88b8-10eb42ba7c7a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_274cdb83-c654-475d-8e36-3e9b13e8ded9_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CommonStockHeldInTrustsNetShares_3444b13e-bd13-4d7b-9a59-e0c82da126a0_terseLabel_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock held in trusts, net (in shares)</link:label>
    <link:label id="lab_bdx_CommonStockHeldInTrustsNetShares_label_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Held In Trusts Net Shares</link:label>
    <link:label id="lab_bdx_CommonStockHeldInTrustsNetShares_documentation_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common stock shares held in trust.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsNetShares" xlink:href="bdx-20230331.xsd#bdx_CommonStockHeldInTrustsNetShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CommonStockHeldInTrustsNetShares" xlink:to="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_124b69e4-1a6c-4b1b-9e5d-c17e62756789_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price allocation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FiniteLivedCustomerRelationshipsNet_6b12f22c-9af4-42c9-a196-83aafebbe2ba_terseLabel_en-US" xlink:label="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships, Net</link:label>
    <link:label id="lab_bdx_FiniteLivedCustomerRelationshipsNet_label_en-US" xlink:label="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Customer Relationships Net</link:label>
    <link:label id="lab_bdx_FiniteLivedCustomerRelationshipsNet_documentation_en-US" xlink:label="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount as of the balance sheet date of an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteLivedCustomerRelationshipsNet" xlink:href="bdx-20230331.xsd#bdx_FiniteLivedCustomerRelationshipsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FiniteLivedCustomerRelationshipsNet" xlink:to="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_967c43eb-1b21-4acf-9c62-dd39b8401989_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Employee Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OrganizationalUnitDomain_7b73371d-16cf-4fc6-819e-6869dce52f5e_terseLabel_en-US" xlink:label="lab_bdx_OrganizationalUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Domain]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitDomain_label_en-US" xlink:label="lab_bdx_OrganizationalUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Domain]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitDomain_documentation_en-US" xlink:label="lab_bdx_OrganizationalUnitDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Organizational Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain" xlink:href="bdx-20230331.xsd#bdx_OrganizationalUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OrganizationalUnitDomain" xlink:to="lab_bdx_OrganizationalUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes4693DueFebruary132028Member_2191eac3-665e-44f2-942a-a541ce2e290c_terseLabel_en-US" xlink:label="lab_bdx_Notes4693DueFebruary132028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.693% due February 13, 2028</link:label>
    <link:label id="lab_bdx_Notes4693DueFebruary132028Member_label_en-US" xlink:label="lab_bdx_Notes4693DueFebruary132028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.693% due February 13, 2028 [Member]</link:label>
    <link:label id="lab_bdx_Notes4693DueFebruary132028Member_documentation_en-US" xlink:label="lab_bdx_Notes4693DueFebruary132028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.693% due February 13, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4693DueFebruary132028Member" xlink:href="bdx-20230331.xsd#bdx_Notes4693DueFebruary132028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes4693DueFebruary132028Member" xlink:to="lab_bdx_Notes4693DueFebruary132028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8b6b84cf-19ec-4c0a-b8a6-bfcc6e0d9a35_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_209ec3b0-05d9-4937-8505-5d070fa3e150_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f1f54aaf-343e-4ab0-8fd9-867720a28174_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_527f6d4f-695f-4e69-b1a7-5c96a4116574_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_41adfc68-1c05-4295-95e4-f5c80cea4fc9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5333af4e-c8e6-457e-b3a7-1302a85ac5c7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_ecfa91cb-0a09-41a8-a808-edc3c1d1a8c4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3553DueSeptember132029Member_f3573c83-4191-4038-948b-c625cb40fa37_terseLabel_en-US" xlink:label="lab_bdx_Notes3553DueSeptember132029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.553% due September 13, 2029</link:label>
    <link:label id="lab_bdx_Notes3553DueSeptember132029Member_label_en-US" xlink:label="lab_bdx_Notes3553DueSeptember132029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.553% due September 13, 2029 [Member]</link:label>
    <link:label id="lab_bdx_Notes3553DueSeptember132029Member_documentation_en-US" xlink:label="lab_bdx_Notes3553DueSeptember132029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.553% due September 13, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3553DueSeptember132029Member" xlink:href="bdx-20230331.xsd#bdx_Notes3553DueSeptember132029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3553DueSeptember132029Member" xlink:to="lab_bdx_Notes3553DueSeptember132029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ProductsandorServicesMember_7f468146-87ec-4356-86d7-10f74913c2b7_terseLabel_en-US" xlink:label="lab_bdx_ProductsandorServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and/or Services</link:label>
    <link:label id="lab_bdx_ProductsandorServicesMember_label_en-US" xlink:label="lab_bdx_ProductsandorServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and/or Services [Member]</link:label>
    <link:label id="lab_bdx_ProductsandorServicesMember_documentation_en-US" xlink:label="lab_bdx_ProductsandorServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and/or Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember" xlink:href="bdx-20230331.xsd#bdx_ProductsandorServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ProductsandorServicesMember" xlink:to="lab_bdx_ProductsandorServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_ab1174af-946f-422f-bb82-16996152d6d9_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3f2dba08-4d79-430f-97fe-8995c28adb31_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_90208301-1e2c-444c-8cf3-93d3ed9db6e4_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MedicalMember_9350f22b-63b6-4e99-9997-eb2649b59e5c_terseLabel_en-US" xlink:label="lab_bdx_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_bdx_MedicalMember_label_en-US" xlink:label="lab_bdx_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:label id="lab_bdx_MedicalMember_documentation_en-US" xlink:label="lab_bdx_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember" xlink:href="bdx-20230331.xsd#bdx_MedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MedicalMember" xlink:to="lab_bdx_MedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_ad5c065d-30a4-4b1d-8310-62263e45ed03_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_5769e31b-3572-4366-a99d-0730fe5b94f0_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_2a671d88-4887-4dd9-ad36-241e2ded65d5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_6a71232c-a6fc-40e6-8139-adec8624cc40_terseLabel_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.208% due June 4, 2026</link:label>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_label_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.208% due June 4, 2026 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_documentation_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.208% due June 4, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member" xlink:href="bdx-20230331.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.208dueJune42026Member" xlink:to="lab_bdx_Notes1.208dueJune42026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled_ba9c1d2b-87cf-41d5-88cb-869ac20547ed_terseLabel_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of EtO lawsuits filed</link:label>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled_label_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of EtO Sterilization Lawsuits Filed</link:label>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled_documentation_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of EtO Sterilization Lawsuits Filed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:href="bdx-20230331.xsd#bdx_NumberOfEtOSterilizationLawsuitsFiled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:to="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_46dfdc60-a721-457d-900c-d0271a45cfe4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_914cd095-c4ef-4018-93f0-c3f4e9652a0e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_246d1f79-a671-4153-91c3-7872745b2531_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_cd14d4a0-a304-4069-a1a2-1897fb5f8eda_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_6706cde3-3b04-45f9-a938-b61487153ca8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_fa91cf64-c64f-4cdf-92c3-0919f7ea7600_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Continuing Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_2ed0fa9e-7b4b-4bb0-bbb0-3bd8078407e5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_25481743-a3bb-4134-8289-6fc1dbe77dec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3a9d7651-54ae-483b-930b-45e031c83cd3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_edc18d65-6141-485d-9e10-e3df7b79efc1_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Starting Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_3ab7617a-2580-4073-8bd0-9250d5f3ec79_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OtherInitiativesMember_84a7214b-fe39-49bd-a74e-a42dd0f3487c_terseLabel_en-US" xlink:label="lab_bdx_OtherInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Initiatives</link:label>
    <link:label id="lab_bdx_OtherInitiativesMember_label_en-US" xlink:label="lab_bdx_OtherInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Initiatives [Member]</link:label>
    <link:label id="lab_bdx_OtherInitiativesMember_documentation_en-US" xlink:label="lab_bdx_OtherInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Initiatives [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherInitiativesMember" xlink:href="bdx-20230331.xsd#bdx_OtherInitiativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OtherInitiativesMember" xlink:to="lab_bdx_OtherInitiativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b38ec577-447a-4baf-aba0-5b43e4bfa724_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_dc3c5cc6-528a-48b8-aa74-84a7ae50fe46_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Research and Development Expense</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_documentation_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:to="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_97ea0e9b-2f39-454b-94de-d72c55576665_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_978c1a53-8a4c-41c0-9010-15fc6a2661e1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3fa77870-5518-49e1-8ad6-aa246ba178c1_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Continuing Operations Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_095f5cc6-c5d4-4506-bb1c-2412eac32662_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_96794bbc-9099-447b-bfca-2032747bdb31_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_4e89613b-3cf9-409b-acc2-11c8aa53a893_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_6af28917-301d-485d-8595-75b9bb0aac5c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_90657231-daae-4ce5-acfb-bc92db06066b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f0f71fa0-f0e6-477c-88f4-f77b5146c810_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_6e2dfe2a-1c52-42f3-a8a2-034f388c4ec5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_7aa53165-a05d-46d9-a27a-9ecb3af7d0c6_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used for investing activities</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Investing Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_d84532f2-ef67-41a8-a96a-24697a3a5401_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash settlements</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_54795ff8-1033-402e-b0e9-c16595813e2a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss before reclassifications, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_a212646f-7140-4b6e-b493-a864407d5daf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_4b115bd7-ba44-4e54-8d32-6030e1e45582_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fcfe21e4-8fe7-4536-be67-fd8991c4aec4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cf99fc0c-3eb4-4ff7-8aba-f8ffac44d66c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_d860de65-ca6f-4b67-a6c0-6530f5f87388_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Discontinued Operations, Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_086d1bac-710b-424f-b052-1587fef57b8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_f1dcf9c3-b399-438c-8890-de049e850ad1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_b6686b58-ea0b-4a35-9058-d7b16d6e6451_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_27b96711-1711-446a-838c-0a04f325d48f_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0770e157-fef7-48b5-aa23-98695fe2fe41_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_770fe48b-5afb-4d6f-84bc-54c8c32fa303_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_8d6dc02c-1c6b-406d-8c0a-d352bc3bbb5f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_578db670-98a9-4140-947f-37b61c6723a9_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_6c8240fc-183b-44da-aa1b-e3d4aeb3474b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3dcb2037-6237-4737-ac5b-b7ef4de32f5d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_71ed6e25-3c43-4d56-99b5-655f1a25da90_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_251c6685-e71d-4a24-b69c-6a017a038aa3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4b417490-3873-4bfd-9cff-8a15ad4ce0cd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ccbdad5e-3cb8-48a4-a89f-53ceec6a8c31_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_70ad5655-0cfe-4483-a09e-03605e80e463_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_1e61daac-eb33-4e54-b918-d2e3f94aec7b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_82308a29-5cf1-44a7-93fe-38d6f4834f8f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_4ca223ac-abde-4f32-9ad9-fc667621e23b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8014198a-e4a6-48ab-b965-994b6c9b138d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_c1077189-2398-47a9-a81a-64897af305c3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d5fc91dc-c584-4d0f-9b0c-0e41bd1ba59e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ProceedsFromSpinoffTransaction_3931e213-b6ad-47f8-9869-fcd22e554aee_terseLabel_en-US" xlink:label="lab_bdx_ProceedsFromSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution from Embecta Corp. (see Note 2)</link:label>
    <link:label id="lab_bdx_ProceedsFromSpinoffTransaction_label_en-US" xlink:label="lab_bdx_ProceedsFromSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Spinoff Transaction</link:label>
    <link:label id="lab_bdx_ProceedsFromSpinoffTransaction_documentation_en-US" xlink:label="lab_bdx_ProceedsFromSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Spinoff Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsFromSpinoffTransaction" xlink:href="bdx-20230331.xsd#bdx_ProceedsFromSpinoffTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ProceedsFromSpinoffTransaction" xlink:to="lab_bdx_ProceedsFromSpinoffTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_15cecb4e-6e66-4edd-bce2-d36432e84b0f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_ef8327d9-401d-4b1d-864a-181b18bc331b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_9a3f9fca-3344-4332-84f2-dc9369ef96a7_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8eb6a16a-5c1e-4a98-9fb5-6078a53f31bb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Institutional money market accounts</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_8e05d672-9b6d-4b83-b16e-9953c80fb9b1_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_46877a7c-8985-407f-9762-bc4144a4375a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income from Continuing Operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_f7c59601-4dda-404e-a984-37152e3ee2e6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income from Continuing Operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_a03b28ea-a379-4f69-a1eb-8cfdbac5d5a5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished products</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_433219a1-5ab6-4895-b5d8-e12a47d839fc_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_9b3d4886-aecf-47d6-8c08-36da7022ce4a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Goodwill by Business Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a950df6e-fb91-4d6e-aa88-a8e3f381d0ab_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic Earnings per Share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_HerniaProductClaimsMember_c70e080f-491a-467a-9fd8-5349a46ed5b7_terseLabel_en-US" xlink:label="lab_bdx_HerniaProductClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hernia Product Claims</link:label>
    <link:label id="lab_bdx_HerniaProductClaimsMember_label_en-US" xlink:label="lab_bdx_HerniaProductClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HerniaProductClaims [Member]</link:label>
    <link:label id="lab_bdx_HerniaProductClaimsMember_documentation_en-US" xlink:label="lab_bdx_HerniaProductClaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HerniaProductClaims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_HerniaProductClaimsMember" xlink:href="bdx-20230331.xsd#bdx_HerniaProductClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_HerniaProductClaimsMember" xlink:to="lab_bdx_HerniaProductClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_e9082b89-7127-44f5-9ac1-80cc00fd5157_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_3e64b7ca-7ccb-46d1-bb05-bc6e8b3da1ce_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_959c7d5e-6af6-4b35-a815-dfd95fee4be1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit&#160;Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_a348603b-0193-4c97-92c3-0d92e2fd3702_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_075aecd9-c54a-435b-af50-dae8916c0eaa_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_2044e315-56af-47a2-8d41-b649d068a7ea_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_8aea9b5c-452d-48ca-a47a-642299ad61e1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_50bb9f08-f4c5-491d-b7c9-267cbd60f256_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2ae91a74-96b9-46d3-aa5f-21dc6c409719_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d4a48de8-8f6d-42f0-898c-6808bb9034e2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_36300bbc-54a6-4c54-8c46-3451ac254355_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_f3ee5959-3c81-48c3-a82e-959294014e72_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3aaacb9c-d712-4293-9ddb-1ea64ef72f4a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_b182ae35-7455-4cf8-bc98-044aaca730e6_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts yet to be collected and remitted to the third parties</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_0f585e35-d87b-4f34-a031-15a4c4dce4d8_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_b775b46e-76f2-4b29-9f0f-7e100f35a9a2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_9003a2e0-9746-4a8c-b239-d96b60462955_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_GA_420e49b9-e83b-4f80-b360-84928cbc9109_terseLabel_en-US" xlink:label="lab_stpr_GA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEORGIA</link:label>
    <link:label id="lab_stpr_GA_label_en-US" xlink:label="lab_stpr_GA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEORGIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_GA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_GA" xlink:to="lab_stpr_GA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_068bfeff-e9a8-4dbb-8de0-226936086c14_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_8858aa22-0086-4cbf-9181-faecbdc1c483_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_d5646554-2aaa-47c6-9b15-2f7e9cec6afe_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock&#160; Issued at&#160;Par&#160;Value</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c2857101-fea6-4e58-9a37-cb42983dcbc3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee and other plans, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_5b301d2b-5944-4002-b666-adf472e600ec_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_acb2d5dd-0c11-4945-9337-ec4b56ca9699_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_7cee6bb0-e4a4-42da-8822-13a54c39b1c7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0c4f5df7-d035-4f1b-9e4b-cc27938ad94c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_513e4d45-d696-4142-a6c7-769ae4244b3f_terseLabel_en-US" xlink:label="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt</link:label>
    <link:label id="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_label_en-US" xlink:label="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt and Term Loans</link:label>
    <link:label id="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_documentation_en-US" xlink:label="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer, and term loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:href="bdx-20230331.xsd#bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:to="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_261d6141-9da1-4567-9d61-32b9f644f198_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e2e8560c-4500-4c78-8ec1-bc3a3f3f6aad_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_88329a9f-5bd2-4d39-a5d1-05891f07dbce_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_61eee425-c3cc-405f-8be0-cb07d9742ca9_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_3a7b4f0d-c69c-46ff-94d1-dd75fca64233_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5f3db3bd-8e84-4bdc-8c95-e10c7c4ef763_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_193f60b7-4ec6-4c65-80c9-c00438c0c8a4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Area</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_28df4cb7-2d98-4ed7-9d7c-3a9198371b73_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_e566b55d-5a51-4b80-8d6a-c9db515f807c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_5a733474-ed61-41f4-a9fe-486b5a190205_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_afac00a5-7519-4984-87df-84678e747663_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_226c696d-5d4f-4788-ade3-301556f14010_verboseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_InterventionalMember_eb3f8b31-e4c0-4f2c-9f90-0b3adf1fd7aa_terseLabel_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional</link:label>
    <link:label id="lab_bdx_InterventionalMember_752bddfb-8a70-44fb-807a-f13481f7b148_verboseLabel_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional</link:label>
    <link:label id="lab_bdx_InterventionalMember_label_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional [Member]</link:label>
    <link:label id="lab_bdx_InterventionalMember_documentation_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember" xlink:href="bdx-20230331.xsd#bdx_InterventionalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_InterventionalMember" xlink:to="lab_bdx_InterventionalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_adedca50-3a4d-4f7e-9655-f69976bcbe52_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_b1e31450-372f-4baf-b50a-9908878190d7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_d4efd229-56fb-4d71-85ca-31cf1c9f89ec_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_baab4a7f-4325-41ee-9f83-dbe8d208cbba_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_a66b9d58-686e-48cd-9fe8-1c1675c03917_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_20918e2a-7c79-4a68-ac64-7c8fceb60de2_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_86cb31d9-ec66-4f58-badc-82d5d11f0610_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_611a7f1b-9027-4a4d-b939-dc5ea2d8c77d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_UrologyandCriticalCareMember_c9169aeb-cc0a-473a-99a9-d8c424022701_terseLabel_en-US" xlink:label="lab_bdx_UrologyandCriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology and Critical Care</link:label>
    <link:label id="lab_bdx_UrologyandCriticalCareMember_label_en-US" xlink:label="lab_bdx_UrologyandCriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology and Critical Care [Member]</link:label>
    <link:label id="lab_bdx_UrologyandCriticalCareMember_documentation_en-US" xlink:label="lab_bdx_UrologyandCriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology and Critical Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UrologyandCriticalCareMember" xlink:href="bdx-20230331.xsd#bdx_UrologyandCriticalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_UrologyandCriticalCareMember" xlink:to="lab_bdx_UrologyandCriticalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b0d724ad-ba40-401b-ba0c-3ccd3283bc3f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_dae80be6-6edc-4e49-bd34-8b23f1e8945e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_fecee36d-4a09-49b0-a1d5-8c4f66de7ab8_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_42d9df33-ec03-492f-a46e-d1039bd262b9_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_96f59ad6-aabf-4d58-acac-a7ca76fdf52a_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_89c362ab-e373-4aae-ae83-b096e84d7593_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_bb74fa27-06e9-49f6-928d-7d9b11f342dd_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_7451f203-6c89-43c3-bfed-caa0192dcf4d_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_727400fe-a435-4198-9164-0c3dafbb722b_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cbd860d9-6317-4f7f-b28b-889410908555_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to net income from continuing operations to derive net cash provided by continuing operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f525ca55-de9f-44ae-9234-6a7913cda1d5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_fa9892f3-a34b-40b2-9e32-305b8c237b1d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_029081c7-891e-478b-a57d-7e4b1114c6b2_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_9bd3102b-3551-4643-b0fc-b25e438dedc0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d01d3a6e-2c47-4fb0-b4be-6b5c405051e0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_73fe06c7-408c-496a-b9ce-34508ebde65f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in Excess&#160;of Par&#160;Value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b6b17bed-a39e-4be7-842e-176220ab8276_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_a52d1269-0d6d-45d4-9528-34c09091949d_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fb8e2d32-fa5f-4e5c-a060-87adf49feb7f_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average common and common equivalent shares outstanding - assuming dilution (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_d3803c3a-5d37-442d-bbbe-ca1643016240_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expense</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_documentation_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:to="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ed4a62b-9591-44df-b5ef-a662fa9f62af_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less allowances for depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_7e2b1601-8797-4ba8-8a71-19879bfa6747_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_0cd60c52-6122-4544-87cb-240413362647_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2bd3a236-ec99-497e-ba79-4ebf4e652c9b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables, accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_30db09ec-41d5-4168-9093-54e3270c180a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock &#8212; $1 par value; authorized &#8212; 640,000,000 shares; issued &#8212; 364,639,901 shares in March&#160;31, 2023 and September&#160;30, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1cf49b70-e234-49d4-9855-5817ed4e46ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Discontinued Operations, Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_779f637a-fdfc-4cd0-892d-3a080212c5a4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_4ff85fb2-319a-4969-8a95-8ba847cd2272_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_fb21680e-2af8-4f6f-8c10-5a79b62ef8f2_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense, net</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_documentation_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:to="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_70d9bb4d-4be7-40d2-8d4c-c45d848dedee_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1213NotesDueFebruary122036Member_9f21884e-6325-4e7d-a802-871fb6319368_terseLabel_en-US" xlink:label="lab_bdx_Notes1213NotesDueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.213% Notes due February 12, 2036</link:label>
    <link:label id="lab_bdx_Notes1213NotesDueFebruary122036Member_label_en-US" xlink:label="lab_bdx_Notes1213NotesDueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.213% Notes due February 12, 2036 [Member]</link:label>
    <link:label id="lab_bdx_Notes1213NotesDueFebruary122036Member_documentation_en-US" xlink:label="lab_bdx_Notes1213NotesDueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.213% Notes due February 12, 2036</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213NotesDueFebruary122036Member" xlink:href="bdx-20230331.xsd#bdx_Notes1213NotesDueFebruary122036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1213NotesDueFebruary122036Member" xlink:to="lab_bdx_Notes1213NotesDueFebruary122036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_15eb14e6-e65f-44fd-8875-357e94a59a38_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_f68eec08-c008-406b-9333-2751a87432cc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_c6a498b8-82e8-4347-a5fb-dd5067d26e37_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_b0185830-daf5-46fb-8420-bcf82ad511f5_terseLabel_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants</link:label>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_label_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants</link:label>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_documentation_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:href="bdx-20230331.xsd#bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:to="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_89fabc37-22b7-41ff-939e-41a1e275ce71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_11ead186-6e15-4a24-961d-605b82ae01df_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening Cash and Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0bc1638d-7200-4b69-8719-8f3932edd2ad_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing Cash and Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0a87e0f5-11e1-41da-ac1f-0e38a1294ca0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e2681aa4-2bfe-43cf-97c1-6e7959df3171_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9c9d23e5-74ea-4e55-8695-2a84f22a3461_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FixedToFloatingMember_fd9c4551-d5f4-484f-8384-cc481ec74311_terseLabel_en-US" xlink:label="lab_bdx_FixedToFloatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_bdx_FixedToFloatingMember_label_en-US" xlink:label="lab_bdx_FixedToFloatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed To Floating [Member]</link:label>
    <link:label id="lab_bdx_FixedToFloatingMember_documentation_en-US" xlink:label="lab_bdx_FixedToFloatingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed To Floating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FixedToFloatingMember" xlink:href="bdx-20230331.xsd#bdx_FixedToFloatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FixedToFloatingMember" xlink:to="lab_bdx_FixedToFloatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b497d949-359a-4445-ba2d-6ec749013375_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_8f9242bb-33eb-47b8-9a72-4ce1471ac367_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b551dff3-f275-4c8a-bb0f-74086411051c_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income applicable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d59ff649-6c80-4377-afd1-b907f2dd9002_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_ec074672-4c86-4698-8196-387435676925_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ced8b2db-0ad8-4ab1-a0cc-241389eb5576_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_b1a5861f-7734-4244-9b10-655d7d9e997c_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_632772ec-8d7c-4740-b100-7b06862b2902_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_39d3bf2a-cd5b-4159-888c-b3256c01704c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_d1de2da5-7194-45d9-8bd7-5a6e4b5e3959_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value hedges</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OrganizationalUnitAxis_9bb8e082-68c7-4847-9d84-6b78bd33ac0d_terseLabel_en-US" xlink:label="lab_bdx_OrganizationalUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Axis]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitAxis_label_en-US" xlink:label="lab_bdx_OrganizationalUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Axis]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitAxis_documentation_en-US" xlink:label="lab_bdx_OrganizationalUnitAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitAxis" xlink:href="bdx-20230331.xsd#bdx_OrganizationalUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OrganizationalUnitAxis" xlink:to="lab_bdx_OrganizationalUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_19373d4c-d9b0-4476-8171-fb795d15ab1d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.401dueMay242023Member_84a8a723-3b2d-44cf-92a1-f734a35984a6_terseLabel_en-US" xlink:label="lab_bdx_Notes1.401dueMay242023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 24, 2023</link:label>
    <link:label id="lab_bdx_Notes1.401dueMay242023Member_label_en-US" xlink:label="lab_bdx_Notes1.401dueMay242023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 24, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.401dueMay242023Member_documentation_en-US" xlink:label="lab_bdx_Notes1.401dueMay242023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 24, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member" xlink:href="bdx-20230331.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.401dueMay242023Member" xlink:to="lab_bdx_Notes1.401dueMay242023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6c87b81a-dfcc-4628-a17c-1abd7d575a74_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss) Income, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_330c379e-8bbe-4c2c-b6d6-32b96400a4e7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_552fef36-25a6-4329-94a5-9399c669b150_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Continuing Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_cedc8799-a310-40a3-bc2d-e2d831c3d4e2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used for Continuing Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ea4d3c1c-781e-434d-b680-c23e9705eea2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Information for Company's Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_1e3d43be-0df5-43d9-9c08-ea13e06d35d1_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operation, Consideration, Cash</link:label>
    <link:label id="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_label_en-US" xlink:label="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operation, Consideration, Cash</link:label>
    <link:label id="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_documentation_en-US" xlink:label="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operation, Consideration, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:to="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e03efec0-9287-41e4-ae0b-01787a9810fa_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce1b3593-c6ea-4f00-95bb-ac3db1141193_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact_9324ae39-c134-4336-8e4c-1d0c11e60e2f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Dividends, Income Statement Impact</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_0c200f1c-2d84-43aa-b10d-0bd950fe3301_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0000DueAugust132023Member_7c165cdf-35c4-417f-9073-3fff788b3471_terseLabel_en-US" xlink:label="lab_bdx_Notes0000DueAugust132023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.000% due August 13, 2023</link:label>
    <link:label id="lab_bdx_Notes0000DueAugust132023Member_label_en-US" xlink:label="lab_bdx_Notes0000DueAugust132023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.000% due August 13, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes0000DueAugust132023Member_documentation_en-US" xlink:label="lab_bdx_Notes0000DueAugust132023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.000% due August 13, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member" xlink:href="bdx-20230331.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0000DueAugust132023Member" xlink:to="lab_bdx_Notes0000DueAugust132023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_b1858cf9-6ae8-44f4-bb7d-31dc3af458a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Discontinued Operations, Net of Tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_8fabb002-64ec-4a99-9e66-2e266e5a937f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Discontinued Operations, Net of Tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_5e698a84-d20c-44dc-8235-aa9d1e288151_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_506b5e1b-8d5e-48c8-8d62-0caaeee74df8_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_5f2d84eb-7237-4faa-840b-70b5e684ec10_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_ce869479-64b2-45fa-b6a4-804170591809_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Termination</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9b880fcb-cc5e-40d9-ba48-1d5761e200f9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_062894d7-20c2-4696-b13e-8eaee7c9c7a7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc0bf021-e4f7-40a2-bda7-8c70c23e6468_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ed6d2863-4edf-4f38-8220-17ff52a1302e_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_678e9384-d1fd-4b0c-8c1d-b1f5b5dbbd21_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_6c474386-e863-464a-9646-33af652821d4_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_23eeafdf-6354-48d5-a1d4-803e6e23ffab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod_810d0f00-7907-480e-8b53-9d2c60682015_terseLabel_en-US" xlink:label="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables transferred to third parties under factoring arrangements</link:label>
    <link:label id="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod_label_en-US" xlink:label="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers of financial assets during the period.</link:label>
    <link:label id="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod_documentation_en-US" xlink:label="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers of financial assets during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:href="bdx-20230331.xsd#bdx_TransfersOfFinancialAssetsDuringThePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:to="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_ce6f4bad-b4b3-4e71-b291-ad923651985b_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7b853d9e-1153-4323-bbb2-5585c2547256_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension and postretirement plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_d7ff5a57-8830-4bb9-be3c-b6d7fe59818a_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MedicationManagementSolutionsMember_cafaa875-dc35-48b0-98db-63fd040fadbc_terseLabel_en-US" xlink:label="lab_bdx_MedicationManagementSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Management Solutions</link:label>
    <link:label id="lab_bdx_MedicationManagementSolutionsMember_label_en-US" xlink:label="lab_bdx_MedicationManagementSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Management Solutions [Member]</link:label>
    <link:label id="lab_bdx_MedicationManagementSolutionsMember_documentation_en-US" xlink:label="lab_bdx_MedicationManagementSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Management Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationManagementSolutionsMember" xlink:href="bdx-20230331.xsd#bdx_MedicationManagementSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MedicationManagementSolutionsMember" xlink:to="lab_bdx_MedicationManagementSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_a5d4ddc6-62d7-42ab-a941-60f06b968a93_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation, Share-Based Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:to="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_854504e8-e7a1-4722-89ca-3f72666c0e22_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b17ed23d-53e5-4008-bcec-7e17ee7961f3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_fdb32615-2189-47d9-8789-c2df6f48a143_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_58353d4c-1a18-4be6-9973-8e81aa0ac088_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_TerminatedCurrencySwapMember_d8f6181a-fb31-49fa-9bf2-fc04d21568fe_terseLabel_en-US" xlink:label="lab_bdx_TerminatedCurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Currency Swap</link:label>
    <link:label id="lab_bdx_TerminatedCurrencySwapMember_label_en-US" xlink:label="lab_bdx_TerminatedCurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Currency Swap [Member]</link:label>
    <link:label id="lab_bdx_TerminatedCurrencySwapMember_documentation_en-US" xlink:label="lab_bdx_TerminatedCurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Currency Swap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TerminatedCurrencySwapMember" xlink:href="bdx-20230331.xsd#bdx_TerminatedCurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_TerminatedCurrencySwapMember" xlink:to="lab_bdx_TerminatedCurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_7b62149e-b526-41b0-ba5d-9cb26d8aff6a_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_72917b3f-da00-4fbd-b2ca-51c077c81aa0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dc5b1927-3719-444e-94eb-2cf9b5041af3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a62a90d3-b1d4-44b2-bb94-f9859a4f7063_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_68a629e8-3ba4-466e-8542-1931aba949b2_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_f6e6a218-57b6-4f60-9278-285ed7678fad_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_99b60679-98eb-4f00-bb0a-e1e5c216c756_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_48d37f3a-d261-4e86-a880-2f6498cebb27_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f9742453-fc5e-4c06-bd3c-5e904b051a5e_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_668a8f28-72ca-4589-b206-1ee9b8f0004d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_3d0a250f-db23-499f-ae59-b3f22f438295_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_66741b9f-2cfc-448b-9b87-380174c0a2da_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_27009fbc-bb2e-4180-af63-1230e4b58772_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_92251ad7-c72a-476a-8972-fdd217b28915_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_2ded86e3-a084-417c-969f-ee4e5cb3b764_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Pension and Postretirement Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_cac72147-4a89-46d7-8c28-242211fb3067_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per Common Share (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_4a041d39-2eac-4a72-92a6-1376e6c64288_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_c5fc5002-e8f2-401d-a95e-684a10fe22cf_terseLabel_en-US" xlink:label="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized to be repurchased (in shares)</link:label>
    <link:label id="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_documentation_en-US" xlink:label="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:href="bdx-20230331.xsd#bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:to="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_f901303a-bbe0-4e0d-bcaf-db01f9d80a73_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction (in years)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CommonStockHeldInTrustsAcquired_2507d8d7-7084-4c6f-bbda-f52d47817a7f_terseLabel_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock held in trusts, net</link:label>
    <link:label id="lab_bdx_CommonStockHeldInTrustsAcquired_label_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Held in Trusts, Acquired</link:label>
    <link:label id="lab_bdx_CommonStockHeldInTrustsAcquired_documentation_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Held in Trusts, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsAcquired" xlink:href="bdx-20230331.xsd#bdx_CommonStockHeldInTrustsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CommonStockHeldInTrustsAcquired" xlink:to="lab_bdx_CommonStockHeldInTrustsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_6d3768f7-65bb-4083-9757-b856b6661a5a_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_64edd2f6-beb0-4c00-a92b-529e861bfdc0_totalLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Discontinued Operations Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_97cde043-e45e-484a-b283-3f28309b95ef_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_974c6b94-351c-4f21-9d1a-9ea67d5fb55d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6dbd9f72-cc6d-4d16-a5e8-22ccd20ac601_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_f91faff1-f239-460c-9cd2-46343fe56e14_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_6e0965d3-6bef-40d5-82ef-e30238dee4b9_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Financing Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_489e0fe7-d238-4393-bceb-b755b2257f95_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4afe1c10-13aa-4102-b0ca-7614d5694f71_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for share-based compensation and other plans, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_4f771abb-bfb9-4205-98ae-4ee138da4311_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Data</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_124a46a9-0e1c-4be3-95bb-ab98f58f4c0e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a27fe118-9787-447c-91bc-c87c126d1d15_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_d13ec803-4359-41b6-84c2-bac08675123b_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC.</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f78e8cc7-96af-4697-97f3-5b8f311a4fa0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_d78a9db7-c0a2-4397-a33a-ee96eda35f24_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_20fb9397-622f-4b85-9b63-f0dd9775498a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to expense</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_18739383-5eb6-4cd7-8862-0df1ac92a8e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Continuing Operations, Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_50255222-0515-47e2-beb1-270a761e64ae_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_dacd55e1-0966-46df-afc7-c50e883b8279_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_53439c48-98e6-4f16-8ef2-3d0f1ab16ba2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average common shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_aeefba69-bbb0-4d7c-be76-3abeb9fca9c2_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_168e45e7-bd48-4a65-b10c-42fffcf60029_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_a5363d3d-96e7-487e-99ea-66c7b53c2ed3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_0507eb5c-aa81-48e1-8578-ae7dfc9df3a7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (See Note 5)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_65b91fe7-16e2-4f6b-96ac-6ab0dd16125b_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_4e375764-9e2b-4bc2-a00b-94c507c868b1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_9c4049e9-60c1-4104-b69f-5653609c92ad_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_5de347e0-7803-416a-b3ef-4bfe57d04be5_terseLabel_en-US" xlink:label="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_label_en-US" xlink:label="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Debt Classified From Long Term To Short Term</link:label>
    <link:label id="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_documentation_en-US" xlink:label="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Debt Classified From Long Term To Short Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:href="bdx-20230331.xsd#bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:to="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_e7281ac1-9e21-492f-b689-9b5c82a554e6_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_bcebf84f-678a-471e-afc0-d8d241e1c430_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_05b0dd01-14aa-47cd-9e0b-a59a6f918aa0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_ac7e5cdc-8f81-4ffa-9e89-c21d7a851b9a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_47e9a0e6-54bb-4048-90d5-379b5dab5519_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_9d47a651-6556-446d-8a84-013368a66ab4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d45711e7-ac6c-4ed7-8705-18c5feda9de7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_bad02858-5a5b-46be-9ebd-7b3a7f2748dc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd76387e-cf46-49be-8b33-20f8f4707c24_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_2763212f-bef2-4aa1-b650-26f1ed96cd17_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_56d33b5f-8dea-4f45-81b9-f60a0184aa5c_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive share equivalents from Series C preferred shares (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_0faf14f8-9b66-473b-9a0d-ca0ffb7888a4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c07d21df-551d-4b17-a969-d82f3b082f5a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_dcdf9877-e3fb-4dc1-a4ba-f63905a51f35_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net interest expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d41fa0f2-1c0c-4c79-99ea-c5bef4f70c0a_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_be990581-c635-449a-af93-4df42b65ce71_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_c845ce00-0336-4a6c-860e-caffddcc1921_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_IncreaseDecreaseinPensionBenefitObligation_006ad493-4611-49d9-84de-fe92ead8630a_terseLabel_en-US" xlink:label="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension obligation</link:label>
    <link:label id="lab_bdx_IncreaseDecreaseinPensionBenefitObligation_label_en-US" xlink:label="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Pension Benefit Obligation</link:label>
    <link:label id="lab_bdx_IncreaseDecreaseinPensionBenefitObligation_documentation_en-US" xlink:label="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in obligation for pension benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:href="bdx-20230331.xsd#bdx_IncreaseDecreaseinPensionBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:to="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_68c1084a-ae02-4334-b3a7-a267fb3ee546_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f16d5d63-a867-4e42-b8fc-78ef90366012_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_c13d1ed5-1c29-422e-b835-bdd54eb7acc8_terseLabel_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.034% due August 13, 2025</link:label>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_label_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.034% due August 13, 2025 [Member]</link:label>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_documentation_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.034% due August 13, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member" xlink:href="bdx-20230331.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0034DueAugust132025Member" xlink:to="lab_bdx_Notes0034DueAugust132025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3f4e21a1-d3dd-4996-9c88-3f5dfcd9d09d_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_51be5fc2-f197-4733-a80a-9058ad33e56b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4c8e18a0-fea5-42da-acea-79ebf62cbcaa_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_21ba48d4-74ec-47cc-97fe-e383f5a0fcc1_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted Earnings per Share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_106042b3-67a2-4aaf-916a-6269802cce01_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_26a6c8e9-2c74-4cbb-bba6-50c1eab44f1c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_cadfc8e2-84aa-4d62-9662-0328a67a0880_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_06516a56-fb9b-4717-bc1d-060cf4d74711_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (a)</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_26413771-1536-488f-99e7-5041d3829913_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_6d598319-cf29-47cf-af3f-4e8a21320b0a_terseLabel_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, trademarks and other</link:label>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_label_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntellectualPropertyMember" xlink:to="lab_us-gaap_IntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_ba286285-267c-4672-8d35-da0621e46b93_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_a8a94245-8e14-4834-845b-9996ff59627d_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Investments, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_b78b439a-8478-429e-9a6b-3c2b56105a47_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_b070a8a4-d4b6-45ee-9929-d697998fd7c6_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-Off of Embecta Corp.</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_1dafb902-51f8-4db1-ad3e-9ae593c32fa4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3ec43e0f-24b2-45e6-ae66-7125afa94001_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_43c936ed-8ac4-42ce-a94d-141a0089b9fc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_2cdd72c0-a247-4f96-9c59-b5c2f7b4fd45_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_7f9fd9bb-1e08-48fb-b82d-f4aa2ff70a0a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in short-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_2c394fc8-c1b5-4cb7-9aec-cb1f42174635_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_3ae461ca-80a4-4af0-82b3-ce4c85b11800_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e430e495-bb75-4333-b965-3b796f15467a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_ef76a65d-1735-45c9-bc3f-b0f549c92607_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ba155690-43be-40c1-aef0-cc25f1ffb653_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_2cdfe94e-f266-4636-afe9-e5dd50aa1844_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_79bce94b-35b6-44f6-b91f-b30569d857c9_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_f1644c9d-22bc-49ca-af7d-eb501cebfcfb_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_b853e414-2523-453f-88b4-eb8e92544d7d_terseLabel_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:href="bdx-20230331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_18f3b3fd-04ff-4c15-801d-ba76ce02cc54_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Expense</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_29758e89-7f29-4dcc-8052-89b71f0ef383_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PeripheralInterventionMember_ff7d12e3-a2a8-4575-a83e-f96818d9d6ed_terseLabel_en-US" xlink:label="lab_bdx_PeripheralInterventionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Intervention</link:label>
    <link:label id="lab_bdx_PeripheralInterventionMember_label_en-US" xlink:label="lab_bdx_PeripheralInterventionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Intervention [Member]</link:label>
    <link:label id="lab_bdx_PeripheralInterventionMember_documentation_en-US" xlink:label="lab_bdx_PeripheralInterventionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Intervention [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PeripheralInterventionMember" xlink:href="bdx-20230331.xsd#bdx_PeripheralInterventionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PeripheralInterventionMember" xlink:to="lab_bdx_PeripheralInterventionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_IntegratedDiagnosticSolutionsMember_de0c0cd3-cab0-4b87-9314-d7c6a9c1c94a_terseLabel_en-US" xlink:label="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Diagnostic Solutions</link:label>
    <link:label id="lab_bdx_IntegratedDiagnosticSolutionsMember_label_en-US" xlink:label="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Diagnostic Solutions [Member]</link:label>
    <link:label id="lab_bdx_IntegratedDiagnosticSolutionsMember_documentation_en-US" xlink:label="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Diagnostic Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IntegratedDiagnosticSolutionsMember" xlink:href="bdx-20230331.xsd#bdx_IntegratedDiagnosticSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_IntegratedDiagnosticSolutionsMember" xlink:to="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_0e80b0a3-7d2f-469d-9fe6-b00289fbec1a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MaturityPeriodOfShortTermInvestment_ed9eadda-fa91-43c7-b054-27a92d1defa6_terseLabel_en-US" xlink:label="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity period of short-term investments at the time of purchase</link:label>
    <link:label id="lab_bdx_MaturityPeriodOfShortTermInvestment_label_en-US" xlink:label="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Period Of Short Term Investment</link:label>
    <link:label id="lab_bdx_MaturityPeriodOfShortTermInvestment_documentation_en-US" xlink:label="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MaturityPeriodOfShortTermInvestment" xlink:href="bdx-20230331.xsd#bdx_MaturityPeriodOfShortTermInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MaturityPeriodOfShortTermInvestment" xlink:to="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_93eb7668-436e-4af7-8aa0-06419393da58_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Swaps</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_311de8cf-61e1-4b63-9694-d0192ad027fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_LifeSciencesMember_9eeb5648-b5af-41d1-a070-36b5b27d03aa_terseLabel_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences</link:label>
    <link:label id="lab_bdx_LifeSciencesMember_3e1e3578-7749-4f58-84f6-bedc90aa35f7_verboseLabel_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life&#160;Sciences</link:label>
    <link:label id="lab_bdx_LifeSciencesMember_label_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences [Member]</link:label>
    <link:label id="lab_bdx_LifeSciencesMember_documentation_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember" xlink:href="bdx-20230331.xsd#bdx_LifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_LifeSciencesMember" xlink:to="lab_bdx_LifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64fdd533-aff5-4325-a2a8-ff5ccd681e88_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_45378bfc-f777-44b1-9f38-89b036430429_terseLabel_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.020% due May 24, 2025</link:label>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_label_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.020% due May 24, 2025 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_documentation_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.020% due May 24, 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member" xlink:href="bdx-20230331.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.020dueMay242025Member" xlink:to="lab_bdx_Notes3.020dueMay242025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_0173099e-7a22-460b-b312-6abf502e9ddd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restructuring Accrual Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a84a1127-72e9-4252-97cc-c7887db82ad5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive share equivalents from share-based plans (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_92572320-adc5-4b68-b509-70127785b594_terseLabel_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in-process research and development</link:label>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unclassified Indefinite-Lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_800e50ec-9c6c-4221-940a-63afd5731b91_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangibles, Net</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsNet" xlink:to="lab_us-gaap_OtherIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CoreAndDevelopedTechnologyNet_493ba0a2-b12b-4a69-b44e-275a23b74156_terseLabel_en-US" xlink:label="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology, Net</link:label>
    <link:label id="lab_bdx_CoreAndDevelopedTechnologyNet_label_en-US" xlink:label="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core And Developed Technology Net</link:label>
    <link:label id="lab_bdx_CoreAndDevelopedTechnologyNet_documentation_en-US" xlink:label="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets arising from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreAndDevelopedTechnologyNet" xlink:href="bdx-20230331.xsd#bdx_CoreAndDevelopedTechnologyNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CoreAndDevelopedTechnologyNet" xlink:to="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0528ba7c-7f83-44d9-b6fb-b9b2090083fd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_46c4a0f9-9038-4336-a11e-a2a9f7f3148a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_71c7d50a-df70-4972-b394-16f45e107d01_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bba980c3-c9fd-41eb-a9df-c452d37c29d0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_GwinnettCountyGeorgiaMember_76de2ded-cb80-4285-babc-2a866b025ffc_terseLabel_en-US" xlink:label="lab_bdx_GwinnettCountyGeorgiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gwinnett County, Georgia</link:label>
    <link:label id="lab_bdx_GwinnettCountyGeorgiaMember_label_en-US" xlink:label="lab_bdx_GwinnettCountyGeorgiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gwinnett County, Georgia [Member]</link:label>
    <link:label id="lab_bdx_GwinnettCountyGeorgiaMember_documentation_en-US" xlink:label="lab_bdx_GwinnettCountyGeorgiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gwinnett County, Georgia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GwinnettCountyGeorgiaMember" xlink:href="bdx-20230331.xsd#bdx_GwinnettCountyGeorgiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_GwinnettCountyGeorgiaMember" xlink:to="lab_bdx_GwinnettCountyGeorgiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_42120550-4888-4ee1-8761-ac7ec51c3da1_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized to be repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_6953e1eb-c30f-4d1f-9376-0e2d80208bb6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7300039b-5069-4726-8cc2-18c83b72d080_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_fa0ebfa4-20a2-4edf-9135-951ae88fddb0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_96ba73e8-f478-44d9-92e4-7afabb20ccb7_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_69494aac-8b52-4e93-beff-f1f8f69624fe_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtMember_37c76778-329a-4290-b240-7e9b62dd1886_terseLabel_en-US" xlink:label="lab_us-gaap_DebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency-Denominated Debt</link:label>
    <link:label id="lab_us-gaap_DebtMember_label_en-US" xlink:label="lab_us-gaap_DebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtMember" xlink:to="lab_us-gaap_DebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_BiosciencesMember_81823109-5df1-4bc6-a0bf-3ea9429eb8ef_terseLabel_en-US" xlink:label="lab_bdx_BiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosciences</link:label>
    <link:label id="lab_bdx_BiosciencesMember_label_en-US" xlink:label="lab_bdx_BiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosciences [Member]</link:label>
    <link:label id="lab_bdx_BiosciencesMember_documentation_en-US" xlink:label="lab_bdx_BiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BiosciencesMember" xlink:href="bdx-20230331.xsd#bdx_BiosciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_BiosciencesMember" xlink:to="lab_bdx_BiosciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRecallExpense_816d373f-a720-4330-879a-8b66c3fce4e4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:label id="lab_us-gaap_InventoryRecallExpense_label_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRecallExpense" xlink:to="lab_us-gaap_InventoryRecallExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a5c48dc7-d003-44c5-acaf-aca4e569c7c6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableFairValueDisclosure_7bebee32-dd51-4a90-be88-0c22d6357760_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LoansPayableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableFairValueDisclosure" xlink:to="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_8ec76178-9206-4ef3-986e-0b5fc36914a2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_e4d558d4-8123-4b50-b7bb-0be79a7c6a49_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_9e4b33ad-2ab8-4779-a949-67b8804d3be2_verboseLabel_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration and restructuring expense</link:label>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_86684ea0-220e-4595-a988-9a938d625a00_negatedLabel_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration and restructuring expense</link:label>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_label_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Costs And Restructuring Charges</link:label>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_documentation_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:href="bdx-20230331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:to="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_8c2f0334-9afc-432b-aba7-47b86842cd1d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_236b9bd7-39e5-4845-97e0-4c3a923c75c5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d855dde7-ff7d-4c4c-9902-a95c3a1ec131_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_122a5f48-d1cb-4984-8143-de9405ea717a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>bdx-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c18e2de7-cbd8-4499-b946-e1533dbcca3e,g:06687f9f-d051-4540-9898-7752ada2060d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bd.com/role/CoverPage" xlink:type="simple" xlink:href="bdx-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_760d0bb9-f76e-449f-a9e9-8cb5437b3aeb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_3aa2b0d3-facf-4485-8e16-bd43670fd637" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_760d0bb9-f76e-449f-a9e9-8cb5437b3aeb" xlink:to="loc_dei_EntitiesTable_3aa2b0d3-facf-4485-8e16-bd43670fd637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b901a231-78d3-4579-8a83-f55305969c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_3aa2b0d3-facf-4485-8e16-bd43670fd637" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b901a231-78d3-4579-8a83-f55305969c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b901a231-78d3-4579-8a83-f55305969c8a" xlink:to="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9c6fa71a-ae96-4c2b-8252-4660e5835822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_us-gaap_CommonStockMember_9c6fa71a-ae96-4c2b-8252-4660e5835822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_988f9290-f8e8-4ab4-b1b7-b03cd72e0878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_988f9290-f8e8-4ab4-b1b7-b03cd72e0878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member_a165ee50-ce40-4486-9e2f-481f4f722a35" xlink:href="bdx-20230331.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes1.900dueDecember152026Member_a165ee50-ce40-4486-9e2f-481f4f722a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member_67672bb9-02f9-4fab-bd82-a452311caaf5" xlink:href="bdx-20230331.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes1.401dueMay242023Member_67672bb9-02f9-4fab-bd82-a452311caaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member_cd652c19-0910-489e-a759-0b56dd10eb4e" xlink:href="bdx-20230331.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes3.020dueMay242025Member_cd652c19-0910-489e-a759-0b56dd10eb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member_b7578ca4-1d9b-4f9d-82bd-344111649970" xlink:href="bdx-20230331.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes0.632dueJune42023Member_b7578ca4-1d9b-4f9d-82bd-344111649970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member_b02b34a4-22a3-4a25-a4e7-997d7580b7d5" xlink:href="bdx-20230331.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes1.208dueJune42026Member_b02b34a4-22a3-4a25-a4e7-997d7580b7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213NotesDueFebruary122036Member_93d237de-68ec-4086-bef4-23f6e01d6e77" xlink:href="bdx-20230331.xsd#bdx_Notes1213NotesDueFebruary122036Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes1213NotesDueFebruary122036Member_93d237de-68ec-4086-bef4-23f6e01d6e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_d06e4d64-bdc1-49be-b24d-918999774d45" xlink:href="bdx-20230331.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes0000DueAugust132023Member_d06e4d64-bdc1-49be-b24d-918999774d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_9cd45965-2ff3-4f3e-9f32-0b07379e7fbc" xlink:href="bdx-20230331.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_616096b0-562d-4ea2-b83e-523dd36f21d1" xlink:to="loc_bdx_Notes0034DueAugust132025Member_9cd45965-2ff3-4f3e-9f32-0b07379e7fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_f7b1d203-51bc-4531-b830-48640ba0d0b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_3aa2b0d3-facf-4485-8e16-bd43670fd637" xlink:to="loc_dei_EntityListingsExchangeAxis_f7b1d203-51bc-4531-b830-48640ba0d0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_0086e526-88bb-4206-8fb7-3dd471b8ab6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_f7b1d203-51bc-4531-b830-48640ba0d0b1" xlink:to="loc_dei_ExchangeDomain_0086e526-88bb-4206-8fb7-3dd471b8ab6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_ac060622-4b42-415d-8df1-4fbec05b5114" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_0086e526-88bb-4206-8fb7-3dd471b8ab6f" xlink:to="loc_exch_XNYS_ac060622-4b42-415d-8df1-4fbec05b5114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_3aa2b0d3-facf-4485-8e16-bd43670fd637" xlink:to="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_0cbbdfd1-d37c-419b-86b6-3e75ab33daa7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentType_0cbbdfd1-d37c-419b-86b6-3e75ab33daa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_c18057f5-e54d-4e83-9589-432c14d7feba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentQuarterlyReport_c18057f5-e54d-4e83-9589-432c14d7feba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f861cf68-d3b3-4505-b749-9d98f12c99a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentPeriodEndDate_f861cf68-d3b3-4505-b749-9d98f12c99a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_54e2c0f4-ba16-4025-be41-e63c49209260" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentTransitionReport_54e2c0f4-ba16-4025-be41-e63c49209260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d8b50061-0acb-41e1-a2f8-f69d09c08fbf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityFileNumber_d8b50061-0acb-41e1-a2f8-f69d09c08fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_54d46bad-0e24-49e3-a072-c280da164b38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityRegistrantName_54d46bad-0e24-49e3-a072-c280da164b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_45318d18-ed8e-4e25-9c42-629f3a2c6731" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityIncorporationStateCountryCode_45318d18-ed8e-4e25-9c42-629f3a2c6731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9818ad56-0e78-496a-8679-d04c11685515" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityTaxIdentificationNumber_9818ad56-0e78-496a-8679-d04c11685515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7fda6ce7-1ff8-439b-bf1c-07b7e9996e61" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityAddressAddressLine1_7fda6ce7-1ff8-439b-bf1c-07b7e9996e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c4c02d88-8c9e-4507-8236-f1335341df0e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityAddressCityOrTown_c4c02d88-8c9e-4507-8236-f1335341df0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f2e4a42a-c45d-4614-84b5-3df9e1011081" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityAddressStateOrProvince_f2e4a42a-c45d-4614-84b5-3df9e1011081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_0abadfb0-789a-499c-91a8-b1fee48c056a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityAddressPostalZipCode_0abadfb0-789a-499c-91a8-b1fee48c056a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ee66d712-e855-435e-8632-ec4bc9080b15" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_CityAreaCode_ee66d712-e855-435e-8632-ec4bc9080b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_405d9d1b-c898-4aae-8396-abbee40adad0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_LocalPhoneNumber_405d9d1b-c898-4aae-8396-abbee40adad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_08926cdd-0bbe-4f58-8f47-1543290e2f7e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_Security12bTitle_08926cdd-0bbe-4f58-8f47-1543290e2f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_73412947-1009-4dbc-b567-5a4b265072c9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_TradingSymbol_73412947-1009-4dbc-b567-5a4b265072c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fff33a09-176b-4224-b201-69ee6532a5ee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_SecurityExchangeName_fff33a09-176b-4224-b201-69ee6532a5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_077dc0b0-d186-4e7e-9391-263310e0ddc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityCurrentReportingStatus_077dc0b0-d186-4e7e-9391-263310e0ddc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9c0ff051-e760-4def-8625-41530b9c6e76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityInteractiveDataCurrent_9c0ff051-e760-4def-8625-41530b9c6e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_72152015-d080-40d0-ad18-8bb66d4090b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityFilerCategory_72152015-d080-40d0-ad18-8bb66d4090b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f1be3f4b-be5e-471c-bcee-482bf49f732d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntitySmallBusiness_f1be3f4b-be5e-471c-bcee-482bf49f732d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ba9e8bd0-df93-4418-abf9-d907c2c105da" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityEmergingGrowthCompany_ba9e8bd0-df93-4418-abf9-d907c2c105da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9d6048c3-9ec0-4426-b49b-1d8fff70027c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityShellCompany_9d6048c3-9ec0-4426-b49b-1d8fff70027c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_21d25d76-03c7-4a9e-9b09-279cc2b7acae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_21d25d76-03c7-4a9e-9b09-279cc2b7acae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7370a4c4-6b71-4e03-8198-55c17ceabc17" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_EntityCentralIndexKey_7370a4c4-6b71-4e03-8198-55c17ceabc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_613c27cb-2f75-4503-a579-24538d799289" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_CurrentFiscalYearEndDate_613c27cb-2f75-4503-a579-24538d799289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e9cb2719-858d-4e9e-8b02-ad4671d1e9d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentFiscalYearFocus_e9cb2719-858d-4e9e-8b02-ad4671d1e9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_5f0f28b6-9dd8-4b31-b95c-8a9d19d309fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_DocumentFiscalPeriodFocus_5f0f28b6-9dd8-4b31-b95c-8a9d19d309fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_377a8d17-98cb-4049-b345-6ce44bdb3e0e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e325507c-4983-4e4d-8025-5499f1035372" xlink:to="loc_dei_AmendmentFlag_377a8d17-98cb-4049-b345-6ce44bdb3e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="bdx-20230331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c1e0cf22-a9b8-484d-b2de-5be9d5931e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_Revenues_c1e0cf22-a9b8-484d-b2de-5be9d5931e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f539d4fa-905e-45e7-9691-1539aab9f061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f539d4fa-905e-45e7-9691-1539aab9f061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2109667d-deaf-4a7b-9425-975ac19d4b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2109667d-deaf-4a7b-9425-975ac19d4b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d8e60e80-3083-4d02-9322-518893cc7766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d8e60e80-3083-4d02-9322-518893cc7766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_41441f9a-b0e3-4cf7-a6b6-7f4dd7c0dc1c" xlink:href="bdx-20230331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_41441f9a-b0e3-4cf7-a6b6-7f4dd7c0dc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_dfd1df34-12c1-41f2-9183-25378c55b1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_dfd1df34-12c1-41f2-9183-25378c55b1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_1cf2f908-215e-4bfc-a3ec-4b8035c6c26f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_CostsAndExpenses_1cf2f908-215e-4bfc-a3ec-4b8035c6c26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_269c010d-5e78-4246-a75d-e2a1365c652e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_OperatingIncomeLoss_269c010d-5e78-4246-a75d-e2a1365c652e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_35874dcf-41bc-4efb-90d8-8c453915ed47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_InterestExpense_35874dcf-41bc-4efb-90d8-8c453915ed47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_169df940-ca8d-4480-8eac-eeac499648a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_InvestmentIncomeInterest_169df940-ca8d-4480-8eac-eeac499648a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5de32d94-8d55-4f6b-a94e-c40eed567b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5de32d94-8d55-4f6b-a94e-c40eed567b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_33aefdff-f004-4e4f-9392-207ba5bc3c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_33aefdff-f004-4e4f-9392-207ba5bc3c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f9b60a5f-5a11-4a2b-afb5-f1164791bee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f9b60a5f-5a11-4a2b-afb5-f1164791bee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_bd15e290-ef05-4aa4-9cd7-97f6a7cd3877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_bd15e290-ef05-4aa4-9cd7-97f6a7cd3877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_27f85257-1539-4421-821d-ae80f221a458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_27f85257-1539-4421-821d-ae80f221a458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_929524d6-8365-40af-bb52-6c51f1acabc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_NetIncomeLoss_929524d6-8365-40af-bb52-6c51f1acabc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_4f068606-9f26-4cbd-bc2e-ccc1384c20c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_4f068606-9f26-4cbd-bc2e-ccc1384c20c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0e6a27f5-81ee-476a-aaf7-bcd0a5225563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0e6a27f5-81ee-476a-aaf7-bcd0a5225563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_375b83d8-726d-4d76-888f-0c0f589cdc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_375b83d8-726d-4d76-888f-0c0f589cdc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_4b45c5f5-4ff5-436c-9d6d-97a60b93a6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_4b45c5f5-4ff5-436c-9d6d-97a60b93a6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3e004db5-a87b-4954-a1bc-7582428341fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_EarningsPerShareBasic_3e004db5-a87b-4954-a1bc-7582428341fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_f9ced2d5-c162-49ba-a954-9e71af434dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_f9ced2d5-c162-49ba-a954-9e71af434dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_cdf620cb-228d-4b34-9bb8-bf802151718a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_cdf620cb-228d-4b34-9bb8-bf802151718a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c74a843f-9862-4926-bb8c-e6c8693f735d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c74a843f-9862-4926-bb8c-e6c8693f735d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1ef23cab-2586-4ffb-950a-51f7c66b399e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93e6f414-2c1e-4d39-8cbd-6f2290a584f1" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1ef23cab-2586-4ffb-950a-51f7c66b399e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="bdx-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_826c547a-344f-4e4c-842c-87ee0a04de81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_84371d17-2aed-4033-a518-1a7c2184874c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_826c547a-344f-4e4c-842c-87ee0a04de81" xlink:to="loc_us-gaap_NetIncomeLoss_84371d17-2aed-4033-a518-1a7c2184874c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da1501c4-1681-4d59-9cf3-5a7b8e5389c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_826c547a-344f-4e4c-842c-87ee0a04de81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da1501c4-1681-4d59-9cf3-5a7b8e5389c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c6627785-985d-483f-9d91-3e37d7ccd90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da1501c4-1681-4d59-9cf3-5a7b8e5389c5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c6627785-985d-483f-9d91-3e37d7ccd90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ba1f16f4-07ab-4fe2-a1f6-80b211e1e788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da1501c4-1681-4d59-9cf3-5a7b8e5389c5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ba1f16f4-07ab-4fe2-a1f6-80b211e1e788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_deac42c9-92ff-4a62-91ff-13469c272b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da1501c4-1681-4d59-9cf3-5a7b8e5389c5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_deac42c9-92ff-4a62-91ff-13469c272b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0b971b4d-560c-4b6b-942e-9b7aa123a0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da1501c4-1681-4d59-9cf3-5a7b8e5389c5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0b971b4d-560c-4b6b-942e-9b7aa123a0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4d55786-8902-419b-80ce-ffee89886926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_826c547a-344f-4e4c-842c-87ee0a04de81" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4d55786-8902-419b-80ce-ffee89886926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bdx-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_176bf785-eb1d-48ea-b992-49ac190e746f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_176bf785-eb1d-48ea-b992-49ac190e746f" xlink:to="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_cf37bdfc-eb36-4bb5-90eb-6a39b288252c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:to="loc_us-gaap_AssetsCurrentAbstract_cf37bdfc-eb36-4bb5-90eb-6a39b288252c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f23abbec-d30b-405c-8ef7-0d45143a5e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cf37bdfc-eb36-4bb5-90eb-6a39b288252c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f23abbec-d30b-405c-8ef7-0d45143a5e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_06dfffe0-1a24-49ab-91e3-8c06a1858c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cf37bdfc-eb36-4bb5-90eb-6a39b288252c" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_06dfffe0-1a24-49ab-91e3-8c06a1858c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments_4cb58d0e-ff1a-4802-bff2-edaef2b63f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cf37bdfc-eb36-4bb5-90eb-6a39b288252c" xlink:to="loc_us-gaap_OtherShortTermInvestments_4cb58d0e-ff1a-4802-bff2-edaef2b63f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8f9f952a-d91f-451e-b2fb-8913e7da90ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cf37bdfc-eb36-4bb5-90eb-6a39b288252c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8f9f952a-d91f-451e-b2fb-8913e7da90ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_bb35cfdb-2036-49e9-b955-dc2f7a5459e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cf37bdfc-eb36-4bb5-90eb-6a39b288252c" xlink:to="loc_us-gaap_InventoryNetAbstract_bb35cfdb-2036-49e9-b955-dc2f7a5459e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_96bd820b-789f-470e-8f62-f53942b3c3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_bb35cfdb-2036-49e9-b955-dc2f7a5459e7" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_96bd820b-789f-470e-8f62-f53942b3c3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_040f61f9-ef66-476b-b174-074e922304d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_bb35cfdb-2036-49e9-b955-dc2f7a5459e7" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_040f61f9-ef66-476b-b174-074e922304d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_97e6bfc8-f8d1-402b-bc1c-29f54c68383a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_bb35cfdb-2036-49e9-b955-dc2f7a5459e7" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_97e6bfc8-f8d1-402b-bc1c-29f54c68383a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_712198d4-4c17-4ed8-9ce8-856a84eea1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_bb35cfdb-2036-49e9-b955-dc2f7a5459e7" xlink:to="loc_us-gaap_InventoryNet_712198d4-4c17-4ed8-9ce8-856a84eea1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_5ed68705-c217-4c7c-98ca-cdf067c563a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cf37bdfc-eb36-4bb5-90eb-6a39b288252c" xlink:to="loc_us-gaap_OtherAssetsCurrent_5ed68705-c217-4c7c-98ca-cdf067c563a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d3dc8bc4-d700-44f4-af14-3d82ccb2a428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cf37bdfc-eb36-4bb5-90eb-6a39b288252c" xlink:to="loc_us-gaap_AssetsCurrent_d3dc8bc4-d700-44f4-af14-3d82ccb2a428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_436ae6b5-0e75-4400-9429-21b703c92b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_436ae6b5-0e75-4400-9429-21b703c92b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_401bf5a6-1304-4633-9c74-44cee799db9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_401bf5a6-1304-4633-9c74-44cee799db9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ed2adf58-ec0e-4c8c-a21d-664e04a8034f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ed2adf58-ec0e-4c8c-a21d-664e04a8034f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_deea5218-948a-4dd3-9c07-27332bb6df6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:to="loc_us-gaap_Goodwill_deea5218-948a-4dd3-9c07-27332bb6df6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreAndDevelopedTechnologyNet_64ca0de8-7db5-4f01-8b7a-067958051cb4" xlink:href="bdx-20230331.xsd#bdx_CoreAndDevelopedTechnologyNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:to="loc_bdx_CoreAndDevelopedTechnologyNet_64ca0de8-7db5-4f01-8b7a-067958051cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteLivedCustomerRelationshipsNet_05eec733-5b3a-4548-aa50-92195b102a43" xlink:href="bdx-20230331.xsd#bdx_FiniteLivedCustomerRelationshipsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:to="loc_bdx_FiniteLivedCustomerRelationshipsNet_05eec733-5b3a-4548-aa50-92195b102a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_b913006d-18c3-4357-941d-777ca1e19886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_b913006d-18c3-4357-941d-777ca1e19886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2efc18f4-e3be-4871-81a7-ac11c44bb4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2efc18f4-e3be-4871-81a7-ac11c44bb4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5b9db0b0-9523-4911-9b61-ad11445d8888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ee50f95-23c5-469f-8147-205bda3d0824" xlink:to="loc_us-gaap_Assets_5b9db0b0-9523-4911-9b61-ad11445d8888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_715de6c2-968e-4749-981f-897e80221428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_176bf785-eb1d-48ea-b992-49ac190e746f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_715de6c2-968e-4749-981f-897e80221428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2a3b2674-b533-4adc-8040-c01e828307af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_715de6c2-968e-4749-981f-897e80221428" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2a3b2674-b533-4adc-8040-c01e828307af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d99bb966-7f75-48ef-9d39-d9ce05710b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2a3b2674-b533-4adc-8040-c01e828307af" xlink:to="loc_us-gaap_DebtCurrent_d99bb966-7f75-48ef-9d39-d9ce05710b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_fe3aacf9-d5fb-4640-b563-e75510ccfe26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2a3b2674-b533-4adc-8040-c01e828307af" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_fe3aacf9-d5fb-4640-b563-e75510ccfe26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f8b2ee36-6c1a-480d-9730-d095648c1016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2a3b2674-b533-4adc-8040-c01e828307af" xlink:to="loc_us-gaap_LiabilitiesCurrent_f8b2ee36-6c1a-480d-9730-d095648c1016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_59e9ecc2-bee2-4b3e-8f8f-7a46c584335a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_715de6c2-968e-4749-981f-897e80221428" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_59e9ecc2-bee2-4b3e-8f8f-7a46c584335a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_7ea3b3e7-2a08-45e1-91b1-ad16b8fd36fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_715de6c2-968e-4749-981f-897e80221428" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_7ea3b3e7-2a08-45e1-91b1-ad16b8fd36fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_945aba76-110c-4e95-900b-ad3f5b309962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_715de6c2-968e-4749-981f-897e80221428" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_945aba76-110c-4e95-900b-ad3f5b309962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1c2499d6-48ff-4815-b64f-ec6e9f611d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_715de6c2-968e-4749-981f-897e80221428" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1c2499d6-48ff-4815-b64f-ec6e9f611d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_9ed80297-8811-475d-b2e8-4eb017255fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_715de6c2-968e-4749-981f-897e80221428" xlink:to="loc_us-gaap_StockholdersEquityAbstract_9ed80297-8811-475d-b2e8-4eb017255fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9630a922-1d48-48c8-82fd-1adab9894444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ed80297-8811-475d-b2e8-4eb017255fa4" xlink:to="loc_us-gaap_PreferredStockValue_9630a922-1d48-48c8-82fd-1adab9894444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2c9eaa23-9846-4555-8f90-9768a5fe391d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ed80297-8811-475d-b2e8-4eb017255fa4" xlink:to="loc_us-gaap_CommonStockValue_2c9eaa23-9846-4555-8f90-9768a5fe391d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4f054df6-0361-42c8-a2f5-2c398130c2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ed80297-8811-475d-b2e8-4eb017255fa4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4f054df6-0361-42c8-a2f5-2c398130c2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_11236e8e-6ce1-4780-8460-b9f58a048b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ed80297-8811-475d-b2e8-4eb017255fa4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_11236e8e-6ce1-4780-8460-b9f58a048b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_f2b32849-3d9c-4a96-9029-f650ee2b9b32" xlink:href="bdx-20230331.xsd#bdx_CommonStockSharesHeldInEmployeeTrust1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ed80297-8811-475d-b2e8-4eb017255fa4" xlink:to="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_f2b32849-3d9c-4a96-9029-f650ee2b9b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_c2cc5775-6fb1-4f3c-997a-5aa70a7964e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ed80297-8811-475d-b2e8-4eb017255fa4" xlink:to="loc_us-gaap_TreasuryStockValue_c2cc5775-6fb1-4f3c-997a-5aa70a7964e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7a17248d-56a8-445f-9bb9-772ffe00a923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ed80297-8811-475d-b2e8-4eb017255fa4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7a17248d-56a8-445f-9bb9-772ffe00a923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ea915f42-fcdc-4df8-86fa-c71cb0daba8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ed80297-8811-475d-b2e8-4eb017255fa4" xlink:to="loc_us-gaap_StockholdersEquity_ea915f42-fcdc-4df8-86fa-c71cb0daba8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a002bd41-0d62-406f-989f-6b2d2fdbe4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_715de6c2-968e-4749-981f-897e80221428" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a002bd41-0d62-406f-989f-6b2d2fdbe4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="bdx-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4f44d90b-25d3-450c-a54f-4a1ed6e3ed46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c8847eb4-aa30-4023-be45-e2d1b310a05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f44d90b-25d3-450c-a54f-4a1ed6e3ed46" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c8847eb4-aa30-4023-be45-e2d1b310a05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_907fae42-7c99-4ef3-a09c-c48df64671d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f44d90b-25d3-450c-a54f-4a1ed6e3ed46" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_907fae42-7c99-4ef3-a09c-c48df64671d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c2c32172-9f92-4728-b954-dced61e53c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f44d90b-25d3-450c-a54f-4a1ed6e3ed46" xlink:to="loc_us-gaap_CommonStockSharesIssued_c2c32172-9f92-4728-b954-dced61e53c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bdx-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1e23a2bf-5699-4dab-8a64-8d1ad6b8c160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1e23a2bf-5699-4dab-8a64-8d1ad6b8c160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_da392c6f-4c92-4a7b-a96f-f52a7cdd986d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1e23a2bf-5699-4dab-8a64-8d1ad6b8c160" xlink:to="loc_us-gaap_NetIncomeLoss_da392c6f-4c92-4a7b-a96f-f52a7cdd986d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_4d2d57f7-252f-4752-ba3b-2f6758f86b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1e23a2bf-5699-4dab-8a64-8d1ad6b8c160" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_4d2d57f7-252f-4752-ba3b-2f6758f86b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_b7b302b7-b945-466b-9ee4-b911ab3fef96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1e23a2bf-5699-4dab-8a64-8d1ad6b8c160" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_b7b302b7-b945-466b-9ee4-b911ab3fef96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f6cdb286-15cb-44a7-af8f-9f4edaa4da90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1e23a2bf-5699-4dab-8a64-8d1ad6b8c160" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f6cdb286-15cb-44a7-af8f-9f4edaa4da90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_54173b9d-9d29-4d9a-8006-aa3240954d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f6cdb286-15cb-44a7-af8f-9f4edaa4da90" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_54173b9d-9d29-4d9a-8006-aa3240954d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_275a1890-87e7-4e30-ad9a-8986d804d64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f6cdb286-15cb-44a7-af8f-9f4edaa4da90" xlink:to="loc_us-gaap_ShareBasedCompensation_275a1890-87e7-4e30-ad9a-8986d804d64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_584e0dfd-79fc-4235-8a6e-15dc3601ea9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f6cdb286-15cb-44a7-af8f-9f4edaa4da90" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_584e0dfd-79fc-4235-8a6e-15dc3601ea9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_47a47255-a88c-4b66-ae14-b40696184a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f6cdb286-15cb-44a7-af8f-9f4edaa4da90" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_47a47255-a88c-4b66-ae14-b40696184a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_1c971c34-1f4b-4437-bcc6-c010ca945da7" xlink:href="bdx-20230331.xsd#bdx_IncreaseDecreaseinPensionBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f6cdb286-15cb-44a7-af8f-9f4edaa4da90" xlink:to="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_1c971c34-1f4b-4437-bcc6-c010ca945da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_55de9206-634b-4622-b06d-1776bbdc686f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f6cdb286-15cb-44a7-af8f-9f4edaa4da90" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_55de9206-634b-4622-b06d-1776bbdc686f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_0a9483a8-acda-4b35-8276-b0af19107f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1e23a2bf-5699-4dab-8a64-8d1ad6b8c160" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_0a9483a8-acda-4b35-8276-b0af19107f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_242f6678-f92b-4fd7-889b-0fb9705bbd47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_242f6678-f92b-4fd7-889b-0fb9705bbd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4489e260-9bf0-411e-84b4-363698afb320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_242f6678-f92b-4fd7-889b-0fb9705bbd47" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4489e260-9bf0-411e-84b4-363698afb320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_60a8c04d-30a7-42be-b9f9-bbfff53aea3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_242f6678-f92b-4fd7-889b-0fb9705bbd47" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_60a8c04d-30a7-42be-b9f9-bbfff53aea3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4ffa0de5-0b74-4e21-97fc-e0e0455721fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_242f6678-f92b-4fd7-889b-0fb9705bbd47" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4ffa0de5-0b74-4e21-97fc-e0e0455721fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_6e2f5fa2-81cc-4b5b-936a-e7e87b9889d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_242f6678-f92b-4fd7-889b-0fb9705bbd47" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_6e2f5fa2-81cc-4b5b-936a-e7e87b9889d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_7be011a8-57d4-412e-a4ea-517c0749667b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_7be011a8-57d4-412e-a4ea-517c0749667b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_8348d211-46b9-4665-9338-9e91bfdfc40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_7be011a8-57d4-412e-a4ea-517c0749667b" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_8348d211-46b9-4665-9338-9e91bfdfc40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_978b5894-3b15-416d-9d1b-da9aea87b624" xlink:href="bdx-20230331.xsd#bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_7be011a8-57d4-412e-a4ea-517c0749667b" xlink:to="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_978b5894-3b15-416d-9d1b-da9aea87b624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsFromSpinoffTransaction_110ae1c3-45fa-4473-9d3a-9c68d0d0f40a" xlink:href="bdx-20230331.xsd#bdx_ProceedsFromSpinoffTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_7be011a8-57d4-412e-a4ea-517c0749667b" xlink:to="loc_bdx_ProceedsFromSpinoffTransaction_110ae1c3-45fa-4473-9d3a-9c68d0d0f40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c566c80a-7fc3-4272-964a-2ad6871d8b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_7be011a8-57d4-412e-a4ea-517c0749667b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c566c80a-7fc3-4272-964a-2ad6871d8b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_c71bb88c-569a-4791-bcc6-760eb551baca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_7be011a8-57d4-412e-a4ea-517c0749667b" xlink:to="loc_us-gaap_PaymentsOfDividends_c71bb88c-569a-4791-bcc6-760eb551baca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_14b2e8e9-29dc-4daa-922c-956b1db07103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_7be011a8-57d4-412e-a4ea-517c0749667b" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_14b2e8e9-29dc-4daa-922c-956b1db07103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a4f3be8d-1d42-478f-857e-4329cdf14ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_7be011a8-57d4-412e-a4ea-517c0749667b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a4f3be8d-1d42-478f-857e-4329cdf14ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_a4a466dc-9bee-4b51-8918-0418c2c14d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_a4a466dc-9bee-4b51-8918-0418c2c14d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_806e57f8-c1aa-48e5-9f99-681e2085876c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_806e57f8-c1aa-48e5-9f99-681e2085876c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_46a6bbb4-d901-4019-a030-0795e6461453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_46a6bbb4-d901-4019-a030-0795e6461453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_aa8a347b-6ca2-4740-b172-157226a233c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_aa8a347b-6ca2-4740-b172-157226a233c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_07b19d0a-766e-4b15-b1f7-78f58eea2b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_07b19d0a-766e-4b15-b1f7-78f58eea2b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c37ffe47-a648-46e5-9978-23270a0426cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c37ffe47-a648-46e5-9978-23270a0426cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_46959331-05b3-4859-887e-5567708344da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_46959331-05b3-4859-887e-5567708344da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9ea04ff2-5c9c-4275-a41e-04c99f2fb455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a5dee4e-026e-4c08-94a6-e986c2e86a1f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9ea04ff2-5c9c-4275-a41e-04c99f2fb455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BasisofPresentation" xlink:type="simple" xlink:href="bdx-20230331.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f5096b3b-a76f-4f7a-828a-29df069e1d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_70d88244-fe6c-4047-b59e-36e3946b3e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f5096b3b-a76f-4f7a-828a-29df069e1d01" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_70d88244-fe6c-4047-b59e-36e3946b3e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorp" xlink:type="simple" xlink:href="bdx-20230331.xsd#SpinOffofEmbectaCorp"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorp" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ad0ba822-591c-4ab7-811d-2d63aa83efe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_b06e913e-0bee-4f51-b867-8a5783666ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ad0ba822-591c-4ab7-811d-2d63aa83efe7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_b06e913e-0bee-4f51-b867-8a5783666ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="bdx-20230331.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_86e5c282-1153-4845-8aa1-68b5bcb39a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d3a82c09-1937-4cab-8ca5-80325d6ed291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_86e5c282-1153-4845-8aa1-68b5bcb39a15" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d3a82c09-1937-4cab-8ca5-80325d6ed291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsPerShare" xlink:type="simple" xlink:href="bdx-20230331.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b6d32c2b-f85b-4331-98c9-d91d985cc9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_edcef092-5cb8-44ae-a1bb-ec4acd90b148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b6d32c2b-f85b-4331-98c9-d91d985cc9da" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_edcef092-5cb8-44ae-a1bb-ec4acd90b148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/Contingencies" xlink:type="simple" xlink:href="bdx-20230331.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_41230402-2f27-41fd-80c1-0a3219393220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_23a82178-c2d8-40a9-9888-2075dee3c2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_41230402-2f27-41fd-80c1-0a3219393220" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_23a82178-c2d8-40a9-9888-2075dee3c2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/Revenues" xlink:type="simple" xlink:href="bdx-20230331.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d9275233-677d-4f73-a6af-5116724404ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f7f9d473-abf7-4e96-9db0-beb387d5a7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d9275233-677d-4f73-a6af-5116724404ec" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f7f9d473-abf7-4e96-9db0-beb387d5a7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentData" xlink:type="simple" xlink:href="bdx-20230331.xsd#SegmentData"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentData" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_aa16e7d2-e553-4b1e-844c-992a04b7b0df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_87fefd5f-14ef-4bac-bc5a-58706f480e05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_aa16e7d2-e553-4b1e-844c-992a04b7b0df" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_87fefd5f-14ef-4bac-bc5a-58706f480e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlans" xlink:type="simple" xlink:href="bdx-20230331.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1ddc5794-8e17-4c03-96ce-0387b5f6d2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1166179d-4d10-41bf-be9d-83f9a1ed883b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1ddc5794-8e17-4c03-96ce-0387b5f6d2c8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1166179d-4d10-41bf-be9d-83f9a1ed883b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringCharges" xlink:type="simple" xlink:href="bdx-20230331.xsd#BusinessRestructuringCharges"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BusinessRestructuringCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f1ed543f-73c2-46e1-bbf6-0126a0548bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6ccdc4e4-de52-4601-b277-0b6029d9488c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f1ed543f-73c2-46e1-bbf6-0126a0548bda" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6ccdc4e4-de52-4601-b277-0b6029d9488c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssets" xlink:type="simple" xlink:href="bdx-20230331.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_115f902a-4b2d-4ff2-a97e-70b480e30f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_89309cf6-ddb6-40d7-9aa9-9a4bf344ce57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_115f902a-4b2d-4ff2-a97e-70b480e30f7a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_89309cf6-ddb6-40d7-9aa9-9a4bf344ce57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="bdx-20230331.xsd#DerivativeInstrumentsandHedgingActivities"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec553549-c21a-434f-a773-0ec85de5a64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7c080298-9186-4e14-be6b-91ed9b64af74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec553549-c21a-434f-a773-0ec85de5a64e" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7c080298-9186-4e14-be6b-91ed9b64af74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="simple" xlink:href="bdx-20230331.xsd#FinancialInstrumentsandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_58761b19-104b-409c-9ecc-db4e6ca97711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_e66c4dd3-3f4f-4f27-865d-39de9e6f9fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_58761b19-104b-409c-9ecc-db4e6ca97711" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_e66c4dd3-3f4f-4f27-865d-39de9e6f9fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/Debt" xlink:type="simple" xlink:href="bdx-20230331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_57801958-62ac-41a1-8194-d36977093729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_d63cc9b7-fa3d-4648-b6e1-7efd3462d443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_57801958-62ac-41a1-8194-d36977093729" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_d63cc9b7-fa3d-4648-b6e1-7efd3462d443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="bdx-20230331.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16a95106-eb9f-4c40-98f9-1b7c12f35bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_fcb8e3db-d3af-4266-a79e-d3d359d95500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16a95106-eb9f-4c40-98f9-1b7c12f35bf5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_fcb8e3db-d3af-4266-a79e-d3d359d95500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_871372f2-9705-4ce1-bab4-a6ff119d77b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16a95106-eb9f-4c40-98f9-1b7c12f35bf5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_871372f2-9705-4ce1-bab4-a6ff119d77b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_b8cb0b6c-0c9e-46b0-937a-cbd0a9b67360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16a95106-eb9f-4c40-98f9-1b7c12f35bf5" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_b8cb0b6c-0c9e-46b0-937a-cbd0a9b67360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f6ea264f-a02c-4fee-8018-4b76ec6e1504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16a95106-eb9f-4c40-98f9-1b7c12f35bf5" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f6ea264f-a02c-4fee-8018-4b76ec6e1504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_f4823c66-7004-44b1-ad67-1673800de6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16a95106-eb9f-4c40-98f9-1b7c12f35bf5" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_f4823c66-7004-44b1-ad67-1673800de6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_f64a76c7-165e-4c6f-847b-bc3b18da2c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16a95106-eb9f-4c40-98f9-1b7c12f35bf5" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_f64a76c7-165e-4c6f-847b-bc3b18da2c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpTables" xlink:type="simple" xlink:href="bdx-20230331.xsd#SpinOffofEmbectaCorpTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c81ca951-4649-436d-983d-4243e5366fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_e356aa02-0c37-4e13-a366-d472eca44bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c81ca951-4649-436d-983d-4243e5366fbc" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_e356aa02-0c37-4e13-a366-d472eca44bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="bdx-20230331.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5dde7541-1c57-4e2f-9b7c-631106930e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_d8daa844-f8e5-43ef-98d7-dcd82152f13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5dde7541-1c57-4e2f-9b7c-631106930e8e" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_d8daa844-f8e5-43ef-98d7-dcd82152f13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0c089ac9-4143-4fa3-adc9-94471df7e671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5dde7541-1c57-4e2f-9b7c-631106930e8e" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0c089ac9-4143-4fa3-adc9-94471df7e671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="bdx-20230331.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_626b1ec9-2a94-49be-8a4f-faf5dc027fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_9905f260-d8f9-4074-8e2d-81a7821c2165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_626b1ec9-2a94-49be-8a4f-faf5dc027fbb" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_9905f260-d8f9-4074-8e2d-81a7821c2165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataTables" xlink:type="simple" xlink:href="bdx-20230331.xsd#SegmentDataTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e191893e-b7d9-4f45-889a-8e220564147e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_046c7d65-d831-4c06-8aa6-54863e0732dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e191893e-b7d9-4f45-889a-8e220564147e" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_046c7d65-d831-4c06-8aa6-54863e0732dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_85eaec9e-1c6c-4db1-9c51-d2afcd0c75f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e191893e-b7d9-4f45-889a-8e220564147e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_85eaec9e-1c6c-4db1-9c51-d2afcd0c75f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="bdx-20230331.xsd#BenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_087d9c6b-f4d7-449b-bac6-8371dc3dcbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_87d0098a-cc15-423a-a0e1-823da8c013ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_087d9c6b-f4d7-449b-bac6-8371dc3dcbaa" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_87d0098a-cc15-423a-a0e1-823da8c013ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringChargesTables" xlink:type="simple" xlink:href="bdx-20230331.xsd#BusinessRestructuringChargesTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BusinessRestructuringChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_cd13267f-41fa-44b7-b012-2b06bd0f5fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_84905642-e871-4880-bdd4-5ced9b01d447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_cd13267f-41fa-44b7-b012-2b06bd0f5fd8" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_84905642-e871-4880-bdd4-5ced9b01d447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="bdx-20230331.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_614ec724-7f6e-4c5a-9663-798d887bf7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_4afd909d-a2f8-4165-9eb7-34cb9689d7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_614ec724-7f6e-4c5a-9663-798d887bf7c5" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_4afd909d-a2f8-4165-9eb7-34cb9689d7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_424ca1cd-4781-4ca9-b27e-f4b88abdf885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_614ec724-7f6e-4c5a-9663-798d887bf7c5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_424ca1cd-4781-4ca9-b27e-f4b88abdf885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="bdx-20230331.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_da7c96f2-8b61-4e2a-b485-aa40002c6b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_9ec61fee-563f-4865-9e44-235af3ba278e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_da7c96f2-8b61-4e2a-b485-aa40002c6b1f" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_9ec61fee-563f-4865-9e44-235af3ba278e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6d3ba456-81ad-43a9-a98f-303a64d4badb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_da7c96f2-8b61-4e2a-b485-aa40002c6b1f" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6d3ba456-81ad-43a9-a98f-303a64d4badb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bdx-20230331.xsd#FinancialInstrumentsandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f5ff6d99-444b-443b-ad80-242b12155b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_6cfc12e1-8aa5-4813-8c31-b0edab7dde82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f5ff6d99-444b-443b-ad80-242b12155b9f" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_6cfc12e1-8aa5-4813-8c31-b0edab7dde82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8d81da65-01f9-47a8-ba58-f3fcca9add17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f5ff6d99-444b-443b-ad80-242b12155b9f" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8d81da65-01f9-47a8-ba58-f3fcca9add17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_c872cc93-2a08-43ea-90fa-4e94598247cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f5ff6d99-444b-443b-ad80-242b12155b9f" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_c872cc93-2a08-43ea-90fa-4e94598247cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#SpinOffofEmbectaCorpAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_189431bb-3ced-49da-9fe1-dc7baf74e007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1c147155-023a-4cdc-b5d8-9f1b0862ec74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_189431bb-3ced-49da-9fe1-dc7baf74e007" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1c147155-023a-4cdc-b5d8-9f1b0862ec74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_90aa442f-a5a1-445d-8289-762ac07c5ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1c147155-023a-4cdc-b5d8-9f1b0862ec74" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_90aa442f-a5a1-445d-8289-762ac07c5ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d9f8ab1a-dbbc-43dd-8d22-354de373c3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_90aa442f-a5a1-445d-8289-762ac07c5ce3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d9f8ab1a-dbbc-43dd-8d22-354de373c3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_ba1c1a4c-a0a5-4c2f-adbd-ad34fd70d153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d9f8ab1a-dbbc-43dd-8d22-354de373c3e8" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_ba1c1a4c-a0a5-4c2f-adbd-ad34fd70d153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2d3106f3-e6fa-4078-a7cc-e8a509842dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1c147155-023a-4cdc-b5d8-9f1b0862ec74" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2d3106f3-e6fa-4078-a7cc-e8a509842dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_158c7563-fa48-41fb-af82-0691b6cef05c" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2d3106f3-e6fa-4078-a7cc-e8a509842dc1" xlink:to="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_158c7563-fa48-41fb-af82-0691b6cef05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_c35a34c1-3440-4ef6-b101-e300afe13d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2d3106f3-e6fa-4078-a7cc-e8a509842dc1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_c35a34c1-3440-4ef6-b101-e300afe13d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d215ea24-8eb1-4346-af16-311a5c570383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_429f966e-97f3-433d-9a57-77d5eb978f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d215ea24-8eb1-4346-af16-311a5c570383" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_429f966e-97f3-433d-9a57-77d5eb978f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4bc82ef4-35e0-42cf-9d54-ef7b2ccf99ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_429f966e-97f3-433d-9a57-77d5eb978f33" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4bc82ef4-35e0-42cf-9d54-ef7b2ccf99ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_71b3a87b-26d6-413e-86cd-d44c8a9ec6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4bc82ef4-35e0-42cf-9d54-ef7b2ccf99ae" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_71b3a87b-26d6-413e-86cd-d44c8a9ec6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_3e95528c-facf-4220-befa-580012d8d9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_71b3a87b-26d6-413e-86cd-d44c8a9ec6c7" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_3e95528c-facf-4220-befa-580012d8d9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_429f966e-97f3-433d-9a57-77d5eb978f33" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_50bd9e8c-b31f-4e34-914b-e13baa56b9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_50bd9e8c-b31f-4e34-914b-e13baa56b9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_f4ddfb40-c2bf-41d1-9735-c913f0c9b20d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_f4ddfb40-c2bf-41d1-9735-c913f0c9b20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_c798d9be-0891-4d19-8458-04cbce074d99" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_c798d9be-0891-4d19-8458-04cbce074d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_bed8e4c9-c407-4c14-8c6b-b9c596ccc00d" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_bed8e4c9-c407-4c14-8c6b-b9c596ccc00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_9e8af93e-9064-4e64-a522-354aa52d6f89" xlink:href="bdx-20230331.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_9e8af93e-9064-4e64-a522-354aa52d6f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_82593d47-fad5-4226-a33b-76fe4551804c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_82593d47-fad5-4226-a33b-76fe4551804c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_53ea9401-f503-44e0-b969-d2d75ff46f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_53ea9401-f503-44e0-b969-d2d75ff46f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_b6b7be64-99b1-4d7a-818b-cdb4ccdc1eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_b6b7be64-99b1-4d7a-818b-cdb4ccdc1eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_e761f037-2257-4e53-bb24-2c13191f29aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_e761f037-2257-4e53-bb24-2c13191f29aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_832a5041-8a16-4cf4-b1a8-c731a9fb4bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_832a5041-8a16-4cf4-b1a8-c731a9fb4bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_7a7c2176-f17a-42b5-9892-2e2300dc873c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b26e2a1f-aa31-479a-b2e1-bc39539c0083" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_7a7c2176-f17a-42b5-9892-2e2300dc873c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2954370e-8042-4590-bb27-1d655bf2ad01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b6555dc2-629c-464d-9cf7-5672027e0cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2954370e-8042-4590-bb27-1d655bf2ad01" xlink:to="loc_us-gaap_StatementTable_b6555dc2-629c-464d-9cf7-5672027e0cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e4979aa3-2404-4a92-9ad3-0df4a4816954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b6555dc2-629c-464d-9cf7-5672027e0cfa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e4979aa3-2404-4a92-9ad3-0df4a4816954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4979aa3-2404-4a92-9ad3-0df4a4816954" xlink:to="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a9408ac1-09f1-45ad-9a18-1030e1fd162f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:to="loc_us-gaap_CommonStockMember_a9408ac1-09f1-45ad-9a18-1030e1fd162f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_01c5e164-8a82-40f5-838d-e8c2b615852e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_01c5e164-8a82-40f5-838d-e8c2b615852e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6b7910e2-a7ae-49c5-8c85-f617e1496c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:to="loc_us-gaap_RetainedEarningsMember_6b7910e2-a7ae-49c5-8c85-f617e1496c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_28dff813-de6e-412b-aa6f-d15cc15d3824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_28dff813-de6e-412b-aa6f-d15cc15d3824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_966afd98-245a-4416-8631-31c5de934777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9c2a4a02-7e43-4f3a-a4f2-27da49972fc4" xlink:to="loc_us-gaap_TreasuryStockMember_966afd98-245a-4416-8631-31c5de934777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b6555dc2-629c-464d-9cf7-5672027e0cfa" xlink:to="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0c956519-7cbc-4d47-b15c-8de17fdd2899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_StockholdersEquity_0c956519-7cbc-4d47-b15c-8de17fdd2899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_cfc35d68-5a56-4436-b58b-1aaccf8dba96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_TreasuryStockShares_cfc35d68-5a56-4436-b58b-1aaccf8dba96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_18ef8b4d-893f-44c5-a73c-435f28710413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_NetIncomeLoss_18ef8b4d-893f-44c5-a73c-435f28710413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_03b033c8-5f3e-4232-98f2-8840e36c9faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_DividendsCommonStockCash_03b033c8-5f3e-4232-98f2-8840e36c9faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock_4f726833-f234-43cd-b5d5-9fd05ec83c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_DividendsPreferredStock_4f726833-f234-43cd-b5d5-9fd05ec83c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_04dc8298-6fa2-4162-8808-d7b6f03869f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_04dc8298-6fa2-4162-8808-d7b6f03869f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5777dc25-1437-495a-9e1f-223a4d8ec12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5777dc25-1437-495a-9e1f-223a4d8ec12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f9bcbfc0-317c-4019-8485-0580cf1e0913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f9bcbfc0-317c-4019-8485-0580cf1e0913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsAcquired_7333efef-2c5e-4fc0-920b-c9d68948d03d" xlink:href="bdx-20230331.xsd#bdx_CommonStockHeldInTrustsAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_bdx_CommonStockHeldInTrustsAcquired_7333efef-2c5e-4fc0-920b-c9d68948d03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsNetShares_251c7f6b-036f-4202-a930-17fe584a2c36" xlink:href="bdx-20230331.xsd#bdx_CommonStockHeldInTrustsNetShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_bdx_CommonStockHeldInTrustsNetShares_251c7f6b-036f-4202-a930-17fe584a2c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_8c0dcbeb-e524-4686-b936-31bd76f4599b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_8c0dcbeb-e524-4686-b936-31bd76f4599b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_fe0098f5-3159-44ef-a55c-d04ec4baf6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_fe0098f5-3159-44ef-a55c-d04ec4baf6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5532d90f-6a46-44a9-b5ea-fceabf8d766a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_StockholdersEquity_5532d90f-6a46-44a9-b5ea-fceabf8d766a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_edf52d13-e0ba-41fd-8aac-49be4b8fc110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_TreasuryStockShares_edf52d13-e0ba-41fd-8aac-49be4b8fc110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_319e1bea-4577-4372-8d93-60d905d5bf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_319e1bea-4577-4372-8d93-60d905d5bf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_76cde591-fdf7-470f-8939-ea3ed31a4e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_76cde591-fdf7-470f-8939-ea3ed31a4e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_14f45dca-77fa-4f8e-a00b-8977a006476b" xlink:href="bdx-20230331.xsd#bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d3e0f38-64f2-445b-bb79-3bfc06dda3cf" xlink:to="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_14f45dca-77fa-4f8e-a00b-8977a006476b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_293da1bf-1b08-4314-ac03-28e65457532a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_caeda11a-5a33-4b1c-8ef5-8427f1ca7b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_293da1bf-1b08-4314-ac03-28e65457532a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_caeda11a-5a33-4b1c-8ef5-8427f1ca7b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_03c57d06-599f-4d00-89fc-230c27ef3fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_caeda11a-5a33-4b1c-8ef5-8427f1ca7b41" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_03c57d06-599f-4d00-89fc-230c27ef3fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e8818ac6-c022-4d88-adf8-97ec8d8f485e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_03c57d06-599f-4d00-89fc-230c27ef3fc1" xlink:to="loc_us-gaap_EquityComponentDomain_e8818ac6-c022-4d88-adf8-97ec8d8f485e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_247231c6-1f43-4561-8ce5-87eda1f68200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e8818ac6-c022-4d88-adf8-97ec8d8f485e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_247231c6-1f43-4561-8ce5-87eda1f68200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_fa5827b5-d17b-474a-ad87-97e5bbe8d15f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e8818ac6-c022-4d88-adf8-97ec8d8f485e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_fa5827b5-d17b-474a-ad87-97e5bbe8d15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0e59506f-b99f-44ff-a7e9-6e8ab29e85b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e8818ac6-c022-4d88-adf8-97ec8d8f485e" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0e59506f-b99f-44ff-a7e9-6e8ab29e85b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_cab4f2c3-4582-49c0-ba5b-04a0016f3e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_caeda11a-5a33-4b1c-8ef5-8427f1ca7b41" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_cab4f2c3-4582-49c0-ba5b-04a0016f3e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_cab4f2c3-4582-49c0-ba5b-04a0016f3e83" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_237abcc5-2766-4cb9-9c91-1bffb39956e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_237abcc5-2766-4cb9-9c91-1bffb39956e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_51ca9776-f60b-4b79-9f8d-9e23a2e3d6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_51ca9776-f60b-4b79-9f8d-9e23a2e3d6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_75af89b9-4091-472c-8513-df9365874d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_75af89b9-4091-472c-8513-df9365874d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3bdf85e2-79f0-48e4-8eec-4a1bc43860f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_49294fe5-1779-435f-be5b-1061e62fd497" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3bdf85e2-79f0-48e4-8eec-4a1bc43860f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_900635e4-b496-4280-af5f-f504df8aff21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5a05eee2-e62b-4007-ae98-4d4e4455cffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_900635e4-b496-4280-af5f-f504df8aff21" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5a05eee2-e62b-4007-ae98-4d4e4455cffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1d152c7b-6a75-4316-822d-a7ed0107a6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_900635e4-b496-4280-af5f-f504df8aff21" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1d152c7b-6a75-4316-822d-a7ed0107a6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2f25ca04-3ffc-4949-853f-8200eb168a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_900635e4-b496-4280-af5f-f504df8aff21" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2f25ca04-3ffc-4949-853f-8200eb168a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0ce6eeb5-13d1-4e0c-abbf-00f344c6f97a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_900635e4-b496-4280-af5f-f504df8aff21" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0ce6eeb5-13d1-4e0c-abbf-00f344c6f97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9b97217b-3d2c-4252-83b6-0134778a28d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_900635e4-b496-4280-af5f-f504df8aff21" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9b97217b-3d2c-4252-83b6-0134778a28d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53019abe-b141-49e0-bd61-38a9aac97ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9b97217b-3d2c-4252-83b6-0134778a28d0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53019abe-b141-49e0-bd61-38a9aac97ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e389e668-27e1-4ff4-9b7d-7e5ee6c49309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53019abe-b141-49e0-bd61-38a9aac97ec3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e389e668-27e1-4ff4-9b7d-7e5ee6c49309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_7b27d86f-0b22-4faa-9b58-7cf57b72a704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e389e668-27e1-4ff4-9b7d-7e5ee6c49309" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_7b27d86f-0b22-4faa-9b58-7cf57b72a704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationMember_6d901147-e4a3-48fb-a26d-e8cfcbf3b0ba" xlink:href="bdx-20230331.xsd#bdx_ShareBasedCompensationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e389e668-27e1-4ff4-9b7d-7e5ee6c49309" xlink:to="loc_bdx_ShareBasedCompensationMember_6d901147-e4a3-48fb-a26d-e8cfcbf3b0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_236f7478-201a-46bf-82f0-65b9d377061d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9b97217b-3d2c-4252-83b6-0134778a28d0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_236f7478-201a-46bf-82f0-65b9d377061d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2ecc42cd-2207-4210-8fa9-8f7ce3f4765c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_236f7478-201a-46bf-82f0-65b9d377061d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2ecc42cd-2207-4210-8fa9-8f7ce3f4765c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ContingenciesDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#ContingenciesDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ContingenciesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c24ca33f-1200-4bd2-8bbd-9bca329831d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c24ca33f-1200-4bd2-8bbd-9bca329831d9" xlink:to="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ee021d0b-a453-4b34-8ffa-c3d2489c2a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ee021d0b-a453-4b34-8ffa-c3d2489c2a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_6a55aa6b-3686-409f-a997-519f3e557a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ee021d0b-a453-4b34-8ffa-c3d2489c2a75" xlink:to="loc_us-gaap_LossContingencyNatureDomain_6a55aa6b-3686-409f-a997-519f3e557a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_HerniaProductClaimsMember_ca9c676e-48b6-462e-975d-b961efe1f53b" xlink:href="bdx-20230331.xsd#bdx_HerniaProductClaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_6a55aa6b-3686-409f-a997-519f3e557a11" xlink:to="loc_bdx_HerniaProductClaimsMember_ca9c676e-48b6-462e-975d-b961efe1f53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5885f1be-bb68-4139-82bf-8ec794544861" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:to="loc_srt_StatementGeographicalAxis_5885f1be-bb68-4139-82bf-8ec794544861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c79a51ff-676b-41ae-b2f7-986e0fd18c4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_5885f1be-bb68-4139-82bf-8ec794544861" xlink:to="loc_srt_SegmentGeographicalDomain_c79a51ff-676b-41ae-b2f7-986e0fd18c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GwinnettCountyGeorgiaMember_de12e9bb-8872-453e-85a4-f3c8870b98c4" xlink:href="bdx-20230331.xsd#bdx_GwinnettCountyGeorgiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c79a51ff-676b-41ae-b2f7-986e0fd18c4c" xlink:to="loc_bdx_GwinnettCountyGeorgiaMember_de12e9bb-8872-453e-85a4-f3c8870b98c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA_81a9478d-aa91-42ab-825b-a39ca577bb3e" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_GA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c79a51ff-676b-41ae-b2f7-986e0fd18c4c" xlink:to="loc_stpr_GA_81a9478d-aa91-42ab-825b-a39ca577bb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4cff7803-6f54-4ecc-86ff-94629d5f7f0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:to="loc_srt_RangeAxis_4cff7803-6f54-4ecc-86ff-94629d5f7f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a6d31fb7-239d-425a-b778-1a71ff240d3a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4cff7803-6f54-4ecc-86ff-94629d5f7f0d" xlink:to="loc_srt_RangeMember_a6d31fb7-239d-425a-b778-1a71ff240d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7cd7950f-c7e5-49b6-94fc-5d2e540baef7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a6d31fb7-239d-425a-b778-1a71ff240d3a" xlink:to="loc_srt_MaximumMember_7cd7950f-c7e5-49b6-94fc-5d2e540baef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8d9d2cf2-2358-4703-b4ef-88301c7e7e44" xlink:to="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_553fcbe4-f1b2-4917-9133-59d0832e5c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_553fcbe4-f1b2-4917-9133-59d0832e5c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_ef325ffc-116b-4b0b-8774-6d08150a0f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_ef325ffc-116b-4b0b-8774-6d08150a0f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_85249563-0f4a-4d45-8d80-a1138e547d84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_85249563-0f4a-4d45-8d80-a1138e547d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled_f2a29010-026e-45dd-83ac-84575ae661da" xlink:href="bdx-20230331.xsd#bdx_NumberOfEtOSterilizationLawsuitsFiled"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled_f2a29010-026e-45dd-83ac-84575ae661da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_04cb75cd-2faa-434a-a7b9-108f0125f509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_04cb75cd-2faa-434a-a7b9-108f0125f509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_1bee89a7-4482-4be6-81a3-953c4dc3b18e" xlink:href="bdx-20230331.xsd#bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_1bee89a7-4482-4be6-81a3-953c4dc3b18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_07bccd76-9c8b-4a75-a6cf-188f9369e4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0966356f-e62b-46f9-a37d-ca4538ca09b7" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_07bccd76-9c8b-4a75-a6cf-188f9369e4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#RevenuesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/RevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_66483146-557d-4e2b-9267-e93293fa0ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_66483146-557d-4e2b-9267-e93293fa0ffd" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_93aee6a9-fe61-4854-9108-6e05a3b73eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_93aee6a9-fe61-4854-9108-6e05a3b73eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:to="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5769e288-b858-409c-abd0-e57944fc9992" xlink:to="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember_7903477c-373c-43f7-9bf9-17020947f9c2" xlink:href="bdx-20230331.xsd#bdx_ProductsandorServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:to="loc_bdx_ProductsandorServicesMember_7903477c-373c-43f7-9bf9-17020947f9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember_5664daa5-9c42-4108-ac18-b5b492900d12" xlink:href="bdx-20230331.xsd#bdx_ConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bc244696-edae-4455-afcf-77b3dc93c249" xlink:to="loc_bdx_ConsumablesMember_5664daa5-9c42-4108-ac18-b5b492900d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4db37dfb-86a7-4eba-a75a-bdd7a1666587" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability_12f26963-4725-4dee-9dee-b899e5a9b665" xlink:href="bdx-20230331.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_bdx_ContractWithCustomerRebateLiability_12f26963-4725-4dee-9dee-b899e5a9b665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_3eab0d47-76d5-4a24-b7eb-a48b89075b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_3eab0d47-76d5-4a24-b7eb-a48b89075b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_580eec8a-7d72-4821-be75-faa4f215d9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_42276b6d-b98f-4441-969f-3b6427738c68" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_580eec8a-7d72-4821-be75-faa4f215d9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails_1" xlink:type="simple" xlink:href="bdx-20230331.xsd#RevenuesDetails_1"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/RevenuesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#SegmentDataAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a4d8c0c2-dc2d-4d6d-a3ed-e0e0818c924e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_cca3dcaf-bf5b-484f-a2a2-0780c65e523c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4d8c0c2-dc2d-4d6d-a3ed-e0e0818c924e" xlink:to="loc_us-gaap_NumberOfOperatingSegments_cca3dcaf-bf5b-484f-a2a2-0780c65e523c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#SegmentDataRevenuesbyGeographicAreasDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0af95673-2b97-49ef-9caf-721d6efc3f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0af95673-2b97-49ef-9caf-721d6efc3f4b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitAxis_9b6fcc0e-ad5e-4e13-a90f-2ae6bf1a2994" xlink:href="bdx-20230331.xsd#bdx_OrganizationalUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:to="loc_bdx_OrganizationalUnitAxis_9b6fcc0e-ad5e-4e13-a90f-2ae6bf1a2994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:href="bdx-20230331.xsd#bdx_OrganizationalUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitAxis_9b6fcc0e-ad5e-4e13-a90f-2ae6bf1a2994" xlink:to="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationDeliverySolutionsMember_e699baab-55e3-4d79-a86e-6384f0315512" xlink:href="bdx-20230331.xsd#bdx_MedicationDeliverySolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_MedicationDeliverySolutionsMember_e699baab-55e3-4d79-a86e-6384f0315512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationManagementSolutionsMember_554ad1e8-6c00-4ad7-a838-6e62f272c7d0" xlink:href="bdx-20230331.xsd#bdx_MedicationManagementSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_MedicationManagementSolutionsMember_554ad1e8-6c00-4ad7-a838-6e62f272c7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PharmaceuticalSystemsMember_60980341-b5fb-4e62-abc0-7eb3cf92bc91" xlink:href="bdx-20230331.xsd#bdx_PharmaceuticalSystemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_PharmaceuticalSystemsMember_60980341-b5fb-4e62-abc0-7eb3cf92bc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IntegratedDiagnosticSolutionsMember_79830f20-1268-49eb-a280-a5c1147bcd8f" xlink:href="bdx-20230331.xsd#bdx_IntegratedDiagnosticSolutionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_IntegratedDiagnosticSolutionsMember_79830f20-1268-49eb-a280-a5c1147bcd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BiosciencesMember_1eb5bdee-ff6d-4e53-90d4-c0e14cc89259" xlink:href="bdx-20230331.xsd#bdx_BiosciencesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_BiosciencesMember_1eb5bdee-ff6d-4e53-90d4-c0e14cc89259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SurgeryMember_dc01933d-6e98-4a68-be2e-6cf843e5600b" xlink:href="bdx-20230331.xsd#bdx_SurgeryMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_SurgeryMember_dc01933d-6e98-4a68-be2e-6cf843e5600b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PeripheralInterventionMember_92dd5595-9764-4b23-a56b-d85d5fc852a2" xlink:href="bdx-20230331.xsd#bdx_PeripheralInterventionMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_PeripheralInterventionMember_92dd5595-9764-4b23-a56b-d85d5fc852a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UrologyandCriticalCareMember_50cf7280-93a2-4308-bc4d-4f72d0143942" xlink:href="bdx-20230331.xsd#bdx_UrologyandCriticalCareMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_00e72050-5fef-42e9-a08c-a617de8bff76" xlink:to="loc_bdx_UrologyandCriticalCareMember_50cf7280-93a2-4308-bc4d-4f72d0143942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_14ba7102-5724-466d-9b02-837b333daeec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:to="loc_srt_StatementGeographicalAxis_14ba7102-5724-466d-9b02-837b333daeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_979964bb-339a-42d4-a705-9bca2edef950" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_14ba7102-5724-466d-9b02-837b333daeec" xlink:to="loc_srt_SegmentGeographicalDomain_979964bb-339a-42d4-a705-9bca2edef950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_40cc1509-53bc-40fc-b011-f224462416f4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_979964bb-339a-42d4-a705-9bca2edef950" xlink:to="loc_country_US_40cc1509-53bc-40fc-b011-f224462416f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_cba02767-8b5b-443c-bff9-fea3b8794eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_979964bb-339a-42d4-a705-9bca2edef950" xlink:to="loc_us-gaap_NonUsMember_cba02767-8b5b-443c-bff9-fea3b8794eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8a4b06d3-1e48-458a-b599-d41b10e4ccd9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:to="loc_srt_ConsolidationItemsAxis_8a4b06d3-1e48-458a-b599-d41b10e4ccd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_32a5a7ef-3694-45df-9454-e70a754b347e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_8a4b06d3-1e48-458a-b599-d41b10e4ccd9" xlink:to="loc_srt_ConsolidationItemsDomain_32a5a7ef-3694-45df-9454-e70a754b347e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6e5b74fe-4fe5-4bd4-a737-d8aaceabb132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_32a5a7ef-3694-45df-9454-e70a754b347e" xlink:to="loc_us-gaap_OperatingSegmentsMember_6e5b74fe-4fe5-4bd4-a737-d8aaceabb132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_44b8a51f-fc8e-44ef-990b-fefbd79691e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_44b8a51f-fc8e-44ef-990b-fefbd79691e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6212b34f-d5d1-4dd1-a8bd-521302689fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_44b8a51f-fc8e-44ef-990b-fefbd79691e7" xlink:to="loc_us-gaap_SegmentDomain_6212b34f-d5d1-4dd1-a8bd-521302689fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_943ebe92-d9a9-4ab1-aec9-76ce699d12fb" xlink:href="bdx-20230331.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6212b34f-d5d1-4dd1-a8bd-521302689fe2" xlink:to="loc_bdx_MedicalMember_943ebe92-d9a9-4ab1-aec9-76ce699d12fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_4befe374-6d20-4af8-8633-12af01a8a616" xlink:href="bdx-20230331.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6212b34f-d5d1-4dd1-a8bd-521302689fe2" xlink:to="loc_bdx_LifeSciencesMember_4befe374-6d20-4af8-8633-12af01a8a616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_0d4bce51-1793-4c0e-8180-ad0682f022c2" xlink:href="bdx-20230331.xsd#bdx_InterventionalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6212b34f-d5d1-4dd1-a8bd-521302689fe2" xlink:to="loc_bdx_InterventionalMember_0d4bce51-1793-4c0e-8180-ad0682f022c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cfa074c7-8b55-4b1d-a4a7-ce9bfe0899d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_afba9986-4501-4083-b074-1cb1756e79d1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_cfa074c7-8b55-4b1d-a4a7-ce9bfe0899d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3574c023-27d6-402e-ab79-adeb3479f680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cfa074c7-8b55-4b1d-a4a7-ce9bfe0899d0" xlink:to="loc_us-gaap_Revenues_3574c023-27d6-402e-ab79-adeb3479f680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#SegmentDataFinancialInformationforCompanysSegmentsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3e3b655a-524c-49da-848f-0dc508d5c1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3e3b655a-524c-49da-848f-0dc508d5c1cb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_01cc4a52-40c0-45fe-a828-2d48e5b2c6ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:to="loc_srt_ConsolidationItemsAxis_01cc4a52-40c0-45fe-a828-2d48e5b2c6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_336f5045-f49b-4176-9269-a3c80ab73d86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_01cc4a52-40c0-45fe-a828-2d48e5b2c6ec" xlink:to="loc_srt_ConsolidationItemsDomain_336f5045-f49b-4176-9269-a3c80ab73d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_93699b92-43e4-45db-82de-409a210234b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_336f5045-f49b-4176-9269-a3c80ab73d86" xlink:to="loc_us-gaap_OperatingSegmentsMember_93699b92-43e4-45db-82de-409a210234b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_3895f11b-3a3b-4124-b42a-659011ef9e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_336f5045-f49b-4176-9269-a3c80ab73d86" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_3895f11b-3a3b-4124-b42a-659011ef9e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_ee95af0c-e12b-4444-ac6d-16418f051aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_336f5045-f49b-4176-9269-a3c80ab73d86" xlink:to="loc_us-gaap_CorporateNonSegmentMember_ee95af0c-e12b-4444-ac6d-16418f051aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_911b23b5-65c9-4645-8f34-4d2c09bd67e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_911b23b5-65c9-4645-8f34-4d2c09bd67e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_58942fee-bf70-467c-a9c4-0262773b494d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_911b23b5-65c9-4645-8f34-4d2c09bd67e6" xlink:to="loc_us-gaap_SegmentDomain_58942fee-bf70-467c-a9c4-0262773b494d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_7d33d1c2-2fb7-4310-9f45-4c0cced002c7" xlink:href="bdx-20230331.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_58942fee-bf70-467c-a9c4-0262773b494d" xlink:to="loc_bdx_MedicalMember_7d33d1c2-2fb7-4310-9f45-4c0cced002c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_d6de455b-126b-439d-839a-3eb16fbb3b48" xlink:href="bdx-20230331.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_58942fee-bf70-467c-a9c4-0262773b494d" xlink:to="loc_bdx_LifeSciencesMember_d6de455b-126b-439d-839a-3eb16fbb3b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_71c42c2b-50cc-493a-be4d-7fdc83c65c85" xlink:href="bdx-20230331.xsd#bdx_InterventionalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_58942fee-bf70-467c-a9c4-0262773b494d" xlink:to="loc_bdx_InterventionalMember_71c42c2b-50cc-493a-be4d-7fdc83c65c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_845fd5a7-c793-4f8b-b38c-819d95c8ba99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_845fd5a7-c793-4f8b-b38c-819d95c8ba99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_349c6cdc-ea14-4ecf-9ce7-eaad1ae67004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_845fd5a7-c793-4f8b-b38c-819d95c8ba99" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_349c6cdc-ea14-4ecf-9ce7-eaad1ae67004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d045a686-e734-4533-bcf0-bba5b6a0ba32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_349c6cdc-ea14-4ecf-9ce7-eaad1ae67004" xlink:to="loc_us-gaap_CostOfSalesMember_d045a686-e734-4533-bcf0-bba5b6a0ba32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6a0f5e4-b6bc-499f-a900-13fc4678fde1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_75942f63-8c3a-464e-a346-71c88597245a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_75942f63-8c3a-464e-a346-71c88597245a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_c3fa3eda-3334-4c7f-a91c-25c1855e5c26" xlink:href="bdx-20230331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_c3fa3eda-3334-4c7f-a91c-25c1855e5c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_4abcf1d6-c8d4-45f5-8782-ac1e3b4e5c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_4abcf1d6-c8d4-45f5-8782-ac1e3b4e5c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4844fc4f-b610-42af-b663-554958267c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4844fc4f-b610-42af-b663-554958267c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b280e104-7328-4475-aa4c-d59b3aae58ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_AssetImpairmentCharges_b280e104-7328-4475-aa4c-d59b3aae58ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_f6f617a5-f2e6-4547-9015-0bc9db67f5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_159e631d-d0ea-4bcf-aad4-bd59433e2772" xlink:to="loc_us-gaap_InventoryRecallExpense_f6f617a5-f2e6-4547-9015-0bc9db67f5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#BenefitPlansDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f43bc2d2-64a8-4a4c-b176-570ece1a30de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_947e4436-8865-4317-87c6-c3653c54b7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f43bc2d2-64a8-4a4c-b176-570ece1a30de" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_947e4436-8865-4317-87c6-c3653c54b7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_18791002-eb40-4419-b4c4-c0f5158e68ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_947e4436-8865-4317-87c6-c3653c54b7e8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_18791002-eb40-4419-b4c4-c0f5158e68ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_57f7c818-5191-48c2-935a-0ff6d8da81ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_18791002-eb40-4419-b4c4-c0f5158e68ab" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_57f7c818-5191-48c2-935a-0ff6d8da81ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a4a3218f-5ba9-4f37-9686-7dddde8093b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_57f7c818-5191-48c2-935a-0ff6d8da81ef" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a4a3218f-5ba9-4f37-9686-7dddde8093b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_947e4436-8865-4317-87c6-c3653c54b7e8" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_f7cac3f6-19e2-4f61-86fb-75f1fb9b4a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_f7cac3f6-19e2-4f61-86fb-75f1fb9b4a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_7e187e85-8e0e-4bd1-99e0-dda7b89d9c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_7e187e85-8e0e-4bd1-99e0-dda7b89d9c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_228ce03b-e2c5-4f1a-9f85-28f36d04d451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_228ce03b-e2c5-4f1a-9f85-28f36d04d451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_46d503da-88f3-463c-a64d-f250f94b89d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_46d503da-88f3-463c-a64d-f250f94b89d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3bede745-0ea2-4bd3-81bb-f2c09ce3c1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3bede745-0ea2-4bd3-81bb-f2c09ce3c1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_fd5c3262-cc99-4c15-b80b-52cbda02a8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_fd5c3262-cc99-4c15-b80b-52cbda02a8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e6d9642b-31bb-41a3-898e-47d13ac4155c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_968727d9-14dc-438d-9eb8-660d37eda488" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e6d9642b-31bb-41a3-898e-47d13ac4155c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringChargesDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#BusinessRestructuringChargesDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BusinessRestructuringChargesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1c08f468-beea-45d6-a10d-92eae39ea390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c6605927-6394-4088-aae9-9ef0e91a0a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1c08f468-beea-45d6-a10d-92eae39ea390" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c6605927-6394-4088-aae9-9ef0e91a0a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_ac24eda1-4702-4e19-a021-1106c29576e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c6605927-6394-4088-aae9-9ef0e91a0a65" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_ac24eda1-4702-4e19-a021-1106c29576e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_570f8ca5-038b-4b7c-85c6-89d6fdb6e570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_ac24eda1-4702-4e19-a021-1106c29576e4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_570f8ca5-038b-4b7c-85c6-89d6fdb6e570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_95a66673-916d-4baf-9056-c30156efb1be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_570f8ca5-038b-4b7c-85c6-89d6fdb6e570" xlink:to="loc_us-gaap_EmployeeSeveranceMember_95a66673-916d-4baf-9056-c30156efb1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_7b23492e-3d8d-4e31-ad58-47b7b7919e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_570f8ca5-038b-4b7c-85c6-89d6fdb6e570" xlink:to="loc_us-gaap_OtherRestructuringMember_7b23492e-3d8d-4e31-ad58-47b7b7919e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_fac87a82-ede9-4542-9dbe-a199957de889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c6605927-6394-4088-aae9-9ef0e91a0a65" xlink:to="loc_us-gaap_RestructuringPlanAxis_fac87a82-ede9-4542-9dbe-a199957de889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9f28b531-455d-4aa6-b8cf-a4e77e210069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_fac87a82-ede9-4542-9dbe-a199957de889" xlink:to="loc_us-gaap_RestructuringPlanDomain_9f28b531-455d-4aa6-b8cf-a4e77e210069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherInitiativesMember_11465aac-7557-4768-8a4f-02e412902031" xlink:href="bdx-20230331.xsd#bdx_OtherInitiativesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_9f28b531-455d-4aa6-b8cf-a4e77e210069" xlink:to="loc_bdx_OtherInitiativesMember_11465aac-7557-4768-8a4f-02e412902031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_3d54b63e-2328-4ef1-affb-ffb08ccaee41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c6605927-6394-4088-aae9-9ef0e91a0a65" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_3d54b63e-2328-4ef1-affb-ffb08ccaee41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3d54b63e-2328-4ef1-affb-ffb08ccaee41" xlink:to="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_424db4ae-cf61-43d0-bff5-685c43d2efda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:to="loc_us-gaap_RestructuringReserve_424db4ae-cf61-43d0-bff5-685c43d2efda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c75256ec-2197-474a-a76d-c8516354afc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:to="loc_us-gaap_RestructuringCharges_c75256ec-2197-474a-a76d-c8516354afc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f2dc5c84-26f5-4a3b-8614-3f3a5c2f302b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:to="loc_us-gaap_PaymentsForRestructuring_f2dc5c84-26f5-4a3b-8614-3f3a5c2f302b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_7f74bb21-a6b3-4168-9234-b43662c9e367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_7f74bb21-a6b3-4168-9234-b43662c9e367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_47ebc257-06ef-4d90-adaf-1e94a77c4082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_da09c03c-1768-4743-a73f-0107b12ef8a1" xlink:to="loc_us-gaap_RestructuringReserve_47ebc257-06ef-4d90-adaf-1e94a77c4082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#IntangibleAssetsComponentsofIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ebd6257a-3378-4bb2-9122-4a440bd5d614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_0e3712c2-f4ab-4d4b-b3fe-b9b582b4b335" xlink:href="bdx-20230331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ebd6257a-3378-4bb2-9122-4a440bd5d614" xlink:to="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_0e3712c2-f4ab-4d4b-b3fe-b9b582b4b335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_309b9f0a-6401-4bb9-bc7f-3d4ebf09e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_0e3712c2-f4ab-4d4b-b3fe-b9b582b4b335" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_309b9f0a-6401-4bb9-bc7f-3d4ebf09e84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a64333f7-659c-40ba-87be-4ec5c2013bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_309b9f0a-6401-4bb9-bc7f-3d4ebf09e84f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a64333f7-659c-40ba-87be-4ec5c2013bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_5e6633a7-332c-4e83-a99f-dbe378119750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a64333f7-659c-40ba-87be-4ec5c2013bcc" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_5e6633a7-332c-4e83-a99f-dbe378119750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4ab64d75-d696-40ce-abc9-f654bb65f2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a64333f7-659c-40ba-87be-4ec5c2013bcc" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4ab64d75-d696-40ce-abc9-f654bb65f2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_dfe2c1d0-856c-4918-9b5a-777451d4fb07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a64333f7-659c-40ba-87be-4ec5c2013bcc" xlink:to="loc_us-gaap_IntellectualPropertyMember_dfe2c1d0-856c-4918-9b5a-777451d4fb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cc35e967-1b0e-4fef-8d4b-8f6674e10090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_0e3712c2-f4ab-4d4b-b3fe-b9b582b4b335" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cc35e967-1b0e-4fef-8d4b-8f6674e10090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b586e160-b7a6-44f5-99de-0586f37a4683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cc35e967-1b0e-4fef-8d4b-8f6674e10090" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b586e160-b7a6-44f5-99de-0586f37a4683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_ed4752f1-dcf6-47e5-839c-9b911bf5d02f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b586e160-b7a6-44f5-99de-0586f37a4683" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_ed4752f1-dcf6-47e5-839c-9b911bf5d02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_545b6d8c-fca0-4e67-85d6-02ff1822ad0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b586e160-b7a6-44f5-99de-0586f37a4683" xlink:to="loc_us-gaap_TrademarksMember_545b6d8c-fca0-4e67-85d6-02ff1822ad0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:href="bdx-20230331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_0e3712c2-f4ab-4d4b-b3fe-b9b582b4b335" xlink:to="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f320f0bd-f44d-4384-9b8e-010bc17b9639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f320f0bd-f44d-4384-9b8e-010bc17b9639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5ca70602-92a6-4b09-ab3a-de5ef134b77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5ca70602-92a6-4b09-ab3a-de5ef134b77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_40136ff5-89b8-4682-a0e5-165e45d9b034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_40136ff5-89b8-4682-a0e5-165e45d9b034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_566fe542-db91-4b8a-9bca-e6af58ac7791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_6299d2a7-0417-4e2d-9a40-8b01f5f0d740" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_566fe542-db91-4b8a-9bca-e6af58ac7791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#IntangibleAssetsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_62e5c0aa-6511-4236-b095-d769a73a7478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_28cf7ec5-ba79-48dd-8f9e-da1c1e6d8f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_62e5c0aa-6511-4236-b095-d769a73a7478" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_28cf7ec5-ba79-48dd-8f9e-da1c1e6d8f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_add45f32-2f31-4f6f-8eec-611da8d623a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_dbe217b8-1f31-4568-8706-732a8da136b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_add45f32-2f31-4f6f-8eec-611da8d623a3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_dbe217b8-1f31-4568-8706-732a8da136b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_88997e2c-2d17-412a-b784-c719e17548a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_dbe217b8-1f31-4568-8706-732a8da136b3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_88997e2c-2d17-412a-b784-c719e17548a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a13e213b-72c4-4796-81f1-10c994e55245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_88997e2c-2d17-412a-b784-c719e17548a0" xlink:to="loc_us-gaap_SegmentDomain_a13e213b-72c4-4796-81f1-10c994e55245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_6b2aa087-dcf4-4db0-a053-6e5df3d00b33" xlink:href="bdx-20230331.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a13e213b-72c4-4796-81f1-10c994e55245" xlink:to="loc_bdx_MedicalMember_6b2aa087-dcf4-4db0-a053-6e5df3d00b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_4f6aba36-20ec-48fc-b3d6-5fe81ee668dd" xlink:href="bdx-20230331.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a13e213b-72c4-4796-81f1-10c994e55245" xlink:to="loc_bdx_LifeSciencesMember_4f6aba36-20ec-48fc-b3d6-5fe81ee668dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_4d1ea7e8-8789-4259-a97a-39f5f0ddc2fc" xlink:href="bdx-20230331.xsd#bdx_InterventionalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a13e213b-72c4-4796-81f1-10c994e55245" xlink:to="loc_bdx_InterventionalMember_4d1ea7e8-8789-4259-a97a-39f5f0ddc2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_141181a0-d0a1-413b-9e2f-fc2a5eb6514b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_dbe217b8-1f31-4568-8706-732a8da136b3" xlink:to="loc_us-gaap_GoodwillLineItems_141181a0-d0a1-413b-9e2f-fc2a5eb6514b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_141181a0-d0a1-413b-9e2f-fc2a5eb6514b" xlink:to="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_62edcb0d-a876-4bb9-b7b7-d6ec5ceb8349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:to="loc_us-gaap_Goodwill_62edcb0d-a876-4bb9-b7b7-d6ec5ceb8349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_95a2369d-ac49-4832-8ecc-9f913557e7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_95a2369d-ac49-4832-8ecc-9f913557e7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_25853c46-ffaa-401c-897b-7e8b85f34362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_25853c46-ffaa-401c-897b-7e8b85f34362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3ce0bb01-edae-4235-9d87-73fb23fed5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_18627545-4134-4da4-9a17-e170ac086c5d" xlink:to="loc_us-gaap_Goodwill_3ce0bb01-edae-4235-9d87-73fb23fed5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cb6a9352-1033-44ef-a1f0-78986523305c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cb6a9352-1033-44ef-a1f0-78986523305c" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_04607df6-6b71-4903-b271-5af2dccccacb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:to="loc_us-gaap_DebtInstrumentAxis_04607df6-6b71-4903-b271-5af2dccccacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35ddfb73-997c-4158-9313-06603b520588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_04607df6-6b71-4903-b271-5af2dccccacb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35ddfb73-997c-4158-9313-06603b520588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember_f0c4e88f-feb9-4b08-8260-c854753f4182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35ddfb73-997c-4158-9313-06603b520588" xlink:to="loc_us-gaap_DebtMember_f0c4e88f-feb9-4b08-8260-c854753f4182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0cdebd0a-fcb9-442b-a68d-b079dc012041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0cdebd0a-fcb9-442b-a68d-b079dc012041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0cdebd0a-fcb9-442b-a68d-b079dc012041" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_12febc82-6918-4bec-8546-21adae2bed77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:to="loc_us-gaap_ForeignExchangeContractMember_12febc82-6918-4bec-8546-21adae2bed77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_9e900714-30b4-4c8a-9ca7-1ba568e7194f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:to="loc_us-gaap_CurrencySwapMember_9e900714-30b4-4c8a-9ca7-1ba568e7194f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FixedToFloatingMember_9a843f92-5666-4dcb-a9b4-c8eeb1a99a35" xlink:href="bdx-20230331.xsd#bdx_FixedToFloatingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:to="loc_bdx_FixedToFloatingMember_9a843f92-5666-4dcb-a9b4-c8eeb1a99a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_96c10ed5-84be-484a-b8a8-c6302c180087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e6eaffc5-4e01-488a-ae07-f31888c2dbc5" xlink:to="loc_us-gaap_InterestRateSwapMember_96c10ed5-84be-484a-b8a8-c6302c180087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_493494c9-9656-46dd-8236-e17aaa58b90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_493494c9-9656-46dd-8236-e17aaa58b90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c2297438-0de5-4101-9370-b8d66b2cc740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_493494c9-9656-46dd-8236-e17aaa58b90e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c2297438-0de5-4101-9370-b8d66b2cc740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6eb7c83d-020a-4177-b225-c7c48ffa695a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c2297438-0de5-4101-9370-b8d66b2cc740" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6eb7c83d-020a-4177-b225-c7c48ffa695a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_64b0c87c-c9c1-4941-a3d6-5dc45b8f6b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c2297438-0de5-4101-9370-b8d66b2cc740" xlink:to="loc_us-gaap_FairValueHedgingMember_64b0c87c-c9c1-4941-a3d6-5dc45b8f6b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_f7dd6011-0fb9-4d5a-8c07-5319e8c983dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c2297438-0de5-4101-9370-b8d66b2cc740" xlink:to="loc_us-gaap_CashFlowHedgingMember_f7dd6011-0fb9-4d5a-8c07-5319e8c983dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f2546f03-ef73-4825-8359-7e9a05913b70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_33b18f8c-2a46-4859-85de-3f525c5d8371" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f2546f03-ef73-4825-8359-7e9a05913b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e62d2cf8-0ae0-4e12-9f60-2806ae6fcaad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f2546f03-ef73-4825-8359-7e9a05913b70" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e62d2cf8-0ae0-4e12-9f60-2806ae6fcaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6b644ee2-fbbd-4ccb-8e4d-c3b6954b4854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d89670d-85e0-4b55-877a-3341b105313a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6b644ee2-fbbd-4ccb-8e4d-c3b6954b4854" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d89670d-85e0-4b55-877a-3341b105313a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_40d7814d-784a-4ef8-b67b-eb29e858f560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d89670d-85e0-4b55-877a-3341b105313a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_40d7814d-784a-4ef8-b67b-eb29e858f560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_304b5672-3b2a-43cb-8782-d85eb014bf16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40d7814d-784a-4ef8-b67b-eb29e858f560" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_304b5672-3b2a-43cb-8782-d85eb014bf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ForeignCurrencyDenominatedDebtMember_56619512-a0df-47a3-a0ed-7e89499c912f" xlink:href="bdx-20230331.xsd#bdx_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_304b5672-3b2a-43cb-8782-d85eb014bf16" xlink:to="loc_bdx_ForeignCurrencyDenominatedDebtMember_56619512-a0df-47a3-a0ed-7e89499c912f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_8153504f-5301-4f0c-8d46-79df8bac3641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_304b5672-3b2a-43cb-8782-d85eb014bf16" xlink:to="loc_us-gaap_CurrencySwapMember_8153504f-5301-4f0c-8d46-79df8bac3641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TerminatedCurrencySwapMember_cb4c7b60-725c-4865-a93e-654d06334887" xlink:href="bdx-20230331.xsd#bdx_TerminatedCurrencySwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_304b5672-3b2a-43cb-8782-d85eb014bf16" xlink:to="loc_bdx_TerminatedCurrencySwapMember_cb4c7b60-725c-4865-a93e-654d06334887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cd2625d2-7b8b-4285-8f5f-a07f5e8a3c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d89670d-85e0-4b55-877a-3341b105313a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cd2625d2-7b8b-4285-8f5f-a07f5e8a3c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e90c64d0-cabd-4117-95df-203919d5640f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cd2625d2-7b8b-4285-8f5f-a07f5e8a3c14" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e90c64d0-cabd-4117-95df-203919d5640f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_be18023b-6292-47c2-a6a2-0772f21c7e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a252bd2b-073e-4641-b373-05751a97ef20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_be18023b-6292-47c2-a6a2-0772f21c7e97" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a252bd2b-073e-4641-b373-05751a97ef20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_04059ef1-fb02-4db9-965b-dfcfbe141f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a252bd2b-073e-4641-b373-05751a97ef20" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_04059ef1-fb02-4db9-965b-dfcfbe141f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3e8ef257-09b6-4bd5-993b-dae3e48848a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_04059ef1-fb02-4db9-965b-dfcfbe141f1a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3e8ef257-09b6-4bd5-993b-dae3e48848a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_bc9e2cbc-9b7d-4a96-8e35-5bb9865e24a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e8ef257-09b6-4bd5-993b-dae3e48848a2" xlink:to="loc_us-gaap_InterestRateSwapMember_bc9e2cbc-9b7d-4a96-8e35-5bb9865e24a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d6716f96-3b3d-4fcd-b0fd-5104410a099c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a252bd2b-073e-4641-b373-05751a97ef20" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d6716f96-3b3d-4fcd-b0fd-5104410a099c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_da98fc07-837e-4e0d-a364-9546632170fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d6716f96-3b3d-4fcd-b0fd-5104410a099c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_da98fc07-837e-4e0d-a364-9546632170fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_211e1ff6-b21c-44c4-b28e-e3966e8e2e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_da98fc07-837e-4e0d-a364-9546632170fb" xlink:to="loc_us-gaap_CashFlowHedgingMember_211e1ff6-b21c-44c4-b28e-e3966e8e2e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_3e9892b3-1da0-4c5f-ae0f-087032a18e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a252bd2b-073e-4641-b373-05751a97ef20" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_3e9892b3-1da0-4c5f-ae0f-087032a18e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_4298b0b6-4b8c-404d-a82f-b187310e7b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_3e9892b3-1da0-4c5f-ae0f-087032a18e3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_4298b0b6-4b8c-404d-a82f-b187310e7b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_03b15721-5ea2-4f4e-ae63-d08cfd89e912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_25b3ab85-4d82-4612-8f66-eefcbc5bfa2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_03b15721-5ea2-4f4e-ae63-d08cfd89e912" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_25b3ab85-4d82-4612-8f66-eefcbc5bfa2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_8c8c1950-a164-473c-a75d-0bfaba60cdec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_03b15721-5ea2-4f4e-ae63-d08cfd89e912" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_8c8c1950-a164-473c-a75d-0bfaba60cdec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1c4f4278-c675-422d-88da-c004ec78bc63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_03b15721-5ea2-4f4e-ae63-d08cfd89e912" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1c4f4278-c675-422d-88da-c004ec78bc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e664019e-291e-4147-ac65-36a03a1597a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_be388bc7-d074-4979-84ee-dbb65fa72c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e664019e-291e-4147-ac65-36a03a1597a8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_be388bc7-d074-4979-84ee-dbb65fa72c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_9b499a3b-88dd-46c2-9969-8e1565540bad" xlink:href="bdx-20230331.xsd#bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e664019e-291e-4147-ac65-36a03a1597a8" xlink:to="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_9b499a3b-88dd-46c2-9969-8e1565540bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableFairValueDisclosure_85399913-1991-43e2-ab42-24cbdf597e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e664019e-291e-4147-ac65-36a03a1597a8" xlink:to="loc_us-gaap_LoansPayableFairValueDisclosure_85399913-1991-43e2-ab42-24cbdf597e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3d013099-006b-43d6-80d5-2ae8220ba501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2673961f-ddbc-4716-bbc9-00bba67b7f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3d013099-006b-43d6-80d5-2ae8220ba501" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2673961f-ddbc-4716-bbc9-00bba67b7f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c2953d64-7007-4145-8fde-4575bb48856c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2673961f-ddbc-4716-bbc9-00bba67b7f95" xlink:to="loc_srt_RangeAxis_c2953d64-7007-4145-8fde-4575bb48856c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd7810d8-1a5a-4096-a8c3-0bf685c043e8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c2953d64-7007-4145-8fde-4575bb48856c" xlink:to="loc_srt_RangeMember_fd7810d8-1a5a-4096-a8c3-0bf685c043e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_82f4a446-fd9e-4ae6-b4ce-ef58fbaf42e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fd7810d8-1a5a-4096-a8c3-0bf685c043e8" xlink:to="loc_srt_MinimumMember_82f4a446-fd9e-4ae6-b4ce-ef58fbaf42e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8425d79a-49d8-4886-bbe9-b68fb932e0ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fd7810d8-1a5a-4096-a8c3-0bf685c043e8" xlink:to="loc_srt_MaximumMember_8425d79a-49d8-4886-bbe9-b68fb932e0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_110fee6d-09cf-4c1a-8d00-d3a5fa4b7036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2673961f-ddbc-4716-bbc9-00bba67b7f95" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_110fee6d-09cf-4c1a-8d00-d3a5fa4b7036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_299c31c4-448e-49cf-a04e-7d7fe7094c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_110fee6d-09cf-4c1a-8d00-d3a5fa4b7036" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_299c31c4-448e-49cf-a04e-7d7fe7094c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_55c65cb2-20f5-4084-9d69-5cbefa2efb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_299c31c4-448e-49cf-a04e-7d7fe7094c1f" xlink:to="loc_us-gaap_CostOfSalesMember_55c65cb2-20f5-4084-9d69-5cbefa2efb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c8b5199-0f1c-4354-a363-c7706f0680e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2673961f-ddbc-4716-bbc9-00bba67b7f95" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c8b5199-0f1c-4354-a363-c7706f0680e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MaturityPeriodOfShortTermInvestment_9587b89d-b21b-4900-965e-617a48fe2a90" xlink:href="bdx-20230331.xsd#bdx_MaturityPeriodOfShortTermInvestment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c8b5199-0f1c-4354-a363-c7706f0680e2" xlink:to="loc_bdx_MaturityPeriodOfShortTermInvestment_9587b89d-b21b-4900-965e-617a48fe2a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_7484eba3-52b6-416b-aaa0-a04026c7b45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c8b5199-0f1c-4354-a363-c7706f0680e2" xlink:to="loc_us-gaap_AssetImpairmentCharges_7484eba3-52b6-416b-aaa0-a04026c7b45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails" xlink:type="simple" xlink:href="bdx-20230331.xsd#FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_efa84aef-17ff-45e8-88fa-45d1ca893229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod_12df3457-52ad-44ba-8714-ac83f52d82c3" xlink:href="bdx-20230331.xsd#bdx_TransfersOfFinancialAssetsDuringThePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_efa84aef-17ff-45e8-88fa-45d1ca893229" xlink:to="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod_12df3457-52ad-44ba-8714-ac83f52d82c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_5e4dde30-ae27-4af8-aef9-8b4d3a76d366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_efa84aef-17ff-45e8-88fa-45d1ca893229" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_5e4dde30-ae27-4af8-aef9-8b4d3a76d366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtDetail" xlink:type="simple" xlink:href="bdx-20230331.xsd#DebtDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f523e129-9413-4072-ab92-d34c86e3d966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_265bc6ff-e070-4d9d-9cff-0539241c5ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f523e129-9413-4072-ab92-d34c86e3d966" xlink:to="loc_us-gaap_DebtInstrumentTable_265bc6ff-e070-4d9d-9cff-0539241c5ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_da15e184-aa19-470f-923a-394769bde136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_265bc6ff-e070-4d9d-9cff-0539241c5ce8" xlink:to="loc_us-gaap_DebtInstrumentAxis_da15e184-aa19-470f-923a-394769bde136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_74ea4cd7-aafb-404a-ae22-7a3f9cea4389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_da15e184-aa19-470f-923a-394769bde136" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_74ea4cd7-aafb-404a-ae22-7a3f9cea4389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4693DueFebruary132028Member_d05601cb-73b8-4fa1-a38d-180b1fe92412" xlink:href="bdx-20230331.xsd#bdx_Notes4693DueFebruary132028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_74ea4cd7-aafb-404a-ae22-7a3f9cea4389" xlink:to="loc_bdx_Notes4693DueFebruary132028Member_d05601cb-73b8-4fa1-a38d-180b1fe92412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3553DueSeptember132029Member_04bdc2a9-2f0f-49db-b37c-5872548ba49d" xlink:href="bdx-20230331.xsd#bdx_Notes3553DueSeptember132029Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_74ea4cd7-aafb-404a-ae22-7a3f9cea4389" xlink:to="loc_bdx_Notes3553DueSeptember132029Member_04bdc2a9-2f0f-49db-b37c-5872548ba49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_f35e904f-0d56-44d2-b885-5fc3a9a736f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_265bc6ff-e070-4d9d-9cff-0539241c5ce8" xlink:to="loc_srt_CurrencyAxis_f35e904f-0d56-44d2-b885-5fc3a9a736f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_9c1e8f31-1c98-47f5-abc2-09550f55b628" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_f35e904f-0d56-44d2-b885-5fc3a9a736f7" xlink:to="loc_currency_AllCurrenciesDomain_9c1e8f31-1c98-47f5-abc2-09550f55b628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_e9755db2-5043-45a7-981f-0dac4e25558b" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_9c1e8f31-1c98-47f5-abc2-09550f55b628" xlink:to="loc_currency_EUR_e9755db2-5043-45a7-981f-0dac4e25558b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_5b26717d-2f1d-4aac-98d1-ab1c4e5363df" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_9c1e8f31-1c98-47f5-abc2-09550f55b628" xlink:to="loc_currency_USD_5b26717d-2f1d-4aac-98d1-ab1c4e5363df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_275f54c6-195d-4d77-a789-94e0bc30f176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_265bc6ff-e070-4d9d-9cff-0539241c5ce8" xlink:to="loc_us-gaap_DebtInstrumentLineItems_275f54c6-195d-4d77-a789-94e0bc30f176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_66cc72c8-56d6-47bf-ba71-a5bc3720a8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_275f54c6-195d-4d77-a789-94e0bc30f176" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_66cc72c8-56d6-47bf-ba71-a5bc3720a8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_37951be1-d937-4ed2-adff-f39dc349d7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_275f54c6-195d-4d77-a789-94e0bc30f176" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_37951be1-d937-4ed2-adff-f39dc349d7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780580652688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-4802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Becton, Dickinson and Company<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-0760120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 Becton Drive,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Franklin Lakes,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07417-1880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(201)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">847-6800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">284,014,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000010795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable Preferred Stock | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDXB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member', window );">Notes 1.900% due December 15, 2026 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.900% Notes due December 15, 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.401dueMay242023Member', window );">Notes 1.401% due May 24, 2023 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.401% Notes due May 24, 2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX23A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member', window );">Notes 3.020% due May 24, 2025 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.020% Notes due May 24, 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0.632dueJune42023Member', window );">Notes 0.632% due June 4, 2023 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.632% Notes due June 4, 2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/23A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member', window );">Notes 1.208% due June 4, 2026 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.208% Notes due June 4, 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/26A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1213NotesDueFebruary122036Member', window );">Notes 1.213% Notes due February 12, 2036 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.213% Notes due February 12, 2036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0000DueAugust132023Member', window );">Notes 0.000% due August 13, 2023 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.000% Notes due August 13, 2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX23B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member', window );">Notes 0.034% due August 13, 2025 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.034% Notes due August 13, 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX25A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.401dueMay242023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.401dueMay242023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0.632dueJune42023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes0.632dueJune42023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1213NotesDueFebruary122036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1213NotesDueFebruary122036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0000DueAugust132023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes0000DueAugust132023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780583605696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 4,821<span></span>
</td>
<td class="nump">$ 4,750<span></span>
</td>
<td class="nump">$ 9,407<span></span>
</td>
<td class="nump">$ 9,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">2,586<span></span>
</td>
<td class="nump">2,637<span></span>
</td>
<td class="nump">5,038<span></span>
</td>
<td class="nump">5,135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="nump">1,205<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
<td class="nump">2,392<span></span>
</td>
<td class="nump">2,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="nump">651<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges', window );">Acquisition-related integration and restructuring expense</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating expense (income), net</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Operating Costs and Expenses</a></td>
<td class="nump">4,193<span></span>
</td>
<td class="nump">4,185<span></span>
</td>
<td class="nump">8,193<span></span>
</td>
<td class="nump">8,212<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income</a></td>
<td class="nump">628<span></span>
</td>
<td class="nump">564<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">1,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(118)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="num">(195)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from Continuing Operations Before Income Taxes</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">442<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
<td class="nump">1,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net Income from Continuing Operations</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">390<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="nump">958<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from Discontinued Operations, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred stock dividends</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income applicable to common shareholders</a></td>
<td class="nump">$ 438<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">$ 924<span></span>
</td>
<td class="nump">$ 1,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from Continuing Operations, Basic (USD per share)</a></td>
<td class="nump">$ 1.54<span></span>
</td>
<td class="nump">$ 1.29<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="nump">$ 3.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Income from Discontinued Operations, Basic (USD per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.22<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.61<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Earnings per Share (USD per share)</a></td>
<td class="nump">1.54<span></span>
</td>
<td class="nump">1.51<span></span>
</td>
<td class="nump">3.25<span></span>
</td>
<td class="nump">3.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from Continuing Operations, Diluted (USD per share)</a></td>
<td class="nump">1.53<span></span>
</td>
<td class="nump">1.28<span></span>
</td>
<td class="nump">3.24<span></span>
</td>
<td class="nump">3.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Income from Discontinued Operations, Diluted (USD per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.22<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.60<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Earnings per Share (USD per share)</a></td>
<td class="nump">1.53<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
<td class="nump">3.24<span></span>
</td>
<td class="nump">3.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per Common Share (USD per share)</a></td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="nump">$ 0.87<span></span>
</td>
<td class="nump">$ 1.82<span></span>
</td>
<td class="nump">$ 1.74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_AcquisitionRelatedCostsAndRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780579641536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 460<span></span>
</td>
<td class="nump">$ 454<span></span>
</td>
<td class="nump">$ 969<span></span>
</td>
<td class="nump">$ 1,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive (Loss) Income, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(21)<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Defined benefit pension and postretirement plans</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Cash flow hedges</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive (Loss) Income, Net of Tax</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income</a></td>
<td class="nump">$ 445<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">$ 882<span></span>
</td>
<td class="nump">$ 1,309<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780580574944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 1,981<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">2,413<span></span>
</td>
<td class="nump">2,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Materials</a></td>
<td class="nump">788<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">428<span></span>
</td>
<td class="nump">397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished products</a></td>
<td class="nump">2,441<span></span>
</td>
<td class="nump">2,120<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">3,656<span></span>
</td>
<td class="nump">3,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,444<span></span>
</td>
<td class="nump">1,559<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">9,587<span></span>
</td>
<td class="nump">8,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment</a></td>
<td class="nump">13,204<span></span>
</td>
<td class="nump">12,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less allowances for depreciation and amortization</a></td>
<td class="nump">6,848<span></span>
</td>
<td class="nump">6,402<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">6,356<span></span>
</td>
<td class="nump">6,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">24,780<span></span>
</td>
<td class="nump">24,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CoreAndDevelopedTechnologyNet', window );">Developed Technology, Net</a></td>
<td class="nump">8,610<span></span>
</td>
<td class="nump">9,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteLivedCustomerRelationshipsNet', window );">Customer Relationships, Net</a></td>
<td class="nump">2,512<span></span>
</td>
<td class="nump">2,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other Intangibles, Net</a></td>
<td class="nump">555<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets</a></td>
<td class="nump">1,994<span></span>
</td>
<td class="nump">1,848<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">54,394<span></span>
</td>
<td class="nump">52,934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">2,214<span></span>
</td>
<td class="nump">2,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Payables, accrued expenses and other current liabilities</a></td>
<td class="nump">5,090<span></span>
</td>
<td class="nump">5,632<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">7,304<span></span>
</td>
<td class="nump">7,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">16,010<span></span>
</td>
<td class="nump">13,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-Term Employee Benefit Obligations</a></td>
<td class="nump">920<span></span>
</td>
<td class="nump">902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Deferred Income Taxes and Other Liabilities</a></td>
<td class="nump">4,471<span></span>
</td>
<td class="nump">5,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (See Note 5)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock &#8212; $1 par value; authorized &#8212; 640,000,000 shares; issued &#8212; 364,639,901 shares in March&#160;31, 2023 and September&#160;30, 2022</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Capital in excess of par value</a></td>
<td class="nump">19,639<span></span>
</td>
<td class="nump">19,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">15,563<span></span>
</td>
<td class="nump">15,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CommonStockSharesHeldInEmployeeTrust1', window );">Deferred compensation</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock</a></td>
<td class="num">(8,327)<span></span>
</td>
<td class="num">(8,330)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,575)<span></span>
</td>
<td class="num">(1,488)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity</a></td>
<td class="nump">25,689<span></span>
</td>
<td class="nump">25,282<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">$ 54,394<span></span>
</td>
<td class="nump">$ 52,934<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CommonStockSharesHeldInEmployeeTrust1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of common stock issued to a trust (for example, but not limited to, rabbi trust) set up specifically to accumulate stock for the sole purpose of distribution to participating employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CommonStockSharesHeldInEmployeeTrust1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CoreAndDevelopedTechnologyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets arising from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CoreAndDevelopedTechnologyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_FiniteLivedCustomerRelationshipsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net carrying amount as of the balance sheet date of an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_FiniteLivedCustomerRelationshipsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780585825792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (shares)</a></td>
<td class="nump">640,000,000<span></span>
</td>
<td class="nump">640,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (shares)</a></td>
<td class="nump">364,639,901<span></span>
</td>
<td class="nump">364,639,901<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780587470480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 969<span></span>
</td>
<td class="nump">$ 1,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from Discontinued Operations, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net Income from Continuing Operations</a></td>
<td class="nump">969<span></span>
</td>
<td class="nump">958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to net income from continuing operations to derive net cash provided by continuing operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,130<span></span>
</td>
<td class="nump">1,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(325)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapital', window );">Change in operating assets and liabilities</a></td>
<td class="num">(1,274)<span></span>
</td>
<td class="num">(1,076)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_IncreaseDecreaseinPensionBenefitObligation', window );">Pension obligation</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(136)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other, net</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net Cash Provided by Continuing Operating Activities</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(389)<span></span>
</td>
<td class="num">(405)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(450)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="num">(134)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net Cash Used for Continuing Investing Activities</a></td>
<td class="num">(524)<span></span>
</td>
<td class="num">(979)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Change in short-term debt</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans', window );">Proceeds from long-term debt</a></td>
<td class="nump">1,662<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ProceedsFromSpinoffTransaction', window );">Distribution from Embecta Corp. (see Note 2)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments of debt</a></td>
<td class="num">(529)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(563)<span></span>
</td>
<td class="num">(541)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net Cash Provided by Continuing Financing Activities</a></td>
<td class="nump">835<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash provided by operating activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash used for investing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations', window );">Net cash provided by financing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations', window );">Net Cash Provided by Discontinued Operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and equivalents and restricted cash</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and equivalents and restricted cash</a></td>
<td class="nump">909<span></span>
</td>
<td class="nump">928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Opening Cash and Equivalents and Restricted Cash</a></td>
<td class="nump">1,159<span></span>
</td>
<td class="nump">2,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Closing Cash and Equivalents and Restricted Cash</a></td>
<td class="nump">$ 2,068<span></span>
</td>
<td class="nump">$ 3,320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_IncreaseDecreaseinPensionBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for pension benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_IncreaseDecreaseinPensionBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ProceedsFromSpinoffTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Spinoff Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ProceedsFromSpinoffTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer, and term loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in cash associated with the entity's discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780583673264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, in the opinion of the management of Becton, Dickinson and Company (the "Company" or "BD"), include all adjustments which are of a normal recurring nature, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented. However, the financial statements do not include all information and accompanying notes required for a presentation in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#8217;s 2022 Annual Report on Form 10-K.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company. The historical results of the Diabetes Care business (previously included in BD&#8217;s Medical segment) that was contributed to Embecta Corp (&#8220;Embecta&#8221;) in the spin-off, as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in the Company&#8217;s condensed consolidated financial statements for the three and six months ended March 31, 2022. Additional disclosures regarding the spin-off are provided in Note 2.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780585398016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-Off of Embecta Corp.<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Spin-Off of Embecta Corp.</a></td>
<td class="text">Spin-Off of Embecta Corp.<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta through a distribution of Embecta&#8217;s publicly traded common stock (listed on NASDAQ under the ticker symbol &#8220;EMBC&#8221;) to BD&#8217;s shareholders of record as of the close of business on March 22, 2022 (the &#8220;record date&#8221;). The Company distributed one share of Embecta common stock for every five common shares of BD outstanding as of the record date and shareholders received cash in lieu of fractional shares of Embecta common stock. BD retained no ownership interest in Embecta subsequent to the spin-off. The distribution is expected to qualify and has been treated as tax-free to the Company and its shareholders for U.S. federal income tax purposes.  On March 31, 2022, Embecta used a portion of the proceeds from its financing transactions to make a cash distribution of approximately $1.266&#160;billion to the Company.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off. Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and supply agreements, a lease agreement, a distribution agreement to support commercial operations, a logistics services agreement and other agreements including an employee matters agreement and a tax matters agreement. Under these agreements, the Company will continue to provide certain products and services to Embecta following the spin-off. The agreements do not provide the Company with the ability to influence the operating or financial policies of Embecta subsequent to the spin-off date. Amounts included in the Company&#8217;s condensed consolidated statements of income during the three and six months ended March&#160;31, 2023 as a result of these agreements were</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> immaterial.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are as follows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.309%"><tr><td style="width:1.0%"/><td style="width:67.283%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.821%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations Before Income Taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations, Net of Tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended March&#160;31, 2022, the Company incurred $53&#160;million and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$78&#160;million, respectively,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of separation costs, including those for consulting, legal, tax and other advisory services associated with the spin-off, which were previously recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense (income), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These amounts were recast as components of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income from Discontinued Operations, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as detailed above</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The amounts of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span> from discontinued operations detailed above include previously eliminated intercompany transactions that occurred between BD and Embecta, which resulted in a third-party sale in the same period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584443248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders' Equity<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"/><td style="width:35.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.027%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,283)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,330)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.91 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,590&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,384&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,738)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,333)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.91 per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,639&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,563&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,625)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,327)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"/><td style="width:35.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.027%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,164)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,723)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.87 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,869)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.87 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,495&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,416&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,575)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,866)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Common stock held in trusts consists of the Company&#8217;s shares held in rabbi trusts in connection with deferred compensation under the Company&#8217;s employee salary and bonus deferral plan and directors&#8217; deferral plan. During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company&#8217;s Series C preferred shares to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business was completed on April 1, 2022.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10&#160;million shares, which has been fully utilized. In November 2021, the Board of Directors authorized the Company to repurchase up to an additional 10&#160;million shares of BD common stock, for which there is also no expiration date.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components and changes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the first two quarters of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"/><td style="width:47.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,488)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,559)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,575)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,088)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"><tr><td style="width:1.0%"/><td style="width:47.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,251)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(774)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,910)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,173)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of foreign currency translation recognized in other comprehensive income during the three and six months ended March&#160;31, 2023 and 2022 included net (losses) gains relating to net investment hedges. The amounts recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022 are primarily related to forward starting interest rate swaps. Additional disclosures regarding amounts the Company recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022 are provided in Note 11.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impacts for amounts recognized in other comprehensive income (loss) before reclassifications and for reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to benefit plans and cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584505456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per Share</a></td>
<td class="text">Earnings per Share<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:49.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.461%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from share-based plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from Series C preferred shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common and common equivalent shares outstanding &#8211; assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,645&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,299&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share equivalents excluded from the diluted shares outstanding calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mandatory convertible preferred stock (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based plans (c)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business on April 1, 2022 was completed.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#8217;s common shares.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584615536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations. Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries). With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#8220;CIDs&#8221;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company is defending approximately 33,285 product liability claims involving the Company&#8217;s line of hernia repair devices (collectively, the &#8220;Hernia Product Claims&#8221;). The majority of those claims are currently pending in a coordinated proceeding in Rhode Island State Court (&#8220;RI&#8221;) and in a federal multi-district litigation (&#8220;MDL&#8221;) established in the Southern District of Ohio, but claims are also pending in other state and/or federal court jurisdictions. In addition, those claims include multiple putative class actions in Canada. Generally, the Hernia Product Claims seek damages for personal injury allegedly resulting from use of the products. From time to time, the Company engages in resolution discussions with plaintiffs&#8217; law firms regarding certain of the Hernia Product Claims, but the Company also intends to vigorously defend Hernia Product Claims that do not settle, including through litigation. The outcome in any one trial is not representative of potential outcomes of all cases or claims related to the Company&#8217;s product liability matters.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The first bellwether trial in the hernia MDL resulted in a complete defense verdict in favor of the Company in September 2021.  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The second hernia MDL bellwether resulted in a $255&#160;thousand verdict in April 2022. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The first bellwether trial in RI resulted in a $4.8&#160;million verdict in August 2022, which the Company plans to appeal.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trials are currently scheduled in state and/or federal courts, including additional bellwether trials in the MDL in October 2023 </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and January 2024. The Company also expects additional trials of Hernia Product Claims to take place over the next 12 months in RI, including trials in September 2023 and October 2023.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also continues to be a defendant in certain other mass tort litigation. As of March&#160;31, 2023, the Company is defending product liability claims involving the Company&#8217;s line of pelvic mesh products, the majority of which are pending in various federal court jurisdictions and in a coordinated proceeding in New Jersey Superior Court. Also, as of March&#160;31, 2023, the Company is defending product liability claims involving the Company&#8217;s line of inferior vena cava (&#8220;IVC&#8221;) filter products. The majority of those claims are pending in various federal court jurisdictions after having been remanded from the MDL in the United States District Court for the District of Arizona.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In most product liability litigations like those described above, plaintiffs allege a wide variety of claims, ranging from allegations of serious injury caused by the products to efforts to obtain compensation notwithstanding the absence of any injury. In many of these cases, the Company has not yet received and reviewed complete information regarding the plaintiffs and their medical conditions and, consequently, is unable to fully evaluate the claims. The Company expects that it will receive and review additional information regarding any remaining unsettled product liability matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, a putative class action captioned Kabak v. Becton, Dickinson and Company, et al., Civ. No. 2:20-cv-02155 (SRC) (CLW), now captioned Industriens Pensionsforsikring v. Becton, Dickinson and Company, et al., was filed in the U.S. District Court for the District of New Jersey against the Company and certain of its officers. The complaint, which purports to be brought on behalf of all persons (other than defendants) who purchased or otherwise acquired the Company's common stock from November 5, 2019 through February 5, 2020, asserts claims for purported violations of Sections 10 and 20 of the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;) and Securities and Exchange Commission (&#8220;SEC&#8221;) Rule 10b-5 promulgated thereunder, and seeks, among other things, damages and costs. The complaint alleges that defendants concealed certain material information regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, allegedly rendering certain public statements about the Company&#8217;s business, operations and prospects false or misleading, thereby allegedly causing investors to purchase stock at an inflated price. After an initial without prejudice dismissal, the plaintiff filed amended pleadings, which the Company in turn moved to dismiss. Ultimately, the court permitted certain aspects of the case to proceed. An answer with affirmative defenses was thereafter filed on October 3, 2022. Discovery has commenced and plaintiff&#8217;s motion for class certification was filed on January 17, 2023. The Company believes that it has strong defenses to the allegations that were not dismissed and it intends to defend itself vigorously.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 2, 2020, a putative shareholder derivative action captioned Jankowski v. Forlenza, et al., Civ. No. 2:20-cv-15474, was filed in the U.S. District Court for the District of New Jersey by a shareholder, derivatively on behalf of the Company, against certain of the Company&#8217;s directors and officers. The complaint asserts claims for breach of fiduciary duty, violations of sections 10(b), 14(a) and 21D of the Exchange Act, and insider trading. The complaint principally alleges that the Company made misleading statements regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> infusion pumps in a proxy statement and other SEC filings. A second derivative action was filed on January 24, 2021, and the two actions were consolidated. In March 2021, the Company received letters from two additional shareholders which, in general, mirrored the allegations in the derivative actions, and demanded, among other things, that the Board of Directors pursue claims against members of management for claimed breaches of fiduciary duties. Consistent with New Jersey law, the Board appointed a special committee to review the allegations and demands in the derivative actions and demand letters. Following an investigation, the special committee determined that no action was warranted, and rejected the shareholders&#8217; demands, communicating its determination to counsel for the shareholders. On January 10, 2023, one of the two shareholders referenced above filed a separate derivative action that: (i) is generally consistent with the shareholder letter and the two prior actions; and (ii) purports to challenge the reasonableness of the special committee&#8217;s process and determination. The Company believes that is has strong defenses to these claims and intends to defend itself vigorously.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company was sued by a competitor in the Northern District of New York, alleging antitrust violations related to certain aspects of the Company&#8217;s medical delivery solutions business in a case captioned AngioDynamics, Inc. v. C. R. Bard, Inc. et al., Civ. No. 1:17-CV-0598. Trial began on September 19, 2022, resulting in a complete defense verdict for the Company on October 6, 2022, from which AngioDynamics filed a notice of appeal. AngioDynamics withdrew its appeal and on February 17, 2023, the Second Circuit Court of Appeals entered an order dismissing the appeal, which preserved the trial victory and closed the case.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company received a subpoena from the Enforcement Division of the SEC requesting information from the Company relating to, among other things, Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps. The Company is cooperating with the SEC and responding to these requests. The Company cannot anticipate the timing, scope, outcome or possible impact of the investigation, financial or otherwise. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Department of Justice served the Company and CareFusion with CIDs seeking information regarding certain of CareFusion&#8217;s contracts with the Department of Veteran&#8217;s Affairs for certain products, including Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Pyxis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, in connection with a civil investigation of possible violations of the False Claims Act, and the government recently expanded the investigation to include several additional contracts. The government has made several requests for documents and interviews or depositions of Company personnel. The Company is cooperating with the government and responding to these requests. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company received a CID related to an inquiry initiated by the Northern District of Georgia in 2018.  The requests concern sales and marketing practices with respect to certain aspects of the Company&#8217;s urology business. The government has made requests for documents and has interviewed employees. The inquiry is ongoing and the Company is cooperating with the government and responding to its requests.  The Company and the government have agreed to mediation in an effort to resolve this dispute. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023, the Department of Justice served the Company with a CID seeking information regarding the Company&#8217;s Genesis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> container products in connection with an investigation of possible violations of the False Claims Act. The government has made requests for documents and the Company is cooperating with the government and responding to its requests.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company was served with a complaint from the New Mexico Attorney General, alleging violations of the state&#8217;s consumer protection laws in connection with the sales and marketing of its IVC filters. The Company&#8217;s motion to dismiss certain of the claims was granted on May 10, 2022 and discovery is proceeding as to the remaining claims. The Company intends to vigorously defend itself in the litigation. As the case is in its early stages, the Company cannot anticipate the timing, scope, outcome or possible impact at present.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company was sued in state and federal courts in Georgia by plaintiffs who work or reside near Company facilities in Covington, GA, where ethylene oxide (&#8220;EtO&#8221;) sterilization activities take place. The federal cases have been dismissed and refiled in state court. The plaintiffs in the cases seek compensatory and punitive damages. Pursuant to Georgia statute, punitive damages in these cases are generally capped at $250,000 per claimant. The cases allege a variety of injuries, including but not limited to multiple types of cancer, allegedly attributable to exposure to EtO. The Company does not believe these cases are appropriate for class action treatment and they have not been filed as such. The Company currently has approximately 220 of such suits involving approximately 320 plaintiffs; approximately 45 of the cases also allege injury caused by exposure to a chemical of another defendant entirely unrelated to the Company. Three trial dates have been set in 2024. The Company has meritorious defenses and intends to defend itself vigorously and believes that future claims would generally face statute of limitations hurdles.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business. The Company believes that it has meritorious defenses to these suits pending against the Company and is engaged in a vigorous defense of each of these matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict the outcome of these other legal matters discussed above, nor can it predict whether any outcome will have a material adverse effect on the Company&#8217;s consolidated results of operations and/or consolidated cash flows. Accordingly, the Company has made no provisions for these other legal matters in its consolidated results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a potentially responsible party to a number of federal administrative proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#8220;Superfund,&#8221; and similar state laws. The Company also is subject to administrative proceedings under environmental laws in jurisdictions outside the U.S. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are underway or commencing. For several sites, there are other potentially responsible parties that may be jointly or severally liable to pay all or part of cleanup costs. While it is not feasible to predict the outcome of these proceedings, based upon the Company&#8217;s experience, current information and applicable law, the Company does not expect these proceedings to have a material adverse effect on its consolidated results of operations and/or consolidated cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Accruals</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly monitors and evaluates the status of product liability and other legal matters, and may, from time-to-time, engage in settlement and mediation discussions taking into consideration developments in the matters and the risks and uncertainties surrounding litigation. These discussions could result in settlements of one or more of these claims at any time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the following information when estimating its product liability accruals, including, but not limited to: the nature, quantity, and quality of unfiled and filed claims; the continued rate of claims being filed in certain product liability matters; the status of certain settlement discussions with plaintiffs&#8217; counsel; the allegations and documentation supporting or refuting such allegations; publicly available information regarding similar medical device mass tort settlements; historical </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information regarding other product liability settlements involving the Company; and the stage of litigation. Because the information that is currently available regarding product liability matters is often limited, there is inherent uncertainty and volatility relating to the Company&#8217;s estimate of product liability. As additional information becomes available, the Company records adjustments to its product liability accruals as required.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for the Company's product liability claims which are discussed above, as well as the related legal defense costs, amounted to approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.9&#160;billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $2.1 billion on March&#160;31, 2023 and September&#160;30, 2022, respectively. These accruals, which are generally long-term in nature, are largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the Company's condensed consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition, and/or consolidated cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780588979440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text">Revenues<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policies for recognizing sales have not changed from those described in the Company&#8217;s 2022 Annual Report on Form 10-K. The Company sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products which are distributed through independent distribution channels and directly by BD through sales representatives. End-users of the Company's products include healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns. The Company&#8217;s rebate liability at March&#160;31, 2023 and September&#160;30, 2022 was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$541&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $525&#160;million, respectively. The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Revenue Arrangements on Consolidated Balance Sheets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized contract costs associated with the costs to fulfill contracts for certain products in the Medication Management Solutions organizational unit are immaterial to the Company's condensed consolidated balance sheets. Commissions relating to revenues recognized over a period longer than one year are recorded as assets which are amortized over the period over which the revenues underlying the commissions are recognized. Capitalized contract costs related to such commissions are immaterial to the Company's condensed consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities for unearned revenue that is allocable to performance obligations, such as extended warranty and software maintenance contracts, which are performed over time are immaterial to the Company's consolidated financial results. The Company's liability for product warranties provided under its agreements with customers is not material to its condensed consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligations relative to service contracts and pending installations of equipment, primarily in the Company's Medication Management Solutions unit, represent unsatisfied performance obligations of the Company. The revenues under existing contracts with original expected durations of more than one year, which are attributable to products and/or services that have not yet been installed or provided are estimated to be approximately $2.5 billion at March&#160;31, 2023. The Company expects to recognize the majority of this revenue over the next three years.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Company's Medication Management Solutions, Medication Delivery Solutions, Integrated Diagnostic Solutions, and Biosciences units, some contracts also contain minimum purchase commitments of reagents or other consumables, and the future sales of these consumables represent additional unsatisfied performance obligations of the Company. The revenue attributable to the unsatisfied minimum purchase commitment-related performance obligations, for contracts with original </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expected durations of more than one year, is estimated to be approximately&#160;$2.2 billion&#160;at&#160;March&#160;31, 2023.&#160;This revenue will be recognized over the customer relationship periods.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A disaggregation of the Company's revenues by segment, organizational unit and geographic region is provided in Note 7.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584653536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Data</a></td>
<td class="text">Segment Data<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's organizational structure is based upon three worldwide business segments: BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional (&#8220;Interventional&#8221;). The Company's segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services. Segment disclosures are on a performance basis consistent with internal management reporting. The Company evaluates performance of its business segments and allocates resources to them primarily based upon segment operating income, which represents revenues reduced by product costs and operating expenses. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to its spin-off on April 1, 2022, the Company reported the Diabetes Care business as an organizational unit within the Medical segment. As such, historical financial information of the Medical segment has been recast in the tables below to reflect the total segment revenues and revenues from continuing operations. Revenues and operating income from the Diabetes Care business prior to its spin-off are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 2 for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by segment, organizational unit and geographical areas for the three and six-month periods are detailed below. The Company has no material intersegment revenues. </span></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.590%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,339&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from continuing operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,733&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,081&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.058%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.624%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,515&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Company revenues from continuing operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,462&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,944&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,407&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,096&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,468&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment income for the three and six-month periods was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Income from Continuing Operations Before Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Segment Operating Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other unallocated items (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income from Continuing Operations Before Income Taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,041&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The amounts for the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended March 31, 2022 include a charge of $54&#160;million recorded to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to write down the carrying value of certain fixed assets in the Pharmaceutical Systems unit, as well as a charge of $35&#160;million to adjust estimated future product remediation costs.</span></div>(b)Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584563856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit Plans<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has defined benefit pension plans covering certain employees in the United States and certain international locations. The measurement date used for these plans is September&#160;30.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension cost included the following components for the three and six-month periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:45.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in prior periods. All components of the Company&#8217;s net periodic pension and postretirement benefit costs, aside from service cost, are recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense), net</span> on its condensed consolidated statements of income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584640624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Business Restructuring Charges</a></td>
<td class="text">Business Restructuring Charges<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred restructuring costs during the six months ended March&#160;31, 2023, primarily in connection with the Company's simplification and other cost saving initiatives, which were recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These simplification and other costs saving initiatives are focused on reducing complexity, enhancing product quality, refining customer experience, and improving cost efficiency across all of the Company&#8217;s segments. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring liability activity for the six months ended March&#160;31, 2023 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"><tr><td style="width:1.0%"/><td style="width:36.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee<br/>Termination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a)&#160;&#160;&#160;&#160;Expense primarily relates to other costs associated with the execution of the Company&#8217;s cost efficiency and restructuring programs, such as incremental project management costs and asset write-offs.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780599042192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,979)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, trademarks and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(604)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,481)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,632&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,723)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,264&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible amortization expense for the three months ended&#160;March&#160;31, 2023 and 2022&#160;was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$366 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and $352 million, respectively.  Intangible amortization expense for the six months ended&#160;March&#160;31, 2023 and 2022&#160;was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$731 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $707 million, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"/><td style="width:38.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.357%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life&#160;Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interventional</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,780&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780588320720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text">Derivative Instruments and Hedging Activities<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to mitigate certain exposures. The Company does not enter into derivative financial instruments for trading or speculative purposes. The effects these derivative instruments and hedged items had on the Company&#8217;s balance sheets and the fair values of the derivatives outstanding at March&#160;31, 2023 and September&#160;30, 2022 were not material. The effects on the Company&#8217;s financial performance and cash flows are provided below.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risks and Related Strategies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts. In order to mitigate foreign currency exposure relating to its investments in certain foreign subsidiaries, the Company has hedged the currency risk associated with those investments with certain instruments, such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments as of March&#160;31, 2023 and September&#160;30, 2022 were as follows:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"/><td style="width:36.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.089%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains or losses relating to the net investment hedges, which are attributable to changes in the foreign currencies to U.S. dollar spot exchange rates, are recorded as accumulated foreign currency translation in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the termination of a net investment hedge, any net gain or loss included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relative to the investment hedge remains until the foreign subsidiary investment is disposed of or is substantially liquidated.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (losses) gains recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the Company's net investment hedges for the three and six-month periods were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:45.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The amounts for the three and six months ended March&#160;31, 2023 include a gain, net of tax, of $13&#160;million recognized on terminated cross-currency swaps.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risks and Related Strategies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If interest rate derivatives designated as cash flow hedges are terminated, the balance in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attributable to those derivatives is reclassified into earnings, within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the remaining life of the hedged debt. The amounts reclassified from accumulated other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022, as well as the amounts expected to be reclassified within the next 12 months, are not material to the Company's consolidated financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net after-tax gains (losses) recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to interest rate cash flow hedges during the three and six months ended March&#160;31, 2023 were immaterial to the Company&#8217;s consolidated financial results and were $43&#160;million and $39&#160;million during the three and six months ended March&#160;31, 2022, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates. Amounts recorded during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s interest rate-related derivative instruments as of March&#160;31, 2023 and September&#160;30, 2022 were as follows: </span></div><div style="margin-top:3pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"/><td style="width:39.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.   </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Risk Exposures</span></div>The Company purchases resins, which are oil-based components used in the manufacture of certain products. Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results. From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts. The Company's commodity derivative forward contracts at March&#160;31, 2023 and September&#160;30, 2022 were immaterial to the Company's consolidated financial results.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780579648928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments and Fair Value Measurements</a></td>
<td class="text">Financial Instruments and Fair Value Measurements<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciles cash and equivalents and restricted cash reported within the Company's condensed consolidated balance sheets at March&#160;31, 2023 and September&#160;30, 2022 to the total of these amounts shown on the Company's condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"><tr><td style="width:1.0pt"/><td style="width:166.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase. Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s financial instruments are as follows:</span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"/><td style="width:40.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional money market accounts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">These financial instruments are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the condensed consolidated balance sheets. The institutional money market accounts permit daily redemption. The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The short-term investments consist of instruments with maturities greater than three months and less than one year. All other instruments measured by the Company at fair value, including derivatives and contingent consideration liabilities, are immaterial to the Company's condensed consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonrecurring Fair Value Measurements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of fiscal year 2022, the Company recorded a noncash asset impairment charge of $54&#160;million to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Medical segment. The amount recognized was recorded to adjust the carrying amount of assets to the assets' fair values, which was estimated, based upon a market participant's perspective, using Level 3 inputs, including values estimated using the income approach.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transfers of trade receivables</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the normal course of its business activities, the Company transfers certain trade receivable assets to third parties under factoring agreements. Per the terms of these agreements, the Company surrenders control over its trade receivables upon transfer.&#160;Accordingly, the Company accounts for the transfers as sales of trade receivables by recognizing an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade receivables, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when proceeds from the transactions are received.&#160;The costs incurred by the Company in connection with factoring activities were not material to its consolidated financial results. The amounts transferred and yet to be remitted under factoring arrangements are provided below.</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables transferred to third parties under factoring arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"/><td style="width:56.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.628%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts yet to be collected and remitted to the third parties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584561856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">DebtIn February 2023, the Company issued $800&#160;million of 4.693% notes due February 13, 2028. Also in February 2023, Becton Dickinson Euro Finance S.&#224; r.l., a private limited liability company (soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e), which is an indirect, wholly-owned finance subsidiary of the Company, issued &#8364;800&#160;million ($868&#160;million) of 3.553% Euro-denominated notes due September 13, 2029 (the &#8220;BD Finance Notes&#8221;). The BD Finance Notes are fully and unconditionally guaranteed on a senior unsecured basis by the Company. No other of the Company's subsidiaries provide any guarantees with respect to the BD Finance Notes. The indenture covenants included a limitation on liens and a restriction on sale and leasebacks, change of control and consolidation, merger and sale of assets covenants. These covenants are subject to a number of exceptions, limitations and qualifications. The indenture does not restrict the Company, Becton Dickinson Euro Finance S.&#224; r.l., or any other of the Company's subsidiaries from incurring additional debt or other liabilities, including additional senior debt. Additionally, the indenture does not restrict Becton Dickinson Euro Finance S.&#224; r.l. and the Company from granting security interests over its assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780583287840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text">The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations. Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries). With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#8220;CIDs&#8221;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition, and/or consolidated cash flows.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.</span></div>The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text">The Company uses derivative instruments to mitigate certain exposures. The Company does not enter into derivative financial instruments for trading or speculative purposes.The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If interest rate derivatives designated as cash flow hedges are terminated, the balance in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attributable to those derivatives is reclassified into earnings, within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense,</span> over the remaining life of the hedged debt.For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents</a></td>
<td class="text">Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions.Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The short-term investments consist of instruments with maturities greater than three months and less than one year.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780599042192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-Off of Embecta Corp. (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.309%"><tr><td style="width:1.0%"/><td style="width:67.283%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.821%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations Before Income Taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations, Net of Tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780585348256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Shareholders Equity</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"/><td style="width:35.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.027%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,283)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,330)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.91 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,590&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,384&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,738)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,333)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.91 per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,639&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,563&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,625)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,327)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"/><td style="width:35.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.027%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,164)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,723)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.87 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,869)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.87 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares under employee and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,495&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,416&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,575)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,866)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Common stock held in trusts consists of the Company&#8217;s shares held in rabbi trusts in connection with deferred compensation under the Company&#8217;s employee salary and bonus deferral plan and directors&#8217; deferral plan. During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company&#8217;s Series C preferred shares to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business was completed on April 1, 2022.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10&#160;million shares, which has been fully utilized. In November 2021, the Board of Directors authorized the Company to repurchase up to an additional 10&#160;million shares of BD common stock, for which there is also no expiration date.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components and changes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the first two quarters of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"/><td style="width:47.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,488)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,559)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,575)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,088)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"><tr><td style="width:1.0%"/><td style="width:47.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,251)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(774)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,910)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,173)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584565440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:49.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.461%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from share-based plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from Series C preferred shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common and common equivalent shares outstanding &#8211; assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,645&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,299&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share equivalents excluded from the diluted shares outstanding calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mandatory convertible preferred stock (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based plans (c)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business on April 1, 2022 was completed.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#8217;s common shares.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780585753744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Area</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by segment, organizational unit and geographical areas for the three and six-month periods are detailed below. The Company has no material intersegment revenues. </span></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.590%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,339&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from continuing operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,733&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,081&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.058%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.624%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,515&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Company revenues from continuing operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,462&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,944&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,407&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,096&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,468&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Financial Information for Company's Segments</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment income for the three and six-month periods was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Income from Continuing Operations Before Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Segment Operating Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other unallocated items (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income from Continuing Operations Before Income Taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,041&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The amounts for the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended March 31, 2022 include a charge of $54&#160;million recorded to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to write down the carrying value of certain fixed assets in the Pharmaceutical Systems unit, as well as a charge of $35&#160;million to adjust estimated future product remediation costs.</span></div>(b)Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584626128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Net Pension and Postretirement Cost</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension cost included the following components for the three and six-month periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:45.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584620016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Restructuring Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Summary of Restructuring Accrual Activity</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring liability activity for the six months ended March&#160;31, 2023 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"><tr><td style="width:1.0%"/><td style="width:36.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee<br/>Termination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a)&#160;&#160;&#160;&#160;Expense primarily relates to other costs associated with the execution of the Company&#8217;s cost efficiency and restructuring programs, such as incremental project management costs and asset write-offs.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584584480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Components of Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,979)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, trademarks and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(604)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,481)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,632&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,723)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,264&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Reconciliation of Goodwill by Business Segment</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"/><td style="width:38.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.357%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life&#160;Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interventional</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,780&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780592026880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments as of March&#160;31, 2023 and September&#160;30, 2022 were as follows:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"/><td style="width:36.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.089%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s interest rate-related derivative instruments as of March&#160;31, 2023 and September&#160;30, 2022 were as follows: </span></div><div style="margin-top:3pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"/><td style="width:39.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  </span></div>(b)Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (losses) gains recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the Company's net investment hedges for the three and six-month periods were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:45.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The amounts for the three and six months ended March&#160;31, 2023 include a gain, net of tax, of $13&#160;million recognized on terminated cross-currency swaps.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780510615152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciles cash and equivalents and restricted cash reported within the Company's condensed consolidated balance sheets at March&#160;31, 2023 and September&#160;30, 2022 to the total of these amounts shown on the Company's condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"><tr><td style="width:1.0pt"/><td style="width:166.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s financial instruments are as follows:</span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"/><td style="width:40.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional money market accounts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">These financial instruments are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the condensed consolidated balance sheets. The institutional money market accounts permit daily redemption. The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock', window );">Transfer of Financial Assets Accounted for as Sales</a></td>
<td class="text">The amounts transferred and yet to be remitted under factoring arrangements are provided below.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables transferred to third parties under factoring arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"/><td style="width:56.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.628%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts yet to be collected and remitted to the third parties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780580643232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-Off of Embecta Corp. - Additional Information (Details) - Discontinued Operations, Disposed of by Means Other than Sale, Spinoff<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash', window );">Disposal Groups, Including Discontinued Operation, Consideration, Cash</a></td>
<td class="nump">$ 1,266<span></span>
</td>
<td class="nump">$ 1,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense', window );">Disposal Group, Including Discontinued Operation, Other Expense</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Groups, Including Discontinued Operation, Consideration, Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780587242528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-Off of Embecta Corp. - Income from Discontinued Operations, Net of Tax (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from Discontinued Operations, Net of Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember', window );">Discontinued Operations, Disposed of by Means Other than Sale, Spinoff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet', window );">Other operating expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Total Operating Costs and Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income from Discontinued Operations Before Income Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from Discontinued Operations, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Research and Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1063-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1060-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780579314384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Sep. 24, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="nump">$ 1,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 25,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per Common Share (USD per share)</a></td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="nump">$ 0.87<span></span>
</td>
<td class="nump">$ 0.87<span></span>
</td>
<td class="nump">$ 1.82<span></span>
</td>
<td class="nump">$ 1.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Number of shares authorized to be repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased', window );">Number of additional shares authorized to be repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock&#160; Issued at&#160;Par&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Capital in Excess&#160;of Par&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">19,590<span></span>
</td>
<td class="nump">19,553<span></span>
</td>
<td class="nump">19,435<span></span>
</td>
<td class="nump">19,272<span></span>
</td>
<td class="nump">19,553<span></span>
</td>
<td class="nump">19,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under employee and other plans, net</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CommonStockHeldInTrustsAcquired', window );">Common stock held in trusts, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">19,639<span></span>
</td>
<td class="nump">19,590<span></span>
</td>
<td class="nump">19,495<span></span>
</td>
<td class="nump">19,435<span></span>
</td>
<td class="nump">19,639<span></span>
</td>
<td class="nump">19,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">15,384<span></span>
</td>
<td class="nump">15,157<span></span>
</td>
<td class="nump">14,233<span></span>
</td>
<td class="nump">13,826<span></span>
</td>
<td class="nump">15,157<span></span>
</td>
<td class="nump">13,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">509<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="nump">677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Common dividends</a></td>
<td class="num">(259)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Preferred dividends</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">15,563<span></span>
</td>
<td class="nump">15,384<span></span>
</td>
<td class="nump">14,416<span></span>
</td>
<td class="nump">14,233<span></span>
</td>
<td class="nump">15,563<span></span>
</td>
<td class="nump">14,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under employee and other plans, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">$ (8,333)<span></span>
</td>
<td class="num">$ (8,330)<span></span>
</td>
<td class="num">$ (7,855)<span></span>
</td>
<td class="num">$ (7,723)<span></span>
</td>
<td class="num">$ (8,330)<span></span>
</td>
<td class="num">$ (7,723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares)</a></td>
<td class="num">(80,738)<span></span>
</td>
<td class="num">(81,283)<span></span>
</td>
<td class="num">(79,869)<span></span>
</td>
<td class="num">(80,164)<span></span>
</td>
<td class="num">(81,283)<span></span>
</td>
<td class="num">(80,164)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under employee and other plans, net</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued for share-based compensation and other plans, net (in shares)</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">556<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="nump">762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CommonStockHeldInTrustsAcquired', window );">Common stock held in trusts, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CommonStockHeldInTrustsNetShares', window );">Common stock held in trusts, net (in shares)</a></td>
<td class="nump">92<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(462)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (8,327)<span></span>
</td>
<td class="num">$ (8,333)<span></span>
</td>
<td class="num">$ (7,866)<span></span>
</td>
<td class="num">$ (7,855)<span></span>
</td>
<td class="num">$ (8,327)<span></span>
</td>
<td class="num">$ (7,866)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares)</a></td>
<td class="num">(80,625)<span></span>
</td>
<td class="num">(80,738)<span></span>
</td>
<td class="num">(79,575)<span></span>
</td>
<td class="num">(79,869)<span></span>
</td>
<td class="num">(80,625)<span></span>
</td>
<td class="num">(79,575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CommonStockHeldInTrustsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock Held in Trusts, Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CommonStockHeldInTrustsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CommonStockHeldInTrustsNetShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common stock shares held in trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CommonStockHeldInTrustsNetShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780579180368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">$ (1,559)<span></span>
</td>
<td class="num">$ (1,488)<span></span>
</td>
<td class="num">$ (2,043)<span></span>
</td>
<td class="num">$ (2,088)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss before reclassifications, net of taxes</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(1,575)<span></span>
</td>
<td class="num">(1,559)<span></span>
</td>
<td class="num">(1,910)<span></span>
</td>
<td class="num">(2,043)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(1,067)<span></span>
</td>
<td class="num">(987)<span></span>
</td>
<td class="num">(1,251)<span></span>
</td>
<td class="num">(1,292)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss before reclassifications, net of taxes</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(1,088)<span></span>
</td>
<td class="num">(1,067)<span></span>
</td>
<td class="num">(1,173)<span></span>
</td>
<td class="num">(1,251)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit&#160;Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(563)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
<td class="num">(774)<span></span>
</td>
<td class="num">(784)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss before reclassifications, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(552)<span></span>
</td>
<td class="num">(563)<span></span>
</td>
<td class="num">(763)<span></span>
</td>
<td class="num">(774)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss before reclassifications, net of taxes</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780587486848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Average common shares outstanding (shares)</a></td>
<td class="nump">284,292<span></span>
</td>
<td class="nump">285,243<span></span>
</td>
<td class="nump">284,087<span></span>
</td>
<td class="nump">284,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive share equivalents from share-based plans (shares)</a></td>
<td class="nump">1,353<span></span>
</td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">1,273<span></span>
</td>
<td class="nump">2,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Dilutive share equivalents from Series C preferred shares (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Average common and common equivalent shares outstanding - assuming dilution (shares)</a></td>
<td class="nump">285,645<span></span>
</td>
<td class="nump">287,299<span></span>
</td>
<td class="nump">285,360<span></span>
</td>
<td class="nump">287,202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Share equivalents excluded from the diluted shares outstanding calculation (shares)</a></td>
<td class="nump">6,060<span></span>
</td>
<td class="nump">5,639<span></span>
</td>
<td class="nump">6,060<span></span>
</td>
<td class="nump">5,639<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bdx_ShareBasedCompensationMember', window );">Share Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Share equivalents excluded from the diluted shares outstanding calculation (shares)</a></td>
<td class="nump">617<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">617<span></span>
</td>
<td class="nump">676<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bdx_ShareBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bdx_ShareBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780579288704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>plaintiff </div>
<div>lawsuit </div>
<div>claim</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="nump">$ 255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bdx_GwinnettCountyGeorgiaMember', window );">Gwinnett County, Georgia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants', window );">Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bdx_GwinnettCountyGeorgiaMember', window );">Gwinnett County, Georgia | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss Contingency, Damages Sought, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_GA', window );">GEORGIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_NumberOfEtOSterilizationLawsuitsFiled', window );">Number of EtO lawsuits filed | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Loss Contingency, Number of Plaintiffs | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=bdx_HerniaProductClaimsMember', window );">Hernia Product Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_NumberOfEtOSterilizationLawsuitsFiled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of EtO Sterilization Lawsuits Filed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_NumberOfEtOSterilizationLawsuitsFiled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bdx_GwinnettCountyGeorgiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bdx_GwinnettCountyGeorgiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_GA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_GA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=bdx_HerniaProductClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=bdx_HerniaProductClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780580653040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenues (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ContractWithCustomerRebateLiability', window );">Rebate liability</a></td>
<td class="nump">$ 541<span></span>
</td>
<td class="nump">$ 525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | Products and/or Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ContractWithCustomerRebateLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Rebate Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ContractWithCustomerRebateLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bdx_ProductsandorServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bdx_ProductsandorServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bdx_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bdx_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780584520544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of principal business segments (segment)</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780579833136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Revenues by Geographic Areas (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 4,821<span></span>
</td>
<td class="nump">$ 4,750<span></span>
</td>
<td class="nump">$ 9,407<span></span>
</td>
<td class="nump">$ 9,468<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,360<span></span>
</td>
<td class="nump">2,154<span></span>
</td>
<td class="nump">4,515<span></span>
</td>
<td class="nump">4,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,275<span></span>
</td>
<td class="nump">1,485<span></span>
</td>
<td class="nump">2,577<span></span>
</td>
<td class="nump">2,968<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,186<span></span>
</td>
<td class="nump">1,111<span></span>
</td>
<td class="nump">2,315<span></span>
</td>
<td class="nump">2,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,733<span></span>
</td>
<td class="nump">2,669<span></span>
</td>
<td class="nump">5,462<span></span>
</td>
<td class="nump">5,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,339<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">2,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">581<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="nump">1,226<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">813<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="nump">1,595<span></span>
</td>
<td class="nump">1,498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,088<span></span>
</td>
<td class="nump">2,081<span></span>
</td>
<td class="nump">3,944<span></span>
</td>
<td class="nump">4,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">978<span></span>
</td>
<td class="nump">1,873<span></span>
</td>
<td class="nump">1,892<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">694<span></span>
</td>
<td class="nump">738<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="nump">1,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">364<span></span>
</td>
<td class="nump">720<span></span>
</td>
<td class="nump">727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember', window );">Medication Delivery Solutions | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,070<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
<td class="nump">2,109<span></span>
</td>
<td class="nump">2,146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember', window );">Medication Delivery Solutions | United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="nump">1,235<span></span>
</td>
<td class="nump">1,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember', window );">Medication Delivery Solutions | International | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">454<span></span>
</td>
<td class="nump">460<span></span>
</td>
<td class="nump">873<span></span>
</td>
<td class="nump">936<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember', window );">Medication Management Solutions | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">723<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">1,430<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember', window );">Medication Management Solutions | United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">550<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="nump">1,114<span></span>
</td>
<td class="nump">945<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember', window );">Medication Management Solutions | International | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember', window );">Pharmaceutical Systems | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="nump">976<span></span>
</td>
<td class="nump">897<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember', window );">Pharmaceutical Systems | United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember', window );">Pharmaceutical Systems | International | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">394<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="nump">684<span></span>
</td>
<td class="nump">669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember', window );">Integrated Diagnostic Solutions | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="nump">1,841<span></span>
</td>
<td class="nump">2,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember', window );">Integrated Diagnostic Solutions | United States | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">422<span></span>
</td>
<td class="nump">618<span></span>
</td>
<td class="nump">930<span></span>
</td>
<td class="nump">1,232<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember', window );">Integrated Diagnostic Solutions | International | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">466<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="nump">911<span></span>
</td>
<td class="nump">1,062<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember', window );">Biosciences | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">386<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="nump">736<span></span>
</td>
<td class="nump">674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember', window );">Biosciences | United States | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember', window );">Biosciences | International | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="nump">416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember', window );">Surgery | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">381<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="nump">701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember', window );">Surgery | United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember', window );">Surgery | International | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember', window );">Peripheral Intervention | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="nump">902<span></span>
</td>
<td class="nump">863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember', window );">Peripheral Intervention | United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="nump">492<span></span>
</td>
<td class="nump">457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember', window );">Peripheral Intervention | International | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember', window );">Urology and Critical Care | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="nump">670<span></span>
</td>
<td class="nump">661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember', window );">Urology and Critical Care | United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="nump">522<span></span>
</td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember', window );">Urology and Critical Care | International | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_BiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_SurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780583369104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Financial Information for Company's Segments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges', window );">Acquisition-related integration and restructuring expense</a></td>
<td class="num">$ (62)<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="num">$ (106)<span></span>
</td>
<td class="num">$ (62)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from Continuing Operations Before Income Taxes</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">442<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
<td class="nump">1,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRecallExpense', window );">Inventory Recall Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember', window );">Medical | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) Before Income Taxes</a></td>
<td class="nump">1,333<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">2,621<span></span>
</td>
<td class="nump">2,602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) Before Income Taxes</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">1,048<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) Before Income Taxes</a></td>
<td class="nump">394<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="nump">827<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) Before Income Taxes</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges', window );">Acquisition-related integration and restructuring expense</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Net interest expense</a></td>
<td class="num">(108)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="num">(191)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) Before Income Taxes</a></td>
<td class="num">$ (635)<span></span>
</td>
<td class="num">$ (665)<span></span>
</td>
<td class="num">$ (1,301)<span></span>
</td>
<td class="num">$ (1,307)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_AcquisitionRelatedCostsAndRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRecallExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRecallExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780583193232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Detail) - Pension Plans - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service credit</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of loss</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Settlements</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net pension cost</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780583557056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Restructuring Charges (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to expense</a></td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bdx_OtherInitiativesMember', window );">Other Initiatives</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash settlements</a></td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Termination</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to expense</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Termination | Other Initiatives</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash settlements</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other (a)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to expense</a></td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other (a) | Other Initiatives</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash settlements</a></td>
<td class="num">$ (11)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bdx_OtherInitiativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bdx_OtherInitiativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780579152144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Components of Intangible Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 21,113<span></span>
</td>
<td class="nump">$ 20,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(9,481)<span></span>
</td>
<td class="num">(8,723)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">11,632<span></span>
</td>
<td class="nump">12,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember', window );">Acquired in-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">15,140<span></span>
</td>
<td class="nump">15,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(6,530)<span></span>
</td>
<td class="num">(5,979)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">8,610<span></span>
</td>
<td class="nump">9,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">4,859<span></span>
</td>
<td class="nump">4,853<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,347)<span></span>
</td>
<td class="num">(2,170)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">2,512<span></span>
</td>
<td class="nump">2,683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Patents, trademarks and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,113<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(604)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 509<span></span>
</td>
<td class="nump">$ 473<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite And Indefinite Lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780579280816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible amortization expense</a></td>
<td class="nump">$ 366<span></span>
</td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 731<span></span>
</td>
<td class="nump">$ 707<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780580563040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 24,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase price allocation adjustments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">24,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">10,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase price allocation adjustments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">10,968<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember', window );">Life&#160;Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase price allocation adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">899<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember', window );">Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">12,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase price allocation adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 12,913<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780587416080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">$ 1,617<span></span>
</td>
<td class="nump">$ 2,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-Currency Swaps | Net investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">2,119<span></span>
</td>
<td class="nump">910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_FixedToFloatingMember', window );">Interest Rate Swaps | Fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Forward Starting Interest Rate Swaps | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_DebtMember', window );">Foreign Currency-Denominated Debt | Net investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">$ 1,831<span></span>
</td>
<td class="nump">$ 2,140<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_FixedToFloatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bdx_FixedToFloatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_DebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_DebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780580395744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="num">$ (21)<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="num">$ (101)<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_ForeignCurrencyDenominatedDebtMember', window );">Foreign Currency-Denominated Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="num">(22)<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="num">(164)<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-Currency Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="num">(21)<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_TerminatedCurrencySwapMember', window );">Terminated Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bdx_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_TerminatedCurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bdx_TerminatedCurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780583331408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Cash flow hedges</a></td>
<td class="num">$ (6)<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780583545072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 1,981<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and equivalents and restricted cash</a></td>
<td class="nump">$ 2,068<span></span>
</td>
<td class="nump">$ 1,159<span></span>
</td>
<td class="nump">$ 3,320<span></span>
</td>
<td class="nump">$ 2,392<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780588351344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Institutional money market accounts</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm', window );">Current portion of long-term debt</a></td>
<td class="nump">1,609<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableFairValueDisclosure', window );">Long-term debt</a></td>
<td class="nump">$ 14,676<span></span>
</td>
<td class="nump">$ 12,119<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Debt Classified From Long Term To Short Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780510599520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="nump">$ 54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_MaturityPeriodOfShortTermInvestment', window );">Maturity period of short-term investments at the time of purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_MaturityPeriodOfShortTermInvestment', window );">Maturity period of short-term investments at the time of purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_MaturityPeriodOfShortTermInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_MaturityPeriodOfShortTermInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780588376672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_TransfersOfFinancialAssetsDuringThePeriod', window );">Trade receivables transferred to third parties under factoring arrangements</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 1,490<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Amounts yet to be collected and remitted to the third parties</a></td>
<td class="nump">$ 359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 323<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_TransfersOfFinancialAssetsDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfers of financial assets during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_TransfersOfFinancialAssetsDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139780583389056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Detail)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes4693DueFebruary132028Member', window );">Notes 4.693% due February 13, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.693%<span></span>
</td>
<td class="nump">4.693%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3553DueSeptember132029Member', window );">Notes 3.553% due September 13, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.553%<span></span>
</td>
<td class="nump">3.553%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3553DueSeptember132029Member', window );">Notes 3.553% due September 13, 2029 | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3553DueSeptember132029Member', window );">Notes 3.553% due September 13, 2029 | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes4693DueFebruary132028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes4693DueFebruary132028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3553DueSeptember132029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3553DueSeptember132029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>bdx-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bdx="http://www.bd.com/20230331"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:exch="http://xbrl.sec.gov/exch/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bdx-20230331.xsd" xlink:type="simple"/>
    <context id="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idbd00d98847d4346bbbb95d667436629_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i72ac9970494e4587812cec9482d864f2_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8689c0dffdb740849c7558594b18d09e_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8d6885122ce848019de4e5ba402acae7_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i172bee2a01394be3b975442f6778fdf5_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.020dueMay242025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i251c5edff8504792bf4d77355a515f20_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iea9376c80dbf43e1a4985f4578efd18d_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iad1f5fe5077d4b74b42910c15b30993a_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1213NotesDueFebruary122036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib9fc4c1858fb4a4296c2836d425fc4e3_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i50e4270210b441d8a749af6681865102_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i798de8f735874f948c11fa53069df187_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i88f747ff4b7f43869b7fa5bb86a41c80_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9c3c3fab267a46a88f3f39dfcc2cf90a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i838793163e4f492f987f08dd7af25df3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2574ec0c91f14c3f937606f7e1fa9cff_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i85998d24a6604a978712c8df1da2a7c9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie8832464205e4aec9d9dc8cdc63dcb72_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id83705567a26476994261cc7b5a25d33_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2f12e83843f74a02ae51ea3d6b8a6a20_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i671cc096e3784769a513d12258a4a23c_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7c23e44aea374d2fb54a3b6aedeadc11_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia116d571cab942aeb5f677df8f19d44c_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i15828c3d0e91477790a5db6c52c366cc_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1646e6cae76e477ea277db5cfc3e2db2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia8944e67417c44f49a70a8c33ea2603c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0a00598163e14d4ba75663154d5576e6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i093e1c6251c446969afe57366b0f9d4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i868aa31ce93e406aaad8f6e77dc6b180_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idfd5089106d54575b654a9e7e308e583_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8cf7721ab8534ff39ac5f79dc98c0378_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i53fc9c3af28f47f7ab9ed1893b981c2a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i04e93ba713f84c2293fdbd3f08dd5eb9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if9161e65f73442d4a2e22bfce36dc56d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i79acf93fa3e9494198d48e60df910f20_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic8ca5cb05c6f4abaaba6eeeeea095bd8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i382cb5c56e50416a96a86b779a0dd809_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if6921b343dee4c03b1537facc8f6e180_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i547348e51c474a16aabca1490b09fed7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i24d5b4db143146d3bb147d94438ec1fd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9075e2707bb44b9ebba0bff02efce052_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i20cfc39ccaee446ba852752323e51724_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic3dddbf166b34f98ab399f4fcb3f2ebe_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i336f8c4b2c4b4be4a1d5e5e1c5497d18_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9e15f85977ce439d9169b789f07b511d_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i04e794f49df74ce1bbe110052dc73130_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9feb4047fcf64ef0af2f6485859117a9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f99435036b34bd2a24d925a56120f91_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d976db8005448e0afc273870324e7ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76d02aecab48442e86778fa7099b3161_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a0740ea75854a55b2cdec3baa4f058f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icb38e09788ba4aecab8c912c9af71397_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i706eb0202c0e496fb7a2947d80c016d2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iddbd8602678b425dbb7e0ea97f55fb4b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i38c11f85d6c5428f8a5759883d9c4623_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5930df7450554cf3a1702154aa7730a1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i59879870004c4696b50bacebdf8bcae1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iee4905aacc8d41638bc2468d4a3aa787_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if965b175d9504baba439a1be95582e62_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1850d5cec6e84eb88c655caaf1c6c1c2_I20130924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2013-09-24</instant>
        </period>
    </context>
    <context id="iafa9e6f344374994b897a26cc64ef107_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="i22e38a99ac5c405ebd50cfe207177871_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4628e244401242e9bab162e1505a9dfc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7858fb0adb264894a55e4fd4a4920f2d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i460c979af9204674924048511da49f37_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6f6d62e03f8b42f0baf0cd748c67b33e_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iee28abe315584e678b6d0f8d1b55cc26_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6484295e8f144d2ca1b524717f92829c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4b3958263aac436d944c047db32c756d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ffdd529f695442cbae3dcc9fb039743_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19815e83945a4850ad5382563a523f5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0351329551fe4153b41300f0e72fb456_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ife590ddfab834d788b4a069ff3e68d73_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i81ebc98ee32546b19b83fb3e2840c977_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iddd2e59573d94341b0593806ecbb2b66_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7572947a7339481dbfa89e6c783ec342_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8ae99b2183b243ea802f1c0ed0b8683a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i34563c7f6e514f3db19ecc98619eddd9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie9e294f037204c3cbf4ef8d9020868bb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0f33c5109e8848e994e743835c4960c0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i393529c2cae1491ebcb200f597fe10b6_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib0ff75f2224d450085c05c8c295a92e6_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if2eccb757d0246f0b29f6b496ee41a6f_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57ce0d1979c14028a69248c8a1c3d791_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie11149ff1cbe4132939e7ba61c7ab73b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id309abc3d0f943158c9c635b60c3eb5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i262febcea4f54f9dbc968f38708aba55_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ac52748f1bd40758c972a0bcd5b63b8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id944a60370e646709b33b07adb648682_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7f262081f40a4906ba90bc6c1a7ee290_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i83f3c899736b48bdb1be13f9cb594bc1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i87f59be873544367bac32f07887de058_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9a175b22e49a4de78fd2e4b373cdb8d7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i01fbd913bf3a47cba0482d35f46f5378_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibad42ccfdde04dfeab3962ec66d145cd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i23e198e459c54dbea71d1e6b83cfd466_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5186e284952c4354937b2883eb1ed3c9_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if312210c4d564f8ca13516875c02a909_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i81e88067fa28438ba8960a6e5bc92844_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i20be471d9fcf485d8a8e25204e5c84de_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8ce1dc78d6a642b08e49f83600f8f112_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i185f69d2666a40e4a30b82e27d557e28_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">bdx:HerniaProductClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i17ab8a33ac194031acaea6ce23adb206_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i85d6531a6a844787a70ff90d4a02d6d2_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i75b32e3d8e8340148d564fd167111da6_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:GwinnettCountyGeorgiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic7b1e10a6ef444648b8782378dd142ad_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i742947532c9941f6849b56745999efdf_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:GwinnettCountyGeorgiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieadfd52ff47344dfb0623e297b9b64ac_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ProductsandorServicesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idedcceb572a947ea828bc036cbc9e150_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i68fed519b8cd4c66b77d2a0a682a2b45_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4e6cfe7b18de4673af52bf049d65ba26_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i841c8c1c798a45e383da584c83869082_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i95a4dcf151164a38b3e08ed29a9e68b0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i480503378bf24ffb84276d4a75ebeccf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i850e88e8269243c1868bfdf976704aa5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if70224594e54407c8dd9540e8e74477c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8b2a45e650ea481fb6ca48710434086b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i54f4a58a812d48d593df5bcd251c3825_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5dc5cef384ba465f8ab03695864d424b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if90dbbe1b6674b059da0798a1fc9ea36_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i91cc5d94e87144d2a0196c9c9a1bc9c8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i81baf0b1c1814041b160e3e27a6f6d6d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifb10a2eb439f431591e11fb203a7fb1b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iecb2838196d148ddb37b681f30800842_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie6fee6e221a248209720d8a0e606b821_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i12c9c9d66d504014a5a55dde651ad588_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6779e1ee9eb34798ba7826f0deb428d2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5042268ba57746368d9792ad3b7053f5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie714b836ac7743ceb2e70b68ac3982e7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1642dd23d79c4ea2a197172a38abeb19_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4a102dfb15ad4d198bd87f3bc598fc50_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibb0c35da7f9f433891a2e11f5d381e5c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4f33f7206b1249e7a4ffc0c52c4ea01b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id16e4ff23fc7479ebc10e4339a6b8316_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib10678e67d194aea9b79aeba4ae564b7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if8f00ef36a864b3999035cdb8ca1ee40_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie4bf63d0944d4969b56d747a6c4aeb85_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic4d29cbf115b4cd089b94dca6058cf55_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iffd3f6c968b14773be92bfcc86c33822_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8a2ad16216754861899cd606d682d1d2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iac9e2fef4302405ab4e45ed6c9f072a2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i00d4dd1d35ad4ec39bf242fec7861a8d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idb6fc50a3487452ea53c1aee2fe9c14d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4639b945d6594926868a1a5ff039304c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i974dfe38797443ae9e91fe0d747005d8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7a9c34ff96cf4cc6847d29c3560db0d2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i98e867a4015f4a468735111b4fe9d81b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i99bc7afb1cf047caaff82d8a6516065c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i830727d2878946c7a8c7364a0ae99248_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifa75e3193e3740ee93a99cb81d32c403_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibfbdecd6ec9547c59053303e9f460db8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if875d3bce9114d8a858c7e589c047056_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i49e6649d813d4bd4bb104a487c73ea90_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2d0af07733084d968cb84d8736f680e1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib97632afcf314eb4af27293756ab1c1e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id0e000d0a8774353b9d53bade6b21fd0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia1354f7e1cf648458386b045b469c10b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i833303fa6d4c4eaf8bffbb0864a695e5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i06722ea31e2b4061818de6fa498196a9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie60c2aa29c68466aac9d1af165f3af43_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i88e20f23d8d1419989d15f68c97503c9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie9732021b95147b48552d9d3400e0eb5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id76c90ada79245109d735834db48fef0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5693529ca4bf4fd99017046f306ad832_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibff7917a45934be1ba662f42794d4841_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i04846b7cd7654f27ada57fc63f9519fb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i812ecaa6f69a4d0bb57f4bc354aae8be_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8117301a37b74e709259d5375dc30d4e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5d0e86f8e82342be9d1959871d421a6e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icaa76677d46442d6a7e1c895ce1f71f6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibfbbee50f40c4484ae7bfad73328da8b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4353504b6abc40a8a4e50df3b63865ff_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i781b5ad29da34317ae891593af457aaf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i06e1a559e5074fabab4366e975d71095_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iac6febd1d5d74cf894e20097ea0c3390_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i30c82c8da537457ba89775a6dd6f0b63_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i36d58f5ff4a94d7c856a21852d1578b7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i53fe0413309b43b185ddaeb63704cdb0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i74cf5d046cdc48458773f0a0e6bf124f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic1c7400b54fe4071a338cdd26f00e096_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9b866a81d48541e088ce519c699ba906_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i841975175f6d48f9998a0e2f82f4053f_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia6f0652aab2a42f7b530f8be482e3007_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idf48c33124124a6384e276cfa077767c_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icb44f9df8a8441409d61f508251b69aa_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ec08bb3ff4a4875acf201b377a5a9b0_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i39d0373baf3640f7b41985d5833685d7_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if0f23cf9a7224b2c96d80a76679ed1c7_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia89519a3b58a4032909e18f5a356e5a1_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0ffb55ab8ff54c96b1bce767d9e6a6f7_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i54d6c43b47e544ef87eb3da99d03b1f8_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id87cda00c76043079c6b7f0a255628d4_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9624f4572d0a44edaf5bf06b2c5e83da_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5db5726397684d848e7e71ffe39a0df9_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id5e183c9ad474d139768c9162aa1e53f_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i38080f49c0974324a50d6dc48d77476b_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaa34ed7252744dce9d3eba22fbc460f8_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i77fe6f0478484e77ad34a61a2fd7bd78_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1f4358855e40480593e5e0d8f0a7e32b_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i36bf788445f641f087a217afce45d835_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2f2c8adfb65e496fb380376104a49088_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id377017a26ec446cad1d57bd60564384_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic4ff1d287bc641a68106273fcd8ed5ef_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie90ad306379a4c1599fe2b2e0c34c487_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifbfde066976740859db427662a57e26b_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i11d3d3ae80f74f4dbf461c7291881e0e_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic6739aa1eaa040ea8aaddd516c1851c7_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id5db012c6f554b589b2cd464565b693a_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia046d9031e8949509f12a761a4224417_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a3976b2f0f14c4e810f7005d15f1f87_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibca9b2a4d3aa462596e3df837b933591_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5e4cad3300d84f2689a1f443e74e0314_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0edb37cc9b764458800e90102f48a86e_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib6fe277067c2414fbf929d3d6a219636_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i31eb79bf50ec41998fb767b6987ce2c4_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie2438e94418c407792bbee2d9179b645_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i32ae32f54613472793706f04236ad157_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5fdb48a107794c3980fba70b8372a30d_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie0960222376b41418e431c7c966fc960_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i251719fc5666450f8e498d90117d7c34_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifb8cdd96ead14cd69f012accd6f4cb9d_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a0b9a3d052c46ca890a9c69797e68df_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i78cb2306c82a4761a95fcb3e304bdb8c_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5894b055a36a458e8e85e4215a55ce54_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i062534c0a42743d2ad7922a783a173e7_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icd38fe9a5f124e0e8b44cb18e864a957_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6ee1acdcb66d4d898504b646745a30bd_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0d0fc699d0c846a289328d4a13ae3b9f_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i67d3a9dbf7fa414fb11aa805abb03094_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i86ee63bfe8004d68970b72dd4b8b7d1a_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i28e6ab6ff6df496ca592e90b3d330de5_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f24e1d9f83e4d8eb797dd90c4d7bedf_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7c7297cc444f4d0b8d08c060e92ae0c2_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6e8831acd8644cdeb56db066b2fd08a3_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i09b09ea684154e4ebccff4d00f43571e_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i340d4b0fbfa344bfabdd8b6f46ab528f_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i844e28d1b31e43c882cf05e613660ac9_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i937287b0005849adba3700159c44bb1c_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i703a5ae640f84088b9eb12321f883fcf_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if00d7790a83c4d398536842126ba0870_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie0498cba50954a96b0f4785b9369da89_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie0f0d62528e643e486e8b63e17adcab2_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icda13f7ccb434390a542b94eedf89184_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8accfab0194747e99802361c4bcba9f8_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iea5cc875dbfa4dd69f9ffea1d08fc7bd_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i068965d16303486fb4323bb08ee4bc27_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifd93e9175cc64c60bbc8a3d92a9e7649_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i39cfb89f6f8b448f9b5f3bfcc58dc9dc_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f1ebdedf0894f6f9d6eb7853eecb428_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib85825c4d3c641cc99a05dc9d8c18d83_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifb7bc81847b84350b2fab646e9bcd447_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i255166fe111d4bd2b7b0f9c57d1e3013_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if0fc6cb6378a44c4a1cd9a34c079468c_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieab59e058d394ac989a56f0af7be79db_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i62acc25f7e924071a6f2be9aaaf46d77_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icf252968a2584238b4d790d9ccf2097d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if641350edac64e2986b37525b239f9b8_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i022895c1add14102909469676a06a30a_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic8bcf14bc4de46d4ab342052f56f0f63_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i50d91ec151c8409cb91d3361be377daf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7af6142a51f740c396515df1281ab028_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if415726d4f1042da942db59fd9b75797_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5d85cf2e75c44573a9069a35792fbae2_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i59035e46fc504f16bd9ced72ced1a8c3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i80186f01cae8428cb7bbf64cc561eb04_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a8a4974f9e942689ee74356ba8c98ba_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i43c15c774be8471399b53c4f55f32175_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2e6ce19cb68c42798ae7f6c22f37cc17_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ide33f573b2814d269fa446f57a3a0186_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4aa9ecd5e70e410190486fa72a3b558e_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iced9cd9c70654eb388559493c61723b9_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i58665f2a2c8643dcb3ad595e2d019b33_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bdx:OtherInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i52290dbfca2d4f50a401175ba723901f_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bdx:OtherInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1f40fa9998b54795b2c752de8c531048_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bdx:OtherInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie0dbe3ded00545ab83fb4e0b4a84ec32_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia23a5e3848cd4f44a166523143770660_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5df4422b58204b28a8c87b3ec9a100d4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id0ee2f4c36e04145806001b090363988_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3cf4edbbb2c84bebb017b70ec26907d9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9763e9cfce3546598374a98e82482d84_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5909630c3dc3461db24bb07bbef1d70f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie4bcaff2cdea468f9adea6ca88bfd572_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i55f7422c872948b7aa942c44ddec9006_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i244628a30e084b02a041278475ead62a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i369713e8a2814ee3b1545e6f40f52598_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i09ed9f30fe6f49b080fbe7dafbf98b8e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3102b14dbddd4ffc86e7d5d2db6bce27_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib1a34123952a4177976f05690781d3d7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4127c3a1dc864463babc0aa7d4467455_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic9a28f207cd5467ba5f864965c31b4d2_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6c0d32994d5d4acb92ad95e9804d5595_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f5415d8bbac4b359e15026a6417f893_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie6c6efdde649461c9e16742dfa4f98cb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i73beddac0b344212a9ac5a9c6b13e93c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i65aae17d8b844902ba366c6f8483abbe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i12b6aa99d5be460d83d9bca02ddddd61_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6aeb4d2755fe46f299e5a6c74bc5a32b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib3304ad8423a4080868ba0df9040363c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9f298aa8db0e4d16915009c38a45b4fd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0a7b5571b4914526a7939314fe5ac29b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idc31e4316a5f42a9af36adc57ea908b0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i82512cdc5bbe47b99fd3ea95885689f8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1bdfaba42a0147ab9cf6e5fe931bcb98_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i39c3539460274df6ac6d2c96ecc34090_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i67552823db3d48dba3a132df51727d27_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i13543c57601d49cdad0d49ed6c6a810e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0266480813824139b60fa979b8c5a110_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia3c212ff13284f898a191374e5b1fb18_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id1a554cbf33a4c3cbe41709cb273beba_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i26ec7721173741bfa63336e0a220a540_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:TerminatedCurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iac6d0546403e4cb8bee77368cc2a109d_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:TerminatedCurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i21832cc6769747ce9b9665d67123f229_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i52fcd6bc58b842908f344893c07f0e4a_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic6efa31d0f394c2fa26a85b8356810a7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0f198f784a2e4fbebfc73c9adccb8ca7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i28e41cac0d444490be6885ce232f8d86_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6cf2158a605543ce9c94011e2077fc47_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i028e3d9d8c454377856d5376339cff80_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i404c88c20ea54232a7e62321ba370898_D20221001-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if5012eda058545d5b7ac41306aa4ba16_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0781942758c64dd5afd26d84a4911721_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4693DueFebruary132028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="i2642155c253549deb25e07021badb5aa_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3553DueSeptember132029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="i37b7d299193b4c9989d811dd4b4236cf_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3553DueSeptember132029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="i031378f9d14d45c988ebf0bc09980e9d_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3553DueSeptember132029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="claim">
        <measure>bdx:claim</measure>
    </unit>
    <unit id="lawsuit">
        <measure>bdx:lawsuit</measure>
    </unit>
    <unit id="plaintiff">
        <measure>bdx:plaintiff</measure>
    </unit>
    <unit id="segment">
        <measure>bdx:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80L2ZyYWc6NDJmMDc3N2RkYjBiNDg1MmJjMWIyZDBhNWViN2IwMTgvdGFibGU6NDE2OTc2ODMzZTFkNDllMzhmMGVkNjU1NDljMjI5ZmEvdGFibGVyYW5nZTo0MTY5NzY4MzNlMWQ0OWUzOGYwZWQ2NTU0OWMyMjlmYV8yLTEtMS0xLTE0OTExNw_8b8bbd11-b37b-4edc-97cc-a2e861d5076d">0000010795</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80L2ZyYWc6NDJmMDc3N2RkYjBiNDg1MmJjMWIyZDBhNWViN2IwMTgvdGFibGU6NDE2OTc2ODMzZTFkNDllMzhmMGVkNjU1NDljMjI5ZmEvdGFibGVyYW5nZTo0MTY5NzY4MzNlMWQ0OWUzOGYwZWQ2NTU0OWMyMjlmYV8zLTEtMS0xLTE0OTExNw_1cfed2a4-62c7-407a-af1a-79c4b4398e86">--09-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80L2ZyYWc6NDJmMDc3N2RkYjBiNDg1MmJjMWIyZDBhNWViN2IwMTgvdGFibGU6NDE2OTc2ODMzZTFkNDllMzhmMGVkNjU1NDljMjI5ZmEvdGFibGVyYW5nZTo0MTY5NzY4MzNlMWQ0OWUzOGYwZWQ2NTU0OWMyMjlmYV80LTEtMS0xLTE0OTExNw_19cb0dfb-a9a5-46e2-9737-613fdb9c91ba">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80L2ZyYWc6NDJmMDc3N2RkYjBiNDg1MmJjMWIyZDBhNWViN2IwMTgvdGFibGU6NDE2OTc2ODMzZTFkNDllMzhmMGVkNjU1NDljMjI5ZmEvdGFibGVyYW5nZTo0MTY5NzY4MzNlMWQ0OWUzOGYwZWQ2NTU0OWMyMjlmYV81LTEtMS0xLTE0OTExNw_613d3e71-c50c-4af2-a8c2-e0e8a553fbec">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80L2ZyYWc6NDJmMDc3N2RkYjBiNDg1MmJjMWIyZDBhNWViN2IwMTgvdGFibGU6NDE2OTc2ODMzZTFkNDllMzhmMGVkNjU1NDljMjI5ZmEvdGFibGVyYW5nZTo0MTY5NzY4MzNlMWQ0OWUzOGYwZWQ2NTU0OWMyMjlmYV82LTEtMS0xLTE0OTExNw_0e6e04bf-050c-411e-b580-fbd824aeec14">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQ3_9d66de0a-2afd-4177-9f80-210339b7ad57">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6MDgzNjAzZTI3MTIyNGM5YmI1NzM1ZjJjNDRiN2E4MDMvdGFibGVyYW5nZTowODM2MDNlMjcxMjI0YzliYjU3MzVmMmM0NGI3YTgwM18wLTAtMS0xLTE0OTExNw_b979e29c-56a3-4222-bca3-446f23ac5616">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xMzI_45029796-04d8-4544-b17e-bc3567a71c71">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NGQ0NDYyYmU4MWRiNGQwZGJkMTg3Zjk2MjI5MjdjMTMvdGFibGVyYW5nZTo0ZDQ0NjJiZTgxZGI0ZDBkYmQxODdmOTYyMjkyN2MxM18wLTAtMS0xLTE0OTExNw_f67833f0-3310-416d-86f1-3abdeebd8d9a">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQy_c3c8f276-4012-4102-9df9-1e7971fd3b6a">001-4802</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQz_5f681ada-ff72-48f9-9c58-33be2c1ff986">Becton, Dickinson and Company</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8wLTAtMS0xLTE0OTExNw_f1a81998-017c-4973-aef4-83e607383387">NJ</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8wLTUtMS0xLTE0OTExNw_29f96356-df79-4020-97ed-e62087e5cd5f">22-0760120</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTAtMS0xLTE0OTExNw_4a4b7c0c-d51f-40c6-b23f-45d8f42e27be">1 Becton Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTEtMS0xLTE0OTExNw_e75ef6dd-9833-40cc-8081-b3256beca0c0">Franklin Lakes,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTItMS0xLTE0OTExNw_177ff6c2-a4c8-44ff-9eac-5ec8c80586f9">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTMtMS0xLTE0OTExNw_7ae5f182-2dfe-4a74-983f-0b5471389c43">07417-1880</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTUtMS0xLTE0OTExNw_f8bc0138-0e3a-40cd-90cb-e7ae2b48dffb">(201)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OWViNDk4ZTJmOTc5NGFiYTg5ZmVkMDdjYjdkYTJhM2UvdGFibGVyYW5nZTo5ZWI0OThlMmY5Nzk0YWJhODlmZWQwN2NiN2RhMmEzZV8zLTYtMS0xLTE0OTExNw_d0039a23-8f5d-4089-acd1-181ca809153b">847-6800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="idbd00d98847d4346bbbb95d667436629_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xLTAtMS0xLTE0OTExNw_7c4c5c93-fd97-4432-8cb3-738d8583a5f3">Common stock, par value $1.00</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="idbd00d98847d4346bbbb95d667436629_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xLTItMS0xLTE0OTExNw_19ea8e96-38d5-43ed-b546-62e716fc91a9">BDX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="idbd00d98847d4346bbbb95d667436629_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xLTQtMS0xLTE0OTExNw_493260b8-b487-460c-aa51-d839b67f9fa1">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i72ac9970494e4587812cec9482d864f2_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8yLTAtMS0xLTE0OTExNw_cd4737b3-303c-41ae-86a8-270d8a5ad7eb">Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i72ac9970494e4587812cec9482d864f2_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8yLTItMS0xLTE0OTExNw_2d65265c-731d-4697-a08f-2e820a561a2d">BDXB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i72ac9970494e4587812cec9482d864f2_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8yLTQtMS0xLTE0OTExNw_6791f81b-dfdf-425a-a22a-5e923117d06a">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i8689c0dffdb740849c7558594b18d09e_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8zLTAtMS0xLTE0OTExNw_5615f150-971a-4f61-ab84-a12255b68cd1">1.900% Notes due December 15, 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8689c0dffdb740849c7558594b18d09e_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8zLTItMS0xLTE0OTExNw_053facae-04e1-4ca6-9c44-716e17e9dc7d">BDX26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8689c0dffdb740849c7558594b18d09e_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8zLTQtMS0xLTE0OTExNw_1b28c3d9-7b18-4488-a8e7-a0de871e35f5">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i8d6885122ce848019de4e5ba402acae7_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl80LTAtMS0xLTE0OTExNw_ffabfc52-9eb8-465e-9d1c-87ad34aa8ad5">1.401% Notes due May 24, 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8d6885122ce848019de4e5ba402acae7_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl80LTItMS0xLTE0OTExNw_334e83e1-cc1c-4ded-8dde-65386492d09c">BDX23A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8d6885122ce848019de4e5ba402acae7_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl80LTQtMS0xLTE0OTExNw_cddedbec-40d1-43d8-be19-a9d20395ba97">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i172bee2a01394be3b975442f6778fdf5_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl81LTAtMS0xLTE0OTExNw_b2e4f815-a040-4caa-8efa-191c3dba13f0">3.020% Notes due May 24, 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i172bee2a01394be3b975442f6778fdf5_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl81LTItMS0xLTE0OTExNw_a9181b40-bad4-47b5-84c9-512b0bbc83ab">BDX25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i172bee2a01394be3b975442f6778fdf5_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl81LTQtMS0xLTE0OTExNw_bafa1ca6-af98-41e3-bc2e-32a876bfa048">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i251c5edff8504792bf4d77355a515f20_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl82LTAtMS0xLTE0OTExNw_5b4f8d5e-42ef-4b9b-a117-fc210bc99162">0.632% Notes due June 4, 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i251c5edff8504792bf4d77355a515f20_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl82LTItMS0xLTE0OTExNw_a8454913-9c0c-4b69-8771-afd23e3db11f">BDX/23A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i251c5edff8504792bf4d77355a515f20_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl82LTQtMS0xLTE0OTExNw_d207db66-aeff-4f88-b295-5d16f097b1da">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="iea9376c80dbf43e1a4985f4578efd18d_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl83LTAtMS0xLTE0OTExNw_0395e236-bdd3-4281-8c58-c713d2bac3f8">1.208% Notes due June 4, 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iea9376c80dbf43e1a4985f4578efd18d_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl83LTItMS0xLTE0OTExNw_4deb1225-bb15-4c82-a35e-bef216f42ac5">BDX/26A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iea9376c80dbf43e1a4985f4578efd18d_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl83LTQtMS0xLTE0OTExNw_61cf60b2-e445-420f-a17d-91a7dcb1cde5">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="iad1f5fe5077d4b74b42910c15b30993a_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl84LTAtMS0xLTE0OTExNw_4a24d97e-355d-4951-92ea-a76b5f54c757">1.213% Notes due February 12, 2036</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iad1f5fe5077d4b74b42910c15b30993a_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl84LTItMS0xLTE0OTExNw_31c5f11e-20bd-417d-a896-e9aa1baf5a17">BDX/36</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iad1f5fe5077d4b74b42910c15b30993a_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl84LTQtMS0xLTE0OTExNw_1536bfc1-48cb-4b9d-bdca-c4dffac5717d">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib9fc4c1858fb4a4296c2836d425fc4e3_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl85LTAtMS0xLTE0OTExNw_e7231451-d5a7-470f-ac50-cc903cc8715a">0.000% Notes due August 13, 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib9fc4c1858fb4a4296c2836d425fc4e3_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl85LTItMS0xLTE0OTExNw_4a84ae68-a2d7-4ca5-abe9-17d284e10c84">BDX23B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib9fc4c1858fb4a4296c2836d425fc4e3_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl85LTQtMS0xLTE0OTExNw_85367e5f-8166-43a2-ada6-e7d7caee14d9">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i50e4270210b441d8a749af6681865102_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xMC0wLTEtMS0xNDkxMTc_68770428-3d66-4bf5-bb56-f41dbf4044c1">0.034% Notes due August 13, 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i50e4270210b441d8a749af6681865102_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xMC0yLTEtMS0xNDkxMTc_615b1075-d627-4a3b-ad87-8ba31b28d4cd">BDX25A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i50e4270210b441d8a749af6681865102_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6NmM1OTRiNzJhYTNlNDY3ODk1YTgzMDYxM2JiYmViOGIvdGFibGVyYW5nZTo2YzU5NGI3MmFhM2U0Njc4OTVhODMwNjEzYmJiZWI4Yl8xMC00LTEtMS0xNDkxMTc_962bb023-829d-47ac-8c1b-0d9571346800">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQ0_237a87c5-ad06-4d7c-a7d9-dde0a30c4d54">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQ1_39d5de6e-27a4-4b63-971c-05c36e28e09e">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OGUxMzBlMTYwNzA5NGUyODk0OGYxY2UzZTMwNTdhNWYvdGFibGVyYW5nZTo4ZTEzMGUxNjA3MDk0ZTI4OTQ4ZjFjZTNlMzA1N2E1Zl8wLTAtMS0xLTE0OTExNw_112f6c0c-3e7c-4ffd-82a7-b7fd7f3fa121">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OGUxMzBlMTYwNzA5NGUyODk0OGYxY2UzZTMwNTdhNWYvdGFibGVyYW5nZTo4ZTEzMGUxNjA3MDk0ZTI4OTQ4ZjFjZTNlMzA1N2E1Zl8xLTYtMS0xLTE0OTExNw_53f6f12c-4f78-44b4-bfa6-520f3895a286">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGFibGU6OGUxMzBlMTYwNzA5NGUyODk0OGYxY2UzZTMwNTdhNWYvdGFibGVyYW5nZTo4ZTEzMGUxNjA3MDk0ZTI4OTQ4ZjFjZTNlMzA1N2E1Zl8yLTItMS0xLTE0OTExNw_3a961993-585f-4dec-a3b2-775bb012c004">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNjQ2_0f0219a7-9185-4c2c-a152-825aa58f19e4">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xL2ZyYWc6ZDgwMGQ4ZDE3OTAwNGMzYzg3MTc3MTZjNDI3Y2Q2N2YvdGV4dHJlZ2lvbjpkODAwZDhkMTc5MDA0YzNjODcxNzcxNmM0MjdjZDY3Zl8xNTgx_0766854e-a321-4562-a572-ad084054f012"
      unitRef="shares">284014905</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMi0xLTEtMS0xNDkxMTc_96a52fc7-c56a-40dc-81f4-80ec2ede8719"
      unitRef="usd">4821000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMi0zLTEtMS0xNDkxMTc_347ce05c-fefc-4b85-b394-f187a2fa880c"
      unitRef="usd">4750000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMi01LTEtMS0xNDkxMTc_3ae3870d-7805-417a-a92d-0630768a58e1"
      unitRef="usd">9407000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMi03LTEtMS0xNDkxMTc_9ef3b662-b961-4803-937e-e8377608e817"
      unitRef="usd">9468000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMy0xLTEtMS0xNDkxMTc_a2ddbc62-8c1c-4584-8c98-0bcfd839db6a"
      unitRef="usd">2586000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMy0zLTEtMS0xNDkxMTc_b4d03f8d-110a-4a2f-b05b-bc69a6c0c104"
      unitRef="usd">2637000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMy01LTEtMS0xNDkxMTc_cc45aaaf-0f01-41c4-9e17-a5c6c88a121b"
      unitRef="usd">5038000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMy03LTEtMS0xNDkxMTc_b3bce7f1-95f2-4ac5-8b0b-5c515d8ebc0e"
      unitRef="usd">5135000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNC0xLTEtMS0xNDkxMTc_1dcec54f-79a4-4408-b06e-f1a7245cfed6"
      unitRef="usd">1205000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNC0zLTEtMS0xNDkxMTc_f0fe4b29-e19e-4cbb-8bf2-e11970ad5761"
      unitRef="usd">1192000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNC01LTEtMS0xNDkxMTc_9e038bc7-4512-4a51-87be-bed90282851e"
      unitRef="usd">2392000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNC03LTEtMS0xNDkxMTc_b252a794-cd06-4230-8839-0d8bade3defb"
      unitRef="usd">2378000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNS0xLTEtMS0xNDkxMTc_2bdc6847-5590-4040-b3aa-40339bdd71cb"
      unitRef="usd">337000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNS0zLTEtMS0xNDkxMTc_c0395348-dbf4-41e5-b45b-5a7bb53ee3ce"
      unitRef="usd">327000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNS01LTEtMS0xNDkxMTc_5e71f705-06cf-47db-bdbc-c17d61d82e52"
      unitRef="usd">651000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNS03LTEtMS0xNDkxMTc_1c62ca18-7562-4ac5-9edb-04df72f260f6"
      unitRef="usd">641000000</us-gaap:ResearchAndDevelopmentExpense>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNi0xLTEtMS0xNDkxMTc_d9e87879-c179-4d2a-bcc9-e5a3ec0adcf3"
      unitRef="usd">62000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNi0zLTEtMS0xNDkxMTc_88ec2d80-e5a2-4d94-b806-107bb6c9fdd4"
      unitRef="usd">28000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNi01LTEtMS0xNDkxMTc_2a4b4b50-1eab-4753-a2b4-9f339e0f0f8b"
      unitRef="usd">106000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNi03LTEtMS0xNDkxMTc_ea2f4d79-8a2e-458e-b648-10567a2afa78"
      unitRef="usd">62000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNy0xLTEtMS0xNDkxMTc_619e6608-1bbe-42fa-9800-cfde10b8a87f"
      unitRef="usd">-4000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNy0zLTEtMS0xNDkxMTc_17b3e4f7-4d59-410f-a191-943325630fea"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNy01LTEtMS0xNDkxMTc_378f7a01-7f8e-45b3-a10b-3ec9ebe2a744"
      unitRef="usd">-7000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfNy03LTEtMS0xNDkxMTc_ab7283df-276e-42bd-a37f-8f2adb0e3ded"
      unitRef="usd">4000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostsAndExpenses
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOC0xLTEtMS0xNDkxMTc_61dd8db1-8f4f-4786-91c6-594d9f4b1fd9"
      unitRef="usd">4193000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOC0zLTEtMS0xNDkxMTc_c7309ef8-6d61-4333-88c3-43a4d1ab4997"
      unitRef="usd">4185000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOC01LTEtMS0xNDkxMTc_cd1e75a6-9b02-4723-b37d-c6d43e34f56a"
      unitRef="usd">8193000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOC03LTEtMS0xNDkxMTc_de480c18-fd17-4c7f-8970-33217c704f3a"
      unitRef="usd">8212000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOS0xLTEtMS0xNDkxMTc_8ec8b47f-49bc-4bd3-8a22-248b7817441f"
      unitRef="usd">628000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOS0zLTEtMS0xNDkxMTc_e7691b3a-2f0c-4b25-a6c4-fc5d8705456b"
      unitRef="usd">564000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOS01LTEtMS0xNDkxMTc_3cc15252-9b48-4bc8-8845-fe6cc3c1944b"
      unitRef="usd">1213000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfOS03LTEtMS0xNDkxMTc_46c04840-3e90-4285-bef4-731138c44415"
      unitRef="usd">1256000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTAtMS0xLTEtMTQ5MTE3_b07a4f31-9e25-487e-837c-2f5885d06c6b"
      unitRef="usd">118000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTAtMy0xLTEtMTQ5MTE3_b7420bd9-8491-46ac-9b45-84e64841d66f"
      unitRef="usd">97000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTAtNS0xLTEtMTQ5MTE3_23723d0a-a04f-46be-807b-6da50bcb8095"
      unitRef="usd">220000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTAtNy0xLTEtMTQ5MTE3_4013d0b9-5d94-4ea6-8a0f-4ddf0d7f6c7d"
      unitRef="usd">195000000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTEtMS0xLTEtMTQ5MTE3_c8be47f5-836d-454b-abcb-d49037c92c3c"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTEtMy0xLTEtMTQ5MTE3_4f16f618-91e4-47e5-af42-0204150ed7dd"
      unitRef="usd">2000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTEtNS0xLTEtMTQ5MTE3_051a5084-69b8-4077-ab19-d187e41424cf"
      unitRef="usd">16000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTEtNy0xLTEtMTQ5MTE3_82cbb1bc-3abb-4ea6-a114-f19de7f1f96a"
      unitRef="usd">4000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTItMS0xLTEtMTQ5MTE3_66e53d96-1ce8-48fd-8fae-cd46f836b562"
      unitRef="usd">8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTItMy0xLTEtMTQ5MTE3_2cd3416c-7032-462d-9a10-3c48d28a0957"
      unitRef="usd">-27000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTItNS0xLTEtMTQ5MTE3_62ae7e8b-d3e4-4ad4-8c27-4627f2ee4036"
      unitRef="usd">1000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTItNy0xLTEtMTQ5MTE3_43cd22ba-f7d6-41a8-a3b2-2381c173aa81"
      unitRef="usd">-24000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTMtMS0xLTEtMTQ5MTE3_57742137-c217-4524-9438-6cdb05cf539d"
      unitRef="usd">529000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTMtMy0xLTEtMTQ5MTE3_01062956-bbcd-4006-a332-7a6a75f04baa"
      unitRef="usd">442000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTMtNS0xLTEtMTQ5MTE3_037bd451-2d40-47f3-8b71-7b2d9cf0ac1d"
      unitRef="usd">1009000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTMtNy0xLTEtMTQ5MTE3_1c64b442-b330-4e7d-82a9-1985ba3fc9e7"
      unitRef="usd">1041000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTQtMS0xLTEtMTQ5MTE3_8060a42d-e3c6-4a3b-941f-08c7577e6ed3"
      unitRef="usd">68000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTQtMy0xLTEtMTQ5MTE3_0a85795a-67e5-4550-a63b-4cbf7869bb96"
      unitRef="usd">52000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTQtNS0xLTEtMTQ5MTE3_4662ca78-1eb6-41e9-85f2-552c81b72f89"
      unitRef="usd">40000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTQtNy0xLTEtMTQ5MTE3_64fbd5de-0277-4b74-9845-c936fadfe674"
      unitRef="usd">84000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTUtMS0xLTEtMTQ5MTE3_41d3ab6c-c627-4bee-8153-be4912acbc1a"
      unitRef="usd">460000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTUtMy0xLTEtMTQ5MTE3_3b21d80f-d7ee-4b77-b851-cbaebc913a02"
      unitRef="usd">390000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTUtNS0xLTEtMTQ5MTE3_dedcb556-24c4-4af0-b7e6-b0eaee95f547"
      unitRef="usd">969000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTUtNy0xLTEtMTQ5MTE3_899e1c31-712c-4b71-8dd2-6d2dc99d48e3"
      unitRef="usd">958000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTYtMS0xLTEtMTQ5MTE3_752b7718-22aa-4364-b7ca-1fbe69e7dd91"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTYtMy0xLTEtMTQ5MTE3_3f5f31d8-ac64-41fb-8ee0-ce63b981b3f0"
      unitRef="usd">64000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTYtNS0xLTEtMTQ5MTE3_e152fc48-35e7-44e5-b8bd-318b90519fc5"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTYtNy0xLTEtMTQ5MTE3_597e067c-e049-450b-82fe-20903731abfc"
      unitRef="usd">173000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTctMS0xLTEtMTQ5MTE3_7a7dd197-ea6e-496d-9947-c1575f79b7b6"
      unitRef="usd">460000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTctMy0xLTEtMTQ5MTE3_ef55d009-a3b5-4b7e-81be-f5deb57db10f"
      unitRef="usd">454000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTctNS0xLTEtMTQ5MTE3_2f7aabfb-e4e6-4947-9459-ef0d59f60c9d"
      unitRef="usd">969000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTctNy0xLTEtMTQ5MTE3_6aaa18d6-4c7b-4ac7-aabd-a95c9ef2288c"
      unitRef="usd">1131000000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTgtMS0xLTEtMTQ5MTE3_dd4ba358-765e-4ddd-9fc2-2f8d9f6bcd07"
      unitRef="usd">23000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTgtMy0xLTEtMTQ5MTE3_4bd4065e-51c9-40f0-874d-0778c2240414"
      unitRef="usd">23000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTgtNS0xLTEtMTQ5MTE3_f749df6c-5f99-4eab-82cf-0b251848108f"
      unitRef="usd">45000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTgtNy0xLTEtMTQ5MTE3_08f9f29e-eb82-4b5e-a9da-825a59d326db"
      unitRef="usd">45000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTktMS0xLTEtMTQ5MTE3_ca3b8644-b3c8-4da7-a835-c0f6041fa29d"
      unitRef="usd">438000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTktMy0xLTEtMTQ5MTE3_114bd32b-ce51-4ab2-8bb5-1c9d80d4b165"
      unitRef="usd">431000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTktNS0xLTEtMTQ5MTE3_9d50b97f-8fac-4c16-bdfa-3caeadbcf8c6"
      unitRef="usd">924000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMTktNy0xLTEtMTQ5MTE3_8de02365-9045-4377-8909-e79ff27d0fb1"
      unitRef="usd">1086000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjItMS0xLTEtMTQ5MTE3_2c54ff0b-54e4-4730-b40c-0264a18f2cbf"
      unitRef="usdPerShare">1.54</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjItMy0xLTEtMTQ5MTE3_8fcfca6c-197f-444e-8ced-dc4ef3ad8dfd"
      unitRef="usdPerShare">1.29</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjItNS0xLTEtMTQ5MTE3_3abcb279-6362-4a73-b76e-f6398fbaf475"
      unitRef="usdPerShare">3.25</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjItNy0xLTEtMTQ5MTE3_491912e7-2896-4d71-b344-b1d1c97d05ca"
      unitRef="usdPerShare">3.20</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjMtMS0xLTEtMTQ5MTE3_4a0e6b14-c713-4b58-989b-27f7ba51692a"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjMtMy0xLTEtMTQ5MTE3_f8836939-91a6-4c69-8770-86ac78965228"
      unitRef="usdPerShare">0.22</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjMtNS0xLTEtMTQ5MTE3_4ace10bf-ff68-4e12-bdbc-fa1655bdb8c7"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjMtNy0xLTEtMTQ5MTE3_362a4fba-17f4-49d0-996e-5addc9f7f096"
      unitRef="usdPerShare">0.61</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjQtMS0xLTEtMTQ5MTE3_bc709717-4c81-4631-b233-66cf4a8b0460"
      unitRef="usdPerShare">1.54</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjQtMy0xLTEtMTQ5MTE3_49b1d022-d219-447c-b417-b26f179390de"
      unitRef="usdPerShare">1.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjQtNS0xLTEtMTQ5MTE3_009b02da-4161-4dac-be12-716e43b069e7"
      unitRef="usdPerShare">3.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjQtNy0xLTEtMTQ5MTE3_e4d1e6e3-62be-4519-a235-28818022f6fa"
      unitRef="usdPerShare">3.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjctMS0xLTEtMTQ5MTE3_97b1b8f1-79b3-46c1-b7e8-d02af13fae70"
      unitRef="usdPerShare">1.53</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjctMy0xLTEtMTQ5MTE3_eefd0218-27ae-4124-b899-505522d8de87"
      unitRef="usdPerShare">1.28</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjctNS0xLTEtMTQ5MTE3_04711d06-f026-4cd7-a55c-2a8004eb06bd"
      unitRef="usdPerShare">3.24</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjctNy0xLTEtMTQ5MTE3_122c7523-db33-493c-85ca-5c47959cb85e"
      unitRef="usdPerShare">3.18</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjgtMS0xLTEtMTQ5MTE3_18c8a283-3a41-4573-b98b-0e688aa6efa5"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjgtMy0xLTEtMTQ5MTE3_44421f8b-15e7-461b-99bd-a1e204afa433"
      unitRef="usdPerShare">0.22</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjgtNS0xLTEtMTQ5MTE3_3297bf50-3d57-4688-98ca-c20791f62a77"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjgtNy0xLTEtMTQ5MTE3_f3008e14-9c78-44a0-8e5e-c864c67947ac"
      unitRef="usdPerShare">0.60</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjktMS0xLTEtMTQ5MTE3_8ada95db-4696-4b66-8904-3b158b52b5e9"
      unitRef="usdPerShare">1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjktMy0xLTEtMTQ5MTE3_d1d47001-34af-413f-8bd2-129e761804b4"
      unitRef="usdPerShare">1.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjktNS0xLTEtMTQ5MTE3_66b30e64-01dd-4016-b303-950daf0e4df5"
      unitRef="usdPerShare">3.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMjktNy0xLTEtMTQ5MTE3_fd251a3f-19fc-4133-b012-3e55f463e43a"
      unitRef="usdPerShare">3.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMzEtMS0xLTEtMTQ5MTE3_723bcf96-1132-4ee7-ac07-2a047698b1cc"
      unitRef="usdPerShare">0.91</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMzEtMy0xLTEtMTQ5MTE3_cb86fed7-3eb6-4c39-bb4c-da748faef1ab"
      unitRef="usdPerShare">0.87</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMzEtNS0xLTEtMTQ5MTE3_d4ae086c-b4d5-4774-8447-88071729dda9"
      unitRef="usdPerShare">1.82</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xNi9mcmFnOjhiM2M4MTAxNTYyMDQ5ZWRiMjgyZTVjYzI4NWNmMzc1L3RhYmxlOmQ3MGRiY2Q3NDRhZjRkMjk4MjhlNzE4NDAwOWE2YWQxL3RhYmxlcmFuZ2U6ZDcwZGJjZDc0NGFmNGQyOTgyOGU3MTg0MDA5YTZhZDFfMzEtNy0xLTEtMTQ5MTE3_c98a7756-c08f-486c-ba68-ca0a7867f4d1"
      unitRef="usdPerShare">1.74</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:NetIncomeLoss
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfMi0xLTEtMS0xNDkxMTc_7a7dd197-ea6e-496d-9947-c1575f79b7b6"
      unitRef="usd">460000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfMi0zLTEtMS0xNDkxMTc_ef55d009-a3b5-4b7e-81be-f5deb57db10f"
      unitRef="usd">454000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfMi01LTEtMS0xNDkxMTc_2f7aabfb-e4e6-4947-9459-ef0d59f60c9d"
      unitRef="usd">969000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfMi03LTEtMS0xNDkxMTc_6aaa18d6-4c7b-4ac7-aabd-a95c9ef2288c"
      unitRef="usd">1131000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNC0xLTEtMS0xNDkxMTc_9089620c-0234-43f0-a697-da8b81324b7a"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNC0zLTEtMS0xNDkxMTc_fd6ec6cc-8378-4980-81b3-2858cc42ea5a"
      unitRef="usd">78000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNC01LTEtMS0xNDkxMTc_ab28c56e-88e7-4140-a0d6-c3682178dab5"
      unitRef="usd">-101000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNC03LTEtMS0xNDkxMTc_b0965b71-6d4b-4b3a-8a86-cd9416788c4b"
      unitRef="usd">119000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNS0xLTEtMS0xNDkxMTc_b03b0e9e-03f3-47cf-ab21-5b703301f341"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNS0zLTEtMS0xNDkxMTc_7e852491-ac70-4153-a3b7-060f1476b7f8"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNS01LTEtMS0xNDkxMTc_e82e0962-a079-45cc-9788-568848013d94"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNS03LTEtMS0xNDkxMTc_db20ac6a-592c-4643-ac0b-942c87245b57"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNi0xLTEtMS0xNDkxMTc_da1408e6-1203-4e87-8222-c9b61ea18afa"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNi0zLTEtMS0xNDkxMTc_aeb555fb-1502-4bad-a214-703cc667f008"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNi01LTEtMS0xNDkxMTc_04e8d9d1-ed3a-4fe8-bc91-a756133ea06d"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNi03LTEtMS0xNDkxMTc_8fb01ac1-d77d-4893-aa3e-b67bd6db59ad"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNy0xLTEtMS0xNDkxMTc_bd227e31-f2eb-4e8b-a8f7-a1a086846d43"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNy0zLTEtMS0xNDkxMTc_02569dd4-a86e-4a80-b5d7-1591596b701b"
      unitRef="usd">133000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNy01LTEtMS0xNDkxMTc_53c7b0eb-018a-40bc-9b8c-a9ac7a197ef0"
      unitRef="usd">-87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfNy03LTEtMS0xNDkxMTc_a81e72be-9a96-4595-8abe-7bff5c3dd55a"
      unitRef="usd">178000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfOC0xLTEtMS0xNDkxMTc_65528c4f-e6fd-4d66-ba77-021e6b8e3506"
      unitRef="usd">445000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfOC0zLTEtMS0xNDkxMTc_13015da0-db80-4b5d-b69d-de66732b5a60"
      unitRef="usd">586000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfOC01LTEtMS0xNDkxMTc_f8850fa6-0c0a-4e07-ba23-7162e0ecaea4"
      unitRef="usd">882000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8xOS9mcmFnOmI0Mjc4NzI3ZGUxYTRhMTdhYTdkMDAwM2M0N2E0NDIzL3RhYmxlOmJhNzZlNjZhZTlhNTQ0Yzc5ZGJiOWMxNTRiNzEwYTM2L3RhYmxlcmFuZ2U6YmE3NmU2NmFlOWE1NDRjNzlkYmI5YzE1NGI3MTBhMzZfOC03LTEtMS0xNDkxMTc_c376ad11-b003-4a24-8c0a-8ed734918f4c"
      unitRef="usd">1309000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMy0xLTEtMS0xNDkxMTc_4719c5d1-02bf-4315-9131-e6560480e924"
      unitRef="usd">1981000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMy0zLTEtMS0xNDkxMTc_3a85763c-b28a-4a10-9923-dae6ad639e26"
      unitRef="usd">1006000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNC0xLTEtMS0xNDkxMTc_12b7d64f-4b21-4099-bf71-0f447ee32c8f"
      unitRef="usd">87000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNC0zLTEtMS0xNDkxMTc_83582b45-704c-4fb0-b17a-77002bd54427"
      unitRef="usd">153000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:OtherShortTermInvestments
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNS0xLTEtMS0xNDkxMTc_4fe12d78-b368-44d1-8c7c-17572ab785eb"
      unitRef="usd">6000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNS0zLTEtMS0xNDkxMTc_671d1181-5966-4701-8041-343a8e5bbda5"
      unitRef="usd">8000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNi0xLTEtMS0xNDkxMTc_40af5d22-70ab-40e2-9463-7d4f464c11b2"
      unitRef="usd">2413000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNi0zLTEtMS0xNDkxMTc_a7cd2854-6938-4999-b695-e2f19d22d1da"
      unitRef="usd">2191000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfOC0xLTEtMS0xNDkxMTc_cca60849-0af1-4e19-89b1-e5f2a71279de"
      unitRef="usd">788000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfOC0zLTEtMS0xNDkxMTc_ad7e35ee-f7a9-48e0-be79-389aac9d0e23"
      unitRef="usd">707000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfOS0xLTEtMS0xNDkxMTc_4fe0195b-0adf-4767-b72a-edd19a8aea42"
      unitRef="usd">428000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfOS0zLTEtMS0xNDkxMTc_40ea40c2-9190-4c69-aa89-7247f678e941"
      unitRef="usd">397000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTAtMS0xLTEtMTQ5MTE3_4e8ccef3-718b-4e35-b580-8cb2ebf69142"
      unitRef="usd">2441000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTAtMy0xLTEtMTQ5MTE3_c0a8b6cd-6b8a-42ac-86ba-6f847efdc557"
      unitRef="usd">2120000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTEtMS0xLTEtMTQ5MTE3_13691a55-80bb-4dbe-98a0-402793843f65"
      unitRef="usd">3656000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTEtMy0xLTEtMTQ5MTE3_12664e87-8aa3-4d8d-9e89-b0822a6c06a0"
      unitRef="usd">3224000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTMtMS0xLTEtMTQ5MTE3_7370afd9-dbaf-4b3c-a7ec-1c96f7ef41ce"
      unitRef="usd">1444000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTMtMy0xLTEtMTQ5MTE3_e601f792-87f6-4590-8d77-1e24c949e543"
      unitRef="usd">1559000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTUtMS0xLTEtMTQ5MTE3_b7f0bbe6-7f73-4175-9891-d833da5558e7"
      unitRef="usd">9587000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTUtMy0xLTEtMTQ5MTE3_5ab30852-3ebc-433a-b3af-56c18c7580cc"
      unitRef="usd">8141000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTYtMS0xLTEtMTQ5MTE3_b25a4aee-c053-4553-b511-efbb47bae534"
      unitRef="usd">13204000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTYtMy0xLTEtMTQ5MTE3_f359dd63-bd44-495a-9de6-5354308961bb"
      unitRef="usd">12415000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTctMS0xLTEtMTQ5MTE3_3fe93b4e-b5ff-4305-a609-290c7f5dd68d"
      unitRef="usd">6848000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTctMy0xLTEtMTQ5MTE3_8e8867a5-d0ab-4d11-8739-ff9cc29acff1"
      unitRef="usd">6402000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTgtMS0xLTEtMTQ5MTE3_cae71b3f-c6f4-490e-9c19-08396fc272b1"
      unitRef="usd">6356000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTgtMy0xLTEtMTQ5MTE3_467457f9-d4a1-4937-9e84-fb3394cfb9fd"
      unitRef="usd">6012000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTktMS0xLTEtMTQ5MTE3_a3017483-2378-4b3b-aa07-c60014aa1942"
      unitRef="usd">24780000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMTktMy0xLTEtMTQ5MTE3_6fa79489-7cb3-4ff8-9ff0-aac12252b81d"
      unitRef="usd">24621000000</us-gaap:Goodwill>
    <bdx:CoreAndDevelopedTechnologyNet
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjAtMS0xLTEtMTQ5MTE3_9e86cefb-e372-45ec-a3cc-4bf771f98f2c"
      unitRef="usd">8610000000</bdx:CoreAndDevelopedTechnologyNet>
    <bdx:CoreAndDevelopedTechnologyNet
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjAtMy0xLTEtMTQ5MTE3_27c86afe-dd9c-4a45-a1f5-b0a9932cfc70"
      unitRef="usd">9108000000</bdx:CoreAndDevelopedTechnologyNet>
    <bdx:FiniteLivedCustomerRelationshipsNet
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjEtMS0xLTEtMTQ5MTE3_9f05476a-2c71-4b6a-8ba8-9ff8a5414c81"
      unitRef="usd">2512000000</bdx:FiniteLivedCustomerRelationshipsNet>
    <bdx:FiniteLivedCustomerRelationshipsNet
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjEtMy0xLTEtMTQ5MTE3_85b750f4-6888-440d-b560-e97e7ba05340"
      unitRef="usd">2683000000</bdx:FiniteLivedCustomerRelationshipsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjItMS0xLTEtMTQ5MTE3_18c7559a-7195-4a87-a30b-3937ab1f4e8d"
      unitRef="usd">555000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjItMy0xLTEtMTQ5MTE3_fbbf6c87-824b-4005-a138-3cbac1c5904f"
      unitRef="usd">519000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjQtMS0xLTEtMTQ5MTE3_5a7dcefe-663e-4c0c-b804-548b4af1e789"
      unitRef="usd">1994000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjQtMy0xLTEtMTQ5MTE3_f5fe15ce-ca8d-4212-9491-4d889fa37054"
      unitRef="usd">1848000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjYtMS0xLTEtMTQ5MTE3_f3963ee6-3219-4d38-a717-c81204bd5bc3"
      unitRef="usd">54394000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjYtMy0xLTEtMTQ5MTE3_6717a753-3c1a-46e2-ab63-e3371be0f910"
      unitRef="usd">52934000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjktMS0xLTEtMTQ5MTE3_447d14b1-f5f7-42f2-9bcc-d089ce514ec4"
      unitRef="usd">2214000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMjktMy0xLTEtMTQ5MTE3_a5fb1fd4-872e-4305-b195-e081a1df1345"
      unitRef="usd">2179000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzAtMS0xLTEtMTQ5MTE3_a39197b3-063b-4658-9bce-9eeddedba489"
      unitRef="usd">5090000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzAtMy0xLTEtMTQ5MTE3_8629e0eb-ba0f-427f-80e5-644b59ca5ff3"
      unitRef="usd">5632000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzMtMS0xLTEtMTQ5MTE3_0b7dddf3-7bbc-4207-9f75-ba53e3e92177"
      unitRef="usd">7304000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzMtMy0xLTEtMTQ5MTE3_99d02a97-518d-4106-845a-c2e9e3c4aacb"
      unitRef="usd">7811000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzQtMS0xLTEtMTQ5MTE3_1dfe8713-42bd-46fb-b195-b8f6cbcda299"
      unitRef="usd">16010000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzQtMy0xLTEtMTQ5MTE3_ef8f8921-6dac-4aed-9d25-d017104ced6c"
      unitRef="usd">13886000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzUtMS0xLTEtMTQ5MTE3_c55bb87d-b7e4-44d8-b416-8b5fd0c92b68"
      unitRef="usd">920000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzUtMy0xLTEtMTQ5MTE3_8591c175-5ea8-4a7f-873f-55117149e3ae"
      unitRef="usd">902000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzYtMS0xLTEtMTQ5MTE3_84fc7e31-89ba-43e6-80ac-dd5b6760e1a3"
      unitRef="usd">4471000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzYtMy0xLTEtMTQ5MTE3_59fcbd2e-825a-4fe4-a3fd-8c58453ed1d9"
      unitRef="usd">5052000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzgtMS0xLTEtMTQ5MTE3_80a6cc06-33ce-4f22-96d9-d061d5ea20d6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfMzgtMy0xLTEtMTQ5MTE3_9c038dc1-458e-4d17-998a-e7417a37f31a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDAtMS0xLTEtMTQ5MTE3_27a92972-9086-4ef8-8b3d-17bc0b69d767"
      unitRef="usd">2000000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDAtMy0xLTEtMTQ5MTE3_6266256b-4e6c-461c-84ac-1aa23b34c887"
      unitRef="usd">2000000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMTY0OTI2NzQ0MTgyNA_4b51e3e9-d031-4c9a-80de-b0b03d931139"
      unitRef="usdPerShare">1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMTY0OTI2NzQ0MTgyNA_b70c915c-4ef2-44b4-8d80-21844fbece7b"
      unitRef="usdPerShare">1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMTY0OTI2NzQ0MTgyNw_26d837c5-9539-4c9b-bae6-766d58997244"
      unitRef="shares">640000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMTY0OTI2NzQ0MTgyNw_9049aba7-8c61-487c-bda6-7d53141219e1"
      unitRef="shares">640000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMjE5OTAyMzI1NTcxOA_026388fe-6dd2-4239-bd4f-008119ffb66c"
      unitRef="shares">364639901</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MDRiNWI3ZDQzZjM4NDg4MGE1NDVlMTdiOGY1ZjE1NTRfMjE5OTAyMzI1NTcxOA_23340a34-4c15-44e8-a444-29afe88d2b9b"
      unitRef="shares">364639901</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMS0xLTEtMTQ5MTE3_ed22dde8-a043-44a0-8241-cc2ec58825bf"
      unitRef="usd">365000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDEtMy0xLTEtMTQ5MTE3_7f778c4e-02a4-45d2-a1bf-14716f7751e0"
      unitRef="usd">365000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDItMS0xLTEtMTQ5MTE3_8cc3ec89-7430-4392-9c74-c1a1f22e6118"
      unitRef="usd">19639000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDItMy0xLTEtMTQ5MTE3_195afbfe-64be-43d5-9263-8daade370fe8"
      unitRef="usd">19553000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDMtMS0xLTEtMTQ5MTE3_afc3a1c5-b68b-454f-b6ac-6613fbe06739"
      unitRef="usd">15563000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDMtMy0xLTEtMTQ5MTE3_d3248ad2-c901-4c94-9c16-3616785130d7"
      unitRef="usd">15157000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <bdx:CommonStockSharesHeldInEmployeeTrust1
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDQtMS0xLTEtMTQ5MTE3_e4c6faee-4617-4ad0-a0f3-97135d14ae04"
      unitRef="usd">24000000</bdx:CommonStockSharesHeldInEmployeeTrust1>
    <bdx:CommonStockSharesHeldInEmployeeTrust1
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDQtMy0xLTEtMTQ5MTE3_e83a1448-d306-48ab-8015-5920b1493ded"
      unitRef="usd">23000000</bdx:CommonStockSharesHeldInEmployeeTrust1>
    <us-gaap:TreasuryStockValue
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDUtMS0xLTEtMTQ5MTE3_7840cff1-765f-4246-89de-040f6959774c"
      unitRef="usd">8327000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDUtMy0xLTEtMTQ5MTE3_728a272c-2df8-48b6-9a62-edc441db29c4"
      unitRef="usd">8330000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDYtMS0xLTEtMTQ5MTE3_b3db876d-85c3-4216-b869-f5b28beb3acd"
      unitRef="usd">-1575000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDYtMy0xLTEtMTQ5MTE3_3f8009c8-5399-44ee-931b-1dadfb29ec63"
      unitRef="usd">-1488000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDctMS0xLTEtMTQ5MTE3_f7b4e8df-c3a3-41b9-b251-494e30cca2cf"
      unitRef="usd">25689000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDctMy0xLTEtMTQ5MTE3_a547caff-299e-4f72-b264-51c0dba7cdf5"
      unitRef="usd">25282000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDgtMS0xLTEtMTQ5MTE3_7a3275d0-b204-450d-96ee-24085168adcf"
      unitRef="usd">54394000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yMi9mcmFnOjk4YTUxNzgwODdiZTQ1MTRhY2U5ZDc3ZTk0YTg1YjUyL3RhYmxlOjIyMzVkODMyYjljNTQ5NmNhNTA5YTVmYmIzODBmZGUwL3RhYmxlcmFuZ2U6MjIzNWQ4MzJiOWM1NDk2Y2E1MDlhNWZiYjM4MGZkZTBfNDgtMy0xLTEtMTQ5MTE3_e6f3a1a4-14b4-4265-963f-4f639a5649f2"
      unitRef="usd">52934000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMy0xLTEtMS0xNDkxMTc_2f7aabfb-e4e6-4947-9459-ef0d59f60c9d"
      unitRef="usd">969000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMy0zLTEtMS0xNDkxMTc_6aaa18d6-4c7b-4ac7-aabd-a95c9ef2288c"
      unitRef="usd">1131000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNC0xLTEtMS0xNDkxMTc_e152fc48-35e7-44e5-b8bd-318b90519fc5"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNC0zLTEtMS0xNDkxMTc_597e067c-e049-450b-82fe-20903731abfc"
      unitRef="usd">173000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNS0xLTEtMS0xNDkxMTc_dedcb556-24c4-4af0-b7e6-b0eaee95f547"
      unitRef="usd">969000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNS0zLTEtMS0xNDkxMTc_899e1c31-712c-4b71-8dd2-6d2dc99d48e3"
      unitRef="usd">958000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNy0xLTEtMS0xNDkxMTc_984c463b-8ad3-48a8-a868-58f6163f199e"
      unitRef="usd">1130000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNy0zLTEtMS0xNDkxMTc_89109b41-74a9-4961-a56b-045bafd485b5"
      unitRef="usd">1094000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfOC0xLTEtMS0xNDkxMTc_26bfca9b-8db5-4adc-888a-a25b68ee51ad"
      unitRef="usd">145000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfOC0zLTEtMS0xNDkxMTc_cfb1cbd5-16ba-457f-8696-37d3ea32b574"
      unitRef="usd">134000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfOS0xLTEtMS0xNDkxMTc_a19a87fb-3c8f-4234-bb1c-54910aacd9bd"
      unitRef="usd">-325000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfOS0zLTEtMS0xNDkxMTc_f43e4ee3-11e7-4f3a-8105-e75506dcb611"
      unitRef="usd">-53000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTAtMS0xLTEtMTQ5MTE3_eeb74707-70e7-4704-85cd-52897a11310d"
      unitRef="usd">1274000000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTAtMy0xLTEtMTQ5MTE3_cb4f8b29-fcb1-47ca-95f5-b8790cdfe5c9"
      unitRef="usd">1076000000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <bdx:IncreaseDecreaseinPensionBenefitObligation
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTEtMS0xLTEtMTQ5MTE3_d600ffdf-8b86-42c0-a9f3-45d68cef6725"
      unitRef="usd">44000000</bdx:IncreaseDecreaseinPensionBenefitObligation>
    <bdx:IncreaseDecreaseinPensionBenefitObligation
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTEtMy0xLTEtMTQ5MTE3_1b7c16f3-c957-4304-bd8c-f80a40436af5"
      unitRef="usd">-136000000</bdx:IncreaseDecreaseinPensionBenefitObligation>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTUtMS0xLTEtMTQ5MTE3_9d31b706-7a43-4ee9-ab61-39ff0b54d8dc"
      unitRef="usd">-105000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTUtMy0xLTEtMTQ5MTE3_b2366867-3e5d-4f0f-9822-339e7572c9da"
      unitRef="usd">-101000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTYtMS0xLTEtMTQ5MTE3_425dd271-9af4-40bf-b32b-33abee18098e"
      unitRef="usd">584000000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTYtMy0xLTEtMTQ5MTE3_ac1856b0-ad9a-480e-8abb-fb08d4d15b6c"
      unitRef="usd">820000000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTgtMS0xLTEtMTQ5MTE3_b678d00d-29cb-44ff-99bf-aad9a47bfc5f"
      unitRef="usd">389000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMTgtMy0xLTEtMTQ5MTE3_fb62afa6-4e5a-40d0-9419-8970ea3606f6"
      unitRef="usd">405000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjEtMS0xLTEtMTQ5MTE3_53f6507a-79c8-45e0-b428-c56e654c1b5f"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjEtMy0xLTEtMTQ5MTE3_9f416010-9ab3-4daa-975e-4ec3b0d16809"
      unitRef="usd">450000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjMtMS0xLTEtMTQ5MTE3_32d994e3-6bae-486e-a223-a26c5166a127"
      unitRef="usd">134000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjMtMy0xLTEtMTQ5MTE3_9a8b44bb-0169-4aed-ae9b-3bcaea0c520c"
      unitRef="usd">124000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjQtMS0xLTEtMTQ5MTE3_13f4ac7e-8832-4b4a-9244-350db7ce1839"
      unitRef="usd">-524000000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjQtMy0xLTEtMTQ5MTE3_a5dc4442-351e-42ff-98b2-085426912fbb"
      unitRef="usd">-979000000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjYtMS0xLTEtMTQ5MTE3_8218b90b-b4b9-42b3-a600-c1a4265a35f9"
      unitRef="usd">365000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjYtMy0xLTEtMTQ5MTE3_13c44798-9827-45e5-abf0-b4f303559884"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjctMS0xLTEtMTQ5MTE3_5dd9cf29-f2a4-4c5a-9bb8-3fee1434d336"
      unitRef="usd">1662000000</bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans>
    <bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjctMy0xLTEtMTQ5MTE3_337dce12-2cf3-4984-b84e-021303e6c9b5"
      unitRef="usd">0</bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans>
    <bdx:ProceedsFromSpinoffTransaction
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjgtMS0xLTEtMTQ5MTE3_8135f745-a7c5-4a40-879d-a41ed8e7174c"
      unitRef="usd">0</bdx:ProceedsFromSpinoffTransaction>
    <bdx:ProceedsFromSpinoffTransaction
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMjgtMy0xLTEtMTQ5MTE3_20bfd7c6-d688-401c-b70e-1577a6d1be03"
      unitRef="usd">1266000000</bdx:ProceedsFromSpinoffTransaction>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzEtMS0xLTEtMTQ5MTE3_a925e6bb-4fc8-488f-88a7-cbe66ec481fc"
      unitRef="usd">529000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzEtMy0xLTEtMTQ5MTE3_29805b22-6ed5-4b9b-a471-9ab42ced4965"
      unitRef="usd">2000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzQtMS0xLTEtMTQ5MTE3_e6d719f4-0344-4f71-a466-c9cf11479c0c"
      unitRef="usd">563000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzQtMy0xLTEtMTQ5MTE3_bbc838e0-9efc-42df-a69a-d11b854ba09d"
      unitRef="usd">541000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzUtMS0xLTEtMTQ5MTE3_53f1defb-809f-43bf-aec2-181299aa0484"
      unitRef="usd">-101000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzUtMy0xLTEtMTQ5MTE3_506e53c8-3307-4d55-b530-0114efbdc07a"
      unitRef="usd">-63000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzYtMS0xLTEtMTQ5MTE3_48e0bd9b-2534-4352-8ac9-02d74b938ca4"
      unitRef="usd">835000000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzYtMy0xLTEtMTQ5MTE3_66d3bdac-59cd-4a93-a030-b097e021edb6"
      unitRef="usd">659000000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzgtMS0xLTEtMTQ5MTE3_d77c74b8-ef86-4fa0-a2da-941aa89dde71"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzgtMy0xLTEtMTQ5MTE3_6de9edac-9ecf-4908-be42-93e0dc0d1a30"
      unitRef="usd">298000000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzktMS0xLTEtMTQ5MTE3_548220da-3372-45d2-bbd9-29fa38ef21cf"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfMzktMy0xLTEtMTQ5MTE3_486d4011-24a5-4574-86cf-2bc11f5eda6e"
      unitRef="usd">-11000000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDAtMS0xLTEtMTQ5MTE3_f5671190-ba04-4767-9eeb-71406db27a8c"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDAtMy0xLTEtMTQ5MTE3_dc00a919-3087-485a-87f7-2420691c23a3"
      unitRef="usd">145000000</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDEtMS0xLTEtMTQ5MTE3_31993be6-bedf-43a2-8cc5-978e52de1ab3"
      unitRef="usd">0</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDEtMy0xLTEtMTQ5MTE3_afc9f1e9-6735-4cbd-9b14-6b34e5a707c1"
      unitRef="usd">432000000</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDItMS0xLTEtMTQ5MTE3_dc522829-e486-4a5a-8f12-491a9bd73875"
      unitRef="usd">14000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDItMy0xLTEtMTQ5MTE3_2b32be12-e30b-4fe9-817b-0fc6cb343919"
      unitRef="usd">-4000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDMtMS0xLTEtMTQ5MTE3_c3498db5-f310-44ed-bc3e-9741efa78d07"
      unitRef="usd">909000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDMtMy0xLTEtMTQ5MTE3_37199dce-4020-4f6e-9022-b287a476c239"
      unitRef="usd">928000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDQtMS0xLTEtMTQ5MTE3_ca46ae5a-0fb0-40fd-90e7-213f30ea1150"
      unitRef="usd">1159000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i798de8f735874f948c11fa53069df187_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDQtMy0xLTEtMTQ5MTE3_a59a2aa0-06d1-483d-8ca9-4328c702be03"
      unitRef="usd">2392000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDUtMS0xLTEtMTQ5MTE3_13f338db-6b26-4ac9-9cbb-58295de49854"
      unitRef="usd">2068000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i88f747ff4b7f43869b7fa5bb86a41c80_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8yNS9mcmFnOmIzNjBhNTcwZTEzMTQwNDc5OGY2YWYwZDZlZDY4MDI0L3RhYmxlOjNlNDVlZDRiMTFlYzQyZWVhMjJhYWI4MTQwN2U1MGNiL3RhYmxlcmFuZ2U6M2U0NWVkNGIxMWVjNDJlZWEyMmFhYjgxNDA3ZTUwY2JfNDUtMy0xLTEtMTQ5MTE3_15e6f277-790b-4aa7-ab9f-ac19404b0ccc"
      unitRef="usd">3320000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zMS9mcmFnOmU2NWExZDExMGVkYzQ5ZTBhYzgzNzQ5OTU4OTY2NzQzL3RleHRyZWdpb246ZTY1YTFkMTEwZWRjNDllMGFjODM3NDk5NTg5NjY3NDNfMTg3Mw_9c6aaf41-6e1f-45bd-a7c2-cfcf03e629cb">Basis of Presentation&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, in the opinion of the management of Becton, Dickinson and Company (the "Company" or "BD"), include all adjustments which are of a normal recurring nature, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented. However, the financial statements do not include all information and accompanying notes required for a presentation in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#x2019;s 2022 Annual Report on Form 10-K.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company. The historical results of the Diabetes Care business (previously included in BD&#x2019;s Medical segment) that was contributed to Embecta Corp (&#x201c;Embecta&#x201d;) in the spin-off, as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in the Company&#x2019;s condensed consolidated financial statements for the three and six months ended March 31, 2022. Additional disclosures regarding the spin-off are provided in Note 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RleHRyZWdpb246YThhMzVmMWEyYmJiNDY3MjhkZTAzZmI4NTEwOTFjOWVfMjcxNA_91969039-c6f0-4a71-938e-2a3260c6a6eb">Spin-Off of Embecta Corp.&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta through a distribution of Embecta&#x2019;s publicly traded common stock (listed on NASDAQ under the ticker symbol &#x201c;EMBC&#x201d;) to BD&#x2019;s shareholders of record as of the close of business on March 22, 2022 (the &#x201c;record date&#x201d;). The Company distributed one share of Embecta common stock for every five common shares of BD outstanding as of the record date and shareholders received cash in lieu of fractional shares of Embecta common stock. BD retained no ownership interest in Embecta subsequent to the spin-off. The distribution is expected to qualify and has been treated as tax-free to the Company and its shareholders for U.S. federal income tax purposes.  On March 31, 2022, Embecta used a portion of the proceeds from its financing transactions to make a cash distribution of approximately $1.266&#160;billion to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off. Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and supply agreements, a lease agreement, a distribution agreement to support commercial operations, a logistics services agreement and other agreements including an employee matters agreement and a tax matters agreement. Under these agreements, the Company will continue to provide certain products and services to Embecta following the spin-off. The agreements do not provide the Company with the ability to influence the operating or financial policies of Embecta subsequent to the spin-off date. Amounts included in the Company&#x2019;s condensed consolidated statements of income during the three and six months ended March&#160;31, 2023 as a result of these agreements were&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; immaterial.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;      &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Details of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Discontinued Operations, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.309%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.688%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.688%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Millions of dollars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Operating Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from Discontinued Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from Discontinued Operations, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended March&#160;31, 2022, the Company incurred $53&#160;million and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$78&#160;million, respectively,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of separation costs, including those for consulting, legal, tax and other advisory services associated with the spin-off, which were previously recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other operating expense (income), net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. These amounts were recast as components of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income from Discontinued Operations, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as detailed above&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The amounts of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt; from discontinued operations detailed above include previously eliminated intercompany transactions that occurred between BD and Embecta, which resulted in a third-party sale in the same period.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <bdx:DisposalGroupsIncludingDiscontinuedOperationConsiderationCash
      contextRef="i9c3c3fab267a46a88f3f39dfcc2cf90a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RleHRyZWdpb246YThhMzVmMWEyYmJiNDY3MjhkZTAzZmI4NTEwOTFjOWVfMTY0OTI2NzQ0NTEzMg_ac62a791-7176-4098-8e4d-0424c827117d"
      unitRef="usd">1266000000</bdx:DisposalGroupsIncludingDiscontinuedOperationConsiderationCash>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RleHRyZWdpb246YThhMzVmMWEyYmJiNDY3MjhkZTAzZmI4NTEwOTFjOWVfMjcxNQ_8044e44c-f311-47fc-9e6c-efe14339565b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Details of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Discontinued Operations, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.309%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.688%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.688%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Millions of dollars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Operating Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from Discontinued Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from Discontinued Operations, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMi0zLTEtMS0xNDkxMTc_af31ed31-8521-4bbb-bb7d-c8a09c383c69"
      unitRef="usd">261000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMi01LTEtMS0xNDkxMTc_76e3646c-806e-4f1a-8bf5-9c9b386432c2"
      unitRef="usd">538000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMy0zLTEtMS0xNDkxMTc_aed91252-b15d-458c-9ffc-004b4ac0ffed"
      unitRef="usd">69000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMy01LTEtMS0xNDkxMTc_4cb8cc38-9fbe-4f87-81c7-09239c8fad2b"
      unitRef="usd">143000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNC0zLTEtMS0xNDkxMTc_a1f9e388-852b-4600-b53e-9a061572b8cc"
      unitRef="usd">40000000</bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNC01LTEtMS0xNDkxMTc_c3c96660-dcd1-4f28-a486-b26c99777292"
      unitRef="usd">78000000</bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNS0zLTEtMS0xNDkxMTc_9129996e-209f-48d8-a473-ad07bf3e2a43"
      unitRef="usd">16000000</bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNS01LTEtMS0xNDkxMTc_504a0f8c-926d-4468-9ee6-119300767ec5"
      unitRef="usd">32000000</bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNy0zLTEtMS0xNDkxMTc_143f91e7-3a79-4b3e-ba3d-85bf43444055"
      unitRef="usd">-49000000</bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet>
    <bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfNy01LTEtMS0xNDkxMTc_80322b03-fdfd-4e1a-9cc7-b10db78f07b5"
      unitRef="usd">-74000000</bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfOC0zLTEtMS0xNDkxMTc_5b38756a-8d6a-4755-91c2-4c43fafd72fe"
      unitRef="usd">174000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfOC01LTEtMS0xNDkxMTc_71e8b26c-529d-4ea8-9fbe-341f40c9ea3c"
      unitRef="usd">327000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfOS0zLTEtMS0xNDkxMTc_ef2a9f2b-17e9-40e4-bab2-4e7a8a506f3e"
      unitRef="usd">88000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfOS01LTEtMS0xNDkxMTc_abbd2838-5813-40f2-bcd6-ff1e76be06db"
      unitRef="usd">211000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTAtMy0xLTEtMTQ5MTE3_999eaa2c-a6a6-4eb3-9277-81dfa5450a12"
      unitRef="usd">4000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTAtNS0xLTEtMTQ5MTE3_e3e04480-d7b3-4d18-90dd-b5ef1bb2a985"
      unitRef="usd">4000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTMtMy0xLTEtMTQ5MTE3_94d119cf-745b-47be-bcd9-e26d9146853c"
      unitRef="usd">83000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTMtNS0xLTEtMTQ5MTE3_b1bc8b46-4847-4ee1-adf5-01777570a95f"
      unitRef="usd">207000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTQtMy0xLTEtMTQ5MTE3_89237e4e-db4e-4d49-bdd1-9d4596b0d7b5"
      unitRef="usd">19000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTQtNS0xLTEtMTQ5MTE3_c05c1419-f198-452e-967e-e84ee0f382fa"
      unitRef="usd">33000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTUtMy0xLTEtMTQ5MTE3_a453af54-c4bc-4cdf-9b94-584b32f0d9f2"
      unitRef="usd">64000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RhYmxlOjgxODVjMzhmZjliYjQxYWE4N2Q3YTFiMGVjOWNmZmY5L3RhYmxlcmFuZ2U6ODE4NWMzOGZmOWJiNDFhYTg3ZDdhMWIwZWM5Y2ZmZjlfMTUtNS0xLTEtMTQ5MTE3_6ed322e5-4330-4d9a-92b0-0a1c9600b81f"
      unitRef="usd">173000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense
      contextRef="i838793163e4f492f987f08dd7af25df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RleHRyZWdpb246YThhMzVmMWEyYmJiNDY3MjhkZTAzZmI4NTEwOTFjOWVfMjE5OTAyMzI1ODMzNg_83885d53-8466-4575-b146-f1c12ca85477"
      unitRef="usd">53000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense
      contextRef="ida8ab2f47d3a47ec96c0df45b639f4d8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNC9mcmFnOmE4YTM1ZjFhMmJiYjQ2NzI4ZGUwM2ZiODUxMDkxYzllL3RleHRyZWdpb246YThhMzVmMWEyYmJiNDY3MjhkZTAzZmI4NTEwOTFjOWVfMjA0Nw_d2cfe6fd-f2af-428b-ac86-9816b693c3df"
      unitRef="usd">78000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RleHRyZWdpb246Mjc4OTAxMmQxYTU1NDg3YWFiNDkxYzU2ZjE1MDg0NTRfMTc0Nw_18397658-b000-462b-bcf2-a4e836bd2db2">Shareholders' Equity&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common&lt;br/&gt;Stock&#160; Issued&lt;br/&gt;at&#160;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capital in&lt;br/&gt;Excess&#160;of&lt;br/&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred&lt;br/&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.91 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of shares under employee and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.91 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of shares under employee and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common&lt;br/&gt;Stock&#160; Issued&lt;br/&gt;at&#160;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capital in&lt;br/&gt;Excess&#160;of&lt;br/&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred&lt;br/&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.87 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of shares under employee and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.87 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of shares under employee and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Common stock held in trusts consists of the Company&#x2019;s shares held in rabbi trusts in connection with deferred compensation under the Company&#x2019;s employee salary and bonus deferral plan and directors&#x2019; deferral plan. During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company&#x2019;s Series C preferred shares to adhere to trust requirements until the Company&#x2019;s spin-off of its Diabetes Care business was completed on April 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021. T&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10&#160;million shares, which has been fully utilized. In November 2021, the Board of Directors authorized the Company to repurchase up to an additional 10&#160;million shares of BD common stock, for which there is also no expiration date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components and changes of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the first two quarters of fiscal years 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency&lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency&lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,251)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts of foreign currency translation recognized in other comprehensive income during the three and six months ended March&#160;31, 2023 and 2022 included net (losses) gains relating to net investment hedges. The amounts recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022 are primarily related to forward starting interest rate swaps. Additional disclosures regarding amounts the Company recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022 are provided in Note 11.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax impacts for amounts recognized in other comprehensive income (loss) before reclassifications and for reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to benefit plans and cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RleHRyZWdpb246Mjc4OTAxMmQxYTU1NDg3YWFiNDkxYzU2ZjE1MDg0NTRfMTc0OA_cee6e82a-153c-48ce-811e-91d7204d18d5">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common&lt;br/&gt;Stock&#160; Issued&lt;br/&gt;at&#160;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capital in&lt;br/&gt;Excess&#160;of&lt;br/&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred&lt;br/&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.91 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of shares under employee and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.91 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of shares under employee and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common&lt;br/&gt;Stock&#160; Issued&lt;br/&gt;at&#160;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capital in&lt;br/&gt;Excess&#160;of&lt;br/&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred&lt;br/&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.87 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of shares under employee and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.87 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of shares under employee and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Common stock held in trusts consists of the Company&#x2019;s shares held in rabbi trusts in connection with deferred compensation under the Company&#x2019;s employee salary and bonus deferral plan and directors&#x2019; deferral plan. During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company&#x2019;s Series C preferred shares to adhere to trust requirements until the Company&#x2019;s spin-off of its Diabetes Care business was completed on April 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021. T&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10&#160;million shares, which has been fully utilized. In November 2021, the Board of Directors authorized the Company to repurchase up to an additional 10&#160;million shares of BD common stock, for which there is also no expiration date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i2574ec0c91f14c3f937606f7e1fa9cff_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi0xLTEtMS0xNDkxMTc_e4c19846-d296-46e7-a039-68644ad1304f"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i85998d24a6604a978712c8df1da2a7c9_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi0zLTEtMS0xNDkxMTc_04d29ac7-b0b9-47d6-9185-dd0ec69fd291"
      unitRef="usd">19553000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie8832464205e4aec9d9dc8cdc63dcb72_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi01LTEtMS0xNDkxMTc_51b5bfeb-f823-4b8d-aa5f-c74c354d0986"
      unitRef="usd">15157000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id83705567a26476994261cc7b5a25d33_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi03LTEtMS0xNDkxMTc_0bbba762-3033-40f9-ab58-349a70cddf0e"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i2f12e83843f74a02ae51ea3d6b8a6a20_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi05LTEtMS0xNDkxMTc_d354a63d-5186-42c6-8a1a-20423d609b9c"
      unitRef="shares">81283000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i2f12e83843f74a02ae51ea3d6b8a6a20_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMi0xMS0xLTEtMTQ5MTE3_c9238249-b782-44be-952b-5ffae3b70e31"
      unitRef="usd">-8330000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i671cc096e3784769a513d12258a4a23c_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMy01LTEtMS0xNDkxMTc_81373c45-a2b8-42ee-b589-d454a6c92133"
      unitRef="usd">509000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i7c23e44aea374d2fb54a3b6aedeadc11_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNC0wLTEtMS0xNDkxMTcvdGV4dHJlZ2lvbjo4N2Q2YTNjZDIxNjM0YzNiYjdhNDY2MzQzYzE0OTczNF8yMg_f3ec6c39-93aa-4b11-a072-52a27e6ccaa5"
      unitRef="usdPerShare">0.91</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i671cc096e3784769a513d12258a4a23c_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNC01LTEtMS0xNDkxMTc_351d5853-dc31-4ea0-a770-303e3afa9e22"
      unitRef="usd">259000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="i671cc096e3784769a513d12258a4a23c_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNS01LTEtMS0xNDkxMTc_455a6848-f9bf-4afa-865b-c3311f9966e2"
      unitRef="usd">23000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia116d571cab942aeb5f677df8f19d44c_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNi0zLTEtMS0xNDkxMTc_adc1b275-77b4-4e0e-8e59-a7c6745d7ff6"
      unitRef="usd">-52000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i15828c3d0e91477790a5db6c52c366cc_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNi05LTEtMS0xNDkxMTc_bc041931-7754-4756-87f9-dcc375898148"
      unitRef="shares">556000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i15828c3d0e91477790a5db6c52c366cc_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNi0xMS0xLTEtMTQ5MTE3_3dc8b425-04b8-4efb-a602-de140e4823cc"
      unitRef="usd">-3000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia116d571cab942aeb5f677df8f19d44c_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfNy0zLTEtMS0xNDkxMTc_14db326f-e7ef-4687-ad65-c249562366a8"
      unitRef="usd">89000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="i15828c3d0e91477790a5db6c52c366cc_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfOC05LTEtMS0xNDkxMTc_40bdfa8a-2aad-4c87-a270-c40745b568c9"
      unitRef="shares">-11000</bdx:CommonStockHeldInTrustsNetShares>
    <us-gaap:StockholdersEquity
      contextRef="i1646e6cae76e477ea277db5cfc3e2db2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtMS0xLTEtMTQ5MTE3_a8183193-59e4-43cf-a704-a71523e946fb"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia8944e67417c44f49a70a8c33ea2603c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtMy0xLTEtMTQ5MTE3_9b4a5bbb-1f6d-4da4-bbaf-bbb483a3ec3d"
      unitRef="usd">19590000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0a00598163e14d4ba75663154d5576e6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtNS0xLTEtMTQ5MTE3_173cf6c4-ab76-4899-9975-a60ddd312a6a"
      unitRef="usd">15384000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i093e1c6251c446969afe57366b0f9d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtNy0xLTEtMTQ5MTE3_a341d946-b1f3-4b79-b57f-9e91118187a7"
      unitRef="usd">24000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i868aa31ce93e406aaad8f6e77dc6b180_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtOS0xLTEtMTQ5MTE3_cab50311-a2dc-4711-83c7-a09451f47bb3"
      unitRef="shares">80738000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i868aa31ce93e406aaad8f6e77dc6b180_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTEtMTEtMS0xLTE0OTExNw_c7e6eba8-868f-4ed2-a969-68e00314edf8"
      unitRef="usd">-8333000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="idfd5089106d54575b654a9e7e308e583_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTItNS0xLTEtMTQ5MTE3_e9e11959-3ca7-418c-9b52-8e2def9c7bbf"
      unitRef="usd">460000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTMtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246YzI5NzY4MzZjYTU4NGVhMGE5YWZiMjBiNDIzNzE2YmVfMjI_6bcb6eed-a60e-4cbb-9bcd-ff963c1fbe1b"
      unitRef="usdPerShare">0.91</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="idfd5089106d54575b654a9e7e308e583_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTMtNS0xLTEtMTQ5MTE3_9424e555-4ab4-40df-8115-602af4b6284c"
      unitRef="usd">259000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="idfd5089106d54575b654a9e7e308e583_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTQtNS0xLTEtMTQ5MTE3_0734aa4b-6a38-48e2-a490-425775c1f934"
      unitRef="usd">23000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8cf7721ab8534ff39ac5f79dc98c0378_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTUtMy0xLTEtMTQ5MTE3_ed0bb620-5d2e-4946-a5e3-18d13eb8dbfb"
      unitRef="usd">-7000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i53fc9c3af28f47f7ab9ed1893b981c2a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTUtOS0xLTEtMTQ5MTE3_617c54f2-eeb7-4f71-8ef8-4d576f50a6f6"
      unitRef="shares">21000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i53fc9c3af28f47f7ab9ed1893b981c2a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTUtMTEtMS0xLTE0OTExNw_de381790-a57a-4e01-9149-9f8c522b3e83"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8cf7721ab8534ff39ac5f79dc98c0378_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTYtMy0xLTEtMTQ5MTE3_84664160-542b-4bb5-ba36-39bbf5d6ab91"
      unitRef="usd">56000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="i53fc9c3af28f47f7ab9ed1893b981c2a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTctOS0xLTEtMTQ5MTE3_606d4935-8068-4c80-a9f5-ed3319a4a240"
      unitRef="shares">92000</bdx:CommonStockHeldInTrustsNetShares>
    <us-gaap:StockholdersEquity
      contextRef="i04e93ba713f84c2293fdbd3f08dd5eb9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtMS0xLTEtMTQ5MTE3_2f897f06-642e-4597-a949-5d1d12e2278d"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if9161e65f73442d4a2e22bfce36dc56d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtMy0xLTEtMTQ5MTE3_b0b12b77-7f5b-4389-9298-ba645c080108"
      unitRef="usd">19639000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79acf93fa3e9494198d48e60df910f20_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtNS0xLTEtMTQ5MTE3_6c6af018-16b3-48fe-9415-09c3f673e2cf"
      unitRef="usd">15563000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic8ca5cb05c6f4abaaba6eeeeea095bd8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtNy0xLTEtMTQ5MTE3_1be25388-c79f-4f8e-a7c9-18d62c5b0335"
      unitRef="usd">24000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i382cb5c56e50416a96a86b779a0dd809_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtOS0xLTEtMTQ5MTE3_669b49d1-1987-4a44-ae6d-68dedd9aaec6"
      unitRef="shares">80625000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i382cb5c56e50416a96a86b779a0dd809_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjZkODRlN2M3MTEwZDQxNDM4M2E3MjY3MTgyOTdjMDc0L3RhYmxlcmFuZ2U6NmQ4NGU3YzcxMTBkNDE0MzgzYTcyNjcxODI5N2MwNzRfMTgtMTEtMS0xLTE0OTExNw_6ab65834-b537-4ca4-9a24-8fa95b147b3f"
      unitRef="usd">-8327000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if6921b343dee4c03b1537facc8f6e180_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi0xLTEtMS0xNDkxMTc_5ff34fd8-a8b5-4245-881e-1318a9419954"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i547348e51c474a16aabca1490b09fed7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi0zLTEtMS0xNDkxMTc_c2563488-3fb9-4871-b0cc-f0a73d03434a"
      unitRef="usd">19272000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i24d5b4db143146d3bb147d94438ec1fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi01LTEtMS0xNDkxMTc_58aa9af9-3562-4627-955d-8fb4fd8aaccb"
      unitRef="usd">13826000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9075e2707bb44b9ebba0bff02efce052_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi03LTEtMS0xNDkxMTc_ca49c010-81dc-47b9-98b8-fdebd399f5c1"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i20cfc39ccaee446ba852752323e51724_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi05LTEtMS0xNDkxMTc_3a700d89-403e-468f-9f55-dcffab0b47a6"
      unitRef="shares">80164000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i20cfc39ccaee446ba852752323e51724_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMi0xMS0xLTEtMTQ5MTE3_5f100c68-245b-49b5-ae0e-8d2f21054098"
      unitRef="usd">-7723000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ic3dddbf166b34f98ab399f4fcb3f2ebe_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMy01LTEtMS0xNDkxMTc_a32ede28-384d-432f-996d-e0996a276bc3"
      unitRef="usd">677000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i336f8c4b2c4b4be4a1d5e5e1c5497d18_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNC0wLTEtMS0xNDkxMTcvdGV4dHJlZ2lvbjoyZDUyNjA4Y2MwMjM0ZjBiOWU4YmUyYzMwM2UxNjNlN18yMg_cc7c4448-75db-4c7a-a44d-140e20f95265"
      unitRef="usdPerShare">0.87</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic3dddbf166b34f98ab399f4fcb3f2ebe_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNC01LTEtMS0xNDkxMTc_0d5d7081-0174-4fd8-aa6b-159acc81a752"
      unitRef="usd">248000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="ic3dddbf166b34f98ab399f4fcb3f2ebe_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNS01LTEtMS0xNDkxMTc_cbfcc9ff-bd56-4121-a1db-584af44bfa62"
      unitRef="usd">23000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9e15f85977ce439d9169b789f07b511d_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNi0zLTEtMS0xNDkxMTc_e533df7d-1664-4d9e-ab5d-c80d83e509bb"
      unitRef="usd">-71000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNi05LTEtMS0xNDkxMTc_7f943475-2005-4936-9222-a765ebc79954"
      unitRef="shares">762000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNi0xMS0xLTEtMTQ5MTE3_9e370c7e-88fc-4be0-bac7-375ee9d31acc"
      unitRef="usd">19000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9e15f85977ce439d9169b789f07b511d_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfNy0zLTEtMS0xNDkxMTc_1b7fc83c-7b66-4626-b197-14badfde0da0"
      unitRef="usd">83000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfOC05LTEtMS0xNDkxMTc_3052c9e3-14dd-4d2d-b989-bbb301b246e6"
      unitRef="shares">-5000</bdx:CommonStockHeldInTrustsNetShares>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9e15f85977ce439d9169b789f07b511d_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTAtMy0xLTEtMTQ5MTE3_5fe44c83-d88b-4b68-a488-89dcc34dfcc5"
      unitRef="usd">-150000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTAtOS0xLTEtMTQ5MTE3_e96fa935-2118-479e-9c00-3615fc0a9d49"
      unitRef="shares">462000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i26b10076a5ca41b9a85152965a34b43e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTAtMTEtMS0xLTE0OTExNw_5d1562ba-2664-49a1-bbb4-aeba9cfe3b06"
      unitRef="usd">150000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquity
      contextRef="i04e794f49df74ce1bbe110052dc73130_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtMS0xLTEtMTQ5MTE3_fddfb3ce-220a-483c-9213-7f2f467c4756"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9feb4047fcf64ef0af2f6485859117a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtMy0xLTEtMTQ5MTE3_86d36064-9aa1-4d43-b18c-1d8984fc231f"
      unitRef="usd">19435000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6f99435036b34bd2a24d925a56120f91_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtNS0xLTEtMTQ5MTE3_2fec68d2-9b2e-4dd0-b78b-2569b84b4097"
      unitRef="usd">14233000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7d976db8005448e0afc273870324e7ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtNy0xLTEtMTQ5MTE3_2d6237df-9a32-43fd-b657-35ddb82e0544"
      unitRef="usd">24000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i76d02aecab48442e86778fa7099b3161_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtOS0xLTEtMTQ5MTE3_6a80f935-7b67-4609-907f-471b2be94c28"
      unitRef="shares">79869000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i76d02aecab48442e86778fa7099b3161_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTEtMTEtMS0xLTE0OTExNw_3449bec7-6fec-4ae6-8b46-39401eb90e36"
      unitRef="usd">-7855000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i2a0740ea75854a55b2cdec3baa4f058f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTItNS0xLTEtMTQ5MTE3_ad74e57d-cb0c-4917-bcc6-fa9663937e55"
      unitRef="usd">454000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTMtMC0xLTEtMTQ5MTE3L3RleHRyZWdpb246MWY0ZTQwM2E0NDgyNDJmOTlmZGJlY2Y5ZmY4OTY1MmRfMjI_455e84c5-a36d-451a-9a41-c334d2ade703"
      unitRef="usdPerShare">0.87</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i2a0740ea75854a55b2cdec3baa4f058f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTMtNS0xLTEtMTQ5MTE3_594a7974-6835-44b6-822a-cd090aaa62b4"
      unitRef="usd">248000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="i2a0740ea75854a55b2cdec3baa4f058f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTQtNS0xLTEtMTQ5MTE3_72eb1326-e370-4c29-af5b-3daa5a4533cf"
      unitRef="usd">23000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="icb38e09788ba4aecab8c912c9af71397_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTUtMy0xLTEtMTQ5MTE3_c2b1de3a-d1bc-4daf-ba56-131d8a157d4c"
      unitRef="usd">-21000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i706eb0202c0e496fb7a2947d80c016d2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTUtNy0xLTEtMTQ5MTE3_5ae2006c-6c53-4474-89a7-1a485d4a87b9"
      unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iddbd8602678b425dbb7e0ea97f55fb4b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTUtOS0xLTEtMTQ5MTE3_43254f42-faca-4846-827d-ef4f74abbd68"
      unitRef="shares">284000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iddbd8602678b425dbb7e0ea97f55fb4b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTUtMTEtMS0xLTE0OTExNw_b9666298-d91c-4609-a887-b1ef5e4ef385"
      unitRef="usd">14000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icb38e09788ba4aecab8c912c9af71397_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTYtMy0xLTEtMTQ5MTE3_4b5ec39a-06ad-4856-ad3f-65ede182b755"
      unitRef="usd">56000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsAcquired
      contextRef="icb38e09788ba4aecab8c912c9af71397_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTctMy0xLTEtMTQ5MTE3_9f6c6a08-8173-4411-8bcd-f1570a630c5e"
      unitRef="usd">24000000</bdx:CommonStockHeldInTrustsAcquired>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="iddbd8602678b425dbb7e0ea97f55fb4b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTctOS0xLTEtMTQ5MTE3_a97d4516-ba86-4314-8dee-434679384911"
      unitRef="shares">9000</bdx:CommonStockHeldInTrustsNetShares>
    <bdx:CommonStockHeldInTrustsAcquired
      contextRef="iddbd8602678b425dbb7e0ea97f55fb4b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTctMTEtMS0xLTE0OTExNw_f4381af5-42c9-45ae-900b-1c781a49167d"
      unitRef="usd">-24000000</bdx:CommonStockHeldInTrustsAcquired>
    <us-gaap:StockholdersEquity
      contextRef="i38c11f85d6c5428f8a5759883d9c4623_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktMS0xLTEtMTQ5MTE3_daee2532-bb0c-4305-b7cd-1ef47f3db9f8"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5930df7450554cf3a1702154aa7730a1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktMy0xLTEtMTQ5MTE3_801cc7b6-59ff-4519-a99d-a98c13aca698"
      unitRef="usd">19495000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i59879870004c4696b50bacebdf8bcae1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktNS0xLTEtMTQ5MTE3_bfda0159-18de-4959-b2a7-00f6a0a3d84d"
      unitRef="usd">14416000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iee4905aacc8d41638bc2468d4a3aa787_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktNy0xLTEtMTQ5MTE3_d864355b-6996-4d9f-8134-cdecc74aeec0"
      unitRef="usd">24000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="if965b175d9504baba439a1be95582e62_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktOS0xLTEtMTQ5MTE3_2a7fa864-b54e-41ed-ba14-156430926a4d"
      unitRef="shares">79575000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="if965b175d9504baba439a1be95582e62_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOmVkZTgyMTQ5NGE1NTQ0Nzc5MzNmNjlhMjQ1ZmIwNzIyL3RhYmxlcmFuZ2U6ZWRlODIxNDk0YTU1NDQ3NzkzM2Y2OWEyNDVmYjA3MjJfMTktMTEtMS0xLTE0OTExNw_676cbb6a-5e93-4e26-8a89-dd467269b109"
      unitRef="usd">-7866000000</us-gaap:StockholdersEquity>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i1850d5cec6e84eb88c655caaf1c6c1c2_I20130924"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RleHRyZWdpb246Mjc4OTAxMmQxYTU1NDg3YWFiNDkxYzU2ZjE1MDg0NTRfNjk4_5b6aa7f2-a7bd-43f0-ab87-a0cde741907b"
      unitRef="shares">10000000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <bdx:StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased
      contextRef="iafa9e6f344374994b897a26cc64ef107_I20211130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RleHRyZWdpb246Mjc4OTAxMmQxYTU1NDg3YWFiNDkxYzU2ZjE1MDg0NTRfODQ2_6e927e76-2081-408d-b883-76ddaba65708"
      unitRef="shares">10000000</bdx:StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RleHRyZWdpb246Mjc4OTAxMmQxYTU1NDg3YWFiNDkxYzU2ZjE1MDg0NTRfMTc1MA_fe9bfc37-d3e2-48c5-801e-1258901bda48">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components and changes of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the first two quarters of fiscal years 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency&lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency&lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,251)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMS0xLTEtMS0xNDkxMTc_3f8009c8-5399-44ee-931b-1dadfb29ec63"
      unitRef="usd">-1488000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i22e38a99ac5c405ebd50cfe207177871_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMS0zLTEtMS0xNDkxMTc_89cae44f-a2a6-4173-90ee-050ee6374bd3"
      unitRef="usd">-987000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4628e244401242e9bab162e1505a9dfc_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMS01LTEtMS0xNDkxMTc_65e191aa-fbb6-4d91-b36c-122c0a05bac1"
      unitRef="usd">-574000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7858fb0adb264894a55e4fd4a4920f2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMS03LTEtMS0xNDkxMTc_a8adefac-566b-4b4d-8283-0a3910425c82"
      unitRef="usd">75000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7c23e44aea374d2fb54a3b6aedeadc11_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMi0xLTEtMS0xNDkxMTc_bcfdf5e0-0faa-40a3-a44d-5efa2d70164a"
      unitRef="usd">-84000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i460c979af9204674924048511da49f37_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMi0zLTEtMS0xNDkxMTc_6cabf589-0541-479e-b0a7-37456379da3b"
      unitRef="usd">-80000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6f6d62e03f8b42f0baf0cd748c67b33e_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMi01LTEtMS0xNDkxMTc_1278fa8f-ac95-4223-afaa-2e8189743a08"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iee28abe315584e678b6d0f8d1b55cc26_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMi03LTEtMS0xNDkxMTc_57993455-6994-42f7-8775-6acc769bac34"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7c23e44aea374d2fb54a3b6aedeadc11_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMy0xLTEtMS0xNDkxMTc_e6081b4c-49bd-420d-9c84-f4183993ec58"
      unitRef="usd">-12000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i460c979af9204674924048511da49f37_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMy0zLTEtMS0xNDkxMTc_fefdc846-2e6b-4243-9115-df5d049623be"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6f6d62e03f8b42f0baf0cd748c67b33e_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMy01LTEtMS0xNDkxMTc_22321ecd-e04e-44cc-bef2-915ae0ab9958"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iee28abe315584e678b6d0f8d1b55cc26_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfMy03LTEtMS0xNDkxMTc_cd5f85f0-2c0f-4055-94ca-7f783ccdd6a8"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6484295e8f144d2ca1b524717f92829c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNC0xLTEtMS0xNDkxMTc_c5626ba6-748a-485d-ba3e-7a9f7d2dbb5a"
      unitRef="usd">-1559000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b3958263aac436d944c047db32c756d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNC0zLTEtMS0xNDkxMTc_1a86af5a-ffb8-4a01-b19c-fe1907154e17"
      unitRef="usd">-1067000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5ffdd529f695442cbae3dcc9fb039743_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNC01LTEtMS0xNDkxMTc_b5372c5c-8fbc-4c7f-8dfd-ac3d1b41b8cd"
      unitRef="usd">-563000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i19815e83945a4850ad5382563a523f5b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNC03LTEtMS0xNDkxMTc_a4fc9323-c92c-4b74-b84f-0ca4286eeb55"
      unitRef="usd">73000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNS0xLTEtMS0xNDkxMTc_7a964a50-571a-4109-98a3-5d7dd420be64"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0351329551fe4153b41300f0e72fb456_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNS0zLTEtMS0xNDkxMTc_b95821e0-2765-468e-8f1b-e08d0e5ce939"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ife590ddfab834d788b4a069ff3e68d73_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNS01LTEtMS0xNDkxMTc_4f359fb7-b14b-4bfe-bcc6-03a42c07d999"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i81ebc98ee32546b19b83fb3e2840c977_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNS03LTEtMS0xNDkxMTc_cf3bd5f8-5d27-486d-9367-12e014d59129"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNi0xLTEtMS0xNDkxMTc_abacc837-7e8d-47a1-93e3-f7922cea112c"
      unitRef="usd">-13000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0351329551fe4153b41300f0e72fb456_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNi0zLTEtMS0xNDkxMTc_364581f1-7d97-40ab-843a-ba2258383f38"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ife590ddfab834d788b4a069ff3e68d73_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNi01LTEtMS0xNDkxMTc_4ecc0be7-fb13-4f19-bde8-35c3fa0b94aa"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i81ebc98ee32546b19b83fb3e2840c977_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNi03LTEtMS0xNDkxMTc_9ef5c3ac-5907-4242-a224-ac4885b9785e"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNy0xLTEtMS0xNDkxMTc_f6412d20-9f47-442d-a833-1731c560e8eb"
      unitRef="usd">-1575000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iddd2e59573d94341b0593806ecbb2b66_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNy0zLTEtMS0xNDkxMTc_6be7b92e-e71d-4567-9e5f-3a0409bd7666"
      unitRef="usd">-1088000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7572947a7339481dbfa89e6c783ec342_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNy01LTEtMS0xNDkxMTc_e17cd644-6680-4cd8-8076-f45935afb770"
      unitRef="usd">-552000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8ae99b2183b243ea802f1c0ed0b8683a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjhhMTIyYzIwMjFiNDQ5Yjk5Mzg0MDdlNDM3YTI5N2VjL3RhYmxlcmFuZ2U6OGExMjJjMjAyMWI0NDliOTkzODQwN2U0MzdhMjk3ZWNfNy03LTEtMS0xNDkxMTc_5ac7823f-ddd4-45ab-9147-b902f92d14a9"
      unitRef="usd">67000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i798de8f735874f948c11fa53069df187_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMS0xLTEtMS0xNDkxMTc_ea1aa7de-acd3-4bbd-b897-5027e80700bc"
      unitRef="usd">-2088000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i34563c7f6e514f3db19ecc98619eddd9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMS0zLTEtMS0xNDkxMTc_2037dd24-d3cf-4b46-9bd8-8b6aafd70c98"
      unitRef="usd">-1292000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie9e294f037204c3cbf4ef8d9020868bb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMS01LTEtMS0xNDkxMTc_f4724d96-1a04-4aca-b8a1-3586fc12717d"
      unitRef="usd">-784000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0f33c5109e8848e994e743835c4960c0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMS03LTEtMS0xNDkxMTc_50660e21-3309-4539-8385-1e791638293e"
      unitRef="usd">-10000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i336f8c4b2c4b4be4a1d5e5e1c5497d18_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMi0xLTEtMS0xNDkxMTc_21994857-0484-4e51-a213-e4c1ab2a6354"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i393529c2cae1491ebcb200f597fe10b6_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMi0zLTEtMS0xNDkxMTc_ee3fdd99-acca-455e-b808-250e38b3be9c"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib0ff75f2224d450085c05c8c295a92e6_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMi01LTEtMS0xNDkxMTc_7ec18b1b-b860-4f11-8e46-e8d4a51a5c3f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if2eccb757d0246f0b29f6b496ee41a6f_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMi03LTEtMS0xNDkxMTc_0f23fe09-8b9f-41c3-8515-041a8e988540"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i336f8c4b2c4b4be4a1d5e5e1c5497d18_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMy0xLTEtMS0xNDkxMTc_bb9d0480-dbbf-4899-b26f-77f31eb3a11f"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i393529c2cae1491ebcb200f597fe10b6_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMy0zLTEtMS0xNDkxMTc_e8b470bc-d736-42e1-b89f-d323c95b522a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib0ff75f2224d450085c05c8c295a92e6_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMy01LTEtMS0xNDkxMTc_7a40d330-80b7-4db2-830f-89b6b9b953c1"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if2eccb757d0246f0b29f6b496ee41a6f_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfMy03LTEtMS0xNDkxMTc_820a3616-e3d6-47c0-b8b9-5b634df51641"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i57ce0d1979c14028a69248c8a1c3d791_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNC0xLTEtMS0xNDkxMTc_9325703a-eadf-437c-8310-c17b2fa26174"
      unitRef="usd">-2043000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie11149ff1cbe4132939e7ba61c7ab73b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNC0zLTEtMS0xNDkxMTc_a1f8b58a-c81b-4bb0-8554-eb724268bbb3"
      unitRef="usd">-1251000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id309abc3d0f943158c9c635b60c3eb5f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNC01LTEtMS0xNDkxMTc_060e2bf7-7919-4bd8-976b-cb022e33290a"
      unitRef="usd">-774000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i262febcea4f54f9dbc968f38708aba55_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNC03LTEtMS0xNDkxMTc_84cd9828-2bc5-41f0-b09a-657d773499e2"
      unitRef="usd">-17000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNS0xLTEtMS0xNDkxMTc_bda00eae-2ece-4ed0-959a-fdf987144ace"
      unitRef="usd">122000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6ac52748f1bd40758c972a0bcd5b63b8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNS0zLTEtMS0xNDkxMTc_25d41c3e-3322-44df-9fd6-6f40dd31f240"
      unitRef="usd">78000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id944a60370e646709b33b07adb648682_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNS01LTEtMS0xNDkxMTc_72bda1c1-6a94-4900-a2cd-1caa761ecad6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7f262081f40a4906ba90bc6c1a7ee290_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNS03LTEtMS0xNDkxMTc_de8cd2e9-ee2e-43ba-91fd-8399521f6e47"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNi0xLTEtMS0xNDkxMTc_4299b8a3-46e2-4094-8d81-0b0e84c9c19f"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6ac52748f1bd40758c972a0bcd5b63b8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNi0zLTEtMS0xNDkxMTc_4564f5fb-4ff2-42c2-bb9d-d84b17c1bde1"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id944a60370e646709b33b07adb648682_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNi01LTEtMS0xNDkxMTc_b40d8487-769a-4aff-b8bc-9d3d3732fc62"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7f262081f40a4906ba90bc6c1a7ee290_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNi03LTEtMS0xNDkxMTc_2cb4d47d-66ef-4fda-9a9c-32740ea15b14"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i88f747ff4b7f43869b7fa5bb86a41c80_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNy0xLTEtMS0xNDkxMTc_19f17c3c-5e32-43e0-83d5-54f7fa991d8d"
      unitRef="usd">-1910000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i83f3c899736b48bdb1be13f9cb594bc1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNy0zLTEtMS0xNDkxMTc_5749a7af-51da-4d74-8ff0-02d7060a3894"
      unitRef="usd">-1173000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i87f59be873544367bac32f07887de058_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNy01LTEtMS0xNDkxMTc_4caa9d8d-ee68-4392-970e-914a19fc9e9b"
      unitRef="usd">-763000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9a175b22e49a4de78fd2e4b373cdb8d7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl8zNy9mcmFnOjI3ODkwMTJkMWE1NTQ4N2FhYjQ5MWM1NmYxNTA4NDU0L3RhYmxlOjFjMjEyOTE1N2E5OTRjMDY4ZmM2ZTAzN2Y0YmJmZDRiL3RhYmxlcmFuZ2U6MWMyMTI5MTU3YTk5NGMwNjhmYzZlMDM3ZjRiYmZkNGJfNy03LTEtMS0xNDkxMTc_4080ce1b-9ea4-4ed9-85e4-17f929a7a85c"
      unitRef="usd">28000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RleHRyZWdpb246NDQyMDlkYzgxNTRmNDEyNGJhZTdlZjY5YjIzN2MwYTJfNDU0_dd5a5c21-0aad-463c-8ee8-0510e4cbff5d">Earnings per Share&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from share-based plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from Series C preferred shares (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common and common equivalent shares outstanding &#x2013; assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share equivalents excluded from the diluted shares outstanding calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mandatory convertible preferred stock (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based plans (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#x2019;s spin-off of its Diabetes Care business on April 1, 2022 was completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#x2019;s common shares.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RleHRyZWdpb246NDQyMDlkYzgxNTRmNDEyNGJhZTdlZjY5YjIzN2MwYTJfNDU2_9e1754d5-c6e5-406b-bbb9-cbdbbaae5d14">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from share-based plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from Series C preferred shares (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common and common equivalent shares outstanding &#x2013; assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share equivalents excluded from the diluted shares outstanding calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mandatory convertible preferred stock (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based plans (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#x2019;s spin-off of its Diabetes Care business on April 1, 2022 was completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#x2019;s common shares.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMi0xLTEtMS0xNDkxMTc_41bf5ef0-7a6b-40b1-99af-268fae7fae31"
      unitRef="shares">284292000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMi0zLTEtMS0xNDkxMTc_83629d01-a630-4df2-b7f1-acb0c9d1e11a"
      unitRef="shares">285243000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMi01LTEtMS0xNDkxMTc_cb99f2a2-3e00-4891-a33d-87dfd75ba047"
      unitRef="shares">284087000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMi03LTEtMS0xNDkxMTc_715a9e89-86cc-4b7c-bc2a-28f0ec1c7ab6"
      unitRef="shares">284961000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMy0xLTEtMS0xNDkxMTc_27151d00-d40f-4428-bd43-8274426f055a"
      unitRef="shares">1353000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMy0zLTEtMS0xNDkxMTc_6285226a-f2da-4fed-be66-8b1f216fb9ae"
      unitRef="shares">2003000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMy01LTEtMS0xNDkxMTc_19d4377f-345b-4ce0-83e4-8449f561c012"
      unitRef="shares">1273000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfMy03LTEtMS0xNDkxMTc_a802d434-c78d-4d89-a1b5-0d363fc4d886"
      unitRef="shares">2215000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNC0xLTEtMS0xNDkxMTc_4faa33dd-88c8-444d-b879-4afcdd99e1c4"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNC0zLTEtMS0xNDkxMTc_1df34ab3-924c-442f-8f92-36042f6525ee"
      unitRef="shares">53000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNC01LTEtMS0xNDkxMTc_f272e895-9cbe-44b7-8277-819b0d8366ab"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNC03LTEtMS0xNDkxMTc_e8487a2c-5fe4-4fc6-b62f-4f14a084fb0e"
      unitRef="shares">26000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNS0xLTEtMS0xNDkxMTc_0e9d5440-567a-4eb9-a61a-4b99aaf53c21"
      unitRef="shares">285645000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNS0zLTEtMS0xNDkxMTc_ffbd2691-b517-472e-adcc-133740418cac"
      unitRef="shares">287299000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNS01LTEtMS0xNDkxMTc_57fd3315-06c7-4cd1-acad-3302862d9f36"
      unitRef="shares">285360000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfNS03LTEtMS0xNDkxMTc_69e24c8c-238b-4511-b437-ccd4a7e4e90c"
      unitRef="shares">287202000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i01fbd913bf3a47cba0482d35f46f5378_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOC0xLTEtMS0xNDkxMTc_3a60eca9-6d3d-41b6-b555-a96d2c21c523"
      unitRef="shares">6060000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibad42ccfdde04dfeab3962ec66d145cd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOC0zLTEtMS0xNDkxMTc_23d8a539-ab32-4557-9dd6-0da77c369b77"
      unitRef="shares">5639000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i23e198e459c54dbea71d1e6b83cfd466_D20221001-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOC01LTEtMS0xNDkxMTc_c3392451-84e1-4f98-adbd-42ee94420665"
      unitRef="shares">6060000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5186e284952c4354937b2883eb1ed3c9_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOC03LTEtMS0xNDkxMTc_1589bc80-2cbd-42ce-9748-f4e0d2ca3082"
      unitRef="shares">5639000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if312210c4d564f8ca13516875c02a909_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOS0xLTEtMS0xNDkxMTc_275653a5-21e9-41db-b65e-811813f3c16e"
      unitRef="shares">617000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i81e88067fa28438ba8960a6e5bc92844_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOS0zLTEtMS0xNDkxMTc_17b2725f-8014-407e-8bfe-14f61c7b25d4"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i20be471d9fcf485d8a8e25204e5c84de_D20221001-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOS01LTEtMS0xNDkxMTc_6d4d5177-735c-4b24-8b19-6b5450ee6c15"
      unitRef="shares">617000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8ce1dc78d6a642b08e49f83600f8f112_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80MC9mcmFnOjQ0MjA5ZGM4MTU0ZjQxMjRiYWU3ZWY2OWIyMzdjMGEyL3RhYmxlOjBhMTc2ZjI5ZmI5NDRkMzliZWZmMDIyMTEyZGYxMGUwL3RhYmxlcmFuZ2U6MGExNzZmMjlmYjk0NGQzOWJlZmYwMjIxMTJkZjEwZTBfOS03LTEtMS0xNDkxMTc_fdbf3854-8a07-40d1-acf6-b552600df461"
      unitRef="shares">676000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTQyMDU_631c28fe-f51b-4284-aa8e-3ea764622b67">Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations. Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries). With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#x201c;CIDs&#x201d;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Liability Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company is defending approximately 33,285 product liability claims involving the Company&#x2019;s line of hernia repair devices (collectively, the &#x201c;Hernia Product Claims&#x201d;). The majority of those claims are currently pending in a coordinated proceeding in Rhode Island State Court (&#x201c;RI&#x201d;) and in a federal multi-district litigation (&#x201c;MDL&#x201d;) established in the Southern District of Ohio, but claims are also pending in other state and/or federal court jurisdictions. In addition, those claims include multiple putative class actions in Canada. Generally, the Hernia Product Claims seek damages for personal injury allegedly resulting from use of the products. From time to time, the Company engages in resolution discussions with plaintiffs&#x2019; law firms regarding certain of the Hernia Product Claims, but the Company also intends to vigorously defend Hernia Product Claims that do not settle, including through litigation. The outcome in any one trial is not representative of potential outcomes of all cases or claims related to the Company&#x2019;s product liability matters.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The first bellwether trial in the hernia MDL resulted in a complete defense verdict in favor of the Company in September 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The second hernia MDL bellwether resulted in a $255&#160;thousand verdict in April 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The first bellwether trial in RI resulted in a $4.8&#160;million verdict in August 2022, which the Company plans to appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trials are currently scheduled in state and/or federal courts, including additional bellwether trials in the MDL in October 2023 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and January 2024. The Company also expects additional trials of Hernia Product Claims to take place over the next 12 months in RI, including trials in September 2023 and October 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also continues to be a defendant in certain other mass tort litigation. As of March&#160;31, 2023, the Company is defending product liability claims involving the Company&#x2019;s line of pelvic mesh products, the majority of which are pending in various federal court jurisdictions and in a coordinated proceeding in New Jersey Superior Court. Also, as of March&#160;31, 2023, the Company is defending product liability claims involving the Company&#x2019;s line of inferior vena cava (&#x201c;IVC&#x201d;) filter products. The majority of those claims are pending in various federal court jurisdictions after having been remanded from the MDL in the United States District Court for the District of Arizona.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In most product liability litigations like those described above, plaintiffs allege a wide variety of claims, ranging from allegations of serious injury caused by the products to efforts to obtain compensation notwithstanding the absence of any injury. In many of these cases, the Company has not yet received and reviewed complete information regarding the plaintiffs and their medical conditions and, consequently, is unable to fully evaluate the claims. The Company expects that it will receive and review additional information regarding any remaining unsettled product liability matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 27, 2020, a putative class action captioned Kabak v. Becton, Dickinson and Company, et al., Civ. No. 2:20-cv-02155 (SRC) (CLW), now captioned Industriens Pensionsforsikring v. Becton, Dickinson and Company, et al., was filed in the U.S. District Court for the District of New Jersey against the Company and certain of its officers. The complaint, which purports to be brought on behalf of all persons (other than defendants) who purchased or otherwise acquired the Company's common stock from November 5, 2019 through February 5, 2020, asserts claims for purported violations of Sections 10 and 20 of the Securities Exchange Act of 1934 (&#x201c;Exchange Act&#x201d;) and Securities and Exchange Commission (&#x201c;SEC&#x201d;) Rule 10b-5 promulgated thereunder, and seeks, among other things, damages and costs. The complaint alleges that defendants concealed certain material information regarding Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infusion pumps, allegedly rendering certain public statements about the Company&#x2019;s business, operations and prospects false or misleading, thereby allegedly causing investors to purchase stock at an inflated price. After an initial without prejudice dismissal, the plaintiff filed amended pleadings, which the Company in turn moved to dismiss. Ultimately, the court permitted certain aspects of the case to proceed. An answer with affirmative defenses was thereafter filed on October 3, 2022. Discovery has commenced and plaintiff&#x2019;s motion for class certification was filed on January 17, 2023. The Company believes that it has strong defenses to the allegations that were not dismissed and it intends to defend itself vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On November 2, 2020, a putative shareholder derivative action captioned Jankowski v. Forlenza, et al., Civ. No. 2:20-cv-15474, was filed in the U.S. District Court for the District of New Jersey by a shareholder, derivatively on behalf of the Company, against certain of the Company&#x2019;s directors and officers. The complaint asserts claims for breach of fiduciary duty, violations of sections 10(b), 14(a) and 21D of the Exchange Act, and insider trading. The complaint principally alleges that the Company made misleading statements regarding Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; infusion pumps in a proxy statement and other SEC filings. A second derivative action was filed on January 24, 2021, and the two actions were consolidated. In March 2021, the Company received letters from two additional shareholders which, in general, mirrored the allegations in the derivative actions, and demanded, among other things, that the Board of Directors pursue claims against members of management for claimed breaches of fiduciary duties. Consistent with New Jersey law, the Board appointed a special committee to review the allegations and demands in the derivative actions and demand letters. Following an investigation, the special committee determined that no action was warranted, and rejected the shareholders&#x2019; demands, communicating its determination to counsel for the shareholders. On January 10, 2023, one of the two shareholders referenced above filed a separate derivative action that: (i) is generally consistent with the shareholder letter and the two prior actions; and (ii) purports to challenge the reasonableness of the special committee&#x2019;s process and determination. The Company believes that is has strong defenses to these claims and intends to defend itself vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company was sued by a competitor in the Northern District of New York, alleging antitrust violations related to certain aspects of the Company&#x2019;s medical delivery solutions business in a case captioned AngioDynamics, Inc. v. C. R. Bard, Inc. et al., Civ. No. 1:17-CV-0598. Trial began on September 19, 2022, resulting in a complete defense verdict for the Company on October 6, 2022, from which AngioDynamics filed a notice of appeal. AngioDynamics withdrew its appeal and on February 17, 2023, the Second Circuit Court of Appeals entered an order dismissing the appeal, which preserved the trial victory and closed the case.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company received a subpoena from the Enforcement Division of the SEC requesting information from the Company relating to, among other things, Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infusion pumps. The Company is cooperating with the SEC and responding to these requests. The Company cannot anticipate the timing, scope, outcome or possible impact of the investigation, financial or otherwise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, the Department of Justice served the Company and CareFusion with CIDs seeking information regarding certain of CareFusion&#x2019;s contracts with the Department of Veteran&#x2019;s Affairs for certain products, including Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and Pyxis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; devices, in connection with a civil investigation of possible violations of the False Claims Act, and the government recently expanded the investigation to include several additional contracts. The government has made several requests for documents and interviews or depositions of Company personnel. The Company is cooperating with the government and responding to these requests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company received a CID related to an inquiry initiated by the Northern District of Georgia in 2018.  The requests concern sales and marketing practices with respect to certain aspects of the Company&#x2019;s urology business. The government has made requests for documents and has interviewed employees. The inquiry is ongoing and the Company is cooperating with the government and responding to its requests.  The Company and the government have agreed to mediation in an effort to resolve this dispute. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2023, the Department of Justice served the Company with a CID seeking information regarding the Company&#x2019;s Genesis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; container products in connection with an investigation of possible violations of the False Claims Act. The government has made requests for documents and the Company is cooperating with the government and responding to its requests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company was served with a complaint from the New Mexico Attorney General, alleging violations of the state&#x2019;s consumer protection laws in connection with the sales and marketing of its IVC filters. The Company&#x2019;s motion to dismiss certain of the claims was granted on May 10, 2022 and discovery is proceeding as to the remaining claims. The Company intends to vigorously defend itself in the litigation. As the case is in its early stages, the Company cannot anticipate the timing, scope, outcome or possible impact at present.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company was sued in state and federal courts in Georgia by plaintiffs who work or reside near Company facilities in Covington, GA, where ethylene oxide (&#x201c;EtO&#x201d;) sterilization activities take place. The federal cases have been dismissed and refiled in state court. The plaintiffs in the cases seek compensatory and punitive damages. Pursuant to Georgia statute, punitive damages in these cases are generally capped at $250,000 per claimant. The cases allege a variety of injuries, including but not limited to multiple types of cancer, allegedly attributable to exposure to EtO. The Company does not believe these cases are appropriate for class action treatment and they have not been filed as such. The Company currently has approximately 220 of such suits involving approximately 320 plaintiffs; approximately 45 of the cases also allege injury caused by exposure to a chemical of another defendant entirely unrelated to the Company. Three trial dates have been set in 2024. The Company has meritorious defenses and intends to defend itself vigorously and believes that future claims would generally face statute of limitations hurdles.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business. The Company believes that it has meritorious defenses to these suits pending against the Company and is engaged in a vigorous defense of each of these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company cannot predict the outcome of these other legal matters discussed above, nor can it predict whether any outcome will have a material adverse effect on the Company&#x2019;s consolidated results of operations and/or consolidated cash flows. Accordingly, the Company has made no provisions for these other legal matters in its consolidated results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a potentially responsible party to a number of federal administrative proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#x201c;Superfund,&#x201d; and similar state laws. The Company also is subject to administrative proceedings under environmental laws in jurisdictions outside the U.S. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are underway or commencing. For several sites, there are other potentially responsible parties that may be jointly or severally liable to pay all or part of cleanup costs. While it is not feasible to predict the outcome of these proceedings, based upon the Company&#x2019;s experience, current information and applicable law, the Company does not expect these proceedings to have a material adverse effect on its consolidated results of operations and/or consolidated cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation Accruals&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company regularly monitors and evaluates the status of product liability and other legal matters, and may, from time-to-time, engage in settlement and mediation discussions taking into consideration developments in the matters and the risks and uncertainties surrounding litigation. These discussions could result in settlements of one or more of these claims at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers the following information when estimating its product liability accruals, including, but not limited to: the nature, quantity, and quality of unfiled and filed claims; the continued rate of claims being filed in certain product liability matters; the status of certain settlement discussions with plaintiffs&#x2019; counsel; the allegations and documentation supporting or refuting such allegations; publicly available information regarding similar medical device mass tort settlements; historical &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;information regarding other product liability settlements involving the Company; and the stage of litigation. Because the information that is currently available regarding product liability matters is often limited, there is inherent uncertainty and volatility relating to the Company&#x2019;s estimate of product liability. As additional information becomes available, the Company records adjustments to its product liability accruals as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals for the Company's product liability claims which are discussed above, as well as the related legal defense costs, amounted to approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.9&#160;billion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $2.1 billion on March&#160;31, 2023 and September&#160;30, 2022, respectively. These accruals, which are generally long-term in nature, are largely recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the Company's condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#x2019;s consolidated results of operations, financial condition, and/or consolidated cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTQyMTA_0f2e8fce-e0ed-47de-bf01-d2994e2f5393">The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations. Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries). With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#x201c;CIDs&#x201d;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#x2019;s consolidated results of operations, financial condition, and/or consolidated cash flows.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i185f69d2666a40e4a30b82e27d557e28_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTc1NA_59ce5350-e51d-4067-9dca-9985662ad618"
      unitRef="claim">33285</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i17ab8a33ac194031acaea6ce23adb206_D20220401-20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMjgwNQ_7966f73f-b082-4649-8a5f-a8298e13f15f"
      unitRef="usd">255000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i85d6531a6a844787a70ff90d4a02d6d2_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMjg3OQ_ddf9a605-2390-49c5-9335-05d04a45a43d"
      unitRef="usd">4800000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i75b32e3d8e8340148d564fd167111da6_D20221001-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTA2ODg_2e766885-a8e9-4876-8ae5-c706d35cb2c8"
      unitRef="usd">250000</us-gaap:LossContingencyDamagesSoughtValue>
    <bdx:NumberOfEtOSterilizationLawsuitsFiled
      contextRef="ic7b1e10a6ef444648b8782378dd142ad_D20221001-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTEwMDU_6d942a65-dbb3-44d8-ae2f-e4b5b59f8627"
      unitRef="lawsuit">220</bdx:NumberOfEtOSterilizationLawsuitsFiled>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="ic7b1e10a6ef444648b8782378dd142ad_D20221001-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTEwNDY_9905c6e8-739a-475f-9421-8d160baa54a4"
      unitRef="plaintiff">320</us-gaap:LossContingencyNumberOfPlaintiffs>
    <bdx:NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants
      contextRef="i742947532c9941f6849b56745999efdf_D20221001-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTEwNzU_1f637520-8469-4c33-b012-0e02f6866156"
      unitRef="lawsuit">45</bdx:NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTM1NzM_2195d2a4-55a9-48c7-85f1-a2556994a363"
      unitRef="usd">1900000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80My9mcmFnOmRkODE0NWY5NTkzNDRjMDQ4N2ZlMTUwNDY5NGEwOWNiL3RleHRyZWdpb246ZGQ4MTQ1Zjk1OTM0NGMwNDg3ZmUxNTA0Njk0YTA5Y2JfMTM1ODA_d5089eac-d373-48e3-8562-d246babb0b3e"
      unitRef="usd">2100000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMzk0OA_b6fa7402-847f-4662-ab1e-b764f32c949a">Revenues&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s policies for recognizing sales have not changed from those described in the Company&#x2019;s 2022 Annual Report on Form 10-K. The Company sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products which are distributed through independent distribution channels and directly by BD through sales representatives. End-users of the Company's products include healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns. The Company&#x2019;s rebate liability at March&#160;31, 2023 and September&#160;30, 2022 was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$541&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $525&#160;million, respectively. The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effects of Revenue Arrangements on Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized contract costs associated with the costs to fulfill contracts for certain products in the Medication Management Solutions organizational unit are immaterial to the Company's condensed consolidated balance sheets. Commissions relating to revenues recognized over a period longer than one year are recorded as assets which are amortized over the period over which the revenues underlying the commissions are recognized. Capitalized contract costs related to such commissions are immaterial to the Company's condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities for unearned revenue that is allocable to performance obligations, such as extended warranty and software maintenance contracts, which are performed over time are immaterial to the Company's consolidated financial results. The Company's liability for product warranties provided under its agreements with customers is not material to its condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's obligations relative to service contracts and pending installations of equipment, primarily in the Company's Medication Management Solutions unit, represent unsatisfied performance obligations of the Company. The revenues under existing contracts with original expected durations of more than one year, which are attributable to products and/or services that have not yet been installed or provided are estimated to be approximately $2.5 billion at March&#160;31, 2023. The Company expects to recognize the majority of this revenue over the next three years.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within the Company's Medication Management Solutions, Medication Delivery Solutions, Integrated Diagnostic Solutions, and Biosciences units, some contracts also contain minimum purchase commitments of reagents or other consumables, and the future sales of these consumables represent additional unsatisfied performance obligations of the Company. The revenue attributable to the unsatisfied minimum purchase commitment-related performance obligations, for contracts with original &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expected durations of more than one year, is estimated to be approximately&#160;$2.2 billion&#160;at&#160;March&#160;31, 2023.&#160;This revenue will be recognized over the customer relationship periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A disaggregation of the Company's revenues by segment, organizational unit and geographic region is provided in Note 7.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMzk1Mw_709afed8-638a-4435-a3a5-a1dd9a167844">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <bdx:ContractWithCustomerRebateLiability
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMTQwNg_3ec9ae92-3e24-4269-a5d1-8a40ecc2fe3c"
      unitRef="usd">541000000</bdx:ContractWithCustomerRebateLiability>
    <bdx:ContractWithCustomerRebateLiability
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMTQxMw_4f253278-a97d-4b46-a004-c4ff9a671a4f"
      unitRef="usd">525000000</bdx:ContractWithCustomerRebateLiability>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ieadfd52ff47344dfb0623e297b9b64ac_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMzA3MQ_620d06e8-863b-42ff-ab75-1cabb020c125"
      unitRef="usd">2500000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="idedcceb572a947ea828bc036cbc9e150_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMzE1Nw_c5649e49-ef2f-43f9-b5e4-a9282e6254ff">P3Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i68fed519b8cd4c66b77d2a0a682a2b45_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80Ni9mcmFnOjM1NjUzYzE0ZGZkNzQ3NDJhYWFhNTc5ZTg4Y2YwYjQ4L3RleHRyZWdpb246MzU2NTNjMTRkZmQ3NDc0MmFhYWE1NzllODhjZjBiNDhfMzcxOA_234c7d2d-6577-47bc-9e3d-1f038ab8a35c"
      unitRef="usd">2200000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMTY1Mg_ddcb17e9-9624-4a77-9c3e-57ddc7656117">Segment Data&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's organizational structure is based upon three worldwide business segments: BD Medical (&#x201c;Medical&#x201d;), BD Life Sciences (&#x201c;Life Sciences&#x201d;) and BD Interventional (&#x201c;Interventional&#x201d;). The Company's segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services. Segment disclosures are on a performance basis consistent with internal management reporting. The Company evaluates performance of its business segments and allocates resources to them primarily based upon segment operating income, which represents revenues reduced by product costs and operating expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to its spin-off on April 1, 2022, the Company reported the Diabetes Care business as an organizational unit within the Medical segment. As such, historical financial information of the Medical segment has been recast in the tables below to reflect the total segment revenues and revenues from continuing operations. Revenues and operating income from the Diabetes Care business prior to its spin-off are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Discontinued Operations, Net of Tax.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; See Note 2 for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by segment, organizational unit and geographical areas for the three and six-month periods are detailed below. The Company has no material intersegment revenues. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Delivery Solutions (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Management Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Systems (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integrated Diagnostic Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Intervention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Delivery Solutions (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Management Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Systems (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integrated Diagnostic Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Intervention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Company revenues from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment income for the three and six-month periods was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Segment Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration and restructuring expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net interest expense &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other unallocated items (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;The amounts for the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; months ended March 31, 2022 include a charge of $54&#160;million recorded to &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to write down the carrying value of certain fixed assets in the Pharmaceutical Systems unit, as well as a charge of $35&#160;million to adjust estimated future product remediation costs.&lt;/span&gt;&lt;/div&gt;(b)Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfODA_2502689d-625c-4549-a3e6-e36a3700b515"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMTYzOA_acbbcf5a-0711-43da-a71f-a3ef69485a62">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by segment, organizational unit and geographical areas for the three and six-month periods are detailed below. The Company has no material intersegment revenues. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Delivery Solutions (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Management Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Systems (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integrated Diagnostic Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Intervention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Delivery Solutions (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Management Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Systems (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integrated Diagnostic Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Intervention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Company revenues from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="i4e6cfe7b18de4673af52bf049d65ba26_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC0xLTEtMS0xNDkxMTc_ca805d41-61b6-417e-834f-656851cd30d6"
      unitRef="usd">616000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i841c8c1c798a45e383da584c83869082_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC0zLTEtMS0xNDkxMTc_a5139dc2-3380-4d4c-af2e-00c6c0cacca5"
      unitRef="usd">454000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i95a4dcf151164a38b3e08ed29a9e68b0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC01LTEtMS0xNDkxMTc_b60ab2e0-3662-4690-b014-23f72f4997f2"
      unitRef="usd">1070000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i480503378bf24ffb84276d4a75ebeccf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC03LTEtMS0xNDkxMTc_f924e8ed-6e7b-41bb-a722-fad649ec7f8f"
      unitRef="usd">590000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i850e88e8269243c1868bfdf976704aa5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC05LTEtMS0xNDkxMTc_8b0ff1b7-ce39-4c98-83a5-a8c2d080b4ec"
      unitRef="usd">460000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if70224594e54407c8dd9540e8e74477c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNC0xMS0xLTEtMTQ5MTE3_20e113a3-2ba5-4026-afaf-e00fa135deb0"
      unitRef="usd">1049000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8b2a45e650ea481fb6ca48710434086b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS0xLTEtMS0xNDkxMTc_1d8db30b-e8ee-4ddd-97ae-1905980aff29"
      unitRef="usd">550000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54f4a58a812d48d593df5bcd251c3825_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS0zLTEtMS0xNDkxMTc_3153bf2f-8482-4157-adfe-4186d3a1a85d"
      unitRef="usd">173000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5dc5cef384ba465f8ab03695864d424b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS01LTEtMS0xNDkxMTc_1456e591-fe66-469e-9284-3dccbc963af4"
      unitRef="usd">723000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if90dbbe1b6674b059da0798a1fc9ea36_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS03LTEtMS0xNDkxMTc_3fd5fb78-9e5d-4eb7-ab14-fa4169dca473"
      unitRef="usd">461000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i91cc5d94e87144d2a0196c9c9a1bc9c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS05LTEtMS0xNDkxMTc_abbfb1d7-9926-46b7-84dc-8123e8c76edc"
      unitRef="usd">143000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i81baf0b1c1814041b160e3e27a6f6d6d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNS0xMS0xLTEtMTQ5MTE3_ba09ded9-fa59-4772-b3e8-64e379c7494a"
      unitRef="usd">604000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb10a2eb439f431591e11fb203a7fb1b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi0xLTEtMS0xNDkxMTc_88b85663-1ea0-490c-84c5-1ff5b1781370"
      unitRef="usd">173000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iecb2838196d148ddb37b681f30800842_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi0zLTEtMS0xNDkxMTc_032b9866-151e-40a5-b9a5-7d7581cfde9b"
      unitRef="usd">394000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie6fee6e221a248209720d8a0e606b821_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi01LTEtMS0xNDkxMTc_409bcadc-e35f-47e9-b20a-0c46d1dc2d52"
      unitRef="usd">567000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i12c9c9d66d504014a5a55dde651ad588_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi03LTEtMS0xNDkxMTc_b4c40b5b-6f8d-4a8b-925b-af9abb50c49c"
      unitRef="usd">125000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6779e1ee9eb34798ba7826f0deb428d2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi05LTEtMS0xNDkxMTc_043efd29-0e9c-4f1a-bd64-b43c8fc7195d"
      unitRef="usd">375000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5042268ba57746368d9792ad3b7053f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNi0xMS0xLTEtMTQ5MTE3_39c1165b-4a73-4bf5-a395-051a866f53a3"
      unitRef="usd">501000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie714b836ac7743ceb2e70b68ac3982e7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy0xLTEtMS0xNDkxMTc_b0a901a7-4a41-4ad9-b07d-d764a9d78ff7"
      unitRef="usd">1339000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1642dd23d79c4ea2a197172a38abeb19_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy0zLTEtMS0xNDkxMTc_0acaa3dd-36cf-4154-a046-b4afb86bf818"
      unitRef="usd">1022000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a102dfb15ad4d198bd87f3bc598fc50_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy01LTEtMS0xNDkxMTc_2ec31718-e9b3-4022-9a0c-a9a76a708970"
      unitRef="usd">2360000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibb0c35da7f9f433891a2e11f5d381e5c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy03LTEtMS0xNDkxMTc_a64ce22c-a422-4904-b553-81e66f2c1487"
      unitRef="usd">1176000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4f33f7206b1249e7a4ffc0c52c4ea01b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy05LTEtMS0xNDkxMTc_ff14d52e-bbd8-46cf-bf9a-3c49d6827ff5"
      unitRef="usd">978000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id16e4ff23fc7479ebc10e4339a6b8316_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfNy0xMS0xLTEtMTQ5MTE3_0734829c-a10b-4712-8129-671db85e7f76"
      unitRef="usd">2154000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib10678e67d194aea9b79aeba4ae564b7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtMS0xLTEtMTQ5MTE3_212435c3-5902-466c-b5ca-864b56a5aa03"
      unitRef="usd">422000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8f00ef36a864b3999035cdb8ca1ee40_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtMy0xLTEtMTQ5MTE3_1f1dc3dd-8764-4eff-b974-6fc7f26a14ae"
      unitRef="usd">466000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie4bf63d0944d4969b56d747a6c4aeb85_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtNS0xLTEtMTQ5MTE3_6563ccb1-7d64-42e9-9b50-9437ed9aaed8"
      unitRef="usd">888000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic4d29cbf115b4cd089b94dca6058cf55_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtNy0xLTEtMTQ5MTE3_53913aa1-31b9-43c0-a7a3-95455959f2de"
      unitRef="usd">618000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iffd3f6c968b14773be92bfcc86c33822_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtOS0xLTEtMTQ5MTE3_bc2edaeb-c0c0-4e21-9a4a-a7767208af3d"
      unitRef="usd">532000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8a2ad16216754861899cd606d682d1d2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTAtMTEtMS0xLTE0OTExNw_820f864d-2b73-46e2-9ce0-aad2012d189d"
      unitRef="usd">1150000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac9e2fef4302405ab4e45ed6c9f072a2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtMS0xLTEtMTQ5MTE3_147f8ccb-4d4e-438b-922e-dc86ce91af04"
      unitRef="usd">159000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00d4dd1d35ad4ec39bf242fec7861a8d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtMy0xLTEtMTQ5MTE3_2f86ff57-8834-4e83-a5be-3046c90e5888"
      unitRef="usd">228000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idb6fc50a3487452ea53c1aee2fe9c14d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtNS0xLTEtMTQ5MTE3_5134b1e3-9543-4ca0-bc84-376d16b6a01a"
      unitRef="usd">386000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4639b945d6594926868a1a5ff039304c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtNy0xLTEtMTQ5MTE3_9c5b7c04-7701-457a-9197-3b487b829450"
      unitRef="usd">129000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i974dfe38797443ae9e91fe0d747005d8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtOS0xLTEtMTQ5MTE3_933da8f0-6a1a-4f78-8d72-35c7677f786e"
      unitRef="usd">206000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7a9c34ff96cf4cc6847d29c3560db0d2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTEtMTEtMS0xLTE0OTExNw_f1fed8fe-f876-4149-8b25-4df5022b10e9"
      unitRef="usd">335000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i98e867a4015f4a468735111b4fe9d81b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItMS0xLTEtMTQ5MTE3_3efe0217-a239-4aa4-bd5c-5db3d7ca7bd6"
      unitRef="usd">581000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i99bc7afb1cf047caaff82d8a6516065c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItMy0xLTEtMTQ5MTE3_4faa880b-41bf-4ed5-8336-9995c152d0b0"
      unitRef="usd">694000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i830727d2878946c7a8c7364a0ae99248_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItNS0xLTEtMTQ5MTE3_4d5a5f97-d945-4e33-a00f-5188fd620e63"
      unitRef="usd">1275000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifa75e3193e3740ee93a99cb81d32c403_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItNy0xLTEtMTQ5MTE3_da8572df-4aa0-45fc-90b2-dfeeb0bf0c2c"
      unitRef="usd">747000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibfbdecd6ec9547c59053303e9f460db8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItOS0xLTEtMTQ5MTE3_385b4d61-6278-4740-b5cb-cb0f475341e5"
      unitRef="usd">738000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if875d3bce9114d8a858c7e589c047056_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTItMTEtMS0xLTE0OTExNw_4b650030-ee65-49f2-ae67-c82ad6f314ca"
      unitRef="usd">1485000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i49e6649d813d4bd4bb104a487c73ea90_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtMS0xLTEtMTQ5MTE3_08fd1def-1f23-4cfd-8f27-f6f075dd6ef1"
      unitRef="usd">295000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2d0af07733084d968cb84d8736f680e1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtMy0xLTEtMTQ5MTE3_3d9df253-92f4-4948-918e-dd1f9c36e9de"
      unitRef="usd">86000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib97632afcf314eb4af27293756ab1c1e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtNS0xLTEtMTQ5MTE3_575f305f-96c0-46b0-821a-76d7750e65d8"
      unitRef="usd">381000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id0e000d0a8774353b9d53bade6b21fd0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtNy0xLTEtMTQ5MTE3_afc4e756-8b9c-4ee0-a962-33f8af1606dd"
      unitRef="usd">268000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1354f7e1cf648458386b045b469c10b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtOS0xLTEtMTQ5MTE3_4c058005-5071-429a-a94f-049454772405"
      unitRef="usd">72000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i833303fa6d4c4eaf8bffbb0864a695e5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTUtMTEtMS0xLTE0OTExNw_8aa86511-ecf3-42a9-b0ce-03eda2183b82"
      unitRef="usd">340000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06722ea31e2b4061818de6fa498196a9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtMS0xLTEtMTQ5MTE3_ebfed4cd-d02b-4cf5-b109-0908c0bb462e"
      unitRef="usd">256000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie60c2aa29c68466aac9d1af165f3af43_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtMy0xLTEtMTQ5MTE3_4ffe90ea-308e-47a0-bd77-9a953ada9067"
      unitRef="usd">213000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i88e20f23d8d1419989d15f68c97503c9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtNS0xLTEtMTQ5MTE3_bfc537f0-d289-4401-925d-4b3a55edc953"
      unitRef="usd">468000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie9732021b95147b48552d9d3400e0eb5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtNy0xLTEtMTQ5MTE3_dc85554c-6725-43de-ad97-deab53d52b27"
      unitRef="usd">240000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id76c90ada79245109d735834db48fef0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtOS0xLTEtMTQ5MTE3_4cf459aa-4f6e-4e0c-90c3-bee259eab862"
      unitRef="usd">210000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5693529ca4bf4fd99017046f306ad832_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTYtMTEtMS0xLTE0OTExNw_6d281a89-5163-4a60-a644-8c036980cde5"
      unitRef="usd">450000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibff7917a45934be1ba662f42794d4841_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctMS0xLTEtMTQ5MTE3_c014ba7e-d502-4dd7-a6ac-d79864bec70b"
      unitRef="usd">263000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i04846b7cd7654f27ada57fc63f9519fb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctMy0xLTEtMTQ5MTE3_20f74378-50d2-4a5c-8089-a1c1fe063a7a"
      unitRef="usd">74000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i812ecaa6f69a4d0bb57f4bc354aae8be_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctNS0xLTEtMTQ5MTE3_7e01ee7f-b896-406d-8ac9-5cfed8ea7e4d"
      unitRef="usd">336000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8117301a37b74e709259d5375dc30d4e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctNy0xLTEtMTQ5MTE3_4427091f-8622-48c3-880d-7b4720ae082e"
      unitRef="usd">239000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d0e86f8e82342be9d1959871d421a6e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctOS0xLTEtMTQ5MTE3_e7610d63-4c64-4e85-934d-980a2488d4dc"
      unitRef="usd">82000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icaa76677d46442d6a7e1c895ce1f71f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTctMTEtMS0xLTE0OTExNw_03bcc567-f6ed-4a32-929c-e3c69fd2eb0f"
      unitRef="usd">320000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibfbbee50f40c4484ae7bfad73328da8b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtMS0xLTEtMTQ5MTE3_d09973b9-7dca-4baa-8e1a-a5ea9644abf7"
      unitRef="usd">813000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4353504b6abc40a8a4e50df3b63865ff_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtMy0xLTEtMTQ5MTE3_33dc121c-2f51-4f10-9c86-5640244487b8"
      unitRef="usd">373000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i781b5ad29da34317ae891593af457aaf_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtNS0xLTEtMTQ5MTE3_b682605a-50dc-451f-bb76-afd535e516e6"
      unitRef="usd">1186000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06e1a559e5074fabab4366e975d71095_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtNy0xLTEtMTQ5MTE3_3d3bf558-2fe9-4197-b4ba-c0b495fe313a"
      unitRef="usd">746000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac6febd1d5d74cf894e20097ea0c3390_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtOS0xLTEtMTQ5MTE3_871a562b-389e-4a60-884e-d36f9c366623"
      unitRef="usd">364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i30c82c8da537457ba89775a6dd6f0b63_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMTgtMTEtMS0xLTE0OTExNw_138ecf90-d504-459b-a659-9255e3222491"
      unitRef="usd">1111000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i36d58f5ff4a94d7c856a21852d1578b7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtMS0xLTEtMTQ5MTE3_f17dea4d-c26f-4c7d-ac3e-a13eee076538"
      unitRef="usd">2733000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53fe0413309b43b185ddaeb63704cdb0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtMy0xLTEtMTQ5MTE3_446afdb0-1d46-46fa-95ac-5a2fb936ca76"
      unitRef="usd">2088000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtNS0xLTEtMTQ5MTE3_96a52fc7-c56a-40dc-81f4-80ec2ede8719"
      unitRef="usd">4821000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i74cf5d046cdc48458773f0a0e6bf124f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtNy0xLTEtMTQ5MTE3_5f2f412b-ecd9-47f5-955f-0e0e17e4c125"
      unitRef="usd">2669000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic1c7400b54fe4071a338cdd26f00e096_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtOS0xLTEtMTQ5MTE3_1fa9be59-455f-4a9a-9f48-e2dd7528cd9d"
      unitRef="usd">2081000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjkwODJjZTkyNThkNDQ2N2JiNTFiNDhjNjAyNjMxN2JiL3RhYmxlcmFuZ2U6OTA4MmNlOTI1OGQ0NDY3YmI1MWI0OGM2MDI2MzE3YmJfMjAtMTEtMS0xLTE0OTExNw_347ce05c-fefc-4b85-b394-f187a2fa880c"
      unitRef="usd">4750000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b866a81d48541e088ce519c699ba906_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS0xLTEtMS0xNDkxMTc_fa89f386-1b27-475d-9b50-a2edb2973a93"
      unitRef="usd">1235000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i841975175f6d48f9998a0e2f82f4053f_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS0zLTEtMS0xNDkxMTc_1056f8a0-53f7-4e7e-ab98-313057e892b3"
      unitRef="usd">873000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia6f0652aab2a42f7b530f8be482e3007_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS01LTEtMS0xNDkxMTc_beb7c7e3-66ea-4426-92a0-edc8ef3787f8"
      unitRef="usd">2109000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf48c33124124a6384e276cfa077767c_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS03LTEtMS0xNDkxMTc_06e3c67f-a1a7-4295-a36b-86b04a8d0579"
      unitRef="usd">1210000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb44f9df8a8441409d61f508251b69aa_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS05LTEtMS0xNDkxMTc_7c9c6a64-d61f-4b52-94cd-71a079f87814"
      unitRef="usd">936000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ec08bb3ff4a4875acf201b377a5a9b0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNS0xMS0xLTEtMTQ5MTE3_b98205d1-9305-4aa0-a3c0-9ddb194460e9"
      unitRef="usd">2146000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i39d0373baf3640f7b41985d5833685d7_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi0xLTEtMS0xNDkxMTc_08ea338a-b5ca-4dc2-b57a-491780375520"
      unitRef="usd">1114000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if0f23cf9a7224b2c96d80a76679ed1c7_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi0zLTEtMS0xNDkxMTc_934d55d4-e902-4b17-865d-57e2a893c8b0"
      unitRef="usd">316000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia89519a3b58a4032909e18f5a356e5a1_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi01LTEtMS0xNDkxMTc_cd70a79e-ad9f-4522-8cb9-18596715a2b4"
      unitRef="usd">1430000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0ffb55ab8ff54c96b1bce767d9e6a6f7_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi03LTEtMS0xNDkxMTc_a55f4fb0-4a23-4a28-8374-9ead22c80c28"
      unitRef="usd">945000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54d6c43b47e544ef87eb3da99d03b1f8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi05LTEtMS0xNDkxMTc_327f2ac8-e359-4227-b9ea-e8b1c4d27b89"
      unitRef="usd">286000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id87cda00c76043079c6b7f0a255628d4_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNi0xMS0xLTEtMTQ5MTE3_311b1d79-afd6-407a-9952-31b97bab3b2c"
      unitRef="usd">1231000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9624f4572d0a44edaf5bf06b2c5e83da_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy0xLTEtMS0xNDkxMTc_4e0b9ce5-4643-40a4-b867-3b4581cc4c43"
      unitRef="usd">292000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5db5726397684d848e7e71ffe39a0df9_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy0zLTEtMS0xNDkxMTc_9732d4f7-d20d-43c8-a175-078d2e176281"
      unitRef="usd">684000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id5e183c9ad474d139768c9162aa1e53f_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy01LTEtMS0xNDkxMTc_4efe3b53-0e88-469b-8fc9-3d19ec466119"
      unitRef="usd">976000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i38080f49c0974324a50d6dc48d77476b_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy03LTEtMS0xNDkxMTc_16ec090a-eedb-4526-8504-7c747e26936f"
      unitRef="usd">228000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa34ed7252744dce9d3eba22fbc460f8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy05LTEtMS0xNDkxMTc_a2ffe1e5-ad93-45d7-8d33-c9fd8884ca5a"
      unitRef="usd">669000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i77fe6f0478484e77ad34a61a2fd7bd78_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfNy0xMS0xLTEtMTQ5MTE3_3afab318-f959-471b-b7a6-a5e7a741730e"
      unitRef="usd">897000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1f4358855e40480593e5e0d8f0a7e32b_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC0xLTEtMS0xNDkxMTc_ee6bc8fd-fa88-439b-9bf7-24ef56382e07"
      unitRef="usd">2642000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i36bf788445f641f087a217afce45d835_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC0zLTEtMS0xNDkxMTc_42526b1f-6b6c-45db-a4e4-17ac2146a125"
      unitRef="usd">1873000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f2c8adfb65e496fb380376104a49088_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC01LTEtMS0xNDkxMTc_b76ac210-e8ea-4f83-a121-c85603750e3b"
      unitRef="usd">4515000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id377017a26ec446cad1d57bd60564384_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC03LTEtMS0xNDkxMTc_ba2bb96c-c036-4a60-96ce-f31b7f62660f"
      unitRef="usd">2383000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic4ff1d287bc641a68106273fcd8ed5ef_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC05LTEtMS0xNDkxMTc_b90b7a33-6aab-4610-8a0e-010ac4c668a6"
      unitRef="usd">1892000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie90ad306379a4c1599fe2b2e0c34c487_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfOC0xMS0xLTEtMTQ5MTE3_4f3e6fc7-4df5-4d60-a6d3-8d1b71724877"
      unitRef="usd">4274000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifbfde066976740859db427662a57e26b_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtMS0xLTEtMTQ5MTE3_f889735e-bd4e-4484-b51d-e32aa6e08d8b"
      unitRef="usd">930000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i11d3d3ae80f74f4dbf461c7291881e0e_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtMy0xLTEtMTQ5MTE3_bc204bfd-5a7f-44b0-9ed5-877049f19067"
      unitRef="usd">911000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic6739aa1eaa040ea8aaddd516c1851c7_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtNS0xLTEtMTQ5MTE3_5cd736d0-81a2-4c5d-bb5b-a32b463573ed"
      unitRef="usd">1841000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id5db012c6f554b589b2cd464565b693a_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtNy0xLTEtMTQ5MTE3_6ac03dfa-53bd-4ca5-986c-2eca59cc2a43"
      unitRef="usd">1232000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia046d9031e8949509f12a761a4224417_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtOS0xLTEtMTQ5MTE3_83155267-8daa-4237-97a7-138b96f3f1fd"
      unitRef="usd">1062000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6a3976b2f0f14c4e810f7005d15f1f87_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTEtMTEtMS0xLTE0OTExNw_639848f5-816f-4cfd-9e97-6174346de924"
      unitRef="usd">2295000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibca9b2a4d3aa462596e3df837b933591_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItMS0xLTEtMTQ5MTE3_4c24b0d8-32f1-4c9a-bda3-0d389649b20f"
      unitRef="usd">296000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5e4cad3300d84f2689a1f443e74e0314_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItMy0xLTEtMTQ5MTE3_030974a8-fa09-460e-b7f6-438d73ad9840"
      unitRef="usd">440000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0edb37cc9b764458800e90102f48a86e_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItNS0xLTEtMTQ5MTE3_0f57a35f-d65f-40f1-9420-784fb250d11b"
      unitRef="usd">736000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib6fe277067c2414fbf929d3d6a219636_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItNy0xLTEtMTQ5MTE3_1cebcdc6-86cc-4b0e-94ea-d47afc10ed54"
      unitRef="usd">258000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i31eb79bf50ec41998fb767b6987ce2c4_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItOS0xLTEtMTQ5MTE3_f5eeac08-dbd4-4660-8e9c-ce584905e265"
      unitRef="usd">416000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie2438e94418c407792bbee2d9179b645_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTItMTEtMS0xLTE0OTExNw_f84634e7-cdab-4820-b0d8-49b786c1528d"
      unitRef="usd">674000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i32ae32f54613472793706f04236ad157_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtMS0xLTEtMTQ5MTE3_e20aadfe-0387-4752-b6c6-273d181dc5a2"
      unitRef="usd">1226000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5fdb48a107794c3980fba70b8372a30d_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtMy0xLTEtMTQ5MTE3_513e1aff-829e-4902-a38e-da0b07c29336"
      unitRef="usd">1351000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie0960222376b41418e431c7c966fc960_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtNS0xLTEtMTQ5MTE3_a92ef40d-1016-4505-b593-b7e3ae3e7da6"
      unitRef="usd">2577000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i251719fc5666450f8e498d90117d7c34_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtNy0xLTEtMTQ5MTE3_6987e422-0d42-4745-b74f-3e4014893a2b"
      unitRef="usd">1490000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb8cdd96ead14cd69f012accd6f4cb9d_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtOS0xLTEtMTQ5MTE3_70f67556-c729-411d-b8ad-97045e10a0b9"
      unitRef="usd">1478000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6a0b9a3d052c46ca890a9c69797e68df_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTMtMTEtMS0xLTE0OTExNw_d2b2de67-8a2c-40e1-87b4-5f25947150cc"
      unitRef="usd">2968000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i78cb2306c82a4761a95fcb3e304bdb8c_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtMS0xLTEtMTQ5MTE3_8ff9cb56-c14a-444f-a004-afe9d7d8e653"
      unitRef="usd">582000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5894b055a36a458e8e85e4215a55ce54_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtMy0xLTEtMTQ5MTE3_8b740b94-ec6a-432d-b235-23e630146ab3"
      unitRef="usd">162000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i062534c0a42743d2ad7922a783a173e7_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtNS0xLTEtMTQ5MTE3_ea9f8ff1-8840-4def-a789-d00aaf954131"
      unitRef="usd">744000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icd38fe9a5f124e0e8b44cb18e864a957_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtNy0xLTEtMTQ5MTE3_dafe96ec-5a2a-4888-946b-0c31b1556b66"
      unitRef="usd">549000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ee1acdcb66d4d898504b646745a30bd_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtOS0xLTEtMTQ5MTE3_8ad02ea3-060c-4a3e-acef-d5b06d0f60f1"
      unitRef="usd">152000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0d0fc699d0c846a289328d4a13ae3b9f_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTYtMTEtMS0xLTE0OTExNw_7254dae8-9954-4e7f-bb86-292feaa6c467"
      unitRef="usd">701000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i67d3a9dbf7fa414fb11aa805abb03094_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctMS0xLTEtMTQ5MTE3_037b0726-2031-4188-9657-488f820f2ee7"
      unitRef="usd">492000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i86ee63bfe8004d68970b72dd4b8b7d1a_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctMy0xLTEtMTQ5MTE3_f4dc7e96-4c24-4579-91de-d16276971682"
      unitRef="usd">410000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28e6ab6ff6df496ca592e90b3d330de5_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctNS0xLTEtMTQ5MTE3_c7a74ff8-242d-4081-bbad-3d45357f6932"
      unitRef="usd">902000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5f24e1d9f83e4d8eb797dd90c4d7bedf_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctNy0xLTEtMTQ5MTE3_da35df87-736a-441c-93cf-f13a0158019c"
      unitRef="usd">457000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7c7297cc444f4d0b8d08c060e92ae0c2_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctOS0xLTEtMTQ5MTE3_b736595b-27d1-416a-b0f3-b06e0c3e0abc"
      unitRef="usd">407000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6e8831acd8644cdeb56db066b2fd08a3_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTctMTEtMS0xLTE0OTExNw_5d740ce2-2f95-4aad-9a87-ecdd5d07e9b3"
      unitRef="usd">863000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i09b09ea684154e4ebccff4d00f43571e_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtMS0xLTEtMTQ5MTE3_63dc309b-5578-40cb-b14d-7ad40c7551a9"
      unitRef="usd">522000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i340d4b0fbfa344bfabdd8b6f46ab528f_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtMy0xLTEtMTQ5MTE3_1824c7ec-ddd6-4a09-acf4-509c936beacd"
      unitRef="usd">148000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i844e28d1b31e43c882cf05e613660ac9_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtNS0xLTEtMTQ5MTE3_b2898e30-500d-41fe-86de-52b38d1526ec"
      unitRef="usd">670000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i937287b0005849adba3700159c44bb1c_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtNy0xLTEtMTQ5MTE3_a8b2bdf9-4245-4859-86b5-79c14a152830"
      unitRef="usd">492000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i703a5ae640f84088b9eb12321f883fcf_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtOS0xLTEtMTQ5MTE3_cc8e0aa8-a973-480c-a52c-8d34366ed787"
      unitRef="usd">168000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if00d7790a83c4d398536842126ba0870_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTgtMTEtMS0xLTE0OTExNw_14fa3a86-211a-41ca-9798-730c0cc2e954"
      unitRef="usd">661000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie0498cba50954a96b0f4785b9369da89_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktMS0xLTEtMTQ5MTE3_00fc0427-34d8-46ef-bd61-5147c67d6d2f"
      unitRef="usd">1595000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie0f0d62528e643e486e8b63e17adcab2_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktMy0xLTEtMTQ5MTE3_099ab3d5-33f5-4707-8ddd-76753f0bac27"
      unitRef="usd">720000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icda13f7ccb434390a542b94eedf89184_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktNS0xLTEtMTQ5MTE3_da7bf537-8d4c-46ce-95d1-29ac5fab5431"
      unitRef="usd">2315000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8accfab0194747e99802361c4bcba9f8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktNy0xLTEtMTQ5MTE3_3b83b0c0-2905-42fd-8394-0a86105dba09"
      unitRef="usd">1498000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iea5cc875dbfa4dd69f9ffea1d08fc7bd_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktOS0xLTEtMTQ5MTE3_f8d7f6ac-4dbb-4bc6-979c-b815af16414c"
      unitRef="usd">727000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i068965d16303486fb4323bb08ee4bc27_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMTktMTEtMS0xLTE0OTExNw_d01b4878-4863-456f-aef0-99075deed1e8"
      unitRef="usd">2225000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd93e9175cc64c60bbc8a3d92a9e7649_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtMS0xLTEtMTQ5MTE3_1d094329-cf57-4eb8-854e-8f4f756012e7"
      unitRef="usd">5462000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i39cfb89f6f8b448f9b5f3bfcc58dc9dc_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtMy0xLTEtMTQ5MTE3_fcef99fa-e160-4e28-aa73-bf1605bcef66"
      unitRef="usd">3944000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtNS0xLTEtMTQ5MTE3_3ae3870d-7805-417a-a92d-0630768a58e1"
      unitRef="usd">9407000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5f1ebdedf0894f6f9d6eb7853eecb428_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtNy0xLTEtMTQ5MTE3_8657c4b7-0baa-43fc-8227-1fb613534aa1"
      unitRef="usd">5372000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib85825c4d3c641cc99a05dc9d8c18d83_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtOS0xLTEtMTQ5MTE3_b81c1a70-5ed4-4712-84d9-10f48f96758b"
      unitRef="usd">4096000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjc2YjZjOTgzNzY1MDQzMTViNjhjNDEzY2E0NDI2ZGY1L3RhYmxlcmFuZ2U6NzZiNmM5ODM3NjUwNDMxNWI2OGM0MTNjYTQ0MjZkZjVfMjEtMTEtMS0xLTE0OTExNw_9ef3b662-b961-4803-937e-e8377608e817"
      unitRef="usd">9468000000</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMTY0NQ_0c10f7b1-2103-43b4-a2c1-92a3f7a5a2d3">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment income for the three and six-month periods was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Segment Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration and restructuring expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net interest expense &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other unallocated items (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;The amounts for the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; months ended March 31, 2022 include a charge of $54&#160;million recorded to &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to write down the carrying value of certain fixed assets in the Pharmaceutical Systems unit, as well as a charge of $35&#160;million to adjust estimated future product remediation costs.&lt;/span&gt;&lt;/div&gt;(b)Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4a102dfb15ad4d198bd87f3bc598fc50_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMy0xLTEtMS0xNDkxMTc_24b7736b-6934-4e90-95ed-3160fa3b2180"
      unitRef="usd">641000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id16e4ff23fc7479ebc10e4339a6b8316_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMy0zLTEtMS0xNDkxMTc_fcc202b2-65e6-4bf9-9cbf-9a89325a9ea6"
      unitRef="usd">476000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2f2c8adfb65e496fb380376104a49088_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMy01LTEtMS0xNDkxMTc_febd6515-baa2-4482-9b86-ad4619675b8a"
      unitRef="usd">1195000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie90ad306379a4c1599fe2b2e0c34c487_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMy03LTEtMS0xNDkxMTc_b43f42a7-ba99-4484-813e-c66240838e5c"
      unitRef="usd">1048000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i830727d2878946c7a8c7364a0ae99248_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNC0xLTEtMS0xNDkxMTc_2fccc533-6f90-4a02-a514-614ab14b1d8c"
      unitRef="usd">394000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if875d3bce9114d8a858c7e589c047056_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNC0zLTEtMS0xNDkxMTc_ea7aece5-e6c2-46a9-a1be-f6c85774776b"
      unitRef="usd">475000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie0960222376b41418e431c7c966fc960_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNC01LTEtMS0xNDkxMTc_ab4b34c5-58be-4449-970d-6b46dd5b05a6"
      unitRef="usd">827000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i6a0b9a3d052c46ca890a9c69797e68df_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNC03LTEtMS0xNDkxMTc_1dba1b02-5bbb-45bd-8fd9-211fe581495e"
      unitRef="usd">1009000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i781b5ad29da34317ae891593af457aaf_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNS0xLTEtMS0xNDkxMTc_3618edbc-3da7-47c5-bd7b-adc8728b2a94"
      unitRef="usd">297000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i30c82c8da537457ba89775a6dd6f0b63_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNS0zLTEtMS0xNDkxMTc_19f6f79c-4318-468f-be98-265f5157b3e8"
      unitRef="usd">280000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="icda13f7ccb434390a542b94eedf89184_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNS01LTEtMS0xNDkxMTc_510d1a66-91f8-401d-b54c-bcf65116c01e"
      unitRef="usd">598000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i068965d16303486fb4323bb08ee4bc27_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNS03LTEtMS0xNDkxMTc_6815ca5c-d82a-437e-8d6a-42ae5535e13c"
      unitRef="usd">544000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ifb7bc81847b84350b2fab646e9bcd447_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNi0xLTEtMS0xNDkxMTc_da741d46-7854-4cf7-ae8b-dd1c2cff6aba"
      unitRef="usd">1333000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i255166fe111d4bd2b7b0f9c57d1e3013_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNi0zLTEtMS0xNDkxMTc_48087077-e18f-4039-adf1-c81397057e7d"
      unitRef="usd">1231000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if0fc6cb6378a44c4a1cd9a34c079468c_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNi01LTEtMS0xNDkxMTc_f192bf6f-9cc8-4b7d-b6bd-3ca1c9a182ef"
      unitRef="usd">2621000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ieab59e058d394ac989a56f0af7be79db_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNi03LTEtMS0xNDkxMTc_6525a433-27af-4c22-9003-1cdbac32ffc9"
      unitRef="usd">2602000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i62acc25f7e924071a6f2be9aaaf46d77_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNy0xLTEtMS0xNDkxMTc_223fe803-6b0d-4584-88c3-328e7579677f"
      unitRef="usd">62000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="icf252968a2584238b4d790d9ccf2097d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNy0zLTEtMS0xNDkxMTc_69192512-a2bb-4a0a-9db2-b4077fd6b458"
      unitRef="usd">28000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="if641350edac64e2986b37525b239f9b8_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNy01LTEtMS0xNDkxMTc_a29f60bf-d930-4f7f-b50d-60056b2a7783"
      unitRef="usd">106000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i022895c1add14102909469676a06a30a_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfNy03LTEtMS0xNDkxMTc_f6ef5802-6609-4472-8ca1-20f5a3dbf173"
      unitRef="usd">62000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i62acc25f7e924071a6f2be9aaaf46d77_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOC0xLTEtMS0xNDkxMTc_8f59155c-ff4a-45d7-b503-d592d6240acb"
      unitRef="usd">-108000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="icf252968a2584238b4d790d9ccf2097d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOC0zLTEtMS0xNDkxMTc_e0e57df3-56b8-45d2-a285-ad43ebbec39e"
      unitRef="usd">-95000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="if641350edac64e2986b37525b239f9b8_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOC01LTEtMS0xNDkxMTc_6ab7646c-384a-445e-aece-d2e8cabc21b8"
      unitRef="usd">-204000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i022895c1add14102909469676a06a30a_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOC03LTEtMS0xNDkxMTc_647251af-0c95-4a20-8219-ca8f89c53e77"
      unitRef="usd">-191000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic8bcf14bc4de46d4ab342052f56f0f63_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOS0xLTEtMS0xNDkxMTc_8b63908d-ae9a-45e0-8b2e-5553587b41bd"
      unitRef="usd">-635000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i50d91ec151c8409cb91d3361be377daf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOS0zLTEtMS0xNDkxMTc_1d95f5c1-bfc4-4d82-ac44-7d15bd639428"
      unitRef="usd">-665000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7af6142a51f740c396515df1281ab028_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOS01LTEtMS0xNDkxMTc_e3cfd5cc-8587-4f3d-83e5-bab61d452af1"
      unitRef="usd">-1301000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if415726d4f1042da942db59fd9b75797_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfOS03LTEtMS0xNDkxMTc_75b7b591-16bf-4d57-b781-2ff1f4680803"
      unitRef="usd">-1307000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMTAtMS0xLTEtMTQ5MTE3_57742137-c217-4524-9438-6cdb05cf539d"
      unitRef="usd">529000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMTAtMy0xLTEtMTQ5MTE3_01062956-bbcd-4006-a332-7a6a75f04baa"
      unitRef="usd">442000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMTAtNS0xLTEtMTQ5MTE3_037bd451-2d40-47f3-8b71-7b2d9cf0ac1d"
      unitRef="usd">1009000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RhYmxlOjUxM2VhYjcxZmEwMzRjMGU5ODg1YzBkMGY1NmQyM2UxL3RhYmxlcmFuZ2U6NTEzZWFiNzFmYTAzNGMwZTk4ODVjMGQwZjU2ZDIzZTFfMTAtNy0xLTEtMTQ5MTE3_1c64b442-b330-4e7d-82a9-1985ba3fc9e7"
      unitRef="usd">1041000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:AssetImpairmentCharges
      contextRef="i5d85cf2e75c44573a9069a35792fbae2_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMjE5OTAyMzI1NzQwOA_4e1894a8-b2f5-4bfb-999f-aef5edbd41aa"
      unitRef="usd">54000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i59035e46fc504f16bd9ced72ced1a8c3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMjE5OTAyMzI1NzQwOA_ee9bf3fa-04e4-492d-b38e-8e1ece5f46fd"
      unitRef="usd">54000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:InventoryRecallExpense
      contextRef="i80186f01cae8428cb7bbf64cc561eb04_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMTY0OTI2NzQ0NDE5NA_3c9f97d5-0962-4ce6-9ad9-edd08b5eb0ac"
      unitRef="usd">35000000</us-gaap:InventoryRecallExpense>
    <us-gaap:InventoryRecallExpense
      contextRef="i0a8a4974f9e942689ee74356ba8c98ba_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl80OS9mcmFnOmNjMDU2YTkzNmU3YTQxZjNiYTk4YmZiNjE1YTk4NThlL3RleHRyZWdpb246Y2MwNTZhOTM2ZTdhNDFmM2JhOThiZmI2MTVhOTg1OGVfMTY0OTI2NzQ0NDE5NA_f298b512-7fee-46e7-bc2a-14ad36a32e07"
      unitRef="usd">35000000</us-gaap:InventoryRecallExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RleHRyZWdpb246OGMxYzA0MzE4YTM4NGIwMzk1NWNkNzIzY2FkMmQzZWFfNzcx_56a0a085-18c8-48f8-9e2c-c9c0c63f98f6">Benefit Plans&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has defined benefit pension plans covering certain employees in the United States and certain international locations. The measurement date used for these plans is September&#160;30.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net pension cost included the following components for the three and six-month periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in prior periods. All components of the Company&#x2019;s net periodic pension and postretirement benefit costs, aside from service cost, are recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other income (expense), net&lt;/span&gt; on its condensed consolidated statements of income.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RleHRyZWdpb246OGMxYzA0MzE4YTM4NGIwMzk1NWNkNzIzY2FkMmQzZWFfNzcz_d7d1bc79-343e-4c34-ba68-0050d11e96ad">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net pension cost included the following components for the three and six-month periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMi0xLTEtMS0xNDkxMTc_cc2d9bec-3bb5-44b3-9857-564d6740fbd2"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMi0zLTEtMS0xNDkxMTc_ab77d2f7-13df-47dc-b31a-bed4e710de02"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMi01LTEtMS0xNDkxMTc_9bcec139-fe99-4f04-a033-f1fa2c29fabf"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMi03LTEtMS0xNDkxMTc_15c7e549-b766-45da-ac39-54589a4acc86"
      unitRef="usd">69000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMy0xLTEtMS0xNDkxMTc_db4cc149-466f-4226-a142-89da3ed71086"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMy0zLTEtMS0xNDkxMTc_c78f82eb-9d2e-43fb-86f1-faac77afe813"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMy01LTEtMS0xNDkxMTc_562c49a1-2546-4154-965a-653cde1035f1"
      unitRef="usd">67000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfMy03LTEtMS0xNDkxMTc_17cbe58c-8527-4e3f-963b-74693db0be72"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNC0xLTEtMS0xNDkxMTc_ba92e248-5c92-49b1-b9e2-72d875e83658"
      unitRef="usd">35000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNC0zLTEtMS0xNDkxMTc_f9cdd3d2-5925-420a-94b1-88654c018c2a"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNC01LTEtMS0xNDkxMTc_314ad441-455b-4568-936c-fa2e95004421"
      unitRef="usd">73000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNC03LTEtMS0xNDkxMTc_e0f9e573-8ebd-458a-86c9-73ffc2cfe438"
      unitRef="usd">94000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNS0xLTEtMS0xNDkxMTc_fa8c0e48-03be-426b-bc52-0905404eb4ae"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNS0zLTEtMS0xNDkxMTc_99242894-5f03-4581-bc4a-86eb87869729"
      unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNS01LTEtMS0xNDkxMTc_ed04676d-f21a-4783-8d81-e267c0b3dffb"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNS03LTEtMS0xNDkxMTc_2c28c2e9-8f9c-4b6c-bbe3-906fa86896e9"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNi0xLTEtMS0xNDkxMTc_1116e9c7-2fb5-43a0-9e78-2f05682d2bb6"
      unitRef="usd">-15000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNi0zLTEtMS0xNDkxMTc_2b26c60b-35dc-494e-8ba3-b477700616b2"
      unitRef="usd">-15000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNi01LTEtMS0xNDkxMTc_94e67184-1b2c-463d-8a0e-e02a2bfc1f70"
      unitRef="usd">-32000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNi03LTEtMS0xNDkxMTc_527ed179-7355-46b7-8b43-c0e8818e3af2"
      unitRef="usd">-31000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNy0xLTEtMS0xNDkxMTc_9ca48b83-f314-4b7e-9517-ec0cbf8e514d"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNy0zLTEtMS0xNDkxMTc_080e0534-5a0a-49d4-bbf3-3fb29523744e"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNy01LTEtMS0xNDkxMTc_c0b40c7a-5c36-4dcb-a14f-51627e997037"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfNy03LTEtMS0xNDkxMTc_cfc8cc0e-1890-4b4c-a4ca-8d060d43024e"
      unitRef="usd">-6000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfOC0xLTEtMS0xNDkxMTc_40d3497a-b4f6-45f8-a79a-7c1ce41c5328"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i43c15c774be8471399b53c4f55f32175_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfOC0zLTEtMS0xNDkxMTc_7b04dc1b-3878-4708-be8f-a13edc412cc6"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="icead21f73e324a6ebd06404fc1d296a8_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfOC01LTEtMS0xNDkxMTc_b615ce99-ba1f-4a93-90ec-df325584a5b0"
      unitRef="usd">70000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i52197e66434b4636bd4575ae2b32dbf7_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81Mi9mcmFnOjhjMWMwNDMxOGEzODRiMDM5NTVjZDcyM2NhZDJkM2VhL3RhYmxlOjMwNTEwNzgzOWJmNzQzOTg4ODlhODJkYzIyZDFhNjczL3RhYmxlcmFuZ2U6MzA1MTA3ODM5YmY3NDM5ODg4OWE4MmRjMjJkMWE2NzNfOC03LTEtMS0xNDkxMTc_efd461b5-edb3-4ea7-a4d8-ca003fc919bd"
      unitRef="usd">42000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RleHRyZWdpb246Y2JjYTAyMzBiZjMxNGU5ZDg5ZGQ1NmEwMjkzN2E3ODJfNjAy_0e8a36bf-fac9-4218-bf23-38761c348c3c">Business Restructuring Charges&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred restructuring costs during the six months ended March&#160;31, 2023, primarily in connection with the Company's simplification and other cost saving initiatives, which were recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition-related integration and restructuring expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. These simplification and other costs saving initiatives are focused on reducing complexity, enhancing product quality, refining customer experience, and improving cost efficiency across all of the Company&#x2019;s segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring liability activity for the six months ended March&#160;31, 2023 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.686%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee&lt;br/&gt;Termination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)&#160;&#160;&#160;&#160;Expense primarily relates to other costs associated with the execution of the Company&#x2019;s cost efficiency and restructuring programs, such as incremental project management costs and asset write-offs.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RleHRyZWdpb246Y2JjYTAyMzBiZjMxNGU5ZDg5ZGQ1NmEwMjkzN2E3ODJfNTk5_ada5dfd4-cd21-4a27-9dc2-36f7e4df1cc2">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring liability activity for the six months ended March&#160;31, 2023 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.686%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee&lt;br/&gt;Termination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)&#160;&#160;&#160;&#160;Expense primarily relates to other costs associated with the execution of the Company&#x2019;s cost efficiency and restructuring programs, such as incremental project management costs and asset write-offs.</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i2e6ce19cb68c42798ae7f6c22f37cc17_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMS0xLTEtMS0xNDkxMTc_73cc2082-d85b-4898-880e-eaea9e03e764"
      unitRef="usd">24000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ide33f573b2814d269fa446f57a3a0186_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMS0zLTEtMS0xNDkxMTc_99289e7a-64d3-49f8-8cd9-57e51024a77a"
      unitRef="usd">11000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMS01LTEtMS0xNDkxMTc_96e46b5c-00e2-4b43-963f-ca3997e9e35a"
      unitRef="usd">35000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i4aa9ecd5e70e410190486fa72a3b558e_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMy0xLTEtMS0xNDkxMTc_b2423018-f6de-42c6-8a34-ee6dec00acf9"
      unitRef="usd">10000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iced9cd9c70654eb388559493c61723b9_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMy0zLTEtMS0xNDkxMTc_4fd64d5f-0b85-4aeb-8e45-88fc07723576"
      unitRef="usd">49000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfMy01LTEtMS0xNDkxMTc_368b8256-13fd-467c-b325-2223802c7192"
      unitRef="usd">59000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i4aa9ecd5e70e410190486fa72a3b558e_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNC0xLTEtMS0xNDkxMTc_9422cb4e-3717-4aeb-bb60-45f99edb0750"
      unitRef="usd">14000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="iced9cd9c70654eb388559493c61723b9_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNC0zLTEtMS0xNDkxMTc_0a1ebbcb-f554-4dab-9958-2a195919f495"
      unitRef="usd">46000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNC01LTEtMS0xNDkxMTc_df117282-72d7-4def-9784-b65ca775a299"
      unitRef="usd">60000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i58665f2a2c8643dcb3ad595e2d019b33_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNS0xLTEtMS0xNDkxMTc_ec2c9a11-ed45-46a0-be6e-adf159760ba3"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i52290dbfca2d4f50a401175ba723901f_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNS0zLTEtMS0xNDkxMTc_8ed099b5-cb8e-4635-911c-961715634637"
      unitRef="usd">11000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i1f40fa9998b54795b2c752de8c531048_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNS01LTEtMS0xNDkxMTc_f1a48b2d-61b8-4eca-8f3a-2e6a3ddd5f01"
      unitRef="usd">11000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserve
      contextRef="ie0dbe3ded00545ab83fb4e0b4a84ec32_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNy0xLTEtMS0xNDkxMTc_3108c2e8-f3ea-481a-b356-e56a6d5219d3"
      unitRef="usd">20000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia23a5e3848cd4f44a166523143770660_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNy0zLTEtMS0xNDkxMTc_07b84236-7530-4dfd-944c-0eb520cde23f"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81NS9mcmFnOmNiY2EwMjMwYmYzMTRlOWQ4OWRkNTZhMDI5MzdhNzgyL3RhYmxlOmJiNWEyMWI2ZjIzNzQ4MjA4MzNkOGM1YjNkMGM2M2I3L3RhYmxlcmFuZ2U6YmI1YTIxYjZmMjM3NDgyMDgzM2Q4YzViM2QwYzYzYjdfNy01LTEtMS0xNDkxMTc_610a46b6-2fb6-4840-8d97-5bb122b6f759"
      unitRef="usd">23000000</us-gaap:RestructuringReserve>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMjQ1_9372d94a-1d31-4a18-abc7-a07ca6614479">Intangible Assets&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, trademarks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,481)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible amortization expense for the three months ended&#160;March&#160;31, 2023 and 2022&#160;was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$366 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;and $352 million, respectively.  Intangible amortization expense for the six months ended&#160;March&#160;31, 2023 and 2022&#160;was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$731 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $707 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life&#160;Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price allocation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMjQw_ed45fcbe-440d-4a09-a187-9e03dc24e6b8">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, trademarks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,481)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5df4422b58204b28a8c87b3ec9a100d4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy0xLTEtMS0xNDkxMTc_6b958b64-8724-46ec-8550-129ec5ec6770"
      unitRef="usd">15140000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5df4422b58204b28a8c87b3ec9a100d4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy0zLTEtMS0xNDkxMTc_8d1b4409-4bb7-42c2-8f81-f54018fc8b84"
      unitRef="usd">6530000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5df4422b58204b28a8c87b3ec9a100d4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy01LTEtMS0xNDkxMTc_58ebce00-9b3e-4f1d-8a02-7777170870c7"
      unitRef="usd">8610000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id0ee2f4c36e04145806001b090363988_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy03LTEtMS0xNDkxMTc_e157d2f1-6a34-440d-8ebc-c843f6e975a5"
      unitRef="usd">15087000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id0ee2f4c36e04145806001b090363988_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy05LTEtMS0xNDkxMTc_8c4f84cb-9481-4c45-af9c-bc6bdd08195d"
      unitRef="usd">5979000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id0ee2f4c36e04145806001b090363988_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMy0xMS0xLTEtMTQ5MTE3_6b0f37b9-db5a-4e54-b0d8-21fe4699e8e7"
      unitRef="usd">9108000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3cf4edbbb2c84bebb017b70ec26907d9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC0xLTEtMS0xNDkxMTc_c0c5d9d5-ce81-4cf6-bfe0-58e6fe650f30"
      unitRef="usd">4859000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3cf4edbbb2c84bebb017b70ec26907d9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC0zLTEtMS0xNDkxMTc_70413714-12b6-4b02-8203-5db98901e593"
      unitRef="usd">2347000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3cf4edbbb2c84bebb017b70ec26907d9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC01LTEtMS0xNDkxMTc_5de61cee-29b6-4751-b487-963dda482eb6"
      unitRef="usd">2512000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9763e9cfce3546598374a98e82482d84_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC03LTEtMS0xNDkxMTc_f485aaaf-6c28-44ff-a736-783295c6234d"
      unitRef="usd">4853000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9763e9cfce3546598374a98e82482d84_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC05LTEtMS0xNDkxMTc_c95dfd6f-07b0-4909-ad39-af0e8ac906ad"
      unitRef="usd">2170000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9763e9cfce3546598374a98e82482d84_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNC0xMS0xLTEtMTQ5MTE3_5cfe90ea-192b-4449-9e2d-362195e6b25a"
      unitRef="usd">2683000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5909630c3dc3461db24bb07bbef1d70f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy0xLTEtMS0xNDkxMTc_d346a904-64f0-4dee-878c-cea0849bb6af"
      unitRef="usd">1113000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5909630c3dc3461db24bb07bbef1d70f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy0zLTEtMS0xNDkxMTc_94c9c173-e67f-40f2-bbb5-30502aa4340a"
      unitRef="usd">604000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5909630c3dc3461db24bb07bbef1d70f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy01LTEtMS0xNDkxMTc_ccb3d513-13c5-43a9-8bc3-976e227b4f47"
      unitRef="usd">509000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie4bcaff2cdea468f9adea6ca88bfd572_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy03LTEtMS0xNDkxMTc_0ca478d4-fbb5-47d2-8101-3bc66b71625e"
      unitRef="usd">1046000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie4bcaff2cdea468f9adea6ca88bfd572_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy05LTEtMS0xNDkxMTc_3acfc73e-fdf9-4199-8632-097777edce7a"
      unitRef="usd">574000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie4bcaff2cdea468f9adea6ca88bfd572_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfNy0xMS0xLTEtMTQ5MTE3_5ee11b62-bc37-4e1d-9cb9-a3d534b3f986"
      unitRef="usd">473000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC0xLTEtMS0xNDkxMTc_0a89aa68-6bc4-469e-8a00-5aff85a63ef6"
      unitRef="usd">21113000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC0zLTEtMS0xNDkxMTc_a93118a2-82da-4062-952f-d8f091b3cfbc"
      unitRef="usd">9481000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC01LTEtMS0xNDkxMTc_709dba96-e006-4182-bd30-6b17978f71a9"
      unitRef="usd">11632000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC03LTEtMS0xNDkxMTc_1d83e297-6f61-41a9-b291-aa9f59a00311"
      unitRef="usd">20987000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC05LTEtMS0xNDkxMTc_9f60e648-aacd-4453-a754-f88bd82e1e8a"
      unitRef="usd">8723000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfOC0xMS0xLTEtMTQ5MTE3_61fc56b8-0b53-4c9c-b8ac-240bc8fc976a"
      unitRef="usd">12264000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i55f7422c872948b7aa942c44ddec9006_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTAtMS0xLTEtMTQ5MTE3_0e9b62b7-5949-4143-83c4-5c51c213e4f8"
      unitRef="usd">44000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i244628a30e084b02a041278475ead62a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTAtNy0xLTEtMTQ5MTE3_8fee57ab-c56e-4280-8499-8bbfa4b9c35a"
      unitRef="usd">44000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i369713e8a2814ee3b1545e6f40f52598_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTEtMS0xLTEtMTQ5MTE3_a6c0264f-f5de-4d11-9f74-014e79fbf48f"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i09ed9f30fe6f49b080fbe7dafbf98b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTEtNy0xLTEtMTQ5MTE3_985cbaf3-b4dc-4705-9a28-6e892869b0b3"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTItMS0xLTEtMTQ5MTE3_6b4097f6-3579-4cad-814a-e2e300f0ca3e"
      unitRef="usd">46000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmJhMjIxNTQwZjg3YzRkZWQ5MTg4NWM4ZDVjMzUwNjhkL3RhYmxlcmFuZ2U6YmEyMjE1NDBmODdjNGRlZDkxODg1YzhkNWMzNTA2OGRfMTItNy0xLTEtMTQ5MTE3_8219c65d-ccfa-4aea-bb10-ebe23cb78122"
      unitRef="usd">46000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMTQw_57f0a5e0-89bf-4cde-b483-345cabcc93f4"
      unitRef="usd">366000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMTQ3_40471a3e-0045-48f7-97d2-e90e2d4489d1"
      unitRef="usd">352000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMjE5OTAyMzI1NTk3Mg_e5e7f6cd-2b93-40db-859e-546688347e34"
      unitRef="usd">731000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMjE5OTAyMzI1NTk3Ng_945f279a-1603-4c04-bad3-095468a7eca6"
      unitRef="usd">707000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RleHRyZWdpb246MWVkMTViMzJiMGVkNGRlMzk2YjYwZDljY2JhNTk5ODBfMjQz_4376a9ba-04a5-4b9e-aa35-2d1718192a11">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life&#160;Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price allocation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i3102b14dbddd4ffc86e7d5d2db6bce27_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfMS0xLTEtMS0xNDkxMTc_fc6bc246-3e42-4971-b880-b3f3ba203731"
      unitRef="usd">10909000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib1a34123952a4177976f05690781d3d7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfMS0zLTEtMS0xNDkxMTc_c38eed6d-f611-4c1f-819f-0723b21b7ed8"
      unitRef="usd">888000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4127c3a1dc864463babc0aa7d4467455_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfMS01LTEtMS0xNDkxMTc_db6712e4-2191-435b-9156-a58e313477d5"
      unitRef="usd">12824000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfMS03LTEtMS0xNDkxMTc_9325682b-ce2b-475e-ae30-bf01160dd2bf"
      unitRef="usd">24621000000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ic9a28f207cd5467ba5f864965c31b4d2_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNC0xLTEtMS0xNDkxMTc_0dd91eab-cf10-4a8d-a144-48048c2f28af"
      unitRef="usd">3000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i6c0d32994d5d4acb92ad95e9804d5595_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNC0zLTEtMS0xNDkxMTc_8ea6d9b7-e72b-47b9-b6fd-8e5fd63fa7cc"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i5f5415d8bbac4b359e15026a6417f893_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNC01LTEtMS0xNDkxMTc_b830c0b9-f0e9-41ac-87a6-1145234d3e2a"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNC03LTEtMS0xNDkxMTc_c8b932cd-b8d2-4608-b261-9d450269a2b9"
      unitRef="usd">3000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ic9a28f207cd5467ba5f864965c31b4d2_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNS0xLTEtMS0xNDkxMTc_c1addbfd-84e4-4bcb-9014-ca4972bd4b22"
      unitRef="usd">-56000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6c0d32994d5d4acb92ad95e9804d5595_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNS0zLTEtMS0xNDkxMTc_ac867880-8bab-4d42-99b0-95910beaacb0"
      unitRef="usd">-12000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5f5415d8bbac4b359e15026a6417f893_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNS01LTEtMS0xNDkxMTc_63094a90-940d-403d-b5df-56843c0a3ef2"
      unitRef="usd">-89000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNS03LTEtMS0xNDkxMTc_5a50d770-4cd8-4ba0-969f-039dd9842fc1"
      unitRef="usd">-156000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ie6c6efdde649461c9e16742dfa4f98cb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNi0xLTEtMS0xNDkxMTc_cbecf115-da3f-40e0-9421-6ab5515f8211"
      unitRef="usd">10968000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i73beddac0b344212a9ac5a9c6b13e93c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNi0zLTEtMS0xNDkxMTc_43446f51-45ae-4057-bbf5-10996e9b3155"
      unitRef="usd">899000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i65aae17d8b844902ba366c6f8483abbe_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNi01LTEtMS0xNDkxMTc_92ab9c47-1e6d-4bb2-bfee-e400c0307f91"
      unitRef="usd">12913000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl81OC9mcmFnOjFlZDE1YjMyYjBlZDRkZTM5NmI2MGQ5Y2NiYTU5OTgwL3RhYmxlOmYxYzc1MjdlOTA4YzRlNjJiNGI5NWZjZmZmM2JkNDhjL3RhYmxlcmFuZ2U6ZjFjNzUyN2U5MDhjNGU2MmI0Yjk1ZmNmZmYzYmQ0OGNfNi03LTEtMS0xNDkxMTc_a3017483-2378-4b3b-aa07-c60014aa1942"
      unitRef="usd">24780000000</us-gaap:Goodwill>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfNTkyNg_8b755c49-78b0-4d6b-961d-2af7890335bf">Derivative Instruments and Hedging Activities&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative instruments to mitigate certain exposures. The Company does not enter into derivative financial instruments for trading or speculative purposes. The effects these derivative instruments and hedged items had on the Company&#x2019;s balance sheets and the fair values of the derivatives outstanding at March&#160;31, 2023 and September&#160;30, 2022 were not material. The effects on the Company&#x2019;s financial performance and cash flows are provided below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Risks and Related Strategies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts. In order to mitigate foreign currency exposure relating to its investments in certain foreign subsidiaries, the Company has hedged the currency risk associated with those investments with certain instruments, such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s foreign currency-related derivative instruments as of March&#160;31, 2023 and September&#160;30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.089%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undesignated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other income (expense), net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains or losses relating to the net investment hedges, which are attributable to changes in the foreign currencies to U.S. dollar spot exchange rates, are recorded as accumulated foreign currency translation in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Upon the termination of a net investment hedge, any net gain or loss included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relative to the investment hedge remains until the foreign subsidiary investment is disposed of or is substantially liquidated.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net (losses) gains recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the Company's net investment hedges for the three and six-month periods were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;The amounts for the three and six months ended March&#160;31, 2023 include a gain, net of tax, of $13&#160;million recognized on terminated cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risks and Related Strategies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. If interest rate derivatives designated as cash flow hedges are terminated, the balance in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;attributable to those derivatives is reclassified into earnings, within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the remaining life of the hedged debt. The amounts reclassified from accumulated other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2023 and 2022, as well as the amounts expected to be reclassified within the next 12 months, are not material to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net after-tax gains (losses) recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to interest rate cash flow hedges during the three and six months ended March&#160;31, 2023 were immaterial to the Company&#x2019;s consolidated financial results and were $43&#160;million and $39&#160;million during the three and six months ended March&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates. Amounts recorded during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s interest rate-related derivative instruments as of March&#160;31, 2023 and September&#160;30, 2022 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Risk Exposures&lt;/span&gt;&lt;/div&gt;The Company purchases resins, which are oil-based components used in the manufacture of certain products. Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results. From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts. The Company's commodity derivative forward contracts at March&#160;31, 2023 and September&#160;30, 2022 were immaterial to the Company's consolidated financial results.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfNTkyMw_8fca047c-5b7b-49a4-8b22-5143dc1b936f">The Company uses derivative instruments to mitigate certain exposures. The Company does not enter into derivative financial instruments for trading or speculative purposes.The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. If interest rate derivatives designated as cash flow hedges are terminated, the balance in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;attributable to those derivatives is reclassified into earnings, within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense,&lt;/span&gt; over the remaining life of the hedged debt.For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfNTkxMA_ea03b312-9f40-473d-a8ef-f9e5376a7b8b">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s foreign currency-related derivative instruments as of March&#160;31, 2023 and September&#160;30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.089%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undesignated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other income (expense), net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, during the three and six months ended March&#160;31, 2023 and 2022 were immaterial to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s interest rate-related derivative instruments as of March&#160;31, 2023 and September&#160;30, 2022 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  &lt;/span&gt;&lt;/div&gt;(b)Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i12b6aa99d5be460d83d9bca02ddddd61_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMS0zLTEtMS0xNDkxMTc_44340347-0633-4b26-af28-9894cf8fb650"
      unitRef="usd">1617000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6aeb4d2755fe46f299e5a6c74bc5a32b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMS01LTEtMS0xNDkxMTc_380a8588-5fdc-45fc-8353-e151cc45ff8c"
      unitRef="usd">2766000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib3304ad8423a4080868ba0df9040363c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMi0zLTEtMS0xNDkxMTc_fba448b9-ee0b-4fde-9f7d-a16d79758c0d"
      unitRef="usd">1831000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9f298aa8db0e4d16915009c38a45b4fd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMi01LTEtMS0xNDkxMTc_96f6344d-4a17-4fce-b388-f479c497dbe3"
      unitRef="usd">2140000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0a7b5571b4914526a7939314fe5ac29b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMy0zLTEtMS0xNDkxMTc_de317776-1d55-4030-ab7f-7a2ae81a6fa0"
      unitRef="usd">2119000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idc31e4316a5f42a9af36adc57ea908b0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmJhMGI5Y2FhMGU2NDQ4OGRhYTdlNjljZDNlOTk4ZjlhL3RhYmxlcmFuZ2U6YmEwYjljYWEwZTY0NDg4ZGFhN2U2OWNkM2U5OThmOWFfMy01LTEtMS0xNDkxMTc_542f3160-1894-4431-ac2b-a0229d3edd0e"
      unitRef="usd">910000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfNTkyOQ_f4bf2c52-5a7b-4781-8856-664bd1047dd5">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net (losses) gains recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the Company's net investment hedges for the three and six-month periods were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;The amounts for the three and six months ended March&#160;31, 2023 include a gain, net of tax, of $13&#160;million recognized on terminated cross-currency swaps.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i82512cdc5bbe47b99fd3ea95885689f8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMi0xLTEtMS0xNDkxMTc_16d9dd2d-a561-4e73-a1a0-f7e8ddea1fc8"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i1bdfaba42a0147ab9cf6e5fe931bcb98_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMi0zLTEtMS0xNDkxMTc_6356e893-839e-449b-abb0-d6313f63b000"
      unitRef="usd">45000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i39c3539460274df6ac6d2c96ecc34090_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMi01LTEtMS0xNDkxMTc_d7255812-b3ee-4d52-a519-3c08b39b874a"
      unitRef="usd">-164000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i67552823db3d48dba3a132df51727d27_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMi03LTEtMS0xNDkxMTc_05a0fac7-0758-4473-a65a-87359b6a67c2"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i13543c57601d49cdad0d49ed6c6a810e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMy0xLTEtMS0xNDkxMTc_0d31b42e-2fcc-4688-981c-144082276466"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0266480813824139b60fa979b8c5a110_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMy0zLTEtMS0xNDkxMTc_52bf7d64-a60d-4246-a800-a99a6ed2d1b3"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia3c212ff13284f898a191374e5b1fb18_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMy01LTEtMS0xNDkxMTc_04c9e267-b62e-45db-9feb-6c8ebf06814e"
      unitRef="usd">-101000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id1a554cbf33a4c3cbe41709cb273beba_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmIxZGY5MWM5NjUzNDRmZWVhNmRkNDQ0MjJmYjUzNTQzL3RhYmxlcmFuZ2U6YjFkZjkxYzk2NTM0NGZlZWE2ZGQ0NDQyMmZiNTM1NDNfMy03LTEtMS0xNDkxMTc_1ab088ff-0b14-4bbc-9303-d885eae036f0"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i26ec7721173741bfa63336e0a220a540_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfMTY0OTI2NzQ0OTA2Ng_95dd1d32-eb72-459e-96e6-4b5ad512c417"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iac6d0546403e4cb8bee77368cc2a109d_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfMTY0OTI2NzQ0OTA2Ng_a0e39a93-2a03-40e8-b024-51eb89f6581c"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i21832cc6769747ce9b9665d67123f229_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfMjE5OTAyMzI2MjIwNg_9a8ae716-51bc-423b-816c-835681be5832"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i52fcd6bc58b842908f344893c07f0e4a_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RleHRyZWdpb246NzI1ZTc4NTJjYTdlNDEwZDgzZmZkNGZmMWI0YzY2ZjVfMjE5OTAyMzI2MjIxOQ_138d9944-6c52-40f6-b06e-3c42b3bbfe63"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic6efa31d0f394c2fa26a85b8356810a7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmVkY2E5ZmMzODk1YzQ1YzhiOTY4NDYwNzc0Y2ZjMGJlL3RhYmxlcmFuZ2U6ZWRjYTlmYzM4OTVjNDVjOGI5Njg0NjA3NzRjZmMwYmVfMS0zLTEtMS0xNDkxMTc_96724509-6d6e-4343-afd0-3518e3124cfd"
      unitRef="usd">700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0f198f784a2e4fbebfc73c9adccb8ca7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmVkY2E5ZmMzODk1YzQ1YzhiOTY4NDYwNzc0Y2ZjMGJlL3RhYmxlcmFuZ2U6ZWRjYTlmYzM4OTVjNDVjOGI5Njg0NjA3NzRjZmMwYmVfMS01LTEtMS0xNDkxMTc_cf592aa9-dc37-4c2a-ad02-100bcfb65cc9"
      unitRef="usd">700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i28e41cac0d444490be6885ce232f8d86_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmVkY2E5ZmMzODk1YzQ1YzhiOTY4NDYwNzc0Y2ZjMGJlL3RhYmxlcmFuZ2U6ZWRjYTlmYzM4OTVjNDVjOGI5Njg0NjA3NzRjZmMwYmVfMi0zLTEtMS0xNDkxMTc_1602f6b2-906c-40e4-85c7-369157a55c35"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6cf2158a605543ce9c94011e2077fc47_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82MS9mcmFnOjcyNWU3ODUyY2E3ZTQxMGQ4M2ZmZDRmZjFiNGM2NmY1L3RhYmxlOmVkY2E5ZmMzODk1YzQ1YzhiOTY4NDYwNzc0Y2ZjMGJlL3RhYmxlcmFuZ2U6ZWRjYTlmYzM4OTVjNDVjOGI5Njg0NjA3NzRjZmMwYmVfMi01LTEtMS0xNDkxMTc_3c867986-b119-4683-982b-7b016704b96e"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjI0Mw_a169da8f-29cd-431d-b854-700d7a86be8b">Financial Instruments and Fair Value Measurements&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following reconciles cash and equivalents and restricted cash reported within the Company's condensed consolidated balance sheets at March&#160;31, 2023 and September&#160;30, 2022 to the total of these amounts shown on the Company's condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:166.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase. Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s financial instruments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Institutional money market accounts (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;These financial instruments are recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the condensed consolidated balance sheets. The institutional money market accounts permit daily redemption. The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The short-term investments consist of instruments with maturities greater than three months and less than one year. All other instruments measured by the Company at fair value, including derivatives and contingent consideration liabilities, are immaterial to the Company's condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nonrecurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of fiscal year 2022, the Company recorded a noncash asset impairment charge of $54&#160;million to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the Medical segment. The amount recognized was recorded to adjust the carrying amount of assets to the assets' fair values, which was estimated, based upon a market participant's perspective, using Level 3 inputs, including values estimated using the income approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transfers of trade receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Over the normal course of its business activities, the Company transfers certain trade receivable assets to third parties under factoring agreements. Per the terms of these agreements, the Company surrenders control over its trade receivables upon transfer.&#160;Accordingly, the Company accounts for the transfers as sales of trade receivables by recognizing an increase to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and a decrease to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade receivables, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when proceeds from the transactions are received.&#160;The costs incurred by the Company in connection with factoring activities were not material to its consolidated financial results. The amounts transferred and yet to be remitted under factoring arrangements are provided below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables transferred to third parties under factoring arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.628%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts yet to be collected and remitted to the third parties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjI2MA_a3ddc64a-eab9-4883-805b-3587028356e6">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following reconciles cash and equivalents and restricted cash reported within the Company's condensed consolidated balance sheets at March&#160;31, 2023 and September&#160;30, 2022 to the total of these amounts shown on the Company's condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:166.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMS0xLTEtMS0xNDkxMTc_4719c5d1-02bf-4315-9131-e6560480e924"
      unitRef="usd">1981000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMS0zLTEtMS0xNDkxMTc_3a85763c-b28a-4a10-9923-dae6ad639e26"
      unitRef="usd">1006000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMi0xLTEtMS0xNDkxMTc_12b7d64f-4b21-4099-bf71-0f447ee32c8f"
      unitRef="usd">87000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMi0zLTEtMS0xNDkxMTc_83582b45-704c-4fb0-b17a-77002bd54427"
      unitRef="usd">153000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMy0xLTEtMS0xNDkxMTc_13f338db-6b26-4ac9-9cbb-58295de49854"
      unitRef="usd">2068000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjQ1NjJlOTE2NDFhYTQyYzA4YzY0N2ExMjZmNjllZTEwL3RhYmxlcmFuZ2U6NDU2MmU5MTY0MWFhNDJjMDhjNjQ3YTEyNmY2OWVlMTBfMy0zLTEtMS0xNDkxMTc_ca46ae5a-0fb0-40fd-90e7-213f30ea1150"
      unitRef="usd">1159000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjI1Nw_70c3e506-43ff-4069-ab67-8d3b84567842">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjIzOA_c24c057e-0780-45a9-b68b-4da2a99e2966">Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjIzOQ_3d044a59-3ba9-44d6-ac62-09d8926ef92d">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s financial instruments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Institutional money market accounts (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;These financial instruments are recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the condensed consolidated balance sheets. The institutional money market accounts permit daily redemption. The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMS0zLTEtMS0xNDkxMTc_d5563dfd-e255-429f-9864-c9525ee5cb0e"
      unitRef="usd">50000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMS01LTEtMS0xNDkxMTc_454b7943-6950-452e-afb9-b77ccf26dae7"
      unitRef="usd">1000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMi0zLTEtMS0xNDkxMTc_cc221de1-d6e7-4222-8586-eee279a74758"
      unitRef="usd">1609000000</bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm>
    <bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMi01LTEtMS0xNDkxMTc_75a98c31-2eb4-4c60-a6ed-80e34bc2b09e"
      unitRef="usd">1927000000</bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm>
    <us-gaap:LoansPayableFairValueDisclosure
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMy0zLTEtMS0xNDkxMTc_2c2ec983-8153-4fe7-ae6c-21142c4ee5ae"
      unitRef="usd">14676000000</us-gaap:LoansPayableFairValueDisclosure>
    <us-gaap:LoansPayableFairValueDisclosure
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOjRjMzRiOWJhM2YxNTQ3NWI5NzllYjY2MWE3M2ZiYjNkL3RhYmxlcmFuZ2U6NGMzNGI5YmEzZjE1NDc1Yjk3OWViNjYxYTczZmJiM2RfMy01LTEtMS0xNDkxMTc_28a4f71a-8895-4a4e-adc4-8cc94fc7ae24"
      unitRef="usd">12119000000</us-gaap:LoansPayableFairValueDisclosure>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjI1OA_6882c660-3dff-4d03-8f26-517ec072d47e">The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions.Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The short-term investments consist of instruments with maturities greater than three months and less than one year.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <bdx:MaturityPeriodOfShortTermInvestment
      contextRef="i028e3d9d8c454377856d5376339cff80_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMTI3OA_5ef97a76-e04a-497d-88d9-3a3cbddcb7bd">P3M</bdx:MaturityPeriodOfShortTermInvestment>
    <bdx:MaturityPeriodOfShortTermInvestment
      contextRef="i404c88c20ea54232a7e62321ba370898_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMTI5NQ_05ee9eb9-082c-450e-b5c6-0f1a283452ce">P1Y</bdx:MaturityPeriodOfShortTermInvestment>
    <us-gaap:AssetImpairmentCharges
      contextRef="if5012eda058545d5b7ac41306aa4ba16_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjE5OTAyMzI1OTAxOQ_b1db8a6e-a18b-4608-9ccc-7df1a77a613a"
      unitRef="usd">54000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RleHRyZWdpb246MjE0ZDhkY2JlODJkNGEwMGEzNzgyYzgwYWZhMTc4YjdfMjI1MA_9f11f826-0d40-4042-951a-0f2cec783915">The amounts transferred and yet to be remitted under factoring arrangements are provided below.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables transferred to third parties under factoring arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.628%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts yet to be collected and remitted to the third parties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmFlOGU2OGY0NTZkZDRjYTE5NmIyN2JjNDlmMDBlNjNmL3RhYmxlcmFuZ2U6YWU4ZTY4ZjQ1NmRkNGNhMTk2YjI3YmM0OWYwMGU2M2ZfMi0xLTEtMS0xNDkxMTc_5062c237-853d-4335-b561-663bb1a5f2ea"
      unitRef="usd">750000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="ib5f577a9f407401eab7cd9db86414733_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmFlOGU2OGY0NTZkZDRjYTE5NmIyN2JjNDlmMDBlNjNmL3RhYmxlcmFuZ2U6YWU4ZTY4ZjQ1NmRkNGNhMTk2YjI3YmM0OWYwMGU2M2ZfMi0zLTEtMS0xNDkxMTc_4d8a41ee-b8bf-485a-bf42-5b0f05ecdea7"
      unitRef="usd">292000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmFlOGU2OGY0NTZkZDRjYTE5NmIyN2JjNDlmMDBlNjNmL3RhYmxlcmFuZ2U6YWU4ZTY4ZjQ1NmRkNGNhMTk2YjI3YmM0OWYwMGU2M2ZfMi01LTEtMS0xNDkxMTc_3df3f3ab-aa96-4805-9e0a-432668d17e11"
      unitRef="usd">1490000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="ie36e257bb8f34a258e13ecdec621aaf0_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmFlOGU2OGY0NTZkZDRjYTE5NmIyN2JjNDlmMDBlNjNmL3RhYmxlcmFuZ2U6YWU4ZTY4ZjQ1NmRkNGNhMTk2YjI3YmM0OWYwMGU2M2ZfMi03LTEtMS0xNDkxMTc_0d429775-5821-4f0b-9031-d2e0d75b4d38"
      unitRef="usd">434000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i6580dc6f73864fcaae84aaad3f03d4ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmEzNWVlMjk5NWEyMTRkNGM4NjVjNDM0YjM0ZTIxZDc4L3RhYmxlcmFuZ2U6YTM1ZWUyOTk1YTIxNGQ0Yzg2NWM0MzRiMzRlMjFkNzhfMS0xLTEtMS0xNDkxMTc_a726d4d2-327b-4257-9053-f2337b3d7699"
      unitRef="usd">359000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl82NC9mcmFnOjIxNGQ4ZGNiZTgyZDRhMDBhMzc4MmM4MGFmYTE3OGI3L3RhYmxlOmEzNWVlMjk5NWEyMTRkNGM4NjVjNDM0YjM0ZTIxZDc4L3RhYmxlcmFuZ2U6YTM1ZWUyOTk1YTIxNGQ0Yzg2NWM0MzRiMzRlMjFkNzhfMS0zLTEtMS0xNDkxMTc_67bc8d3b-1755-4c8e-9a7c-c4e4c9774f3d"
      unitRef="usd">323000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzE2NDkyNjc0NTAzMTE_441d47a4-e7cc-47e5-b256-1ae1f07a87f5">DebtIn February 2023, the Company issued $800&#160;million of 4.693% notes due February 13, 2028. Also in February 2023, Becton Dickinson Euro Finance S.&#xe0; r.l., a private limited liability company (soci&#xe9;t&#xe9; &#xe0; responsabilit&#xe9; limit&#xe9;e), which is an indirect, wholly-owned finance subsidiary of the Company, issued &#x20ac;800&#160;million ($868&#160;million) of 3.553% Euro-denominated notes due September 13, 2029 (the &#x201c;BD Finance Notes&#x201d;). The BD Finance Notes are fully and unconditionally guaranteed on a senior unsecured basis by the Company. No other of the Company's subsidiaries provide any guarantees with respect to the BD Finance Notes. The indenture covenants included a limitation on liens and a restriction on sale and leasebacks, change of control and consolidation, merger and sale of assets covenants. These covenants are subject to a number of exceptions, limitations and qualifications. The indenture does not restrict the Company, Becton Dickinson Euro Finance S.&#xe0; r.l., or any other of the Company's subsidiaries from incurring additional debt or other liabilities, including additional senior debt. Additionally, the indenture does not restrict Becton Dickinson Euro Finance S.&#xe0; r.l. and the Company from granting security interests over its assets.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0781942758c64dd5afd26d84a4911721_I20230228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzIxOTkwMjMyNjEzNTg_1d8fbc91-d457-4cdd-b42f-4efe919e8ad2"
      unitRef="usd">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0781942758c64dd5afd26d84a4911721_I20230228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzIxOTkwMjMyNjEzNzI_bba14ec8-f333-4db5-a9f0-a0731123286c"
      unitRef="number">0.04693</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2642155c253549deb25e07021badb5aa_I20230228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzIxOTkwMjMyNjEzODA_472593f5-0ff9-4bf0-88b4-c20cdc0bc389"
      unitRef="eur">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i37b7d299193b4c9989d811dd4b4236cf_I20230228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzIxOTkwMjMyNjEzOTM_9d98cedf-edd3-4500-b3ac-d7014a841f05"
      unitRef="usd">868000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i031378f9d14d45c988ebf0bc09980e9d_I20230228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM5MDFlMjhkYTc4ZjQ0M2NhYjM1NjRhNzk5MDJjNWJiL3NlYzpjOTAxZTI4ZGE3OGY0NDNjYWIzNTY0YTc5OTAyYzViYl84NDYvZnJhZzpkZDNmYTI0YTkzZTM0MmE0OWFiMjg4ZTI4NGI2NTYyMS90ZXh0cmVnaW9uOmRkM2ZhMjRhOTNlMzQyYTQ5YWIyODhlMjg0YjY1NjIxXzIxOTkwMjMyNjE0MDU_2d81eb1f-300f-4ce3-a750-d77bddb72e8d"
      unitRef="number">0.03553</us-gaap:DebtInstrumentInterestRateStatedPercentage>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>63
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M<');I@]<M'G!-2S+/G3'%D7L'*WL''6Q<\>?XD)"+TERR]+6V.$ZYU#.\^R
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MGHCZV9KZC<P7U?,L#[F4>5J]G',6<:%.@,\?<XAK\T9=8/6$T^D?4$L#!!0
M   ( &B$I%9*$NN I@8  &X?   8    >&PO=V]R:W-H965T<R]S:&5E=#(N
M>&ULK5E=<Z,V%/TK&G>GDYU);"0^C-/$,XE-I_N0;F:SVSYT^D",'#,+R!5R
MDO[[2D# UKU@=W=?8B!'5SKW2T=P]2+DUW+#N2*O>5:4UZ.-4MO+R:1<;7@>
MEV.QY87^SUK(/%;Z5CY-RJWD<5(-RK,)<YQ@DL=I,9I?5<_NY?Q*[%26%OQ>
MDG*7Y['\]Y9GXN5Z1$=O#SZE3QME'DSF5]OXB3]P]65[+_7=I+62I#DORE04
M1/+U]>B&7D8L- ,JQ!\I?RGWKHFA\BC$5W/S(;D>.69%/.,K94S$^N>9+WB6
M&4MZ'?\T1D?MG&;@_O6;]5\K\IK,8USRA<C^3!.UN1Z%(Y+P=;S+U"?Q\AMO
M"/G&WDID9?67O-380(-7NU*)O!FL5Y"G1?T;OS:.V!N@[> #6#. V0.\G@%N
M,\ ]=0:O&>"=.H/?#*BH3VKNE>.6L8KG5U*\$&G0VIJYJ+Q?C=;^2@N3* ]*
MZO^F>IR:+T21Z+#SA.BK4F1I$BM]\Z#TC\X'51*Q)A^*E<@YN2!?'I;D[-U[
M\HZD!;E+LTS'NKR:*+T08VZR:B:]K2=E/9.ZY$X4:E.22$^>(..7P^.#@?$3
M[8#6"^S-"[=LT.!=+,?$I>>$.<Q%UK,X?3C#Z'S?[-$WSW[@#+=-";>RY_;8
M:Z+=I@#YZ^:Q5%*7]-]8J&MC'F[,]+G+<ANO^/5(-[*2RV<^FO_\$PV<7S _
M_TACRQ]I+/I!Q@XBXK41\8:LSS_Q9U[L.%II]<B@&FEVA>>Y%S)Z-7G>=RL"
MFOK.(6@)03//F1Z"(@P4A"WH@)[?TO,'Z2U$J4R;V4J1[%:ZY>@^A'6%V]J,
MOS<Y\\/ XHJ  M>BL80@WW%#BRL"HJZ/<PU:KL$@UP>]):;%$XF+A,2);NBI
M*2VS61+^NC6=&",>@)50YO@6<01$9\PB#D',M4$1!IKV!'G:$I\>R>&2QW*U
MJ9@G.J$SL:VZRP#M*5B':T=R@6"8'6V("7RK1"($XU&<<MA2#@<IWZS^V:5E
M:@31A>19M;&FA>)/)N!&)&E/Z&:AI$[ZG319,>"+$*[/"ML"0IB5TDL(H8Y5
M0-'@3 >.F+6.F TZXJ/:<$FTN#7$.YKD+*VVFO?GI. *(ST#2_$LSA!AMS6(
ML'L:1%QX.&'J=++*&:3\6:@X(Q];RJ;'E57$HYH\+IL<2)C.7(LSB@JM=K!$
M4"&P%6$H1GOB3?=4)1V.>$N\5A,H68HD6FASA2 _\&RJ$$09!50QE!_T4&4=
M539(]8.N:%/%0\7;F#A(,4H!5P0ULWL9!F+,L;EB$\YZ]B[:*4,Z*',ZKFE_
M5%VDQ=A$(<;>IS S=J-",'UUVRDM.BRUZE95TR-G34C[&U1C[:!\;+(0<@%V
M* 1D;U"HG3Z^G?2BP]JK$?MK*7)S M0ENS-5V]2O/MV16[X6DK^= 3_'KSVM
M"U%+;&;[ H(\#X0>@JCCS&QW8*B^'9MV\HP.Z[.&IHI?C1Q]3LT+$90NU$@!
MB#S$^( LQ'B@F"$F[ M\)\?HL![[G2MR-/@H<ZB4O !4."++9O;.C(!F 8@S
M O)[M"CME!D=EF;[S)=IN:K):WW6<3\GQD7Z6*)3'O4#U$G "XB4 GO743,1
M J%3M\<%G2:CPZ*L2P"4'2*]8)01D \(0A 290BBU.VI9M:I,#:LPNXE7W,I
M=5Q+)59?29(^IPDO$C2Q&91"%\S67J> EAC(L_19= 1TR+@37FQ8>)FH-KM7
MO-UFZ2I^S'0[$T0_RO69H]S$DF_T^9I+W D4OBJP#\8+%$1M)T#0C'FV$R"(
M.F&/)F.=)F/'--F1QG9.;N,R79$S\T93/ZW]\A[U2#W5='^)8SO+%RC*WO^6
M",H=,Y 9**K')YUV8\>TVPDM[W2O0.UE=X<&$NY#QLS> (\;BE!#05]SZ*0>
M&Y9Z-=<HEH7.C;+B^V#XGD3? TO"D@)%@4*!*"PI,%38YX1._['OU'_G.EFR
MG7EU<8I;?(PPZ*$8"KRJ0%#:+:"!8"C:HP]8)P/923)PN%C^CV.@A /E$IQ4
M+D<-1:BAOI;:Z44VK!??R'YCO4Q/2@P497L @K"\P%!][S!9IQO9L&Y<O@F(
MBN^BWE-/]T((&KLSGMDOZU%4:)\8$10=A_:;7!0UM0\/D[WOASF73]6'VU)+
MAEVAZN]&[=/VX_!-]4G4>GY++Q<4>;ZDEU']Z;<S7W^)OHOE4ZI/F1E?ZZF<
M\51GMJP_[M8W2FRKKY>/0BF15Y<;'FOY8@#Z_VLAU-N-F:#]Q#[_#U!+ P04
M    " !HA*16#)^JNK0#  !'#@  &    'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;*U778^;.A#]*Q:WJEJI7;X)V29(NR%7K=1M5]U^/%1]<, )W(+-M9UD
M^^\[!I8FX-!5FY<$FS/'/C.#9SS;,_Y=9(1(=%\65,R-3,KJTC1%DI$2BPM6
M$0IOUHR76,*0;TQ1<8+3VJ@L3,>R K/$.36B63UWRZ,9V\HBI^26([$M2\Q_
M7)."[>>&;3Q,?,@WF5039C2K\(;<$?FINN4P,CN6-"\)%3FCB)/UW+BR+Y>V
MI0QJQ.><[,7!,U)25HQ]5X,WZ=RPU(Y(01*I*##\[<B"%(5B@GW\WY(:W9K*
M\/#Y@?W?6CR(66%!%JSXDJ<RFQNA@5*RQMM"?F#[UZ05Y"N^A!6B_D7[%FL9
M*-D*R<K6&'90YK3YQ_>M(PX,@$=OX+0&3M_ .V'@M@;N8U?P6@/OL2OXK4$M
MW6RTUXZ+L<31C+,]X@H-;.JA]GYM#?[*J4J4.\GA;0YV,EHPFD+828K@2; B
M3[&$P9V$/\@'*1!;PZL2LC!3Z;$CZ U-6$G02_3I+D;/GCQ'3U!.T4U>%!!Y
M,3,E;$N1FTF[A>MF"\Z)+;CHAE&9";2$K:0:^WC</ABQ-\$=G4^<!Y]<.Z.$
M-YA?(-=^@1S+<37[63S>W-')^;O5EW^\^I$SW"Y!W)K//<'79<+)1/AZM1*2
MPQ?_31?[AMW3LZMC\%)4."%S X@%X3MB1$__L0/KE<[QYR2+STFV/!/948B\
M+D3>&'OT#NI)$PM= !K;H+9596,7>8$U,W>'?M5@?.\8$P\QTV!ZC%D.,;;M
MVAWH2)W?J?-'$_"]S CO9=ZSMTR(YZWH%T@Y ++S([[7.< _9P:>DRP^)]GR
M3&1',0JZ& 6C&0@U&RHRA8+%.:')#P3G 14%;GJ!]#^H8W4QT86G8?8/<N:E
M8_?R<XB9A+WTU-#85H]G.039]E2?GI-.^F14>DS6,).B%:'P)%'5-E&8IJAB
M<# 2F?/F *T*K*^/$\VV>A[X/20>0E0!.-*O@9SX.L-.?C@J?X%%AM;0;J*,
MI!NBE1<.0Q/TY TA7O_\T;#TCY\AQ)WHY4T[>=-1>7]]^$PU:=D7/\38KMM3
MK^$))SWY&IZ#S^1(OVW]Z@^M\0!K2KZVQ[.&-<3S>THU(#_LN2/6@,*PG\D:
MD.U:_6_9/&B,2\(W]8U$H(1MJ6Q:H&ZVN_5<U;U^;_[:OES8FOE8W9+J1OP7
M?7/%@CYLDU.!"K*&I:R+"<2%-[>69B!95;?E*R:AR:\?,[CI$:X \'[-F'P8
MJ 6ZNV/T$U!+ P04    " !HA*16N^.2N30'   8'P  &    'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;*V9;V_;MA/'WPKA%<,&)+5(2K+<) 9:9_O]"K1;
M$&?;8T9F;*&2J%&TD^S5[_0GEBT>F17(@S:2?#Q]CW_N<Z0N'Y7^5F^E-.2I
MR,OZ:K(UIOHPG=;I5A:B?J\J6<(O#TH7PL"MWDSK2DNQ;AL5^90%03PM1%9.
M%I?MLQN]N%0[DV>EO-&DWA6%T,^?9*X>KR9T\O+@-MML3?-@NKBLQ$:NI/FC
MNM%P-SUX66>%+.M,E43+AZO)1_IA&09-@];BSTP^UD?7I GE7JEOS<WG]=4D
M:!3)7*:F<2'@SUXN99XWGD#'W[W3R>&=3</CZQ?OO[;!0S#WHI9+E?^5K<WV
M:I),R%H^B%UN;M7C_V4?4-3X2U5>M_^3Q]XVF)!T5QM5](U!09&5W5_QU'?$
M40,:.AJPO@'[KPUXWX"W@7;*VK"NA1&+2ZT>B6ZLP5MST?9-VQJBR<IF&%=&
MPZ\9M#.+I2K7,"AR3>"J5GFV%@9N/HE<E*DDJ\9Q3<[)'ZMK\M.[G\D[DI7D
M:Y;G, ;UY=2 A,;1-.U?]ZE['7.\[JO0[PFG9X0%C"/-E_[F*UE!\Z!MSDZ;
M3R'P0_3L$#UK_7%7]#NM96G(Q[J&,#]@\70.0MQ!L\@^U)5(Y=4$5E$M]5Y.
M%C_^0./@ HONC9R=Q,H/L7*?]\52U%LBRC61?^^RO<@A;G0 .R]QZZ5) OL%
MG2?T<KH_#@0Q@KQQ,#H1&!X$AEZ!M[(V.DN;Z9>"5DQ;YR Z>FTR&RFS36C$
M<6'105CD%;;:*FW.C=0%3/X]J"Q<?1=9+X]'\FR+!!<7'\3%7G%W6JPE)-14
MPJ#>Y[(^(Z4TF+C8>C4+*1_I0XSHG.(29P>),^\J^PR=5AJE,XDOL=E;+K$W
M<G82:'((-/&.Q5?(G3H3.3HW$JMG9TDRZGW$)ICAG3\_:)I[-?T%%&UR=J55
M*FM4V=QZ:\C&RFP;/G<HH\' GL"K[=>LS !=ZT;<>I?B:ZKW<3IOPW%"PJPH
M"QP*C^A(O0J/IBZJC=K=$D?C-8]9,18ZM WLHEY<+&ZTK$0&^?RI:@A>M\E=
MF:W4J%1F)\8P#,=2$:LHFCND#NBA?O;<*2-R<DI;5"2W7C^/K!2/6"4T="0I
M.N"'^OESHZ$XUN;YC-Q \6/:[OP%6%DUZ1Y5B["&L\#J4\0,,F_DT#M0B?JQ
M] 66,Q$Y%.)-J583J.FA@(6TEF:B*Y$A %$ N[)_V@=H# BRDG"\^C&K,&".
M" 9T43^[O#U^1G[#.49M1L7<7G2(54!=D@>442] %O]3:OT(Y2\J;(9DJED2
MC)5A9C%SS=\!/M1/GVNYAUU9!>GT3J;;4N5J\^SN1!LU24PMJ;;5G :.BH4.
M2*)^)BW;?8W4Y%;F[<RLMUE5N[7:\&'1T5#V6A&K.'&4?FQ@%/,SZO<FH9+/
MI1'E)NOJ*X=,9B,HBJ*12LR(.O(K&S#%_)CJ1+KS*K,)1.?S<:+"K(YSP:FX
MHSV6GU-=\O>(LYD3A=Q6AYBQ.7=@E UL8OP_[0&_9.(^RS/CJE*9%W'?O1-\
M(V^G00^L8W[6O02]EO>&J/L\VW3K$ W<YA=CU!H>Q(K.7#-[@!SS0^Y&//>[
M&I&F>B>Q<H>D?33Y,(1H(#;%HF ^SGF85<P=X& #Z]@K^[23$NC+*TIM>,VX
M55A@5@EU<(0-B&-^Q'U1Y>;\KMGM7L/L0.79!(.9:=$#,^-)XC@F8 /HF!]T
M@\!?BBI7SU*23[*4#YDAO[\RE1&>,4LV8N2J==C /.9GWK5\D##V:T!)"NPC
M=^*IG\-=\GYM1B";M' VW@4A5E$0.;3S@8'<S\"E*HJL._5H%2]5:;)R(\L4
MU)*?5C  ORDC2?0S>J#D=8ZG.H+ES#=P=-H! U\Y]3)BM15:;E6^EKK^\8<$
M$MM%6ZB:9S1@+ZR_EQ1OY>TT]('>_-5=9C]QH69+OZ'QVF0>%V=>DU-E1^>9
MKQQHPJR$74XKB[2CPB[(.THJH<E>Y#MY0<3.;&'S_@^H?S& ?<M9$+3_2-T,
M:WU!LKK>'9GP.#R+^?QL'M#>I#WT%CK==AW[<H#=+H:5K(PL[J7N?T-/I_N.
MLC>N/!Y7B*\8G7;6 'S^"O!%E34 @D#D4W,01-3#T%.H6&3;.H=N&<O%S"+7
MD2L?P,_]X+^51L CX+W0)20;_*S:9C6-@-9CC9@9C1SG5WQ@.O<S_9#3(:,W
M18ESE\VQL]>Q2,3&U8L#R[F?Y7=:BGJGGSV+UX;T><+9^,P%-^.. S8^L)S[
M6?XQ37?%+F\_.O7%'/0E)-OF2^%>DESA9Y;<AO0YC*BUF#"S,''L:?A <^ZG
M>5?-?2<6L&ULG%@+"C-CB2-=A@/$0S_$.\E'94:7O;XKA/X5Q]]]L*T:9H9L
MU:9'GRV;;\:083=969-</D"[X/T,^D!WGV&[&Z.J]DOFO3)&%>WE5@J0WAC
M[P\*JI#^IODX>O@8OO@74$L#!!0    ( &B$I%;K6!\)A0(  )X&   8
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M;#0X1Q+ENZ&?&-FXAK*0!MN3&U;X 0%E _#]4DKS-+$]JO\DY7\ 4$L#!!0
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MUP;J]S53S5E]HF_0?#5<_ ]02P,$%     @ :(2D5FT>0B<Z!0  * P  !@
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MFW-1X+()*-L 3_%#04H)SE/=+(W.$6ETJ"*%+$&G6%*I<9-XG2?1#O*2LQ[
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MR2@ TSX%VHG3M;]^U]K19>Z'!;V>T+  [>=:N]V$#>S?8XM_ %!+ P04
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MB=NAE*UN"(LLUTT+L+-?IA^GO!(HZ*;BP["RM#E_=-/L.U@! :^KPBZL(QD
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MTAD$!(8DH.A:W#RTV*ZWV(_F<,+G%X^4&-S9^>L 56J4)SYWX/8#<C+6P'V
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MXO[^DE*,6VO'/=,QKS_=G[_)K4]D<$2T-P2*F%Q76U]J"EKK0=P[*5<5SZ1
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M\BM8,9JR'DRY71]4^"#]L3@[78KUR?KL@+ZST;4SUG=VV#51>M>(.]CJ00'
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MLM51&@H469RZ<H[R#;M"<. 7"7&;YCK".S '="Z!SBB3.)TK9!_H,BNQ+/;
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M-!K:VJOUG@2^,1J/B@ AUGR< ?OS!.P+VV>0]XFPX;#0J*SGD#+J-(^EMAE
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MD[QC)BCZS72*! $S6O86-MA#! \,1[(,[D^?C!@[ME)F9>5F[="&><"9%3L
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M^'?/P4,UKUU4EKW['S$>%"VZU4+[['"'QI.G?J_,#OYZ@?0K]V^/S]* UO\
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M-5Y+]4W7B 8>VJ;3DZ VIK\8#'198\OUN>RQ(\U"JI8;FJKE0/<*>>6,VF;
MHB@;M%QTP73L9+=J.I8KTX@.;Q7H5=MRM;G$1JXG01SL!)_%LC96,)B.>[[$
M.S1?^UM%L\$>I1(M=EK(#A0N)L$LOKA,[7JWX ^!:WTP!NO)7,IO=O*IF@21
M)80-EL8B<'K=XQ4VC04B&M^WF,%^2VMX.-ZA_^)\)U_F7..5;/X4E:DG01%
MA0N^:LQGN?X5M_X,+5XI&^V>L/9KATD Y4H;V6Z-B4$K.O_F#]LX'!@4T2L&
M;&O '&^_D6-YS0V?CI5<@[*K"<T.G*O.FLB)SA[*G5&D%61GII\ZP[NEF#<(
M,ZW1Z/' $*Q5#LHMQ*6'8*] 9' C.U-K^+FKL/K1?D!T]IS8CM,E.PIXP]4Y
M)'$(+&+)$;QD[V/B\))7\#Y*6:U%TP#O*GCF,%P+7392KQ3"7[.Y-HHRY>^7
MPN!W25_>Q5;/A>YYB9. RD.CNL=@^OY=G$4?COB0[GU(CZ&_[9R.0KQ,\'DX
M#B3<2TI)-:@-5B 7%T"G4];[XX$[[ VV<U201$[$X/2&@DTEIVD]5+)IN-)G
M\%%)K6%6EJMVU7"+]COUG"NNU$9T2YBU<M69-ZZBES+B7]**9VRO\9Y:34\Z
M@V7=R48N-W "\3",TX@&IUDX3*(S&A5A%D=>%16Y50W#43ZRJE$81P5<N?HC
MUQ02%^M1+7H-:5@,1W#*PB3-SX"%PY@Y66)E<1Y9658D<$O\.Z-#H)2JJ)=2
MGW4I*$U-F'$8QV211>D9#*,1S:,T(PHYS=,\.>KC"3!O3IQ'85K$EG,<AUG"
MK"X*1]Z?(LQ9XG0L9%D*7SM^!'56?E\)Y50_]4J62"=A$\4=N"5>^=!23S:$
MF:;^\>71.T:_XWN01>8?AWGF#5R( 1_HPM$(=.$ !8K^"A%:WV+0MIBG*6BI
MN<1;<]H@R3)JE"X!G>8D&;*=(+3^].AN@F9S_F8.6CS\#P9Y$O_(((_RUQA\
MJ>TN#=V--KT%)0@MH((K12,\%ZJAY:Z!S3<P7VFJ:SH9C4M[$!>OE-L-5J+D
M#?PF%@AWI<".SM,Z;.N^L\BD_"(-/1_[HX-XH:(I@2BG*$FI:(K"YU/![/FS
M-,Q8#+<KB@==CM K45(PR:'2T^?5/U1%EJF&!-Z_*UC,/NS?"=684L1M8XND
MT[[,8)C1#E!04=#H";TGH??4,DNJ&(T\M9&K#**6%Q&\U'P'!Q<FU??2?1;8
M1D?-Q=^=>^G^RV/F+]S'Y?ZSA>@L!<6^P0691N?Y, #E/P7\Q,C>7;]S::B9
MN&%-7T^H[ +2+Z0TNXG=8/\]-OT/4$L#!!0    ( &B$I%:EAQ76E D  %8>
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;-596V_;1A;^*P/5:&U
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MP^") '\[W_"N>XK_@H^DK^V>4 SUXX*OAOI-_\)AJFN-9O#-L+8U96B$DK9
M@&G4(MG0VG1K7,70_?>AY..PH'1D>MXD-VZ,U(BC'@;UE/%^+)_F41?HMX+V
MES;"K8VVMK4I(*B<J;[I,3!A2WGP8C*-NL+ZT'W@\O4;)B_&<W ? VGCB&PF
MYA.+L7=:[Q7CMXG>XVMT<Y9]W%76Q)(.SMI10C</3E\VUW_"/B05*LJPPV9K
M?B[U!,39PK$NY%!S<B[\%O)L[IT]L"/@=738@@D275)#%%UB9\3T]Z&F2F-Y
M%:2D*FZDIZ+4\'$+]L%M/ 1^D3=,GG:TIM6FUSCP?N9]JZ,$A7S=.=UQS?Z/
MCVY?\Q2FY\O_R2.8VQU)IBWPW59='XCGXW'\_RX^&L2^;OMK15<,3KTWF\CQ
M#-STUWMZXD*]''MSO+VH-!+#,A(?]'?W(Z:,@XB*S&"'M[Y?PZ5<!T[3GCLW
MC]H\7#:JEYMGCU'T'H]WUU]N7_]ZMW7,WS_0-RUN'J5V$:+/SD\ZZY+"KW%#
MX>;2SE4T[5&N =YI.19OZW5SU\N@D\Z[OES9!;_1=.%I<WCMU]QM7II>AW>%
M+7EXXXH:6]"XR=0<K./1\V<#6,MO,<.%-R6_.9P9[TW.7Y=*(AY$@-_G!M&/
M%Z2@>95\]5]02P,$%     @ :(2D5HWF4?3^!@  8Q(  !D   !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&ULK5C;;MM&$/V5A6HD*:!:5]\2VX#M-&B N@WB
MM'TH^K B1^(V))?975I6O[YG9BF*<B37 ?IBB^3.S)G9,V>6/%]:]]EG1$$]
M%'GI+WI9"-7KP< G&17:']J*2CR96U?H@$NW&/C*D4[%J,@'X^'P>%!H4_8N
MS^7>!W=Y;NN0FY(^..7KHM!N=4VY75[T1KWUC8]FD06^,;@\K_2"[BC\5GUP
MN!JT7E)34.F-+96C^47O:O3Z>LKK9<'OAI:^\UMQ)C-K/_/%^_2B-V1 E%,2
MV(/&OWNZH3QG1X#QI?'9:T.R8??WVOL[R1VYS+2G&YO_8=*07?1.>RJEN:[S
M\-$N?Z(FGR/VE]C<RU^UC&N/ACV5U#[8HC$&@L*4\;]^:.K0,3C=9S!N#,:"
M.P82E&]UT)?GSBZ5X]7PQC\D5;$&.%/RIMP%AZ<&=N'RG2EUF1B=J_>E#ZY&
MO8-7NDS5.VV<^EWG-:E;TKYV),_.!P%AV7B0-"&N8XCQGA#'ZM:6(?/JQS*E
M=-M^ +@MYO$:\_7X28>WVAVJR:BOQL/QY E_D[8&$_$WV5>#3:9OC4]RR\EZ
M]>?5#!4!;?[:E7-T.=WMDEOIM:]T0A<]](HG=T^]RQ??C8Z';YX /&T!3Y_R
M_O]LVI,A=B?PS7'5IXS4W.9H?5,NT,2)A7V.XB;:9V))7VISK_/6$X(%9Y)
M:5SCJ+*.KY8F9*94 1YO;%'I<O42;BPX57I>;$MO<Y-J7CO3.8"2DKZ WZ#
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MY'K,]E3ODOB-O%8&H[]G#>6)@)Q LT-02%ZZ%VA_1*)$-=89Q6SU=9HU/8N
MYJ^A;1KG8^K4SF^@Z$<65R62@)'83Q-=)7$(4'DF)RB99B2RWD]QFOM((1MB
M=M_==]T>V9YQKA[*#2O4+H;=2-7702[2G/A_[%!^X'8F_R'F/N^9^_P@ =_A
MY#4K_=ZA^O#F\5#=4MI5;XW4)/HVW2H0URI-<KI7863>$?7#;$QV0*<3*)KF
M6)IFW=CJ@,'8?H<NI1T?B3ZM31N:UN,<G'+/5^B/N25^E^8V3PPTXS.7/'FJ
M](([8Y(^D28L. 7.IP5="(F:1&3'XX'-)VRO#AO9A)$]IN0(A2^X5W+A\3WB
MWLZ=$?86HENSZ(*VN5YTGO[74/VT7&%^@2'BY4+'C<8%8(@6ZB=CJI1\6IK;
M03MI&<#4VJ$KV0:<Q]0HH>9:';4-ZAF92D748*0M3$-BSD8XJZ&+.LD!M4XV
MBD+4AEKJ(,.4MU)BQ(+S+0I.JR6!\C9%V=7A:$7NI?LPWCYI."(914.?Z=F4
MOU'TJ2VF-%"$B01=2QQDLFMV?>-(DD%7D!@Q/+>QFU[2E<00A)[5Y3$#0*.]
M5TE4?D_1(YM>5_0NB"N&KSV/2&$>"S3A<B>ZH0X>C)'.2^I+2Q(9%M*R0N'X
MJZ)H5SG#[D%7=N/#529L>V.H^_!@V=/0T315TW25;C\X]4,7#6%:!ST]H%\O
M>OUZ<?BU $5.;.8/OWQKX9,E4=BG9G_#E!XLI,M:X,9,(V1EEA5*VQHL47E*
M3OK#ETV>9UI/M&%NHDC$*KTR K<MS6N@"]HE<Q>ZA H.^I"&O^PQ>/F_83#%
M0 &5-,S?_PJIPP>.K#+S,E \C?$#/RS@&SX!I+S<Y%FY#22 -,0VD<6[:PKW
M7W[D&_0AF%[U,+TZZ/5[$H\_.O$87G]]&#K)/B@.&_V\I4HARQ)+^, /JL8T
M K%H4C%^:QVA ]DLDKRE][B(UW_5V (D,$D/=ZO*66YOVPW0Q#:]W?G-U<LC
M*OC4M5(])K61K.O0H^]\%0Y)FG>DU-[;OTJ3J1H[_I#3E,I@5H9T;]2?9S<5
MSD_F=V&IM%5Y[J'[=:H@D]];2-9;[TT*@YR?=O?)!@C=\NP91K&DV,+^\T;U
M/)X>N'I')Z.]T4!&\EYOUW&ZYZ476;@5U5K<0>3V<G,^>G>-D7;);^CS_)E>
M8_=/^S\"7*5WW\/R]!>$C[A=P5^<7&+K\>P%KA0^O95/7Z)K^$WXPD7,S_RQ
MTI@U/2W [Z5#VO(7.J#_T\CE7U!+ P04    " !HA*16T]PIRB4#   0!P
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MSZ0MA'UD*V :@1DHE" U,.?P6&K$%^T",[YZN7'+A?#E(8Z<#)DVKA'B=GC
M9R2/!EY#W(]H/$V&U,'&NZRURIO,&C!*Y- _@RA-8$82X"[)59OE]$UQ5V G
M#H K$CN#D/9@,"1J@TQGI4?FY$>HFO3(=K"H#TD,=[9$#:I-F'C7I\<@*>_T
M# 8I/"I+=;KK("Z^MMVN6["!B&!)/-@"K>]V.(0XBFAED2KPQ_E1^M8__U "
MF"+)-VZ@5 AR.$SH @>;/4O%H=MZYEYMHS-(DO\N[FOHIS1$@P1VM7>XI5(5
MZH778@.9:J1M!:O;[>3^HE6Y/_#V7T&"L."4E\""3'LG U)7W>ION["J]IHW
M5Y84U$]+^F6A=@ Z+Y2RFX5ST/T$)[\!4$L#!!0    ( &B$I%8T6_)?:0<
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ML)@W<>#%OHD#'YT_=R(O[N/ .QL'?CC_&\5!="C:I23X<@Q@K'R3&%BXQR(
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M[K@(:*V=L7//*P&009E6S^F.\7]"'R%S9;NUZA]H!3V]137#0P/-IL?+: P
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M!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q]55%OVC 0_BNGK)I
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M3#4:%PI!S^%6V,0GSK]\^UG(I5"<L3;0G6K;0;\D"'.MJ(IEMJ!ZC#3QAH@
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M,BYX;6RUG&MSHS@6AO\*Y>W:35>U8R.9B[-)JB;F^J&G4IWIV<_$*#'5&#R
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MMA](K5 YP8AEHOP+MC76'8!H(R3+:V$U@SREU2]^K VQ(Z!XS *H%D"ZP.B
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M -3[)6/RZ:88H/D_@_D/4$L#!!0    ( &F$I%;,33X7: 0  *T4   9
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;,U86X_B-A3^*U8J5;M29W(C89@"
MTD!2=:6N-%JZW8>J#Y[$@#5)S-H.3/]]CYT02/!FF&Y4]05LYYS//M^Y^#(]
M,/XLMH1(]))GA9A96REW][8MDBW)L;AE.U+ ES7C.9;0Y1M;[#C!J5;*,]MS
MG-#.,2VL^52//?+YE)4RHP5YY$B4>8[YWPN2L</,<JWCP">ZV4HU8,^G.[PA
M*R(_[QXY].P&):4Y*01E!>)D/;,>W/O8]96"EOB#DH,X:R-ERA-CSZKS(9U9
MCEH1R4@B%02&OSU9DBQ32+".KS6HU<RI%,_;1_1?M/%@S!,69,FR+S25VYEU
M9Z&4K'&9R4_L\"NI#0H47L(RH7_1H99U+)240K*\5H85Y+2H_O%+3<29 N"8
M%;Q:P>LJC+ZAX-<*_K4SC&J%T;4S!+6"-MVN;-?$15CB^92S ^)*&M!40[.O
MM8$O6JA 64D.7RGHR7F,>4&+C4"/A*/5%G.";M 732])T<.>< @7M&1Y#E[5
MWP7Z+. 3+=3HKI18.5P@MD8++&B"<)&BB&:ETF_0=PWZNXA(3+/W,(VHX.H_
M /Q]RTH!^F)J2[!-K=!.:CL6E1W>-^SPT4=6R*U <9&2U* ?]>N'/?HV<-H0
MZQV)77B]@!\QOT6^^Q/R',\WK&=YO;IG,N?[9H__]>PM,OPFRGR-YU\?97\^
M/ G)H4[\97)V!3<RPZGB>2]V."$S"ZJC('Q/K/F//[BA\[.)Z2'!HB'!XH'
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MHHX'/&VOTH%DL>E09DRJ?L=<+E5+"EQ/4,_GC,GM0#<]>9,[_ M02P,$%
M  @ :82D5KI!<& P @  OP0  !D   !X;"]W;W)K<VAE971S+W-H965T,S<N
M>&ULA511;],P$/XK5I#0D&!)TZZ@DD1J-Q![&*I: 0^(!R>Y)-8<.]A.L_U[
MSG8:BM25E\1GW_?==^<[)X-4C[H!,.2IY4*G06-,MPI#73304GTM.Q!X4DG5
M4H.FJD/=*:"E [4\C*-H&;:4B2!+W-Y698GL#6<"MHKHOFVI>MX ET,:S(+C
MQH[5C;$;899TM(8]F&_=5J$53BPE:T%H)@514*7!>K;:+*R_<_C.8- G:V(S
MR:5\M,9]F0:1%00<"F,9*/X.< N<6R*4\7OD#*:0%GBZ/K)_=KEC+CG5<"OY
M#U::)@T^!*2$BO;<[.3P!<9\;BQ?(;EV7S)XWP4Z%[TVLAW!J*!EPO_ITUB'
M$T <OP"(1T#L=/M 3N4=-31+E!R(LM[(9A<N58=&<4S82]D;A:<,<2;;0XTE
M-L2"R3NR+DMFJT4YN1?^RFWMKN[ 4,;?)*'!F!89%B/_QO/'+_ OR8,4IM'D
MDRBA_!<?HM9)<'P4O(DO$CY0=4WFL[<DCN(YT5[^!=[Y5(BYXYW_IQ [Z*0R
M3-3DYSK71F';_#J7MF=;G&>SH[32'2T@#7!6-*@#!-GK5[-E]/&"UL6D=7&)
M/?O:MSDH(BO2*28*UN%UY;U&+ZV/)='D:ER=O34?X,8%L(-[R.9)>#C5%)XT
M50NJ=J.C22%[87Q_3;O3=*Y]4_YU]Z.-=U8SH0F'"J'1]7N,J_RX>,/(SK5H
M+@TVO%LV^,* L@YX7DEICH8-,+U9V1]02P,$%     @ :82D5EFL>Y+?#0
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M5$+D=E9P50D7S,X*A"I.V4!6T 8J\CLH(RNT-P]C9R'\^-&C$4F34)I"T<Q
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MVI%&@]I]J/I@D@MXZ]BL;8;.OU\[R21,2;P#HB\0)[[G'MOWG' 9[Z3ZKM<
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MS4;I<6@L/9<D3"LJLY(*Z: 2HULIS%JC/T4&V?/XT"ZK7AMY6MN,> %OJ;I
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M"]F163U<K!>"KO7T[)$*04M]N0*< 5,"\OZ"4K%;* /MB#?Z!U!+ P04
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M 801T/MSSM5F8A14/R/!'U!+ P04    " !IA*16:YO3ELL"  "0"0  &0
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MT2QAE)/;3&E9X!+0BM!L2D:42?)$>0'D#J@J))1CWTF?JH6%#%\*MJ2\ICP
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;*U574_;,!3]*U:&)I"
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M+[??H/'C!&:2:_<DVR8V\$A6:2.+!HP*"B;J-WUN\M !A(,/ %$#B/X5$#>
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MC J\5J!+SHEZ/$,FUY-@$&PZ;N@R-ZXCG(X+LL1;-%^*:V5;8<.248Y"4RE
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MV/9!_V5D=?JWQ.F?'F__!5!+ P04    " !IA*16BC%V7\\!   S'P  &@
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MA4\_ 5!+ 0(4 Q0    ( &B$I%8'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ :(2D5A?HT)CO
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ :(2D5IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " !HA*16B(M[%&D(  #M-   &
M            @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ :(2D5DH2ZX"F!@  ;A\  !@              ("!K1   'AL+W=O
M<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( &B$I%8,GZJZM ,  $<.
M   8              " @8D7  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q0
M2P$"% ,4    " !HA*16N^.2N30'   8'P  &               @(%S&P
M>&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ :(2D5NM8'PF%
M @  G@8  !@              ("!W2(  'AL+W=O<FMS:&5E=',O<VAE970U
M+GAM;%!+ 0(4 Q0    ( &B$I%;>*I%>8@8  $$<   8              "
M@9@E  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !HA*16
M;1Y")SH%   H#   &               @($P+   >&PO=V]R:W-H965T<R]S
M:&5E=#<N>&UL4$L! A0#%     @ :(2D5FTX@%WY!@   Q$  !@
M     ("!H#$  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    (
M &B$I%9M\6EM)0@  ,T;   8              " @<\X  !X;"]W;W)K<VAE
M971S+W-H965T.2YX;6Q02P$"% ,4    " !HA*16>#<^F@8$  ";"0  &0
M            @($J00  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4
M Q0    ( &B$I%;X>M!T(A<  ,E$   9              " @6=%  !X;"]W
M;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ :(2D5NUE10+'!P
M9!0  !D              ("!P%P  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX
M;6Q02P$"% ,4    " !HA*162'%&EG,(  !@%0  &0              @(&^
M9   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( &B$I%:S
MTGF!Y@,  )T(   9              " @6AM  !X;"]W;W)K<VAE971S+W-H
M965T,30N>&UL4$L! A0#%     @ :(2D5GJ0I+25 P  $@@  !D
M     ("!A7$  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &B$I%;O2>R @@D  "89   9              "
M@1N/  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ :(2D
M5M/<*<HE P  $ <  !D              ("!U)@  'AL+W=O<FMS:&5E=',O
M<VAE970R,2YX;6Q02P$"% ,4    " !HA*16-%OR7VD'  "Z&   &0
M        @($PG   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0
M   ( &B$I%9),Z+-'P0  -H)   9              " @="C  !X;"]W;W)K
M<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ :(2D5H/?JF/Z!@  <Q$
M !D              ("!)J@  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q0
M2P$"% ,4    " !HA*16.#0J%>L"  !=!@  &0              @(%7KP
M>&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( &B$I%:<0N+C
MU0(  !\&   9              " @7FR  !X;"]W;W)K<VAE971S+W-H965T
M,C8N>&UL4$L! A0#%     @ :(2D5BR^1XP-!   4@D  !D
M ("!A;4  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !H
MA*16T_-CF*(%   D#P  &0              @(')N0  >&PO=V]R:W-H965T
M<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( &B$I%8]<DOYW 0  -@,   9
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M970S,RYX;6Q02P$"% ,4    " !IA*16S$T^%V@$  "M%   &0
M    @($$W0  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (
M &F$I%:UY )_N 0  )(=   9              " @:/A  !X;"]W;W)K<VAE
M971S+W-H965T,S4N>&UL4$L! A0#%     @ :82D5D49)_14 P  \ X  !D
M             ("!DN8  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"
M% ,4    " !IA*16ND%P8# "  "_!   &0              @($=Z@  >&PO
M=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( &F$I%99K'N2WPT
M -"<   9              " @83L  !X;"]W;W)K<VAE971S+W-H965T,S@N
M>&UL4$L! A0#%     @ :82D5FW7I[];!@  ]C   !D              ("!
MFOH  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " !IA*16
M.AURJX<#   D#0  &0              @($L 0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0P+GAM;%!+ 0(4 Q0    ( &F$I%;CT((=V ,  "X2   9
M      " @>H$ 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%
M  @ :82D5B%<&E^>!   N!@  !D              ("!^0@! 'AL+W=O<FMS
M:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " !IA*16^!8L7J@"  #Q!P
M&0              @('.#0$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+
M 0(4 Q0    ( &F$I%9TF#F"S ,  &\0   9              " @:T0 0!X
M;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ :82D5K9R;5+
M P  !1(  !D              ("!L!0! 'AL+W=O<FMS:&5E=',O<VAE970T
M-2YX;6Q02P$"% ,4    " !IA*16%>Y[Z@L$  #N%0  &0
M@(&G& $ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( &F$
MI%:BBWJ1"P,  )@,   9              " @>D< 0!X;"]W;W)K<VAE971S
M+W-H965T-#<N>&UL4$L! A0#%     @ :82D5FN;TY;+ @  D D  !D
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M=#4R+GAM;%!+ 0(4 Q0    ( &F$I%82]+]4+0,  ! 2   -
M  "  :0P 0!X;"]S='EL97,N>&UL4$L! A0#%     @ :82D5I>*NQS
M$P(   L              ( !_#,! %]R96QS+RYR96QS4$L! A0#%     @
M:82D5L0"5VL\!   ;2(   \              ( !Y30! 'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( &F$I%:*,79?SP$  #,?   :              "
M 4XY 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( &F$
MI%8RX8'AQP$  !(?   3              "  54[ 0!;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     \ #P 6Q   $T] 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>334</ContextCount>
  <ElementCount>229</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CondensedConsolidatedStatementsofIncome</Role>
      <ShortName>Condensed Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Spin-Off of Embecta Corp.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SpinOffofEmbectaCorp</Role>
      <ShortName>Spin-Off of Embecta Corp.</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/Revenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Segment Data</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentData</Role>
      <ShortName>Segment Data</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Business Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BusinessRestructuringCharges</Role>
      <ShortName>Business Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Derivative Instruments and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities</Role>
      <ShortName>Derivative Instruments and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Financial Instruments and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements</Role>
      <ShortName>Financial Instruments and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Spin-Off of Embecta Corp. (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SpinOffofEmbectaCorpTables</Role>
      <ShortName>Spin-Off of Embecta Corp. (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/SpinOffofEmbectaCorp</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/ShareholdersEquity</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/EarningsPerShare</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Segment Data (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataTables</Role>
      <ShortName>Segment Data (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/SegmentData</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansTables</Role>
      <ShortName>Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/BenefitPlans</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Business Restructuring Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BusinessRestructuringChargesTables</Role>
      <ShortName>Business Restructuring Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/BusinessRestructuringCharges</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/IntangibleAssets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables</Role>
      <ShortName>Derivative Instruments and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables</Role>
      <ShortName>Financial Instruments and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Spin-Off of Embecta Corp. - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails</Role>
      <ShortName>Spin-Off of Embecta Corp. - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Spin-Off of Embecta Corp. - Income from Discontinued Operations, Net of Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails</Role>
      <ShortName>Spin-Off of Embecta Corp. - Income from Discontinued Operations, Net of Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails</Role>
      <ShortName>Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail</Role>
      <ShortName>Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail</Role>
      <ShortName>Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Contingencies (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ContingenciesDetail</Role>
      <ShortName>Contingencies (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/Contingencies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Revenues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/RevenuesDetails</Role>
      <ShortName>Revenues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/Revenues</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Segment Data - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataAdditionalInformationDetail</Role>
      <ShortName>Segment Data - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Segment Data - Revenues by Geographic Areas (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail</Role>
      <ShortName>Segment Data - Revenues by Geographic Areas (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail</Role>
      <ShortName>Segment Data - Financial Information for Company's Segments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Benefit Plans (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansDetail</Role>
      <ShortName>Benefit Plans (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/BenefitPlansTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Business Restructuring Charges (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BusinessRestructuringChargesDetail</Role>
      <ShortName>Business Restructuring Charges (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/BusinessRestructuringChargesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail</Role>
      <ShortName>Intangible Assets - Components of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Intangible Assets - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail</Role>
      <ShortName>Intangible Assets - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail</Role>
      <ShortName>Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bdx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DebtDetail</Role>
      <ShortName>Debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/Debt</ParentRole>
      <Position>52</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 6 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. bdx-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 27 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. bdx-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="bdx-20230331.htm">bdx-20230331.htm</File>
    <File>bdx-20230331.xsd</File>
    <File>bdx-20230331_cal.xml</File>
    <File>bdx-20230331_def.xml</File>
    <File>bdx-20230331_lab.xml</File>
    <File>bdx-20230331_pre.xml</File>
    <File>ex2203312023.htm</File>
    <File>ex3103312023.htm</File>
    <File>ex3203312023.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="767">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="56">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>69
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bdx-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 22,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 767,
    "http://xbrl.sec.gov/dei/2022": 56
   },
   "contextCount": 334,
   "dts": {
    "calculationLink": {
     "local": [
      "bdx-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bdx-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bdx-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bdx-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bdx-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bdx-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 406,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 20,
   "keyStandard": 209,
   "memberCustom": 30,
   "memberStandard": 39,
   "nsprefix": "bdx",
   "nsuri": "http://www.bd.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.bd.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Earnings Per Share",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.bd.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Contingencies",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.bd.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Revenues",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.bd.com/role/Revenues",
     "shortName": "Revenues",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Segment Data",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.bd.com/role/SegmentData",
     "shortName": "Segment Data",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Benefit Plans",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.bd.com/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Business Restructuring Charges",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.bd.com/role/BusinessRestructuringCharges",
     "shortName": "Business Restructuring Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Intangible Assets",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.bd.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Derivative Instruments and Hedging Activities",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities",
     "shortName": "Derivative Instruments and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Financial Instruments and Fair Value Measurements",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements",
     "shortName": "Financial Instruments and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.bd.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Statements of Income",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
     "shortName": "Condensed Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Basis of Presentation (Policies)",
     "menuCat": "Policies",
     "order": "20",
     "role": "http://www.bd.com/role/BasisofPresentationPolicies",
     "shortName": "Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Spin-Off of Embecta Corp. (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.bd.com/role/SpinOffofEmbectaCorpTables",
     "shortName": "Spin-Off of Embecta Corp. (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Shareholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.bd.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Earnings Per Share (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.bd.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Segment Data (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.bd.com/role/SegmentDataTables",
     "shortName": "Segment Data (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Benefit Plans (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.bd.com/role/BenefitPlansTables",
     "shortName": "Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Business Restructuring Charges (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.bd.com/role/BusinessRestructuringChargesTables",
     "shortName": "Business Restructuring Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.bd.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Derivative Instruments and Hedging Activities (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables",
     "shortName": "Derivative Instruments and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables",
     "shortName": "Financial Instruments and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i9c3c3fab267a46a88f3f39dfcc2cf90a_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:DisposalGroupsIncludingDiscontinuedOperationConsiderationCash",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Spin-Off of Embecta Corp. - Additional Information (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
     "shortName": "Spin-Off of Embecta Corp. - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i838793163e4f492f987f08dd7af25df3_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Spin-Off of Embecta Corp. - Income from Discontinued Operations, Net of Tax (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails",
     "shortName": "Spin-Off of Embecta Corp. - Income from Discontinued Operations, Net of Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i838793163e4f492f987f08dd7af25df3_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails",
     "shortName": "Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i7c23e44aea374d2fb54a3b6aedeadc11_D20221001-20221231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6484295e8f144d2ca1b524717f92829c_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail",
     "shortName": "Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i798de8f735874f948c11fa53069df187_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail",
     "shortName": "Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i85d6531a6a844787a70ff90d4a02d6d2_D20220801-20220831",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Contingencies (Detail)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.bd.com/role/ContingenciesDetail",
     "shortName": "Contingencies (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i85d6531a6a844787a70ff90d4a02d6d2_D20220801-20220831",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:ContractWithCustomerRebateLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Revenues (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.bd.com/role/RevenuesDetails",
     "shortName": "Revenues (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:ContractWithCustomerRebateLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Segment Data - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
     "shortName": "Segment Data - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Segment Data - Revenues by Geographic Areas (Detail)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail",
     "shortName": "Segment Data - Revenues by Geographic Areas (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i4a102dfb15ad4d198bd87f3bc598fc50_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:AcquisitionRelatedCostsAndRestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
     "shortName": "Segment Data - Financial Information for Company's Segments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryRecallExpense",
       "span",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i0a8a4974f9e942689ee74356ba8c98ba_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InventoryRecallExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Benefit Plans (Detail)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.bd.com/role/BenefitPlansDetail",
     "shortName": "Benefit Plans (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "ic456a1d473ec45a4b522a85fca58c87d_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Business Restructuring Charges (Detail)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.bd.com/role/BusinessRestructuringChargesDetail",
     "shortName": "Business Restructuring Charges (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail",
     "shortName": "Intangible Assets - Components of Intangible Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Intangible Assets - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail",
     "shortName": "Intangible Assets - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i723dc8ff15d347c8be15eeb67e4a1b8e_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
     "shortName": "Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i12b6aa99d5be460d83d9bca02ddddd61_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail",
     "shortName": "Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i12b6aa99d5be460d83d9bca02ddddd61_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
     "shortName": "Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i82512cdc5bbe47b99fd3ea95885689f8_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
     "shortName": "Derivative Instruments and Hedging Activities - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i21832cc6769747ce9b9665d67123f229_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.bd.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i6580dc6f73864fcaae84aaad3f03d4ed_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "if5012eda058545d5b7ac41306aa4ba16_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Financial Instruments and Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i028e3d9d8c454377856d5376339cff80_D20221001-20230331",
      "decimals": null,
      "lang": "en-US",
      "name": "bdx:MaturityPeriodOfShortTermInvestment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:TransfersOfFinancialAssetsDuringThePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i2c547b08d07c4c149a3d292f26eefbc6_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:TransfersOfFinancialAssetsDuringThePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i0781942758c64dd5afd26d84a4911721_I20230228",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Debt (Detail)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.bd.com/role/DebtDetail",
     "shortName": "Debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i0781942758c64dd5afd26d84a4911721_I20230228",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Basis of Presentation",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.bd.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Spin-Off of Embecta Corp.",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.bd.com/role/SpinOffofEmbectaCorp",
     "shortName": "Spin-Off of Embecta Corp.",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Shareholders' Equity",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.bd.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20230331.htm",
      "contextRef": "i62c762872bb541c4b9a48420a5bdc8b0_D20221001-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 70,
   "tag": {
    "bdx_AcquisitionRelatedCostsAndRestructuringCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Acquisition Related Costs And Restructuring Charges",
        "negatedLabel": "Acquisition-related integration and restructuring expense",
        "verboseLabel": "Acquisition-related integration and restructuring expense"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsAndRestructuringCharges",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_BiosciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biosciences [Member]",
        "label": "Biosciences [Member]",
        "terseLabel": "Biosciences"
       }
      }
     },
     "localname": "BiosciencesMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_CommonStockHeldInTrustsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Held in Trusts, Acquired",
        "label": "Common Stock Held in Trusts, Acquired",
        "terseLabel": "Common stock held in trusts, net"
       }
      }
     },
     "localname": "CommonStockHeldInTrustsAcquired",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_CommonStockHeldInTrustsNetShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common stock shares held in trust.",
        "label": "Common Stock Held In Trusts Net Shares",
        "terseLabel": "Common stock held in trusts, net (in shares)"
       }
      }
     },
     "localname": "CommonStockHeldInTrustsNetShares",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_CommonStockSharesHeldInEmployeeTrust1": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of common stock issued to a trust (for example, but not limited to, rabbi trust) set up specifically to accumulate stock for the sole purpose of distribution to participating employees.",
        "label": "Common Stock, Shares Held in Employee Trust1",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "CommonStockSharesHeldInEmployeeTrust1",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ContractWithCustomerRebateLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Rebate Liability",
        "label": "Contract With Customer, Rebate Liability",
        "terseLabel": "Rebate liability"
       }
      }
     },
     "localname": "ContractWithCustomerRebateLiability",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_CoreAndDevelopedTechnologyNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets arising from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date.",
        "label": "Core And Developed Technology Net",
        "terseLabel": "Developed Technology, Net"
       }
      }
     },
     "localname": "CoreAndDevelopedTechnologyNet",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net",
        "label": "Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net",
        "terseLabel": "Other operating expense, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense",
        "label": "Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense",
        "terseLabel": "Selling and administrative expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Research and Development Expense",
        "label": "Disposal Group, Including Discontinued Operations, Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Groups, Including Discontinued Operation, Consideration, Cash",
        "label": "Disposal Groups, Including Discontinued Operation, Consideration, Cash",
        "terseLabel": "Disposal Groups, Including Discontinued Operation, Consideration, Cash"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationConsiderationCash",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Of Debt Classified From Long Term To Short Term",
        "label": "Fair Value Of Debt Classified From Long Term To Short Term",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "FairValueOfDebtClassifiedFromLongTermToShortTerm",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite And Indefinite Lived Intangible Assets [Line Items]",
        "label": "Finite And Indefinite Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite And Indefinite Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite And Indefinite Lived Intangible Assets [Table]",
        "label": "Finite And Indefinite Lived Intangible Assets [Table]",
        "terseLabel": "Finite And Indefinite Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_FiniteLivedCustomerRelationshipsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net carrying amount as of the balance sheet date of an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.",
        "label": "Finite Lived Customer Relationships Net",
        "terseLabel": "Customer Relationships, Net"
       }
      }
     },
     "localname": "FiniteLivedCustomerRelationshipsNet",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_FixedToFloatingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed To Floating [Member]",
        "label": "Fixed To Floating [Member]",
        "terseLabel": "Interest Rate Swaps"
       }
      }
     },
     "localname": "FixedToFloatingMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ForeignCurrencyDenominatedDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign-Currency Denominated Debt [Member]",
        "label": "Foreign Currency-Denominated Debt [Member]",
        "terseLabel": "Foreign Currency-Denominated Debt"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedDebtMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_GwinnettCountyGeorgiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gwinnett County, Georgia",
        "label": "Gwinnett County, Georgia [Member]",
        "terseLabel": "Gwinnett County, Georgia"
       }
      }
     },
     "localname": "GwinnettCountyGeorgiaMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_HerniaProductClaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HerniaProductClaims [Member]",
        "label": "HerniaProductClaims [Member]",
        "terseLabel": "Hernia Product Claims"
       }
      }
     },
     "localname": "HerniaProductClaimsMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_IncreaseDecreaseinPensionBenefitObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for pension benefits.",
        "label": "Increase (Decrease) in Pension Benefit Obligation",
        "terseLabel": "Pension obligation"
       }
      }
     },
     "localname": "IncreaseDecreaseinPensionBenefitObligation",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_IntegratedDiagnosticSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Integrated Diagnostic Solutions [Member]",
        "label": "Integrated Diagnostic Solutions [Member]",
        "terseLabel": "Integrated Diagnostic Solutions"
       }
      }
     },
     "localname": "IntegratedDiagnosticSolutionsMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_InterventionalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional [Member]",
        "label": "Interventional [Member]",
        "terseLabel": "Interventional",
        "verboseLabel": "Interventional"
       }
      }
     },
     "localname": "InterventionalMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_LifeSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Life Sciences [Member]",
        "label": "Life Sciences [Member]",
        "terseLabel": "Life Sciences",
        "verboseLabel": "Life\u00a0Sciences"
       }
      }
     },
     "localname": "LifeSciencesMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_MaturityPeriodOfShortTermInvestment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.",
        "label": "Maturity Period Of Short Term Investment",
        "terseLabel": "Maturity period of short-term investments at the time of purchase"
       }
      }
     },
     "localname": "MaturityPeriodOfShortTermInvestment",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bdx_MedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical.",
        "label": "Medical [Member]",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_MedicationDeliverySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medication Delivery Solutions [Member]",
        "label": "Medication Delivery Solutions [Member]",
        "terseLabel": "Medication Delivery Solutions"
       }
      }
     },
     "localname": "MedicationDeliverySolutionsMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_MedicationManagementSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medication Management Solutions [Member]",
        "label": "Medication Management Solutions [Member]",
        "terseLabel": "Medication Management Solutions"
       }
      }
     },
     "localname": "MedicationManagementSolutionsMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0.632dueJune42023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.632% due June 4, 2023 [Member]",
        "label": "Notes 0.632% due June 4, 2023 [Member]",
        "terseLabel": "Notes 0.632% due June 4, 2023"
       }
      }
     },
     "localname": "Notes0.632dueJune42023Member",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0000DueAugust132023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.000% due August 13, 2023",
        "label": "Notes 0.000% due August 13, 2023 [Member]",
        "terseLabel": "Notes 0.000% due August 13, 2023"
       }
      }
     },
     "localname": "Notes0000DueAugust132023Member",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0034DueAugust132025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.034% due August 13, 2025",
        "label": "Notes 0.034% due August 13, 2025 [Member]",
        "terseLabel": "Notes 0.034% due August 13, 2025"
       }
      }
     },
     "localname": "Notes0034DueAugust132025Member",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.208dueJune42026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.208% due June 4, 2026 [Member]",
        "label": "Notes 1.208% due June 4, 2026 [Member]",
        "terseLabel": "Notes 1.208% due June 4, 2026"
       }
      }
     },
     "localname": "Notes1.208dueJune42026Member",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.401dueMay242023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.401% due May 24, 2023 [Member]",
        "label": "Notes 1.401% due May 24, 2023 [Member]",
        "terseLabel": "Notes 1.401% due May 24, 2023"
       }
      }
     },
     "localname": "Notes1.401dueMay242023Member",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.900dueDecember152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.900% due December 15, 2026 [Member]",
        "label": "Notes 1.900% due December 15, 2026 [Member]",
        "terseLabel": "Notes 1.900% due December 15, 2026"
       }
      }
     },
     "localname": "Notes1.900dueDecember152026Member",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1213NotesDueFebruary122036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.213% Notes due February 12, 2036",
        "label": "Notes 1.213% Notes due February 12, 2036 [Member]",
        "terseLabel": "Notes 1.213% Notes due February 12, 2036"
       }
      }
     },
     "localname": "Notes1213NotesDueFebruary122036Member",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3.020dueMay242025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.020% due May 24, 2025 [Member]",
        "label": "Notes 3.020% due May 24, 2025 [Member]",
        "terseLabel": "Notes 3.020% due May 24, 2025"
       }
      }
     },
     "localname": "Notes3.020dueMay242025Member",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3553DueSeptember132029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.553% due September 13, 2029",
        "label": "Notes 3.553% due September 13, 2029 [Member]",
        "terseLabel": "Notes 3.553% due September 13, 2029"
       }
      }
     },
     "localname": "Notes3553DueSeptember132029Member",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes4693DueFebruary132028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 4.693% due February 13, 2028",
        "label": "Notes 4.693% due February 13, 2028 [Member]",
        "terseLabel": "Notes 4.693% due February 13, 2028"
       }
      }
     },
     "localname": "Notes4693DueFebruary132028Member",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants",
        "label": "Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants",
        "terseLabel": "Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants"
       }
      }
     },
     "localname": "NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "bdx_NumberOfEtOSterilizationLawsuitsFiled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of EtO Sterilization Lawsuits Filed",
        "label": "Number Of EtO Sterilization Lawsuits Filed",
        "terseLabel": "Number of EtO lawsuits filed"
       }
      }
     },
     "localname": "NumberOfEtOSterilizationLawsuitsFiled",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "bdx_OrganizationalUnitAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organizational Unit [Axis]",
        "label": "Organizational Unit [Axis]",
        "terseLabel": "Organizational Unit [Axis]"
       }
      }
     },
     "localname": "OrganizationalUnitAxis",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_OrganizationalUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Organizational Unit [Axis]",
        "label": "Organizational Unit [Domain]",
        "terseLabel": "Organizational Unit [Domain]"
       }
      }
     },
     "localname": "OrganizationalUnitDomain",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_OtherInitiativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Initiatives [Member]",
        "label": "Other Initiatives [Member]",
        "terseLabel": "Other Initiatives"
       }
      }
     },
     "localname": "OtherInitiativesMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_PeripheralInterventionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Peripheral Intervention [Member]",
        "label": "Peripheral Intervention [Member]",
        "terseLabel": "Peripheral Intervention"
       }
      }
     },
     "localname": "PeripheralInterventionMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_PharmaceuticalSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical Systems [Member]",
        "label": "Pharmaceutical Systems [Member]",
        "terseLabel": "Pharmaceutical Systems"
       }
      }
     },
     "localname": "PharmaceuticalSystemsMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ProceedsFromSpinoffTransaction": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Spinoff Transaction",
        "label": "Proceeds From Spinoff Transaction",
        "terseLabel": "Distribution from Embecta Corp. (see Note 2)"
       }
      }
     },
     "localname": "ProceedsFromSpinoffTransaction",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer, and term loans",
        "label": "Proceeds from Issuance of Long-Term Debt and Term Loans",
        "terseLabel": "Proceeds from long-term debt"
       }
      }
     },
     "localname": "ProceedsfromIssuanceofLongTermDebtandTermLoans",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ProductsandorServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products and/or Services [Member]",
        "label": "Products and/or Services [Member]",
        "terseLabel": "Products and/or Services"
       }
      }
     },
     "localname": "ProductsandorServicesMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ShareBasedCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation [Member]",
        "label": "Share Based Compensation [Member]",
        "terseLabel": "Share Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased",
        "label": "Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased",
        "terseLabel": "Number of additional shares authorized to be repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_SurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgery [Member]",
        "label": "Surgery [Member]",
        "terseLabel": "Surgery"
       }
      }
     },
     "localname": "SurgeryMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_TerminatedCurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terminated Currency Swap",
        "label": "Terminated Currency Swap [Member]",
        "terseLabel": "Terminated Currency Swap"
       }
      }
     },
     "localname": "TerminatedCurrencySwapMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_TransfersOfFinancialAssetsDuringThePeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfers of financial assets during the period.",
        "label": "Transfers of financial assets during the period.",
        "terseLabel": "Trade receivables transferred to third parties under factoring arrangements"
       }
      }
     },
     "localname": "TransfersOfFinancialAssetsDuringThePeriod",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_UrologyandCriticalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Urology and Critical Care [Member]",
        "label": "Urology and Critical Care [Member]",
        "terseLabel": "Urology and Critical Care"
       }
      }
     },
     "localname": "UrologyandCriticalCareMember",
     "nsuri": "http://www.bd.com/20230331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States of America, Dollars"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exch_XNYS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]",
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC."
       }
      }
     },
     "localname": "XNYS",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r239",
      "r277",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r299",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r357",
      "r359",
      "r361",
      "r362",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r239",
      "r277",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r299",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r357",
      "r359",
      "r361",
      "r362",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r499",
      "r543",
      "r558",
      "r579",
      "r580",
      "r602",
      "r619",
      "r625",
      "r677",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r499",
      "r543",
      "r558",
      "r579",
      "r580",
      "r602",
      "r619",
      "r625",
      "r677",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r301",
      "r544",
      "r603",
      "r623",
      "r672",
      "r673",
      "r678",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r301",
      "r544",
      "r603",
      "r623",
      "r672",
      "r673",
      "r678",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r451",
      "r499",
      "r503",
      "r504",
      "r505",
      "r542",
      "r543",
      "r558",
      "r579",
      "r580",
      "r602",
      "r619",
      "r625",
      "r667",
      "r677",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r451",
      "r499",
      "r503",
      "r504",
      "r505",
      "r542",
      "r543",
      "r558",
      "r579",
      "r580",
      "r602",
      "r619",
      "r625",
      "r667",
      "r677",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r302",
      "r303",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r604",
      "r624",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r302",
      "r303",
      "r565",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r604",
      "r624",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_GA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEORGIA",
        "terseLabel": "GEORGIA"
       }
      }
     },
     "localname": "GA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Payables, accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r307",
      "r308"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r48",
      "r52",
      "r140",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Benefit\u00a0Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r99",
      "r205"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less allowances for depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r220",
      "r227",
      "r228",
      "r517",
      "r588",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r50",
      "r51",
      "r52",
      "r215",
      "r553",
      "r563",
      "r564"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r226",
      "r227",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r47",
      "r52",
      "r140",
      "r227",
      "r228",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r506",
      "r507",
      "r508",
      "r648",
      "r649",
      "r650",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital in Excess\u00a0of Par\u00a0Value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r130",
      "r131",
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to net income from continuing operations to derive net cash provided by continuing operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r73",
      "r89",
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Intangible amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Share equivalents excluded from the diluted shares outstanding calculation (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r73",
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset Impairment Charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r170",
      "r185",
      "r209",
      "r236",
      "r285",
      "r291",
      "r297",
      "r309",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r515",
      "r518",
      "r530",
      "r622",
      "r675",
      "r676",
      "r689"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r201",
      "r218",
      "r236",
      "r309",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r515",
      "r518",
      "r530",
      "r622",
      "r675",
      "r676",
      "r689"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r75",
      "r203",
      "r582"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and equivalents",
        "verboseLabel": "Cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Institutional money market accounts"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r76",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r70",
      "r75",
      "r77"
     ],
     "calculation": {
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Closing Cash and Equivalents and Restricted Cash",
        "periodStartLabel": "Opening Cash and Equivalents and Restricted Cash",
        "totalLabel": "Cash and equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r70",
      "r161"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash flow hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Cash Provided by (Used in) Financing Activities, Discontinued Operations",
        "terseLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r17",
      "r70"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations",
        "terseLabel": "Net cash used for investing activities"
       }
      }
     },
     "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r17",
      "r70"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations",
        "terseLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r236",
      "r256",
      "r257",
      "r262",
      "r264",
      "r271",
      "r272",
      "r309",
      "r351",
      "r354",
      "r355",
      "r356",
      "r362",
      "r363",
      "r391",
      "r392",
      "r394",
      "r398",
      "r404",
      "r530",
      "r581",
      "r632",
      "r645",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r43",
      "r174",
      "r189"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (See Note 5)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r106",
      "r344",
      "r345",
      "r568",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per Common Share (USD per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r648",
      "r649",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock\u00a0 Issued at\u00a0Par\u00a0Value",
        "verboseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r32",
      "r622"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock \u2014 $1 par value; authorized \u2014 640,000,000 shares; issued \u2014 364,639,901 shares in March\u00a031, 2023 and September\u00a030, 2022"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r53",
      "r223",
      "r225",
      "r232",
      "r549",
      "r555"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r391",
      "r392",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r84",
      "r290",
      "r291",
      "r292",
      "r293",
      "r299",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r61",
      "r544"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Operating Costs and Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Cross-Currency Swaps"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r110",
      "r234",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r380",
      "r387",
      "r388",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r171",
      "r172",
      "r184",
      "r239",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r540",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r163",
      "r165",
      "r364",
      "r540",
      "r598",
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r40",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r41",
      "r239",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r540",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r41",
      "r113",
      "r114",
      "r115",
      "r116",
      "r162",
      "r163",
      "r165",
      "r183",
      "r239",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r389",
      "r540",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual obligation to pay money on demand or on fixed or determinable dates.",
        "label": "Debt [Member]",
        "terseLabel": "Foreign Currency-Denominated Debt"
       }
      }
     },
     "localname": "DebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationShareBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation arrangements (such as stock or unit options and share or unit awards) that are equity-based payments with individual employees. The arrangements are generally based on employment contracts between the entity and one or more selected officers or key employees, and contain a promise by the employer to pay certain amounts or benefits at designated future dates, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Other \"sub-members\" can be added as necessary.",
        "label": "Deferred Compensation, Share-Based Payments [Member]",
        "terseLabel": "Deferred Compensation"
       }
      }
     },
     "localname": "DeferredCompensationShareBasedPaymentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r429",
      "r467",
      "r488",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r429",
      "r468",
      "r489",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Amortization of prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r429",
      "r466",
      "r487",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r429",
      "r433",
      "r465",
      "r486",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r463",
      "r484",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net pension cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r679",
      "r680",
      "r681"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r431",
      "r464",
      "r485",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r73",
      "r280"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r154",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r158",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r149",
      "r151",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r149",
      "r151",
      "r153",
      "r154",
      "r156",
      "r157",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount of derivative"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r143",
      "r145",
      "r149",
      "r150",
      "r155",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r424",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5",
      "r8",
      "r15",
      "r57",
      "r192"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "totalLabel": "Income from Discontinued Operations Before Income Taxes"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r8",
      "r15",
      "r19",
      "r509",
      "r512",
      "r514"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "terseLabel": "Income tax provision"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of in a spinoff and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Means Other than Sale, Spinoff [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Means Other than Sale, Spinoff"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "auth_ref": [
      "r16",
      "r200"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r23"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "totalLabel": "Total Operating Costs and Expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "totalLabel": "Operating Income"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Other Expense",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r16",
      "r200"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r24",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "verboseLabel": "Spin-Off of Embecta Corp."
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Common dividends"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStock": {
     "auth_ref": [
      "r117",
      "r182"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Preferred Stock",
        "negatedTerseLabel": "Preferred dividends"
       }
      }
     },
     "localname": "DividendsPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r233",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r253",
      "r256",
      "r262",
      "r263",
      "r264",
      "r268",
      "r524",
      "r525",
      "r550",
      "r556",
      "r590"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Basic Earnings per Share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r233",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r256",
      "r262",
      "r263",
      "r264",
      "r268",
      "r524",
      "r525",
      "r550",
      "r556",
      "r590"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Diluted Earnings per Share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r531"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Termination"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r112",
      "r197",
      "r226",
      "r227",
      "r228",
      "r240",
      "r241",
      "r242",
      "r244",
      "r250",
      "r252",
      "r270",
      "r310",
      "r405",
      "r506",
      "r507",
      "r508",
      "r510",
      "r511",
      "r523",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r541",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r526",
      "r527",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Financial Instruments and Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair value hedges"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r159",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r207",
      "r326"
     ],
     "calculation": {
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r323",
      "r325",
      "r326",
      "r328",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r93",
      "r546"
     ],
     "calculation": {
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r90",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r93",
      "r545"
     ],
     "calculation": {
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r587",
      "r610",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r206",
      "r311",
      "r547",
      "r592",
      "r622",
      "r656",
      "r663"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r133",
      "r662"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Purchase price allocation adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r60",
      "r74",
      "r138",
      "r245",
      "r246",
      "r247",
      "r248",
      "r260",
      "r264"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      },
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net Income from Continuing Operations",
        "totalLabel": "Net Income from Continuing Operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r56",
      "r168",
      "r177",
      "r195",
      "r285",
      "r290",
      "r296",
      "r299",
      "r551",
      "r591"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from Continuing Operations Before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r285",
      "r290",
      "r296",
      "r299",
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "verboseLabel": "Income (Loss) Before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r55",
      "r176",
      "r178",
      "r191",
      "r233",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r256",
      "r262",
      "r263",
      "r525",
      "r550"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Income from Continuing Operations, Basic (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r55",
      "r191",
      "r194",
      "r233",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r256",
      "r262",
      "r263",
      "r264",
      "r525",
      "r550",
      "r556"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Income from Continuing Operations, Diluted (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5",
      "r8",
      "r15",
      "r19",
      "r139"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income from Discontinued Operations, Net of Tax",
        "totalLabel": "Income from Discontinued Operations, Net of Tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r57",
      "r192",
      "r194",
      "r233",
      "r257",
      "r262",
      "r263",
      "r698",
      "r699"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Income from Discontinued Operations, Basic (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r141",
      "r257",
      "r262",
      "r263"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Income from Discontinued Operations, Diluted (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r18",
      "r20",
      "r21",
      "r22",
      "r101",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpIncomefromDiscontinuedOperationsNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r329",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r237",
      "r251",
      "r252",
      "r283",
      "r509",
      "r512",
      "r513",
      "r557"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapital": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.",
        "label": "Increase (Decrease) in Operating Capital",
        "negatedLabel": "Change in operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r258",
      "r259",
      "r264"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "terseLabel": "Dilutive share equivalents from Series C preferred shares (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r324",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Unamortized intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r91",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]",
        "terseLabel": "Patents, trademarks and other"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r164",
      "r181",
      "r229",
      "r279",
      "r539"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r180"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Net interest expense"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap",
        "verboseLabel": "Forward Starting Interest Rate Swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r87",
      "r584"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished products"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r216",
      "r583",
      "r622"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventories:"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r87",
      "r586"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRecallExpense": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.",
        "label": "Inventory Recall Expense",
        "terseLabel": "Inventory Recall Expense"
       }
      }
     },
     "localname": "InventoryRecallExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r87",
      "r585"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r64",
      "r278"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r37",
      "r173",
      "r187",
      "r622",
      "r647",
      "r655",
      "r686"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r202",
      "r236",
      "r309",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r516",
      "r518",
      "r519",
      "r530",
      "r622",
      "r675",
      "r689",
      "r690"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansPayableFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates.",
        "label": "Loans Payable, Fair Value Disclosure",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LoansPayableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r107",
      "r108",
      "r346",
      "r347",
      "r348",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r107",
      "r108",
      "r346",
      "r347",
      "r348",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r346",
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss contingency accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r669",
      "r670",
      "r671"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r669",
      "r670",
      "r671"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Loss Contingency, Damages Sought, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r107",
      "r108",
      "r346",
      "r347",
      "r348",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Loss Contingency, Number of Plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in cash associated with the entity's discontinued operations.",
        "label": "Net Cash Provided by (Used in) Discontinued Operations",
        "totalLabel": "Net Cash Provided by Discontinued Operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations": {
     "auth_ref": [
      "r644"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations",
        "totalLabel": "Net Cash Provided by Continuing Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": {
     "auth_ref": [
      "r644"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations",
        "totalLabel": "Net Cash Used for Continuing Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "auth_ref": [
      "r70",
      "r71",
      "r74"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
        "totalLabel": "Net Cash Provided by Continuing Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r58",
      "r74",
      "r179",
      "r193",
      "r200",
      "r221",
      "r224",
      "r228",
      "r236",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r260",
      "r285",
      "r290",
      "r296",
      "r299",
      "r309",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r525",
      "r530",
      "r591",
      "r675"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net income",
        "totalLabel": "Net Income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r248",
      "r253",
      "r254",
      "r261",
      "r264",
      "r285",
      "r290",
      "r296",
      "r299",
      "r591"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income applicable to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net investment hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of principal business segments (segment)"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r285",
      "r290",
      "r296",
      "r299",
      "r591"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating Income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r25",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r217",
      "r622"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r52",
      "r54",
      "r227",
      "r532",
      "r534",
      "r538",
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive loss before reclassifications, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent",
        "terseLabel": "Cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments",
        "verboseLabel": "Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r54",
      "r112",
      "r222",
      "r225",
      "r231",
      "r532",
      "r537",
      "r538",
      "r548",
      "r554",
      "r636",
      "r637"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other Comprehensive (Loss) Income, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other Comprehensive (Loss) Income, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r49",
      "r50"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Defined benefit pension and postretirement plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other Intangible Assets, Net",
        "terseLabel": "Other Intangibles, Net"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Deferred Income Taxes and Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other operating expense (income), net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r593",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other (a)"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherShortTermInvestments": {
     "auth_ref": [
      "r175",
      "r190",
      "r634"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term investments classified as other.",
        "label": "Other Short-Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "OtherShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r639",
      "r640"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r333",
      "r643"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r451",
      "r453",
      "r459",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r494",
      "r495",
      "r496",
      "r501",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r30",
      "r427",
      "r428",
      "r450",
      "r611"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Long-Term Employee Benefit Obligations"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r121",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r480",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r496",
      "r497",
      "r500",
      "r611",
      "r612",
      "r616",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends, Income Statement Impact",
        "negatedTerseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r31",
      "r622"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r641",
      "r642"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "terseLabel": "Change in short-term debt"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r98",
      "r204"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r100",
      "r188",
      "r552",
      "r622"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r52",
      "r54",
      "r227",
      "r532",
      "r536",
      "r538",
      "r636"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified into income, net of taxes"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r26",
      "r111",
      "r236",
      "r309",
      "r351",
      "r354",
      "r355",
      "r356",
      "r362",
      "r363",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable Preferred Stock"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Payments of debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r132",
      "r196",
      "r697"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndInvestmentsCurrent": {
     "auth_ref": [
      "r566",
      "r567",
      "r635"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.",
        "label": "Restricted Cash and Investments, Current",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndInvestmentsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r331",
      "r333",
      "r336",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Business Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r73",
      "r337",
      "r339",
      "r668"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charged to expense"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r332",
      "r333",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r333",
      "r338"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r333",
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash settlements"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r34",
      "r117",
      "r186",
      "r562",
      "r564",
      "r622"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r197",
      "r240",
      "r241",
      "r242",
      "r244",
      "r250",
      "r252",
      "r310",
      "r506",
      "r507",
      "r508",
      "r510",
      "r511",
      "r523",
      "r559",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r121",
      "r122",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r480",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r500",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r121",
      "r122",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r480",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r500",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r426",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r414",
      "r415",
      "r425",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/Revenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Area"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction (in years)"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r230",
      "r236",
      "r276",
      "r277",
      "r289",
      "r294",
      "r295",
      "r301",
      "r302",
      "r305",
      "r309",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r530",
      "r551",
      "r675"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r52",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r0",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r18",
      "r20",
      "r21",
      "r22",
      "r101",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r526",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r592",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Reconciliation of Goodwill by Business Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Components of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Net Pension and Postretirement Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.",
        "label": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r332",
      "r333",
      "r334",
      "r335",
      "r339",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Summary of Restructuring Accrual Activity"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Financial Information for Company's Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Shareholders Equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r273",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r299",
      "r305",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r335",
      "r341",
      "r592",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r285",
      "r288",
      "r293",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r304",
      "r305",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Data"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentData"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r198",
      "r273",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r299",
      "r305",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r330",
      "r335",
      "r341",
      "r592",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r236",
      "r256",
      "r257",
      "r262",
      "r264",
      "r271",
      "r272",
      "r309",
      "r351",
      "r354",
      "r355",
      "r356",
      "r362",
      "r363",
      "r391",
      "r392",
      "r394",
      "r398",
      "r404",
      "r530",
      "r581",
      "r632",
      "r645",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r45",
      "r112",
      "r197",
      "r226",
      "r227",
      "r228",
      "r240",
      "r241",
      "r242",
      "r244",
      "r250",
      "r252",
      "r270",
      "r310",
      "r405",
      "r506",
      "r507",
      "r508",
      "r510",
      "r511",
      "r523",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r541",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r270",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r31",
      "r32",
      "r112",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Common stock issued for share-based compensation and other plans, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r31",
      "r32",
      "r117",
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of shares under employee and other plans, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Number of shares authorized to be repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r32",
      "r35",
      "r36",
      "r86",
      "r622",
      "r647",
      "r655",
      "r686"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r235",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r405",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "verboseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized",
        "terseLabel": "Amounts yet to be collected and remitted to the third parties"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r44",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r44",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Ending balance (shares)",
        "negatedPeriodStartLabel": "Beginning balance (shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r32",
      "r112",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r44",
      "r118",
      "r119"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r112",
      "r117",
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r332",
      "r333",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.",
        "label": "Unclassified Indefinite-Lived Intangible Assets [Member]",
        "terseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Dilutive share equivalents from share-based plans (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r255",
      "r264"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Average common and common equivalent shares outstanding - assuming dilution (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r253",
      "r264"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Average common shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.5)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1060-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r626": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r627": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r628": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r629": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r631": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1063-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>70
<FILENAME>0000010795-23-000039-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000010795-23-000039-xbrl.zip
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M5:34UH6J$:QVF&/VUB51BK8M +:)>"U3Y2]LC+,W510B$U0'-9:4H\?:Y@U
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MUA))%I_ MG!1RH&CA+8F8)6 $#A;,U?NZP/@ZB17[T'T%X0[&4N.+0)F\=P
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M&Z[7OE19^8'N*:>[%?U4-'3ZAS@Z/6!_.:PL3XP@ Y<)XEI%I)GRH)8(K47
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MB<@DB4:&1! )5!3()DX1II@3@6-0 42"A:, "UJ;B]8EJ-8%K;6@=4K'QH*
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MXCP0I+WRB"BAJ'5*B^AF5<!=>XM) 6G=XD$!:4T@G1(*I"*!$$V0,%(BKC"
M%'."&&=61^%<L *$^ :!].E8#4X'-L36(/K8^9BC9(;;K5X<%>/!LD6"7>^K
M2*I77U>^'4=?M9!BQZR)C684S>?8)A$H!17%.L1QI,APR9 */'')/2&.;NW0
M;4Z:I*04JT)#Q88"Y$<"\G1M?.4#U8(C:1C(_B;;!J41*-)$#  \D& SD(DI
M77M6 <8L0O=&_4$G_F"@T4-5H%4^HTY)49)G2C1Y1X_L"#X(1%CDPV7+A]?@
MN7IE/WU=]BK)[E6$68!R6NZ/.>Z/6:5QO+<2:VX0"(0$\4@,TL81%$6B5A&J
M3(A;.TK75?*LB($-Q&M=8F#!:]UXG9;W@HH,-@<E90WB.F+DHC*(:6.M-P$T
M.09XQ4UR!M<I[35>//BS/_C0ZO1:%X.^C\/B5WH\(2&O_&'OY7C="^O\,.O,
M]C!A8H0#*2$DQ)54R"EJ40R!&*MS)1.ZM<-ID\S7Q<?4="FA +8NP$Z)"1P#
M)+&GR!"#$??2(&NU08IRE:32T7"RM</,!O976@\QX46GUQF>Q9#EA'#I?S
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M&NG^@OGVP(VL";\9ZW_A[\YQ)L!Y3*UQMD#C7-#8G#:A/.-&!R=08@0CSF-
MSK.(C.(D)JMTP&IMP^ [GYNY)\^REK*G$D]:"<RXERVS@AG+BQE3K3X4,2;X
MB#BF@!E) EP H9$#16*YDI[F/MB&WCDM^?XQXSF$HK:.8C?G_[P=&U'O)HRH
MG[)575.R@RY#/D496$4I$1$85V ?12)B=%)%;HG3\<O["O ,P_<(>*6AP.+
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M>'WV^)<5(G2[X'D 6AX=Y9C0N0=U*UCM9"\WQU!@XB"'PU/ DN$PX]KY:VO
MJ:-F0*MO;1\O7 "4/$[ 3\=5;*Y2#A,O'.2G=*HCWA<>/'N>F4+Y"3FJDW4$
M.%[9 _SIO%1/Z^W!S6T_F#&D:@R]'$N:7N]ZB(T()DKO-,;I"=?QN K I[Y;
M;WP:6P;GIS*X:/^<@#2=V7AY,F.V&KNH\'<X]B-/]FSXYV(C/PD[K=K.S6@4
M6!P__N(81A$X"[+=!L)6P9'4 97IXRB>.VZP!0Q^/CX*AE+[HJ*^7-M6]L!Z
M8[S_?EW8[I+8R#G?/AN)M08--3O=)#QR<9NL-B5KKW>D3B\0"T2H'\?0=AZX
M+LTC>BA$:[0/LZ+N QW69PWPP<91_6^Y@T3KC9L$**[25[-VZ)]S7H6Z/*_B
MH5,D9OK5U_K)DS$ R3VF003MX#=.'3.81^U\4@X^-9?ZU36+W&\HZ*/?C^&X
M$[?27$&A]Q4VGNU)O[&=O /T<3_&X>MN^!D;_AD\&CSKZ-'?7S3F/ *'Y*H7
M!'&5<HLMZ5%,D7#&C)!B*GKD$MC3DABKM +."@Y,:LI<""99;82?C!X]BKAN
M9F>Y4VG,>]85U1-?MH> 4?X& ZMYM'9<+ZGV_**1R_[ R+?M]T=5=%74?C"R
MMP8OS[!H,NAWM0I\-0O"9V+8M9RU\>]J9^.G.JD2E&$].O9H$%^.?WDU3M1L
M=ZM953>]&HUJI(,R\$Z>],OCK+\>8;*FZPR;#,NCE-31BT>(O5XA]D2^=?V=
M5.M4LTN_QNOD_'<WSTJ]ZBD3WTFM;_K^&T^+L'5-+__ZZ@$]RF!O/*"'3F6>
MHU?R=>.04P^=<32H%KV'.0*CK]M>PG6((CLNS=IA>9<=ELKD.0L%WJ#/]1R+
MN%)+\Q$\N1LNS W9[%$/B]ULTLTZSE8I[9"AO'^35N<W%](;G6>Y2>OR.<[%
M+#>;94/\)MWDR\+=;N'N58&L?I^V#_%;!-MWP5(^;ZV7Z^Y[MB=RYY[_TSEP
MR[0RC$@6>>*&)J-5PCH$91,5(;$ZA(')C2O[70AC7!W%& G%LIRHO6UD8G2B
M=N_[UN8_!\T?^X>[!YU\S_>=S^]XB_[-=K9_;S?_^.=@ZW/K</=P1TR>J-W:
MA.L^-W]L_;%[N/4Y1S-^W]_9WF.[FV&_^?G]R>[GIMBAN_FYJ=G&/ZK3M!_Q
M]Q:,H;GMO]C$2 R,("TH0=PYAYQ3P-S:8N.99EX: '(YW91SP4719RBWQRQM
M5>"NP-T$W 6KK:.)J\ L5]$;Z7%(7#C)3.)!SUW(M,#=?<,=F80[)2.37'JD
ML8R()V*1=DD@XXW+I7H8]71M0[ [5VQY7+A[8(OZ=B7#'E7NW_8&5?#X;!L=
M2!/NV<)^WBW@5\2PS(PQV$I_]'IA\!%XHD#N/)![.L/"C,$0*BAR1 3$A?;(
MI.01QMQQZW%*,:QMR$55C%^B*E=%H)?!="H"?3>!GK*AN'?:@VL(8NRR#:45
MTL0KA UEQNMD W6YC19;>HDN@<<K!?QC['3&V9@V'+:[.=.R/A8V.C;YN"')
M4GYZX0;35,+]U=@ZXI _ZB/C5?;0>39Y5W-)0=PY$+?U=H8)19*)3.L<I'.(
M2XR1$[GKCL62"$4S'J]M\#N7O"L5YI=7Q!=F0A417P(1GS*J/ .*2HE1\+FX
M?*(:V=REU%'IC5%*44/7-M2BXE)/QJ9:M6KU'^(@5@DJU1&=^"UV>D?5B9&'
ML:B*Q[KD%M5@S"" M)L_V:/ ["U@]N.T)64(-<;("$0S"7$=,LPJAFS RB46
MJ>4,?-?+SC@NC^M:1'OE+*DBVHL4[2D+2F!N<<K192H#XEQJE*OT(4(,PUA)
MH+18VV!W[LVSVE&IY2L-O2I7/OEPWU9UV/GGD=Z119HK) Y+H&\Y=-<"S-(!
MS!=^NZ42JYAD:\PC]3&MD09KQ:5IEKL:2FS&9BGA+!D2%6)6&<0=B\C9W&A.
MN,09YQP+4&*\]))\PC*^ /NTR/CRR/B4H:HQH]1AAE)(8*A&8I'Q7B%'<'!*
M)_!$0<857WH9+Z&^*T5^NS>TG<:9'#6J1(2ZPD\M3/=]HF.!$8&[I3NO-!P_
M9C+:&?.4(,'\V+LU8R=5.*"FD!;I #^X$@(9XBGB'@POFX*B"<2,W!U\YY6;
M%8H./F,L>,P\MH(%=\."Z;, ).J\O8H$-=D.LZ.,-L9)XMB;:%GN)4C5:F/!
M2D2]'A4 ?IIHM:^S.L&N9PS%2V&6U?SRW]Y@4-!X'C2>L3,;$[4F48>(B@9Q
M'#ERH&L!EQ4H78%E8B!I>L4/9A4T>,*&64&#VZ+!E&UFG0L4(!X)31B@0:+(
M^2!12B0JZ2*6P:UM $57&PY6(H+VJ!CP?J)1T^J$S%80<']9$?MKS!3%$[[%
MB:[MU\/F*?Y>(>[VWZ*Y_8Y],0:\74L]LM)*,+D<0X:J?*XK)"NXP);0M8WI
MH-BORY,U4V3Y]K+\F-93D>6[R7+KXX0L1Q8QYQJCH$",>2 :&1P"<B(FXAQX
M65HLN2R7#+BEO+(L[+(8\JN66GB#<MZ--S'U^G$4@LU%O1^[XF$)O3R:(S#+
M3!C'5GX')IIY2<U ]87 /L62F,N2:,[P"L!X(,8GI, 41%RYF(,P!D4J@R%<
M:I$WR/2=ZSR4D.Q3Q(7[<"H*+CP"+DQY&(XXKQV7B&NN$(^1(!N20)@HI83"
MUHB4BS_?>>.\!&>7/3C[LT]I[A\W !J7 .URP._#F&6 I^^J/IA5#ZKI[PO8
MS@6V?T\;8=I0IB*/*#CXP0,WR(5 D E<&.EPJ++%22F?]X1E^6%,J2++"Y;E
M*</)8^$))P8E8C3B@D9DI(HH:C"B<&*:)KNVP4KAO-7/*;QE [NE[NTQZ@G'
M@)5"[SAWF,OK>+EY_HSJX-]M:9Z,HEJXT7D#]WX 4K250(9>#^L^X+F-X7;O
M0\R]OW.Z/-PP/"W*:R[E]6G:$+5<,)L$1YX[C[@/"1EG.!*:.T83#B;1M0VY
MJ&.+BQ"LU>@A4F"UP.H#V_\%5A\+5J=\ AD#HS0*Q!G#X-\;BPQU&&%+@,X8
M.TU2/I&XX%V6)<+5!3@3OU7<N5$MT?F&R8_3$;HFS/3/B2[U4V.]II/\="?H
M:[O3-R[V)(\\*!>9X-$*KAD!,+&86&E8\(YP^?!(6'<A/^[GPU?#_0C_Y6:W
M^8S\H/V]<=BK>KO&W-NU4?5UK1>2D1>-#'0OJGO>]@YAT*>-=M<?]_MPY;]6
M)(VUJK-QEO>6>OU#FZGT??BR>WR(0F^(1B]:=93MQ#\_G.Y^#D>.<KFSO;_?
M_/'/8?/SN].=PXR8, ,8[^[VZQ^[A^]Y:_O=R=;V[X"X_Z3FP;OJ_<T?[\G6
M9O-':^\+$$R+(!C27$K$A1(HLRY*Q!/JK19<J=S!Z1*X/*R[YU8L-JMK_*7!
ME(<2AGF8]U%/O13FO99Y7^/6R9= ?8HR!92H38A3[9#U6B*CB70 O9Z%=$5E
MYQ'#OFCTX^ H^EQSNW/Z8A;K/A2'YI#5(![9F@^ (P?#P8N,OC6W ";W!C%S
M1&;6P7$G6XLO&IVX9SLOJKW"+'N]JMB<#=_:@U[_%)[7_];V,$8[&/1\VPX!
MQD_:P_T*X ='H I[*;UHG.RW_7[C)/9CXZ@?O[5[QX/.*:R,SV9+?4>[.U.N
M%[@XU1-?MH=@X?@;+-<E9?4:O[0K(_S7"_7U'H6>EV'AXZW99:=^'F-YUAO;
M^Q'H90]!*PP'-?<!RUD8GAT CQ\>@3F:O^FEY5K%QBV#T(_#A /03$/;[L#P
MK.M]NV^:S[F6ZX^Z.)D%SQAPZ=ALLD%Y 3%Z?8O)I?!49[N5U[N)-:2$\Y#2
M^YG)?5&.1Y;!!8T=.^W#=K?2\NT,]7[DP@W[,)G:_!F ZK>P?G[DU+DX/(FQ
MVWBS69=0.W1@#-FQ20#* @R-ZG$-"W>V^P&!A3($RP)LS_QI94B L=N <;9[
M87V: HW\OXL^>O;(JR7Q!I-(=;!*)\Z9MXX)R:TR!E,OG/O"U-KYFZ;=>$(K
M/_Y^J:QF4KG5&\8&:_Q__T>#,_"J,7(P6L>'\#A_T:.0U"M)M:+."4X\=\9R
MS2FVP@6O':[=X;%'P6J/XJ(/\7'8\U_W@=5C?_#N?\?MX6E^?U8_G=[@N!^W
MX65O.G#-8[L#IR-WX. ]V]K\>M+<_L]7,.M):_MOWJ*_PWO^%LW/\*[#G>^M
M[=>\M?D)3[H#S0//\SN;AW]_W]G^1%J;>VSG\^_M5N4^?**[!^](<W,/M[8_
MI.:VS^X T<PH*31R0'3$)77(^421Y5$SZ0(-CD[&;:R5BAHO,9:&*\E<TH)$
M'9(@R1(%_E<$'^L(B##L'\>UC8_[MA]')/B_C9H(8_=B1/:-BXP^$P>N?^W%
M8>K@;,*"X.@E#S(8ID+"$:M '(LZGL6\[XWU_'X,QYVXE::9<+N*7S]CWMMZ
M_<7'**.F%A'!/.+:1Z0)B<B0H"C.1P6#F"0JT>"].BI82IY3(:VWUGLB,-$D
M&9,F>>\2^),/@'Z7J.%]V]V#QX$.\+$/FJE[T69O#"Y(2ZRXI7)?L\I([3YH
M\>%)K_&_8] G<$F^);5S3*-Q&BW\G;FQTDF9/VOW (S9U.MT>B>#E],*97IQ
MQ,7M.Q^S3H3EJJ+:9Y&I.C0/R]:Q1X/X<OS+JW%4O-VM)E_=]&KT]%&8/[]@
M\C!8?E_]]:N3=ACNO]1F74F9K8)1;L[HQ?6W9+TR&":V&>KOF%C7ZO*O\3JY
M]+NK'JO7I;K\SJN>>O5WDO!G/E900BLR5@(W,K4B@UTM)L#T9NLZ2M<;7W &
MKA6BS]ZH6XI,/7VC;?C9NZCGY]0'&)_(0[YB?C5X/\P,U77F/Z[]T,/#7O??
MKO_;1F46U3-NO!\,0,=7']MA_=E?ME__\H_M'%]9:N>*-;DTC?LI+*4]RNX_
MV!+5NKW[[N-@4"]9+U4?E26\9@D_Y.! =\1X[VR_"R._\J#W,UVGS9AB#GQ4
MZY2WN&-W4/EFBUXKLYKKL]V/=G#</VU4F'9A468K+$I636'-GO@OS7I'L')$
M0G8"^H.IVBVSTA?G.$6YW*2OPALCV/UE!,7#_=XQ/#(L;BFN I<GMZ2OJ[V%
M65+T=(N2O+$=V_7@K \;'^/1,!ZZ.-+=#-?Y1?=V4/EI9^W>8/Y/)C67"L6C
MQ]Z01+AGR3 EL4PJDF2-3^G+^RKSQC!\=>;-=,!R>?)F;A>L'*76[G[=VOS0
M:=$F:VZ_.]G=_/M[:[/)F_0=:Q[ ++;W3K>VPT%ST^/)U-K6(3S_CT]LYX?_
MWMQ^\[6U^0XW?^S]@/&=M@[\]ZW-]P*>>]+Z\2$UVZ.TVO,5I;DG1G.) C42
M<1D5LI@9)+7DW ;",$]K&TR*U2Y3<%_'$@J*/1\4T\(8'2BW4F)NC=**4*]#
M(L%2J[RY"XJM1&K@:D#<5-%\S ';;.X=AYU!7 6)#-$"A9#WX$R";TDN#O!"
M7)H06U"NH-PS0;FH-:-<<HI%Y#9Z$TSPV@<O<V*+H@7EE@+EICN[$R=<B@XE
M31GB3@=DK4C(*["X!0_8: DH)UX0L>(EIPK*%92[\V%1S1060BI+)5?2&$XE
M\5XY8:D(C!6/]*& C$V9:\XYJR1%.7LI=S4QR#JA$>/&*NQ#SI9:VZ#/S51[
MS@4U+R_37Z4E#2;#38G0J)GF+"EN,;51D&A9D$Y;:2F^1+C9I'"/=T\J(?\X
M>M--;!A61/\FHB\F13^ H6+!SD2":(DX]1)I2RRBF%,@'S;.Y%JZY 6=44_W
MYJ7Y5TSRB_GR/,R7>9J1W!+BP"89P#SAM^*N/6S<O3E5YLY0IFDN5*DT19R[
MB(R@#HF4;&1.X<@(8-T+QO *0-T#%?)]O'W0? "P?77CVZ=9@;,Z$$,GBW,\
M>G'%4BBUD&D%R32'BI>*>(^-C$SI'**P@K! *!7:<DN9OWC4!XA_7=T*@+!E
M;+ZZ"@K\=#K>J@E3S'.!+'4:?)48D1/:H,"S#P/:G3"VMB%PJ3F]:C):H+20
MJ9#IR9#I05,TJ_.+C[',]?F5!KR_'6(W#!J_7%DCZZ_8KP*:$S:'\I1%SFVT
M3/% DP-=QIRT,40;/"'7V!QTTN2H1U7%%C;'(QN_>C/Z#OP3SBP17"R1:RV1
MUEM\,F&)? M__,/#G__I[-+.-W?0RQ4YZ<YVZV!W\_WWUD$3[_QHM7<.PGYK
M<X<V?_S]8^?'.[RU[7^T?M>GS;TOB44O/3/(,&L1=X0@BQ5%@EJJHO3>6K&V
M@=?-=!OY7":B/AG\Z\43O+?9M'@VV#8;7U9E;ZF0J9#I\>/?"W>.S]33.97U
MU@[VBY\\GW::\I.9($%HP5#PC" >+496*9QW]R.SR9I(Z=H&%=-^\MQ1[B*J
M!5$+F0J9"IG*[MW%%?ZK/SHH_M-!+MMX)5I6R%3(M,*NRAFJ5=Y*\53F\50^
M3GLJ7 @K-=<H&9<0!]\$:2D<\HR17,5/RDAG)A[?W%$I@EKPM)"ID*F0:07V
M\AYCA7.]N:K>RKCDZ@!,BQ#[C7AXU.F=CMH^U7U!CCHVMR8XUQBC^,LEK+$\
M9)K'2+:$R"# 4K;.<&JC$TDJ%9).Q 3.;V(D7Y787I=QK%NH_565MJ\J#U;[
MT&_L((;SM>.*(3V/(3VCX$).%7!4":24XXA'')&.PB"KO%1<!)627-L0M$3\
M5T>8"^86,A4RW7L:^,SSK$1HJCT+.!K"E5(&6Q&<]()Z)J6_5CE.'6R]1"?6
M1URO48KE;.N-E.+4V5;G,2>&$5"* I2B$A)IE0P*WC,EM-&$:U"*0B[H7'L1
MYF6T<^\JRL7.?3R1GC[#R7+/'4X%PCR? 8G)(2LQ12$2CB/7E'F_MK& H^IE
MD_<&<EAQ.7*9S:OF-=?6 B]!NA)+73X3\%Z"(Q=UQ>MP<#P8'N;>3MN]U[!T
M>02V\Y=MA_?=4?N&2IK<I,[XD#L_#=K#^+'N15PKF0_1]_:ZU5,J?5,TRSR:
MY70Z@D)X<(S*A***"7&I%;)!"N0I-T)2,!4L&(NZG"U<-:DOX%S(5,A4R%3(
M5+:-%W_Z<Y!C (W]V*E:/ _[8.35&\2-7^SE+5^>9E2F1,(+F0J9"ID*F0J9
MEHU,<]:S7<#^W\2F@0O?S]=F^!,LAO?=[<I>:,7AN-1MV?&[<1!GZ^WTCA_'
M+B2K+:+6!L1]#N)0A9'G6''AA-3>K&V0Z;(*)0UF:27WT0'V&E=FW.8>V"E>
M3=ERY6I>61C@F5_YY/=QS[4<W8R^ZCC:8&3.9J.C25]:^/A)%T:?;_++K7'G
M2:Z17$;I;50R@IT<P=I2P0F?/(LTN%'KJNNW1TM3E[M52QW9P1=29:PFFA'#
MD#"1(\Y\0E9A#C^(H"P:+I-;2)_1N7C_D>/^!;T*>OW,\M"&\R@5)\ISGJIN
M1Q;<?@8X)C'S=T&OTLEA@=!V.@%MQG$KG'.() E^?K <.6<3_'!<,\NB9Z'N
M+VJF6SD4="OH]AS0#5N,A=%$LDAXX,XJ(24C@@<AP%R3!=V6 ]U:DX8;46"K
M20^6FE,2<6T,,D:)G.@<0F"$6FFKOJ),\X)N!=V>)[H9@#4OJ2!@NDDCC4U1
M*":EP\D$GHKG^7  -FF>6<9) /\2.9)R8V1ED!,J(1,-(03<4F75V@9]5N U
M3\+9'8!L^61ZSIU7+;6UC/@(\LVQM-8&G614*GCIB,:7R'7I)/K04K\UU5[/
M.H%9KF5/@T=<P6^:>84L-ER0Q)5S;&U#XQ>*Z;L7]%H)H2\6RU.W6.8YB7I+
M:"L=1!\M[O0SK(ZWMM]];YU\\2K*Z*Q&0,R$> P463 ^D=01 _C!!TG7/407
M4+3P?C'NR:=HW[&!:$F9*9E-A4R%3'-H^)""P-H0+(/@0@DG!;<FJLBPCD*S
M*FV485*GC3+,2@/1^]/?[Z<CJ]%$0HPPB'FK$"?:(^,$13K2$)/QX**DM0TN
M[[QI5(2T8&DA4R%3(=,*5,Y9\0ZBU NN'-8!*\\]X<:R0 U-5 (YG)?7&!VE
M@^C]FR+-8?/M15,$GM>)?WXXW?T<CASE<N<'7/]CAS=_[![L;'^"9_^SW_SC
MG=CYO-MN'KQIMS9A_C_>T9W#?U+SX/T7Z;P#^H:\*1P1]\Z!)>,#2LE(YDER
MD;A[;2%:SL8_=G"YD*F0Z?')-$\ ?.'N<6DANB#U-.4I&TYY%$(@;G-!<1P2
MTH0()#&UB3M)-?=W[2%:9+5 :B%3(5,A4]G N]<>HB404^)EA4R%3,OAJY0>
MHG=P5?Z>=E6P8MQ:[I"T3".N(T66&XPX%4H)3Y)A_(Y-1(ND%D M9"ID*F1:
M@>V\QUCA!VPB6ASF$M=8&BM9^Z04)=9IP7A*S%@ODC+!&^TQ4_H&5G)IKO0X
MEO2GZ;(*,6#G),5(!!H1SR?XK(@,$1T(BTX'ERO&J!+R7QUA+IA;R%3(]#A-
M1 5+WGAF$]6)JZ2L,S$0;9@SFGAJKU..I8GH(RC%J6.MDB@O>*(H1J<03XH@
M'9-&/ @ED\!6YM;:=#K/J@CSB@KSM)E[5TF>776B6+?W:MU.']X,D6FB# :K
M5EG$(Y#+$&Z02=H+2AV+FJUM+*H>8MGBO8$0+K2#:(G0E4#JLJB,!41&2@?1
M)58P.]/A$\VEY"# 2'#J$'=. + QB9AQ+HD@P6H@H%Y*N_E5$_N"SH5,A4R%
M3(5,9=-X%5J(KFY,IL3!"YD*F0J9"ID*F9:-3(^T^5<:ARX\=N-G[/)A&;AA
M FDL=>X<BI$U2: 8@##&<DLY7MLP=(GV!HK4K@2X/ODMG'/- YNV[_?'G0/9
MO$[CJ-QIO7PO&:QWZ!V[3JQ+GC[/6LF+7)KE%M1Y>C_P"'K4*L*2YIY2PU)P
M@26L0Q#1F:J0\DUWX4OOA]LKTKWIKH,T::,2EDCRG$,JC )%R@T2@01"(Z5*
MAX5T'5R@9#QR(+'@8L'%A>!B,D22*$52C',:P&@%>7/)1R:#%S+<!1=+7?D%
M@N;DSK'#CE"G%%)).,29-LA0HY&SD@N/-;B)NNIG*-ETP9V"FP4W"V[>!3>5
ML3Z!$6ES5V3#B=&!ZRAQ $#%B>*"F\N!FU-'_Z67-F&B$9&.(:Y31$ ^@;#Q
M+$G%(O6IZI0HY/3Q_X*;!3<+;MX%-[WV5GB'A9>)6V?A_S+F_UELA NZ^.$/
M!XV3)B5QD0JF-?+*),23CL@J;_)93DF]<$ 5L8@>C$\'%N?)Y[DWB%P^/)BS
M?R/3U#L!WF84F!-IC;1:@FMC+ Y!X\MB<Z5_XT,CQO06F#2.FT 0V+\*<<LY
MLE$&)'6((1AKHY=5_T9)IX-W<]=2>@* 4>RH8D<MIHS&+4&S=(9\M C>].%"
M:9T4FG'D! /X])8C8RE'.EDPA@E7CJ6J,R2]2P&-)4#/:S:T0WMPU+&G>7[Q
M:L M5Z[FE84!GOF5A0&>^96% 9[YE84!GOF5A0&>^96% 9[YE84!GOF5A0&>
M^945 _PVM*X3-\8M1.O 5NOX,/;;OOX[1SK;W>.J%$W5;'?\S%&XE(NCX:NC
MWJ J1?.R'SMPY;?XZJ0=AOOC/>ES=XUB7OCG+=8->IWCX>6WG(MO^=@=QO[#
MAX1I'I.>Z+=Z[N=^?SR8([L7D>M'^Q79!&-]:3LG]G2P]MN%*1VVN^C\^DU.
MO9[@QK]='^Z;\=8)NM117QV<35@0'+WD00;#5$@X8A5(KHTV:CP,]\3P.@>2
MB<,Q8IUX#)Y;&PWCPGI)&$N26N_7+GD/T2E*1P5+R7,JI/46KB8"$TV2,>DB
M]0YM?P]FFZ.9\N(^R!DQ*Q[\R2!5]!.(VK%'@_AR_,NK,0^WNQ5IJIM>C9X^
MXJJ\E),':_+[ZJ]'JZS-NI(R+_0(_48O'M%@O:+!1"2W_HZ)=:TN_QJODTN_
MN^JQ>EVJR^^\ZJE7?R<)?^9C)9JMR%@)W,C4B@QVM9@ TYNMZ\@@FE!OA%:;
MQK/5ZIR'_.YG0U/?\"#EK+R@\W/J]TXF$VBNF%\-W@\S0S4Q0W5%/99*95;[
MI_6,&W69UNIC.ZP_^\OVZU^JRGFW7)-+\X^>PE+6]0@;[7HYWWWW<3"HEZR7
MJH_*$EZSA!_BT,*'->.]L_TNC/SR]I?/=YTV1]WTJG5Z>Y,2LK=<*[.:ZS-.
MI&M4F'9A468K+$I636'-GO@OS7:G WPPR$V90G8"^H/+ZVF=RP.[+'MB1@+%
M<I.^3INL8?:7$10/]WO'\,BPN*6X"ER>W)*^/NP==X>SI.C2N3^E @\?X]$P
M'KHXTMT,5Y4>R"W3EZ[GAZ>=_GB#^2]WCN,\9Y.EH<0QSD*,W&/FB& J6>]U
MDI'H^HP=P8;AYWE6Y/"?K[O;>Z<Y&[OU1W4/;OWPHOFC==@ZZ.PW#_XFNX?O
M3UH_WI].)B_N?O[0V=I\_[VU^17&](FT-O]F,)<?3;I#MSZ_.VUM_G.X<_":
M-0_^DYKM4=;W1YRO_][<]E]$2HRGH)'53B!.N4!:DX@((]KFXY!&\'LHV7 C
M;; "^=T%Q9X/B@FN&-=1$,\5MT1:Z[PEW&"'38I!W07%GGQ^]L-!W(])B/-4
M2""<1BPY@[A6!#GL/4K8*A8PJ"5NJP(+5-VYQ%M!N8)RJXURE ?A>'"$,\)E
M8 Y^4\%PSG3T)(6"<DN!<F3*D-/6&IL,8D)2Q"55R @1D$XNVW=YD]4!RK$7
MFBZJ"4E!N8)RRS3Q.5#.8"4B55@YQ[DST3F+74J8QN0C%K1XI \%9&S*7+/<
M>$PPTB1XQ!78;$8[C5*(+C!CDO!D;8,NN*;+TH/8V3-N7J'@EH"V?((]9QD"
MBGWRS'AO8^1<.JL%58(RRL!Y4Y1?(MRLE"%X6-$7DZ+/K,(X:'#2,(M@P^B$
M0-P%"CXEZ[#CRM95"(B<KEURVW.T2R_YQ7QY'N;+/$4#;@EQI6C 8\7=IVHE
MBP14]U(CRG/93^,$LA%'I --0#G!L=%K&^J%FF'I+!_4/?E^7:TX;+2[OG=X
M>;I2Z:%06ET4,A4R+:K (@LAN$2D=(PGHZW+SB]/WK%$HXM5$R$"CZV:"!%"
MKZNT"!#VOD*P__8&@Z+ YU'@I]/Q5LMH#)%JQ#0/B#,*OHJ1 44,_UBJI/-L
M;4.JZ8(_14:76T8+E!8R%3(]&3(]:(KFV>G+AU[F43]A>'\[Q&X8-'[YUU6V
MQE^Q7P4T)VL1,IFTYX["?]Q%;DD0443B!3<J$'V-S4$G38YSO0LWQR,;OWHS
M^@[\$\XL$5PLD6LMD=9;?#)AB7P+?_S#PY__Z>S2SC=WT#O=W?QTVCIXS7=H
M\Z1YT,2[!V_:6Y\_\9W#3S!7^(Q^^MXZ:'5:1)\V][YXKSSG7",E@D/<*XLL
M!Y.&<!PI3D90*=8V\+J>MF0:1['?J$+POTZ<,[[%IL6SP;;2S;Z0J9#I;O'O
MA3O'9^KIG,IZ:P?[Q4^>3SM-^<DXB*"P)@@3Q5&=:FZE0T28? " 6"5H[D6@
M[Q[E+J):$+60J9"ID*GLWEU<X;_ZHX/B/QWDLHU7HF6%3(5,*^RJG*%:Y:T4
M3V4>3^7CM*?B7?+>I(1<$!)Q0@FR)#@D-+>)<Y>LI#,3CV_NJ!1!+7A:R%3(
M5,BT GMYC['"N=Y<56^EE^J-E0&8%B'V&_'PJ-,[C;%ANZ'1&^[#1T<=>-&+
M1C<.;^7+%'^YA#66QD@VD8BDA5'*1\Y,,$0:I[1)6#E!2+B!D7Q58GM=QG'S
MN ]+^!?,IA>JRH/5/O0;.XCA?.VX8DC/8TC/*+@0!6,AJ8# Y^&(!Q.1=0(X
M6N.@6138.+>VH4B)^*^.,!?,+60J9+KW-/#9YUFE@]N4M,);3IRQ6A!!C126
M<<?9M1&DJ8.ME^C$^HCK-4JQG&V]D5*<.MNJDN&,*P$DP@)QPR0RE%)DE131
M>5476E-R426(BC _NC#/.+9Y1TF>77^B6+?W*,C3)S=-9 I[%9'6R2/N(D;
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M_)":!^^_<"&BYEX@RV1 7!"+C.4$><9XH#9$A=G:!E[7:LJ4:1S%?MVRZ&=
MHA*!4CVA%+DH9"IDNK_S.HMVC\_TTSF=]=8.]HNG/*=ZFO*4A>%6&<61U$P@
MSIU$FE*+?, &6VLE==46OBYU@U9'5@ND%C(5,CT9,CWY#;RSMND_7>2RDU?B
M985,A4PK[*N<H5KEKA1792Y7Y>]I5T71Z BC$N5N7XA[:I!-PB$6K!66"\9\
M E=E^JA$J0*RM)): +60J9#IR9#IR1=0R8T]JPHJO51OK0S M@BQWXB'1YW>
M:8P-VPV-WG ?/CKJP(NJ?BBE%TJ):RP?F>:QDKUC.F*CM':65ZGMVAM"O;%)
M$6;4#:SDJW+;2[_<^[.D/TV75?#4D1"918$XCWBP"3DK)"*,!&V)4(%[L*1)
MB?FOCC07T%T),LUSC C+Z## J<>1&YF<LM1P%33VF,A YXY,%*B]=ZB=.B(M
M;*082X^D%PQQKCC2QBI$+-<B<*N5,VL;TTA;Y'A%Y7CF8><07- 24ZFTXU0$
MYU3$T1J5A$B.N^M$>>K4\R6B7)]_OD:6R\'GF\GRU,%GSJC@B5/@*)\+[?&<
M*Z$"BHDGQ:US06HPF_2BZAT4:7YT:9[6RG<5Y:*5'\$!FC[?ZXR4DAJ-@B&^
M+F)@M5;(D9A$Y#$QG1MK+),H/_DT@(K;P1,%=L^=F,[XO>0"E&#[\I'I8:-G
M%W7&ZW!P/!@>QNYPL-U[#4N71V [?]EV>-]]:X_:0]NII,E-ZHX/\7_'[4%[
M&#_&_K>VC[6R^1!];Z];/:72.T7#S*5A=J9#;-R)Z)FQ"$L;P%84$MG $I(B
MAD@T=2J?0!6R'$!=,;$OZ%S(5,A4R%3(5!(+%G]$N.X\NQ\[H='N-H95B_0J
MA:#QB[U=-]K5#<J4':V5(--C^$$N?#]_?/U/D)?WW>U*6J;:[A47YB8NC)]V
M84R27EJLD28J;UT1@K3S 24B%+:282_B JO[%HDMP%K(5,BT:F1ZI)W@*U1@
M*P['A;#+EN]<.G!JRQ<($[@@$CFK)>*,<*1#C/ ;E\HPS0TA:QO39:Z+T"ZW
MT,Z3^[J '=^)W-=BOMZ#^3J]QYLXT\0F@3BX&(@+&Y'!V"'B%7P.HBM5F&G
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M%^&DM2I19)4+B+.$D75:(8M]B(H3@Y5;VR#XDMP58/!.9H*:]B\:)_MMO]^
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M\,#.U2U:GO[2O(G=F-K#VEO[*_=\7L;%N+?I7_ ^'F'YW]K!?N-W,& :?\8
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M- Y>)L6TY,E;&S6H>!M8PBSP6)]1F ?CRQF%Q\+X&15RDN2$!HJ121PPGM.
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M[YT2*F#*9<(N-[USW,@8.;$RW4#<2\7FQY;OJ: #3I2EB W2SB3$B6=("R+
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M["G,Z07PJKP/MM>!P^=A329P#3SG".[-=S43SF/, H[MGV_:Y >?NZ$:RL$
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MS+&%T^EBS(G6,T;T%+;/;]+V5<AP\?:M:18_OWUV5*Z.7^+0=T<YH*_K*PR
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M&\7M=#(\;; &Q Y7S._C3@FN/K:]U!C-*W?&J/-3)8&4,-RIA#+Z)SPMQZ<
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M*Y'STUC$JM[6M KT8M'C[GHT*Q'P+_K]W/#RSYB-?J5T!<B8'8+1_UMT\8U
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M6M;;YH]<DC_"-SQ_Y)L#.!X.3ZXOZG5'ETMB%1^^D:E>IQ@$,4[[P+V43JE
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M%,0&H5O[UGV1YXKYV7'/L1,.Y681B%OMD*'PJTW&.B> 2DVV;UW8"KTESR=
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M<KZ[B(Q2R@TI*B>Y=6W?MN7;DVJOU0ZR'>2F#?)'B<]HXC(Z:3@X*:RXVY_
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MJP7:PH((9!=)KUE0)C)G(H?@,AE'?N*'B7EEES<R:F1TZZ<&(T#QF0Q^!R"
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MG@FGO;%"!QFA+JZ@;AS?;.A=7O3R4J+6(;I2--#2&D5,:(W-'DTPQ;: X((
MVMF "%H7*)&3_RU5_>*84Q:8QY"E3(XGZ=;6/=PX#:S!<WGAJ2&;!"J"10V
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MZB<D9^=5R;B17".Y96KX3$>/" U!9:YEJI4CG.?!)^.MMVA<;K+JRT%R%^P
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MNOC&MD/#[/)B=@%QC(;9ZV.V$\C01B;PM1*Z!K+WA0;FC0[,$--F%%SI6I3
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M=IJ%G2XX;>]3 !>=8D4)8! M,J^%99AXBL6A%I#)8UBB T5M2^$>N_X-Y L
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MXY"0R')BZOI@<"8A"5T:QT);ESO4G7-G?9%#XXB1P+2%STT2QXX9)T*8 OB
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MV<]+>,_ES=<OW]I@P).O5SPYO?IHG=Y\I[8?<1HFIA,Q;A+7YF8<>L0$>O&
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M"[/0P/$YX8[I.D%L$G YP&#U7#-Q7#>(71[X4?3BC;OMQKG:$V^*R&M%]T0
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M6 @CQA$Z3RO IQ"$\Y/C[R1PO,A-/--*DL@D,<A &,;$9([%.+-BAIB3*RC
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MZY<W/#_K'67M$FFFS%F0.;HWLHA(3+QB68>$^0TRH8+F:3&VD2M_N:1//>4
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MS#FKFO15X?>!!"66W5726U/&+,K,I,)(99^WZQ0#&+'H9#<KYT8T(LCKJE8
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MK+[S[E?:)-*#U8-]M,'ZZQ1B5A>4.LF] WEVC<(/?>D37OK09E^Z4E57JAY
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M=-I#PRED>^N&S#2)GII$X;HPP_N7]K"[;?4X&:!1LLZVNJ*AHZ'CGSUTO/M
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M_)<_ R$/VB?V1A[.ZG$ITY-3/%+?/(:I/Y1:3\LU2_]9^2X:WZ,;Z2DS$3Z
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M,A[0 !^=SJ.HKS3S:)&1FL8CC5[EHPT%)FPI:S$-U30))4;0YY7A=4S@TE[
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M_AP+$B=(]RFZ"9:/Z05UHZBBI>.9OUK:SD<7',R":\X/(Y=?'MKS(!CT@=K
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MX@/Z%8R8#Z(?L=?34I6=J-RG*8$JX?:&$4@)ZYVQQO86"O@,D:&I3D\:,-X
M$S!4@*2>@7''N>?+,"0\ZVH*9^FT%5:+XYR4+K9=VY!#*2G]@S*\$KRO ;&X
M(\138 1%I])\^Z4Z_J!!6LJ(P7HFW^4+Y&(U>!)\Q:/J(LD=E+<922^\\+15
M6B=K O$19%2AGXS#])ZB!;!34$*QAY L*ZG$R]'! +AL FV1/,.L73@:Q4*R
M/*^MYE 8S*.DGBJ?5#;AG+PB]O:BX1F:G+,<1<<2S2-Q85&LP0G6C> E,'AN
MSO666+=HJ7$X,K$+096M&&=9B!U[0<71;'%%M.OTH]!%XQ2+0GR*"3%IFKS5
M*!RD=.T49(DY8"$L49M3-]*TIF#G0O_@RL F*'P(IK?]23O@@Y\D+KRR*5+_
MW>*1X@C)"DN6N6H@,I4X,*DPH#F/E.LPA+-/)$B%T.D6BI(VFWVHQP&O"8)N
M1A$'U>";%!!@BG$E6T_$D$)"*F2)J[6R[HIN=%DSO(R# '82GG"G\IT$5PFG
M2@$H^A0FB9)]I7F%DHFQ.Q*90!P_:0H_<9B34.=6<E.'BZ7HEM>"XHCDVE+>
MLY6784@Z*:"F7]XQ"DVZ<^A Q&F,L *;UPAG!K2$YK<AE#F#)"ZT2,@*TM0R
M3R!X*A2KM,(I&AC,."0I/2W]9HM(C/%EC30K]>\+([0RU[4B8=0LE4G8 QG8
M\8)LA6J<<+D\E7_"\=6TLD#7#I[F2M2?.DF.(2TZ09+\E(W(6#COL:[I&CR-
M">B@FO/I/;>,@/_ 0?_V%64,*0:2Z^91JBB>\\B^9FPB 4H]7#DC$'PRVT"I
M=PR;#O&/<>HQKEB1G;5OU(XJNFM>AP+A^Y1P87CWKE9NBXD S<\,'6?MT @>
MZ**!6<N;@C+63NAA"GO -CZ*[]X@E#MPU1YT,,)=&KW 9;N8!<&U!_@9RJZK
M]@'P_M_30 ;*[[&@,R&<QN]SLL;06J2H6?\FUK)%PN_B-+H7T<PB.SKPI2Y'
MD43V\O)@BK4>L33DV%9JMG5_CE5UR8D.&YG<F3'_7&HL$;*LRL:F/BG3_[W2
M$ I"S/+P[^Z_X><0E. 5+/T6'(XTP;+6GYQLH%!_/\X]X"ZS6],30=[C+:D5
M?, 7<6_$[1>*"[_%G?*Z;] E]R9(6KQ^SB*BV8DX-^<*D1TQ&8N@*H&_TPE;
MC9E5KF;-8GS'.C"3"R1SC2Q;9)9_I $BZ=5=I8&O,E;%+T"Y(XO\";@T< -D
M^BEB4T!X/HXEOI'MVDP.<@CZS*0+X9)):VM^9^,M$IB3(PR6E"?*I'3I<&P[
M%W[DVG<2)=*L7<3@-24:%EN4EA0D(Q=D:YI(3E(=5"R50'6V$OJ#_1)NBNWD
M2);BH5A'$Z5(X\Y9(LX-V_ @8V()9"VVE[ P+)BQ*)YRQ96"%$<IN,KN-]G7
M1JH3,@U(]\82R.4A44;I5#G4RP*E; O #PN%4%;I*V#SHP?49E1T'C"W^$J4
M5JVQRF,-J5><?;Y$KZ'R8_J08DZ5Z&1EH3:8J#V&2\&!@??@8;$-N53R>"0P
MVW>]2:QE\2_OMN>FT=6!QRJOP/:\;"\+:6AE)TL9@9P8)U0S2M!^^%  #=Y/
MW<N&F1V5R@$1&@D9=OGP[N"2-E<QBLP'#W02&4J,U&4$/A#6E8](]L/+Y'[]
MN-<LKA>,TIC3FI,I,.^]&TA! J(*T064A-4!.BY:<TU.1*5SADQ<F0P:2+1K
M4$D?^ 5VEBM+DMIR(?DORPUC NYFEH<<':18,9=*$SF,& !CWM)N@$J^"09U
M-J**-D1OL9XD.YT)'TSDBHJ>3T7%K<CJ7+?U9!. LHD=$VNG4GH-#R(JZHM[
M^JT%,5+*\B.I>_KH1P.O45@UW7WFI(AV3ZF#EHL997$?UH"^?0_H/,!TNP(S
M4#R45##F'-$5FSB=RS86=E+!GL5MN;]EV4VWO\&LI,X,VL@A:I&2@9!E0#_:
M]5\,IB.$3B9/4+2/HI.@SBT$N-.KR';=L3""'-;.Z#K[%#[!MZ_-MQFNH<\"
M/6P.JB*@KZB3@I=0&?-08#K;HY(\.C]C(UEAD )T6]%R\[?F3J?"-;WQ5&5"
MS8FQJ2:!A,&V);G(-7]H19$9PTWVZ/.#F33ZI.UCK7@F$ADW4:O&+<8*?IR8
M6H@34;\'&6IP!F/XFJ\R5?;V&.+^@$ \:[?*,;V^,IZIROLZ#\B*BCL(P)"U
MC5FYP\M.Z^ H%H ("N^R5DQ!N@C:(/&2L>T:XQXC,4;S_D',WQP9DQR%(I :
M0<:&LLF7+O2A8HA$9I[02I;>'[B#;CJ47>>(0HO6F-7"EE-EBM+!ON.&+-@*
M#CBJ\#GDJ*93:CM'V9CBS5A 2S2G,]PNM>.,"P.QY,&T>5$%\6QD\[XTILN"
M(5K8+E@&RKO(]:P@\QS9P^$67JG,MNT:!I8Y@<U08%G!0VZ<%*]S@D 37M8^
MRMVBQ?XY8&R<7:^=(\#:Y4<=83!A115K2#)-4JUX(<@[06!6T[F4UZ_6 F>2
M1I%*"!/*F?W+B<OBF<F4_Z5) 8OP)D2,F?(HY0 N!LN]/OA'NX)_K-?C+Z?J
M==-$#;FN*7%#RDG%#JP"@%S*"]$@%&E.N?DM58@9/T'I/H-N0EQ_QO#%-@*8
M*C.1$@K1S251* PH\V]VK[HI_&KH3MQ[(9N4=FMPCJA)J&<:_J]>/I8]/V+Z
MV?-9ZX#HE)![KA8(LP'?O("2+3.;IB<+/AZ5BVG452I4GCFRL.][]ZJ\$\^,
MPHJ4ZLE5]/7A.M)8%!MT2A_@4[6-Y*BVIRJ6RA$C979:G1KR]+=0AV7#M)QO
MA<,&L6OU@2FZ(OCB&VSTE(V&6N 0N4L[B,G)'1V-RX.!6#['2IT8E9Q_M]:!
MM0(E6,MD&U&4U\R&:O*8M4K!N.M0-X&G!)1-F!G#+KN,@ZN3E?TGZ4H3CB.;
M!KUX"AJ#E8E:@;[L7+;>2N^0SPF?8Q1X//:F4V6(2>E2Z&9S&ESGQN%-RK8.
M!.:;5-TYJ7%>D9!2"U/TX2AYQ#=3-PK&&67C;KK2D P-@I\13@SWP[4<5J$2
M4(VQ\Y7+ QRG8JT+#@"7SQDQ=!79P)3/MO!NE(J7O9/17;(P,3KNGZW[6/;*
M=(J]#[G(6=E:X90L2I+H7,!54]W:'RA!3G3.YK9,=POJW9$#I@5 7/) )4:X
M< GZ\(WAI=ZD"FAJ&=0>>6*S/D;PJ:_&3*V%],MBC!':OA-A=Y')P7>>N)MY
MHE,%<-KPF[^NO"121*Q3\717)MD%=%)?5NOMRBHWP1F9D777RF8-^])7T\6(
M^- R%VA@N"G2K@OR6JKA.UC3'L\=HYTNU%5_4GU)38%-6(1SZX)[>@,>!EYB
M$XPC*816J11>FNY8*)+W5,=^[1+P'#6/;EV&26;I%\(!8U.9LU_#D.2S:6]6
MHITMLGJ]6,9&3)1\)/?CR_W$>C]DJDAVQ5I$JY/N2 RI^X)IR$-@#)#VLH#!
MHP8L<A0,.5VQ-D)JDI\0K)EP140-_@A&KM)U2]:$@2O*DG/A*:=U53<-D)MP
MR$"_$2H5#KJ$$8H](TZM9\G0)1LQ7!T3&_OL[OUUC9LOJ!=)\<WMP/$4B67L
M,3=U31X%2U> .5-S*D651,X\AHA]X*9"L8HZ8KRE)@-@ZG<8*P*VS/U6]C/)
M_YIU7/ZW*.+RO\-&_;E?@<'J#;PI:K7\&F+VS-6OZ6!(ZO V,*L-]AYH $T[
MU/7&@&SPH(L-:R.W8L;'<S^K'#+,M$@1D0XL6Y,+L'8&* Q\CD=\$=@#/"N
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M>BD&[#U@?0V#)2KFWQWS?\ZJ=7<PIF$OTD3#K",V06'C #QF[SM2E@Y.(T2
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MJLR59V5E>&8O]R8AAJ:*)^IC:\)=-%P)>=^8,!8-:841+NHVG%BO"^RO&D.
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MR02\P7KS/]ZX>3]KJV15YJQOJTOUVBGVZ[C#X8-"-N.Z(1.!AJ!QXRSN[&F
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M#0K1 TO4$(:>*9%@.;%<(!#-;63&I2AJTV(-C-T#ZC.8+7&=MHH%CM,-1Y(
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MEH3($E%"0%0V,5Z]1\#V:$>5"/(4M+V5IKP?Q=?+B'\\WDL'_*=()YE3EK+
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MZL#&E&4W<ALZ@*9KUEMX:'?LLE[[P6+1-F&Y*&W4OLX_PVDI6(.2Q']8_)A
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M'H1$7&4#P*V?*UP\P!#$DXRR-)BTP_*[=HSG3VH-X56\B7Z#BS,Q^^+5%-Y
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M9;\9QSX,;R+.#((*)3TJ9YU0\90@CB9)T 1A,D;KN');,'OOP<^<QW:"JMQ
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M.B>IE$^#_(J'O<NIO1B/8?(6#>S^J,APN?@&;BF@Q4Z,X)9(:11*2T9TZEQ
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M:=^'=(QUJ;)^W-^VZI'0P3'K.G@]R64*T@.)Y=2WO+BE[9 BVJJ(WR&H5+M
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M5FS^2[E</[Y?B/G:'NN8WXI&II);D9^562&OE8U'2/)8(4"AK3L$\QS06$I
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M+48F,Q'C3 (8,V3+H4I 8!(#G*88*I0I&4._P().>5/CHJVZT6JKKV_ 03?
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M+X(Q4(6 %RJ]>-'<2S4"0I5+-%Y(L5#RE5J8'U:?S.!O=B!L!-R,QCC+4Y@
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M<<OGAMQ$"^-'+G6?R)YKQM"-_$8:F8$)\6*+MIO-\!Q9<Q/]U@R/L2@<60:
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MA 4R;/NZ*TLF2%7,WIJGKIX^J[O"/FJQ^LV\\C.A*=4B%@ J;APZK7- &&=
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MQP@2$0O"D%_9Q=ZZ3(T(6U.:0].-,='6FH@_13M[(FN0;_'&_L/F1I0C#<;
MG.D_#L,&C05 -5A=R?Z:C%Q\\FK(CBM47O_(, 5L]TJ7OS&T+XK5+"52(V%8
M-964&&J5]A \%P RFE "\X3G7C[E99'3(\^V=JL*4MCV!,:N%!@2N<&9[GG!
MVQ_W^Q^T"@?T!MW1&:@2[@F!+UH5]SP ERKD=MS9CV8^VHH'V_S'7<,[6^3G
MW7SYQS:@=*8RC'F629"Q+#$K6!(#(C$#@DJ>)9DF<>Z5G^ L>6JD4RO>HSR$
M.]1NI#,(@ -S3ZWS7E[T3NNFK%=D%8^VFH?C(&^P E&1N]Q1&<D;CN?$Y/^
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M^W!OOS_67>&_%@_FDH_ZBTVZT4S8?S,:E:LW1JMZ"U(BI66:4I!ALVY!,D\
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M&C+_4"GY8V35M*EJU0+7.I5723<1T^9X$GU58FZ,J4(7HDHWV2O;/#):(^<
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MBI_T&E[^5-_XPE:MP3+QITQQOQ6;XGL9Q+AO,[5OPLYAKB1*)$@394ZM<4P
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MQE@!:IL&(:$I3V,,F=^-H^?\4Z/==I'Y97EU+PY<-V:U/*\<?1>$98C16":
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M&CP"7O:<4CC45<[!V.->U)Q2Z^@:YN1#?1N)?WMB\WF3FFR,CAQ#;G8H$EH
MC D'QMC(04)BF)MC$4/2*>CTS/A3.UY6(D:EC%$CI&]+\$,$NS=L %P&WK)^
MD/1H[GU2\2N:>1^.-W+S[I/*'#?K/OU8^.+?]@W_8;[\PP9HJ;^R8F%_>6L+
M$+\N46S..O?LSR^L?,F@/(ZIY@)PCA3 D,2 Z2P!$"6QPCPE>>Y?$":HB%,C
MCM)*UD:-Z-'J$;"<=\\E=+,3WG9A!F8NA[B3<MFLDF5LJ[J)K)Z[OYXIYFW]
M.4;?FZC2>)PRWM>MQ@@5O'L*.)GBW=<![%.W^\J9^J:7+\5_/R[GYA-KZ]#:
MO'Q:;M2IJC 4H10RF0.1(P9PGC% :(Z EA+!G"-"W1J ><\\-4XO$_QKP?\U
MJD3W31UW!=V-K@>!<F 6;LO<H!A9L8<ONN,-5[!L<==Y1\X3]X3C.$/<=X">
M7"6,$;6=J\_ZDVH:&92U\,OVJ/M-@Z22)%,)8#'!QDS-!:"9.:LJA54J>,+S
MS*FQL.>\4^,IZZ7]TFHO<]@(HNPBX$E;CO@[DE9X5(>FK%IB&Y)LP6U:O%3]
M&*K6QL-$@WAB%8JO'&<=EZW\H#CB*L^/7UWRZUUA_>@+N?ZB5J7E\,X:<RLE
M9X(92PKB'&!F:W]EQK0B A& ,$(0:I[$F5_@AL.D4^.HG:"VI634%+6R$D<_
M_/;M7?G;L@Y8_S)@YQ? ,;8@,*Q#AQ8<% ;;26Q.I0;*4FC;HZH2>Y J81=!
M"E\N[/R4;U4W["(('07$+G^V'RE]*!;%1OUBSISRXV)COC.%8;SJDL!PX0RS
M&$.94( 4$X:3S-&.(I8!F.29RD2&D2T<YG[]UCW=U.[CJBOM.N[F]FFY[7#@
M]$'7C6O"838PRU2"@E+2:"]JU%SD?>HHDNU-+FZH!**5"Y.-2BANBK^F$L=/
M^=?G*MGIJWHV7Z)'ME9?5LN'%7OZM+6%-3[K6RD+ZYQB\]<5$.^7/ZO]QXSA
MDVJ1QC$"BF@$< PE8#15(".8P5@KA(1V+>452*:IV465 O:@P78JG*B1NEE&
MW/:CW^D1_5 L(J_"J2$7MIODWFBYQO!C17O9HEHGPX&[-=SK=5RIM5[#EG+C
MKYM[3;,W6+^1RI^-N(Y>A=,"(]Y18RW43*.58PL,3;MR6^BA^[94^*X66S/@
M$RML&0AS(-#+U9,M0_"9SXN'<DO8)$";B')?/)E'/NMOYK=KS83]VY>R1 *<
M:1I#L]@,<*YB@%4L 1?,1MK%4%-)8I9[MED((]C47KNU7C?FE5IK9CT0C6K1
M<J?;39D872:*;4KU+#VL6PJ6+^(7Q5:^!<R#K;G;B>,M5G+@-_)N$7=*12VM
MHL^M16P4B^YWB]C6K72:&.U"]GL("W>P'A"!Q!JY+T18,(][100>W__(U7(+
M_9N:F_/<_6J[WJQOQ=^WA75AHC3.)9$YR,NK+I%I0_&2 9TBB7,"<Y8['Z4N
MS#4UKF[WCX@>C<"18=Q-*;)'DRX7D"\?:P)"-Z)[./JW&K7[&K5&WG#0N9\L
M D(XTHGA.BB]#@&.X'08]Y=&&,UH=U2E;8R[?J2OD2V587@^-U9^W7JQG*HN
M&YS)),^(SD&6<@YP3!) \S0'G*09S[(,LM0ITMUMNJF1[%[::"=N]8WWM6H[
M07:U54-!-[@%>@ZU 1JQNJ$2S%#LG&QD\\]%\6.CSNE3O6N1G:K6TT1X?C Z
MG'SD9V4,RSH4M*S$B)642&> *Q[;,@,Q8!1QD-KRC!GD6HK8YRXND%Q3N[2K
MH[;M5^-<TFE4J= $>!LE?(/P0ZVI&\>]P4H-3(;GBYFU0NZ[UO FXJ_7,&CA
MLY!XAZN"%D2JL4NBA83R1'VTH,/[)T)^4V*[*C8O$/'[8C-7,YH+J6*< (5M
M-1B"&>#(&(B)-O^-*:>I<CI]GQI\:I9@*91UD$'T _\Q:L1U3X(\0J^;$*_%
M9&!6\X7#*P'RG-Z]LA^/!ALM]?&<&NV\Q[//7!LB_D[I8J%D'>+YQ2Q>N_I\
M&>UI]B\6F:TUGJ10 *P1!%1"!JAB62Y3S=/4J_ZKU^Q3V^#MZ.9:_%V$<ZG
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MX(-(J(P'ISG'37?P@>$HU\'KPWUK-SX]%9NR,*0AP_ULA5K/XC3.%4\%8(Q
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M[P+5U;T?"*K!??S'/<)OH@:[NR[L>KCZ'3 )YN_OFFMDI[^#VL>>?Y</]>]
M5GNY9DSD*A52 *)M )#6S%"$.=,)!&7.2 HY]:H;U!I[:H30./:L#R]:\GGQ
M<*'%WT7P7*F@%R2#;WR^N8EJN<*V#WNE;,"68<W(H[<)>Z72J=9@KQ_Q#[>Y
M6WY7JUU=;IPKRF*5@11S#G!L$V!MF]4DISR5C*<I=,YC/QAY<OO2"N=2EOL"
M8-V[\2H8!MZ+S@AXA=&<U+97_,SA2*,%SIQ4H!TQ<_J!$&TYJ^0?*G'.LA2"
M+$TS@'$F 6$$@Q@F2498EC&.^[?DG&3^5KM-R"^[:Z]7K2=[YFR=@MC]%7H%
M<$,[.5]C=M\+LRM;=0Z1JW1JAC=LT=F9 ]3UZ% E^'Y6>KE2U7/W[$^U_K58
M+&T,W\>%V3=J;;./#D>I6AC\JC:/2VEK@JZKH-V9Q&D.H<H!$YD 6-GR?7F<
M DA$JI5D5*K<+57\#:3WV8OCY*0?%J*K%&W\<:6JH>O\A?LFN#'B1%=W8*9U
MK2\8\6K%ZY8OE4I12Z>;@R^##6]<6'>=T:&ZHJHA&K,L8?#U&JVD83C))U8.
M,?B2^)=2#"]"@*+39LZRC)N2MV)3?*]:]33',,YDC$A*0,I2<V[-N )4<0ER
MGK!<HQP3*7I7HNZ:>6JF]&$19ILB58L>[67W/O;ZKX?;^V00E =^&X0"^+KZ
MURY@#5$4NW/>MZN4[0)'9_ELIP&F6DOFEV*ARBB*F9!YEMCD?:%Q!C U-$AX
MDIA%U43C/,X%\O(=C"C[U(BT-M5VNMN2:Z7V4:E^N?/W +3:,AL[\"7J4ZG$
M0E'%*4VN+,W^&^9S4)C<]V:<@\+$OC(3K'!SM'C_,%5N]I+_?ZS2S=&2C%_M
MYEB$*UM(_6VY^N^/BR^KI5#K]2>U^:S-.U^MOMO.->8]B:"-);9%73%C$/ L
MC0'*-%229D)"KQ(4#G-.[05G)8V*1?1<R=JSZ50'QJZOBJ#(#4[QNQ95#7ZU
MQ&7/*NN,;Z0>H'_598A"M[7JF/%MNEU=AN!L$RR'C_:V\%<E*;+Y75DAN2KM
M>KO9K J^W92=SI=W2R/':FT#\O1AXMTLS622\%0#(A4#6.,4$,@IT%G,8D@,
M.Z5>SHLKY9D:4;TKYEN;C5S5G8[4W[?%=S8O;[=*9^PW99OF17>&R7:IM57%
MY'Y5J:]=3F<3>:Q%&M[L;32)*E6:BM5M96S#M-U*OM=:B9(M]QK:GU[E 0>U
M:4.@'<Y.O4J:L6W/$-"=L">##-O7LVQ>"EO5.,"MF^=OQ>;Q;KO>&"MW=:_^
MW/P\MYLYUDQ#K(EM;)@!G"<<4!9+(%BL-<\)(<S+H^(Z\=1(N);;TTQTAMG5
M7QP>O,'=Q:7(^VM#*W3TAY$Z:L2.?K>"1Z7D0?W%?F %<Q<[3CNRM]@/C&-G
ML>?G^]%2G;GX595U !8/N_L4$><20:E!FD(),(<Y8#2C0!*D$QZ;_Z9>$=/G
M)IH:[>Q3.6M!>]]=G876C7I" #9T1%@?K+QIY1(0@6CD[#2CTL8E95_3Q,7G
M^QXPJVOWR@?WOFH[7#9(%U)3DN= )9H#+ 4$#'-F3HX)C5.60ITXE5"Y--'4
M:,&Z6HI:UGYMF,]"ZGIZNQZHP8]E-3Y-_%(MY8_!NZMW0Q'LS'1FFI$/0]W*
M'I]R+CP?*@/S]LDRSO]4&9_ZKZQ8K&ULCK)!GE";PPH"4-C.(B*G56EWD7*E
ML<YC$;/90CW8RV\WEO"8W6D_T&H_M&48;ENT1:W*+/GZOGW =V.3T("^91;G
M:WRM[.&ST?T!&RS%\_S,;YSP>1&2R^F?EX?HV92B8+R85U$VB\JA\[B<F\^O
MJT#"&5?4&# $ I$E*<"8,L T38R)HS'B62I4#GUJ<5R:T,O &:':QKV=(VI)
M708/E"ZR6NY_^2>"8/Z7.MK8LT7%)?C=:"LDJ -SU6LD+Z#FWY;"$8I0'2DN
M33=N,PI'Y8_Z4+A^KA_)_'6YE'\4\_G7Y7S^8;GZ@ZWD3!!LN"..09PDF6VX
M)@#)8@4$TUI*(2!%7B6H3\PQM;-2(V+TNQ4RJJ7T])Z<PM*-)*Y$:&!>\ 7'
MFQ@ZU _$!:=F&'7[=ZCX>L=W/>I?<;:\0F)K]4Y5_ULLOICCE3%5:@OF\Z[<
MPBR.,R:Q-2 R:*L(2@H(E@IH19%BDF1)[.0_]9MV:E10R]FJ0^%>Y-0#[&YB
M& [",>ZYC;#1#XW8/Y;Q/S6HS3'H\[#@NM>.'0;DD:K&WNY:)10[V&4;]OUW
M.-++5?1<KP*O=%O_%*9XK#^&'65C/08;K6"LOX+M4K$]/MW/EONT7/S65"O-
MB( QP>9$J&($<))@8+.\ $-9KGFB5(J]*L*VQIX:89?NPP6K(FO]++8V8FZ6
M6D\<!F9=(Y7YWP$JMYY0-Y!%UAYY5$OLA$JO+;!3C_3;DI]7#VQ1^X;NEHOU
M<E[(\@=SEOMBO@'-.^*S_E LV$(4;+Z+'M\G"FJ8R51F"6 DRP%6& %.M  Y
M49K&29;%$/ELYB!238T&VDK=1 =JE=Z,MF+VE;E3;9^+TC_I,\PZNU'0Z*LW
M,'F-M7#>Y!<4Z$"T&4:F40DW*(ROJ3KLX/[':]N(=&U P>^VZG;[L%UO8&(6
M+:V-"@$3"95, 12( HR0,LR=I(!+F6+%<R8$<3U2=T\U-3HNI8WBGXR\_QS)
MK8HJD2.8W$16:O=SWP6(+Q^DPP$WN!G7C=EE \\7//>#<C@01SH<]_X">IU]
MW6#I..]>&&"T,ZZ;(NUSK>,G^AG.MY_O/AZ&N7]AMHAGF9)TS_YL^]@3C16"
M# *92 DPI1F@@A"0Z%1J(:F,J5>#/(^YI\:Z5O2CC))*^EWNG='@JFL.GZ5Q
MLV@' GQ@M@Z,M;=YV@.U0$:HS\RCFIH]('EM4/89HF>O3_926J'WRUOQ]VVQ
M4C]OU\5"V<B1<K([MGZL_R)G*>0JU0(!#6EN4VRL,R!FP : ,)DD*LUX$Z!V
M[]$+U$,&IZUW&*9V/P;E6?'696+]^B9:5/M.&+DC5@ONV3[49UG<^"TXRB,U
M'*W%MKQ6BQ?M)=]QG)6^^7O(-J0]0 O5G]1GZG$;E_8 Y:BC:9\Q>M1,KZJN
M?RC6@LW_4['5^X5\9TAAA@51D+ 8:,52<R:6#)CO'P,Y55QG2'#!G*Z9NR:9
MFEW6=#BH!(VLI)$1-;*R>E15/P=I-PV% FI@NNF%D5_=]0L@]"O!?F[0\:JQ
M7U#KH##[I6?[V3+OV6I1+![67]2JC+\LD]C-^Q%!SC"1&.18"=OG2 "::P54
M0LSIC,5:"*\0U3/S>&WW$2)3:[&B1MSH6:VJP-3HA]^^O2M_+,LN>%9=. >S
MFQD2 +R!*6"'UY<&KYNHEC*<87$!AD VQ+E91C47+JCZVC*X]'A/5X[\KVU=
MZM:8'+L:6%]8(3\N[MAS8?9C.1UG:R7OED\V3*5T#GY5E6FOZ@Y+1JYB*6U;
MS(=%.4K9@7<&XRS&B"<@RUE9ITH#:ANE9RBC)$9"J-@K7G5H@:=FG)2Z@%*9
M2+2T\70+#;W,CKZD"2W>T ZH+Q_O;BJ:!#^7JU>;]M'M:F4>K.LK[D+R; B8
M;5(6M70*Z(X:"?A0/JRAQ1W7\342^$?>LK'F]7OUK%>;V<%M<%DR\?;/8CU#
M&<O, 90")'(,L. <<,XRD,8"*L8QUM"ICMCY*:9&[X<1%76/;RNHH]^_ \QN
M2@X#T="G3G]TG*GQ,@!=9&8^W2(R\].>Q#H&'H5V+BO6$(7#DU=G1S9-'P63
MVFQM!$C95%=F"-#,_"=.$&'&-HP)\>I-?CS%U,Z9509DXSAIR=L[U=&O@>9U
M" V\LUO"#=!.\[SJX=,7WZ2YYGD%.U(4KVNUN0OJVCRJU4'K@3I<)<Y2<[!+
M,Z YY0#G, =<0 G, 5!H+'/S&Z^3WKF)IO8*+^6,?F">[J*S.+KM[A#H#+S'
M*V .VXV$CX*_!$2HV,YSTXP;KGE!V:,(S$O/7\$!M^NUVNS>22C#,,ES"&!J
M\Y()T;9(2VY,=PQE0A"E,/'>_0=33&W??UFI9W.4:JHW56GY2RMV#R(X!-.#
M GI#-,KFKZ0;X U_7O>0^_UP@O%W^DD%3^[QTT_V+]8VGRM#&&S^9;5\5BO;
M&*W*7),I)0FD0&@;,IT+#9A.-,"*,&0C#+E;%O+EJ2:WV]FFZH"X63&IGMCJ
MOWMO^ Y\W39^&-0&)H"VD%$CY0#O_\M@!*S?=F:BT2NX=2M\JH;;A4]<T=ZP
M$!LER[B41;MS8O,NXPR1#)$4H"P7 &<Y D0F*9 LSA!4../4RS!PF'-JW+$7
MN8Q]Z]&R\ +&C#"*D>VZH" VQE>" <$I-Q88S;1.:89RZ=<&.3#*X[0O'AQG
M-WH.C-W /-T"K0P6M"^U@Y:_P6TW#WQ"=H"\,./XO1_=(#C9]='QHP&:UMH[
MR;*W9-EHYI==&SV>$XX3R@S1Y 1@1!6@+.,@$8BG&8Q3AKWZ3[E,.DE>W[DV
MRMO;JIUJ*?85_1"=5L"#C +B.@8;70GI=8UI+V T1$_:<U.^73O:"R!T=J*]
M]-F>!8-]&O'M6_CM&W3P.(^-G82!Q#P#.%6&L*@YQ,J,YN9;J64N,C\;Z5J1
MIF= ?7LN%N"SUC9SX+TY'X@-,WMP]7R^%M$P:^5&;6/B/S#M^;=.O6EU7QVH
M_THH?$,5+KY6G'&K&0<"[ZC$<:AQKVH[]54]L<*&HWY1*[U</=E.JJT2;U R
MS6F,0 JU,0XEAX#)Q%J(*J6)2)#NU7.J>];I68>ET#?1JA';AI8W<K?*O]U$
MK*P5UZLSU865<#42 ^,[N)580[N3.&J)W"I@6%9S[X*V;U,J-ZC"=J2Z,.=;
MM*-R@^%,+RK'#_MGM[TW1+AYN972?.?6]?]8.Q3.$B5PHF(-$.;(&H$98"K+
M0 Y1RC2C.':+1N^<96I$5 D:U2+>-/^(RK/4YX5'CMMY8+MY)AA< _-*;Z2\
M,MTN(M$KU>W\J*/ENEU4K)WL=OGAGIG[MCVRDFO;Z:[)IOVP7)6WI'69J<7#
MK=@4W\N@J!E.!$TR)0%A @.,A *&!R2 &+(X)I13[=6[V'/^J9%%*6>9JN^9
MF>\)NYMA,B"8 U-)(WG5-_.'7;J^>=']&%7!$3L%HKT& 5/T^T$7*DO?<_9Q
M$_7[07.4J]]S&/]T"3.3W(K-YU6=CU$E2P@I<R1BP!#. =9E9:64 IX*I'..
MM<1.K?/.33 U9JIEK/K(5&)ZITJ<!+*;BD+ ,SS7^"+CE2;1I?X521(GAQTM
M1:)+J7:"1.=SUYLH7]5S31V?];?'Y6ISKU9/[Q3?S')-M:2< ZAB C#1''""
M)-"8,:1U'C._6"NG6:>VZ>\>;:ZD+9>_MF(",^=3)(V@_:V3\XC[VR1!<!S7
M$MF+'"WUCU$I-;!B1^^Z8+W*_K@(TP!6Q_DYW\S6N A#EX5Q^</]R.ANSM9V
M2-N\ZMW2>F2,99%0K 4! O+4IF'FUG,K@.!08P1SG/DUY3V>8G(T8R6TMUZE
MC-'OE92>M_8GD'1CE.OP&9@^?*'Q)HKSV@=BA1,3C$H!YQ5\O=\[G@S59M=V
M\+7!0U_59KM:?%Z433++X/%9PA3.H&" Q P#S'0,B*W<(106).40DCB^ML_N
M^>F=OO*C-MIM9(U6I;#1<A$]FP<B5LI[;<O=CH5PO/X.#>Y;-MW=85W)7O?;
MM9#;O]=Y)$.VW[V,W6#]=SNF?N,&O)=!N=R!UV&,?MSV@16KL@[%_I9[WZU#
MX216F*: \SRU+982P&F6@H3G--,PQ5GN=7CJFFQJQHR5-2J%;<6(]&^?THFS
M&U6%0F]@:NH/G#<!N2 2B' ZIQJ58%R4?DTH3I_IG^=F1MN\KQ(X9TKG&<M2
M"6!N6W:G@@(N$@UXK%-,!459G/O9/Z]FF)Z)TPC8)+'Z)[*U 70C@SZ@C)>R
M5J+Q_@(:O9+43N@<,#.M/?KHZ6@G5#N5@W;JL;[GFE7QG6V*[^KCPH8>5QV#
M%O+?E'PXN'39L\;NE<493-.,QL8JX K@6$# E#GK"(%2#;7F6>J5D':%+%.S
M'/:J1"U=RGN%6IO65>5! &I/V^*:=70])8VR.H,?FH9;F!Z'IZLA#7:6ZB_)
MR$>KJR$[/FE=/V2/T+H_17DCL_,42ZTH5D"C+ ,X2S+ S"^ 2J5,8\8@P4Z!
MOL=#3XT:&^D\?<,G,.OFK>N0&)B&W$'P"X@[J6^_*+C#H<8+?3NIPD&\V^DG
M^H;A;XI564+6NE/NS2!E)$-.N3#;D8,DM3E.6&> 4VA.,$EL+!Y)TEQ0O[C[
M4]-,;6ONI:R<A59.K\B0"ZBZ&1K78S7PYNT#4X_P^"X4@L7#GYQDY #X+D6/
M(]X[G_8C 5%F>8N7V6_?WMGVTQ@+*@%"7 !,!3-OX%P"Q=,8"L6UT-QER[<'
MG=H&_VU1V*N!LC=L>15Y^V2,'\%NHG?+^9RM'.]B#G#KWM1]T1AX"_<'PGDC
MG]*\XTW</%YMV^:G_98]&&Z4#7I*@68[GOR;?U_A#X5=A[+T@K3W'>:'7XP=
M;G[<F-4J^%Q5%QSWMD?=C),T41AB@%*4 )PF&A#"L=FA1%&48BQSIPZ8WC-/
M;1M7PD>W98&11ORHE#_:*U#?]46_ESIX=-/U6Y7N_3\HUD/?8DP)9O<>QH/!
M/5)+X["P>_4Y[@5=1]MCO_%&ZX+<2\UV4^1^ P2H5]&=IETF##1W*)#HA"=:
M@AAK#;" *2 QE("S/!/*-LQ)O5*G>\HQM7?'88&$R_41;NH<FTLW.4'7SM$C
M/?R*#.V-'F@QKJM0X0_E$(4I/*1XNWH4_E!UEJ'H,5S?I.Y[]N=':5[FA3;'
M'COZIVU9.!71/"6*4)"7A6FE$(8V4P0(Y3G4L=()<;K4NSC3U(BQ3EFVO<P/
MQ8TJ>7V3N\\![."U#@7;T$[LOHCU2/*^@,85B=[G1AXYV?N"@L<)WY<^X'\:
MM\VIG@W%L'D98_#=#KY<U 65M<XE1"H!##%B#M]Y"AA)%- T(Y!(*C/E?/CN
MFFAJM+"7-6H+ZW[,ZT3U\N$Y%%8#<\$9F"Z7J?;#R_T4' JWD0Z]O?'S.M^Z
M@-)QG.W\^&BG5Q<EVH=5I^?]V=(.]K"RH87O"O:P6*XWA?BVG&_+>F'-UU7%
M(A8R 8+Q&&!.<D 3B($MD<BH@()BI^!IQ_FFQIU[D:.]S-%.:'=.<,'Z,I4&
M1G!@1KT 7@]F=?K&.A-L8#1'XMFK4?7B6P^,.FC79931V-=#I38)^WSLJH**
M-L/WSAR=;7C6WXK-X]UVO5D^J=4NVC%6Q#9724 ND08XHQ)0K3+ XQ@1JKD2
MT"NAQ7'>J7%S+7:5R]X('OUA)(\:T7L'H[HNA9N;;P" !Z;N0-CV+:GHBE38
MHHH79WV+LHJN4)PIK.C\<7_S\5=FBWQO7JJ.T*U*!/LN!#,EJ6)2,J 9A0 G
M(C<LE6* <D:1A%)IEKF:CP[S38VB&I%MM5<CLPW3:-4N*?;=&B*VB3:/*MH4
M3\H^]6PD>&2NEQ6NJW'9P R,\< LM8.W$C?ZK*L:)E%9PV0O<E@4W0W,P&B.
M9&#>F^_AT_$7M_QJ2O6\7!?F^RIL>8)"%\8*9>MS7^IB47ZIQ:ZOM'F:LWE9
MF'?]J-3F?#%Y+R/5 ^<.(]5EE-&,5 ^5VD:JS\=ZUHBIXZ:^_<&>ZQ,7313/
MLXP8?L^4+1:1 \)8#.(,0YK01+*4>-6(.9IB:KQ^MUJNUZ"1,[*">A:!. &C
MFRUY'3@#$_(!(@,T^#NO?*CZ,,<3C%L?YJR"1_5ASC\9JC[,5R66#XOB?Y3\
MI#9_9<7"%N)XMU7WRV]JLYFK)LW(B+)AQ;S\$<X2:,PZ(C3(H#(F'\\20#.*
M@8PA14S&*->\29V^]TFM#"*>TV8YS+N^'X%06A)?6TRFWZJYD<^8B_"6)6B,
M+K5-68C=G\H.5#_<K90L-C_>1%;9IC:-43C:+*.]RF4Z9DOG(<O57+4$@U6R
MZ2?5&Q>YN0K*R_5OKAO>_X3^2Z'5-U&8UX1JO.-4*9YFF ">,@TPE!"P.(]!
MDO&4HUS&"7.^SSD>?FIVFI4P:D1T/P6>P"U14"5I3D">8PJP3@D@94Z=DH+&
MC"6ISMU:AEV/W#@-P*R,__)/,(O_$@3 R[Z'ZT 9^#UQ\$WJ<7-U A%W/\)U
MR(SD-O!$R.N ?QZ CO/\B0^-=GP_+W#[M-[Q5,_#.5L_VO]___=M\9W-[?OC
MJ$?LX2]:3U8&S\>%6"FV5N]4];^[@,XF:?FKL8G?:ZW$9I9A+66:)(!I;2NK
MH;2*K3(_"2$S A4Q!__EALT=#_ZCBN_ULMHI,=P&LD9G48MO76>B:<&L]DJ6
M/Z^NZ6T]\E?$T:DQV84?VF%B5+FIFFVW-++-S XZ<=\TG6\/VG,??*)V@3<P
M1#\T0/S8#LK?56VP:$05' '=,V^RC*%</^,*/ZY;Z4T6YLAE]392^)^;/BTW
M:IW\%*-8;M6O[ 5A\VU):[,-ITE.N!9 YWD.,.804)T0FUX0)QE.8HR<"FM<
MFFAJ9ZE2UJ@4]I\C(VYDY(T0OHFLR.Z&<">VEP\)H1 ;F-<[P>IQ?.A$S?T@
M$0J]D8X45Z+H=<1P@:;CL-'Y\=&.'2Y*M \@3L_W.XI\$X]*;N?JLS[H"%^W
M@O_YQ18^^:RM3W7?ZSN&>1)3JD#.$ (XBSG@"40@8URG,5)42J<,C2MDF!KK
M?ML^/;'5B[V /] ANA5BM67SIM;?B]\IH,_JN)GR V,^,&\WTA_C72L0\9>J
M6I)YH+P0J++WHT&ZKE^!92"CN(\$HUJV5T#TVCR]9JA^'/DW53P\&E/W]KM:
ML0=5I;^]*^9;\[MOC\Q\L3]O-^N-.?O9*H[RO[9U!!(CF$&(<I ;3@08I0C0
M7 @@<D)RR0EBTJLI3T\YIL:5I<2V+NK:RGS@-BGC6,M? VZ.#;+LWK&.?BA_
MM?[1CSS[+IL;@8ZP& .3:*-!5*M0)].6C8-*!:*6!C=1K9MML=PH$XY"KT0S
M$(WVE6)4*KT2JM=T>NUP_2CUM\4^,G%?VF5^JK1+<R.*TAPE* 9,BM3&J]B[
MT9B"/#8,FY.4I]2KRHJW!%.CT5MAB'-EMF^Q ,^VZ]QZ;5W.RJQ%Y8^6ZKN:
M+Y_=(VO[+XX;90X*^<!DV9:]52T*G*T6%3RHKC=Z@<C1?_Y1:;$W/*\)L?]
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MLSQ1!&B<DRHPCR*%0<XTXQS%0O#<JR:Z^]Q3V]][6:.Z%JK35_WJ)7 CA8&
M'9@Q>F+J7]'+'YU0Y;@\9AZWEI8_)$>%L'H,X4=9HJX./WO_V]=91C'%C E
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MS2$Z0W(*VCIIC$E=B.@HFOLUC%UB\$%OM5-J]V"3]QWG<=:1T:M=#N^.&3S
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M',DS_/6"(L<YV>FZVGV$>\]T$89!KKD!Q6Q]R"DR.!XL&><D*+;OS%CM0>A
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M_M$]ZP-A->M#QP,X4^XP^S2OJX/TW>_U-1&.DM1!JL1!*L5 83$0.>. DK%
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MK%?M7W[>6GZ([98/0<.QDNWYU*B/.V:3<5Y)?E6.N#*/+JC(3); 45&8I5V
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M0&. /4M,1[KL5)$/Y^!_!T#ZG6RGX2?B9_R!LS!-FT';7@=CC)7@N<FTC%#
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MXID!,EQ&6GT#\6YA[\/W3=.&8)24LM@Z2#(!;>  SD:L'?3)]6%<QM0Z:?U
M$L?5C6>#ROZ0/%EN'<#R#?[ Z^&OZHJD;]/A>OCZ\]/DZ[?;6;D:C9$R6#I4
M!"T''5G'M;%^CK3-'>?>ZM:Y>;\@J5O8G0Z')\43[633 =1>W\P7P_>:!72]
M:D3[;?+79BET5!B5K89LO*D#PA%"3!Z*T;1=C2XBMCYZ=Y S[F7M)2'62B8=
MP*MV6+B^1G+&P_7'&6V;61T_L)H:4U DGADX;>I@$.Z C)$ UEJE>58ELM;7
M;<]3,^X][B7!U4@B76!KI^'[Q.!(26KTQ@*/M<%'P0*N&L*N&&,5<L::URT=
M2.(X*NZRWL0YI=8_*+=N9V*:06X81!M(IZNBP?N,P.CU(FU0QLG+ K,_S^*L
ML#D,HB?+L .8_G.:Z@(F98+WMOSUUN6N#@?,RFI1..14:($6=9U=F^B$J,.N
MB\Y,M#8&#R:R:XB>#IOADC+L *1?9B'C]S#[SUO?2NEHLDM04F!D[=#V=K5@
ME,@NW D1,FM]_?*8AG&]D$M#["0)C#XH;%^CYMUMWI\1Q!I!SCM3W-+R1 8?
M%!G$D?&B"\M6/3(13XIFO!LW_?8RAM_Y)=&!JMKAP?UC-LSG5T4*5EC,Q#F5
M:[\.15K780UHQ\1M]$:VKB#Y%4W]QRZ.A,/^E\6'RZ9OK+U*Z>;[S:K5PKV>
M65<Z!<L,$^!%/0,B\Q"B#)!18^%216LO&+=XALK^O=^SX[&%_/I)?]JQT.4P
M/\:EJ?G+CG8;D!DB(# R2;G1J'3VD<G6212[*>K_%#X[  ^52P<#Y7[!LM__
M3M<W>3+]NLG;N-+&%*Q%BCG6SOO1!5+W*0":4+0+R5K?NB+F4!K'2?B\/!+/
M*KO^1HP]4?<Y+^?HANM[(]J:Y>[M^O3&27M[+V24;#TC4"<6 AC-"31"&J 3
M5$.VQ@<K@U6V]>"(BV3K;1[VL#WJX^=="9>*Q:0A!NM!N9S!%8^0 T\<R9LO
MS6]-=E/TDO+W#L'.DUF;[>32ORZK34ZG:7(]67[F4#9LCC\W#0W78RF;Z;=#
MG]A8YYVTX%'T8,A9:7)V091:HU], 8>8P'">@\M&R- ZSG11/7A71KYY[.K6
M*D<4Y,8[X,MUZ]I'@-RI.NN6EAW(VHVMU_T,*2])\QV"EN<;,QXOB0YN6CZ3
M;);=F1_MZ%6(T3GO+8H$(E?#EXL T3H%R7*/W&KE0NM\@IT$]=* \021/X91
M,_[W *;U:;!.X>&2^"(C6)$4*.L-.%XX<):\5ZBU4,V;Q]XG8&2PM!/L8\@<
MS>61NPC]B7F2PO4ZSF:B"($Y6R.U1'B.# +3$@SJ7&1F+$KY"W/IR8>.+/+C
M!3.TX-+(XGTW*?@Y37":;ML;T9$:8B"'0C Z5I4K":+,!G1!QQ&-(8]@#QD_
M_>21&\XU$?2)_!H]]KP<+?:#^+"\%=FL(',,%NL)Z,CC$]I#\+4VS"\ORG(2
M)>TA\6V?/7(#IR8R/YEGHTK]L95]=T/*%>>.!P:9U2[!E3,>18&21- 8C>:J
M=;^*)T3TTH2RG7%X&I\[, @W"[A?]\Z=$63@Z$I]/=&" A_(""*SAX7$G$DZ
MGPDJW73H.E&PS\#D6"YW!)1Z&9E39!F"LV9=,F<CF3^F)OYC=%*U3B(Y*")U
M=D@<+<1G0'$01[MIJ;6A_N/-+'T+<WR5TG!#I^;TZZO\'S?SQ=*3JCW A32>
MEI94O5Z6 ARF!+YX+K6V:$/K'EM[$3;N270N)+6314<*AQB$DZ_3US=$PS3]
M_#(+T_FJ)&TSQ>Q*:*=E4@9*"0$4XPF<MV3ZH8M.%ZFD:=W-9G_JQC6*SP6U
MQE+I)U_H5BO+A"Q&Q@%SP!ITT^ SN?E6EBADP:R;CX8=-_/B[.?<(1SML_W1
M&_KP'\OVT'],:W^GI6(-T_QOF+]6;7L[66KC:PSE_;#R)%]]KRIY/I0/-XOY
M@GZG3D^X_;B/PWR9NW!\TZ2+D79B!',<%C8*=6XE_M46XK>$LE(TP4LM@)/,
M0"DL$'AA8)UW1@LIV1EF31Y-[NG=(PY^]#J]7\K(77$)1*"S0SGM:W4'@BQ:
M:%(S3MKV8^*/)'9<A^12:'S:?>(2LNW !'V#<7&WQ&58B"G#;"X&3+0<E&<2
MHJ"O=*@M2>E/2*VOT9Y2\>)@=XSXGX#N)%ETAZ9[Q7%2YURBE>"]361A:0=>
M<@G,&":C%DR[UJF!S]$R-K).D_%.R!S)\$Z LPY$%)84.E>@8/2U!L.!$X;5
M[MG*:ED4;]ZW]>[I/8'C6&EN@<@1K.T"%$^U\*?)_#]7NR9EC)D%**FNI4[/
M#L9EB,SZG!@7K/F EUWTC'O;-M9YU4@^76'M]3!=VH]U%.!Z^Z'!4$K2H+"V
MT',N0$!FH4CNG$LBQ]0ZB6@7/6,KJ592?Q9.)XJ@ SBM[PY__SM]"].OMPO:
M#-P2I("3$V!J[R<5L<Z2I.TG>,@!1<1L6[?DVDE0+X Z5>Z/Z^^:":$#1&VN
MH3__*_RUF3Z+GC%;1T*PJ$"E6J250FW%$[1Q:+EOWK+W*16]''R-L7,BNT?.
M@GL[^1OSE^'M]1 6=]-F?7!*%B] &T-G?4ZDG#TM)3G$R(/W8<\>XEL^?-P0
M4',8M&%B!VICF>N%\\6GL,#[6#:),\P:G*K]#)T*$%UPD(QD(G''F#M'4\BG
ME(P;!SJ;^FC ]BZ2[+8Z%IOPYV\_U_[%_0:J2S-0>:F\2AZ\T;1)3"VYJR5]
MR&T(0;OH6>MI],=1VHO:&MMM:RS3#A3?EF6L]W42PELE';",-=I+F]M+RV@G
M9F.B2.E)\ZF3P?DL,;U8WN=#PG .L72 K_>X^&/Z U>91^M5;<HE,-KD9 8F
MR!-6W%J(0FA(-BE72C!>MY[:^3PUXR*LD;B'L_"^ Q2]#9/9OX?K&WRT"A59
M<C9!\JF&!!2'L"S!R$GIZ(J)KO7YN9V2<;V[\Z"G <\[0$Z=UT>NR;\>+J+8
MG WC'%BI]V]9!W");%8MN4>7/.V,UGGM6PD9UZXZ#VY.YW@'L#G&Y'QW6R!0
MA%:F, E8K"2S4]3&MF1[6O2!:<]EM.T'HIQ <"_>Y>CF_5DDW!6<'V;0D?,N
MLDB%-CKY[.3!<P&^& ;",1/0E!1":T7X'"T=VOCG@<.S0#Q!-OTUY-D[N_..
MH=6EFE>?"N?#](GQBNMTSODY4V(/)^922; GLJF#M%<3C5*( DJ,&51*$1RJ
M#$E&<C=4)/W=NL%F;VFO.R\-?OOYQY1P@;?=*-[5A]";O_U\+IB\.@9Y=MY8
MENGPJXHB:M(^=CGC4_'(&9E8LK4C?;G5O;ACX2B\GW[Y>!'T=&7*;,FK4"Q;
MQXG'ML8,%-+A&8V-@%&0EZ%=T>82AO=!V4X=75M>!D.'I$<=(M"NP+DE4"89
M,<98 3(*6HNL^L Z 9F8%AE7L?#6%; O-#WJ(*D?DAYUB C&SDUX6%;Y!J?#
M]\FT5CC>RU35QG"O>>V(G0LH&V3MC9UK8:57WB?/'T]!VIZJL,>S>H'+J5(=
MSLCB#C30EH0<Q[743!70L@;H"TMU]I@!ZW-Q,21IFJ< OZC\IV/@TXC=(^N8
M+SA; W[+.E)4R4;#P I=^UL9#<%+!*-59H9.=O<X]V6K;MGUC%[2"AKJE&8L
M[4"7[#0@[RZ_4A9&Z"S 1A=!"4?&7]&%U*0M&EV0B5_$KW]"62\ZY\69WR<*
MN0/H?EA\P]GKX3L]_QM.Y\O55=;616UK6$&;O\)BFN^UK[CKF/(>%Q_*E_#W
M%7J6#.U52*&Z])Q;\)K, L&DYSYKHUCK5.+SK*07:ZX=YH;N - P,_'RM_)M
M9X$T>>RE;MHO/3WDE#O&B-P1HR,8X05Y)XG\%!,$,&M%$3Q9]*T3E'N[4]\K
M4AR$%C&+2(PA>TN1"0Y16@E,6\V#MUA$#Q'Y%W[C?0@:V[62.$2V'9@FNPL#
M%=,>"X<2F:@MI)?9HQ%R286XJWCAEPCE='R!W1X2!Y7K'B"?KK"VS<5%1WS0
M%IB/M=EDKI.8:?/F@!+)%54NM.\@\"+OHP^2^D'WT0>(H ,X/5.N$Y-'D6(=
MW&[)* ZUP39*#3K&VD((A0H=54F-=$=]B*3WJY(ZA.T=@.?(*HIL+#>%UB:C
MI%665*OD2P;-F5*<!>;]19JEM:F1ZK"U1>NSLK%,.T#N\WG2.7A7:AJSDQ9K
M 62&((T"KY4Q4G#+2NL>8/^S:J0.0L+>-5*'B*4#?&W/F!><(R_%0"3/"91*
MBKYR""B],72:"&2MS;/C:Q1&J(PZ2,A[U2@<PO$.8'-:RK)$[[R($G@.#%2J
M]ZK("C!GF12!DREQD:3!IC4*'98@-S]>SR+A#N"\Z\;^_G[%S:GRJM##/V&Z
M#O/YI$Q6H;)Z@Q_^_K@4ZI42WD6VM+<=;6BFZF %42!R9R5G:*-K/6FS_2HZ
M/-?/ \$#(C@7P$-_%15O)],P39,:EK@?O[BMT_P30V7_\O7*('KO]_^Z(>E=
MKW_R$_F0LTFJN0GT]O'5%&<BY,3XSB78TRCB<TO3O4US>XG.9.3:"@X:@R"3
M6"'M&2,A,Y=*=AX];VWW[:*GA7%+F[#^<X_=KQ:OPVSVDS3(\KE70D<9HM.@
MLJ-%&R[ %6, L:28="Q!M*[DWHNP<95O,YQLLW_;"J6+-CP/=_!RKO2F-&J^
MBO8OKEQRB7O-('!3IP'*!,'J#(R6$X.IG1E;WR?M0=:XET=GPUEK@72!LKJ4
M1SOGR3H?OG#O)Z]X(A8*6YM96=I90F1P+@=(C"E,UL5D6MND)Q$\KM]U5@UX
M&2$>;T@.BW ]MB%Y-WOE]NU7\SDN?^'=),3)]=+Z7_]*'J9D@-/&IC/DMS"?
MG%"R.P*1%S1 S\'62QBG:(QBW",(SQ$45Q9",AJD"4P&KKT-K0<47-XXW?+$
MJXC2T;:VI%PLG5+>>G *$7*,1I=@11*MDYSW)JYC(_40O.QGI)XJG+'+NC;D
M?RBUR.CU^K("\UMB[+MA^K46$'P9/G\;9HOZY96/JC9+C?6 R62$)P'>&UH@
M<FVT5BP^[M"QO<3KP.=V;) >@ZFSL[Z#"]1W0YC./X:?]=IYVRYQ6GKON01.
M?X.2*"!$)4"H%',AMJ%O':S\!4D=VY:G**Z6@GC9UY!ML\A;/?F"=MZE<\EW
M8EIFQB7S'A@SD7"7#3B6-8B 3@C29IJU+@0]I_'VR')^M=5R_G!G.=,/O!^F
MLP>&]"I&)XR5WO ".<<$RG(#,:;*IQB#L=$6WWIP23/B.S;^#L';L]TG+RK<
M$4_Q^6QQ]:G.WUCFQ23A-?%+@67,UN.GECYE.HBTU3$JY[39ZY:2/O4>&NF[
M.R0^>& G*+JLL(=3.=\#7#;]-6O'#)8=\*#KB&UO(+@DZRVJ<3HQLC+V<LSW
M <R8>4$G".NQN(_@W,@"_W,RG7R_^;YI-""*"JI.5<]DIZJ A'65$+!H5V(H
M2N!>@<)?B/S!0T<6^C$B&UKP;VS!A[_O$ZZ$SM;3RCWQ@%!>E1QZB(;H]E(@
M"WLY<K\2_/V'CG,?T$SP1_.O [_^F:8 2P7(.2N()@/SJ8!*/(#+C$&609>@
MHF6R=4^I'>1T<FDTBA716EK] F^=?RN\3Y(G!4HY4I]U18$I!)MM0<L\+:]U
M+X2=!(UKPC83^WYP.D(&'0#J]3!??"B?PW7=CZON6CH9G:(@61=-"MTI\-EX
MH->PII>4:)J'51X3T25PCA'PX_C)2=SN "XM%/J[VUQ4GES4O-Y&E)K=+[6J
M]0(2DK7,%&8<V\]<OO ES[L^$N#[.%S'0\3(8<,_P^)F-EG\_(BSR9!I5V^"
M5'<)55=>.QN=S[5\)9*NH!/&&XU@N W*%13!/^IQL352N,>C7OYMT9$@&,XG
MD0[T[9*??WS_B_A;R7_]+<R^XOS**J<P!@E:U-1Y;B*$$%@]B)@PR4:E6^?F
M;J?DY;L7I\&NH9Q>=EAQV:.+B![*[6^MA9)2'9V!N0RS,%^:/I?)0#N&H@N&
M(4]FV$5RRTIP*F !;@NY21H=.%<"?95Y"LY+(?P+"$\NNX"N^3W_\)CA;VZJ
M,OCR#5?GQA47N4BE+6W:D,G*C^0;UN'9(;DZQ2@[D>0>A_;>#^SDZ#Y5_@]:
MKIZ%V1V<QYN%/5G7[:Y].\Q>K7;M:F;0&Z3S9O@ZG?PWYBN-*F>4= "@L*!"
M<?15\>"BRC)8DZ5I?3=X&L6=G.^ML#F"&/L[UFNFW0EM(V]_^>3FC]O):-;"
MD3[^:3\\TBD2N?#@%9>@F*V)7EY EBHY@S+[YCMP.R6GMQJ(BSLS8^/'ZY@,
M[09DEH'*Y.;X1-\R+;U0/.FT7\3YP,4](F/LZNB3Y?ZTYO\T5G=P;CU<PJK/
M2^ :N:.C-G /RK("7L@ TBMK?,S(F\>IGE(Q/E9.$NQ.H!S,Y>YP\CY\WS1+
MLPJ#2MG2.DJL=?JA'GX";)#%)WI/NM:>P'.T](29PV6\$S)',GSDF]#WPP+G
MRGCYY@;?8IS=A-E/+DF>;AWDR$P;QE,$*Z,#54(=4.TR<,<B+UCWE?B%W;'/
M<WH"QK&2',[$UAX@(K6N:_F,?RV6"U@NQJ\7PU3,200/HM#^43['VI0G@796
M:.5BH)?VQ<BN!XW=$_ <(&G&V)%SJC;M_Y=:M4B-O@[M85D;4"H+B,YIT"7)
MX(.5INS5PO07*57WG]D3-HZW1D[BY(@(2&N:KUY=7Z_IKTV,5OO#)XZN2 X\
M>=)UMFBRWY, YK5F1>MHQ"[79H[I?W\=?OR?S3-6B-A\=X>(732,EVAYO#2'
MQJSM 1Z___/3%7JK=8X"-%/DSNE@P3M>>1*20J&U=KOR+0^& SUS'/&WD]QC
M*!S*QAY$_\_/;ZYT%,9RF^D\X[7'<DA$<R;3)W*B64LC\ZXDMX-%3\\<YUPX
MG^@/96-WCNF[VZ"ML+IHE0QPKVD9V9(%95V]YD$6DV2%V_/>8KSK(QGHO%<9
MQ_&[.]B\#0E7U_E7QJ1D17*@3:93U,8",5B"/[%,6L$"&<9GQ<T=+3VYK4<*
M>B=XCN1Z=^AYT/._)H?FCSA+559?\4I:KWE$#ME+"PK)*@N9]EJ1/B=)+I9M
M/G!A?^IZ\FO.@;!FDCE_L&[]1OTKACG^W__U_P%02P,$%     @ :82D5OW+
MJ=@$ P  Y0P  !    !E>#(R,#,S,3(P,C,N:'1MW5=M3]LP$/Z^7W$K&FQ2
M\^(DE)*62D!A8P*&H!/:I\F)KZU%8E>V0^A^_9RD%46#B2%-6\F'R.?<G9_G
M_%@Y]]\.OQR.OET<P=3D&5Q\/3@].826XWG7X:'G#4=#^#0Z.X7(]0F,%!6:
M&RX%S3SOZ+P%K:DQL]CSRK)TR]"5:N*-+KTJ5>1E4FITF6&M0;^:L6^D;/"F
M_]9Q8"C3(D=A(%5(#3(H-!<3N&:H;\!Q%EZ'<C97?#(U$/A!"-=2W?!;VGPW
MW&0X6.;I>XW=]^I%^HED\T&?\5O@;*_%_9"0W7 7NR0*HF[2[9(@HHR1W7'H
MAZ&_\YU8D)YU;V*TF6>XU\JY<*98K1_O!#/3*SDSTYCX_KO60S^J)M8UD<;(
M//9=OSLSUF,LA;%(E,W<#)L%?EWF0;B-[1F\,P[-^$3$-?U%LF5 *C.IX@V_
M?GK5%V=,<Y[-XZT1SU'#.99P*7,JMMK:;IFC4?%QXZCY#XQ)Q:8VRP4]FR?C
M I=T2;!M.1[=37G";?&#APR>BSVU&X/JGX!O8#!,I:*58.-",%255VMP522:
M,T[5'$ZT+E!ID&/X6% K;X-6BU>8%LKJ'/7S>?]UEM&C6[1?8S^C*IUN;I".
MWPM)NSXL;3C U$C1AB%/;[C04@ 5S!ZI?$;%'-YO;G2#P.\=#.L!Z7T KL%,
M$29-(:2J,E<3&@6W5B%T51=;'X43KNW.VJ&0QI+)*I-!@IDL;1I;4VO,%PA6
M !P52L(Q%U2D"%?NYD801#U0;N:NX%DZ+'&Y8.=D*70;&%<V938'"X>+I=6&
MZDA6:.^#W5>EV#\IY']-_'$1^VXG#-[!>:TE5B!\+@1"U AY#?D0-_"[3_#I
MK"$?WPW#:)7/?C$IM $2UI2Z:T@I=+>WPU5*5S@SF">HEJQVUY"5%1YYP.H8
M$U54/SH25*3"=50?L>KK/*F^B#R34M.6]1:31L[BSF](/M*WO<;,+TNUVA//
M9',CB!5F]K]UBT]VR<N5[T-HHF56F*=#7M)8+][-!:"^B@Q^ E!+ P04
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MP$PV$8;\45 -R)=3<LMSI2U1&?FH=$J"=N,/HF+R@4=6@9FN1'0G,@/%-&-
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M+3(P,C,P,S,Q+FAT;5!+ 0(4 Q0    ( &F$I%;!:,QBFP\  "Z;   0
M          "  80E @!B9'@M,C R,S S,S$N>'-D4$L! A0#%     @ :82D
M5L0%@U%N'@  \R,! !0              ( !334" &)D>"TR,#(S,#,S,5]C
M86PN>&UL4$L! A0#%     @ :82D5KU&/>&L10  ?>0" !0
M ( ![5," &)D>"TR,#(S,#,S,5]D968N>&UL4$L! A0#%     @ :82D5I5Z
M#ZR-N0  "YT' !0              ( !RYD" &)D>"TR,#(S,#,S,5]L86(N
M>&UL4$L! A0#%     @ :82D5FRWMH)!;@  !,4$ !0              ( !
MBE,# &)D>"TR,#(S,#,S,5]P<F4N>&UL4$L! A0#%     @ :82D5OW+J=@$
M P  Y0P  !               ( !_<$# &5X,C(P,S,Q,C R,RYH=&U02P$"
M% ,4    " !IA*16$K=-\\T(  "@2@  $               @ $OQ0, 97@S
M,3 S,S$R,#(S+FAT;5!+ 0(4 Q0    ( &F$I%8I75&$ZP0  .<?   0
M          "  2K. P!E>#,R,#,S,3(P,C,N:'1M4$L%!@     )  D /@(
' $/3 P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
